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Immunology and immunotherapy
P1315 Kinetics of the release of nitric oxide and tumour
necrosis factor-alpha after activation of microglia via Toll-like
receptors-2, -4, and -9
S. Ebert, J. Gerber, S. Bader, F. Mu¨hlhauser, T. Mitchell, R. Nau
Goettingen, D; Glasgow
Objectives: Microglial cells, the major constituents of innate immu-
nity within the brain, express Toll-like receptors (TLRs) recognis-
ing exogenous and endogenous ligands. The present study aimed
at quantifying the activation of microglial cells in response to
stimulation with one or two simultaneously administered speciﬁc
agonists of TLR-2, -4, and -9 at concentrations causing sub-
maximum and maximum effects.
Methods: Primary mouse microglial cell cultures were stimulated
with the TLR agonists Pam3Cys and heat-killed Acholeplasma
laidlawii (TLR-2), endotoxin and pneumolysin (TLR-4) and oligo-
nucleotides containing unmethylated cytosin-guanosin motifs
(CpG) (TLR-9). Nitric oxide (NO) release was quantiﬁed using the
Griess reaction. TNF-a release was measured using the Quantikine
M Mouse TNF-a Immunoassay (R&D Systems GmbH). Cell viabi-
lity of microglial cells was determined using the WST-1-Cell
Proliferation Reagent (Roche Applied Science).
Results: Maximum stimulation of TLR-2, -4, and -9 resulted in
approximately equal amounts of NO release. LPS was most potent
in stimulating microglia (concentration causing the half-maximum
effect [EC50]-NO: 0.00037 lg/mL; EC50-TNF-a: 0.024 lg/mL), fol-
lowed by pneumolysin (0.024 lg/mL; 0.136 lg/mL), CpG
(0.119 lg/mL; 0.685 lg/mL) and Pam3Cys (52.3 lg/mL) (EC50-
values represent means of six experiments with at least triplicate
measurement, respectively). Pneumolysin was a potent activator
of microglial cells at concentrations below 3 lg/mL; at higher
concentrations it reduced cell viability. No cytotoxicity was noted
with the other TLR agonists. Co-stimulation with maximum con-
centrations of two TLR agonists did not further increase NO
release. Co-stimulation with sub-maximum concentrations had an
additive effect.
Conclusions: Stimulation of microglial cells via different TLRs
resulted in a relative uniform release of NO and TNF-a. Simulta-
neous stimulation with low concentrations of two agonists led to
an additive effect. Not only microbial products, but also endog-
enous compounds can act as agonists in the TLR system. The
additive effect of stimulating more than one TLR does not only
increase the sensitivity of microglia during infections, yet may
also entail interactions among exogenous and endogenous agon-
ists of TLRs. This may be one reason for the exacerbation or
induction of autoimmune diseases by infections.
P1316 Drug modulation of Toll-like receptors expression
by human macrophages stimulated with lipopolysaccharide and
bacteria
O. Beran, D. Lawrence
Albany, USA
Objectives: Human Toll-like receptors (TRL) TLR2 and TLR4 rec-
ognise the speciﬁc patterns of a variety of bacterial cell-wall com-
ponents and transduce signals in cells during an early phase of
the innate immune response. Glucocorticoids (GC) are potent im-
munomodulatory drugs. Although GC can supress many func-
tions of macrophages (Mph), a role of GC in enhancing host-
immune responses, particularly through an effect on TLR expres-
sion in Mph, remains unknown. The aim of the study was to
evaluate the effect of dexamethasone (DXM) on TLR2 and TLR4
expression and cytokine production by Mph upon stimulation
with LPS or Salmonella typhimurium (STM). We also determined
modulation of these parameters by ceftriaxone (CFX), a cefalospo-
rin antibiotic used in the treatment of bacterial infections.
Methods: PBMCs were isolated from human buffycoats by Hist-
opaque (Sigma,USA) density gradient centrifugation. Monocytes
were isolated by adherence to plastic (3 h, 37C). Adherent mono-
cytes were stimulated with LPS (100 ng/mL) or STM (300 CFU/
mL) for 24 and 48 h. DXM and/or CFX (Sigma, USA) were used
at concentrations 1 lM a 5 lg/mL, respectively. CFX was added
into some wells after 24 h. The supernatants were collected and
frozen at 70C for quantiﬁcation of IL-6, IL-10 and IL-12 by
ELISA (Pharmingen, USA). Mph were harvested and stained for
ﬂow-cytometric analysis using mAb against CD14 (Becton-Dickin-
son, USA), TLR2 and TLR4 (eBioscience, USA).
Results: TLR2 expression by Mph was enhanced by LPS or
STM  DXM. Unlike TLR2, DXM inhibited IL-6, IL-10, and IL-12
by LPS-stimulated Mph. However, DXM increased IL-10 produc-
tion by STM-stimulated Mph. Interestingly, Mph stimulated by
LPS or STM and treated with CFX showed lower expression of
TLR2 compared with those without CFX. This was associated
with a decrease in IL-6 and IL-10. We did not observed any effect
of LPS or STM on TLR4 expression by Mph.
Conclusion: Our results demonstrate the ability of GC to increase
the expression of TLR2 on human Mph. This indicates a possible
immunostimulatory effect of GC. However, involvement of TLR2
induction by GC in subsequent innate and speciﬁc immune
responses requires further study. Decreased TLR2 expression
associated with lower production of IL-6 and IL-10 in Mph treated
by CFX indicates a role of TLR2 in the immunomodulatory effect
of this antibiotic.
Acknowledgement: The study was partly supported by the grants
TW00915 and TW00233 NIH Fogarty International Centre.
P1317 Exopolysaccharides from marine thermophilic
bacilli induce a Th1 cytokine proﬁle in human PBMC
A. Arena, B. Pavone, C. Gugliandolo, T.L. Maugeri, G. Bisignano
Messina, I
Objectives: The exopolysaccharides (EPS) produced by a strain of
Geobacillus thermodenitriﬁcans and a strain of Bacillus lichenifor-
mis were used to evaluate their immunoregulatory and antiviral
effects. The two strains were isolated from a shallow marine hot
spring of Vulcano Island (Italy). In view of the important regula-
tory role in antiviral defence played by cytokines modulator fac-
tors, we analysed both the effects of EPS of two marine bacteria
on cytokine production and the antiviral activity on peripheral
blood mononuclear cells (PBMC).
Methods: PBMC were obtained from healthy donors, after centrif-
ugation of heparinised venous blood over a Ficoll-Hipaque gradi-
ent. Supernatants were harvested and analysed for the presence
of IFNc, IFNa, TNFa, IL-12, IL-18, IL-4. In order to establish if the
EPS antiviral activity was related either to the marked production
of Th1 cytokines or to a direct interaction with virus replication,
we used WISH cell line. To evaluate the effects of the on HSV-2
replication in PBMC and WISH cell line, the amounts of virus
production were titrated and expressed as PFU/mL.
Results: The EPS trigger mononuclear phagocytes in releasing cy-
tokines involved in Th1 proﬁle, such as IL-12, IFNc, IFNa, TNFa,
IL-18, whereas did not induce the production of Th2 cytokine (IL-
4). Furthermore, treatment of HSV-2 infected PBMC with EPS
down-regulated virus replication. This effect on HSV-2 replication
seems to be related to the pattern of cytokines induced in PBMC
by EPS. The addition of EPS to WISH cells, infected with HSV-2,
did not show any antiviral effect.
Conclusion: We have shown that the two EPS are powerful stimu-
lators of Th1 cell-mediated immunity. They are immunomodulato-
ry agents which could be potentially used as a therapy in the
immunocompromised host.
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P1318 Differential induction of IL-8 expression by LPS
and LTA
R. Munke, L. Hareng, S. Aulock von, T. Hartung
Constance, D
Objectives: Lipopolysaccharide (LPS) from Gram-negative bacteria
and lipoteichoic acid (LTA) from Gram-positive bacteria are key
inﬂammatory principles which differ regarding the cytokine pat-
tern they induce: LTA is a stronger inducer of chemokines, i.e. IL-
8 and G-CSF, than LPS, which is a stronger inducer of pro-inﬂam-
matory cytokines, such as TNFa. We have shown previously for
LPS stimulation that IL-8 and G-CSF production is increased by
db-cAMP, while TNFa production is decreased, and described a
novel activating CRE in the G-CSF promotor. Thus we now inves-
tigated whether the IL-8 promotor also has an activating CRE ele-
ment, which might explain the parallel strong induction of IL-8
and G-CSF by LTA.
Methods: HL-60 cells were transfected with mutated or wild-type
promotor constructs with a luciferase reporter. b-galactosamine
was co-transfected and values were normalized to its activity.
mRNA expression in whole blood was measured by real-time
PCR. Protein release in whole blood supernatants was quantiﬁed
by ELISA.
Results: Screening of the IL-8 promoter identiﬁed a putative CRE
(TTTCgTCA). We transfected HL60 cells with a minimal IL-8 pro-
moter containing different disrupted transcription factor binding
sites, namely NFkB, AP-1 and the putative CRE with a luciferase
reporter. However, LPS and LTA induced the same signal height
both in cells with normal and mutated CRE, indicating this is a
nonfunctional element, while NFkB and AP-1 were conﬁrmed as
essential elements. Moreover, cAMP elevation in human whole
blood led to an increase in LPS-induced IL-8 release but a
decrease in LTA-induced IL-8 release. This indicated that the
strong LTA-induced IL-8 release was dependent on a different
parameter, so we characterised this induction more closely. IL-8
mRNA expression peaked at 4 h in LPS-stimulated whole blood
but continued to rise until 24 h in LTA-stimulated blood. In line,
IL-8 protein levels induced by LTA became signiﬁcantly higher
than those induced by LPS only at time points after 8 h following
stimulation and peaked at 28 h (stimuli 10 lg/mL: LPS,
64  17 ng/mL IL-8 vs. LTA, 205  47 ng/mL IL-8, P < 0.01,
n ¼ 16). This divergence was retained in plasma-free blood but
was not observed in PBMC. However, addition of erythrocytes to
PBMC reconstituted this effect.
Conclusion: The strong induction of IL-8 by LTA in whole blood
appears to depend on an ampliﬁcation or presentation factor sup-
plied by erythrocytes and not on increased cAMP levels.
P1319 Mannose-binding lectin (MBL) and susceptibility to
infection in preterm neonates
A.B. Dzwonek
London, UK
Rationale: Premature infants are particularly susceptible to infec-
tions. It is estimated that up to 50% of neonates born at
<32 weeks gestation may suffer from clinical sepsis. The reasons
for this are complex but immaturity of the immune system with
sub-optimal levels of circulating immunoglobulins is at least
partly responsible for high mortality and morbidity associated
with infection. Another protein, mannose-binding lectin (MBL)
has also been shown to be low in premature infants and may be
important in defending premature infants from infection. Genetic
polymorphisms resulting in deﬁciencies of MBL have been shown
to increase susceptibility to infection especially in children. The
aim of the current study is decide the role of MBL in determining
the susceptibility and outcome of premature neonates to severe
sepsis.
Methods: A total of 50 premature neonates have been recruited to
the study. Serum levels of MBL were measured by enzyme immu-
noassay and polymorphisms at codons 52, 54 and 57 within exon 1
(A, wild type, 0, variant) and a promoter polymorphisms (X/Y)
of the MBL gene were determined by PCR and heteroduplex
analysis.
Results: Birth weight and gestational age were both found to inﬂu-
ence MBL levels. Neonates born at <30 weeks gestation and
<1500 g were signiﬁcantly lower than neonates of >30 weeks and
>1500 g. This difference persisted (P < 0.0005). 40% of preterm
neonates had exon 1 mutations (A/0 or 0/0). 50% of these neo-
nates were diagnosed with sepsis and/or multiple organ system
failure. In comparison, only 26% of neonates with wild-type
alleles (A/A) were diagnosed with sepsis. When MBL levels were
analysed in all 50 neonates, levels of MBL were signiﬁcantly less
in those with sepsis when compared with those without sepsis
(mean 1 492 ng/mL (SD 1 451 ng/mL) vs. 2 342 ng/mL (SD 2
070 ng/mL), P ¼ 0.037).
Conclusion: In this preliminary study, MBL deﬁciency appears to
be associated with increased susceptibility to severe sepsis in
premature neonates. Further studies are required to elucidate
the true impact of this ﬁnding on neonatal susceptibility to
infection.
P1320 Immunotherapy with RUTI, a new useful vaccine
for treatment of Mycobacterium tuberculosis infection
P.J. Cardona, I. Amat, S. Gordillo, V. Arcos, E. Guirado, J. Dı´az,
G. Ferna´ndez-Rivas, G. Tapia, V. Ausina
Badalona, E
Objectives: To study the usefulness of RUTI in the treatment of
M. tuberculosis infection in a experimental murine model. RUTI is
a vaccine (patent pending) composed by M. tuberculosis fragmen-
ted cell wall, detoxiﬁed (MtbFCW) and liposomed.
Methods: Female mice DBA/2 and C57BL/6, 6 weeks old, were
infected by aerosol using a Middlebrook device. On week nine
postinfection treatments were started: (I) Control, inoculated with
50 mL of empty liposomes on weeks 9, 11 and 15 postinfection,
s.c; (II) chemotherapy from week 9–17; (III) chemotherapy plus
RUTI on weeks 17, 19 and 21 i.n. and (IV) chemotherapy plus
RUTI on weeks 17, 19 and 21 s.c. Chemotherapy with 25 mg/kg
isoniazid the ﬁrst 4 weeks and rifampicin 10 mg/kg the follow-
ing last 4 weeks was administered orally through gavage
5 days/week. 50 uL of RUTI containing 185 lg of MtbFCW were
injected in every inoculation. On week 22 postinfection, we
determined colony forming units (CFUs) in lungs and spleens;
quantiﬁed cytokine mRNA in lungs using by Real-Time PCR
and levels of antibodies against MtbFCW antigens through west-
ern blot. Finally we determined the area occupied by granulo-
mas with digital microphotography and processed with
appropriate software.
Results: A signiﬁcant and synergistic reduction of CFUs was
revealed in groups III and IV in DBA/2 mice compared with
group II. No differences were detected in C57BL/6 mice as
treatment with only chemotherapy revealed a high efﬁciency.
Relative increase of IFN-c was detected in both mouse strains
treated with RUTI, specially in i.n. Inoculated groups. levels of
TNF were kept low. After i.n. C57BL/6 mice elicited a strong
IgG2b response against a broad spectrum of cell wall antigens.
DBA/2 increased the IgG2a and IgG2b ones. After s.c. inocula-
tion, C57BL/6 enhanced also the IgG1 and IgG3 levels, while
DBA/2 increased just the IgG1. High IgA levels were detected
in the BAL of DBA/2 mice after i.n. and s.c. immunisations. In
C57BL/6 only after i.n. Histometrical analysis did not reveal
any signiﬁcant increase regarding on the area occupied by gra-
nulomas in RUTI-treated mice, but in intranasal inoculated
C57BL/6 mice.
Conclusions: The use of RUTI as a coadjuvant of chemotherapy
has demonstrated its usefulness in DBA/2 mice with a combined
Th1/Th2 response against M. tuberculosis infection without provo-
king an increase of pulmonary parenchymal lesions.
Research support: Fondo de Investigaciones Sanitarias. Grant no
01/0341.
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P1321 Coadministration of intranasal RUTI with
chemotherapy improves the treatment of Mycobacterium
tuberculosis infection
P.J. Cardona, I. Amat, S. Gordillo, V. Arcos, E. Guirado, J. Dı´az,
A. Pallare´s, G. Tapia, V. Ausina
Badalona, E
Objectives: To improve the use of RUTI as a coadjuvant of che-
motherapy in the treatment of M. tuberculosis infection in the
mouse strains that triggers the strongest resistance against this
infection.
Methods: Female mice BALB/c and C57BL/6, 6 weeks old, were
infected using a Middlebrook device, allowing the inoculation of
10 to 20 bacilli in the lungs. On week nine postinfection we
deﬁned four different groups according intranasally inoculation of
RUTI. BALB/c mice treated with chemotherapy from week 9–15
postinfection, and inoculated on week 13 with 50 lL of empty
liposomes (group I) or RUTI (group II). C57BL/6 mice were trea-
ted with chemotherapy from week 9 to 17 postinfection, and
inoculated on weeks 13, 15 and 17 with three doses of empty lipo-
somes (group III) or RUTI (group IV). Chemotherapy was done
orally through gavage 5 days a week with 25 mg/kg isoniazid.
50 lL of RUTI containing 185 lg of M. tuberculosis fragmented cell
wall (MtbFCW) were injected in every inoculation. We deter-
mined colony forming units (CFUs) in lungs and spleens on week
15 (groups I–II) and 15 and 28 postinfection (groups III–IV).
Expression of cytokine was quantiﬁed in lungs using Real-Time
PCR. We also determined the ratio between the area occupied by
granulomas and the total area analysing four consecutive 5 lm
thick sections of two lobes from the right lung of each mouse
stained with haematoxilin–eosin and photographed at 10x in a
Nikon stereoscopic microscope. Images were processed with
appropriate software.
Results: A signiﬁcant and synergistic reduction of CFUs was
revealed in groups II and IV in both mice strains. No signiﬁcant
differences on IFN-c and TNF expression were found in both
groups of BALB/c mice. Besides, these cytokines were signiﬁ-
cantly low in RUTI treated C57BL/6 mice on week 15 and 28,
reﬂecting a decrease on inﬂammatory response. Histometrical ana-
lysis did not reveal any signiﬁcant difference in both mice strains
on week 15.However, control mice doubled the area when com-
pared with RUTI treated group on week 28.
Conclusions: The use of RUTI as coadministrated with chemother-
apy inoculated intranasally has demonstrated its beneﬁt in chemo-
therapy treatment even in those mice strains able to trigger the
strongest immunological response against M. tuberculosis infection.
Research support: Fondo de Investigaciones Sanitarias. Grant no.
01/0341.
P1322 Early prognostic markers of outcome in severe
sepsis
A. Lekkou, M. Karakantza, A. Mouzaki, D. Siagris,
F. Kalfarentzos, H.P. Bassaris, C.A. Gogos
Patras, GR
Objective: Since mortality in severe sepsis remains high, the aim
of this study was to estimate the prognostic value of certain early
immunological markers for the clinical outcome.
Methods: Thirty patients (15 male, 15 female, mean age
68.5  9.7 years) with severe sepsis (sepsis plus at least one organ
dysfunction) were studied. The aetiology of sepsis was: pneu-
monia (n ¼ 11), pyelonephritis (n ¼ 5), intra-abdominal infection
(n ¼ 9), skin or joint infection (n ¼ 5). The control group included
14 healthy subjects (seven male, seven female, mean age
67.9  8.6 years). The percentage of monocytes expressing human
leucocyte antigen-DR (CD14-HLADR) was determined by ﬂow
cytometry on admission, days (d) 3, 10, 13 and on discharge.
Serum cytokine levels were determined by using ELISA (Quanti-
kine, R & D Systems, Minneapolis) on the same days. Stepwise
multiple regression and logistic regression analysis were used for
statistical analysis.
Results: Seventeen patients died 1–14 days after admission. A sig-
niﬁcant contribution to positive outcome was detected for CD14-
HLADR on admission [odds ratio (OR), 1.04; 95% conﬁdence
intervals (CI), 1.00–1.09, P ¼ 0.03], while serum interleukin-10 (IL-
10) levels on day 3 (OR, 0.92; 95% CI, 0.86–0.99, P ¼ 0.03) and IL-
10 on day 10 (OR, 0.80; 95% CI, 0.65–0.98, P ¼ 0.04) were found
to be predictors of poor outcome. The strongest effect on IL-10
levels on day 10 was attributed to CD14-HLADR on day 3
(r2 ¼ 0.4; P ¼ 0.008) without further contribution of other cytok-
ines (tumour necrosis factor-a, IL-4, IL-6, IL-8, transforming
growth factor-b).
Conclusions: (i) Immunosupression associated with low levels of
monocyte HLA-DR expression precedes immunosupression corre-
lated with high levels of IL-10. (ii) Monocyte HLA-DR expression
is an early prognostic marker of outcome in severe sepsis and a
diagnostic tool for identifying high risk patients.
P1323 Evaluation of cardiac troponin I in elderly patients
with sepsis
N. Komitopoulos, N. Lionakis, A. Giakoumaki, I. Ioannidis,
P. Paraskeuopoulou, D. Avramidis, A. Komitopoulou, E. Varsamis
Athens, GR
Sepsis is a common cause of organ dysfunction and ﬁnally
multiple organ failure. Cardiac dysfunction in septic patients is
due to myocardial ischaemia and endothelial-leucocyte interac-
tions that result to microcirculatory tissue damage. Measure-
ment of cardiac troponin I (TnI) provides a sensitive and
speciﬁc indicator of cardiac injury over a wide diagnostic win-
dow. Aim of this study was to investigate if serum troponin I
correlates with severity of sepsis in elderly patients and to
evaluate whether TnI might be a prognostic marker in these
patients
Subjects and methods: A total of 46 patients with sepsis of var-
ious origin, 26 females and 20 males, aged 76  11 years old,
were included in this study. Blood samples were collected and
TnI levels was measured within 6 h after hospital admission.
Patients with possible myocardial infarction or unstable angina
were excluded from this study. Serum TnI was determined by
colorimetric immunoassay in DADE-BEHRING biochemical ana-
lyser.
Results: A total of 24 patients had TnI values >0.2 ng/mL and
22 had levels <0.2 ng/mL. The CPK–MB values were not ele-
vated and ECG did not differ between groups. In patients with
higher TnI levels APACHE II score and DIC score (criteria of
International Society on Thrombosis and Haemostasis ), were
calculated and they were found higher in comparison with
those of patients with low TnI (24.2  7.8 vs. 19.4  5.3,
P ¼ 0.025 and 3.45  0.3 vs. 2.26  0.3, P ¼ 0.009, respectively
Student’s t-test). A positive correlation between TnI and APA-
CHE II score as well TnI and D-Dimers values were also
observed (P ¼ 0.0037 and P ¼ 0.015, respectively, stepwise
regression analysis)
Conclusion: Serum troponin I may be of value in the recognition
of clinically unrecognised myocardial injury in septic elderly
patients and a cut-off prognostic value could be determined and
used as a means for risk stratiﬁcation of these patients.
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Host defenses
P1324 Inﬂuenza and Sendai viruses induce a differential
IFN, chemokine and IKKe gene expression in A549 lung
epithelial cells
S. Matikainen, V. Veckman, J. Pirhonen, P. O¨sterlund, J. Siren,
J. Hiscott, G. Uze, M. Severa, I. Julkunen
Helsinki, FIN; Montreal, CAN; Montpellier, F
Lung epithelial cells are the primary targets for respiratory vir-
uses such as inﬂuenza A, inﬂuenza B and parainﬂuenza viruses.
To study the ability of these viruses to induce host cytokine and
chemokine gene expression we infected human lung epithelial
A549 cells with inﬂuenza A (H1N1 and H3N2 strains), inﬂuenza
B and Sendai viruses, isolated total cellular RNA and analysed
host cell cytokine and chemokine mRNA expression by Northern
blotting and RT-PCR. Inﬂuenza A and inﬂuenza B virus infection
lead to a relative weak induction of interferon (IFN-a/b) and IFN-
like genes, IL-28 (IFN-k2/3) and IL-29 (IFN-k1). The expression of
IRF-3 and IRF-7 activating kinase, IKKe was also weakly induced
by inﬂuenza viruses. In similar experimental conditions Sendai
virus infection activated the expression of IFN-a, IFN-b, IL-28, IL-
29 and IKKe genes very well. Similarly, while Sendai virus readily
induced TNF-a, CCL2 (MCP-1), CCL5 (RANTES), CXCL8 (IL-8)
and CXCL10 (IP-10) gene expression, inﬂuenza A and inﬂuenza B
virus-induced expression of these genes was either lacking (TNF-
a) or occurred at a relatively low level. Pretreatment of A549 cells
with IFN-a lead to a dramatic increase in inﬂuenza A virus-
induced IFN, IL-28, IL-29 and chemokine gene expression. This
induction correlated with enhanced expression of virus-activated
signalling molecules, TLR-3, IKKe and IRF-7. The results indicate
that in human lung epithelial cells inﬂuenza A and B viruses are
relative poor inducers of type I IFN, IL-28, IL-29 and chemokine
genes, but their ability to induce these genes can be fully restored
by pretreatment of cells with type I IFNs.
P1325 Monoclonal antibodies against recombinant spike
protein neutralise the infection of severe acute respiratory
syndrome coronavirus (SARS-CoV) through inhibition of virus
binding to vero E6 cells
Y.C. Wang, S.C. Lai, C.T. Yeh, J.T. Jan, H.W. Liu
Taipei, TW
Objectives: To generate monoclonal antibodies against spike pro-
tein that can neutralise the infection of severe acute respiratory
syndrome coronavirus (SARS-CoV) SARS-CoV infection.
Methods: In this study, the coding sequence (amino acid 268–1255)
of spike glycoprotein of SARS-CoV was cloned into prokaryotic
expression vector, pET101/D-TOPO, and recombinant protein
(rS268) was puriﬁed to near homogeneity. After immunisation
with recombinant proteins, speciﬁc monoclonal antibodies were
obtained and conﬁrmed both by ELISA, Western blot and immu-
noﬂuorescent assay (IFA). The neutralization effect of monoclonal
antibodies against recombinant spike protein of SARS-CoV was
evaluated in Vero cells by Western blot.
Results: Results showed that some of these monoclonal antibodies
could effectively neutralise the infection of SARS-CoV in a dose-
dependent manner. Furthermore, binding inhibition assay revealed
that these neutralising monoclonal antibodies, but not SARS
patient’s serum, could inhibit SARS-CoV binding to Vero E6 cells.
Conclusion: To our knowledge, this was the ﬁrst report revealing
neutralising monoclonal antibodies, generated by immunising
mice with prokaryotic cell-expressed recombinant spike protein,
that inhibit infection of SARS-CoV in Vero E6 cells through inhib-
iting virus binding to cells. Result from this study should facilitate
description of the receptor-binding domain and target epitope of
the spike protein of SARS-CoV, and peptide-based subunit vac-
cine as well.
P1326 Interaction of respiratory tract pathogens and
epithelial cells
C. Kratzer, W. Graninger, A. Georgopoulos
Vienna, A
Objectives: Epithelial cells play an important role in the regulation
of local inﬂammatory and immune response in reply to bacterial
infection. In the present study we analysed the epithelial cell cyto-
kine release of interleukin-6 (IL-6), interleukin-8 (IL-8), and inter-
leukin-1a (IL-1a) after stimulation by different strains of
Streptococcus pyogenes and nontypeable Haemophilus inﬂuenzae
(NTHi).
Methods: All investigated strains were clinical isolates from
patients with community acquired respiratory tract infections in
2003. The human bronchial epithelial cell line NHBE was seeded
into 24-well tissue culture plates and was infected by group A
beta-haemolytic streptococci (GAS) and NTHi at a ratio of 100
bacterial cells to one bronchial cell. After different incubation
times within 24 h, the invasion medium was aspirated and cen-
trifugated. IL-6, IL-8 and especially IL-1a were quantiﬁed in the
cell culture supernatant of infected NHBE by enzyme-linked im-
munosorbent assay (ELISA).
Results: In response to infection by S. pyogenes, NHBE released ele-
vated levels of IL-6, IL-8, and especially IL-1a. Different cytokine
kinetics’ were detected after infection by clarithromycin-susceptible
and resistant GAS. Apart from only one NTHi strain, isolated from
a patient with cystic ﬁbrosis, ampicillin-sensitive and b-lactamase-
positive nontypeable H. inﬂuenzae induced similiar cytokine kinetics
with high concentrations of IL-6, IL-8, and IL-1a.
Conclusion: After stimulation by both respiratory tract pathogens,
NHBE released increased cytokine levels of IL-6, IL-8, and IL-1a.
H. inﬂuenzae induced the epithelial cells to secrete high concentra-
tions of all tested cytokines, while S. pyogenes caused a high
release of only IL-1a. Additionally, we demonstrated a difference
in the time-dependent NHBE cytokine induction provoked by
clarithromycin-susceptible and resistant GAS.
P1327 Role of dendritic cells in the immune regulation of
primary Epstein-Barr virus infection
O.H. Wong, F.P. Huang, A.K.S. Chiang
Hong Kong, HK
Epstein-Barr virus (EBV) is a human gamma herpesvirus that
infects 95% of human populations and usually persists without
harm for the lifetime of the host. Yet, it is a highly transforming
virus as shown by its association with a number of malignancies
of which nasopharyngeal carcinoma and nasal lymphoma are pre-
valent in the Chinese. The virus-speciﬁc CD8+ cytotoxic T-cells
are important in effecting the intricate balance between the host
and the virus. It is not known, however, how the primary
immune response is regulated.
Objectives: As dendritic cells (DCs) are the most potent antigen
presenting cells, we investigate whether exposure to apoptotic or
necrotic EBV-transformed lymphoblastoid B cell lines (LCLs)
could mediate neonatal DCs maturation and subsequent T cell
priming.
Methods: To study primary EBV infection, samples of fetal cord
blood are collected, from which LCLs are established by infection
of cord blood mononuclear cells with B95-8 EBV producer cell
lines. Autologous monocyte-derived DCs and T cells are gener-
ated after positive selection by anti-CD14 and anti-CD3 immuno-
magnetic microbeads.
Results: We found that neonatal DCs phagocytosed both apoptotic
and necrotic LCLs efﬁciently after 5 h coculture. Phagocytosis of
both necrotic and apoptotic LCLs led to a lightly up-regulation of
CD40, HLA-DR, CD80 and CD86 when compared with LPS acti-
vation. T-cell proliferation and cytotoxicity assays are in progress
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to determine the capacity of neonatal DCs in activating the cord
blood derived naı¨ve T cells.
Conclusions: In conclusion we suggest that neonatal DCs are efﬁ-
cient in phagocytosing dying cells. The relative immaturities of
DCs phenotype may due to the compromised antigen presenta-
tion in neonatal DCs.
P1328 Role of endogenous tumour necrosis factor alpha
and beta on cytomegalovirus replication in human placental
cells
E. Paradowska, M. Studzinska, D. Nowakowska, J. Wilczynski,
Z.J. Lesnikowski
Lodz, PL
Objectives: The proinﬂammatory cytokine tumour necrosis factor
(TNF) has been identiﬁed as mediator of human cytomegalovirus
(HCMV) stimulation and reactivation in human progenitor cells.
We postulated that TNF may have an antiviral activity and play
an important role in limiting of HCMV replication in placental tis-
sues. The aims of our study were: to characterise the antiviral
activity of placental TNF in an organ culture (OC) and isolated
placental cells system, and to compare TNF production in normal
placentas and amniotic membranes (AM), and in placentas infec-
ted with HCMV in utero.
Methods: The studies were performed in organ cultures and isola-
ted placental cells (cytotrophoblasts, macrophages) obtained from
normal placentas infected with HCMV strain AD169 in vitro. The
neutralising antibodies to TNFa or/and b were used as a means
of blocking cytokine activities. Treatment of cells were started
immediately after HCMV infection of cultures or 24 h before
HCMV infection and continued for another 14 days.
Results: In villous culture infected with HCMV in utero, an increase
in TNF production was found compared with that in uninfected cell
cultures. Infection of decidual tissue with HCMV resulted in pro-
duction of massive amounts of TNF. Treatment of organ cultures
with anti-TNF-a or anti-TNF-b anibodies resulted in increase in
peak levels of HCMV release, intensely in cultures treated with
anti-TNF-a. In individual experiments, treatment with anti-TNF
antibody resulted in a 100-fold increase in virus levels. Increases of
10-fold to 100-fold of HCMV replication in the cytotrophoblasts and
macrophages treated with anti-TNF-a or/and anti-TNF-b were
observed. We found that the enhancement of HCMV replication by
TNF was present mainly in fetal part of organ.
Conclusion: Obtained results indicate the importance of the endog-
enous TNFs in placental immunity. This work was supported by
the State Committee for Scientiﬁc Research, grant no. 3 P05E 001 25.
P1329 Assessment of the correlation between anti-
inﬂammatory therapy and concentration of pro-inﬂammatory
cytokines in cerebrospinal ﬂuid (CSF) and its effect on the
outcome of bacterial meningitis (BM)
M. Bociaga-Jasik, A. Garlicki, A. Kalinowska-Nowak, T. Mach
Cracow, Warsaw, PL
Objectives: To determine the inﬂuence of antiinfalmmatory ther-
apy with dexamethasone (DX) and DX with pentoxiﬁlline (PX) on
concentration of TNF-a, IL-1b, IL-8 in CSF and the course of BM.
Methods: Forty-two patients, 13 (31%) female and 29 (69%) male
with BM were investigated. They were divided into three groups:
A – treated only with antibiotics, A + DX – treated with antibiot-
ics and DX, A + DX + PX – treated with antibiotics, DX and PX.
Cytokines concentration was measured in CSF by ELISA at the
day of admission (before initiation of therapy) and 72 h later.
Results: Antiinﬂammatory therapy did not have impact on the reso-
lution of inﬂammation (pleocytosis, protein, glucose level) in CSF.
However it was established that adjuvant therapy with DX and PX
has beneﬁcial effect on the course of BM. In this group 61.5% patients
recovered, in comparison with 28.6% in the group A + DX and
26.7% in the group A. Mortality rate was: in the group A – 33%,
A + DX – 21.4%, A + DX + PX – 7.7%. Correlation between outcome
of the BM in the investigated groups and cytokines concentrations in
CSF was observed. In the group A + DX + PX all patients respond to
the therapy with decrease of cytokines concentration, and coefﬁcients
of variation were low (TNF-a, 1%; IL-1b, 23.6%; IL-8, 18.9%). Also in
the group A + DX decrease of cytokines concentration in CSF was
observed, however not such signiﬁcant (coefﬁcients of variation were:
TNF-a, 28.7%; IL-1b, 31.4%; IL-8, 53.8%) In the group A concentra-
tion of cytokines in CSF varied and coefﬁcients of variation were high
(TNF-a, 91.4%; IL-1b, 33% and IL-8, 21.4%).
Conclusion: (i) Anti-inﬂammatory therapy with DX + PX inhibits the
release of cytokines in CNS and has beneﬁcial effect on the course of
BM. (ii) Anti-inﬂammatory therapy with DX alone also inhibits
cytokines production in CNS but its effect is not suchwell deﬁned.
P1330 Complement activation during meningococcal
disease: engagement of alternative and lectin pathway and
association with disease severity
T. Sprong, T.E. Mollnes, C. Neeleman, J.W.M. van der Meer,
M. van Deuren
Nijmegen, NL; Oslo, N
Objectives: Invasive infection with Neisseria meningitidis leading to
meningococcal meningitis or fulminant meningococcal sepsis
(FMS), is an important cause of childhood mortality and morbid-
ity. Activation of the complement cascade has been implicated in
the pathogenesis of FMS, but the initial pathways that activate
complement, the relation between complement activation and acti-
vation of the cytokine- and coagulatory- system, or disease sever-
ity still remains subject to investigation.
Methods: In the present study, 11 patients with meningococcal dis-
ease admitted to the paediatric intensive care unit (PICU) of the
UMC St Radboud were included, informed consent was obtained
from both parents. Complement activation products, coagulation
parameters and cytokines were measured at ﬁxed time intervals
after admission.
Results: C3bc and terminal complement complexes C5-9 (TCC), both
reﬂecting total complement activation, were signiﬁcantly increased
at admission. Unsurpassed by any other inﬂammatory parameter,
C3bc and TCC were highly correlated with disease severity (PRISM-
score): Spearman rank correlation with PRISM for TCC, R ¼ 0.95
(P < 0.001), for C3bc R ¼ 0.89 (P < 0.001). TCC was also signiﬁ-
cantly correlated with platelet and ﬁbrinogen consumption (R ¼
-0.93 for platelet count and R ¼ -0.71 for ﬁbrinogen) and ﬁbrinolytic
activity (R ¼ 0.93 for D-dimer). In addition, TCC at admission was
signiﬁcantly correlated with cytokine concentrations (R ¼ 0.88 for
IL-1b, R ¼ 0.64 for IL-10, R ¼ 0.61 for IL-12 and R ¼ 0.76 for IFN-c).
During the ﬁrst 8–24 h after admission TCC and C3bc slowly
declined. The early complement activation was caused by alternat-
ive a´nd lectin pathway engagement, but not by classical pathway
activation as shown by repeated measurements of C3bBbP (alternat-
ive), C4b (classical or lectin), and C1rs-C1inh-complexes (classical).
However, after 24 h C1rs-C1inh complexes slowly increased, reﬂect-
ing classical pathway activation from this time onwards.
Conclusions: Our data indicate that initial activation of the comple-
ment system during meningococcal infection is highly correlated
with disease severity. Complement activation occurs via the alter-
native and lectin pathway, whereas classical pathway engagement
develops only after 24 h.
P1331 The importance of cytokine and cortisol levels in
cerebrospinal ﬂuid as clinical and biological markers of
bacterial meningitis
M. Holub, O. Beran, J. Hnykova´, D. Lawrence, O. Dzupova´,
Z. Lacinova´
Prague, CZ; Albany, USA
Objectives: Despite the advent of modern antibiotical treatments,
bacterial meningitis (BM) continues to be associated with signiﬁ-
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cant morbidity and mortality. It was suggested that an exagger-
ated intrathecal immune response plays a pivotal role in disease
pathogesis. This response is characterised by an increased intra-
thecal production of proinﬂammatory cytokines – interleukin (IL)-
1b, IL-6, IL-8, IL-12 and tumour necrosis factor (TNF)-a. Produc-
tion of these cytokines is controlled by antiinﬂammatory media-
tors such as IL-10 and cortisol. The aim of this study was to
assess the clinical relevance of cytokine and cortisol levels in the
cerebrospinal ﬂuid (CSF) from patients with BM.
Methods: We examined 20 samples of CSF from BM patients
obtained by diagnostic lumbar puncture performed after admis-
sion. The samples were analysed with three colour ﬂow cytometry
using Cytokine Bead Array (BD Biosciences, San Jose´, USA). CSF
cortisol levels were measured by radioimmunoassay purchased
from the DSL (Webster, USA). Severity of the illness was deter-
mined using APACHE II and Sepsis Organ Failure Assessment
(SOFA) scores; level of unconsciousness was scored with Glasgow
Coma Scale (GCS).
Results: CSF levels of cortisol correlated positively with APACHE
II (r ¼ 0.596, P ¼ 0.041) and negatively with GCS (r ¼ 0.743,
P ¼ 0.01). CSF levels of IL-10 correlated negatively with GCS
(r ¼ 0.631, P ¼ 0.012). CSF levels of IL-12 correlated negatively
with SOFA (r ¼ 0.636, P ¼ 0.018). Moreover, the levels of IL-10
correlated positively with CSF protein concentration and number
of neutrophils (r ¼ 0.604, P ¼ 0.01; r ¼ 0.498, P ¼ 0.049) and with
IL-1b (r ¼ 0.50, P ¼ 0.033), IL-6 (r ¼ 0.693, P ¼ 0.01) and TNF-a
(r ¼ 0.611, P ¼ 0.01) in the CSF.
Conclusion: Our results indicate that severe course of BM is associ-
ated with a high concentration of antiinﬂammatory mediators in
the CSF. Furthermore, increased levels of IL-10 are closely connec-
ted with elevated concentrations of proinﬂammatory cytokines in
the CSF during BM. These ﬁndings allude to IL-10’s attempt to
suppress the intrathecal proinﬂammatory response. Thus, IL-10
and cortisol levels in the CSF could be used as markers of the
disease severity and progression.
Acknowledgement: This study has been supported by grants GA
UK 03/2003 and NIH-Fogarty 3D43TW00915.
P1332 Two-year follow-up analysis of the
class-speciﬁc immune response after infection with
Yersinia pseudotuberculosis followed by erythema nodosum
and reactive arthritis – case report
W. Rastawicki, M. Jagielski, R. Gierczyn˜ski, J. Buratowska
Warsaw, PL
Objectives: Yersinia enterocolitica and Y. pseudotuberculosis are
important causative agents of enteric infections in humans. Postin-
fectious complications, such as reactive arthritis and erythema
nodosum, may also follow the infection. Isolation of bacteria from
faeces in such cases is not achieved, and consequently the diagno-
sis depends on serology. In this study the results of 2 years sero-
logical investigation after infection with Y. pseudotuberculosis
followed by erythema nodosum and reactive arthritis in a
27-year-old women are described.
Methods: The IgM, IgG and IgA class antibodies were measured
in nine serum samples, collected at 2–12 weeks intervals, by two
ELISA, using Yersinia outer membrane proteins (YOPs) and lipo-
polysaccharides (LPS) extracted from Y. enterocolitica serotypes
O:3, O:5,27, O:8, O:9 and Y. pseudotuberculosis serotype I and III.
The antibody responses were also studied by immunoblotting
(Western Blot, Mikrogen).
Results: In the ﬁrst serum sample, obtained 3 days after onset of
the clinical symptoms of erythema nodosum and arthritis, were
diagnosed a very high levels of IgA, IgG and IgM antibodies to
YOPs and to LPS extracted from Y. pseudotuberculosis serotype I.
In the immunoblot analysis we found antibodies, in all of the
immunoglobulin classes, only against YopD protein (33–36 kDa).
In the second serum sample, obtained after 14 days, we observed
a decrease of antibody titres to LPS and increase of antibody titres
to YOPs. Obtained results with the next seven serum samples
showed that antibody titres measured against LPS antigens in
comparison to YOPs antigens decreased more rapidly after recon-
valescence. Antibodies to YOPs, in all immunoglobulin classes,
were still demonstrable at high level at the end of the follow-up
period of 2 years. At this late period the antibodies to LPS were
not found in a diagnostically signiﬁcant titres.
Conclusion: Results of our study indicate that after infection
caused by Y. pseudotuberculosis, complicated by erythema nodo-
sum and reactive arthritis, a maximum levels of speciﬁc IgA, IgG
and IgM antibodies to YOPs are reached later than antibodies to
LPS. However, antibodies against YOPs in comparison to antibod-
ies against LPS persist longer after reconvalescence. Demonstra-
tion of IgM-class Yersinia antibodies 2 years after onset of the
disease showed that this class of antibodies cannot be considered
in all cases as good marker of recently acquired infection.
P1333 Pro-inﬂammatory cytokine production by human
monocytes in response to P. aeruginosa infection mainly
involves TLR2 and mannose receptor
P. Xaplanteri, G. Lagoumintzis, G. Dimitracopoulos, F. Paliogianni
Patras, GR
Pattern recognition receptors play an important role in protec-
tion against pathogens linking innate and adaptive immunity.
P. aeruginosa, an oppurtunistic pathogen, is capable of establish-
ing both chronic and acute infections in immunocompromised
hosts. We have recently shown that Slime-GLP, an extracellular
product of P. aeruginosa containing mannose, is the most import-
ant stimulant for TNF-a production by human monocytes and a
potent inducer of NFeˆb-mediated transcriptional activation. In this
study we sought to investigate the role of different pattern recog-
nition receptors to inﬂammatory pathway triggered by P. aerugi-
nosa. To this end, we have treated human monocytes with
P. aeruginosa puriﬁed LPS (5 ng–50 lg/mL), Slime (5–5 lg/mL),
or viable bacteria (10 bacteria/monocyte) in the presence of block-
ing antibodies speciﬁc for TLR4 (5–2 lg/mL), TLR2 (5–25 lg/
mL), and Mannose receptor (5–25 lg/mL) and measured TNF-a,
IL-1b and IL-6 production for 2–24 h. An isotype matching, non-
speciﬁc antibody was used as negative control. TNF-a, IL-1b and
IL-6 induction was inhibited by 80–90% in the presence of anti-
Mannose receptor and anti-TLR2 blocking antibodies, whereas
blocking of TLR4 caused a less prominent inhibition (40%). Com-
parable levels of inhibition were obtained when monocytes were
stimulated by P. aeruginosa Slime-GLP or whole viable bacteria.
P. aeruginosa LPS caused a weak proinﬂammatory cytokine induc-
tion not amenable to blocking of TLR2, TLR4 or mannose recep-
tor. Our results suggest that TLR2 or mannose receptor-mediated
pathway could be a speciﬁc target for inhibition of inﬂammatory
responses triggered by P. aeruginosa.
P1334 Pseudomonas aeruginosa LPS and slime
glycolipoprotein (GLP) differentially activate the same mitogen-
activated protein kinase signalling pathways for tumour
necrosis factor alpha in fresh human monocytes
G. Lagoumintzis, P. Xaplanteri, G. Dimitracopoulos, F. Paliogianni
Patras, GR
TNF-a production has a central role in the development and
progression of P. aeruginosa septic shock. We have previously
shown that P. aeruginosa GLP is the most potent stimulant com-
pared with homologous LPS, for TNF-a production and NF-kb
activation in human monocytes. In this study, using fresh human
monocytes stimulated for 15 min–6 h with P. aeruginosa LPS
(5 ng/mL–50 lg/mL) or GLP (10–50 lg/mL), we show that secre-
tion of TNF-a induced by P. aeruginosa GLP and LPS was paral-
leled by phosphorylation of mitogen-activated protein kinases
(MAPK’s) ERK1/2, p38 and the stress-activated protein kinases
c-jun N-terminal kinases 1 and 2 (JNK). Phosphorylation of p38
and ERK1/2 correlated with an increase of activity. TNF-a levels
were signiﬁcantly reduced by (60–80%) and by (80–95%) when
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inhibitors of ERK1/2, PD98059 (50uM), or p38, SB203580 (10 lM)
respectively, were added in the culture 1 h before stimulation.
Combination of both inhibitors almost abolished TNF-a induction.
P. aeruginosa GLP differed from the homologous LPS only regard-
ing the strength of p38 and ERK1/2 activation, with GLP leading
to a stronger activation of p38 and ERK1/2. No differences were
observed at the level of JNK activation between LPS and GLP.
Involvement of TLR-2 and TLR-4 for phosphorylation of p38
was shown by employing speciﬁc blocking anti-human TLR-2
(10 lg/mL) and TLR-4 (10 lg/mL) antibodies. Activation of p38
induced by P. aeruginosa GLP was dramatically reduced in the
presence of anti-TLR2 antibody and to a lesser degree in the pres-
ence of anti-TLR4, whereas the LPS induced stimulation was
inhibited only in the presence of anti-TLR4. Our results suggest
that P. aeruginosa GLP stimulates the MAP kinase pathway more
effectively than the homologous LPS, probably by using different
combination of TLRs.
P1335 In vitro stimulation of innate immunity by
susceptible and resistant Escherichia coli
M. Bristianou, A. Antonopoulou, D. Plachouras,
A. Tzivra, H. Giamarellou, E.J. Giamarellos-Bourboulis
Athens, GR
Objective: It has already been shown that susceptible and multi-
drug-resistant (MDR) Pseudomonas aeruginosa differ on their stimu-
latory effect on innate immunity (Giamarellos-Bourboulis et al.
Clin. Exp. Immunol. 2004). A similar study has been performed on
susceptible and MDR E. coli.
Method: Seventeen isolates of E. coli were studied, eight suscept-
ible and nine MDR all pathogens of different cases of pyelone-
phritis. Mononuclear cells separated from whole blood of healthy
volunteers were suspended in ﬂasks and monocytes isolated after
removal of nonadherent cells were resuspended in RPMI with
10% FBS and 2 mM glutamine. After incubation of 1 h the mono-
cytes were triggered by a 4.7 log 10 and a 6.7 log 10 inoculum of
each isolate. Tumour necrosis factor-alpha (TNF-a) and interleu-
kin-8 (IL-8) were measured in culture supernatants after 2 h of
incubation, with an enzyme immunoassay.
Results: They are given in the ﬁgure.
Conclusions: Triggering by susceptible and MDR isolates of E. coli
lead to different production of cytokines, results that might reﬂect
difference in virulence.
P1336 The role of human beta-defensins during
Campylobacter jejuni infection
M. Zilbauer, N. Dorrell, J.T. George, P.K. Boughan, M. Bajaj-Elliott
London, UK
Objectives: Campylobacter jejuni (C. jejuni) is one of the commonest
causes of infective diarrhoea worldwide effecting mainly young
children (<5 years) both in developing countries and in the wes-
tern world. The clinical spectrum varies from mild watery to
bloody, inﬂammatory diarrhoea and is frequently associated with
postinfectious extraintestinal complications such as Guillain-Barre´
Syndrome. Despite the serious health problem caused by the bac-
terium, disease pathogenesis remains poorly understood. Bacterial
adhesion and invasion of the intestinal epithelium is known to be
a critical feature of infection. Human beta defensins (hBDs), a
family of epithelial antimicrobial peptides are a major component
of innate host defence. We and others have highlighted the role of
these peptides during gastrointestinal infection and inﬂammation.
In the present study we have investigated the role of hBDs during
C. jejuni infection.
Methods: Human colonic intestinal cell line (Caco-2) was infected
with virulent strain (NCTC 11168) of C. jejuni. Both time and dose
dependent studies of hBD gene expression were assessed by RT-
PCR. The bactericidal activity of recombinant hBD-1, -2 and -3
against wild type and isogenic mutants of C. jejuni was evaluated
by broth-dilution assay.
Results: A marked time-dependent induction of hBD3 was
observed with maximal expression at 8 h postinfection. In contrast
hBD2 gene expression was modest. Importantly the bacterium
was found to be highly susceptible to the antimicrobial action of
hBD-3 amongst the peptides tested.
Conclusions: The present study provides evidence for dynamic
cross talk between the bacterium and host epithelial innate
defence. The potent bactericidal activity of hBD3 may contribute
to the self-limiting nature of the infection via enhanced bacterial
clearance in a healthy host.
P1337 Association between Helicobacter pylori infection
and chronic idiopathic urticaria
M. Marcano, M. Urrestarazu, N. Serrano, M.E. Cavazza Porro,
D. Ortiz, O. Rodriguez
Caracas, VE
Objectives: The present study intends to understand the associ-
ation between Helicobacter pylori infection and chronic idiopathic
urticaria.
Methods: We studied 30 patients with chronic idiopathic urticaria
diagnosed for H. pylori infection with the urea breath test using
carbon 14, 22 patients were infected and received triple eradica-
tion therapy (amoxicilin, claritromicin and omeprazol) and anti-
histamine (loratadine); and eight noninfected individuals received
only antihistamine treatment. Serum concentrations of total IgE
and speciﬁc IgG against H. pylori was determined. In addition, we
standardised an ELISA to detect speciﬁc IgE against H. pylori, at
time 0 and 6 weeks after concluding treatment.
Results: Bacteria was eradicated in all the patients infected, with
variable clinical improvement (14 without clinical signs, eight
with partial clinical signs); patients without H. pylori infection fail
to improve after treatment.
Conclusions: The present study established a statistical signiﬁcant
difference (P < 0.0001) between the eradication of H. pylori infec-
tion and the improvement of clinical signs for chronic idiopathic
urticaria, when compared with the noninfected group. In patients
with moderate symptoms, we observed the best treatment response
with clinical improvement (P ¼ 0.0083). There were not statistically
signiﬁcances between the concentrations of total IgE, IgG anti
H. pylori and the values for H. pylori-speciﬁc IgE, except in those
patients with moderate partial improvement, where the H. pylori-
speciﬁc IgE signiﬁcantly diminished (P ¼ 0.0286) after eradication.
The eradication of H. pylori clearly improves chronic idiopathic
urticaria, by an unknown mechanism independent of IgE.
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P1338 Some biochemical and serological aspects of Q fever
diagnosis
K. Slaba, L. Skultety, R. Toman
Bratislava, SK
Coxiella burnetii, an obligate intracellular parasite of eucaryotic
cells, is the aetiological agent of Q fever. The disease is a wide-
spread zoonosis and is endemic throughout the world. In
humans, the acute form of Q fever is characterised as a ﬂue-like
illness or atypical pneumonia, or less frequently as granulomatous
hepatitits with a signiﬁcant incidence of neurologic complications.
Persistent infections may lead to chronic form of the disease,
which may be associated with endocarditis. Human infection is
aquired most often by inhalation of contaminated aerosols, or less
frequently, by drinking infected milk, infection through skin
trauma, sexual contact or mother to fetus transmission. Upon
serial laboratory passages in embryonated hen eggs, C. burnetii
undergoes a virulent (phase I) to low-virulent (phase II) variation,
which is accompanied by noticeable modiﬁcations in both compo-
sition and structure of the cell outer-membrane components. Dur-
ing the acute Q fever, antibodies against the phase II antigen are
detected earlier and at higher titres than those against the phase I
antigen. In contrast, titres to phase I antigen are higher during the
chronic form of the disease. We have found that the phase I anti-
bodies are mostly directed against the O-speciﬁc chain of the
C. burnetii smooth-form lipopolysaccharide (LPS). A remarkable
decrease in the serological activity of the LPS was observed when
two unusual sugars virenose (Vir) and dihydrohydroxystreptose
(Strep) were selectively removed from its O-speciﬁc chain. This
indicates that most phase I antibodies are directed against the epi-
topes containing terminal Vir and Strep. Thus, our results may
suggest that Vir and Strep are involved in the immunobiology of
the disease. Mild acid treatment of the C. burnetii phase I cells
resulted in a considerable degradation of the LPS and exposure of
the surface proteins exhibiting a high-immune response to the
phase II antibodies. 1D SDS-PAGE revealed the most intense sil-
ver-stained proteins at about 29 and 60 kDa. The subsequent, ini-
tial proteomic studies have identiﬁed the latter protein as the
Chaperonin 60 kDa (GroEL protein, heat shock protein B). This
protein is localised in cytoplasm of several bacteria but a signiﬁ-
cant fraction of it is also associated with their cell envelopes. Most
likely, the protein has a dual association also in C. burnetii as it is
immunogenic. Further peptide mass ﬁngerprinting is in progress.
P1339 Evaluation of inﬂammatory capacity of fungal
spores in human whole blood
M. Daneshian, I. Kindunger, T. Gabrio, T. Hartung, S. von Aulock
Constance, Stuttgart, D
Objectives: Fungal spores are clinically relevant contaminants as
they are ubiquitous, inhalable and release mycotoxins. Cell wall
structures such as glucans and mannans seem to play an import-
ant role in inﬂammatory processes but no deﬁned structure could
be described up to now as responsible for the inﬂammatory
potential of fungi. In addition to well-known human-pathogenic
fungi, like Candida albicans and facultative pathogens, e.g. Aspergil-
lus fumigatus, nonpathogens – particularly moulds – endanger
human health in immunosuppressed patients.
Methods: Over 50 different moulds and yeasts were cultured and
their spores were prepared in order to measure their inﬂamma-
tory capacity in comparison to endotoxin from E. coli O-113 ⁄ .
We used a standardised whole blood assay to detect pyrogenic
activity of the fungal spores on the basis of release of cytokines,
e.g. IL-1b, IL-6 and TNF-a as pro-inﬂammatory cytokines, IL-8 as
a chemoattractant and IL-10 as an anti-inﬂammatory cytokine.
Results: We detected considerable differences in the immunological
response to spores between different fungal species. We found
these differences in cytokine induction between representatives of
different fungal genera and between members of the same genus.
However, there was a strong correlation between cytokine induct-
ive capacity and estimated total spore surface. The variance
between the response of individuals to fungal spores was greater
than that towards endotoxin. We investigated whether structures
on intact spore surfaces are recognized by toll-like receptors (TLRs)
by incubating fungal spores with bone marrow cells from TLR-4
and TLR-2 deﬁcient mice, and found that the TNF a-inducing activ-
ity of none of the tested species was fully dependent on TLR recog-
nition, only some species were partially dependent on these TLRs.
Conclusion: Cytokine induction capacity seems to be dependent on
the exposed total spore surface rather than on the spore count.
Immune recognition does not appear to be centrally dependent on
TLR activation. Further studies will attempt to deﬁne the role of differ-
ent surface structures of selected fungal spores in cytokine induction.
P1340 The differentiation of human monocytes into
dendritic cells is tunable and exploitable by micro-organisms to
modulate the host’s adaptive immune response: the Candida
albicans model
G. Romagnoli, A. Torosantucci, A. Stringaro, P. Chiani,
S. Mariotti, G. Arancia, A. Cassone, R. Nisini
Rome, I
Objectives: To investigate whether the ability of Candida albicans
to convert from yeast (Y) to mycelial forms, through germ-tube
(GT) formation, that is considered a key feature of its transition
from commensalism to virulence, could be related to an abnormal
human monocyte differentiation into dendritic cells (DCs).
Methods: Noninfected and Y or GT infected monocytes were
allowed to differentiate into DCs by culture with GMCSF and IL-
4. After a 6 days culture, cells were analysed for their ultrastruc-
ture, phenotype and function.
Results: Human monocytes cultured with GM-CSF and IL-4 after
phagocytosis of Y forms did not differentiate into DCs: they
retained CD14, did not acquire molecules of the CD1 family, and
were unable to express the maturation markers CD83 and CCR7.
Moreover, they produced TNFa, IL-6 and IL-10 rather than IL-12,
and were able to induce proliferation of alloreactive memory, but
not naı¨ve, T lymphocytes. Conversely, monocytes that had phago-
cytosed GT forms differentiated into mature CD83+ and CCR7+
DCs with, however, a failure in the up-regulation of MHC class II
and CD80, irrespective of LPS treatment. In addition, they synthe-
sised TNF-a, but not IL-6, IL-10 or IL-12. These cells were able to
prime naı¨ve T cells, but not to induce their functional polarisation
into effector cells. In details, expanded T lymphocytes were
unable to secrete cytokines, in particular IL-4 and IFN-c suggest-
ing that they could be ineffective in helping the macrophage kill-
ing of microorganisms. These data indicate that phagocytosis of Y
and GT forms have profound and distinct effects on the differenti-
ation pathway of monocytes. These data imply that differentiation
of human monocytes is tunable by microorganisms, which may
exploit this process to elude immune-surveillance.
P1341 Monocyte chemotactic protein-1 production by
human astrocytes and astrocytoma cell lines during toxoplasmic
infection: differential regulation by interferon-gamma and
D-609
F. Durand, M. Brenier-Pinchart, J. Simon, P. Marche, F. Berger,
H. Pelloux
Grenoble, F
Objective: We have used human astrocyte cultures to investigate
the cellular responses of central nervous system resident cells to
intracellular Toxoplasma gondii infection. The objectives of this
study were to evaluate the secretion and the expression of mono-
cyte chemotactic protein-1 (MCP-1) and to measure the effect of
IFN-c and D-609, a speciﬁc inhibitor of phosphatidylcholine-speci-
ﬁc phospholipase C (PC-PLC), on the regulation of the expression
and the secretion of this CC chemokine during infection by
T. gondii.
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Methods: Human astrocytes ex vivo and human astrocytoma cell
lines (U-373, CCF) were infected by the virulent RH strain and para-
site multiplication and penetration were measured. Using a real-
time PCR technique and a ribonuclease protection assay, the copies
of mRNA encoding MCP-1 and seven other chemokines were ana-
lysed 24 h postinfection (p.i.). MCP-1 levels were determined by
ELISA in culture supernatant at 24 h p.i. D-609 was added 45 min
before the infection in culture medium. Furthermore, the effect of
preincubation with IFN-c (1000 IU/mL) was studied.
Results: Penetration and multiplication rates of T. gondii were
higher in human astrocytoma cell lines than in human ﬁbroblasts
(P ¼ 0.01 and P ¼ 0.009, respectively). Parasitic infection increased
MCP-1 production by astrocytes. Preincubation of these cells with
IFN-c did not modify signiﬁcantly the secretion of MCP-1 by astro-
cytoma cell lines in our experimental conditions. Nevertheless,
MCP-1 production by astrocytoma cells lines treated by D-609 were
decreased compared with those not treated by this inhibitor.
Conclusion: Astrocytes and astrocytoma cell lines are signiﬁcantly
more infected by T. gondii than ﬁbroblasts and the parasite indu-
ces production of MCP-1 in these cells. Moreover, in our protocol,
both secretion and expression of this CC chemokine are regulated
by D-609, a PC-PLC inhibitor, but not by IFN-c. These results
suggest that the upregulation of MCP-1 may be involved in the
pathogenesis of toxoplasmic encephalitis and regulated by
intracellular messengers.
P1342 Yersinia toxin YopE Targets granulocytes in the
intestinal tract and associated lymphatic tissues
J.M. Balada Llasat, I. Basu, M. Guerau-de-Arellano, J. Mecsas
Boston, USA; Auckland, NZ
Objective: To determine the immune cell targets of Yersinia Yops
during infection.
Background: Yersinia pseudotuberculosis colonises the gastrointesti-
nal tract (GI) and associated lymphatic tissues, such as mesenteric
lymph nodes (MLN) and Peyers’ patches (PP) after orogastric
infection of humans or mice. Colonisation requires Yersinia outer
proteins (YOPS), which are virulence factors that are translocated
into mammalian cells by a type III secretion system where they
inhibit cellular functions. Competition studies in mice coinfected
with wild type (WT) Yersinia and single yop deletion mutants
(yopE, yopH, yopO) demonstrated that these Yops are important
in colonization of the GI, MLN and PP. Previous work demonstra-
ted that YopE, YopH and YopO have antiphagocytic activity in
cultured cells. As phagocytes are an early defence used by the
host to ﬁght bacterial infection, we tested whether YopE, YopH
and/or YopO target phagocytes in mice.
Methods: To study a possible role of these Yops in inhibiting the
bactericidal effects of phagocycytes during an infection, CD18 /
, granulocyte-depleted and CD18 / granulocyte-depleted
mice were orogastrically infected with an equal mixture of WT
and yopE, yopH or yopO mutant strains. The ratio of WT to
mutant bacteria recovered from GI, MLN and PP tissues was
quantiﬁed and compared with the ratio from WT mice. If a higher
number of a yop mutant is recovered in the deﬁcient mice com-
pared with the nondeﬁcient mice, then the mutant yop strain is
more susceptible to phagocytes in the tissue studied. Hence, the
missing Yop likely functions to neutralise the bactericidal effects
of phagocytes.
Results: Our results show that there is a high recovery of yopE
mutant strain in the MLN, PP and caecum of the granulocyte-
depleted mice. In contrast, yopO mutant strains are recovered in
the small intestinal lumen and mesenteric lymph nodes in the
CD18 / mice. CD18 / granulocyte-depleted mice showed
that yopE and yopO were rescued in most of the tissues studied.
Conclusion: Our data documents the signiﬁcant role of yopE and
yopO in neutralising phagocytes during infection, speciﬁcally
YopE is crucial to inhibit granulocytes function while YopO tar-
gets other CD18-expressing cells.
Nosocomial infection: Gram-positive micro-organisms
P1343 Surveillance of glycopeptide-resistant enterococcal
bacteraemias in England
D. Brown, N. Brown, B. Cookson, G. Duckworth, M. Farrington,
G. French, L. King, D. Lewis, D. Livermore, B. Macrae, G. Scott,
D. Williams, N. Woodford – GRE Bacteraemia Surveillance
Working Group
Introduction: Glycopeptide-resistant enterococci (GRE) have
emerged as important nosocomial pathogens in recent years. As
part of the Department of Health’s programme of mandatory sur-
veillance of Healthcare Associated Infection in England, a surveil-
lance scheme for GRE bacteraemias is being developed. A
questionnaire was devised to obtain background data to inform
the development of the proposed surveillance scheme.
Objectives: (i) To establish current approaches to detection of GRE
(ii) To review technical problems associated with detection and
reporting of GRE (iii) To review issues related to the signiﬁcance
of reports of GRE bacteraemia and the comparability of data from
different hospitals
Methods: A questionnaire reviewing methods, approaches to test-
ing and risk factors for GRE bacteraemia was designed by the
national group, piloted and administered to all laboratories in
England (n ¼ 205) in June 2003.
Results: A response rate of 82% (n ¼ 169) was achieved; several
questionnaires were not fully completed. Thirty-four per cent
(n ¼ 55) of respondents identiﬁed GRE Bacteraemias in 2002 and
of those laboratories, 29% (n ¼ 16) saw more than ﬁve in that
year; 33% (n ¼ 18) of identiﬁed bacteraemias were not reported
via the routine communicable disease reporting system; 87%
(n ¼ 142) of respondents reported using three or more routine
methods of GRE identiﬁcation and 22% (n ¼ 37) did not identify
isolates to species level; 80% (n ¼ 13) of respondents did not test
vancomycin on all enterococci from bacteraemias. Glycopeptide
susceptibility testing was primarily carried out using the disc-dif-
fusion method (91%, n ¼ 148). Specialist units such as bone mar-
row and liver transplantation units were the predominant sites
for routine screening of patients’ faeces for GRE. The majority of
respondents (69–99%, n ¼ 108–156) could provide data for indica-
tors of clinical signiﬁcance of GRE bacteraemias.
Conclusions: The majority of laboratories in England did not see
GRE bacteraemias in 2002. Routine reporting of these infections in
2002 was incomplete. A varied approach to the identiﬁcation of
enterococci from blood cultures and glycopeptide-susceptibility
testing was observed. Most laboratories could provide data on the
clinical signiﬁcance of GRE bacteraemias. A standardised proce-
dural guideline is required if robust data are to be produced as
part of a mandatory surveillance scheme in England.
P1344 Epidemiology of vancomycin-resistant enterococci in
a Greek tertiary hospital: comparison of two point prevalence
studies on intestinal colonisation
A. Christidou, A. Gikas, E. Scoulica, G. Minadakis, M. Dialynas,
I. Kyriakakis, M. Roumpelaki, J. Pediaditis, A. Georgiladakis,
Y. Tselentis
Heraklion, GR
Objectives: Two point prevalence studies were undertaken in
order to investigate the intestinal colonisation with vancomycin-
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resistant enterococci (VRE) among the patients of our hospital.
The ﬁrst study took place on February 1, 2001 and the second
22 months later.
Methods: The prevalence studies were performed by the same meth-
odology. All patients cared in high-risk departments including: the
intensive care unit (ICU), the cardiology intensive care unit (CICU),
the renal unit, and the neonatal unit were tested. In addition,
through a systematic random sampling process, 25% of all patients
cared in all other wards (non high-risk departments) were also tes-
ted. Faecal samples or rectal swabs were inoculated into enterococci
broth with vancomycin 6 mg/L and subcultured on bile-esculin az-
ide agar with vancomycin 6 mg/L. Enterococci were identiﬁed by
conventional methods. Glycopeptides susceptibility testing was
performed by disc diffusion, Etest, and MIC (agar dilution) meth-
ods. Characterization of van genotypes was performed by a multi-
plex PCR assay using speciﬁc primers for vanA, vanB, van C1,
vanC2/C3, ddlE. faecalis, ddlE. faecium, and rrs genes.
Results: The prevalence rate of VRE faecal carriers increased from
18.8% (ﬁrst study) to 30% (second study). VanA, vanB, and vanC
prevalence rates in the ﬁrst study were 1.8, 3.7, and 13.8%, respect-
ively, while in the second study were 10.3, 5.9, and 14.8%, respect-
ively. In the ﬁrst study, vanA-harbouring isolates were detected in
ICU and renal unit only, but the second study revealed a further
dissemination within the hospital. VRE prevalence in high-risk
departments did not present any signiﬁcant difference, but in sur-
gical wards increased from 10.4–45.5%, and in medical wards from
15.9 to 33.9%. The haematology, the nephrology, and the orthopae-
dic wards contributed signiﬁcant number of VRE faecal carriers.
Species distribution in the ﬁrst study was: E. faecium, 11 (27%); E. fae-
calis, one (2%); E. gallinarum, 24 (57%); and E. casseliﬂavus/ﬂaves-
cens, six (14%), but in the second study changed to: E. faecium, 24
(38.1%); E. faecalis, four (6.3%); E. avium, four (6.3%); E. hirae, one
(1.6%); E. gallinarum, 28 (44.4%) and E. casseliﬂavus/ﬂavescens, two
(3.2%).
Conclusion: Twenty-two months after the appearance of VRE in
our hospital the prevalence of VRE faecal carriers increased, espe-
cially in surgical and medical wards. VanA isolates were detected
in more wards and distributed in more species.
P1345 Clonal dissemination of van A-type glycopeptide-
resistant Enterococcus faecalis between hospitals located in two
cities in the State of Sao Paulo, Brazil
M.L. Moretti, O.J. Bratﬁch, R.B. Stucchi, C. Levi, A.S. Levin,
G. Duboc, E. Vormittag, D. Blum-Menezes
Sao Paulo, BR
Nosocomial dissemination of glycopeptide-resistant enteroccocci
represents a major problem in hospitals worldwide. In Brazil, the
dissemination among hospitals in the city of Sao Paulo of poly-
clonal DNA proﬁles was previously described for vancomycin-
resistant E. faecium.
Objectives: To describe the dissemination of VanA phenotype
E. faecalis between two hospitals located in different cities in the
state of Sao Paulo.
Methods: The index outbreak occurred in a university hospital in
the city of Sao Paulo (HCUSP) and 3 years later a cluster caused
by the same strain was recognised in a tertiary care hospital
located in the country side (CMC). From May to July 1999, 10
strains of E. faecalis vancomycin-resistant were isolated from 10
patients hospitalised in the HCUSP. From May to July 2002, three
strains of vancomycin-resistant E. faecalis were isolated from two
patients hospitalised in CMC and both patients were colonised by
the VRE in skin lesions. All the isolates were tested for suscepti-
bility to vancomycin and teicoplanin using Etest. The detection
of Tn1546 was performed by PCR method and the strains were
typed using PFGE.
Results: All strains had the presence of the transposon Tn1546 and
were closely related when typed by pulsed-ﬁeld gel electrophor-
esis.
Conclusions: The dissemination of VanA phenotype E. faecalis to
hospitals located in different cities is of great concern and monit-
oring measures are necessary to reduce the risk of dissemination.
P1346 Virulence factors and antimicrobial resistance in
Enterococcus faecalis strains of clinical origin
S. Cosentino, A. Corda, G.S. Podda, M.B. Pisano, T. Pisanu,
M.E. Fadda Monserrato
Cagliari, I
Objectives: Enterococcus faecalis has long been identiﬁed as a cause
of endocarditis, bacteraemia, urinary tract and neonatal infections.
Knowledge on the pathogenic factors of E. faecalis is still limited,
although several virulence factors have been described, such as
cytolysin, aggregation substance, surface proteins. The aims of this
work were to investigate the presence of known virulence deter-
minants in 135 E. faecalis strains isolated from clinical specimens
in Sardinia, and to determine their antimicrobial resistance pat-
terns.
Methods: Enterococcus faecalis strains were mainly isolated from
patients with urinary tract infections. The following virulence
genes, gelE (gelatinase), esp (enterococcal surface protein), agg
(aggregation substance) and cylM (post-translational modiﬁcation
of cytolysin) were ampliﬁed by PCR using published speciﬁc
primers. Production of gelatinase and haemolysin was also pheno-
typically determined. In vitro susceptibilities of the clinical isolates
towards 13 antibiotics were determined by the Vitek method.
Results: Of the 135 strains examined, only seven did not harbour
any of the virulence determinants tested; the majority possessed
two or three factors (51 and 41%, respectively) and 16 carried all
the genes investigated. Most strains presented the gelE and agg
determinants (65 and 64% positivity, respectively), while esp and
cylM were detected in about half of the isolates. Several strains
contained apparently silent gelE and cylM determinants, when
comparing genotypic and phenotypic results. Multiple antimicro-
bial resistance was uncommon, the majority of strains being resist-
ant to two antibiotics (86%) only. A large proportion of isolates
was resistant to phosphomycin (90%) and tetracycline (79%) and
only one strain was resistant to vancomycin. All the isolates were
susceptible to ampicillin and teicoplanin.
Conclusion: Our results conﬁrm the presence of various virulence
genes in clinical isolates of E. faecalis, providing further support-
ing evidence for their role in pathogenesis. It is worth noting the
generally low rate of antibiotic resistance in the clinical strains
examined, especially when vancomycin-resistance is considered, if
compared with data reported from other countries.
P1347 Five-year molecular epidemiology of high-level
gentamicin-resistant Enterococcus faecalis in a Belgian academic
hospital
E. Prospero, A. Deplano, C. Nonhoff, F. Rost, B. Byl,
M.J. Struelens
Ancona I; Brussels, B
Objective: To monitor the molecular epidemiology of high-level
gentamicin-resistant E. faecalis (HLGRE) from 1995 to 1999 and to
evaluate the impact of control measures on their nosocomial
transmission
Patients and methods: During the period 1995–1999, a total of 1301 .
A total of 114 patients were admitted at Erasme Hospital, a 850-
bed tertiary-care University Hospital. HLGRE strains (gentamicin
MIC > 2000 lg/mL) were isolated from 370 patients. The infection
control team reviewed the patient charts to deﬁne if strains were
imported/nosocomial and responsible of infection/colonisation.
Since May 1996, all colonised/infected patients were placed in
contact isolation. HLGRE incidence rate was monitored in the pre-
intervention period (1 January 1995 to 30 April 1996) and the
postintervention period (01 May 1996 to 31 December 1999). PCR
analysis of aacA-aphD gene and macrorestriction analysis (SmaI)
resolved by pulsed-ﬁeld gel electrophoresis (PFGE) were per-
formed.
Results: The rate of HLGRE nosocomial acquisition was 0.24 and
0.21% for the pre- and postintervention period, respectively.
Among nosocomial HLGRE strains, 31% were isolated from inten-
sive care units, 17% from gastroenterology ward and 13% from
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the surgical vascular ward. All HLGRE strains harboured the
aacA-aphD gene and a total of 49 PFGE types, deﬁned as patterns
differing by 7 DNA fragments, were found among the 286/370
HLGRE strains typed. Major epidemic PFGE types 1, 3 and 4
were recovered from 18, 37 and 12% of patients with nosocomial
and from 8, 29 and 31% of patients with community-acquired
strains, respectively. Type 1 was recovered predominantly during
the preintervention period whereas types 3 and 4 were isolated
during both periods.
Conclusions: Typing data showed a major shift in transmission of
a few predominant HLGRE epidemic types in our hospital. There
was continuous introduction of patients colonised with types that
appear to be regionally endemic. Contact precautions appeared to
have no signiﬁcant impact on the long-term incidence of nosoco-
mial acquisition of HLGRE.
P1348 Epidemiology and antimicrobial patterns of
multiresistant nosocomial strains of Enterococcus faecium
isolated over 3 years in a Bulgarian university hospital
N. Hadjieva, N. Hadjieva, D. Ivanova
Soﬁa, BG
Objectives: Enterococcus spp. are among the common organisms
associated with hospital-acquired infections. The emergence of en-
terococci as signiﬁcant pathogens is a matter of concern because
these organisms are inherently resistant to a multiple antimicrobi-
als, especially Enterococcus faecium. The aim in this study was to
examined in vitro activities of different antimicrobial agents to 54.
E. faecium isolates collected in Queen Joanna University Hospital,
Soﬁa, Bulgaria during 3-year period and to determined theirs pre-
valence among different wards in our hospital.
Materials and methods: Between November 2000 and December
2003 a total 54 isolates of E. faecium were collected that causes the
nosocomial infection. The identiﬁcation and susceptible to antibi-
otics has been performed in automated system Sceptor Streptococ-
cus MIC/ID (Becton Dickinson) MIC/ID panels as described by
the NCCLS.
Results: There was an increase in the proportion of E. faecium isola-
ted in 2003 (25%) compared with 2002 (15%) and 2001 (3.6%).
About of 60 % of all E. faecium strains were multidrug resistant
and exhibited ampicillin resistance, high-level gentamicin (HLGR)
and quinolones resistance. The strains were susceptible only to li-
nezolid and glycopeptides. Nine (27%) of them were isolated from
ICU’s, 14 (42%) from abdominal surgery, four (12%) from neuro-
surgery and 19% from medical units. Isolates were recovered from
surgical-site infections (48%), urinary-tract infections (33%), pri-
mary blood stream infections (9%) and other infections (10%).
Conclusion: The emergence of multidrug resistant E. faecium and
theirs dissemination in our hospital has highlighted the need for
continual surveillance. The most important problems determined
were the high frequencies of resistance to ampicillin, aminoglyco-
sides and quinolones. The most active antimicrobials to which no
resistance has been found were linezolid and glycopeptides. It is
concluded that glycopeptide resistance is not yet an important
problem for enterococcus isolates.
P1349 Hospital and community-acquired Staphylococus
aureus bacteraemia: risk factors, location of inﬂammation and
outcome
E. Kalogeropoulou, L. Mourgos, P. Tsiodra, M. Belechri
Athens, GR
Objectives: To access the incidence, to recognise risk factors and
describe location of speciﬁc tissue inﬂammation along with the
outcome of patients with community acquired and nosocomial
Staphylococcus aureus bacteraemia (SAB), treated in a tertiary med-
ical department.
Methods: This is retrospective study of 7250 patients who were
hospitalised in a medical department, during 7-year period
(January 1995 to January 2002). Community acquired and nosoco-
mial SAB were determined according to positive blood cultures,
taken less or >72 h from admission, respectively. Categorical vari-
ables were compared with Chi-square techniques.
Results: During the 7-year period, 55 (28 male, 33 female) and 182
(85 male, 97 female) patients developed community acquired and
nosocomial SAB corresponding to an incidence of 1 per 1000 per-
son years and 3.5 per 1000 person years, respectively. Risk factors
for the developed of SAB bacteraemia in group A vs. group B,
was: injection drug use: 12 (21.8%) vs. 17 (9.3%) (P ¼ 0.02), hae-
modialysis-dependent patients: seven (12.7%) vs. 18 (9.9%)
(P ¼ NS), diabetes mellitus: 20 (36.4%) vs. 16 (8.8%) (P ¼ 0.01),
neoplasmatic diseases: ﬁve (9.1%) vs 18 (9.9%) (P ¼ NS), cortico-
steroid use: eight (14.5%) vs. 62 (34.1%) (P ¼ 0.01), haematologic
disorders: three (5.5%) vs. 28 (15.4%) (P ¼ 0.05), surgery within
the previous 30 days: 0 vs. 10 (5.5%) (P ¼ NS) Determination of
location of septic inﬂammation was feasible in 29 (52.7%, group
A) vs. 94 (51.6%, group B) (P ¼ NS), including: deep tissue
abscess: ﬁve (9.1%) vs. 23 (12.6%) (P ¼ NS), psoas abscess: two
(3.6%) vs. 18 (9.9%) (P ¼ NS), vertebral osteomyelitis: four (7.3%)
vs. 12 (6.6%) (P ¼ NS), soft-tissue infection: 10 (18.2%) vs. eight
(4.4%) (P ¼ 0.01), septic arthritis: two (3.6%) vs. nine (4.9%)
(P ¼ NS), septic thrombophlebitis: four (7.3%) vs. eight (4.4%)
(P ¼ NS), endocarditis: two (3.6%) vs. eight (4.4%) (P ¼ NS),
meningitis: zero vs. eight (4.4%) (P ¼ NS), infection of orthopae-
dic prosthetic devises: zero vs. 13 (7.1%) (P ¼ NS). Mortality was
three (5.5%, group A) and 28 (15.4%, group B), respectively
(P ¼ 0.05).
Conclusions: Among risk factors for community acquired SAB are
injection drug use and diabetes mellitus, while for nosocomial
SAB is use of corticosteroids and haematologic disorders. Soft-tis-
sue infection was more frequent on group of community-acquired
SAB. Higher mortality rate was noticed in the group of nosocomi-
al SAB.
P1350 Endocarditis is not a common complication of
catheter-related Staphylococcus aureus bacteraemia
R. Finkelstein, I. Oren, I. Kassis, E. Braun, I. Mogilewski,
S. Edelstein, F. Nakhoul, H. Sprecher, A. Raz, Y. Agmon,
S. Reisner
Haifa, IL
Background: Staphylococcus aureus is probably the most important
pathogen isolated from intravascular (IV) catheter-related (CR)
bloodstream infections (BSI). Recently, it has been suggested that
25% of cases of S. aureus CRBSI are complicated by infective
endocarditis (IE).
Objective: To characterise the clinical and epidemiological features
of CRBSI due to S. aureus at our institution
Methods: Prospective cohort registry started in August 2002. All
consecutive adult patients with 1 positive blood cultures (BC)
were evaluated for the following data: demographics, microbiolo-
gical and epidemiological characteristics of positive-blood cul-
tures, including number and duration of positive BC, source of
bacteraemia, presence, type and duration of catheterisation,
underlying conditions, type and duration of treatment and out-
come. Transoesophageal echocardiography (TEE) was recommen-
ded for all patients and performed if an informed consent was
obtained.
Results: During a period of 15 months, there were 187 episodes of
nosocomial S. aureus BSI, of which 115 (61%) were primary and
occurred among patients with IV catheters. Of these 115 episodes,
48 (42%) were IV-related, 67 (58%) were IV-associated, 24 (21%)
were haemodialysis catheter-related and 74 (64%) were due to
MRSA. There were nine cases of deﬁnite hospital-acquired IE, of
which four (6%) were diagnosed among 64 episodes of CRBSI in
which TEE (59 cases) or TTE (ﬁve cases) were performed. These
four cases of IE presented with at least one ﬁnding (predisposing
heart condition, clinical signs or persistent bacteraemia after
removing the catheter) that would have required TEE. There were
10 episodes of relapse, all but one occurring among patients trea-
ted for 14 days. Of the 94 episodes treated with antibiotics for
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10 days the mean duration of bacteraemia was signiﬁcantly lon-
ger for vancomycin than for b-lactam drugs (6.5 days vs. 1.0 day,
respectively, P < 0.001). The overall mortality rate of patients with
CRBSI was 26%.
Conclusion: Staphylococcus. aureus CRBSI is an important cause of
morbidity and mortality in our institution. Episodes of bacterae-
mia treated with vancomycin persisted for signiﬁcantly longer
period of time than that observed in episodes treated with b-lac-
tam antibiotics. This preliminary data show that IE, as a complica-
tion of S. aureus CRBSI, appears to be less common than
previously reported.
P1351 Characteristics of staphylococci from hip prostheses
infections
A. Longauerova, D. Kotulova, L. Slobodnikova, F. Ruzicka
Bratislava, SK; Brno, CZ
Objectives: Study of virulence factors of staphylococci isolated
from patients with infected total hip prosthesis.
Methods: Swabs sampled from inﬂamed places of total hip pros-
thesis (THP) of patients from 1st Department of Orthopaedics
were examined by standard microbiological methods in the per-
iod from January 2000 to June 2003. Antimicrobial susceptibility
was tested according to NCCLS. Detection of b-lactamase was
performed by nitroceﬁn method, and production of PBP2a was
measured by latex agglutination test. Mec A gen detection was
performed by PCR. Production of slime was detected by use of
congo red agar plates. IcaA gen in 11 selected strains was detec-
ted by PCR. The surface hydrophobicity in all staphylococcal
strains was evaluated by method based on bacterial adhesion to
hydrocarbon-xylene. Haemolysins, coagulase, and DNase were
tested by standard microbiological methods.
Results: Staphylococci represented 51% of all bacterial isolates;
their occurrence showed increasing tendencies during the study
period. Coagulase-negative staphylococci (CoNS) prevailed (62
of 91 strains; 68%). All tested staphylococcal strains were
vancomycin susceptible. 84 strains (92%) produced b-lactamase
and 37 CoNS strains (60%) produced PBP2a and were mec A
gen positive. Slime (a signiﬁcant virulence factor in the devel-
opment of endoplastitids) was produced in 10 strains (34%) of
S. aureus and in 23 strains (37%) of CoNS. In 11 CoNS (a mix-
ture of positive and negative for slime production in congo red
method), icaA gen presence was tested. Only three strains were
icaA positive. 12 strains (41%) of S. aureus produced a-haemoly-
sin and two strains (7%) d-haemolysin. Delta-like toxin was
produced by 24 strains (39%) of CoNS. 26 of 29 S. aureus
strains produced DNase.
Conclusions: Staphylococci were the most frequently isolated bac-
teria in patients with THP infection. The occurrence of methicillin-
resistant CoNS is still rather high. This fact should be taken in
account in the regular updating of antimicrobial pre-, and peri-
operative prophylaxis of THP patients.
P1352 Five-year review of Staphylococcus aureus
bloodstream infections in renal patients, 1998–2002
S.F. FitzGerald, F.M. Fitzpatrick, R. Crowley, H. Humphreys,
E.G. Smyth
Dublin, IRL
Objectives: Staphylococcus aureus bloodstream infection (BSI) is
common amongst patients on renal dialysis and serious complica-
tions may follow. Beaumont Hospital houses the national renal
transplant unit and all patients with S. aureus BSI are clinically
reviewed by the microbiology team.
Methods: A retrospective analysis of the incidence, source and out-
come of S. aureus BSI was carried out on renal dialysis patients
from January 1998 to December 2003 using clinical records and
the laboratory database. Antibiotic susceptibilities, source and out-
come were recorded for each isolate.
Results: There were 185 patient episodes between January 1998
and December 2002. A total of 400 blood cultures yielded S. aure-
us; of which 41% (n ¼ 236) were resistant to methicillin. By com-
parison 38% of all BSI isolates of S. aureus in our hospital were
methicillin resistant in 2002. The majority (85%) of renal patient
episodes were secondary to catheter-related sepsis. Complications
were documented in 19% of episodes, infective endocarditis
(40%) being the most common. 4% (n ¼ 7) of patients died. The
data for 2003 is currently being updated.
Conclusions: Staphylococcus aureus BSI is common amongst renal
dialysis patients; infective endocarditis is a signiﬁcant complica-
tion but the mortality is low. Interventions to reduce the incidence
are a priority in this compromised patient group.
P1353 Antimicrobial resistance of nosocomial strains of
S. aureus isolated from patients with skin and soft tissue
infections in Russia
A. Dekhnich, L. Stratchounski, I. Edelstein
Smolensk, RUS
Objective: To determine the rates of antimicrobial resistance in no-
socomial strains of S. aureus isolated from patients with skin and
soft tissue infections in different parts of Russia.
Methods: A total of 624 S. aureus strains isolated from patients
with nosocomial skin and soft tissue infections were studied.
Patients were hospitalised in 17 hospitals in different parts of Rus-
sia – four in Central region, two in north-west region, three in
south region, two in Volga region, three in Ural region, three in
Siberia. Antimicrobials tested included chloramphenicol, ciproﬂ-
oxacin, clindamycin, erythromycin, fusidic acid, gentamicin, levo-
ﬂoxacin, linezolid, lincomycin, moxiﬂoxacin, mupirocin, oxacillin,
quinupristin/dalfopristin, rifampicin, tetracycline, trimethoprim/
sulphamethoxazole, vancomycin. Susceptibility testing and its
interpretation were performed by agar dilution according to
NCCLS guidelines where applicable.
Results: Majority of strains (45%) were isolated from patients hos-
pitalised in general surgical units, 25% of patients were hospital-
ised in burn units, 14.9% to traumatology/orthopedic units, 8%
in ICUs, 4.5% in neonatal units, 2.6% in general medical units.
Results of susceptibility testing are presented in the Table.
Conclusions: (i) The overall rate of methicillin-resistance was
35.9%; (ii) the most potent antimicrobials were linezolid, vanco-
mycin and fusidic acid, to which no resistant strains were found,
followed by quinupristin/dalfopristin, mupirocin and co-trim-






Vancomycin 0 1/1 0.5–4
Linezolid 0 2/2 1–4
Fusidic acid 0 0.125/0.125 0.03–2
Mupirocin 0.3 0.25/0.25 0.125–16
Trim./Sulfa. 1.1 0.125/0.5 0.06–64
Quinu./Dalfo. 1.9 0.5/1 0.125–16
Rifampicin 7.5 0.03/0.03 <0.03–128
Levoﬂoxacin 8.3 0.25/0.5 0.06–16
Ciproﬂoxacin 12.5 0.5/4 0.125–64
Clindamycin 29 0.125/256 0.06–>256
Gentamicin 32.9 0.5/256 0.125–>256
Oxacillin 35.9 0.5/128 0.125–>256
Tetracycline 37.7 0.5/64 0.125–256
Erythromycin 41.2 0.5/256 0.125–>256
Chloramphenicol 47 8/128 0.5–256
Lincomycin NA 2/256 0.25–>256
Moxiﬂoxacin NA 0.06/0.125 <0.015–4
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lincosamydes, tetracyclines and chloramphenicol should not be
used for the empiric therapy of nosocomial skin and soft tissue
infections caused by S. aureus.
P1354 Staphylococcus hominis subsp. novobiosepticus –
new pathogen in nosocomial infections
M. Balejova, P. Petras
Ceske Budejovice, Prague, CZ
Objectives: To evaluate phenotype properties of 67 strains of Sta-
phylococcus hominis subsp. novobiosepticus, cultured in the Depart-
ment of Bacteriology, Ceske Budejovice Hospital in 1999–2003.
Methods: Isolates of coagulase-negative staphylococci from clinic-
ally important material have been analysed using biochemistry
identiﬁcation system STAPHYtest 16. Resistance to novobiocine
was determined by a disc-diffusion test. Novobiocine-resistant
strains were evaluated by ORIDES system. Susceptibility to anti-
microbials was tested by quantitative dilution test. The results
were conﬁrmed in the National Reference Laboratory. This facility
also tested the capability to produce slime using the method of
growth in Congo red, and the presence of staphylococcal delta
lysine by exposing its synergy with beta b-haemolysine.
Results: The majority of evaluated strains of Staphylococcus hominis
subsp. novobiosepticus tested in Staphytest 16 (Pliva-Lachema Brno)
with their typical biochemical proﬁle. The glucose-novobiocine
test was, however, in most cases false-positive. The strains were
easy to be identiﬁed in the ORIDES system. One 100% of strains
were resistant to oxacillin. Resistance rate to erythromycine, clind-
amycine, chloramphenikol and ciproﬂoxacine exceeded 90%. All
strains were susceptible to teicoplanin and vancomycine. Slime
was produced by 98.5% of strains, and staphylococcal delta
haemolysine was produced by 79% of strains.
Conclusions: In 1999–2003, we have isolated from clinically import-
ant materials total of 67 strains of Staphylococcus hominis subsp. no-
vobiosepticus. Blood cultures accounted for 48% of these strains,
vascular catheters 42, and 10% were found in other clinically sig-
niﬁcant materials. This recently recognised Staphylococcus subspe-
cies mostly evades to be diagnosed, since it is missing in the
database of majority of marketed diagnostic sets. Strains of this
subspecies manifest unusually high resistance to antimicrobials
and signiﬁcant production of virulence factors – namely slime
and staphylococccal delta lysine. These properties can make it a
dangerous nosocomial pathogen.
P1355 Pathogenic Staphylococcus epidermidis bloodstream
isolates: PFGE analysis and bioﬁlm formation
B. Parschalk, H. Adametz, F. Yassin, A.-M. Hirschl, W. Graninger,
E. Presterl
Vienna, A
Background: In this analysis, 60 bloodstream isolates of patients
with clinically deﬁned infections and 60 nonpathogenic Staphylo-
coccus epidermidis were investigated for particular genotypes
responsible for infection.
Methods: During the years 19982 –2000 blood stream isolates from
60 patients with S. epidermidis foreign body infections, and 60 iso-
lates from case-matched controls without foreign body infection
were collected at the University Hospital of Vienna. Cases were
matched with regard to hospital placement and time of bacterae-
mia. All isolates were typed by pulsed-ﬁeld electrophoresis, and
essayed for formation of bioﬁlms in static bioﬁlm model. Isolates
were clustered by the unweighted pair group method of arith-
metic averages. Similarity (SAB) between paired isolates A and B
was calculated from the constructed dendrogram. Isolates were
considered to be of the same strain if SAB was 100%; to be rela-
ted or closely related variants if SAB was 80 or 90%, respect-
ively; or to be distinct strains if SAB was <80%.
Results: Thirty-one clusters of related or closely related strains
were identiﬁed. Twelve small clusters with identical strains were
identiﬁed occurring in 12 patients and in 11 controls. Strains of
three of the clusters only were isolated at the same ward at the
same time strains of the other nine clusters were distributed
over the whole hospital. Patients had infections of implanted
pacemakers, central venous catheters and prosthetic valves. They
had signiﬁcantly higher temperatures and a lower platelet count
than controls (38.8 + 1.0C vs. 37.9 + 1.1C, and 158 + 91 vs.
233 + 122 g/L, respectively, P < 0.05). Bioﬁlms were formed by
87% of the pathogenic isolates.
Conclusion: Small clusters of S. epidermidis strains were isolated
from patients and controls as well, thus distinct strains causing
bacteraemia and infection were not identiﬁed.
P1356 Resistance proﬁles in bioﬁlm-positive strains of
Staphylococcus epidermidis isolated from blood cultures
V. Hola´, F. Ruzicka, R. Tejkalova, M. Votava
Brno, CZ
Objectives: Bioﬁlm formation on the surface of medical devices
represents a serious problem that is magniﬁed with the increasing
use of prosthetic devices. The bioﬁlm-forming bacteria difﬁcult to
eradicate with antibiotics often cause chronic infections. Determin-
ation of minimum inhibitory concentration (MIC), based on activ-
ities of antimicrobial agents against planctonic bacteria, is
conventionally used for antibiotic susceptibility testing. Bioﬁlm
phenotypes have different susceptibility proﬁles. The Minimum
Bioﬁlm Eradication Concentration (MBEC) was measured on bio-
ﬁlm grown on pegs of the polystyrene plate. The aim of this study
was to determine the resistance proﬁles of 45 blood culture-iso-
lates, which were bioﬁlm-positive by genotypic and phenotypic
methods.
Methods: The 45 Staphylococcus epidermidis strains repeatedly isola-
ted from blood cultures were used in this study. All isolates were
ica-positive and showed the phenotypic ability to form bioﬁlm.
As the control, ﬁve ica-negative, bioﬁlm-negative strains were
used. For the antibiotic testing, the plates of polystyrene with 96
pegs that ﬁt into standard microtitre plates were used. The pegs
of the plates were coated with poly-L-lysine and transferred into
microtitre plate with a fresh overnight culture of staphylococcal
strains to enable primary adhesion. For the quantiﬁcation of
attached cells soniﬁcation was used. After 18 h of bioﬁlm forma-
tion the plates were transferred into microtitre plates containing
logarithmic dilutions of antibiotics (penicillin, oxacillin, chloram-
phenicol, tetracycline, co-trimoxazole, erythromycin, clindamycin,
ciproﬂoxacin, gentamicin, teicoplanin and vancomycin). After
overnight cultivation the plates were transferred into colorimetric
medium, which indicates metabolic activity of surviving cells. The
changes of the medium were detected spectrophotometrically. The
MBEC was determined as the minimal concentration of antibiotics
that eradicates the bacteria and so inhibits their metabolic activity.
Results and conclusions: All the tested strains showed drastically
higher resistance to all the above-mentioned antibiotics when tes-
ted in bioﬁlm form. All antibiotics exceeded maximal concentra-
tions achievable in human plasma. That explains why the
treatment of these infections with normal dosage of antibiotics
often fails. The study was supported by the grant IGA 6818-3 of
the Ministry of Health and grant 0463-2003 FRVS.
P1357 Staphylococcus lugdunensis: an emerging pathogen
in bone and joint infections? Report of 17 cases
S. Khatibi, E. Bonnet, M. Archambaud, G. Giordano,
B. Chaminade, P. Bonnevialle, C. Cauhepe, R. Bauriaud,
B. Marchou, P. Massip
Toulouse, F
Objectives: To describe epidemiological and clinical features, and
outcome of 17 cases of S. lugdunensis bone and joint infections in
traumatologic and orhtopaedic units in two university hospitals in
Toulouse (Southern France)
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Patients and methods: We conducted a retrospective study over a
7-year period (1996–2002) in two orthopaedic-traumatological
units. Inclusion criteria were: patients with articular signs or ﬁs-
tula, positive pure cultures for S. lugdunensis from articular ﬂuid
or surgical samples. First identtiﬁcation criteria for S. lugdunensis
were: ornithine de´carboxylase, L-pyrrolidonyl arylamidase and
catalase-positive tests, negative-coagulase test. Full identiﬁcation
was assessed by API ID32 Staph Gallery (Bio Me´tieux). Criteria
for a favourable outcome were: lack of pain, disability or local
inﬂammatory signs.
Results: Our study included 17 patients (10 male and seven
female). Mean age was 56 years (30–87). Seven patients had co-
morbidity factors (history of cancer: three, rheumatoid arthritis:
one, rheumatoid spondylitis: one, diabetes mellitus: two). Fifteen
had a bone or joint foreign body (joint prosthesis: nine (hip: ﬁve,
knee: four), osteosynthesis: six). Mean time between surgical
operation and S. lugdunensis identiﬁcation was 52 weeks (3–26),
mean time between clinical signs and S. lugdunensis identiﬁcation
was 12 weeks (2–104). Twelve patients had local inﬂammatory
signs, only four had fever. In all cases pus and/or macroscopic
inﬂammatory signs were noted by surgeons during operation. All
strains of S. lugdunensis were susceptible to oxacillin and only six
(35.3%) and one (6%) were, respectively, resistant to penicillin
and ﬂuoroquinolones. However 13 (76.5%) were resistant to phos-
phomycin. All patients received antibiotics (combination: 11
cases), for a mean period of 12 weeks (3–63): quinolones: nine,
oxacillin : 8, rifampin : 8, fusidic acid : 2, clindamycin : 2, pristina-
mycin : 3, miscellaneous: three. All patients but two had also a
surgical treatment. Mean follow-up time was 15 months (2–48). A
favourable clinical course of the S. lugdunensis infection was
observed in all cases except for the two patients who had no sur-
gical treatment.
Conclusions: S. lugdunensis is an emerging pathogen, associated
with infections of orthopaedic devices. Inﬂammatory signs and
macroscopic aspects are similar to those described in S. aureus
infections. As for other pathogens, treatment of such infections
must associate surgery and general antibiotherapy.
Nosocomial infections: multiresistant Gram-negative bacteria
P1358 Clinical presentation and outcome of multi-resistant
Enterobacter aerogenes infections: a review of 116 episodes
J. Frankard, B. Byl, H. Rodriguez-Villalobos, C. Me´lot,
J.-L. Vincent, M. Struelens, F. Jacobs
Brussels, B
Objectives: Multi-resistant Enterobacter aerogenes (MREA) is a major
nosocomial pathogen associated with epidemics in several coun-
tries, including Belgium. The objective of this study was to assess
the clinical and therapeutic aspects and outcome of MREA infec-
tions in a 858-bed academic hospital.
Methods: We retrospectively reviewed the medical ﬁles of patients
(pts) with a positive culture for MREA over a 5-year period and
selected those with infection according to CDC criteria. Antimicro-
bial susceptibility was determined by standard disc diffusion and
extended-spectrum b-lactamase (ESBL) screening was performed
by double-disc potentiation test. Isolates were considered multi-
resistant if resistant to third generation cephalosporins and to a
ﬂuoroquinolone and/or an aminoglycoside.
Results: MREA was isolated in a total of 347 hospitalisations and
was responsible for infection in 122 (35%). Among the 116 stud-
ied episodes, foci of infection were: urinary (43), respiratory (39),
abdominal (20), soft tissue (eight), blood (three), central venous
catheter (two), and bone (one). Infection was polymicrobial in 36
cases and associated with bacteraemia in 17. At total of 63 epi-
sodes were complicated by sepsis (24), severe sepsis (18) or septic
shock (21). Most pts with urinary infection (UI) had no signs of
sepsis by contrast to pts with pneumonia and peritonitis (27/39
and four of six, respectively). ESBL production was identiﬁed in
79% of the strains. Appropriate treatment consisted of merope-
nem (71%), temocillin (22%, given only for UI) and cefepime
(6%) combined with aminoglycosides in 43 episodes (37%). Clin-
ical outcome was favourable in 58% of the cases; 38 patients died
(34%), 32 due to infection. The highest mortality rate was found
in patients with peritonitis (67%), catheter-related infection (50%)
and pneumonia (41%) while the lowest rate was found in patients
with urinary infection (9%). Multivariate analysis outlined sepsis
as the only factor statistically associated with increased risk of
mortality. Microbiological eradication was obtained in 46.5%.
Temocillin in uncomplicated urinary infection had a favourable
clinical outcome in 97% of the cases and microbiological eradica-
tion in 50%.
Conclusion: Nonurinary MREA infections can be associated with
severe initial clinical presentation and non-negligible mortality.
Given the favourable clinical outcome, temocillin could be used
for selected patients with uncomplicated urinary tract infection.
P1359 ESBL-producing Enterobacter aerogenes outbreak in
neonates hospitalised in a neonatal unit
J. Komarnicka, T. Czajkowska, I. Domzalska-Popadiuk, B. Rybak,
A. Thrun, E. Czarniak, A. Samet, J. Szczapa
Gdansk, PL
Objectives: Analysis of a nosocomial ESBL-producing Enterobacter
aerogenes outbreak in neonates.
Methods: We analysed medical reports and results of bacteriologi-
cal and epidemiological data from October 2002 to April 2003 in
our Department of Neonatology (63 beds with eight on NICU).
Identiﬁcation and susceptibility was performed by routine meth-
ods and VITEK (bioMerieux). Production of ESBL was detected
by double disc-diffusion method. Colonisation was determined by
a positive rectal/throat culture without any sign of infection.
Results: Outbreak strain which was susceptible only to imipenem,
meropenem and ciproﬂoxacin was isolated from 71 patients: 41
with respiratory distress syndrome, 19 congenital infection, ﬁve
dysadaptation, two persistent fetal circulation, two asphyxia, two
NEC. Only four of the neonates were born at term, other were
premature (48, born in 30–38 Hbd and 18 before 30 Hbd). 41 were
colonised and 30 had infections: nine with sepsis, 12 pneumonia,
11 UTI, two osteomyelitis, one soft-tissue infections (several
patients had more than one infection). E. aerogenes ESBL+ was iso-
lated in October–April from 1.8, 8.6, 14, 17, 13, 7.4 and 2.9% of all
hospitalised neonates, respectively.
Conclusion: We considered that 42% patients developed infection
and were therefore treated with carbapenems. The outbreak
ended after the implementation of the strict infection control.
P1360 Study of antibiotic resistance, production of ESBL
and other virulence factors in enterobacterial strains isolated
from nosocomial infections in cardiovascular devices inserted
patients
V. Lazar, O. Banu, C. Balotescu, R. Cernat, A. Cotar, O. Dracea,
C. Bleotu
Bucharest, RO
Introduction: Since 1980s, ESBL-producing microorganisms, mostly
Enterobacteriaceae emerged in the whole world. The increasing
use of broader-spectrum cephalosporins is one of the major fac-
tors responsible for the high rate of selection of ESBL-producing
microorganisms in Romanian hospitals.
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Purpose: To establish the incidence of ESBL-producing enterobac-
terial strains isolated from cardiovascular devices (CDs) inserted
patients in the intensive care unit of the Institute of Heart Disease
‘C.C. Iliescu’ and to correlate the ESBL production with other
virulence factors and with the plasmidial proﬁle of these strains.
Methods: Antibiotic susceptibility determined by the disc diffusion;
double disc-diffusion for ESBL phenotype detection; in vitro study
of adherence and invasion capacity to HeLa cells investigated by
gentamycin-protection assay; adherence to an inert substrate evalu-
ated by the slime test; other virulence factors: Kanagawa and sheep
erythrocytes haemolysins, DNase, lipase, lecitinase, amylase, gela-
tinase, mucinase and caseinase, Congo red test were tested on spe-
ciﬁc media; plasmid DNA isolation by alkaline lysis method.
Results: In our study enterobacterial strains are placed on the sec-
ond place in the aetiology of infections in CDs inserted patients,
after staphylococci. The incidence of the main antibiotic markers
was: 65% for aminopenicillins, 60% for third generation cephalo-
sporins, 20% for aminoglycosides and 25% for ﬂuoroquinolones.
The ESBL screening test was positive in 60% of these strains. The
multi-resistance feature was not associated with the production of
other enzymatic virulence factors, which proved to be very poor
for the tested strains. In exchange, the adhesion to the inert and
to the cellular substrate proved to be a general feature of ESBL-
producing enterobacterial strains. The plasmid DNA analysis
revealed the presence of variable number of plasmids (ranging
from 2.5 kbp to 30 kbp) in 20% of strains.
Conclusion: All isolated enterobacterial strains proved to be mul-
tiple drug resistant and of great concern is the fact that the third
generation cephalosporins resistance and ESBL-production were
highly prevalent in these strains suggesting the emergence of no-
socomial infections with b-lactamases producer strains. The gen-
etic determinism was in the great majority of cases nonplasmidial.
The resistance to b-lactams is probably accompanied by changes
in the bacterial wall structure promoting the adhesins expression.
P1361 Urinary pathogens in a general hospital in Greece:
antimicrobial resistance and incidence of ESBL producing
strains during 2001–2003
F. Markou, A. Poulou, F. Mountaki, X. Efthimiou
Serres, GR
Objectives: The aim of this study was to determine the incidence
of urinary pathogens, their antimicrobial resistance and the detec-
tion of ESBL-producing strains, which is necessary to guide anti-
bacterial therapy selection.
Methods: A total of 12640 urine samples were examined in our
laboratory in northern Greece during 2001–2003. The Auto Scan-4
system of Dade Behring was used to identify the bacteria isolated
and evaluate their susceptibility to common antibiotics. Discs of
ceftazidime 30 lg, ceftazidime/clavulanic 30/10 lg, cefotaxime
30 lg, and cefotaxime/clavulanic 30/10 lg were used to determine
the presence of ESBL production among E. coli and Klebsiella spp.
and the results were interpreted according to NCCLS guidelines.
Results: A total of 2852 urine cultures were positive, (22.5%). The
most frequently isolated pathogens were: E. coli 1912 (67%), Pro-
teus spp. 253 (8.9%), Klebsiella spp. 189 (6.6%), Pseudomonas spp.
113 (3.9%), Enterococcus spp. 102 (3.6%), Enterobacter spp. 78
(2.7%), Acinetobacter spp. 38 (1.3%), Citrobacter spp. 28 (1%), Ser-
ratia 16 (0.6%), Staph aureus 21 (0.7%), Staph epidermidis 20 (0.7%),
Staph saprophyticus 11 (0.4%), other CoNS 19(0.7), and fungus 34
(1.2%). The incidence of ESBL producing strains among the iso-
lated E. coli and Klebsiella spp. was 3.24% (62 of 1912) and 8.47%
(16 of 189) respectively. The resistance rates (%) for E. coli, Pro-
teus spp. and Klebsiella spp. to antimicrobial agents were as fol-
lows: amoxicillin/clavulanic 12/21/12, cefuroxime 10/17/17,
ceftazidime 5/8/7, ciproﬂoxacin 11/20/12, trimethorpim/sulpha-
methoxazole 20/37/14, amikasin 6/6/5. The resistance of Pseudo-
monas spp. to amikasin was 26%, ceftazidime 19%, cefotaxime
75%, ceﬁpime 26%, ciproﬂoxacin 40%, imipenem 16%, piperacil-
lin/tazobactam 5%. Enterococcus spp. were resistant to ciproﬂoxa-
cin 35% while strains resistant to Vancomycin and Teicoplanin
were not observed.
Conclusions: As expected the prevalent urine pathogen was E. coli.
It was observed that acinetobacter and enterobacter were more
sensitive to ampicillin/sulbactam (60.67%) than amoxicillin/cla-
vulanic (25.20%). Ceftazidime is more efﬁcient against Pseudomon-
as spp. than cefotaxime and ceﬁpime. The rates of ESBL
producing strains of E. coli and Klebsiella spp were similar to those
of other studies reported from our country and these strains
showed decreased susceptibility to nonlactamic antibiotics com-
pared with non-ESBL producing strains.
P1362 Clinical and epidemiological analysis of Klebsiella
pneumoniae bacteraemia in a neonatal department
E. Czarniak, J. Komarnicka, A. Sledzinska, A. Samet, J. Kur,
J. Szczapa
Gdansk, PL
Objective: The aim of this study was to analyze the epidemiologi-
cal and clinical characteristics of patients with extended-spectrum
b-lactamase-producing Klebsiella pneumoniae (KP ESBL) bacterae-
mia.
Methods: Study period covered ten months from April 2002 to
January 2003. We retrospectively studied the records of patients
with KP ESBL detected in blood. Specimens were incubated in
automated system BacT/Alert (Bio Merieux). Identiﬁcation and
susceptibility was performed by VITEK system (Bio Merieux) and
disc-diffusion method according to the NCCLS standards.
Molecular study of isolates was done using ADSRRS-ﬁngerprint-
ing.
Results: KP ESBL was recovered from blood of 10 patients. All of
them were earlier colonised by KP ESBL. Neonates (60%) were
female, mean gestational age was 32.7 weeks, mean birth weight
was 1638 g, 70% of deliveries were by cesarean section, mean
1 min Apgare score was 5.7, in 50% of neonates mechanical venti-
lation were necessary and 40% were ventilated longer than
5 days, all of neonates had parenteral nutrition in the beginning
of life, mean hospital stay was 52 days. Bacteraemia occurred
between 4 and 45 days of life. Comparing infected and colonised
neonates (n ¼ 86) we found: higher gestational age (34.2 weeks),
higher birth weight (2089 g), higher 1 min Apgar score (6.6), shor-
ter hospital stay (30.1 days) in colonised patients. 44.2% of colo-
nised neonates were mechanically ventilated however only 10.5%
of analysed population were ventilated more than
5 days. Molecular study with ASDSRRS-ﬁngerprinting con-
ﬁrmed that only one genotype was responsible for that outbreak.
Conclusions: We detected an outbreak of KP ESBL bacteraemia
affecting immature neonates with some risk factors. ADSRRS-ﬁn-
gerprinting which is a new typing method proved useful in deter-
mining the strain responsible for infections.
P1363 Molecular epidemiology of ESBL-producing
Klebsiella from different perinatal intensive care units (PICUs)
in Hungary
I.B. Damjanova, A´. To´th, J. Pa´szti, M. Jakab
Budapest, HUN
Objectives: Molecular and phenotyping of 132 ESBL-producing
K. pneumoniae and K. oxytoca strains from seven PICU outbreaks
in ﬁve Hungarian county hospitals.
Methods: Conﬁrmation of ESBL production by E-test, double-disc
diffusion and agar dilution methods according to the NCCLS;
PCR analysis for b-lactamase detection using speciﬁc primers;
phage typing, resistance transfer, plasmid proﬁle analysis, genom-
ic ﬁngerprinting by ERIC-PCR and PFGE.
Results: The isolates were multidrug-resistant but were still sus-
ceptible to ciproﬂoxacin. Of 132 isolates, 103 belonged into six dif-
ferent phage types, but 29 were not typable. ERIC-PCR was
performed on all strains and we found ﬁve major ERIC-types and
nine subtypes. PFGE analysis revealed seven different genetic
clones at 85% homology level. All isolates harboured plasmids
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ranging from 2 to 140 MDa in 12 plasmid proﬁles. The sequence
analysis of the SHV PCR products showed that SHV-2a was pre-
sented in two outbreak clones, SHV-5 in ﬁve outbreak clones, and
two isolates carried both SHV-5 and SHV-26. Of these, SHV-2a
and SHV-5 were on transferable plasmids.
Conclusions: These results show that SHV-2a and SHV-5 are the
most prevalent ESBLs producing by klebsiellae in hungarian PI-
CUs. Our work also conﬁrms that ERIC-PCR, when it is combi-
ning with phage typing, plasmid proﬁle analysis and PFGE is an
effective tool for investigating the epidemiologies of ESBL-produ-
cing K. pneumoniae and K. oxytoca strains.
P1364 Adhesion to and invasion of human epithelial cells
by ESBL and non-ESBL-producing Klebsiella pneumoniae strains
H. Sahly, R. Podschun, S. Schutt, U. Ullmann
Kiel, D
Objective: Extended spectrum b-lactamse (ESBL)-producing Klebsi-
ella pneumoniae strains are suggested to possess higher pathogenic
potential than non-ESBL-producing strains, mainly by virtue of
their higher ability to adhere to human epithelial cells, and to resist
the bactericidal activity of serum and the phagocytosis by poly-
morph nuclear leucocytes. Because the adhesion to and invasion of
epithelial cells are considered to be major virulence factors of bac-
teria that are prerequisites for the infectious process we sought to
compare the ability of ESBL and non-ESBL-producing Klebsiella
pneumoniae isolates to adhere to and invade human epithelial cells.
Methods: The invasion of human ileocecal (HCT8), bladder (T24)
and lung epithelial cells (A549) by ESBL-producing and non-
ESBL-producing Klebsiella pneumoniae strains was tested using an
imipenem killing assay. In total, 28 ESBL-producing and 48 non-
ESBL-producing Klebsiella pneumoniae strains were tested. Six
ESBL-producing strains bearing the ESBL-coding plasmid were re-
tested for their adhesion and invasion ability after eliminating of
the R-plasmid.
Results: No signiﬁcant differences could be shown between the
ability of ESBL-producing strains and non-ESBL-producer to
invade the HCT8 ileocaecal (2.7  3.4% of inoculum vs.
2.7  3.7%), the T24 bladder (0.94  1.8% vs. 0.75  0.8%) or
A549 lung epithelial cells (0.06  0.27% vs. 0.12  0.54%)
(P > 0.05). Likewise, the adhesion of the ESBL and non-ESBL-pro-
ducing isolates to the HCT8 cells did not differ signiﬁcantly
(51.6  26.3%; 63  17.6) (P > 0.05). Plasmid curing did not inﬂu-
ence the ability of the strains to adhere to or invade the HCT8
cells, all six plasmid-cured derivatives retained the same adhesion
and invasion potential to the HCT8 epithelial cells (54.6  43%
and 2.9  3.1%) (P > 0.05).
Conclusion: The results indicate that the ESBL-coding plasmids do
not contribute to the sadhesion or invasion potential of Klebsiella
pneumoniae.
P1365 Isolation of multi-resistant strains of Klebsiella
oxytoca from neonatal intensive care unit – colonization or
infection?
J. Jursa, A. Kordek, S. Giedrys-Kalemba
Szczecin, PL
Introduction: Existence of MDR strains of Gram() rods creates
serious epidemiological danger and therapeutic problem in newb-
orns’ infections and it is important to differentiate between colon-
ization and infection.
Objective: The aims of the study were: analysis of the occurence of
ESBL and antibiotic susceptibility of Klebsiella oxytoca (K. ox.)isola-
ted from newborns, determine the genetic relatedness between
strains and differentiation between colonisation and infection in
the cases of newborns from whom K. ox. was isolated.
Material and methods: A total of 26 K. ox. isolated from newborns
hospitalised in NICU between b October 2002 were tested for anti-
biotic susceptibility (by NCCLS) and the DD test for detection of
ESBL. To molecular typing of K. ox. isolates was used PFGE
(Xba). 13 cases of the newborns with MDR K. ox. were analysed.
Attention was paid: Apg. scale, HBD, birth weight, clinical state
during the hospitalisation and duration, the day of hospitalisation
in which K. ox. was isolated, treatment and potential coexisting
diseases.
Results: All strains of K. ox.: produced ESBL, were sensitive to:
amox.-clav. acid, aminoglicosides and carbapenems. Analysis of
the banding pattern for the isolates can be divided into two types:
A (three newborns) isolated between 8 September 2002 and B (13)
9 October 2002.Two of them were isolated from one newborn in
different time. In analysed 13 newborns’ group: four of colonisa-
tion (without any symptoms) and nine cases of infection was
found. In all of colonised newborns K. ox. was isolated up to ﬁfth
day of hospitalisation. Ampicillin and meropenem were adminis-
trated in prophylaxis in two cases with low weight. In all of infec-
ted newborns K. ox. was isolated after 10th day of hospitalisation.
Ampicillin, amikacin, meropenem were administrated. Character-
istics of infected newborns: one born in good condition with
proper weight, diarrhoea was the only symptom; eight premature
birth: one born in good condition with weight 1750 g developed
NEC; seven born in medium or severe manifestations appeared
(pneumonia, meningitis and sepsis). One of them died. The
duration of hospitalisation 13–57 days.
Conclusions: All ESBL + K. oxz. belong to two genetic types. Isola-
tion of the same type from different newborns during 3 months
spreading of the bacterium clone on the department. Colonisation
developed in cases of healthy newborns. Infection developed in
cases of newborns with low weight and severe or medium condi-
tion, more often during long hospitalisation.
P1366 Antimicrobial resistance of Gram-negative bacilli
isolated from patients with bloodstream infections in ICUs
A. Yuce, M. Erdenizmenli, N. Yapar, S. Senger
Izmir, TR
Objectives: To investigate antimicrobial resistance of Gram-negat-
ive rods causing bloodstream infections (BSI) in the ICU of a uni-
versity hospital in Turkey.
Methods: The study included 27 Pseudomonas aeruginosa, 44 Acine-
tobacter spp, 16 Klebsiella pneumoniae, and 12 Escherichia coli isola-
ted from the blood samples of patients having bloodstream
infections in the period of 2000–2003. The antibiotic susceptibilities
and extended-spectrum b-lactamase (ESBL) production were
determined by Etest (AB BIODISC) using Mueller–Hinton agar
(OXOID) according to NCCLS recommendations.
Results: The antibiotic resistances and rates of ESBL production of
the strains are presented in the table.
Conclusions: Among the microorganisms causing BSI multi-drug
resistant Acinetobacter spp was the leading pathogen. Regarding
all the strains, carbapenems and cefepime are identiﬁed as the
most effective antimicrobial agents.























spp (n ¼ 44)
84 98 100 100 100 98 100 98
P. aeruginosa
(n ¼ 27)
59 85 85 70 85 81 77 92
K. pnemoniae
(n ¼ 16)
0 43 81 94 87 94 69 62 10
(62%)
E. coli (n ¼ 12) 0 0 33 50 66 66 25 25 3
(25%)
MEM: Meropenem, IPM: Imipenem, CAZ: Ceftazidime, CIP:
Ciproﬂoxacin, P+T: Piperacillin-tazobactam, Tom: Tobramylin,
PM: Cefepime, CTX: Cetotaxime
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P1367 Risk factors for ICU-acquired imipenem-resistant
Gram-negative bacterial infections
E. Akinci, A. C¸olpan, H. Bodur, N. Balaban, A. Erbay
Ankara, TR
Objective: Intensive care units are high-risk areas for imipenem-
resistant ﬁnfections. The main objective of this study was to
investigate risk factors for ICU-acquired imipenem resistant
Gram-negative bacterial infections and to develop strategies to
prevent imipenem resistance in our hospital.
Patients and methods: This study was conducted prospectively in
three surgical and one medical ICUs from April to December 2002
at a tertiary care hospital in Ankara. The patients who had ICU-
acquired Gram-negative infections were included in the study. The
patients were assigned as imipenem-resistant (IR) cases if they had
IR bacterial infections and as imipenem-sensitive (IS) cases if they
had IS bacterial infections. ICU-acquired Gram-negative infections
were detected in 128 patients during the study period. Overall 163
Gram-negative infections were diagnosed. Of the 128 patients, 42
had IR Gram-negative infections and 86 had IS Gram-negative
infections. Overall 173 Gram-negative bacteria were isolated from
the clinical specimens of the infected patients. Of these bacteria, 52
were IR and 121 were IS. The highest imipenem resistance rate
was detected in Acinetobacter spp (67.4%), and followed by P. aeru-
ginosa (48.3%). IR Gram-negative bacteria were most frequently
recovered from surgical site cultures (30.8%). However, IS Gram-
negative bacteria were most frequently recovered from urine cul-
tures (49.7%). According to the univariate analysis, hospital stay
before ICU admission, hospitalisation period before ICU, length of
ICU stay, surgical ICU stay, surgical operation, previous antibiotic
use and previous administration of imipenem, meropenem, pipera-
cillin-tazobactam, fourth generation cephalosporin, aminoglycoside
and glycopeptide were signiﬁcant risk factors for IR infections
(P < 0.05). In multivariate analysis, length of ICU stay (OR, 1.02;
95% CI, 1.00–1.04), surgical operation (OR, 4.31; 95% CI, 1.79–
10.35) and previous carbapenem use (OR, 3.31; 95% CI, 1.22–8.98)
were independently associated with imipenem resistance.
Conclusions: This study suggests that long ICU stay, surgical
operation and administration of carbapenem were major risk fac-
tors for IR Gram-negative infections.
P1368 Epidemiology of integron-associated resistance in
two ICUs during a nonoutbreak period
S. Nijssen, A. Florijn, M. Bonten, A. Fluit
Utrecht, NL
Objective: Integrons (ints), present on plasmids and transposons in
Gram-negatives play a role in horizontal transfer (HT) of antibi-
otic resistance. Little is known about the prevalence, incidence,
and HT of int-associated resistance in Enterobacteriaceae in a non-
outbreak period in an intensive care unit (ICU).
Methods: During an 8-month period all patients (pts) admitted to
two ICUs were screened for rectal colonisation with Enterobacte-
riaceae with reduced susceptibility to cephalosporins (ERSC) by
means of rectal swabs taken on admission and twice weekly
thereafter and cultured on agar with cefpodoxime. Isolates (iso)
were identiﬁed using the VITEK. Two iso of each species/pt
were selected for susceptibility testing, int-speciﬁc PCR, and
AFLP genotyping. Ints were characterised by CS-PCR, RFLP and
DNA sequencing. Demographics and data on antibiotic use were
collected.
Results: In total, 458 pts were admitted to these ICUs of which 121
were colonised with ERSC. A total of 61 pts were colonised on
admission and 56 acquired colonisation in the ICU. A total of 174
iso were selected and 52 iso of 29 pts (24%) carried at least one
int. The daily endemic prevalence of ints was 7% (range: 0–33%).
Multivariate analysis did not reveal risk factors for acquisition of
int-positive isolates. Characterisation revealed three groups con-
taining the majority of int-positive iso. Two of these groups were
only found in E. coli iso collected from ICU-1. The ﬁrst group
comprised 11 iso carrying two ints with the aadA2 and the aadB/
catB3 genes. The second group comprised four iso carrying an int
with the dfrIa and aadA1a genes. The third group comprised
eight E. cloacae iso, one K. oxytoca iso, and one K. pneumoniae iso
from ICU-2, which carried an int-containing the aadB gene. Iso
carrying identical ints were, with a few exceptions, part of the
same AFLP clusters. HT of a complete int-carrying organism
(i.e. cross-transmission) was identiﬁed four times (two times in
each ICU). HT of an int was suspected in two patients colonised
with genetically different iso of E. coli. Tranfer of an int from
E. cloacae to K.oxytoca isolated within a pt was identiﬁed once.
Conclusion: No risk factors for acquisition of int-positive isolate
could be identiﬁed. HT of a complete int-carrying organism is
more likely than HT of individual ints.
P1369 Intravenous (IV) colistin for the treatment of
multiresistant Gram-negative bacilli: review of experience in 30
patients
F. Kidd, S. Arias-Lopez, D. Socivica, B. Byl, M.J. Struelens,
J.-L. Vincent, F. Jacobs
Brussels, B
Objectives: Colistin (IV) could be a therapeutic option for the treat-
ment of infections due to multiresistant Gram-negative bacilli. As
data on efﬁcacy and tolerance with this drug are limited, we
report our experience with colistin.
Methods: We reviewed the medical charts of all patients (pts) trea-
ted with IV colistin for systemic infection due to multiresistant
Gram-negative bacilli.
Results: From January 2001 to October 2003, 32 episodes of infec-
tion (two with different multiresistant strains) due to Pseudomonas
aeruginosa (22), Enterobacter spp (three pts), Acinetobacter baumannii
(three) or others (six) were treated with IV colistin in 30 pts (12 F,
18 M, median age 61 years). At initiation of treatment, the median
APACHE II score was 16 (range: 8–27). Nineteen pts were treated
in the ICU. Infections were pneumonia (16, including ﬁve ventila-
tor-associated pneumonia), intra-abdominal (nine), urinary (ﬁve),
catheter-related infections (ﬁve) and others (ﬁve). Ten pts were
bacteraemic. Twenty-seven of these 32 infections had been previ-
ously treated with other antibiotics. Colistin was used at a median
dosage of 3.5 (range: 1–8) million unit daily for a median of
10 days (1–70 days). In all cases, another antibiotic was added
despite in vitro resistance: meropenem (13; eight standard dose,
six double dose), ceftazidime (15; 11 by continuous infusion), ce-
fepime (three) or aztreonam (one). Fourteen episodes beneﬁted
from concomitant drainage or catheter removal. A good clinical
outcome was achieved in 13 patients (43%). Seventeen patients
died after a median of 11 days of colistin treatment (range 1–
26 days), 11 probably related to infection. Microbiological eradica-
tion was obtained in eight of the 23 pts (35%) who were treated
for at least 7 days. Signiﬁcant side effects were reported in eight
patients: alteration in renal function (doubling of serum creati-
nine) in seven pts (renal function returned to near baseline in all
survivors) and myoclonia due to excessive dose in one pt.
Conclusions: These retrospective data suggest that IV colistin could
represent a valuable therapeutic option for the treatment of infec-
tions caused by multiresistant. Gram-negative bacilli. since toler-
ance of the drug appears to be good, higher doses may be
considered to improve outcome.
P1370 The frequency of multidrug-resistant bacteria from
clinical samples
A. Dedeic Ljubovic, M. Hukic, M. Hadjijamakovic, A. Zvizdic,
M. Sisirak
Sarajevo, BIH
Objectives: To analyse the frequency of multiresistant bacteria iso-
lated from urine, blood and wound swabs culture.
Methods: During 3-month study we analysed isolates from urine,
blood and wound swabs, which were resistant to three and more
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antibiotics. Susceptibility testing was performed by Kirby-Bauer
disc-diffusion method following NCCLS guidelines.
Results: In urine culture 470 (24.5%) of total 1918 isolates were
multidrug resistant. The most frequently isolated microorgan-
ism was Klebsiella pneumoniae with total of 165 (34.2%), followed
by Escherichia coli with 123 (26.2%) and Proteus mirabilis 42
(9%). Urine samples from neurology and nephrology depart-
ments had the highest rate of multidrug-resistant microorgan-
ism. In blood culture 115 (58%) of bacteria were multidrug-
resistant. The most frequently isolated microorganisms among a
total of 115 isolates were: coagulase-negative staphylococci
(CNS) 60 isolates (52%), Acinetobacter calcoaceticus 11 (9.5%),
Pseudomonas aeruginosa nine (7.8%), Klebsiella pneumoniae eight
(7%), Serratia marcescens seven (6%), Enterococcus faecalis six
(5.2%) ans Staphylococcus aureus ﬁve (4.3%). Blood samples
from paediatric, haematology and Department for Infectious dis-
eases had the highest rate of multidrug-resistant microorgan-
isms. In wound swab culture 109 (15.8%) of isolates were
multidrug resistant. Staphylococcus aureus was the most frequent
with total of 54 (50%), followed by A. calcoaceticus 17 (15.5%),
E. faecalis 12 (11%) and S. marcescens 9 (8.3%). Orthopaedic and
plastic surgery departments had the highest rate of multidrug-
resistant bacteria in wound samples. All Gram-negative bacilli
expressed high frequency of resistance to Ampicillin, cefalospo-
rins I and II generation, aminoglycosides and quinolones, mod-
erate resistance to cephalosporin IV generation -Cefepime, and
high sensitivity to Imipenem and Amicacin. Gram-positive
cocci Staphylococcus aureus and coagulase-negative staphylococci
were in high per cent resistant to oxacillin. E. faecalis expressed
resistance to almost all antibiotics, except to amoxicillin + cla-
vulanic acid.
Conclusions: Resistance to antibiotics has been permanently devel-
oping as well. Klebsiella pneumoniae, coagulasa-negative staphylo-
cocci and Staphylococcus aureus are the most frequently isolated
multiresistant bacteria which reﬂected ecosystem in our hospital.
The obtained data point to the need of changing the empirical
antimicrobic therapy and better (antibiotic policy).
P1371 Occurrence of extended-spectrum b-lactamase-
producing Escherichia coli strains in a university hospital
V. Popova, M. Sredkova, H. Hitkova, E. Kanjovska
Pleven, BG
Objectives: To determine the occurrence and the antimicrobial
resistance of the extended spectrum b-lactamase-producing
Escherichia coli (ESBL-EC) strains in an University Hospital, Ple-
ven, Bulgaria.
Methods: Non-replicated isolates (845) of E. coli, collected from
hospitalised patients during a 1-year period were studied. ESBL
production was determined by the double disc synergy method.
Susceptibility to antimicrobials was tested by a disc diffusion
method according to the NCCLS recommendations.
Results: ESBL-EC strains accounted for 9.2% of total E. coli iso-
lated from clinical specimens during 2002. According to the
date of isolation the prevalence of E. coli ESBL producers was
relatively lower (4.6%) in January–June but it was increased to
13.3% in July–December. Isolates were most often recovered
from urine (48.7%), soft tissues (33.3%), respiratory tract
(7.6%), and blood cultures (5.1%). Colonisation/infection with
ESBL-EC isolate was detected in 77 patients. The majority of
ESBL-EC originated from ICU and urology, where 25.4–28.8%
of E. coli isolates were producers of ESBL. The ESBL producers
were more resistant than nonproducers to gentamicin, ciproﬂ-
oxacin, and trimethoprim-sulphamethoxazole (89, 85, 62% and
22, 21, 28%, respectively). Both groups showed similar low
resistance rates to amikacin (12 and 8%, respectively), and were
fully susceptible to imipenem.
Conclusions: The data suggest that in our hospital there is an
ongoing outbreak of ESBL-producing multiresistant E. coli. Further
investigations will be necessary to characterise the type of ESBL
and the epidemiology of strains.
P1372 Serratia marcescens in clinical specimens over
3 years
L. Naumiuk, E. Dziemaszkiewicz, A. Samet
Gdansk, PL
Objectives: The aim of the study was to determine the role of
S. marcescens in tertiary care hospital.
Methods: The analysis of microbiological records from 2001 to
2003 was done. We used Vitek GNI+ cards (Biomerieux) to iden-
tify isolates and disc-diffusion method to determine their suscepti-
bility. ESBL production was detected by double disc method.
Results: About 140 000 clinical specimens were send for culture
over 3 years. 501 specimens were positive for S. marcescens. It was
isolated from: wounds/drainage (35%) respiratory tract (22%),
urine (16%), blood (12%) and catheter tips (3%). Most of 225
affected patients were from surgery (43%) and internal medicine
(32%) wards. Twenty-three patients suffered from bacteraemia.
Considering one isolate per patient the incidence of ESBL-produ-
cing isolates was 29%. The number of ESBL isolates decreased
from 33 in 2001 to nine in 2003. Most isolates displayed cefotaxi-
mase phenotype which was in agreement with our earlier study
(1996–2000) showing dominance of CTX-M-3 enzyme in S. marces-
cens population.
Conclusions: Serratia marcescens seems to be an endemic pathogen
in our setting responsible for numerous infections. The incidence
of ESBL-producing isolates has decreased over time, which is
probably due to strict implementation of infection control meas-
ures. CTX-M phenotype predominates among ESBL.
P1373 Genotyping of S. marcescens and K. pneumoniae
nosocomial isolates from newborns
G. Fabio, M. Pecorari, L. Piccinini, C. Venturelli, D. Barbarini,
M.G. Tamassia, W. Gennari, A.T. Sabbatini, P. Marchegiano,
F. Ferrari, S. Cattani, F. Rumpianesi, C. Casolari
Modena, Pavia, I
Objectives: Serratia marcescens and Klebsiella pneumoniae are well-
known causative agents of nosocomial infections in newborns.
The aim of the present work is to investigate, by the use of
molecular typing methods, two putative epidemic clusters of new-
born cross-infections due to S. marcescens and K. pneumoniae,
respectively, in order to establish clonal relationships among the
isolates and to identify the possible source and mode of transmis-
sion.
Methods : Over a 6-month period, 11 newborns, from an intensive
care unit, where either infected or colonised by S. marcescens, 10
by K. pneumoniae, three by both of them. Four premature neonates
among these patients yielded invasive infections. Repetitive
positive blood cultures were associated in two cases with
K. pneumoniae, in one case with S. marcescens, in another fatal case
with both microorganisms. The nurses and the environment were
checked by microbiological studies. The antibiograms and the
results from two molecular typing methods (automated Riboprint-
ing and ERIC-PCR) of all bacteraemic or colonising isolates from
newborns and from patients elsewhere in the hospital during the
same time period, were compared in order to investigate the
epidemiology of the clusters.
Results: Totally 20 S. marcescens isolates, including 12 from newb-
orns and eight from other patients of the same hospital, and 10
K. pneumoniae strains from newborns were examined. An initial
analysis performed after the identiﬁcation of the ﬁrst nine newb-
orns contaminated by S. marcescens established clonal relationships
among all the isolates, including the two bacteraemic strains. A
second analysis revealed one different pattern in three S. marces-
cens strains successively isolated. Six genotypes unrelated to
newborns isolates were found in the eight strains from the other
examined patients. The three K. pneumoniae bacteraemic strains
resulted genetically related among them but unrelated to the colo-
nising isolates. S. marcescens isolates among different molecular
patterns showed identical antibiograms. A focal source for both
microorganisms was not identiﬁed.
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Conclusion: Typing results revealed that two different microorgan-
isms (S. marcescens and K. pneumoniae) were involved at the same
time in invasive nosocomial infections in premature newborns and
documented two contemporaneous clonal clusters of cases. Hetero-
geneous genotypes among both species were also demonstrated to
be simultaneously present in the neonatal intensive care unit.
Surveillance studies
P1374 Prevalence and risk factors for nosocomial
infections in 19 hospitals of Veneto Region (Italy)
G. Pellizzer, L. Timillero, P. Mantoan, B. Allegranzi, M. Saia,
P. Benedetti, E. Pegoraro, P. Spolaore
Vicenza, Castelfranco Veneto, Verona, Padua, I
Objective: To estimate the prevalence and risk factors for nosoco-
mial infections (NIs) in 19 hospitals of Veneto Region (northern
Italy).
Methods: A 7-day period-prevalence survey was conducted in
May 2003 in 19 selected acute care hospitals, for a total of 10 598
beds (63% of the total regional hospital beds). An investigation
team for each hospital was trained for the purpose. Standard deﬁ-
nitions for NI according to CDC were used. Eligible patients (pts)
were older than 1 year and present in the 24 h preceding the sur-
vey day on surgical, medical (excluding dermatology, psychiatry,
long-term care) and intensive-care wards (except for neonatal
intensive care units). A standardised questionnaire was completed
for all eligible pts and an additional one for pts with NI, identi-
ﬁed by reviewing of nursing and medical records. All data were
checked and validated by the local co-ordinator and by the co-
ordinating centre. A descriptive, univariate and multivariate
(step-wise regression model) analysis were performed.
Results: A total of 6352 pts were suitable for analysis (55%, med-
ical area; 45%, surgical area; 5% ICU). The average age was
62.5 years; the mean length of stay pre-survey was 10.2 days.
Overall, 1931 pts had surgery prior to the study point. The total
number of NIs was 483 (rate 7.6%), occurring in 441 pts (rate
6.9%); prevalence of NIs in ICU, medical and surgical wards was
25.8, 6.5 and 5.1%, respectively. Urinary-tract infections accounted
for 28.4%; surgical site infections 20.3%, bloodstream infections
19.3%, pneumonia 17.5%, other infections 14.5%. Rates of NIs in
the participating centres ranged from 2.6 to 17.7%. The NI was
microbiologically proven in 65.2%;Gram-positive bacteria were
47.9%, Gram-negative 42.8%, fungi 8.6% and anaerobes 0.7%. In
the multivariate analysis, the following variables were independ-
ently associated with an increased risk for NI: presence of central
venous catheter (CVC) (OR 2.2; 95% CI 1.6–3.0), urinary catheteri-
sation (UC) (OR 2.5; 95% CI 1.9–3.2), intubation (OR 3.1; 95 CI
2.0–5.0), and length of stay >15 days (OR 12.9; 95 CI 9.3–18.1).
Conclusions: This is the ﬁrst prevalence study performed at regio-
nal level in Veneto. It displayed a great interhospital difference in
NI rates, with higher rates observed in larger hospitals; it con-
ﬁrmed the importance of length of stay, intubation, UC, CVC, as
major risk factors for NIs; it also showed a frequency of blood-
stream infections higher than expected.
P1375 Tn21-like elements disseminating carbapenemase
genes in Italy: report from the SENTRY antimicrobial
surveillance programme
M. Toleman, R. Mendes, M. Castanheira, D. Bennett, R. Jones,
T. Walsh
Bristol, UK
Objective: To analyse the genetic context of metallo-b-lactamase
(MBL) containing integrons in Pseudomonas aeruginosa strains isola-
ted from geographically distinct regions of Italy.
Methods: MBL expressing strains were collected from three geo-
graphically distinct hospitals in Italy. These were SENTRY sites
no. 75 (Genoa, northern Italy), no. 86 (Rome, central Italy) and no.
85 (Catania, Sicily). These strains were previously characterised
with respect to their PFGE proﬁle, the integrons they contained
and the order of the gene cassettes within these integrons. The
genetic context of these integrons was further analysed by a com-
bination of PCR based approaches. These included (i) ampliﬁca-
tion using primers anchored to 5’ and 3’ conserved sequences
(CS) together with random primers designed to amplify upstream
and downstream sequences, (ii) PCR ampliﬁcation using primers
designed against Tn21 tnpR and tnpA sequences and (iii) primers
designed to amplify the insertion site of the Tn402/Tn5090 integ-
ron.
Results: All SENTRY site no. 75 isolates contained blaVIM-1 con-
taining integrons harboured on a Tn21-like transposon with a
complete tnpR gene and a partially deleted tnpA gene. SENTRY
site no. 86 isolates were of two different types. Type (A) consisted
of an blaIMP-13 containing integron harboured by a complete
Tn5051-type transposon and type (B) a blaVIM-1 containing integ-
ron harboured by a Tn21 like transposon with a complete tnpR
gene but the tnpA gene could not be ampliﬁed. This integron was
also characterised by having the insertion sequence IsPa7 inserted
downstream of the integrase gene. SENTRY site no. 85 isolates
also contained two different types. Type (C) contained a blaVIM-1
integron on a Tn21 type transposon with intact tnpA and tnpR
genes and like type (B) had an identical IsPa7 insertion sequence
in an identical place. Type (D) also contained a blaVIM-1 integron
harboured on an intact Tn21-like transposon and a defective IsPa7
insertion sequence.
Conclusions: All MBL containing integrons in this study were har-
boured on either an intact or defective Tn21-like transposon. This
may give an additional level of mobility to the MBL gene cas-
settes harboured on the intact transposons. Interestingly integrons
from one strain isolated in Rome and two strains isolated in Cata-
nia harboured the identical insertion element IsPa7 in the exact
site just downstream of the class 1 integrase gene. This suggests
that this integron has spread across a large geographical area.
P1376 Clinical efﬁcacy of cefepime in hospitalised patients
with severe nosocomial infections. Results of a German
surveillance study
F. Vogel, K. Bodmann
Hofheim, Hildesheim, D
Objectives: Cefepime (CEP) is a fourth generation cephalosporin
(group 4) with a broader spectrum of activity against Gram-negat-
ive pathogens than ceftazidime and other extended spectrum ce-
phalosporins and a higher activity against Gram-positive cocci
such as streptococcal and staphylococcal species. The broad spec-
trum including Pseudomonas aeruginosa and Enterobacter spp.
together with low rates of resistance and favourable pharmacoki-
netic properties make cefepime a drug of choice for initial empiric
treatment of severe nosocomial infections. Excellent efﬁcacy and
tolerability has been proven in prospective, randomised clinical
trials and was also investigated under daily routine conditions in
hospital.
Methods: This study was done as multicentre, retrospective sur-
veillance study in German hospitals. Data were collected and
documented for a period of 11 months.
Results: In total 639 patients have been evaluated. About 75%
were ICU patients. Main indications were pneumonia (n ¼ 322)
and septicaemia (n ¼ 188), followed by UTI infections and bile/
gall-bladder infection. A total of 188 pneumonia patients were
mechanically ventilated. In total 252 patients received antibiotic
pretreatment before cefepime therapy was initiated. The median
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duration of cefepime treatment was 8 days, most patients received
2  2 g cefepime daily as monotherapy. In 197 patients an addi-
tional antibiotic (combination therapy) was given. Clinical success
rates were 83.2% in pneumonia patients, 79.2% in septicaemia
patients, 86.9 in UTI and 93.8% in gall-bladder/bile infections.
Overall the tolerability was very good.
Conclusion: This surveillance study conﬁrms high clinical success
rates for cefepime in hospitalised patients with severe nosocomial
infections.
P1377 Evolution of nosocomial infections rates during
5 years in a university hospital
M.F. Geyik, S. Hosoglu, C. Ayaz, O.F. Kokoglu, S. Akalin,
M.K. Celen
Diyarbakir, TR
Objectives: To investigate the epidemiology of nosocomial infec-
tions at Dicle University Hospital in Turkey.
Methods: The study was carried out at the Dicle University Hospi-
tal (1050 beds). A prevalence study was performed prospectively,
at the hospital from January 1997 to October 2001. Nosocomial
infections searched for in 89 270 in-patients.
Results: During 5-year follow-up period, 1558 nosocomial infection
episodes were detected in 1441 patients out of 89 270 inpatients.
The overall prevalence rate of patients with nosocomial infections
were 1.7% and for each year as follows: 1997, 4.3%; 1998, 1.3%;
1999, 1.2%; and 2000, 1.4%; and 2001,1.6%. The most common no-
socomial infections by primary site were urinary-tract infection
(31.9%) and surgical-site infections (27.1%), followed by bacterae-
mia (21.1%) burn infections (6.7%), skin infections (4.6%), pneu-
monia (3.5%) and sepsis (2.6%). Nosocomial infections were seen
frequently in the department of burn unit (23.5%), urology
(7.1%), general surgery (3.7%), neurology (3.7%), orthopaedics
(3.2%), cardiovascular surgery (2.9%), internal medicine (2.2%),
neurosurgery (2.2%), infectious disease (1.2%). and paediatric sur-
gery (1.1%). The most prevalent microorganisms were Escherichia
coli (26%), Pseudomanas spp (15%), Staphylococcus aureus (12%),
Klebsiella spp (13%), coagulase-negative staphylococci (10%) and
Enterobacter spp (9%). The most frequent associated procedure
was vascular access (86.3%), followed by indwelling urethral cath-
eter (64.6%). and draining catheter (20.1%), The most common
predisposing risk factors associated with infection were usage of
histamine-2 blockers (36.3%) followed by transfusion (17.6%) and
renal failure (17.1%).
Conclusions: The surveys indicate that the prevalence of nosocomi-
al infections has been reduced over the last 4 years in Dicle Uni-
versity Hospital. The routine application of standard infection
control practices may reduce the incidence of nosocomial infec-
tions.
P1378 Nosocomial infection in Italy: results from the ﬁrst
point prevalence for the INF-NOS 2002–2004 surveillance
G. Ippolito, G. Gesu, L. Giuliani, M. Larosa, G. Privitera – the
INF-NOS Study Group
Objective: The aim of the present study was to assess the fre-
quency of NI in Italian hospitals and wards, as wide national
available data date back to 1983.
Methods: The survey of NI was carried out through the point pre-
valence studies method, repeated every 12 months for the 1st year
(2002–2003) and every 6 months for the 2nd (2004) year. Participa-
ting Hospitals all round Italy were given a standardised protocol,
a software designed ad hoc, a local training on the study proce-
dures and, as feedback to sites, a statistical data report available
on the web at http://www.6-gsk.it between one prevalence and
the other. A descriptive analysis was conducted to evaluate the
prevalence of NI, of risk factors and of their association.
Results: A total of 186 wards participated to the ﬁrst prevalence,
performed in 1 day during October–November 2002: 44.1% were
medical, 38.2% surgical and 17.7% critical services belonging to
31 Italian hospitals. A sample of 3210 subjects was surveyed with
a NI global prevalence of 6.8% that, stratiﬁed by type of ward
was: 4.2% (95% CI: 3.2–5.5) in the surgical; 4.5% (95% CI: 3.6–
5.6) in the medical; 42.5% (95% CI: 36–50) in the critical area. The
microbiological diagnosis was performed in 80.8% of NI: P. aergi-
nosa was the most frequent pathogen isolated (20.6%), followed
by MRSA (7.8%) and E. faecalis (7.8%). In the Table below the
sites of NI are reported.
Conclusions: This study represent an organised and economic
effort aimed to highlight the relevance of the problem, the import-
ance of continuous surveillance on an issue with huge implica-
tions on quality of care.
P1379 Surveillance of bloodstream infections in Czech
hospitals: epidemiological background of CZ-EARSS
V. Jindrak, T. Bergerova, E. Bebrova, E. Stastna, E. Simeckova,
P. Urbaskova
Prague, Pilsen, Kladno, Prerov, Strakonice, CZ
Objective: Bloodstream infections (BSI) are associated with high
mortality, prolonged hospital stay and extra costs. Globally grow-
ing resistance of invasive pathogens represents serious threat.
Detailed knowledge of changing epidemiology of BSI at the local,
national and international level is critically important for their
successful control. Priorities of BSI surveillance have to be identi-
ﬁed continuously.
Methods: Prospective study on the incidence of BSI in ﬁve hospi-
tals of different structure and size was performed during 3-month
period (April–June 2003). The internet based protocol of National
Register of Nosocomial Infections was applied. Clinical cases were
characterised by the date of infection, diagnosis, classiﬁcation (pri-
mary, secondary, nosocomial or community-acquired), pathogens,
invasive procedures and devices, risk factors, sources of secon-
dary BSI, patient and hospital stay characteristics. BSI rates, their
origin and aetiology were analysed and compared with CZ-
EARSS results to obtain more detailed characteristics of their
importance.
Results: Total number of 313 cases of BSI were found during study
period. Incidence of BSI per 1000 admissions in particular hospi-
tals (A, B, C, D, E) was 18.9, 9.5, 9.5, 10.5, 5.6; percentage of no-
socomial cases 97.6, 60.9, 51.0, 70.5, 73.5%; percentage of catheter-
related cases 41.2, 18.3, 17.6, 9.1, 10,5%; percentage of ICU-
acquired cases 70.2, 37.4, 9.8, 27.8, 10.5%, while percentage of ICU
beds was 38.9, 10.8, 8.8, 5.6, 8.1%. Source of secondary BSI was
the most frequent in the urinary, biliary, gastrointestinal and
lower respiratory tract. Frequency of pathogens (total percentage
and variations in incidence per 1000 admissions) was: S. aureus
14.0% (0.5–2.1), E. faecalis 6.7% (0–2.0), E. faecium 1.9% (0–0.9), S.
pneumoniae 2.6% (0–0.4), E. coli 19.5% (1.2–3.4), K. pneumoniae
13.4% (0.5–4.3), E. cloacae 6.1% (0–1.8), P. aeruginosa 3.5% (0–1.8),
Acinetobacter spp. 3.5% (0–1.1) and Candida spp. 4.5% (0–1.4).
Polymicrobial BSI were found with following percentage: 11.9, 7.0,
5.9, 27.3, 10.5%.
Site of Infection N (v/n)
Lower Respiratory Tract 90 (36.7)
Urinary Tract 58 (23.7)
Surgical Site 35 (14.3)
Blood Stream 31 (12.7)
Gastrointestinal 7 (2.9)
Skin/Soft Tissue 7 (2.9)
Higher Respiratory Tract 7 (2.9)
Bone and Joint 2 (0.8)
Central Nervous System 2 (0.8)
Reproductive 1 (0.4)
Not Localized/Other 5 (2.0)
Total 245 (100)
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Conclusion: Important differences in the incidence, origin and aeti-
ology of BSI were observed in the particular hospitals. Pathogens
included to the EARSS project were found in high rates, although
other nosocomial pathogens, frequently associated with multi-
drug resistance and high mortality, were also of great importance,
including Candida spp.
P1380 Bloodstream infection: comparing the epidemiology
of the late 1980s to that of the late 1990s at a community
hospital in Brazil
M.B. Souza Dias, V.L. Borrasca, E.M. Psaltkids, D. Zanetta,
G.M. Bo¨hm
Sa˜o Paulo, St. Jose Rio Preto, BR
Objectives: Verify temporal trends in incidence, aetiology, antimi-
crobial (ATM) resistance, therapeutic adequacy and mortality of
hospital acquired (HA-BSI) and community-acquired bloodstream
infections (CA-BSI) in a Brazilian community nonuniversity hospi-
tal.
Methods: Data were collected prospectively for 15 years by the
infection control team. Outcome was measured by 14 days and
in-hospital mortality. Two periods were chosen for comparison:
1987–1989 (P1) and 1997–1999 (P2). Only in P2 the automated
BactAlert and Vitek systems were used.
Results: BSI rates were stable at 9.6 and 9.5/1000 admissions. HA-
BSI rates decreased from 5.8 to 4.1/1000 adm (P < 0.01) while
rates for CA-BSI increased from 3.8 to 5.4/1000 adm (P < 0.01).
Most patients were immunocompromised. Gram-negative bacilli
were involved in most BSI in both periods; neither the incidence
of Gram-positive cocci nor fungi augmented. Unusual bacteria,
mainly S. maltophilia, emerged in both CA and HA-BSI, and the
presence of central venous catheters in CA-BSI increased (16–
33%). CA oxacillin-R S. aureus was detected in P2, but only in
patients with links to the healthcare system. Inadequate treatment
of HA-BSI was more frequent in P1. BSI had a better outcome in
women, in P2 and if CA. There was no difference in BSI mortality
if an appropriate antimicrobial agent (ATM) was introduced until
the second day or between the third or ﬁfth day after BSI. Initi-
ating an appropriate ATM until the ﬁfth day had a better outcome
(12.9% mortality) than after the ﬁfth day or not at all (30.6% mor-
tality). The 14-day mortality was lower in the P2 (23% in P1 vs.
11% in P2), both for CA-BSI (17% vs. 6%) and for HA-BSI (28%
vs. 18%). In-hospital mortality also decreased from 34% in P1 to
17% in P2, both for CA-BSI (24% vs. 9%) and HA-BSI (41% vs.
28%). Among adequately treated BSI, the outcome improved in
the P2; among those inadequately treated however, the outcome
was similar in both decades.
Conclusions: (i). Incidence of BSI was stable; (ii). many so-called
CA-BSI were healthcare-related infections acquired outside the
hospital; (iii). the decrease in HA-BSI probably reﬂects transfer-
ence of patients under care to the outpatient and home care set-
tings; (iv). Gram-negative bacilli remain the most frequently
isolated BSI agents in this hospital; (v). S. maltophilia emergence
probably reﬂects ATM usage patterns; (vi). Oxa-R S. aureus did
not occur in ‘pure’ CA-BSI; 7. Treatment and mortality associated
with BSI improved with time.
P1381 Nosocomial infections: two prevalence studies
(2000–2003)
S. Kastanakis, S. Doukakis, M. Papadakis, L. Tzimis, P. Hatzilias,
E. Tsafaraki, E. Volanis, E. Papadomanolaki, G. Alevraki,
A. Tsouri, I. Varthalitis
Chania, GR
Objectives: As it is well known surveillance of hospital-acquired
infections (HAIs) is an important component of an effective no-
socomial infection control programme. Prevalence surveillance is
a rapid and inexpensive way to estimate the problem of HAIs. To
study the problem of nosocomial infections in our hospital, two
prevalence studies were made from our team during the years
2000–2003.
Methods: The ﬁrst study included 273 patients and the second 330
(the total number of hospitalised patients at the time of the
study).
Results: In the ﬁrst study a nosocomial infection was found in 21
patients and in the second in seven patients. Regarding age the
highest incidence of HAIs occurred in the third age group. The
overall prevalence of HAIs was 7.7 and 2.1% for the two studies,
respectively. In the ﬁrst study, urinary-tract infections were seven
(33.3%), lower respiratory-tract infections were ﬁve (23.8%),
upper respiratory-tract infections were four (19.04%), surgical site
infections were three (14.3%), and other were (9.5%). In the sec-
ond study, urinary-tract infections were four (57.1%) and lower
respiratory-tract infections were three (42.9%), The incidence of
multiresistant bacteria was primarily Enterococcus spp and secon-
dary, Pseudomonas aeruginosa, Escherirchia coli, Staphylococcus spp.,
Klebsiella pneumoniae. Unjustiﬁed prescription of prophylactic che-
motherapy was found despite the suggestions of the infection con-
trol committee.
Conclusion: Repeated prevalence surveillance is a valid way to
estimate the problem of HAIs.
P1382 Five prevalence surveys of hospital-acquired
infections in a Greek hospital
S. Kastanakis, S. Doukakis, M. Papadakis, P. Hatzilias,
E. Tsafaraki, L. Tzimis, E. Volanis, E. Papadomanolaki,
G. Alevraki, A. Tsouri, I. Varthalitis
Chania, GR
Objectives: As it is well known surveillance of hospital-acquired
infections (HAIs) is an important component of an effective no-
socomial infection control programme. Prevalence surveillance is
a rapid and inexpensive way to estimate the problem of HAIs. To
study the problem of nosocomial infections in our hospital, four
prevalence studies were made from our team during the years
1994–2003.
Methods: The ﬁrst study included 288 patients, the second 288 too,
the third 265, the fourth 273 and the ﬁfth 330 (the total number of
hospitalised patients at the time of the study).
Results: In the ﬁrst study a nosocomial infection was found in 20
patients, in the second in 15 patients, in the third study in 13
patients, in the fourth in 21 patients and in the ﬁfth in seven
patients. The overall prevalence of HAIs was 6.9, 5.2, 4.9, 7.7 and
2.1% for the ﬁve studies, respectively. In the ﬁrst study, among
HAIs, urinary-tract infections were 12 (60.0%), lower respiratory-
tract infections were six (30.0%) and surgical site infections were
two (10.0%). In the second study, urinary-tract infections were
four (26.7%), lower respiratory-tract infections were 2 (13.3%),
surgical site infections were ﬁve (33.3%) and bloodstream infec-
tions were four (26.7%). In the third study, urinary-tract infections
were six (46.1%), lower respiratory-tract infections were three
(23.0%), surgical site infections were three (23.0%) and blood-
stream infections was one (7.7%). In the fourth study, urinary-
tract infections were seven (33.33%), lower respiratory-tract infec-
tions were ﬁve (23.80%), upper respiratory-tract infections were
four (19.04%), surgical site infections were three (14.28%) and
other were two (9.52%). In the ﬁfth study urinary-stract infections
were four (57.10%) and lower respiratory-tract infections were
three (42.90%). The incidence of multiresistant bacteria was pri-
marily Enterococcus spp and secondary Pseudomonas aeruginosa,
Enterobacter spp, Klebsiella pneumoniae, Escherirchia coli, Staphylococ-
cus aureus, Staphylococcus epidermidis. Regarding age the highest
incidence of HAIs occurred in the third age group. Unjustiﬁed
prescription of prophylactic chemotherapy was found despite the
suggestions of the infection control committee.
Conclusions: Repeated prevalence surveillance is a valid way to
estimate the problem of HAIs.
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P1383 Multi point prevalence investigation of nosocomial
infections in a Greek tertiary hospital
M. Vasiliadis, E. Maltezos, E. Archontidou, P. Peichamberis,
D. Glaros, S. Kartali-Ktenidou
Alexandroupolis, GR
Objective: To describe the epidemiology of nosocomial infections
(NI) in a Greek tertiary general hospital and the distribution of
isolated microorganisms.
Method: Analysis of surveillance data on 2757 inpatients from
medical, surgical and intensive care units. A number of 11 1-day
surveys were performed between 1995 and 2003 by the infection-
control practitioners of the hospital. The criteria by the CDC
(Atlanta, USA) were used for the deﬁnition of NI.
Results: A total of 122 patients with at least one NI were found.
The overall prevalence was 4.43% (range 2.4–6.8%). The most fre-
quent of all NI were urinary-tract infections (UTI) 34.6%, followed
by lower respiratory tract infections (LRTI) 27.6%, surgical site
infections (SSI) 16.5% and primary bloodstream infections (BSI)
8.7%. Various other infections were reported at a rate of 12.6%.
The isolated microorganisms were for UTI: E. coli (38,5%), Acine-
tobacter spp. (12.8%), Klebsiella spp. (12.8%), Enterobacter spp.
(7.7%), S. aureus (5,1%) and Candida albicans (2,6%); for LRTI: Aci-
netobacter spp. (45,2%), Pseudomonas aeruginosa (6,5%), Staphylococ-
cus epidermidis, S. aureus and S. haemolyticus (6,5% each one); for
SSI: Klebsiella spp. S. haemolyticus and Enterobacter spp. (11,1%
each one), followed by E. coli, Acinetobacter spp., S. aureus, P. aeru-
ginosa and S. epidermidis (5.6% each one); for BSI: Acinetobacter
spp. and S. simulans (22.2% each one), followed by Micrococcus,
C. albicans, S. hominis, S. haemolyticus and S. epidermidis (11.1%
each one). No microorganism could be isolated in 7.7% of UTI, in
6.5% of LRTI and in 38.9% of SSI.
Conclusions: These data show that the rate of NI in our hospital is
in relative low level. The distribution of isolated microorganisms
differs by site and hospital unit. We assume that multi point pre-
valence studies are easy to perform and can be useful for monitor-
ing and surveillance of NI.
P1384 Prevalance of nosocomial infections in Ilam’s
hospitals, Iran
N. Sadeghifard, F. Azizi Jalilian, J. Zaeimi Yazdi
Tehran, IR
Objectives: Nosocomial infections are one of the most important
health problems in this century. according to researches in differ-
ent countries, the rate of nosocomial infections differs from 2.5 to
21%.
Methods: In this study, prevalence of nosocomial infections has
been investigated in three hospital of Ilam during January 1999 to
September 2001. For this purpose, 1786 patients who were hospi-
talised >72 h, were monitored. Clinical ﬁndings helped us for
diagnosis of infections during hospitalisation. Blood agar, choco-
late agar, EMB agar and manitol salt agar madia were used to
isolation of bacteria.
Results: According to clinical ﬁndings, 216 patients (7.75%) were
suffering from nosocomial infections. In Mostafa Khomini hospi-
tal, 122 cases (9.5%) of nosocomial infections were observed, so
that its rate was more than two other hospitals. the highest rate of
infections has been observed in burn ward 41 patients (35%) and
ICU 25 patients (8.2%).The most common infections were urinary-
tract infection 64 cases (29.7%) and surgery and burned wound
infection 59 cases (27.3%). The causative agent of infections have
been isolated by culture method just in 194 cases (89.8%) . The
most common isolated orgnisms were coagulase-negative staphy-
lococci 43 (22.2%), E. coli 37(19.1%), Pseudomonas aeruginosa 30
cases (15.5%) and Staphylococcus aureus 22 cases (11.3%).
Discussion: Results of this study showed that, the rate of nosoco-
mial infections varis among different hospitals in Ilam, and this
difference was signiﬁcant (P ¼ 0.0048). The rate of nosocomial
infection also showed a signiﬁcant differences between different
age groups (P ¼ 0.044).
P1385 Surveillance for nosocomial infections using special
monitoring protocol in Austrian ICU
A. Reiter, H. Hetz, P. Faybik, K. Krenn, H. Steltzer
Vienna, A
Objective: Nosocomial infections (NI) in the intensive care unit
(ICU) signiﬁcantly inﬂuence mortality rates and also cause sub-
stantial additional costs. The objective of the present surveillance
study was to evaluate the current frequency of NI, the predomin-
ant infecting organisms, the risk factors for developing NI and its
impact on outcome of critically ill patients in order to better strat-
ify for future management of critically ill patients.
Methods: Data were prospectively collected by the Austrian Center
for Documentation and Quality Assurance in intensive care medi-
cine in accordance with the protocol of the study surveillance for
NI on the Austrian ICU’s. All patients consecutively admitted to a
combined medical-surgical ICU within teaching hospital between
June 1 2003, and November 3 2003 were included in this study.
All patients were monitored for NI at six body sites. The data
included the presence or time course after admission; the most
common cause and antibiotics administration; level of provided
care (TISS-28); length of ICU stay and outcome data.
Results: Of 125 evaluated patients, 31 (24.8 %) acquired NI. It
occurred after 4.2 days in patients without antimicrobials, after
3.2 days in patients receiving prophylaxis and after 7.3 days in
patients receiving antimicrobials for treatment already at admis-
sion. Regarding bacterial agents the most common pathogens
were Gram-positive cocci, Gram-negative no Enterobacteriaceae
and fungi or parasite, which were respectively 15.2, 9.7, and 7.3%
of the isolated agents. Enterobacteriaceae accounted for 5.7%.The
most commonly observed NI was pneumonia. In infected
patients length of stay was signiﬁcantly longer than in noninfect-
ed patients (21 days vs.7 days, t-test, P < 0.05). With regard to
provided level of care, infected patients showed signiﬁcantly
higher level of care than patients without NI (782 vs.266 TISS-28
score/patients ICU stay, P < 0.05) The mortality rate was compar-
able in the two groups.
Conclusion: The mean overall patient infection rate was 25 NI per
100 patients. The documented data conﬁrmed clinical impression,
that patients with NI have a prolonged length of stay and a
increased need of care. Despite enormous progress in the inten-
sive care, the rate of NI remains a problem. The knowledge about
the ICU population have an important impact on risk estimates
and may provide better strategies in the patients management.
P1386 Calculation of incidence and repartition of
nosocomial infections
F. Tissot Guerraz, N. Fayolle, R. Sibelle, O. Claris
Lyon, F
Objectives: Calculation of incidence and repartition of nosocomial
infections (NI).
Methods: A total of 431 neonates hospitalised 48 h or more, in
2000 and in 2002, were studied: gestational age, birth weight, arti-
ﬁcial ventilation and central vascular catheter utilisation were
noted.
Results: We have counted 61 NI and 51 infected neonates. Patients
(n ¼ 431); total number of hospitalisation days (6180) Sixty-one NI
(14.1% of entries) for 51 infected neonates (11.8% of entries) : 9.9
NI/1000 hospitalisation days and 8.2 infected neonates/1000 hos-
pitalisation days. Forty bacteriaemias: 67.2% of NI; 6.6 bacteriae-
mias/1000 hospitalisation days; 15.7 bacteriaemias/1000 device
days (vascular catheter utilisation). A total of 14 pulmonary infec-
tions: 23% of NI; 2.3 IP/1000 hospitalisation days; 9.8 IP/
1000 days artiﬁcial ventilation. Infection risk for a weight3
1500 g: RR** ¼ 7.45 – infection risk for gestational age
32 weeks: RR** ¼ 3.48 – CRIB* >4: RR** ¼ 4.80.
Conclusions: The infection risk is far higher when the birth weight
is 1500 g. When gestational age is 32 weeks and when the CRIB
is >4, relative risk is multiplied by 4.80. The ﬁrst micro-organism
responsible for bacteriaemias is Staphylococcus epidermidis. When a
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device, such as a central vascular catheter is used, the RR of NI is
multiplied by 80. In 2000, one possible death was noted. *CRIB:
clinical risk index for babies; **RR: relative risk.
P1387 A computerised system of administrative data for
nosocomial infection monitoring
M. Saia, L. Timillero, P. Mantoan, B. Allegranzi, G. Pellizzer,
P. Spolaore
Padua, Castelfranco Veneto, Vicenza, Verona, I
Objective: To assess the accuracy of a computerised system (CSy)
linking data from hospital discharge forms (HDF) and microbiolo-
gical reports for monitoring nosocomial infections (NI) in the
Veneto Region, northern Italy.
Methods: Within the frame of the regional project for NI surveil-
lance and control, we have set up a data base applying a linkage
between all the HDF and the microbiological reports of patients
(pts) discharged from regional hospitals. We selected a list of ICD-
9 CM diagnosis proxy of NI [urinary tract (UTI), and wound infec-
tions (SSI), pneumonia (PNEU) and bloodstream infections (BSI)]
and a list of microorganisms (isolated from urine, blood, wound
swab and respiratory samples) commonly recognised as nosocomi-
al pathogens. Then, three groups of discharged pts with events
proxy of NI could be identiﬁed: one group with a diagnosis, a sec-
ond with a nosocomial isolate, and a third with both diagnosis and
nosocomial isolate. A sample (control group) of pts from each
group was randomly selected and their medical records reviewd
for NI according to the CDC deﬁnitions.The positive predictive
value (PPV) of the CSy in identifying NI events, when compared
with the NI detected in the control group (true NI), was calculated.
Results: Three regional hospitals (Vicenza, Verona and Treviso)
have been analysed for the 2001. Discharged pts were 93 740 (pts
days 81 8737). Overall, our CSy identiﬁed 5906 events proxy of NI
in 4518 pts (rate 6.3%). In the control group (1800 of 4518) the CDC
criteria of NI were met in 1244 cases, and the PPV of the CSy was
69.1%.The PPV for PNEU, BSI, UTI, and SSI were 77, 73, 72 and
72%, respectively. Microbiological records had the highest PPV
(81%), in comparison to ICD-9 CM (42%). By applying the PPV esti-
mates obtained from the control group to all HDF, the adjusted rate
of NI proxi detected by our CSy was 3.5% (7.2/1000 patient days).
Conclusions: Our CSy based on linkage of currently available infor-
mations from administrative records is able to produce an adequate
evaluation of NI epidemiology in comparison with data obtained
by a retrospective review of medical records. This method could be
convenient in terms of cost sparing compared with active surveil-
lance of NIs. It can be easily applied on a large scale, allowing a
continuous monitoring of NI at regional level, and a useful compar-
ison of control programmes among different hospitals.
P1388 Cumulative microbiological laboratory data: an
important tool for management of health care quality in the
hospital
I. Wybo, D. Pie´rard, A. Naessens, A. Van Zeebroeck,
R. Van De Velde, S. Lauwers
Brussels, B
Objectives: To describe the collection, analysis and use of the
cumulative microbial identiﬁcation and antimicrobial susceptibil-
ity data in our hospital.
Methods: A locally developed data management system is used to
analyse cumulative microbiological test data. Patient demographic
information, specimen information and test results are exported
from the laboratory information system to the analysis software.
Detection of duplicate isolates is based on patients’ names and
identiﬁcation numbers, organism identiﬁcation and susceptibility
patterns. Isolates from screening specimens are excluded.
Results: Listing of identiﬁcation and antibiotic susceptibility test
results are generated each month. All species are presented, regard-
less of the number isolated. Speciﬁc subsets are tabulated such as
different patient groups (e.g. inpatient, outpatient, speciﬁc wards,
intensive care units), specimen types (blood, urine) and special
patient groups (cystic ﬁbrosis). Semiautomatic detection of devia-
tions (2 and SD ¼ 3) is used for surveillance of isolation and
resistance frequencies. Other applications are monthly listings of
all patients with bacteraemia, daily listings of patients with resist-
ant or highly transmissible micro-organismes and an expert system
for detection of patients with possible nosocomial infection. Cumu-
lative antimicrobial susceptible data of relevant species are presen-
ted in tabular form. Separate tables are made for speciﬁc subsets if
needed. graphs are made to follow accumulated data over several
years. These data are used to update empiric therapy schemes.
Conclusions: Cumulative identiﬁcation and antimicrobial suscepti-
bility reports can give useful information if obtained in a consis-
tent matter. They are not only very helpful in surveillance of
nosocomial pathogens and their resistance patterns but also in the
quality assesment of the laboratory and in the selection of empiric
therapy. Accessible and clear presentation of cumulative microbio-
logical data can convince healthcare professionals to comply with
prudent use of antibiotics and hygienic precautions.
P1389 AMBU-KISS: quality control in ambulatory surgery
D. Mlangeni, R. Babikir, M. Dettenkofer, P. Gastmeier,
F. Daschner
Freiburg, Hannover, D
Introduction: Surgical site infections are associated with consider-
able morbiditiy and additional healthcare costs arising from
lengthy hospitalisation in these patients. According to the German
Infection Protection Act implemented on 1 January 2001, hospitals
and ambulatory surgery institutions are required to assess and
document nosocomial infections. The data must be available to
health organisations on demand.
Method: We report on a new Surveillance Module (AMBU-KISS)
designed to assess and document surgical site infections in ambu-
latory surgery. The objective is to create a reference database for
these institutions.
Results: Preliminary results have been obtained and for two indica-
tor procedures show no signiﬁcant differences in surgical site
infection rates between ambulatory surgery institutions and the
hospital setting (OP-KISS). The arithmetic mean values of surgical
site infection rates in arthroscopic surgery of the knee are 0.09% in
AMBU-KISS and 0.11% in OP-KISS (http://www.nrz-hygiene.de).
For inguinal hernias the respective rates are 0.65 and 0.78%. A
signiﬁcant difference was observed for vein-stripping procedures
with surgical site infection rates of 0.38% in AMBU-KISS
and 0.64% in OP-KISS.
Conclusions: The results indicate that the surveillance module
(AMBU-KISS) is reliable in assessing surgical site infections in
ambulatory surgery.
P1390 Investigation of the antibiotic susceptibility patterns
of pathogens causing nosocomial infections using the Etest
A. Yaman, Y. Tasova, F. Kibar, A.S. Inal, N. Saltoglu,
O. Buyukcelik, B. Kurtaran, I.H. Du¨ndar
Adana, TR
Objectives: We investigated the antibiotic resistance patterns of no-
socomial bacteria according to the Meropenem Yearly Susceptibil-
ity Test Information Collection (MYSTIC) Programme. The
outcome of this resistance was followed for 3 years.
Methods: During 2000–2002, the resistance patterns a total of 570 bac-
teria (390 Gram-negative, 180 Gram-positive) against meropenem,
imipenem, ceftazidime, cefotaxime, cefepime, piperacillin/tazobac-
tam, ciproﬂoxacin and tobramycin were investigated using the Etest.
Extended-spectrum b-lactamase (ESBL) production was determined
using ceftazidime and ceftazidime/clavulanic acid Etest strips.
Results: Meropenem was the most effective antibiotic against
Gram-negative organisms (89.0%); this was followed by imipenem
(87.2%) and piperacillin/tazobactam (66.4%). The most active
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antibiotic against Gram-positive bacteria was imipenem (87.2%)
and this was followed by, piperacillin/tazobactam (81.7%) and
meropenem (77.8%). The rates of production of ESBL by Escheri-
chia coli, Klebsiella pneumoniae and Serratia marcescens were 20.9, 50.0
and 46.7%, respectively. ESBL production increased each year
(21.7, 22.1 and 45.5% in 2000, 2001 and 2002, respectively). All of
the ESBL producing isolates were sensitive to meropenem and
98.5%, sensitive to imipenem. AmpC b-lactamase was produced
by 20.9% of the Enterobacter spp., Citrobacter spp. and S. marcescens.
All of these were sensitive to meropenem and 77.8%, to imipenem
and ciproﬂoxacin. Multi-drug resistance (MDR) rates were 45.4%
in Acinetobacter spp and 37.7% in Pseudomonas aeruginosa isolates.
Conclusion: As in the entire world, resistance to antibiotics is a
serious problem in our country. Solving of this problem depends
primarily on prevention of the development of resistance.
P1391 A 6-year study of risk factors, aetiology and
outcome of late-onset septicaemia in premature neonates treated
in a NICU
M. Wasek, J. Behrendt, J. Karpe, U. Godula-Stuglik
Zabrze, PL
Objectives: To analyse perinatal and postnatal risk factors, clinical
symptoms, biochemical and haematological disorders and results
of treatment of late-onset septicaemia (LOS) in premature neo-
nates admitted to NICU between 1997 and 2002
Methods: A retrospective chart review of ﬁrst incidence of LOS in
premature infants. Diagnosis of LOS was made based on positive
blood culture and inﬂammatory signs appearing after 72 h of life.
Material: A total of 151 (86 boys and 65 girls) premature neonates
(52% of all septic prematures) treated in the NICU within 6 years.
Birth asphyxia in 60%, ELBW in 25%, gestational age below or
equal to 28 weeks in 30%, other perinatal risk factors in 91% of
cases were noted. Eighty-two per cent of infants were mechanically
ventilated and 75% received parenteral nutrition before they devel-
oped septicaemia. All of them underwent vessel catheterization.
Results: The most common bacteria isolated from blood were meti-
cillin-resistant Staphylococcus epidermidis (33%) and multidrug-
resistant Klebsiella pneumoniae (21%). Other staphylococcal strains
in 14%, Pseudomonas aeruginosa in 15%, others Gram-negative bac-
teria in 11%, Enterococcus in 4% and Candida (C. sake, C. albicans) in
1.3% were found. Typical clinical symptoms comprised of pneu-
monia (79%), shock (59%), gastrointestinal disorders (50% inclu-
ding NEC in 21%), purulent meningitis (30%) and DIC syndrome
(28%). Metabolic acidosis (84%), increased CRP level (89%) and
hyper or hypoglycaemia (16%) were the most frequent biochemical
disorders. Thrombocytopenia in 53% and stab cells over 5% in
42% were noted. Despite of intensive antibiotic therapy based on
antibiograms 29 (19.2%) premature infants died, their mean birth-
weight was 1111.5  357 g. The aetiology of septicaemia of infants
who died was Gram-positive in 14 cases, Gram-negative in 13 and
Candida in two cases. In 48% severe brain injury and 31% broncho-
pulmonary dysplasia were main cause of death.
Conclusion: Multidrug-resistant Klebsiella pneumoniae and methycil-
lin-resistant Staphylococcus epidermidis are potentially important
pathogens in aetiology of ﬁrst incidence of late-onset septicaemia in
premature infants. ELBW, birth asphyxia and severe chronic lung
disease are the factors of bad prognosis in LOS in premature infants.
P1392 Antimicrobial resistance patterns of bacteria isolated
from intensive care unit infections
A. Bayram, I. Balci
Gaziantep, TR
Objectives: Hospital-acquired infections, especially among inten-
sive care unit (ICU) patients not only increase the rates of mortal-
ity and morbidity, they also lead to higher treatment costs with
growing antimicrobial resistance. In this study performed from
January 1999 through January 2001, aetiological agents of ICU
infections and their resistancy patterns to various antimicrobials
were evaluated.
Methods: Clinical specimens from suspected sites of infection of
ICU patients were cultured onto 5% sheep blood agar, eosin-
methylene-blue agar and Sabouraud’s dextrose agar. The identiﬁ-
cation and antimicrobial sensitivity of bacterial pathogens were
performed with Sceptor system (Becton Dickinson, USA).
Results: Of 871 specimens belonging to 612 patients, 771 patho-
gens were isolated and identiﬁed. Four major infection sites repre-
sented 91.83% of all reported infections; lower respiratory-tract
infections were most frequent (31.52%), followed by urinary-tract
infections (27.88%), bloodstream infections (23.09%) and surgical-
site infections (9.34%). Most commonly identiﬁed microorganisms
were as follows: Pseudomonas aeruginosa (20.36%), Candida species
(15.04%) and Staphylococcus aureus (12.97%). Among the Gram-
negative microorganisms P. aeruginosa were mostly resistant to
third generation cephalosporins (71–98%), while A. baumannii
were resistant in all cases to piperacillin, ceftazidime and ceftriax-
one. Coagulase-positive staphylococci were mostly resistant peni-
cillin and ampicillin (95%), whereas coagulase-negative
staphylococci were 98% resistant to methicillin and in all cases
resistant to ampicillin and tetracyclin.
Conclusion: To reduce the emergence and spread of antimicrobial-
resistant pathogens in ICUs, monitoring and optimisation of anti-
microbial use should be considered carefully.
P1393 Isolation frequency and antibiotic resistance of
bacteria recovered in a respiratory ICU in the years 1997 and 2003
S. Karabela, S. Kanavaki, H. Moraitou, M. Makarona,
G. Dimopoulos, M. Daganou, S. Triantaphyllou, P. Koumentakis,
A. Rasidakis
Athens, GR
Objectives: We studied and compared the isolation frequency and
resistance phenotype of clinical isolates in intensive care respirat-
ory unit of ‘Sotiria’ Chest Diseases Hospital of Athens for the
years 1997 and 2003.
Methods: The hospitalised patients were 140 and 131, respectively,
while the total of isolates consisted of 106 (65.4%) Gram() and
56 (34.6%) Gram(+) in 1997 and 207 (70.2%) Gram() and 88
(29.8%) Gram(+) in 2003.
Results: In 1997, among Gram() strains, Enterobacteriaceae were
27/106 (25.5%), Ps. aeruginosa 40/106 (37.7%) and A. baumanii 39/
106 (36.8%). In 2003, Enterobacteriaceae were 70/207 (33.8%),
Ps. aeruginosa 67/207 (32.4%), A. baumanii 59/207 (28.5%) and
S. maltophilia 11/207 (5.3%). Regarding the prevalence of Gram(+)
strains in 1997, 26/56 (46.4%) were S. aureus, 19/56 (33.9%) S. epi-
dermidis,8/56 (14.4%) Enterococcus spp and 3/56 (5.4%) Corynobac-
terium spp, while in 2003, 34/88 (36.8%), 28/88 (31.8%), 11/88
(12.5%), 3/88 (3.4%), respectively, plus 12/88 (13.6%) S. haemolyt-
icus. In relation to the clinical source, in 1997 and 2003, lower res-
piratory-tract isolates (LRT) were 105/162 (64.8%) and 213/295
(72.2%), i.v. catheter isolates 22/162 (13.5%) and 31/295 (10.2%)
and blood isolates 19/162 (11.7) and 24/295 (8.1%) respectively.
Conclutions: Concerning LRT isolates, the incidence of A. baumanii
has decreased from 34.3 to 21.1%, while Enterobacteriaceae show
an increasing incidence from 15.2% to 27.2% with Klebsiella pneu-
moniae being the most frequently isolated strain (58.6%). As far as
antibiotic resistance patterns, we noted a signiﬁcantly increased
isolation of imipenem-resistant Kl. pneumoniae (from 11% in 1997
to 28.5% in 2003) and A. baumanii (0 and 66%, respectively).
P1394 Incidence of surgical site infections (SSI) in Italian
surgical settings
N. Petrosillo, M.L. Moro, E. Nicastri, L. Martini and the Italian
Group for the Study of Surgical Site Infections
Objectives:4 To assess the incidence of SSI in Italian surgical units
during in-hospital stay and after discharge, and to identify associ-
ated risk factors.
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Methods: One-month, prospective national multicenter surveil-
lance study of patients undergoing selected interventions. Thirty-
day postdischarge surveillance by telephone call and by surgical-
outpatient cards was conducted. Data on 4665 surgical interven-
tions in 48 surgical units were collected. Interventions included
gastric surgery, colon surgery, cholecystectomy, hernia repair, vas-
cular surgery, hysterectomy, mastectomy, caesarean section. SSI
were deﬁned according to criteria developed by the Centers for
Disease Control and Prevention, Atlanta. A multivariate analysis
of risk factors for SSI was performed.
Results: The global SSIs attack rate was 5.4% (252/4665; 95% con-
ﬁdence intervals: 4.7–6.1); 43/1443 (3.4%) occurred in clean sur-
gery, 137/2629 (5.2%) in clean contaminated surgery, 51/518
(9.8%) in contaminated surgery, and 21/75 (28%) in dirty sur-
gery. The rate of SSIs was 6.3% (195/3067) in general surgery,
and 3.6 (57/1598) in obstetrics and gynaecology. SSI rate was 3.6,
7.7, 15.0, 18.2 according to Infection Risk Index (RI) 0, 1, 2, and 3,
respectively. 98% of patients were actively followed-up after dis-
charge. Of the 252 SSIs, 148 (58.7%) were identiﬁed prior to dis-
charge, and 104 (41.3%) postdischarge. In a multivariate analysis,
the variables independently associated with the risk of SSI were
class of intervention, IRI, presence of surgical drainage, and sep-
sis. In half of the cases, an open surgical drainage was used.
Finally, in one third of patients the length of surgical prophylaxis
was longer than 24 h.
Conclusions: Our study showed that 40% of infections were detec-
ted after discharge; thus, an effective postdischarge follow-up pro-
gramme is essential for a reliable assessment of SSIs. In our study
the SSIs incidence rate is higher than that reported by other Euro-
pean studies, but some of these did not include postdischarge sur-
veillance. Finally, our study showed that a better policy regarding
the use of surgical drainages and antibiotic prophylaxis is nee-
ded. Work supported by Ministry of Health funding Ricerca
Finalizzata IRCCS.
P1395 Incidence of nosocomial infection in Italian surgical
wards
M. Fiorio, F. Vigano, M. Larosa, A. Marvaso – the KIR-NOS Study
Group
Objectives:5 In Italy the last multicentre postoperative study in
surgical patients date back to 1989 and show a NI rate of
10.5%, being surgical site infection (SSI) overall rate of 6.2%.
Principal aim of this study was to update NI rates in surgical
wards.
Methods: The study was carried out from the 1st of April to the
31st of May 2002 in 32 general surgeries belonging to wide hospi-
tals all round Italy. All operated patients were surveyed by the
surgeon during and after hospital stay up to 30 days from opera-
tion. The diagnosis of NI was deﬁned according to CDC criteria.
At discharge each patient received a questionnaire to register
onset of any NI symptoms in the follow up time frame. The statis-
tical analysis was descriptive: NI incidence rates were calculated
both as number of patients with NI and number of NI every 100
operated patients; SSI rates were calculated through the NNIS
method.
Results: In 2972 patients (male ¼ 48.6%) were performed 3066
operations, 75.4% of whom with NNIS index ¼ 0–1. NI onset in
226 patients (7.6%) for a total of 236 NI (7.9%); SSI (5.3%) and
urinary (1.1%) were the most common infections. Among SSI, 98
(62%) and 23 (14.6%), were respectively at superﬁcial and at deep
incisional, 35 (23%) at organ-space site; 48.6% of patients with
organ-space SSI (OS-SSI) required a new operation and 31.4%
died. The average postoperative hospital stay and the average
onset of SSI was respectively 9 and 9.2 days from operation: 6.6
and 13.4 days in patients with pre and postdischarge SSI. Fifty-
ﬁve SSI (34.8%) were diagnosed after discharge, 74.5% of whom
at superﬁcial incision. The postdischarge questionnaire was given
to 2256 (86.0%) patients, among them only 55.6% replied: 110 SSI
symptoms were reported. The agreement between the diagnosis
of SSI made by surgeon and the presence of SSI symptoms repor-
ted by patients was only 36%.
Conclusions: This study allowed to update incidence SSI rates in
Italian general surgeries, stratify the rates through the NNIS
method and conﬁrm the risk for mortality in SSI patients, espe-
cially with OS-SSI. These NI should be targeted by special con-
trol programs in the surgeries. Although postdischarge
surveillance is fundamental to estimate correctly SSI frequency,
the method of postdischarge questionnaire seem misleading in
our experience.
P1396 Surgical site infection after cholecystectomy
(laparoscopic vs. open cholecystectomy)
M. De Frutos Serna, T. Delgado, A. Melian, B. Castro, M.J. Ramos,
A. Sierra
La Laguna, E
Objective: To know the rate of surgical site infection (SSI) after
cholecystectomy in a university hospital and to compare laparo-
scopic cholecystectomy with open cholecystectomy.
Methods: Infection control team prospectively studied patients
admitted to our hospital and operated on cholecystectomy from
May to December 2001 and August 2002 to February 2003.
Patients under surveillance were followed during their length
of stay in hospital and evaluated about surgical site infection.
Postdischarge surveillance was done until 30 days after opera-
tion. Infection rates were stratiﬁed according to NNIS methods
and surgical site infection was deﬁned using the criteria estab-
lished by CDC.
Results: In this study, 207 patients underwent cholecystectomy
(88 laparoscopic and 119 open), however, laparoscopic cholecys-
tectomy increased from 34% in 2001 to 52% in 2002. There
were 86 men and 121 women. Median age in laparoscopic and
open cholecystectomy were 51.22 and 61.69 years, respectively.
Laparoscopic cholecystectomy was associated with a shorter
postoperative stay (3.52 days vs. 10.93 days). There were six
SSIs detected, yielding an infection rate of 2.89%. The SSI rate
was 4.67% in 2001 and 1% in 2002. All SSIs were in open chol-
ecystectomy. The overall rate of SSI was lower for laparoscopic
cholecystectomy (0%) than for open cholecystectomy (5.04%).
The number of cholecystectomy with NNIS risk categories 1,
0, 1, 2 and 3 were 56, 78, 55, 11 and 7, respectively. Five SSIs
belong to NNIS risk category 1 and one to NNIS risk category
3. According to the CDC deﬁnition, there were two superﬁcial
incisional, two deep-incisional and two organ/space infections.
There were polymicrobial infection in two cases. The micro-
organisms isolated were similar for laparoscopic and open
approach. Enterobacteriaceae (three) and P. aeruginosa (three)
were the most commonly microorganisms isolated.
Conclusions: Although the use of a laparoscope in cholecystectomy
has been incorporated into the NNIS risk-index, SSI rates follow-
ing cholecystectomy should be also stratiﬁed by the type of tech-
nique to evaluate the results.
P1397 Surveillance of the infection in valvular
replacement in cardiac surgery: an evaluation over 4 years
M. De Frutos Serna, T. Delgado Melia´n, C. Mene´ndez,
A. Torres Lana, M. Miguel Go´mez, A. Sierra Lopez
La Laguna, E
Objectives: To determine the incidence and aetiology of surgical
site infections in cardiac surgery with valvular replacement.
Methods: Wound infections after cardiac surgery with valvular
replacement have been monitored at the Hospital Universitario de
Canarias for 4 years (2 months in 2000, three in 2001 and six in 2002
and 2003) . A prospective study of 207 patients operated, all were
followed-up for 1 year except corresponding to 2003, and stratiﬁed
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according to intrinsic risk factors of infection NNIS System (Nacion-
al Nosocomial Infection Surveillance, CDC de Atlanta). All infec-
tions are categorised using standard Centers for Disease Control
deﬁnitions.
Results: During this period, ﬁve infections were documented,
three organ-space infections and two superﬁcial incisional infec-
tion. The wound infection rate [wound infection 100/ n surgi-
cal patients (1)] were 0 in 2000, 10 in 2001, 2.3 in 2002 and 0
in 2003. The aetiology of the ﬁve infections was: S. epidermidis,
Corynebacterium sp., S. conii and P. aeruginosa in the three
organ-space infections (one case were polymicrobial infection),
S. aureus, S. epidermidis and in two superﬁcial incisional
infections.
Conclusion: Comparing our data with those of the NNIS report,
our hospital rate in NNIS 2 and NNIS 3 is lower than the percent-
ile 10, and NNIS 1 is higher than the percentile 90. Staphylococci
is the most common pathogen recovered in both major and minor
infections. It is important to monitor the surgical care of the
patients and extensive use of antistaphylococcal antimicrobials in
clinical practice.
P1398 Evaluation of postoperative nosocomial infections in
a university faculty of medicine department of general surgery,
Izmir
M. Isikgoz Tasbakan, B. Arda, T. Yamazhan, H. Pullukcu,
S. Ulusoy
Izmir, TR
Objectives: To evaluate the nosocomial infection rate and the risk
factors associated with nosocomial infections in the Ege Univer-
sity Faculty of Medicine Department of General Surgery.
Methods: A total of 1125 patients who were operated in the Ege
University Faculty of Medicine Department of General Surgery
between September 17, 2001 and March 17, 2002 have been fol-
lowed-up with the patient based active surveillance method for
nosocomial infections.
Results: A total of 51 of 1125 patients operated in this period
were found to have nosocomial infection. 52.9% of these
patients had surgical wound infection, 23.6% pneumonia, 21.6%
bacteraemia/septicaemia, 1.9% urinary-tract infection. The
patients, who had nosocomial infection had a mean of 12.5 days
of (range 3–101) extra hospitalisation and mortality rate was
27.5%.
Discusion: The length of operation time, emergency and night
shift operation, dirty- contaminated or contaminated wounds, dia-
betes mellitus, malignancy and additional diseases were the risk
factors associated with nosocomial infection.
P1399 Evaluation of surgical site infection rates by
surveillance after hip arthroplasty
F. Huenger, A. Schmachtenberg, D. Zolldann, H. Haefner,
K. Nowicki, D.C. Wirtz, K. Bla¨sius, S.W. Lemmen
Aachen, Stolberg, D
Background: Artiﬁcial joint replacement of the hip (HPRO) is one
of about 20 operative procedures of the surveillance of surgical
site infections (SSI) according to the United States National No-
socomial Infections Surveillance System (NNIS) and the national
hospital infections surveillance system (KISS) in Germany. Peri-
prosthetic infection is predominantly due to bacterial contamin-
ation of foreign material during the time of implantation. The
period from implantation to clinically manifestation of peripros-
thetic infection may last for longer than the hospitalisation period
of the patient (according to CDC SSI deﬁnition up to 1 year). We
report on an assessment of infection rates by extended postdis-
charge follow-up in addition to predischarge surveillance.
Material and methods: A total of 508 orthopaedic patients were
evaluated after they underwent HRPO (n ¼ 425 primary; n ¼ 83
revision). SSI were recorded according to KISS-criteria during
their hospitalisation period. Patients without predischarge SSI
were contacted by postal questionnaire 12 months following
operation; nonresponders were reminded after 3–4 months. Ques-
tionnaires were analysed and in case of reported SSI further infor-
mation was gained from clinicians and GPs. From these data
standardised and stratiﬁed infection rates were calculated.
Results: The response rate of the postal questionnaire survey was
76% after ﬁrst contact and 85.4% after reminder. A total of 16
(3,15%) SSI were noticed, 12 (75%) were recorded by predis-
charge surveillance, distributing among type A1(n ¼ 4), A2 (n
¼ 5) and A3 ( n ¼ 3) of SSI, deﬁned by the CDC criteria. Four
cases (25%) of SSI were found by postdischarge questionnaire, all
belonging to type A3 of SSI with the need of reoperation. Time
Table. SSI rates by risk index catogery 2000–2003, and NNIS*
data (pooled mean rate).
NNIS 0 NNIS 1 NNIS 2 NNIS 3
N SSI I-ISQ N SSI I-SSI N SSI I-SSI N SSI I-SSI
2000 1 0 0 7 0 0 4 0 0 1 0 0
2001 8 0 0 19 3 15,7 1 0 0 2 0 0
2002 25 1 4 53 1 1,8 7 0 0 1 0 0
2003 0 0 0 69 0 0 9 0 0 0 0 0
2000-03 34 0 2–9 1–48 4 3–7 21 0 0 4 0 0
NNIS* ** 1–54 2–25 2–25
N: operative procedures
SSI: surgical site infections
I-SSI ¼ N/SSI*100
*National Nosocomial Infections Surveillance (NNIS) (2002) System
Report, data summary from January 1992 to June 2002. Issued
August 2002. Am J Infect Control, 30, 458–475.
**no data available.





Open surgery 5 45
Laparoscopic surgery 1 ..
Morning shift operations 6 33




<1 hour .. ..
1–2 hour 3 4
2–3 hour 2 11
>4 hours 1 30
Pre disposing factors
Age > 65 2 13
Obesity 2 1
Diabetes mellitus .. 5
Malignity .. 12







1Chronic obstructive pulmonary disease, tuberculosis, renal failure,
infective endocarditis, hepatitis B and C infection
2Urinary catheters, nosogastric sound, tracheostomy central venous
catheters.
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between discharge and diagnosis of these cases ranged from
about 8 days up to 8 months, but all cases were noticed and
reported according to KISS already. Standardised wound infection
rate was with 1.25 over the pooled arithmetical mean surgical site
infection rate of KISS (0.87) but below 75%-quantil (1.5).
Conclusions: Our results underline the importance of the surveil-
lance of nosocomial infections beyond the time of discharge, but
present methods seem to be reliable. The pursuit of shorter hospi-
talisation periods in surgical medicine may challenge the methods
of surveillance systems.
P1400 Bacteraemia in patients with haematological
malignancies
D. Mylona-Petropoulou, G. Ganteris, H. Vagiakou-Voudris,
G. Zorbas, H. Malamou-Lada
Athens, GR
Objectives: To investigate the incidence, pathogens and antibiotic
resistance of isolates from bacteraemic patients of the Haematolo-
gy unit over a 3-year period (2001–2003).
Methods: A total of 193 patients presented one ore more episodes
of bacteraemia during a 3-year period. The identity and MIC
determination of isolates were performed by the Vitek II system
(bioMerieux, France), conventional methods and the Etest method
(Solna, Sweden).
Results: Bacteraemia was microbiologically documented in 193/
321 (60.1%) cases. Polymicrobial bacteraemia was observed in 22/
193 cases (11.4%). A total of 265 strains had been isolated, among
which 163/265 (61.5%) were Gram-positive bacteria, 88/265
(33.2%) Gram-negative bacteria, 10/265 (3.8%) fungi and four of
265 (1.5%) anaerobes. Of our Gram-positive isolates 23/163
(14.1%) were ‘infrequent’ in earlier years: Listeria monocytogenes
six of 163 (2.3%), Corynebacterium spp 14/163 (8.6%), Streptococcus
viridans two of 163 (1.3%) and Leuconostoc spp one of 163 (0.6%).
Staphylococci coagulase negative were the most common patho-
gens, 69/265 (36.2%). Of them, 66/96 (68.7%) were methicillin-
resistant and six of 96 (6.25%) were identiﬁed as glycopeptide (te-
icoplanin)-intermediate Staphylococcus species (GISS). Enterococcus
faecium was more common than Enterococcus faecalis (25 strains vs.
six strains) and 18/25 (72%) of them were resistant to glycopep-
tides (vanA). Klebsiella pneumoniae and E. coli strains produced ES-
BLs in 15/17 (88.3%) and ﬁve of 20 (25%) cases, respectively. One
strain Ps. aeruginosa was resistant to all tested agents.
Conclusion: Gram-positive organisms were the predominant patho-
gens in our patients, especially the coagulase-negative staphylo-
cocci, followed by Gram-negative bacteria and fungi. Methicillin
resistant Staphylococcus species (MRSS) accounted for approxi-
mately 68.7% and teicoplanin resistant Staphylococcus species
(GISS) for 6.25% of coagulase negative Staphylococcal infections.
Enterococcus faecium, the most common Enterococcus species,
was 72% resistant to glucopeptides (vanA). Ongoing cooperation
between haematologists and microbiologists is important to detect
the distribution of pathogens, which can be used to design policies
for empirical antibiotic therapy and infection control measures.
Infectious diseases and public health issues
P1401 Surveillance study of incidence of HIV-positive




Introduction: Jaipur in India has been considered a low preval-
ence state for the HIV epidemic and HIV/AIDS was therefore
not a thrust area in government-implemented public health ini-
tiatives. However HIV positivity is seen to be spreading into
the hitherto low risk groups in the community at an alarming
rate warranting immediate energetic efforts to arrest the epi-
demic.
Objective: To establish the incidence of HIV positivity in patients
suffering from pulmonary tuberculosis hospitalised in a civil hos-
pital in Jaipur, India and thereby highlight the alarming rate of
spread of the HIV epidemic in low risk groups. Using this as
baseline data upscale government policy initiatives towards public
awareness campaigns, preventive measures and care and support
of HIV-positive population.
Method: A total of 1000 hospitalised patients in the Civil TB hospi-
tal, through random sampling were identiﬁed as target group.
They were screened over a period of 6 months for HIV using
ELISA method on serum.
Results: A total of 1000 serum samples were screened. 44 samples
were found positive (4.4%) and retesed with a different kit to con-
ﬁrm positivity.
Conclusion: The marked increase in HIV positivity (from <1% as
per ﬁgures in 2001–2002) in a low risk group of population suffer-
ing from community-acquired TB infections is cause for concern.
Data from this study discussed with Department of Health Gov-
ernment of Rajasthan, and has lead to upscaling preventive initia-
tives, which is discussed.
P1402 Epidemiological investigation of tuberculosis in
Western Greece and the examination of the completeness of
notiﬁcations
E. Jelastopulu, G. Tsiros, T. Constantinidis
Rio Patras, Alexandroupolis, GR
Objectives: The objectives of this study were (i) to describe the epi-
demiology of TB in western Greece (W-GR) in the last 4 years by
using all reported cases to the three Public Health Departments
(PHD) of this region, (ii) to evaluate the completeness of notiﬁca-
tions to PHDs and to the Hellenic Centre for Infectious Disease
Control (KEEL) and (iii) to examine the sufﬁciency of the surveil-
lance and monitoring system for notiﬁable diseases in Greece.
Methods: TB notiﬁcations for the region of W-GR for the period
2000–2003 were obtained from the three relevant PHDs and
KEEL. Statistical analyses were performed using the SPSS. inci-
dence rates were calculated on the basis of the 2001 census for
the population in W-GR. For the purpose of evaluation of the
completeness of TB notiﬁcations, records from two representative
tertiary care hospitals – the Specialised Hospital for Pulmonary
Diseases (Thorax-H) and the University Hospital of Rio Patras
(Uni H) were compared with the statutory notiﬁcations to the
PHDs in W-GR.
Results: During the 4-year study period a total of 161 cases of TB
were reported to the PHDs in W-GR, 50 in Achaia, 55 in Aitolo-
akarnania and 56 in Ilia. The average annual incidence rate per
100 000 persons per year was found to be 5.4 (four for Achaia, six
for Aitoloakarnania and 7.2 for Ilia), while the ofﬁcial data presen-
ted by KEEL indicate an incidence of 3.8 for W-GR. A clear male
preponderance was found (m/f ratio 2:1). In contrast to the
reported data, the hospital-documented cases were signiﬁcantly
higher: from the 155 recorded TB cases in the Thorax-H only 5%
were reported to the PHD of Achaia, 45% to Aitoloakarnania and
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67% to Ilia, whereas the notiﬁcations rates for the 46 documented
cases in the Uni-H were 75, 70 and 50%, respectively.
Conclusion: This study demonstrates a signiﬁcant inaccuracy and
insufﬁciency of the obligatory TB monitoring system in Greece. In
order to improve the accuracy of the notiﬁcation system the rea-
sons for underreporting and a proper and sincere co-operation
with the physicians, the health centres and the hospitals are
required. An effective disease control and prevention in Greece, a
country with a high proportion of immigrants and refugees com-
ing from regions with high TB incidence can be achieved only
with a well-organised surveillance of tuberculosis at the local,
regional and national level, in order to evaluate and plan pro-
grammes, to target resources and to develop appropriate policies.
P1403 Survey of brucellosis seroprevalence in risk groups
in Erzurum, Turkey
A. Ayyildiz, H. Uslu, A.E. Aktas, H. Yazgi
Erzurum, TR
Objective: Brucellosis is a systemic and a serious infection that
may affect many systems in the body. Most cases of human bru-
cellosis occur in people directly exposed to infected animals, their
excreta, products of abortion, infected carcasses, and unpasteur-
ised milk and processed dairy foods from infected animals. So the
disease is closely related to certain occupational groups, such as
abattoir workers, farm workers, veterinarians, and meatpacking
employees. Erzurum, where the present study was conducted, has
been known as an endemic area for brucellosis, since the economy
is mainly depended on agriculture and livestock. In this regard
we aimed to investigate the seroprevalence of Brucella antibodies
in risk groups working in this district.
Methods: Blood samples were collected from 280 persons belong-
ing to the four different risk groups. They were consisted of 58
veterinarians, 112 butchers, 60 abattoir workers and 50 farm work-
ers. Additionally 100 serum samples from normal population
were included as controls. During sampling, a questionnaire con-
cerning the age, gender, length of employment, educational level
and protective precautions during work if available, was adminis-
tered to each individual in the risk groups. Sera obtained from
both risk and control groups were analysed by the standard tube
agglutination test (STAT) using B. abortus antigen provided from
Pendik Veterinarian Research Institute, Istanbul/Turkey. Sera
with titres equal or more than 1l40 were accepted as posit-
ive. The data and the results of the laboratory tests were ana-
lysed by using software SPSS.
Results: Screening of 280 serum specimens of risk groups and 100 of
control group by STAT gave positive result in 50 (17.9%) and four
(4.0%), respectively. The differences between risk and control
group was found to be signiﬁcant (P < 0.001). The seropositivity
rates were 24.1% in the veterinarians, 19.6% in the butchers, 16.7%
in the abattoir workers and 8.0% in the farm workers. The differ-
ences in the seropositivity rates obtained from the occupational
groups were not signiﬁcant. However, seropositivity was not asso-
ciated with the demographic characteristics of the individuals.
Conclusion: The results of the present study indicate that seroprev-
alence of brucellosis is higher in certain occupational groups con-
cerned with the aninmal husbandry when compared with the
normal population, mainly due to greater exposure to infected
livestock and their excreta.
P1404 Epidemiological and economic effects of the
proposed recommendation for universal varicella vaccination in
Germany
P. Wutzler, S. Wagenpfeil, T. Hammerschmidt, H. Bisanz,
K. Banz, A. Neiss
Jena, Munich, D; Basle, CH
Objectives: In the past recommendations for varicella vaccination
in Germany focussed on risk groups only. However, universal
vaccination of children aged 1 year has recently been recommen-
ded by the German STIKO and shall become effective in 2004.
The objective of this study is to analyse the potential epidemiolog-
ical and economic effects of this recommendation over the next
30 years compared with the risk group strategy.
Methods: The analysis is based on the validated, dynamic model
EVITA (Economic Varicella VaccInation Tool for Analysis). This
model allows to analyse the number of varicella cases and their
complications, hospitalisations and varicella-related death in a
population. Different vaccination strategies deﬁned by age-group
and coverage rate can be analysed. For the risk group strategy, a
coverage rate of 10% among adolescents aged 12–15 years has
been assumed based on the number of vaccination doses sold.
The development of the coverage rate in children aged 1 year was
calculated from the development in those US states, which do not
require a certiﬁcation of immunity before entering day care cen-
tres, comparable with the situation in Germany. For the base case
scenario which is based on the mean coverage rate in these US
states coverage was assumed to increase from 11 to 85% over
8 years and remain constant afterwards. Pessimistic and optimis-
tic scenarios based on the slowest and the fastest development
have also been analysed. Future costs have been discounted with
a discount rate of 5%.
Results: Under the risk group vaccination strategy, 721.400 varicel-
la cases, 38.700 complications, 5.500 hospitalisation and 21 varicel-
la-related death occur each year in Germany. Average, annual
varicella cost for the society amount to 86.5 million . About 43%
of the costs are paid by sickness funds. Universal varicella vac-
cination reduces the average, annual number of cases and related
events by about 77% in the base case and about 75 and 80% in
the pessimistic and optimistic scenarios. Costs for society are
reduced by 44% in the base case scenario, the ratio of savings (in
treatment and work loss costs) and of the vaccination costs (bene-
ﬁt-cost-ratio ¼ BCR) equals 3.94 reﬂecting the net savings. Even
for sickness funds, net savings occur with a BCR of 1.58.
Conclusions: Universal varicella vaccination of children is a very
effective and cost-saving strategy to reduce the considerable bur-
den of varicella in Germany.
P1405 Infectious diseases imported to the Czech Republic
between 1998 and 2002
J. Kostalova, C. Benes, J. Kyncl, J. Castkova, B. Kriz
Prague, CZ
Objective: In agreement with the national law on public health,
the Public Health Service (PHS) of the Czech Republic and the
National Institute of Public Health also monitor imported infec-
tious diseases by means of EPIDAT. The study objectives were to
assess the relevance of this monitoring to public health and to
analyse the trend in imported infections.
Methods: Geographical, seasonal and age distribution of imported
infections were analysed separately for foreigners and the Czech
population. Case histories were taken from the records of diagno-
sing physicians and PHS epidemiologists.
Results: Between 1998 and 2002, 6758 imported infectious diseases
were reported. They were imported from 139 countries of the
world and 10 regions or continents, with the country not being
speciﬁed. Imported morbidity was detected in 3735 (55.3%) for-
eigners, 2663 (39.4%) Czech tourist travellers and 352 (5.2%)
Czech business-travellers. Among the ﬁve countries from which
infections were imported most frequently are Vietnam (22.0%),
Afghanistan (13.6%), India (12.9%), Sri Lanka (10.5%) and Slova-
kia (6.9%). Among the ﬁve countries from, which infections were
imported by Czech tourist travellers are Slovakia (14.8%), Croatia
(10.7%), Tunisia (8.5%), Spain (7.0%) and Italy (6.3%). Among
the most frequently imported diseases are salmonellosis (17.7%),
campylobacterosis (7.1%), shigellosis (4.7%), viral hepatitis A
(2.3%) and malaria (1.7%). Frequent are also clinically less
important parasitic diseases (ancylostomiasis 11.9%, trichuriasis
10.9%, ascariasis 10.8%, scabies 8.5%, giardiasis 7.5%). In contrast
to infections imported by foreigners, morbidity imported by
Czech tourist travellers showed a clear seasonal trend peaking in
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August and peaks not only for children and parents but also for
the third age (retired people).
Conclusion: In the light of the vast range of the infections impor-
ted and worldwide distribution of their possible source countries,
the EPIDAT monitoring is of crucial relevance to protection of
public health in the meaning of an early warning system.
Although secondary cases of imported infections are not regularly
reported so far, the imported pathogens with different biological
characteristics as identiﬁed by the respective national reference
laboratories must have circulated among the Czech population
not sufﬁciently protected by speciﬁc immune mechanisms.
P1406 Harmonising the acute respiratory infection
Reporting System in the Czech Republic with the European
Community Networks
J. Kyncl, B. Prochazka, C. Benes, M. Havlickova, M. Otavova,
J. Kostalova, B. Kriz
Prague, CZ
Acute respiratory infections (ARI) are the most frequent human
diseases with considerable health and economic impact. In 1951,
the inﬂuenza morbidity monitoring programme started in the
Czech Republic. The age-speciﬁc incidence of ARI and incidence
of complications have been monitored weekly since 1968 and
nowadays the system covers more than 5 million population (half
of the Czech population). In an attempt to improve the healthcare
information systems, substantial changes were made to the ARI
reporting system in 2000–2002. Starting from season 2001/2002,
each District Public Health Service enters the data from collabor-
ating general practitioners and paediatricians in the central SQL
database using a secured protocol https. The basic data processing
is automated and uses a statistical model for early detection of
unusually increased rates of the indicators monitored, based on a
general linear model for left censored data. Direct standardization
and weighting for the size of the monitored population are also
used. In accordance with the European Commission decision on
case deﬁnitions for reporting communicable diseases to the
Community network one more change was made to the system.
Starting from January 2004 the clinical data on incidences of inﬂu-
enza-like illness (ILI) within the same population and the same
age groups as in ARI (0–5, 6–14, 15–24, 25–59, 60+ years) are also
collected. Virological surveillance is performed by the National
reference laboratory (NRL) for inﬂuenza and the NRL for nonin-
ﬂuenza respiratory viruses. The data on morbidity from epidemio-
logical surveillance are integrated with those from virological
surveillance. After approval and advanced assessment, the results
are presented on a weekly basis. Comprehensive outputs to
international centres such as the EISS or FluNet are provided by
the NRL for inﬂuenza.
Conclusions: The ARI/ILI reporting system of the Czech Republic
is a modern and efﬁcient tool of surveillance based on collection
of high quality data. Since using an internet-based platform, it is
easily accessible and provides timely information. The project
was partly supported by the Ministry of Health of the Czech
Republic.
P1407 A prospective search for pertussis in Korean adults
W.B. Park, S.W. Park, H.C. Jang, K.D. Lee, H.B. Kim, M.D. Oh,
E.C. Kim, K.W. Choe
Seoul, Cheonan, KOR
Objectives: Although pertussis is increasingly recognised as a
cause of persistent cough in adults in Europe and North America,
there are few reports, in East Asia, about the prevalence of per-
tussis in adults with prolonged cough. In South Korea, infection
of Bordetella pertussis in adults who had a persistent cough was
prospectively searched. Also, in community the prevalence of
adult patients who were suspected to have pertussis was sur-
veyed.
Methods: From September 2002 through May 2003, 102 adult
patients visiting to a university health service centre and a general
outpatient clinic at a municipal hospital (Seoul, Korea) due to a
cough of 1–12 weeks’ duration without underlying pulmonary
disease were evaluated. The polymerase chain reaction (PCR) and
culture were used for evidence of B. pertussis infection. The fol-
low-up clinical data of laboratory-conﬁrmed patients were
obtained from the weekly telephone visits. In 1412 persons who
participated in the routine health check-up for the faculty in a
university (Seoul, Korea) at September 2002, the morbidity of
cough illness and the presence of the classic symptoms of per-
tussis (paroxysmal cough, whoop and post-tussive vomiting)
within past 6 months were surveyed by the self-administered
questionnaire.
Results: Three patients (2.9%) were PCR-positive for B. pertussis,
but there was no patient with positive culture. All PCR-positive
patients had one or more of classic symptoms of pertussis and
their cough was conﬁrmed to persist for 3–7 weeks. In the com-
munity survey, we identiﬁed 34 cases (2.4%) who had a cough of
>1 week’s duration and one or more of classic symptoms of per-
tussis within past 6 months.
Conclusion: We conﬁrmed that pertussis was a cause of persistent
cough in Korean adults. Therefore, pertussis should be considered
in the differential diagnosis of chronic cough illness in adults.
P1408 Seroprevalence survey of Rickettsia typhi, Rickettsia
conorii, and Bar29 strain in the South of Spain
M. Bernabeu-Wittel, M.D. Del Toro, N. Carden˜osa,
M.M. Nogueras, M.J. Rodrı´guez-Herna´ndez, F. Vaquero,
F. Ma´rquez, M.A. Muniain, F. Segura, J. Pacho´n
Seville, Barcelona, Jae´n, E
Objective: Mediterranean spotted fever is endemic in the South of
Spain. Recently murine typhus has been demonstrated as a cause
of fever of intermediate duration in this area. Bar29 strain has
been detected in Barcelona (north of Spain), but its presence in
the south of Spain has not been determined. The objective was to
evaluate the seroprevalences of Rickettsia conorii, Rickettsia typhi,
and Bar29 in the population of Sevilla (south of Spain).
Methods: People living in the province of Sevilla were eligible.
Those not able to answer the epidemiological survey or with a
febrile disease in the previous 30 days were excluded. Sample size
was established for an estimated seroprevalence of R. typhi of
5  2.5% (conﬁdence level ¼ 99%) in 504 subjects. The popula-
tion was prestratiﬁed according to age (0–14, 15–29, 30–44, 45–64,
and >64 years), and living place [>50.000 inhabitants ¼ urban (U);
5.000–50.000 ¼ suburban (SU); <5.000 ¼ rural (R)]. Epidemiologi-
cal variables surveyed were gender, profession, living place, out-
doors activities, travels in last 12 months, contact with animals,
and insect bites in last month. IgG was measured by indirect
immunoﬂuorescence assays (R. conorii: Ref no. 75901, bioMe´rieux,
France; R. typhi: Ref no. IF0100, Focus Technologies, USA; and
Bar29: local strain, Barcelona, Spain). Past infection was consid-
ered when titres values 31:64. Group comparisons were performed
using Chi square and Fisher tests, and correlations using Spear-
man’s Rho. A P < 0.05 was considered signiﬁcant.
Results: Seroprevalence of R. conorii, R. typhi, and Bar29 strain was
8.73, 3.77, and 3.37%, respectively. Past infection with R. conorii
was present in 9.7% of subjects in U, 6.4% in SU, and 10.8% in R
(P ¼ ns), while R. typhi was present in 4.5% in U, 3.2% in SU and
0% in R (P ¼ ns). Bar29 strain past infection was more common
in R (10.8%) than in U [3.2%, P ¼ 0.05; RR¼3.6 (1.1-12.3)] and SU
[1.9%, P ¼ 0.02; RR ¼ 6.2 (1.3-28.9)]. Older age was associated
with past infecion with R. conorii (P ¼ 0.02), R. typhi (P < 0.0001),
and Bar29 (P ¼ 0.002). Gender, contact with animals, travels to
rural areas, or outdoors activities were not associated to past
infection with any of the Rickettsia. The relative risk of past infec-
tion with R. typhi in those with an insect bite in the month previ-
ous to blood extraction was 3.1 (0.99–10.02).
Conclusion: These results conﬁrm the presence and widespread of
past infections by R. typhi and Bar29 strain in people from rural
and urban areas in the south of Spain.
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P1409 Dynamics of nasopharyngeal colonisation by
Haemophilus inﬂuenzae in infants and young children
A. Sulikowska, A. Mro´wka, W. Hryniewicz
Warsaw, PL
Objective: The aim of the study was to analyse the dynamics of
nasopharyngeal carriage of Haemophilus inﬂuenzae in asympto-
matic children sampled twice a year using phenotypic and
molecular methods.
Methods: A total of 77 children (43 from an orphanage OR; 34
from a cre`che DCC) were examined twice a year, ﬁrst in winter
and again in spring. Clinical data and information about antibiotic
treatment within the 1-month period before sampling, were collec-
ted by questionnaire. Nasopharyngeal swabs were processed and
H. inﬂuenzae was identiﬁed by conventional microbiological meth-
ods. The MICs of antimicrobials were determined by the agar-
dilution method. All H. inﬂuenzae isolates were tested for the pres-
ence of capsule gene and serological type by PCR. Pulsed-ﬁeld gel
electrophoresis (PFGE) of SmaI restriction fragments of the bacter-
ial chromosome was used to determine the relatedness among
H. inﬂuenzae isolates.
Results: Altogether 77 H. inﬂuenzae isolates were identiﬁed; 24
from DCC and 53 from OR. In a single case three different strains
were obtained from the same child. Over 40% of investigated
children were colonised by H. inﬂuenzae in winter and 60% in
spring. Twenty-four children were colonised by H. inﬂuenzae both
in winter and spring. Of them only two were colonized by the
same strain during the second sampling as during the ﬁrst one. In
most cases, H. inﬂuenzae isolated at two different points of a year
from the same child were unrelated but in particular groups the
same strain was often isolated from several children. From all the
77 isolates of H. inﬂuenzae, three (3.9%) produced the capsule and
all the capsular strains belonged to the serotype b (Hib). Almost
all isolates of H. inﬂuenzae were fully susceptible to the antimicro-
bials tested.
Conclusions: Colonisation of nasopharynx by H. inﬂuenzae repre-
sents a dynamic process – bacteria are acquired, eliminated and
reacquired over a period of 3–4 months. Long-term colonisation
(over 4 months) involved only two of the investigated children.
Small closed communities, such as OR and DCC, are places with
a high percentage of nasopharyngeal carriers of H. inﬂuenzae and
create a high risk of the clonal spread of potential pathogens.
P1410 Cell-detaching Escherichia coli activity in
urinary-tract infection isolates
S. Gavilanes, S. Martinez, E. Chavez, A. Navarro, E. Drago,
L. Leon, A. Manjarrez
Mexico City, MEX
As many as 90% of all community-acquired urinary-tract infec-
tions (UTIs) are caused by E. coli, this bacteria is one of the most
common bacterial infections in humans. Symptomatic UTI is
manifest in two syndromes: One is acute pyelonephritis generally
perceived as being a kidney infection, the second is cystitis, which
is generally perceived to be a bladder infection. A recently
deﬁned category of potentially diarrheagenic E. coli is cell-detach-
ing strains, which were originally deﬁned by their capacity to
detach tissue culture cells from solid supports in adherence
assays. However, epidemiological studies have found that these
strains are not really associated with diarrhoea, and their signiﬁ-
cance remains unknown. In this report, we describe the identiﬁca-
tion of urinary E. coli strains (isolated from patients with UTIs)
capable of detaching HEp-2 cells monolayers and characterise
these strains in detail. Serotyping revealed that most of the strains
belonged to serotypes associated with extraintestinal disease, O6
was the most prevalent serogroup. Fifteen of 40 E. coli isolates
from UTIs had the ability to detach HEp-2 cells in the adherence
assay. The culture supernatant of these cell-detaching bacteria
(concentrated 10-folds) caused the same detaching effect and con-
tain several secreted proteins. Two of them were identiﬁed as
Sat (Secreted autotransporter toxin), and haemolysin. Some other
protein bands appears on the gel after SDS-PAGE electrophoresis
of the supernatant, the most prominent and consistent of these
secreted proteins had apparent molecular masses of 176, 120–122,
110, 36–38 and 25 kDa. Western blot analysis shows that most of
these proteins were recognised by secretory immunoglobulin A
(sIgA) antibodies isolated from milk from Mexican women. The
strong sIgA response to these secreted proteins obtained in this
study indicates that such antigens stimulate intestinal or urinary-
tract responses and may elicit protective immunity against uro-
pathogenic disease.
P1411 Long-term surveillance of invasive group A
streptococcal disease in the Netherlands, 1994–2003
B. Vlaminckx, W. van Pelt, L. Schouls, A. van Silfhout,
E.M. Mascini, T. Fernades, A. Bosman, J.F.P. Schellekens
Utrecht, Bilthoven, NL
Objectives: After more than half a century of decreasing morbidity
and mortality a resurgence and persistence of serious group A
streptococcal (GAS) infections has been noted since the mid-1980s.
There are however limited population based and prospective epi-
demiological studies.
Methods: A prospective, nation-wide, laboratory-based surveil-
lance of invasive GAS infections was formally organised with all
regional public health laboratories (national coverage: 45%) in the
Netherlands from May 1994.
Results: Between May 1994 through May 2003,1431 patients with
invasive GAS disease were identiﬁed. Isolates were predomin-
antly obtained from blood (70%). There was a clear seasonal pat-
tern with the preponderance of cases occurring in late winter and
spring. Incidence varied between 4.0/100.000 person years (1995/
1996) and 2.0 per 100.000 person years in 1999. The most fre-
quently identiﬁed M-types were: M1 (23%), M3 (12%), M89
(11%), M28 (10%), M12 (7%) and M6 (4%). The annual relative
contribution of M1 and M3 types showed a high degree of vari-
ation, which was not explained by local outbreaks. Over this dec-
ade of surveillance, the relative proportion of the >65 years age-
group increased gradually from 39% to over 50%.
Conclusion: Population-based surveillance provides data for mon-
itoring incidence trends and identifying the importance of virulent
strains.
P1412 Early and late onset group B Streptococcus (GBS)
disease at a central hospital, Harare, Zimbabwe
S.R. Moyo, J. Lucas
Harare, ZW
Objective: The main focus of this study was to determine the pre-
valence, common presenting symptoms, risk factors and mortality
rate associated with early and late onset neonatal GBS disease.
Methods: This was a prospective study comprising of 115 neonates
suspected to have early and or late-GBS infection, presenting with
sepsis and or meningitis during the period 1st February and 30th
June 2003. On 69 of the neonates, a lumbar puncture to obtain
cerebro spinal ﬂuid (CSF) was performed for microbial analysis
for pathogens. On 46 of the cases, a blood culture was performed
for isolation and identiﬁcation of pathogens. For both CSF and
blood culture standard bacterial methods were used to isolate and
identify pathogens. A questionnaire was also used to collect data
concerning details of birth records, presenting symptoms and
treatment history.
Results: Of the 115 samples 69 (60%) were lumbar punctures
while 46 (40%) were blood cultures. Neonates (57%) were male
and 43% were female. Apart from GBS, especially capsular type
III, there were other causes of neonatal disease of which the pre-
dominant cause was CNS and the others included, Klebsiella spp,
Streptococcus pneumoniae, Staphylococcus aureus, Escherichia coli,
nonlactose fermenting coliforms (NLFC) and lactose-fermenting
coliforms (LFC). Most babies were 0–7 days old (early onset),
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however GBS disease was more frequent in babies 8–90 days of
age (late onset disease).
Conclusion: Late onset disease is more common than early onset
disease. GBS capsular type III is a cause of late onset neonatal dis-
ease, however there are other organisms also causing early and
late onset neonatal disease at Harare Hospital. There are no clear
guidelines dealing with neonatal GBS disease at Harare Hospital.
P1413 Emergence of MRSA strains containing the Panton-
Valentine Leucocidin gene in the Netherlands
W.J.B. Wannet, E. Spalburg, M.E.O.C. Heck, G.N. Pluister,
R.J.L. Willems, A.J. Neeling de, J. Etienne
Bilthoven, Utrecht, NL; Lyon, F
Objectives: Recently, MRSA strains possessing the Panton-Valen-
tine Leucocidin (PVL) gene were detected in the Netherlands. The
PVL gene encodes a highly potent toxin associated with severe
skin infections and lethal necrotizing pneumonia. PVL-positive
MRSA strains have also been noticed in other European countries,
in the USA and Oceania. Our objective was to study the presence
of MRSA harbouring the PVL gene in the Netherlands, and to
compare this with other studies on PVL-MRSA conducted in Eur-
ope and the USA.
Methods: Molecular subtyping (PFGE, MLST and SCCmec typing)
was performed on PVL-MRSA isolates obtained from the national
MRSA surveillance programme in the Netherlands, from 2000 till
2003. When available, epidemiological information was used to
compare the Dutch PVL-MRSA isolates with those found abroad.
Results: In the Netherlands, approximately 10% of all MRSA iso-
lates send to the RIVM (national surveillance programme) in the
period 2000–2003 possess the PVL gene. Molecular subtyping
(PFGE) on the Dutch isolates showed a predominant clone: cluster
28. The PFGE pattern of cluster 28 is identical to the pattern of
predominant PVL-MRSA clones from several other European
countries. By using multi-locus sequence typing (MLST), all clus-
ter 28 isolates were sequence type (ST) 80. Thus far, MRSA with
ST80 has not been observed in the USA, indicating that this PVL-
MRSA genotype might be an European clone. PVL-MRSA ST80
has so far shown to be 100% resistant to fusidic acid, neomycin
and tetracycline, used for ﬁrst line topical treatment of staphylo-
coccal infections. Since 2000, 24 patients were observed in the
Netherlands with PFGE cluster 218. The PFGE pattern of this clus-
ter is identical to the PFGE pattern of a predominant USA PVL-
MRSA strain (USA300; ST8), suggesting transmission from the
American continent. The majority of the Dutch PVL-MRSA iso-
lates harbour a type IV SCCmec region, and therefore might be
community-acquired.
Conclusions: A signiﬁcant proportion of MRSA strains detected in
the Netherlands contain the PVL gene. Relationships with other
countries or continents seem obvious. The combination of the PVL
gene (virulence) and mec cassette (resistance) and proven epide-
micity (e.g. ST80) makes this a well-adapted pathogen, which can
have severe implications, especially when more resistance markers
are acquired.
P1414 Prevalence of group B streptococcal colonisation in
Greek pregnant women
S. Maraki, M. Dialynas, E. Nioti, T. Gavrilidi, Y. Tselentis
Heraklion, GR
Group B streptococcus (GBS) is the leading cause of severe
infections in neonates with high mortality rate. Neonates born to
mothers colonised at delivery with GBS are at risk of developing
the infection.
Objective: Aim of the study was to determine the prevalence of
GBS carriage among pregnant Greek women.
Patients and methods: A study of colonisation by GBS was conduc-
ted in 332 consecutive pregnant women at 35–37 weeks of gesta-
tion. Swabs were placed into 5 mL of selective broth with
antibiotics and after 18 h of incubation were subcultured onto col-
istin/nalidixic acid (CNA) agar. Identiﬁcation was made by con-
ventional microbiological methods and positive agglutination test
for GBS. The isolates underwent antibiotic susceptibility testing by
the disc-diffusion method following the recommendations of the
NCCLS.
Results: A total of 332 women aged 16–40 years were recruited.
Thirty-six (10.8%) were colonised by GBS. All isolates were peni-
cillin-susceptible while resistance to erythromycin and clindamy-
cin was detected in 12 and 6.6%, of them respectively.
Conclusions: Antepartum screening for GBS colonisation and
maternal-intrapartum chemoprophylaxis with antibiotics in the
positive cases appear to be the most effective approach, in order
to prevent the transmission of GBS to the newborn and to reduce
the risk of early-onset disease.
P1415 Seroprevalence of rubella, cytomegalovirus and
Toxoplasma gondii among women of reproductive age in the
region of Thrace, Greece
S. Mela, C. Tsigalou, T. Gkioka, E. Chrysaﬁdou, G. Kampouromiti
Alexandroupolis, GR
Objectives: The purpose of this study was to evaluate serological
analysis of immunity to Rubella, cytomegalovirus (CMV) and
T. gondii in a population of pregnant and nonpregnant women of
reproductive age in the region of Thrace, Greece within 1-year
period.
Methods: From February 2002 to February 2003, sera from 318
women were tested for detection of speciﬁc Rubella, CMV and
T. gondii antibodies. There were three groups of women, group A:
182 (57%). Greek orthodox women, group B: 108 (34%) Greek
Moslem women and group C: 28 (9%) Immigrants of Greek origin
from Former Soviet Union. All tests to detect the levels of IgG
and IgM antibodies were performed by MEIA msethology
(AXSYM –Abbott).
Results: In group A 140 (77%) women were found to be positive
for Rubella IgG, 130 (71%) for CMV IgG and 28 (15%) for T. gondii
IgG. In group B 52 (48%) for Rubella IgG, 78 (72%) for CMV IgG
and 34 (31%) for T. gondii IgG. In group C 20 (71%) women were
found to be positive for Rubella IgG, 24 (86%) for CMV IgG and
eight (29%) for T. gondii IgG. It was also measured the seropositive
rate for IgM antibodies (marker of acute infection) for Rubella,
CMV and T. gondii. The seropositive rate for Rubella IgM was for
group A 0.5%, for group B 0% and for group C 0%. CMV IgM
was for group A 2.2%, group B 4.6% and group C 25%. T. gondii
was for group A 2.7%, for group B 2.7% and for group C 53% .
Conclusions: (i) This study showed that there is a signiﬁcant preval-
ence of Rubella IgG in group A and C. A very low rate was found
in group B, despite the fact that there is a routine Rubella vaccin-
ation programme. A total of 106 women (33%) were not immune to
Rubella. (ii) A total of 248 women (78%) were at higher risk of
acquiring T. gondii infection in pregnancy. This is indeed a large
number of unprotected women. (iii) A total of 232 women (78%)
were found to be positive for CMV IgG and 86 women (22%) were
negative. (iv) The overall seropositive rate for Rubella was 0.3%, for
CMV 2.5% and for T. gondii 1.6%. Further studies with larger
population size may be needed in order to determine the seropreva-
lence of viruses and T. gondii in immigrants. It is important that
all women should be checked prior to planned pregnancy, especi-
ally those from certain minorities that might have difﬁculties
attending the existing vaccination programmes.
P1416 Bacterial evaluation of supermarket bought chickens
in the Maﬁkeng area (RSA)
C.N. Ateba, D.T. Kawadza
Mmabatho, ZA
Background: In developing countries, chickens are marketed live
but in more industrially developed countries (South Africa),
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chickens are dressed in a commercial processing plant before being
marketed. The study was aimed at evaluating the level of bacteria
contamination of chicken carcasses from the supermarkets.
Methods: A total of 48 refrigerated samples were collected from
the some supermarkets (24 in winter and 24 in summer). The bac-
terial analysis was achieved both qualitatively and quantitatively.
Qualitatively, a 10-fold serial dilution was performed from nutri-
ent broth on which 10 g of chicken skin had been placed using
saline. Dilutions were plated using plate count agar. Plates were
incubated at 37C for 24 h and later determined for the level of
contamination in terms of the number of colony forming units
(CFU)/mL of the sample. Quantitatively, the interest was on isola-
ting Salmonella spp. and Staphylococuss aureus. Subcultures were
performed from selenite broth and nutrient broth to XLD agar
and mannitol salt agar (MSA), respectively. Plates were incubated
at 37C overnight. Gram-staining was done [Cruickshank (1975)].
Presumptive Gram-negative Salmonella isolates were further con-
ﬁrmed by the oxidase and the API 20E tests and Gram-positive
Staphylococuss aureus isolates were further tested by the catalase
test, DNase test and conﬁrmed by the coagulase test. Both isolates
were tested for resistance to various antibioticsm (Bauer 1966).
Results: Qualitatively, during winter, 4.2, 87.5 and 8.3% of the
samples had bacterial loads that were insigniﬁcant, acceptable
and were approaching or at a state of spoilage, respectively. Con-
trarily, the summer collection revealed 12.5, 70.8, 16.6% of the
samples had bacterial loads that were insigniﬁcant, acceptable
and were approaching or at spoilage, respectively. The level of
spoilage was higher in summer (16.6%) as opposed to winter
(8.3%). Quantitatively, in 48 and 76% of Salmonella arizonae were
isolated in winter and summer respectively while 35 and 87% of
Staphylococuss aureus were isolated from winter and summer
respectively. Multiple antibiotic resistances (MAR) were observed
for all Salmonella and Staphylococcus isolates.
Conclusion: With the preceding as background it was concluded
that chickens are not free from bacteria contamination, rendering
them unhealthy for human consumption if proper handling and
preservation measures are not implemented.
P1417 Prognostic factors in adult tetanus
N. Saltoglu, Y. Tasova, D. Midikli, A.S. Inal, R. Burgut, I. Du¨ndar
Adana, TR
Objectives: The objective of this study was to determine prognostic
factors related to death from adult tetanus.
Methods: A total of 53 tetanus patients, 25 female and 28 male
admitted to Infectious Diseases Department of Cukurova Univer-
sity Hospital between January 1994 and July 2000 were investi-
gated and were followed for 60 days if they survived. As for
the analytical techniques, the Chi-squared tests or when needed
Fisher’s exact test were used for the association between mortal-
ity and such categorical variables as gender, incubation period,
tetanus type, etc. In evaluating the prognostic value of the scor-
ing scheme, a trend test of Cochran and Armitage was
employed. In addition to the fatality rate among tetanus patients
was examined by multivariate logistic regression models, which
include variables of incubation period and symptoms simulta-
neously.
Results: The mean age was 46.6 years. 41 patients (77.7%) came
from rural areas. Most of the cases had minor trauma (64.1%),
but 19 (35.8%) had deep injuries. The mean incubation period
was 11.5 days. Mortality was high (52.8%), due to cardiac or res-
piratory failure or complications. Mortality was related to the
length of the incubation period. In cases with an incubation per-
iod of 7 days or less the mortality rate was 75% (P ¼ 0.07). Mor-
tality was signiﬁcantly associated with generalized tetanus
(P < 0.05), fever 40C, tachycardia >120 beats/min (P < 0.05),
postoperative tetanus (P ¼ 0.03) and the absence of post-traumatic
tetanus vaccination (P ¼ 0.068). Patients who were given tetanus
human immune globulin or tetanus antiserum (P > 0.05) showed
similar outcomes. Patients who were given penicillin had a similar
mortality rate to patients who were given metronidazole
(P ¼ 0.15).
Conclusion: The fatality rate was higher in patients with severe tet-
anus (92%) than in patients with moderate diseases (53%). The
binary logistic model revealed that the existence of tachycardia
and being >60 years of age are simultaneously the most signiﬁ-
cant prognostic risk factors in relation to mortality for tetanus
patients.
P1418 Quality of life after tick-borne encephalitis
V. Chmelik, P. Petr, I. Slamova, P. Filipova, L. Houserova,
A. Chrdle, H. Kalova
Ceske Budejovice, CZ
Objectives: South Bohemia is a large-size natural focus of tick-
borne encephalitis (hereinafter TBE) in the Czech Republic. In the
Infectious Department in Ceske Budejovice Hospital, TBE virus is
the most frequently proven pathogen of neuroinfection. In recent
years we have hospitalised annualy from 90 to 170 patients with
clinically, by CSF, and serologically proven TBE. Convalescence
period in these patients is very long and unpleasant. The objective
of this study is to measure quality of life during convalescence
period.
Methods: In 2003, we have diagnosed TBE in total 93 patients, 16
of them were children. The 74 adults were offered to ﬁll an SF-36
questionnaire (1) in mean 3.4 months (range 0.5–5 months) after
discharge. 50 of them have replied, one of them sent not fully
completed questionnaire. Total 49 patients (31 males, 18 females)
aged 48.7  14.7 years (18–72) were included in our analysis.
Patients with encephalitic course of disease responded more often
compared with patients with meningitis: 31 (63%) responders
have had encephalitic course of TBE. The responders were strati-
ﬁed by sex and encephalitic vs. meningitic course of disease. The
results were compared with the control of general-population-
based Oxford sample.
Results: TBE patients manifested worse results (P < 0.05) in the
next segments of the SF-36 test (two-sided testing): physical func-
tion, role limitation-physical, role limitation-emotional, social
functioning, pain, mental health, and general health perception.
Vitality was not signiﬁcantly affected. Women compared with
men had signiﬁcantly worse results (P < 0.05) in physical func-
tion, role limitation-physical, role limitation-emotional, social
functioning, pain, mental health, and vitality. Differences in gen-
eral health perception were not signiﬁcant. Postencephalitic
patients compared with those after meningitis had not signiﬁ-
cantly worse results.
Conclusion: Tick-borne encephalitis affects the patient’s quality of
life for months. The quality of life of women compared with men
is signiﬁcantly more affected. 1. Medical Outcomes Trust (1996)
Boston MA, USA, Health Services Research Unit, 1996 Oxford,
Great Britain. Czech version: Zdravotne socialni fakulta, Jihoceska
Univerzita v C.Budejovicich.
P1419 The effect of short-time microwave exposures on
Escherichia coli O157:H7 inoculated into hamburgers
I. Apostolou, C. Papadopoulou, C. Dontorou, C. Salamoura,
K. Ioannides, S. Leveidiotou
Ioannina, GR
The bactericidal effect of short time exposures on Escherichia coli
O157:H7 inoculated into beef hamburgers were studied in vitro.
Hamburgers made from minced bovine meat, weighing 40 g each
were contaminated with E. coli O157:H7 inoculums of concentra-
tion 105–106 CFU/g and subsequently cooked in a domestic
microwave oven (SHARP R-7280, 2450 MHz, 650W). The ham-
burgers were cooked for 10, 20, 25, 30, 35, 40 and 50 s. Viable
counts on selective media were performed following standard
microbiological procedures. Time, temperature and reciprocal
viable counts were recorded and the survival rate was assessed.
After 30 s of exposure to microwave radiation the hamburgers
looked well cooked; however, E. coli O157:H7 viable cells were
recovered at concentration level 0.58  106 CFU/g. After 35 s of
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microwave cooking and at a mean ﬁnal temperature 68.1C, the
mean ﬁnal concentration of E. coli O157:H7 viable cells was
reduced to 500 CFU/g. Complete destruction of E. coli O157:H7
cells was accomplished after 50 s of exposure to microwave radi-
ation, when the mean ﬁnal temperature was 75.6C. The results
indicate that short time exposures to microwave heating are insuf-
ﬁcient for complete decontamination of beef burgers potentially
contaminated with E. coli O157:H7 and the safety of food cooked
very fast are questioned.
P1420 A retrospective evaluation of Listeria infections in
Bari, south Italy, from March 2002 to April 2003
C. Rizzo, M.F. Coscia, G. Ceci, G. De Pascale, R. Monno,
D. De Vito, G. Rizzo
Bari, I
Objective: Listeria monocytogenes is an intracellular ubiquitous
organism that affected patients with decreased cell-mediated
immunity such as the elderly, transplant recipients, cancer
patients, dialysis patients, patients with diabetes mellitus and
those with HIV infection. Women are at particular risk during
pregnancy because cell-mediated immunity is slightly decreased
during pregnancy. We described 10 cases of listeriosis that
occurred in elderly and adults in Bari, south of Italy.
Methods: Strains of L. monocytogenes were isolated according to
standard protocols from various clinical samples. Data regarding
serotyping, antibiotic resistance and clinical information were ana-
lysed by software Epi-Info 6.4.
Results: From March 2002 to April 2003, 10 cases of human listeri-
osis were reported to the Regional Reference Centre for patho-
genic enterobacteria. Seven strains of L. monocytogenes were
isolated from blood culture and three from cerebrospinal ﬂuid
culture. Feto–maternal infections (two cases of still-birth and one
case of spontaneous abortion) and septicaemia in adults (two
cases) and elderly (one case) were most frequent followed by cen-
tral nervous system infections in adults (four cases). Seventy per
cent of the patients presented a current conditions which favoured
the triggering of the disease. The predominant serovars were 4ab
and 1/2 b both frequent (40%), followed by serovar 1/2 a (20%).
The prevalence of antibiotic resistance was lower.
Conclusions: The number of cases of listeriosis in Italy grew up
dramatically in the period of observation. In the same period also
in France was observed an epidemic cluster. No more cases were
notiﬁed to the Regional Reference Centre for pathogenic entero-
bacteria from April 2004 after active surveillance of invasive list-
eriosis has been carried out. This may do a combination of
increased regulatory activity, implementation of HACCP pro-
grammes and speciﬁc reccomendations to immunocompromised
host and pregnant women on how to avoid foodborne listeriosis.
P1421 Microbiologic survey of long-term-care facilities in
Greece
V. Grammelis, K. Kanellakopoulou, A. Kapaskelis, M. Gika,
F. Baziaka, D. Katsala, H. Giamarellou, M.K. Lazanas
Athens, GR
Objectives: A microbiologic survey of LTCF was performed aiming
to determine the prevalence of pathogens colonising the elderly
residents.
Methods: A total of 21 LTCF were randomly selected from the
public sanitation list of Attic province. Urine (U), nasopharyngeal
(N) and wound (W) samples were collected from 662 residents;
from each LTCF, we chose randomly 30% of the existing elderly
population (minimum ¼ 25 residents). Cultures and susceptibility
testing were carried out and information was collected on facility
and resident demographic data.
Results: The residents had a mean age of 86.6 years. The preval-
ence of residents with indwelling bladder catheters ranged from
1.8 to 32%, with a mean of 17.1%. A total of 358 patients (54.1%)
had been receiving a systemic antibiotic during the preceding
month; leading prescribed antibiotic classes were quinolones
(39%) and cephalosporins (21%). The mean prevalence rates of
recent (previous 120 days) hospitalisation, poor functional status
and usage of feeding tube were 2.6, 42.2, and 9.5%, respectively.
A total of 1369 specimens (662 U, 662 N, 45 W) were collected
and 495 bacteria were isolated. The prevalence rate was 36.16%;
the leading isolates were Escherichia coli (34.5% of all found),
Staphylococcus aureus (22%-I`RSA 3.2%), Proteus mirabilis (14%),
Klebsiella pneumoniae (12.5%), Providencia stuartii (4.25%),Morganella
morganii (4.25%), Pseudomonas aeruginosa (1.75%) and Enterococci
species (1%). Of all bacteria found, Gram-negative isolates (387)
accounted for 78.2% and Gram-positive (108) for 21.8%. Among U
isolates (302/495, 61%), Enterobacteriaceae (EB) (83.5%) predomin-
ated. In N pathogens (142/495, 28.7%) and W isolates (51/495,
10.3%), the most frequent were S. aureus (19.5% and 4.9%, respect-
ively) and Proteus mirabilis (6.6 and 2.9%, respectively).
Conclusions: (i) Gram-negative bacteria predominate in the bacter-
ial ﬂora of Greek LTCF. (ii) The high rate of NS colonisation with
GNB and S. aureus is important and must be considered, especi-
ally in case of respiratory infections. (iii). Antibiotic usage is extre-
mely high; further emphasis must be laid on antimicrobial use
management in Greek LTCF.
P1422 Pseudo-contamination of blood components with
Burkholderia cepacia during quality controls
W. Ebner, E. Meyer, C. Schulz-Huotari, G. Zilow, M. Dettenkofer,
U. Frank
Freiburg, D
Objective: To investigate the microbiological detection of Burk-
holderia cepacia in blood components during quality controls.
Methods: Any blood components contaminated with B. cepacia
found during microbiological quality controls at Freiburg Uni-
versity Hospital blood bank in July 2003 were recorded. The
procedures employed in producing blood components were
analysed and the individual steps in quality control were inves-
tigated. One of these entails inoculating the blood culture bot-
tles with samples from the blood components. All the
disinfectants were investigated, including those used for decon-
tamination of the rubber stoppers belonging to the blood cul-
ture bottles.
Results: Burkholderia cepacia was found in three samples (thrombo-
cyte and erythrocyte concentrate and apheresis plasma) investi-
gated during microbiological quality control. No septic reactions
associated with transfusions had been reported in patients over
the last 6 months. A second microbiological control of the affected
blood components was negative. No mistakes could be found
regarding the processing and storage of blood components. Ana-
lysis of quality control procedures revealed that a disinfectant
based on a quaternary ammonium compound (QAC) had been
used to disinfect the rubber stopper of the blood culture bottle.
The disinfectant was prepared with concentrate and tap water
according to the manufacturer’s instructions. B. cepacia was found
in a sample taken from this disinfectant. The four isolates (disin-
fectant and blood components) were found to be identical in their
biochemical reactions and resistance patterns. Genotyping was not
done.
Conclusion: In Germany, leucocyte-depletion of blood components
to reduce the risk of CJK transmission has been required by law
since October 1st, 2001. However, this increases the risk of bacter-
ial contamination of blood products. Our case proved to be a
pseudo-contamination due to the use of a contaminated disinfect-
ant during quality controls. This case report demonstrates that to
ensure the qualitative validity of the results obtained, adherence
to high standards of hygiene during quality control procedures is
important. An alcohol-based disinfectant should be used to disin-
fect the rubber stopper of a blood culture bottle. QAC-based dis-
infectants are not efﬁcacious against part of the spectrum of
Gram-negatives and are therefore inadequate. After introduction
of an alcohol-based preparation no more cases of B. cepacia con-
tamination were found.
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P1423 The proteolitic and lipolitic activity of Pseudomonas
strains isolated from raw milk
G. Uraz, B. Dadakoglu, D. Eto¨z
Ankara, TR
Our research is aimed to determine the Pseudomonas types which
are isolated from the raw milk that indicating proteolytic and
lipolytic activities accordingly. For such a purpose, the naming
works of the bacteria, which are isolated from the 80 pieces of
raw milk collected from 80 places and afterwards, by using cal-
cium cazeinat agar (CCA) feeding place the proteolytic and Trib-
u¨tyrin Agar (TBA) feeding place, the lipolytic activities have been
worked. Of the 104 isolation made from 80 isolated samples are
named as 19 (18.2%) Aeromonas hydrophila, 73 (70.2%) Pseudomon-
as, six (5.75%) Yersinia, one (0.69%) Alcaligenes, two (1.92%) Pro-
teus, two (1.92%) Providencia, one (0.96%) Serratia. species name
and per cents of Pseudomonas were indicated Pseudomonas aerugi-
nosa 38 (36.5%), Pseudomonas aurefaciens three (2.8%), Pseudomonas
cepacia four (3.8%), Pseudomonas mallei 1 (0.96%), Pseudomonas
pseudoalcaligenes ﬁve (4.8%), Pseudomonas pseudomallei one (0.96%),
Pseudomonas ﬂuorescens biovar I, II, III, IV, V 8 (7.6%), Pseudomonas
stutzeri one (0.96%), Pseudomonas picketii two (1.92%) vs. Pseudo-
monas viridiﬂava one (0.96%). The number of species which indi-
cate proteolytic and lipolytic activitiy is 38 from the Pseudomonas
aeroginosa’, the number of species proteolytic and lipolytic activitiy
is ﬁve from the Pseudomonas alcaligenes, the number of species pro-
teolytic and lipolytic activitiy is three from the Pseudomonas aure-
faciens, the number of species proteolytic activitiy is two, the
number of species lipolytic activitiy is three from the Pseudomonas
cepacia, the number of species proteolytic and lipolytic activitiy is
one from the Pseudomonas mallei, the number of species proteolytic
and lipolytic activitiy is ﬁve from the Pseudomonas pseudoalcali-
genes, the number of species proteolytic activitiy is one from the
Pseudomonas putida, the number of species proteolytic and lipolytic
activitiy is three from the Pseudomonas mendocina, the number of
species proteolytic and lipolytic activitiy is one from the Pseudo-
monas pseudomallei, the number of species proteolytic activitiy is
seven, the number of species lipolytic activitiy is eight from the
Pseudomonas ﬂuorescens’ in (biovar I, II, III, IV, V), the number of
species lipolytic activitiy one is from the Pseudomonas stutzeri, the
number of species proteolytic activitiy is one, the number of spe-
cies lipolytic activitiy is two from the Pseudomonas picketii, the
number of species proteolytic and lipolytic activitiy is one from
the Pseudomonas viridiﬂava.
P1424 Endocarditis due to Enterococcus faecalis: risk
factors and outcome in 21 cases from a 5-year national survey
M. Noskovicova, V. Hricak, V. Krcmery
Bratislava, SK
Objectives: Investigate the risk factors, therapy and outcome of
native valve endocarditis due to Enterococcus faecalis (E. faecalis) in
Slovak Republic.
Methods: Between 1992 and 1996 all cases of native valve-infective
endocarditis of E. faecalis origin were prospectively evaluated
using a protocol, which was submitted to all medical departments
in Slovakia. No cases of prosthetic endocarditis were included.
Major and minor criteria of the Duke endocarditis service were
recorded for deﬁnition of endocarditis as deﬁnitive or possible. In
a univariate analysis risk factors and outcome were compared for
the 21 cases of enterococcal endocarditis and all 180 cases of
endocarditis from the national survey.
Results: Among 180 cases 21 (11.7%) were caused by E. faecalis,
which was the third most common pathogen after Staphylococcus au-
reus (33.3%). The most commonly observed risk factors were rheu-
matic fever (eight cases), gastrointestinal neoplasia (GIN) (four),
surgery (ﬁve) and diabetes (three cases). Dialysis, i.v. drug use was
recorded in one case. The mitral valve was infected in 10, the aortic
valve in 10 and the pulmonal valve in one patient. two cases were
probable and 19 were deﬁnitive endocarditis, 15 cases has various
predisposing heart conditions, all presented fever, 10 emboli, 10
immunologic phenomena, 19 major and two minor echocardio-
graphical ﬁndings. Only 10 patients were treated appropriately.
Mortality attributable to E. faecalis endocarditis was 19%. All 55 iso-
lates of E. faecalis from 21 cases were susceptible to vancomycin and
50 of them were also susceptible to ampicillin and gentamicin. Nine
patients underwent valve replacement surgery (one died). From
four deaths due to infection (heart failure, CNS emboli) three were
treated inappropriately. GIN (P < 0.04) and age more than 60 years
(P < 0.05) were related to enterococcal endocarditis.
Conclusion: (i) Only two risk factors GIN and age more than
60 years were related to E. faecalis endocarditis. (ii) Mortality
attributable to E. faecalis endocarditis was 19%, which is lower
than in some other studies. (iii). Good susceptibility to ampicillin
and gentamicin is also different from other reports. (iv) High sus-
ceptibility to antienterococcal antibiotic and early surgical therapy
(47.5% pts) were possible explanation for good outcome of our
cases of E. faecalis endocarditis.
P1425 Knowledge, attitudes and practices of sexually
transmitted infections in immigrant female sex workers
A. Mari, A. Matteelli, M. Guana, S. Capone, C. Pizzocolo,
N. Saleri, M. Manfrin, U. Bianchi, F. Castelli
Brescia, I
Objective: To describe the KAPs on STIs in immigrant female sex
workers in northern Italy.
Methods: Prospective study using a questionnaire administered by
a trained health operator to FSWs working on the street. The
questionnaire had seven components: demographical and social,
knowledge on STIs and HIV, gynaecologic and obstetric history,
sexual history, history of prostitution, sexual behaviours, access to
public health services.
Results: From August to October 2003 50 FSWs answered to the
questionnaire. Thirty (60%) were from Africa, 45 (90%) were ille-
gal immigrants, 37 (74%) were <23 years old, and 76% were in
Europe since 1 year or less. Thirty-three (66%) declared to have
>4 clients/night and 40 (80%) reported rape or rubbery. While 43
(96%) were aware of HIV infection, almost all were unaware of
Chlamydia and Trichomonas infections. Thirty-one (62%) had never
done an HIV test; a pap-test had never been done by 47 (94%).
The proportion of sexual acts with clients, which were protected
with condom was 100% for vaginal, 82% for oral and 80% for
anal intercourse. Clients reportedly requested sexual intercourse
without condom to 84% of the women. Lubricants were used by
52% of the women, of whom 34% used inappropriate substances.
Over the previous month 33 women (66%) reported at least one
condom rupture (broken, slipped off, etc.), 20% >5 times. After
condom rupture 50% performed vaginal douching, 20% urinated;
none adopted measures to prevent pregnancy or STIs. Thirty
females (60%) had a steady boyfriend with whom 50% did not
use condom. Twenty-eight (56%) reported at least one abortion;
11 (22%) more than one. Almost 50% had never attend any public
health service while in prostitution; 78% would attend STI servi-
ces speciﬁcally devoted to immigrant FSWs.
Conclusions: This survey suggests that immigrant FSWs have lim-
ited access to preventive and curative health services, rarely do
the HIV test, and are exposed to a signiﬁcant infective risk due to
condom misuse and rupture. Targeted interventions should aim
at changing high-risk behaviours.
P1426 Bacillus cereus in orthopaedic and traumatology
wards. An unrecognised pathogen? A 63-case study
E. Bonnet, M. Alvarez, M. Archambaud, H. Bensaﬁ, A. Dubouix,
C. Cauhepe, B. Chaminade, P. Bonnevialle, N. Marty,
H. Dabernat, B. Marchou, P. Massip
Toulouse, F
Objectives: To describe epidemiological circumstances and clinical
signs associated with B. cereus isolation, to state its pathogenic role
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in post-traumatic infections and to propose guidelines for treat-
ment and prevention.
Methods: We conducted a retrospective 6-year study (1997–2002)
based on all B. cereus isolations from patients in the orthopae-
dic traumatologic units in Toulouse University Hospitals
(Southern France). The patients selected in this study were
those presenting clinical signs compatible with joint, bone or
soft-tissue infection including fever, local inﬂammation, puru-
lent discharges, wound dehiscence, necrosis. We collected data
on the types of accident. B. cereus was isolated from local sam-
ples, taken in the operative room, from wounds, open fractures
or operative sites.
Results: Sixty-three patients were included in the study (47 male
and 16 female). The average age was 42 years (16–82). The distri-
bution of cases over the study period was homogenous. All
patients were victims of accidents (road accidents: 63%, industrial
or agricultural accidents: 30%, sport accidents: 7%). Patients
(89%) had an open fracture. Almost two-thirds of the patients
presented fever at the time of B. cereus isolation but none presen-
ted severe sepsis. Culture were polymicrobial in 44% of the cases.
E. cloacae was the most frequently associated bacterium. Before
isolation of B. cereus all the patients but three had received antibi-
otics [amoxiclav: 78% (with aminoglycoside: 22%)]. All the strains
were resistant to penicillin, amoxiclav and cephalosporins, but
susceptible to quinolones, aminoglycosides, macrolides, clindamy-
cin, pristinamycin and imipenem. Treatment included a ﬂuoroqui-
nolone in 89% of the cases and miscellaneous in vitro active
agents in the other cases. The healing of the wounds was obtained
in 86% of the cases. Seven patients (two of them not treated by
antibiotics) had to be amputated despite aggressive surgical treat-
ment.
Conclusion: The role of B. cereus should not be underestimated in
patients with clinical signs of infection after injuries soiled by tel-
lurian environment. Quinolones could be proposed as the ﬁrst
choice for antibioprophylaxis or curative treatment of those infec-
tions.
P1427 Determination of the quantity of aﬂatoxin M1 in
pasteurised milk in Shiraz
S. Alborzi, B. Pourabbas
Shiraz, IR
Objectives: Aﬂatoxins are toxic mold metabolites produced by
toxigenic strains of Aspergillus species. They have an important
role in the occurrence of a number of human diseases such as
liver cancer, chronic hepatitis and cirrhosis. When animals eat
food stuffs containing aﬂatoxin B1, these toxins are metabolites
and excreted as aﬂatoxin M1 in milk. These aﬂatoxins are
resistant to thermal inactivation and are not destroyed com-
pletely by pasteurisation, autoclaving or a variety of food pro-
cessing procedures. The aim of this study was to determine
the quantity of aﬂatoxin M1 in pasteurised milk samples in
Shiraz.
Methods: A total of 624 pasteurised milk samples from different
supermarkets in Shiraz were collected during 6 months (April–
September 2003). After centrifugation of milk samples upper
cream layers were completely removed and the lower phases
were analysed by enzyme immunoassay for the quantitative ana-
lysis of aﬂatoxin M1.
Results: Aﬂatoxin M1 was found in 100% of the milk samples
examined. 17.8% of the samples were higher than the maximum
tolerance limit (0.05 ppb) accepted by European Union. As com-
pared with other studies, Turkish milk had higher contamination
(P < 0.00006), Brazil was the same as our ﬁndings and Albania’s
contamination was less than our results (P < 0.0004).
Conclusion: Consequently this subject is a serious problem for
the public health, especially in infants and children consuming
these products. Therefore milk and dairy products have to be
inspected routinely for aﬂatoxin M1 contamination. To achieve
a low level of aﬂatoxin M1 in milk, the dairy cows’ feeds
should be kept away from fungal contamination as much as
possible.
P1428 Fungal contamination in a cheese factory in Iran
S. Alborzi, A. Karbasi
Shiraz, IR
Objectives: Hygienic production and prevention of any kind of
contamination is one of the most important principles of produ-
cing cheese. This study was carried out in the UF cheese factory
with the 21 tones daily production, for the following goals: (i)
Rate of fungal contamination. (ii) The type of fungal contamin-
ation. (iii) The source of contamination. (iv) To suggest effective
methods of preventing fungal contamination.
Methods: To estimate the prevalence of cheese contamination (CI
95%), 180 samples were selected and cultured after 53 days. The
sampling was repeated three times in both warm and cold sea-
sons. The fungus was then identiﬁed by studying the characteris-
tics of the colonies and staining the microscopical structures. To
determine the sources of contamination, the production line was
also examined at the following points. (i) Raw milk. (ii) Milk pass-
ing through the second bactofuge. (iii) Milk passing through the
pasteurisator. (iv) Condensed and pasteurised milk. (v) Cultured
reservoirs.
Results: The plates, waxy papers, aluminum foils and additives
used in cheese production examined for possible contamination.
Air contamination of the different parts of the factory was investi-
gated by precipitation and ﬁltration. The overall rate of cheese
fungal contamination in three periods were 71, 55 and 48%,
respectively with and average of 60%. The most prevalent type of
contaminant was the Penicillium spp. with the rate of 31% fol-
lowed by A. niger (3.3%), Cladosporium (2.77%), Fusarium (2.6%),
Alternaria (2.2%) and Paecilomyces (1.3%). The other fungi were
observed in <1% of the cases. The raw milk to the factory was
100% contaminated. This rate reached zero after pasteurisation.
The rates of contamination of the additives were as follows:
rennet 16.6%, antifoam (5.5%), antiseptic (5.5%), thermophile
(11.68), mesophile (0%) and salt (0%). The plates, papers, alumi-
num foils and water showed fungal contamination rates of 4.3,
8.27, 7.6 and 5.5%, respectively. The air was 100% contaminated
with Penicillium spp.
Conclusion: In spite of multi-factorial sources of contamination the
factory air is the most important factor because the air was 100%
contaminated with Penicillium spp. We concluded Penicillium spp.
were the most prevalent type of cheese fungal contamination.
Since the use of chemicals in dairy products is prohibited, it is
suggested to utilise physical methods.
P1429 An investigation of infection risks of patients newly
ﬁtted with orthokeratology contact lenses
M.V. Boost, P. Cho, V. Chui
Hong Kong, HK
Objectives: Wearing contact lenses overnight has been reported to
signiﬁcantly increase risk of ocular infection. This study aimed to
determine the normal ocular ﬂora of overnight orthokeratology
(ortho-K) patients, and levels of contamination of their lenses, lens
case and accessories, and to correlate compliance with contamin-
ation.
Methods: The lower conjunctiva of 23 new patients was swabbed
on two occasions for culture of normal eye ﬂora before commen-
cing ortho-K lens wear. On six follow-up visits, further specimens
were collected, and cultures performed on swabs from the lens,
the case and suction holder. All isolates were fully identiﬁed.
Patients were interviewed on lens care after the fourth follow-up
visit. Any patient with contamination with Pseudomonas aeruginosa
or considerable numbers of non-normal ﬂora organisms, indica-
ting breaks in compliance, was warned about increased risks of
infection and importance of good lens care reinforced.
Results: Cultures from 21 patients before lens use yielded normal
eye ﬂora only; 16 of these yielding only normal ﬂora after lens
wear. Staphylococcus aureus was isolated from two patients before
lens wear and from one of these after lens wear. Potential
pathogens isolated in low numbers from ﬁve patients on only one
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occasion after lens use, but not present in subsequent samples,
were considered transient. Investigation of lens organisms yielded
only normal ﬂora organisms for 11 subjects on all occasions. Tap
water organisms were occasionally isolated from lenses of two
patients, and 10 patients had one isolate of potential pathogen.
Four patients with lens contamination had the same organism
contaminating their lens case. Suction holders of seven subjects
were contaminated, three with organisms found in either the lens
or the case. Following interview, 13 subjects were judged to have
good compliance. eight patients reporting poor compliance had
contamination of lens or accessories on one occasion. All were re-
educated and improvement was observed.
Conclusions: Use of ortho-K lenses resulted in no change in levels
or content of normal ﬂora. Failure to regularly replace lens case,
and disinfect lens case weekly were common errors correlating
with presence of potential ocular pathogens. With one exception,
patients reporting good compliance had minimal contamination of
eyes, lenses or accessories. Intervention improved compliance and
eliminated contamination, conﬁrming the need for reinforcement
of lens care procedures.
P1430 Evaluation of Bartels ELISA Legionella urinary
antigen in water samples
S. Blanco, J. Domı´nguez, C. Prat, R. Rivelo, M. Pe´rez,
M. Campanya`, V. Ausina
Badalona, E
The aim of this study was to evaluate the utility of Bartels ELISA
Legionella urinary antigen (Trinity Biotech) for the detection of
Legionella in water samples in comparison with conventional
methods.
Materials and methods: Samples A – ATCC strains L. pneumophila
serogroup 1 to L. pneumophila serogroup 14, L. bozemanii, L. long-
beachae and nine wild type strains were used to spike water sam-
ples to a ﬁnal concentration of 104–105 Legionella per millilitre. The
lower detection limit of the test for all reference strains was
assessed by serial dilutions of water samples from 105–100 CFU/
mL. Samples B – in addition to the spiked water samples, 34 dif-
ferent tap water samples will be run.
Sample treatment: One litre of all water samples were ﬁltered over
47 mm, 0.2 mcm Millipore membrane ﬁlters. Each ﬁlter was
placed into a test tube containing 3 mL of distilled water. After-
wards, all samples were sonicated for 2 min.
Culture and identiﬁcation: All tap water samples will be cultured
after heating treatment and acid treatment in selective BCYE-agar.
The identiﬁcation of the isolated will be done by biochemical tests
and immunoﬂuorescence methods.
Results: Legionella antigen was detected in all the ﬁltered spiked
samples except for L. bozemanii and L. longbeachae. In the water sam-
ples spiked with wild strains of L.pneumophila, soluble antigen was
detected in all cases. The lower detection limit to detect soluble
L. pneumophila serogroup 1 antigen was 780 CFU/mL. The sonica-
tion of spiked water samples did not increase the sensitivity of the
technique. In tap water samples, L. pneumophila was not isolated
by culture from any of the 34 water samples tested, while the
Bartels ELISA was positive in three cases. However, we could not
rule out the possibility that these three samples were actually true
positives.
Conclusions: (i) Bartels ELISA is a rapid and useful method for the
detection of L. pneumophila in water samples. (ii) In addition, the
Bartels ELISA has the capability of detecting all L. pneumophila
serogroups. (iii) The test should be used as a rapid screening
method for the detection of Legionella in combination with culture.
Infection in the immunocompromised HIV-negative host
P1431 Fusobacterium nucleatum bacteraemia in paediatric
haematology patients 1997–2003
F. Bosma, P.D. Sturm, T. Schu¨lin
Nijmegen, NL
Anaerobic bacteraemias are still a rare entity, but in the last dec-
ade they have been described increasingly in adult haemato-onc-
ological neutropenic patients. Fusobacterium nucleatum is an
anaerobic, Gram-negative rod that is part of the normal ﬂora of
the mouth and intestinal tract. Over a 6-year period, we identi-
ﬁed 10 episodes of bacteraemia due to F. nucleatum in eight
patients (age 1.9–11.5 years) with a diagnosis of AML (5), ALL
(2) and MDS (1). All children were febrile and neutropenic (gra-
nulocytes <100 cells/ml) by the time bloodcultures got positive.
Two patients had undergone bonemarrow transplantation shortly
before onset of bacteraemia (3 and 4 days). Six of the eight chil-
dren had mucositis as possible source of bacteraemia. In all but
one case, F. nucleatum readily grew on anaerobic cultures. In one
case, growth failed, and F. nucleatum was identiﬁed by 16S
rRNA PCR followed by sequence analysis directly from the
bloodculture bottle. The patients were treated either with ceft-
azidime plus metronidazol or with meropenem for 5–14 days.
All patients recovered, but one child had three recurrent bacter-
aemias due to F. nucleatum. Endocarditis was ruled out by a
transthoracic echocardiography, but the port-a-cath was not
removed. Another persistent focus such as an abscess or an
infected thrombus was not found. Susceptibility data are avail-
able from seven of the 10 isolates. All strains were susceptible to
metronidazol, amoxiclav, and clindamycin. F. nucleatum rarely
causes bacteraemia in neutropenic paediatric patients. Molecular
diagnostic methods can help to identify strains that do not grow
on conventional media.
P1432 Bacteriological ﬁndings in children with
haematological disorders
B. Kowalska-Krochmal, I. Dolna, I. Choroszy-Kro´l, J. Ruczkowska,
R. Franiczek
Wroclaw, PL
Objectives: Infections in neutropenic children in the haematology
ward is a signiﬁcant therapeutical problem. The aim of this
study was the analysis of frequency of isolation and antibiotic
susceptibility of bacterial strains from children hospitalised in
the Haematology Clinic in Wroclaw in the period 1999–2000 vs.
2001–2002.
Methods: Various clinical samples (blood, urine, faeces, material
from respiratory tract and other materials) were examined. Isola-
ted bacterial strains were identiﬁed by bioMerieux tests. Antibiotic
susceptibility was examined by ATB tests (bioMerieux) and the
disc diffusion method (NCCLS).
Results: During the periods compared the total number of isolated
strains was 785 and 1923 (blood 194 and 283). Signiﬁcant changes
in percentage of Gram-negative and Gram-positive isolates from
blood (from 30.4% to 55.8% and from 69.6% to 44.0%, respect-
ively) were noticed. Among the 1923 bacterial strains isolated
from all the materials in 2001–2002, 53% were Gram-positive and
47% Gram-negative. In the group of Gram-positive strains
(n ¼ 1017), coagulase-negative staphylococci (CNS), streptococci
orale and enterococci were dominant (32%, 31% and 23% respect-
ively); in the group of Gram-negative strains (n ¼ 906) it was
mainly Escherichia coli, nonfermentative rods (P. aeruginosa exclu-
ded), Klebsiella and Enterobacter (31%, 12%, 11% and 10%). The
results of antibiotic susceptibility were as follows:
– in the group of Gram-positive bacteria glycopeptide-resistant
strains were not found,
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– there were 75% MRS (methicillin resistant Staphylococcus)
strains among CNS and 24% among S. aureus,
– Increase in antibiotic resistance of Gram-negative rods especi-
ally among E. coli (to amoxicillin/clavulanic acid), P. aeruginosa
(to netilmicin, ceftazidime) and other nonfermentative rods (to
ceftazidime, piperacillin) was observed,
– Gram-negative rods were highly susceptible to imipenem
(96%), meropenem (94%), piperacillin/tazobactam (84%), ciproﬂ-
oxacin (80%) and ceftazidime (79%); among carbapenem-resistant
strains there were mainly nonfermentative rods (P. aeruginosa
inclusive).
Conclusions: 1. Rising trends were observed in the number of
Gram-negative isolates from blood and in antibiotic resistance of
all Gram-negative rods. 2. The empiric therapy with piperacillin/
tazobactam plus amikacin in children with cancer treated in the
Haematology Clinic seems to be the optimal option, but the mon-
itoring of antibiotic susceptibility of bacterial strains is still
required.
P1433 Surveillance of nosocomial sepsis and pneumonia
in patients with bone marrow transplantation or peripheral
blood stem-cell transplantation. A Multicentre project
M. Dettenkofer, R. Babikir, S. Wenzler, E. Meyer, H. Ru¨den,
F. Daschner
Freiburg, Berlin, D
Objectives: To evaluate the incidence of nosocomial infections (NI)
in patients with haematologic malignancies suffering from severe
immunosuppression, and to generate reference data.
Methods: For surveillance of nosocomial bloodstream infections
(BSI) and pneumonia in patients undergoing bone marrow trans-
plantation (BMT) or peripheral blood stem-cell transplantation
(PBSCT), a multicentre study was started in 2001 (within the
framework of KISS – German Hospital Infection Surveillance Sys-
tem). To allow participation with limited resources, the ONKO-
KISS project focuses only on BSI and pneumonia during neutrope-
nia using CDC deﬁnitions with modiﬁed criteria for neutropenic
patients (neutropenia: WBC <1.0  10 to the power of 9 per liter).
Results: Over the ﬁrst 26-month period, 1071 patients with 16 184
neutropenic days were investigated (12 participating hospitals).
Of these, 698 (65%) had undergone allogeneic and 380 (35%) au-
tologous BMT or PBSCT. The mean length of neutropenia was
15 days. In total, 231 bloodstream infections and 114 cases of
pneumonia were identiﬁed. Site-speciﬁc incidence densities
(pooled mean) were: 14.3 BSIs and 7.0 cases of pneumonia per
1000 neutropenic days, respectively. The main pathogens associ-
ated with BSI were coagulase-negative staphylococci (55%), fol-
lowed by streptococci (10.9%).
Conclusions: Surveillance of NI is a key element of infection con-
trol, especially in critically ill patients such as those undergoing
BMT or PBSCT. For the ﬁrst time the ONKO-KISS project pro-
vides reference data (http://www.nrz-hygiene.de) and thus
serves to improve the quality of care provided to BMT and PBSCT
patients.
P1434 Nocardiosis trends in a teaching hospital: a 15-year
study
R. Matulionyte, P. Rohner, I. Uckay, D. Lew, K. Bouchuigui-Waf,
J. Garbino
Geneva, CH
Background: Nocardiosis is an infrequent, but severe infection,
especially in profoundly immunocompromised patients. However,
clinical experience remains rather limited.
Objectives: The objectives were to establish the trends of nocardia
infections, the type of antibiotic treatment and the outcome in
patients.
Methods: A retrospective chart review was undertaken on hospi-
talised patients at the Geneva University Hospitals from 1989 to
2003. All patients in whom Nocardia sp. was isolated were inclu-
ded in the study.
Results: Nocardia sp. was obtained from 20 patients (70% male,
median age 58.5 years). Sixteen patients (80%) had one or more
underlying conditions: solid organ malignancy (4 patients), chro-
nic lung disease (4), HIV (3), diabetes mellitus (3), organ trans-
plantation (3), immunosuppressive therapy (6), lymphopenia (15),
others (6). The median time between the symptom’s onset and
nocardiosis diagnosis was 30 days (range, 3–50). Pulmonary tuber-
culosis (TBC) was the most common initial diagnosis of nocardio-
sis (4). The sites of infection were the lung (16 cases), central
nervous system (CNS) (2), skin (2) and disseminated (1). N. astero-
ides complex spp. were isolated in 19/20 cases. In vitro testing
was performed for 14 strains. No resistance was detected for imi-
penem or amikacin. Treatment was given to 17 patients and con-
sisted of trimethoprim-sulfamethoxazole (TMP-SMX) (14 cases),
imipenem (7), sulfadiazine (3) and ciproﬂoxacin (4). Improvement
was observed in 15/20 patients, one patient relapsed, one patient
had a pulmonary nocardiosis complication with CNS involvement
and three patients died (one had not been treated since the diag-
nosis had been attributed to TBC; for the other two patients the
treatment was started at day 23 and 50 after onset of clinical
symptoms with oral TMP-SMX and sulfadiazine).
Conclusions: Nocardiosis is a severe infection and mainly affects
profoundly immunocompromised patients. Differential diagnosis,
especially with TBC, often delays the time of diagnosis that wor-
sens the outcome. Efforts for more rapid diagnostic techniques
application, such as PCR, should be made. TMT-SMX was the
most common prescribed treatment, however its oral form was
not sufﬁciently efﬁcient in two of our cases with severe infection.
P1435 Reactivation salmonellosis in cancer patients after
antineoplasic chemotherapy
J. Delaloye, G.M. Merlani, P.E. Tarr
Lausanne, CH
Objectives: It is well documented that nonthyphoidal salmonella
(NTS) infections occur more frequently in cancer patients. How-
ever, it is unclear whether this is due to an increased susceptibil-
ity to de novo, exogenous salmonella infection, or due to cancer
chemotherapy induced reactivation of asymptomatic salmonella
stool carriage.
Methods: Retrospective analysis at a Swiss tertiary care centre of
all medical records (1996–2002) from patients with positive clinical
samples for nonthyphoidal salmonella. Non-oncological patients
and cases not meeting our criteria for reactivation NTS (see
below) were excluded. A Medline search (1966–2003, all lan-
guages) was also performed to identify potential cases. Case-
deﬁnition of reactivation NTS
1. Patient asymptomatic at admission to the hospital
2. Symptoms consistent with salmonellosis >72 h after hospital
admission
3. Symptoms arising after antineoplastic chemotherapy
4. No evidence of nosocomial acquisition
Results: From 1996–2002, 235 positive specimens for NTS were
identiﬁed in 214 patients. Five specimens were from cancer
patients who had an illness compatible with reactivation disease
following the administration of chemotherapy. Medline search
yielded four more cases that met our criteria. Of all the nine cases,
ﬁve were women, and the median age was 28 years (range
3 months–72 years). Five patients had diarrhoea; one had salmon-
elluria, while three patients in the literature had bacteraemia. In
two patients asymptomatic stool colonisation was documented
prior to reactivation disease. All patients were successfully treated
with antibiotics, even while chemotherapy was continued in eight
patients. There were no salmonella relapses despite additional
chemotherapy cycles in ﬁve patients.
Conclusions: Asymptomatic salmonella carriers with malignant
neoplasms, unaware of their condition, may develop symptomatic
salmonellosis, triggered by gastrointestinal mucosal damage and
immunosuppression associated with chemotherapy. Current
guidelines recommend bacterial stool analysis after three days of
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hospitalisation only for patients >65 years of age with signiﬁcant
co-morbidity, HIV infection, or neutropenia. However, reactiva-
tion NTS can occur in patients who are <65 years old and in the
absence of neutropenia. Stool cultures should be obtained in can-
cer patients with signiﬁcant chemotherapy associated diarrhoea
even if hospitalised >3 days.
P1436 Pulmonary inﬁltrates in solid organ transplant
recipients. Mortality risk factors
C. Cervera, G. Soto, N. De Benito, P. Rivas, F. Cofan, A. Rimola,
E. Roig, T. Pumarola, A. Torres, A. Moreno
Barcelona, E
Background: Pulmonary infections are a major cause of morbidity
and mortality in transplant organ recipients. Our purpose is to
establish the risk factors for mortality in solid organ transplant
recipients with a new onset of pulmonary inﬁltrates (PI).
Methods: We prospectively evaluated the solid organ transplant
recipients with PI from February 1998 to December 2002. All
patients underwent a diagnostic protocol that included the obtain-
ing of two samples of blood cultures, spontaneous or induced
sputus specimen or bronchoaspirate (in patients with mechanical
ventilation), and samples of blood and urine for antigen testing.
In the case of diffuse and bilateral PI’s and those without clinical
or radiologic improvement after 3 days of treatment, all of them
underwent invasive evaluation, that included ﬁberoptic bronchos-
copy with protected-specimen brush (PSB), bronchial aspirate and
bronchoalveolar lavage (BAL).
Results: We included 75 patients, 56 men (75%) and 19 women.
Mean age was 55  13 years (Range: 16–76). The type of trans-
plant was: kidney 33 (44%), kidney and pancreas 4 (5%), liver 30
(40%), and cardiac 8 (11%). The most frequent diagnoses were:
Bacterial pneumonia 22 (MRSA pneumonia 4 cases; and P. aerugi-
nosa pneumonia 4 cases), Pulmonary aspergillosis 19 cases (3 asso-
ciated with MRSA, 1 with CMV, 1 with Pneumocystis carinii, 1
with Candida albicans and Scedosporium proliﬁcans, and 1 with
Stenotrophomonas maltophila); and Pulmonary oedema 6 cases.
In 22 cases, we found no etiologic diagnosis. Mortality was 33%
(25 patients), and only four of them without diagnosis. The varia-
bles associated with great risk factor for mortality were: mechan-
ical ventilator (RR: 3.5; CI [95%]: 2.1–5.9; P < 0.001); fungal
infection (RR: 2.75; CI [95%]: 1.3–6.0; P < 0.01), ICU admission
(RR: 2.2; CI [95%]: 1.6–3.0; P < 0.001).
Conclusions: The presence of PI in solid organ transplant patients
is associated with high mortality. The most important risk factor
for mortality is the need for mechanical ventilation. In our experi-
ence, bacterial pneumonia is the most frequent diagnosis, fol-
lowed by pulmonary aspergillosis.
P1437 Prevalence of BK virus infection in solid organ
transplant recipients
M. Fogueda, P. Mun˜oz, C. Rodriguez, M.J. Dominguez,
R. Ban˜ares, J. Palomo, E. Verde, E. Bouza
Madrid, E
Background: BK virus (BKV) is a polyomavirus that causes an
emergent infectious disease particularly troublesome in kidney
transplant recipients. BKV remains latent in the urinary tract of
the general population and may reactivate during immunosup-
pression. BKV viruria is prevalent in renal allograft recipients and
BK viremia has been related to nephropathy and graft loss in
renal transplant recipients. Nevertheless, the prevalence of this
viral agent in other solid organ transplant groups (SOT) (cardiac
and liver) has not been well established.
Objectives: to determine the prevalence of BKV infection and dis-
ease in all types of SOT recipients in our centre.
Methods: Seventy-seven consecutive SOT recipients were studied:
19 renal, 23 cardiac and 35 liver transplant recipients. Samples
were obtained, a mean of 1620 days after transplantation (range
3–9.481 days). The presence of BKV-DNA was initially screened
by a nested-PCR in urine. Plasma PCR was performed only in
patients with a positive urine PCR. A pre-established clinical pro-
tocol was fulﬁlled the day the sample was obtained. Transplanta-
tion procedure and immunosuppression was standard.
Results: Polyomavirus BK was found in 10.4% of urine samples.
The prevalence of viruria was 15.8% after renal transplant, 17.4%
after cardiac transplants and 3% after liver transplants. Only one
patient had BKV viremia. He was a 65-year-old renal transplant
recipient who had lost his ﬁrst kidney transplant due to BKV-
associated nephropathy and had again poor renal function
3 months after the second transplantation.
Conclusions: This study conﬁrms that urinary shedding of BK
virus is common in all types of solid organ transplant recipients.
For the time being, we have only been able to ﬁnd BKV disease in
a kidney transplant recipient, in whom it relapsed early after
transplantation after causing the loss of the ﬁrst graft. Further
studies are needed to understand the natural history of primary
infection and reactivation of BK virus in SOT and its relation to
graft function.
P1438 A retrospective study on Pneumocystis carinii
pneumonia in critically ill patients
D. Peres Bota, R. Rodriguez Villalobos, J.-L. Vincent
Brussels, B
Introduction: Despite major advances in diagnosis and manage-
ment, Pneumocystis carinii pneumonia (PCP) is a severe complica-
tion of immunocompromised patients. We analysed the outcome
of patients with PCP with a positive bronchoalveolar lavage (BAL).
Patients and methods: We retrospectively analysed the medical
records of all patients with a positive BAL culture admitted to a
tertiary intensive care department from January 1999 to Septem-
ber 2003. Demographic, clinical and microbiological data were col-
lected.
Results: In the study period, 22 patients had a PCP, conﬁrmed by
clinical, radiological and microbiological data. Five of these
patients had an acquired immunodeﬁciency syndrome and 17 had
a severe immunocompromised state. Twelve patients had severe
respiratory failure with a paO2/FiO2 ratio <300 mmHg, and
among them nine received invasive mechanical ventilation. The
rest of the 13 patients were managed by non-invasive mechanical
ventilation. The degree of severity as calculated by APACHE II
score was 17.2  5.4. The length of stay in the ICU was 8 (5–18)
days. Three of the patients received prophylactic antibiotic ther-
apy at the time the BAL was performed. Overall mortality rate
was 36%, for intubated patients mortality was 55%, and for non-
intubated patients 23% (P ¼ 0.01). There was no signiﬁcant differ-
ence in the ICU and in-hospital mortality between patients with a
PCP associated with a HIV infection compared with other immu-
nocompromised states (40% vs. 35% and 50% vs. 45%, respect-
ively). Risk factors for death were the need of mechanical
ventilation (P ¼ 0.03) and prophylactic antibiotic therapy
(P ¼ 0.04).
Conclusions: PCP is associated with high mortality rates in immu-
nocompromised patients. Critically ill patients requiring invasive
mechanical ventilation and prophylactic antibiotherapy have a
worse outcome.
P1439 Detection of Pneumocystis carinii by polymerase
chain reaction in bronchoalveolar lavage specimens: clinical
signiﬁcance and correlation with other diagnostic methods
E. Nieminen, K. Rantakokko-Jalava, O. Meurman,
J. Nikoskelainen, J.H. Salonen
Turku, FIN
Objectives: To evaluate the clinical signiﬁcance of positive Pneumo-
cystis carinii (PCC) PCR-test in bronchoalveolar lavage (BAL) spec-
imens from adult patients with pneumonia.
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Methods: We evaluated retrospectively all patients treated in
Turku University Central Hospital in 1992–2001 with a positive
result in PCC-PCR-assay in BAL-ﬂuid specimen. The patients
were identiﬁed through microbiology registration system. Clinical
symptoms and radiological signs of pulmonary infection, results
from other diagnostic tests for PCC, antimicrobial chemotherapy
and patient outcome were analysed. Patients were stratiﬁed into
four groups according to the conﬁrmation of diagnosis of Pneumo-
cystis carinii pneumonia (PCP) (deﬁnite, probable, possible and
non-probable). Clinical and radiological ﬁndings and response to
speciﬁc PCP therapy were used in stratiﬁcation.
Results: Altogether 441 patients (480 BAL samples) were tested
during a 10-year period. 66 patients (15%) had at least one posit-
ive result in PCR-assay. The majority (97%) of the patients were
immunocompromised. Immunoﬂuorescence test (IF) was concom-
itantly positive with PCR in 35% of patients tested (19/54) and
methenamine silver staining (MSS) in 29% (19/66), respectively.
Eighty-three per cent of the patients with positive IF test and 95%
of the patients with positive MSS had concomitantly positive
PCR-assay. Only 18% of the patients with positive PCR-assay had
a triad of typical symptoms for PCP (dry cough, shortness of
breath and fever) and 65% had bilateral interstitial pulmonary
inﬁltrates. The diagnosis of PCP was considered deﬁnite or prob-
able in 48% (32 patients) of patients with positive PCR assay. In
24% (16 patients) the diagnosis of PCP was considered non-prob-
able. Seventy-nine per cent of all patients with positive PCR assay
and 94% of patients with deﬁnite or probable diagnosis of PCP
had received appropriate antimicrobial treatment against PCC.
Mortality in patients with deﬁnite or probable diagnosis of PCP
was 25%. Seventy-ﬁve per cent of the patients whose diagnosis
was considered non-probable had not received any treatment
against PCP. Only one of these 12 patients died (invasive aspergil-
losis).
Conclusions: Positive PCC-PCR-assay in BAL specimen correlates
poorly with clinical disease and with other diagnostic methods.
PCR-assay should be used only as a supplementary test for im-
mununoﬂuorescence test and methenamine silver staining.
P1440 Bacterial infection in cirrhotic patients with variceal
bleeding
J. Jurankova, J. Lata, M. Senkyrik, L. Husova
Brno, CZ
Objectives: Bacterial infection seems to be very important in cir-
rhotic patients with variceal bleeding. The aim of our study was
to ﬁnd out the prevalence of bacterial infection in cirrhotics admit-
ted to hospital with variceal bleeding in comparison with patients
with liver cirrhosis admitted because of other reasons.
Material and methods: Bacteriological investigation of urine, stool,
throat smear, haemoculture and ascites were investigated in 40
cirrhotic patients admitted to hospital with variceal bleeding and
65 cirrhotics admitted because of other reasons.
Results: There were differences in bacteriological ﬁndings between
the patients with and without variceal bleeding. Bacterial infection
was signiﬁcantly more frequent in the cirrhotic patients with
bleeding – positive in 19 patients (47.5%), in comparison with
patients without bleeding – positive in16 patients (24%). Bacterial
sepsis was more frequent in groups of patients with variceal bleed-
ing – 5 patients (12.5%) vs. 3 (4%) in a group of patients without
bleeding. There was also a difference in the bacterial colonisation
of proximal parts of the gastrointestinal tract. The patients with
bleeding were colonised with Gram-negative bacteria in 32.5%, the
patients without bleeding were colonised in 10%.
Conclusions: Bacterial infection is more frequent in cirrhotic
patients admitted with variceal bleeding in comparison with
patients with liver cirrhosis admitted because of other rea-
sons. Also the colonisation of proximal parts of the gastrointesti-
nal tract with Gram-negative bacteria is more frequent in the
group of patients with bleeding than in the sample of patients
with liver cirrhosis without bleeding. The study was supported
by the Grant Agency of the Ministry of Health of the Czech
Republic (NK6661-3/2001).
P1441 Diabetic foot infections: risk factors and
microbiological spectrum
M. Kompoti, S. Drimis, M. Bitza, L. Thiaspras, A. Melidonis,
D. Gianneli, C. Nikolopoulou, S. Heraklianou
Athens, GR
Objectives: To determine risk factors and evaluate the microbiolo-
gical spectrum of diabetic foot infections.
Methods: We studied 44 consecutive diabetic patients with foot
ulcers, 26 men (59%) and 18 women (41%) (group A). Each
patient was matched for sex, age (3 years) and diabetes duration
(5 years) with two diabetic case-controls without foot ulcers
(group B). All patients had been regularly followed-up during a
10-month period in our department. Mean age was 62.0 years
(13.8) in group A and 62.7 years (10.3) in group B. Mean dur-
ation of diabetes was 14.2 years and 13.2 years in group A and B
respectively. The two groups were compared for body mass index
(BMI), mean glycosylated haemoglobin concentration, serum
lipids (total cholesterol, HDL, triglycerides), hypertension, smo-
king (pack  years), angiopathy, neuropathy. Samples for culture
were taken from all ulcers, excluding necrotic material.
Results: Mean BMI was 29.1 (4.4) in group A and 29.3 (4.8) in
group B, P ¼ NS. In group A, 22 patients (53%) were on insulin,
and 19 (47.5%) on antidiabetic oral agents, while in group B 32
patients (39%) were on insulin and 50 (61%) on antidiabetic
agents. Mean glycosylated haemoglobin concentration was 8.6 g/
dl in group A and 7.5 g/dl, P ¼ 0.0008. Mean serum cholesterol
levels were 236 mg/dl in group A (mean HDL levels 39 mg/dl)
and 225 mg/dl in group B (mean HDL levels 43 mg/ dl), P ¼ NS.
Mean serum triglycerides were 184 mg/dl in group A and
196 mg/dl in group B, P ¼ NS. Eighty-seven microorganisms
were isolated, 83 aerobes (35 Gram-positive and 48 Gram-negat-
ive) and four anaerobes. The most common pathogens were Staph.
aureus (13.8%: methicillin-susceptible 11.4% and methicillin-resist-
ant 2.3%), Proteus sp. (12.6%), coagulase-negative staphylococci
(12.6%), Pseudomonas sp. (13.8%). The mean number of microor-
ganisms per patient was 1.97. No statistically signiﬁcant differ-
ences in the aforementioned risk factors were identiﬁed among
patients with monomicrobial or polymicrobial infections. Rates of
antimicrobial resistance were low, because the study group inclu-
ded only outpatients, not previously treated with antibiotics.
Conclusions: Poor diabetic control is the main risk factor for the
development of diabetic foot infection. Most diabetic foot infec-
tions are polymicrobial. Gram-negative isolates, particularly
Enterobacteriacae, predominated in our study group.
P1442 Actinomyces neuii isolation from foot necrotic ulcer
in an immunocompromised patient
K. Papaefstathiou, M. Sonikian, M. Zoumberi, D. Arvanitis,
D. Vlassopoulos, G. Kouppari
Athens, GR
Objectives: An unusual case of Actinomyces neuii isolation from a
foot necrotic ulcer in a diabetic end stage renal disease (ESRD)
patient on continuous ambulatory peritoneal dialysis (CAPD) is
presented.
Methods: Specimens from ulcer after surgical debridement were
cultured at 1st and 4th day of admission onto appropriate media.
Also direct smears by gram stain were examined. The identiﬁca-
tion of the microorganism was performed by standard methods
and API Coryne (bioMerieux). Susceptibility testing was per-
formed by disc diffusion method and Etest.
Case report: A 68-year-old woman on ESRD, came to the hospital
with fever (38 C) and painful, oedematous, necrotic ulcer in the
small ﬁnger of the foot. She was suffering also from diabetic com-
plications (retinopathy, nephropathy, coronary artery disease,
hypertension and generalised peripheral arteriopathy). She started
CAPD 2 years ago and 18 months later she presented fungus
peritonis. On admission she was treated with metronidazole
500 mg 1  3 I.V. and ciproﬂoxacin 100 mg 1  2 I.V. together
with surgical debridement. WBCs count of blood was 14 700/ı`l
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(80% neutrophils). The ESR was 100 mm/h. Abundant leucocytes
and gram(+) small robs were seen on direct smears by gram stain.
A. neuii ssp neuii was isolated from the cultures of both samples.
The growth was better under anaerobic conditions. The strain was
resistant to cinolones, aminoglycosides, and susceptible to penicil-
lin G, cefaclor, cefotaxime, erythromycin, clindamycin, vancomycin
and teicoplanin. On the 3rd of hospitalisation, the antimicrobial
treatment changed and clyndamicin 600 mg 1  1 IV was adminis-
tered. On the 5th day because of worsening of local inﬂammation
ﬁndings, an amputation of the small ﬁnger was decided with con-
comitant teicoplanin 400 mg 1  1 IV for 15 days and then for the
next 10 days 400 mg/48 h IM administration. Follow-up cultures
did not isolate A. neuii.
Conclusions: A. neuii is an unusual cause of severe ulcers and
abscesses in immunocompromised and diabetic patients. Antibiotic
treatment is seldom successful, without surgical cleaning or ampu-
tation. All the ‘coryneform’ isolates should be identiﬁed either then
or grown in pure culture or coexist with other microorganisms.6
P1443 Serum and peripheral blood mononuclear cells
infectious burden: correlation to inﬂammation and
atherosclerosis in haemodialysis patients
G. Tsirpanlis, S. Chatzipanagiotou, A. Ioannidis, F. Bouﬁdou,
S. Moutaﬁs, A. Lagouranis, P. Tseke, C. Nicolaou
Athens, GR
Infectious agents may be implicated in the inﬂammatory athero-
sclerotic process. Not only speciﬁc microorganisms but also the
infectious burden, deﬁned as the number of pathogens to which a
patient is exposed, has been associated with atherosclerosis. In this
study, the infectious burden, determined directly – by identiﬁca-
tion of viable pathogens in peripheral blood mononuclear cells,
PBMCs - and indirectly - by serum antibodies detection – is corre-
lated to the inﬂammatory and atherosclerotic status in haemodialy-
sis (HD) patients, a population at high risk for cardiovascular
disease. The viable forms of four microorganisms (Chlamydia
pneumoniae, Herpes Virus I and II and Cytomegalovirus) were
identiﬁed in patients’ PBMCs by cell cultures and subsequent
polymerase chain reaction. Serum IgG against the above pathogens
and Helicobacter pylori were also determined. Inﬂammation was
assessed by C-reactive protein (CRP), serum amyloid A (SAA),
three pro-, one anti-inﬂammatory cytokines and four adhesion
molecules measurement. Atherosclerosis was deﬁned by a scoring
system using medical history data. The number of viable patho-
gens identiﬁed in PBMCs, in the 122 HD patients included in the
study, were 0 in 22.1% of them, one in 33.6%, two in 43.4% and
three in one patient. The number of IgG antibodies determined
was one in 6.6% of the patients, two in 32%, three in 48.4% and
four in 13.1% of them. Seropositivity wasn’t signiﬁcantly different
between patients with or without the respective viable pathogen
identiﬁed in PBMCs. Atherosclerosis was present in 40.2% of the
patients and CRP, SAA as well as Interleukin-6 were increased in
these patients. Neither inﬂammatory indexes nor atherosclerosis
were signiﬁcantly different in patients with a higher number of
viable pathogens detected in PBMCs or in those with higher num-
ber of antibodies. The direct infectious burden determination (the
number of viable pathogens in PBMCs) doesn’t coincide with the
serum (by IgG detection) infectious burden. Although inﬂamma-
tion correlates to atherosclerosis, neither PBMCs nor serum infec-
tious burden is associated to these two entities in the inﬂamed and
atherosclerotic HD patients.
P1444 Human herpesvirus 8 infection in haematopoietic
stem cells transplant recipients
K. Roubalova´, A. Vı´tek, J. Sajdova´, A. Sucha´nkova´
Prague, CZ
Background: HHV8 is the cause of Kaposi’s sarcoma or lympho-
proliferative disorders in immunodeﬁcient individuals. In western
and central European countries, the seroprevalence of HHV8
infection is low. Increased HHV8 seroprevalence and occasional
occurrence of Kaposi’s sarcoma was described in solid organ
transplant recipients. The aim of this study was to evaluate the
risk of HHV8 infection in haematopoietic stem cells transplant
(HSCT) recipients.
Methods: HHV8 seroprevalence was retrospectively studied in 80
adult allogeneic HSCT recipients. Antibodies to the lytic HHV8
antigen were detected in pre-transplant and late post-transplant
sera using indirect immunoﬂuorescence test. Nested PCR was
used to detect the presence of viral DNA in consecutive periph-
eral blood samples from patients who seroconversed after trans-
plantation.
Results: The HHV8 seroprevalence rates before and after trans-
plantation were 2.6 and 3.8%, respectively. Two patients seropos-
itive before transplantation tested negative for anti-HHV8
antibodies in the post-transplantation period. Two patients
showed HHV8 seroconversion after HSC transplantation. Both
exhibited intermittent presence of viral DNA in peripheral blood.
Conclusions: HSCT recipients were not at signiﬁcant risk for
HHV8 infection. Allogeneic HSCT recipients may lose HHV8 se-
ropositivity after transplantation. Active infection with HHV8
during post-transplantation period in two HSCT recipients was
associated neither with high viral load in peripheral blood nor
with signiﬁcant signs of clinical illness. In one patient, reactivation
of HHV8 infection was associated with active CMV infection and
GVHD.
P1445 Acquired Shapiros syndrome (recurrent
hypothermia) due to human herpesvirus 6 after stem cell
transplantation
L. Arenillas, F. Graus, A. Smithson, R. Palmero, M. Rovira
Barcelona, E
Introduction: Human herpesvirus-6 (HHV-6) is a human pathogen
of emerging clinical signiﬁcance. Although overt clinical disease is
infrequent in adults, HHV-6 reactivates with immunosuppression.
We describe a patient who developed an HHV-6 encephalitis
characterised by recurrent episodes of hypothermia in association
with extreme hyperhidrosis after a cord blood stem cell trans-
plant. These clinical features resembled those described by Shap-
iro and Plum in patients with agenesia of the corpus callosum,
that usually respond to treatment with clonidine (an alfa 2 agon-
ist). After antiviral treatment with foscarnet associated with cloni-
dine was started, a resolution of the symptoms was achieved.
Case report: The patient was a 34-year-old man who received a
cord blood stem cell transplant for the treatment of a Philadelphia
chromosome-positive acute lymphoblastic leukaemia. Condition-
ing was performed with cyclophosphamide, total body irradiation
and anti-thymocite globulin. Prophylaxis against graft-versus-host
disease consisted of cyclosporine and prednisone. Prophylaxis of
infections was carried out with aerosolised pentamidine, oral acy-
clovir and with unspeciﬁc gamma globulin. On day 20, the patient
developed episodes of hypothermia, profuse sweating and shiver-
ing as well as confusion and abdominal pain. Routine blood ana-
lysis revealed no abnormalities except for a severe hyponatremia
(Na 111 mEq/l), hypoosmolarity and a high cyclosporine concen-
tration. A magnetic resonance of the brain showed bilateral
lesions involving amygdala and hippocampus while the corpus
callosum was present. An electroencephalogram showed diffuse
slow waves. The lumbar puncture demonstrated: mononuclear
pleocytosis (44 cells/ul), a high protein level (103 mg/dl) with
normal glucose level (71 mg/dl). Viral studies were negative
except for HHV-6 DNA, which was isolated from cerebrospinal
ﬂuid by PCR. With the diagnosis of HHV-6 encephalitis, foscarnet
was started. As the symptoms of our patients were similar to
those of Shapiros Syndrome, clonidine was added to foscarnet.
After combined therapy was initiated control cerebrospinal ﬂuid
HHV-6 DNA PCRs were negative and a remission of the symp-
toms was observed. Five months after transplant the patient died.
The autopsy demonstrated the presence of HHV-6B infected cells
in the hippocampus.
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P1446 Ganciclovir-resistant Cytomegalovirus infection in a
heart transplant recipient
J. Garcia-Martinez, L. Folgueira, R. Delgado, S. Hernando,
C. Prieto, J. Aguado, J. Otero
Madrid, E
Objectives: Cytomegalovirus (CMV) infection is a serious compli-
cation for solid-organ recipients. UL97 phosphotransferase and
DNA polymerase gene mutations can confer ganciclovir (GCV)
resistance. We studied a documented case of disseminated GCV-
resistant (CMV) infection in a heart transplant recipient, the asso-
ciated risk factors and the viral monitoring of the process.
Methods: Viral load was retrospectively monitored by a real-time
quantitative ampliﬁcation of a 250 bp viral glycoprotein B (gpB)
gene fragment from 200 lL peripheral blood extracted DNA using
a LightCycler instrument (Roche Molecular Biochemicals); DNA
quantiﬁcation was performed through 10-fold serial dilutions of a
plasmid standard (pDrive, Qiagen PCR Cloning) containing the
primer-spanning region of the gpB gene; plasmid standard DNA
concentration was calibrated by spectrophotometry at 260 nm.
CMV pp65 antigenemia was prospectively performed at least once
a week on a 200 000 peripheral mononuclear cell extension and
detected with ﬂuorescent monoclonal antibodies (BioRad). Differ-
ent clinical samples were inoculated on diploid human ﬁbroblasts,
incubated for 4 weeks on CO2 enriched atmosphere at 37
C and
examined twice a week for the speciﬁc cytopathic effect. Pheno-
typic and genotypic antiviral susceptibility studies were per-
formed by plaque reduction assays, inoculating 24-well plaques
with increasing concentrations of GCV (0, 6, 12, 24, 48 and 96 lM,
respectively), and sequencing of the UL97 gene on an ABI Prism
377 DNA Sequencer (Applied Biosystems), respectively.
Results: Higher plasmatic viral load and pp65 antigenemia values
correlated with viral syndromes, in the setting of and at the end
of GCV treatment. Viral load and pp65 antigenemia did not
become negative until the foscarnet treatment was implemented.
CMV strains were isolated on cell cultures from blood and gastric
biopsy samples. All viral strains presented an A594V mutation on
the UL97 gene, with a GCV IC50>96 lM.
Conclusions: GCV-resistant CMV infection is exceptional in heart
transplant recipients. D + /R- CMV serostatus, GCV treatment at
subtherapeutic levels, high number of viral syndromes and per-
sistent subclinical reactivation in the setting of antiviral prophy-
laxis are the main factors that have contributed to the infection
with a GCV-resistant CMV strain.
P1447 Prevention of iatrogenic Creutzfeldt–Jakob disease
in recipients of corneal transplants: genetic testing of donors
E. Mitrova, G. Belay, D. Slivarichova, V. Verchovodkova,
V. Jovankovicova
Bratislava, SK
Creutzfeldt–Jakob disease (CJD) is the most common, fatal and
transmissible neurodegenerative disease, most important in a
group of human prion diseases. Effective therapy is not available.
CJD occurs as sporadic (the cause unknown), genetic (with CJD-
speciﬁc mutation of the prion gene) and iatrogenic, caused by
transmission of the infectious agent by contaminated tissue or
instruments. The ﬁrst iatrogenic CJD reported in 1974 was caused
by corneal transplantation. Subsequent experimental studies dem-
onstrated infectivity in corneas of animals inoculated with CJD
agent. At present there is no speciﬁc method for deﬁnite diagnosis
of CJD intra vitam, therefore asymptomatic carriers of CJD-speciﬁc
mutations are excluded from a tissue donation. Slovakia is charac-
terised by exceptionally high percentage (75%) of genetic CJD
patients with CJD-speciﬁc mutation E200K, and by a ‘genetic CJD
risk group’, represented by asymptomatic carriers of this mutation.
About 59% of these long-term observed carriers have been found
to develop the disease. This experience as well as an increasing
number of corneal transplantations initiated introduction of pre-
ventive genetic testing of all corneal donors. The testing started
in April 2001. Since then 608 donors have been tested. DNA was
isolated from the peripheral blood. Mutation E200K and poly-
morphism at codon 129 of the prion gene, indicating susceptibility
to iatrogenic CJD, were tested in all donors. Since donors are a ran-
domly arisen group representing the general population, results on
129 polymorphisms correlate with data for normal controls.
Obtained distribution of codon 129 polymorphism demonstrated
that majority of donors are homozygots, either methionine (48.4%)
or valine (8.6%), indicating high susceptibility to CJD. These data
are not in agreement with preponderance of heterozygots, reported
previously by other authors or observed by us, but obtained in sig-
niﬁcantly smaller tested groups. Presented results suggest an
urgent need to reevaluate the generally accepted indicators of gen-
etic susceptibility to prion diseases. Concerning the tested genetic
CJD risk, unexpectedly, two out of the 608 DNA examined were
positive for mutation E200K. Carriers of CJD-speciﬁc mutation,
present in a relatively small group of donors, justify the preventive
measure introduced exclusively in Slovakia.
P1448 Putative role of SV40 in BMT children
M. Comar, P. D’Agaro, M. Andolina, N. Maximova, B. Gregoretti,
G. Dal Molin, M. Tognon, C. Campello
Trieste, I
Objectives: Polyomavirus SV40 has been found in human tumours
and normal tissues. In bone marrow transplant patients, polyoma-
viruses, particularly BKV, were associated with post-engraftment
haemorrhagic cystitis. Recently, a co-infection of BKV and SV40 has
been observed in kidney transplanted adults with nephropathy. In
paediatric patients, distinct SV40 strains were occasionally detected
in transplanted kidneys suggesting that the human kidney could be
a reservoir for polyomaviruses and that the host immunosuppres-
sion may favour viral replication. This study aimed to investigate
the presence of SV40 in children who underwent allogenic BMT
and whether SV40 infection can be correlated to clinical events.
Methods: During the period 2000–2002, 28 patients underwent allo-
geneic BMT in the paediatric hospital ‘Burlo-Garofolo’ of Trieste.
DNA from PBMC and urine (sediment cells and supernatant) was
analysed by PCR for HCMV, AV, BKV, JCV, and SV40. DNA ﬁlter
hybridisation was carried out in all SV40-positive samples while
direct sequencing was done for two patients.
Results: SV40 footprints were detected in the blood of seven out 28
patients (25%) by PCR. In ﬁve patients, SV40 infection was transient
and unrelated to any clinical relevant condition. On the contrary, in
two patients who developed a severe form of haemorrhagic cystitis,
SV40 was revealed in blood and in urine. The positivity was found
starting from the onset of HC and frequently during the follow-up
(mean time +100 days). The direct sequencing of the SV40 Tag-N-C
terminal and regulatory regions indicated that the two viruses were
related to the SV40 archetypal strain 776.
Conclusions: In this study, SV40 infection was found in seven chil-
dren who had undergone BMT; two of these later developed a
severe post-engraftment HC. As we excluded a vertical transmis-
sion or the contamination of transfused stem cells, blood transfu-
sions, received by one patient in the past, or other invasive
procedures may have been a possible route for the SV40 infection.
However, this explanation remains merely hypothetical, since the
epidemiology of the SV40 in humans is largely unknown. In con-
clusion, this study points out that SV40 may infect children and
suggests a possible role of SV40, in addition to BKV and AV, in the
aetiology of severe HC after BMT deserving further evaluation.
P1449 Contribution to the studies of the role of
Chlamydiae and human herpesvirus 6 (HHV-6) in pathogenesis
of multiple sclerosis
N. Sojkova, V. Frankova, E. Havrdova, K. Mlcochova
Prague, CZ
Objective: Sera and cerebrospinal ﬂuids (CSF) of patients with pro-
ven multiple sclerosis (MS) and adequate controls were examined
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for the presence of speciﬁc antibodies to chlamydiae (n ¼ 349)
and HHV-6 (n ¼ 250).
Methods: IgM, IgG and IgA antibodies to common LPS antigen of
chlamydiae were detected by ELISA. The species-speciﬁc antibod-
ies to major outer membrane protein (MOMP) of elementary bod-
ies and IgM and IgG antibodies to HHV-6 were detected by MIF.
The ﬁndings of anti-chlamydial antibodies in sera were classiﬁed
into the following categories: IgG only – anamnestic response; IgG
and IgA – suspected chronic infection; IgM, IgG and IgA or IgM
and IgA – suspected reactivation.
Results: No substantial difference between MS patients and
healthy controls was found in antibody response detected by
ELISA method. Antibodies to MOMP antigen were mainly
Chlamydophila pneumoniae-speciﬁc. The ﬁndings of antibodies
to Chlamydia trachomatis and Chlamydia psittaci were negli-
gible both in MS patients and controls. The proportion of an-
amnestic response to MOMP was nearly identical in MS
patients and controls. On the other hand, the signs of chronic
infection or activation were found in 9.4% of MS patients, but
in none of the control subjects. Anamnestic antibodies to HHV-
6 (IgG only) were detected in 32.6% of MS patients and in
26.8% of controls. The signs of activation of infection were
found in 27.5% of ill subjects but in only 15.5% of healthy con-
trols. In CSF, speciﬁc antibodies to chlamydiae detected by
ELISA or MIF as well as anti-HHV-6 antibodies were found
only rarely, in no case exceeding 3% in both MS and control
subjects.
Conclusions: In all the serological methods used, a similar pro-
portion of anamnestic antibodies to both Chlamydophila pneu-
moniae and HHV-6 was found in MS patients and healthy
controls, but signs of activation of chlamydial and HHV-6
infections were signiﬁcantly more frequent in patients. Analysis
of our results leads to the suggestion that chlamydia and
HHV-6 infections probably do not play an important role in
triggering the autoimmune process of MS and that the more
frequent activations may be the result of immunosuppressive
therapy.
P1450 Retrospective analysis of cancer patients with
neutropenic fever and predictors of treatment success
G. Sain Gu¨ven, B. Cakir, Y. Cetinkaya Sardan, P. Zarakolu,
O. Uzun, S. Unal, M. Akova
Ankara, TR
Objective: Infections remain the most frequent cause of morbidity
and mortality in neutropenic cancer patients. We examined the
characteristics of febrile neutropenic cancer patients and predic-
tors of treatments success in a tertiary care university hospital, in
Turkey, between January through December 1999.
Methods: Medical charts of 167 patients were analysed retrospec-
tively. The febrile attacks were categorised as: ‘microbiologically-’
and ‘clinically documented’ infections and ‘fever of unknown ori-
gin’ (FUO). The results of the treatment were grouped as ‘success’
or ‘success only after modiﬁcation of treatment/failure’. If a par-
ticular patient experienced more than one febrile neutropenic
attack during hospitalisation, only the ﬁrst attack was included in
the analysis.
Results: Of the patients 61.1% were male; the mean age was
48  18 years; 55.1% of the underlying diseases were haematolog-
ical malignancies. The infection was clinically documented (CD)
in 52 patients, microbiologically documented (MD) in, and the
aetiology of fever was undetected in 75 patients (44.9%). In multi-
variate logistic regression analysis, vancomycin use was a signiﬁ-
cant predictor of treatment success and patients with FUO were
more likely to have a successful outcome compared with those
with MD infection.
Conclusion: Our results indicate that therapy success is more com-
mon in case of FUO compared with both CD and MD infections,
indicating a need for extensive care in the latter groups, partic-
ularly if fever is not resolved in 3 days. Success rate was higher
in patients who received vancomycin during the course of the
treatment compared with no use, yet, this ﬁnding does not justify
the empirical use of this drug since all of our patients received
vancomycin upon documentation of a Gram-positive infection.
P1451 High-dose levoﬂoxacin for the treatment of febrile
neutropenia
J. Kahn, N. Davis
Raritan, USA
Background/Objective: The variety of organisms isolated from febrile
neutropenic patients (FNP) warrants empiric antimicrobial therapy
broad enough to cover most clinically signiﬁcant Gram positive and
negative bacteria. In an adult, low-risk, subset of such patients, cur-
rent IDSA guidelines include the option of giving ciproﬂoxacin (C)
and amoxicillin-clavulanate (AC) jointly. Several features of the
ﬂuoroquinolone levoﬂoxacin (L) make it an attractive potential mo-
notherapy alternative to that of combination regimen. Its spectrum
encompasses the same implicated pathogens, the serum and tissue
levels achieved with the 750 mg dose exceed PD targets for those
bacteria. It is administered orally once daily, and it has an extensive
and reassuring tolerability and safety proﬁle. We report here on
two pilot studies using L in the management of FNP.
Methods: Talcott IV out-patients were randomised to receive C
750 mg q12 h plus AC 875/125 mg po q12 h (following at least
one IV dose each of ceftriaxone (CTX) 2 gms and amikacin (AK)
15 mg/kg) or L 750 mg po qd (poster presentation, ICID, 2002).
More severely ill in-patients were randomised to cefepime (CP)
2 g iv q8 h or L 750 mg iv qd. Fever defervescence was the pri-
mary endpoint in both trials; secondary endpoints included safety
and tolerability and microbiologic eradication.
Results: In the outpatient study, the total defervescence in the
L-treated patients (n ¼ 27) was 74% compared with 63% of the
comparator-treated patients (n ¼ 19). The clinical cure rate at post
therapy in the inpatient study was 72.7% for L-treated patients
(n ¼ 11) and 20.0% for the comparator-treated patients (n ¼ 15).
Adverse events were comparable between arms in both studies
and none were considered to be drug-related.
Conclusion: These limited data suggest that L 750 mg iv/po qd
may offer a safe, effective, and convenient new option in the anti-
microbial management of febrile neutropenia. Since ﬂuoroquino-
lone agents are cidal in a concentration-dependent manner, higher
doses have been thought possibly capable of retarding the emer-
gence of resistance. Recent PD studies in vitro are lending experi-
mental support to this hypothesis and give one more reason for
considering this higher dose of L in the setting of febrile neu-
tropenia. Based on these results, we propose additional full-scale







(ref. ¼ solid tumours)
0.693 0.818 0.302–2.214
FUO (ref. ¼ MD infection) <0.001 16.937 4.670–61.429
MD infection
(ref. ¼ CD infection)
0.682 1.285 0.388–4.255
Vancomycin use
(ref. ¼ no use)
0.016 7.787 1.470–41.251
Amphoericin




(ref. ¼ no resolution)
<0.001 0.039 0.008–0.180
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P1452 Empiric antibiotic treatment of adults with
neutropenic fever in a general internal medicine ward
R. Shichmanter, E. Miller, M. Shtalrid, Z. Landau
Rehovot, IL
Objectives: To compare the efﬁcacy of piperacillin/tazobactam
(PTZ) 4.5 g q 8 h plus amikacin 15 mg/kg/day (AMK) to cefepi-
me (CFP) 2 g q 2 h plus AMK in patients with neutropenic fever
and underlying haematologic malignancies; and PTZ versus CFP
in febrile neutropenic patients with solid tumours who were trea-
ted in a general medical setting.
Methods: A prospective randomised open label study of adult
patients (>18 years old) with neutropenic fever enrolled from
January 2000 to December 2002.
Results: A total of 151 patients were enrolled and randomised to
treatment. One hundred and two (102) individuals had haemato-
logic malignancies of which 56 were randomised to PTZ + AMK
and 46 received CFP + AMK. There were 43 patients with solid
tumour malignancies of which 19 received PTZ and 25 were
assigned to CFP treatment. Treatment groups were found to be
equal in terms of mean age, duration of neutropenia and number
of individuals receiving antibiotic prophyllaxis. For patients with
both haematologic malignancies and solid tumour malignancies
there were no signiﬁcant differences in the number of clinically
documented infections, positive blood culture isolates (Gram pos-
itive or Gram negative) or the outcome of patients (cured/dis-
charged or died from sepsis) regardless of which antibiotic
regimen received.
Conclusions: PTZ + AMK and CFP + AMK are equally efﬁcacious
in neutropenic patients with haematologic malignancies, and mo-
notherapy with CFP or PTZ is equally efﬁcacious in neutropenic
patients with solid tumours. Low dose CFP is safe and allows a
reduction of cost and less antibiotic exposure.
P1453 Aspergillus: air quality monitoring in areas reserved
for the treatment of immunodepressed patients
G. Finzi, P. Cacciari, N. Manoni, N. Alvaro, L. Mavilla
Bologna, I
Aims: To ensure that the hyphomycete contamination levels of
areas reserved for the treatment of immuno-depressed patients
meet the speciﬁcations of the IAQ-1998 guidelines, as reported in
the Microbiology Reference Guide: total Hyphomycetes at 20 C
<15 cfu/m3; airborne level of Aspergillus <1 cfu/m3.
Methods: Monitoring air quality in areas reserved for the treat-
ment of immuno-depressed patients, making technical adjust-
ments to the air-conditioning system, and establishing a clear
code of conduct for hospital personnel. The presence of airborne
hyphomycete spores was detected using both active and passive
sampling techniques.
Results: Analyses on hyphomycete spores were carried out by
Regional Ofﬁce Hazard Prevention Environment. The results
obtained from 60 active samples taken during 2002 showed that
the mean level of airborne hyphomycete spores in the areas
under investigation was within the norms established for IAQ-
1998 in the Microbiology Reference Guide (total hyphomycetes
at 20 C <15 cfu/m3). However, Hyphomycetes belonging to the
Aspergillus family (though not those of ﬂuvus fumigatus niger)
were found in some areas, including the intensive care ward.
The maximum airborne level of Aspergillus, as established by
the IAQ guidelines, should be <1 cfu/m3. Following these
results, a series of maintenance operations were carried out on
the air ﬁlters, air-conditioning and ventilation systems, with the
aim of reducing and measuring the quantities of hyphomycete
spores present. However, the results obtained in 2003, from
both passive and active samples, were similar to those obtained
in 2002.
Conclusions: Comparison of the results obtained in 2002 and 2003
suggests that the carrying out of regular maintenance checks on
air ﬁlters, ventilation units and air-conditioning systems, together
with the introduction of codes of conduct for hospital personnel,
designed to reduce the production and dissemination of airborne
particles within areas reserved for the treatment of immuno-
depressed patients, are not sufﬁcient to ensure that the level of
airborne hyphomycetes falls within the limits proposed by the
IAQ-98. A more fundamental overhaul of the ventilation system
would seem, therefore, to be required, along with a wider diffu-
sion of the established codes of conduct among hospital person-
nel. To the latter end, a monitoring programme should also be set
up to assess to what extent hospital staff are following the recom-
mended procedures.
P1454 Control but not eradication of Legionella
pneumophila sg1 in a teaching hospital
A. Bile´n, B. Eriksson, G. Tufveson, A. Johansson, J. Evebjo¨rk,
S. Bernander, U. Ransjo¨
Uppsala, Stockholm, S
Objectives: To examine the sources and methods for control of
Legionella pneumophila serogroup 1
Methods: A renal transplant patient developed severe pneu-
monia in July 2003. Bronchial lavage (BAL) was examined by
immunoﬂuorescence against L. pneumophila and by culture for
Legionella and other organisms. Cultures were taken from
showers and other sources of water in the transplant unit and
adjacent buildings. Earlier outbreaks of Legionella pneumonia
had occurred in the same and other buildings of the hospital in
1993 and 1997. Control measures performed had included hot
water ﬂushing, heat disinfection of shower tubings and recon-
struction of water pipes. Legionella isolates from 1993, 1997
and 2003 were compared, using monoclonal antibodies and
ampliﬁed fragment length polymorphism (AFLP) as recommen-
ded by the European Working Group for Legionella Infections
(EWGLI).
Results: L. pneumophila serogroup 1 (sg1) was isolated from the
patient’s BAL. The patient was cured from his legionella infection
by treatment with macrolides in high doses. Patient and water
isolates from 1997 and 2003 in the transplant unit were identiﬁed
as L. pneumophila sg1 Knoxville or Oxford. AFLP patterns were
identical. Other L. pneumophila sg 1 isolates from buildings in the
hospital in the same years were closely related. Between 1997 and
2003, cultures from the water system of the building housing the
transplant unit were stably negative, and no clinical Legionella
cases were detected despite close surveillance with legionella cul-
tures of all sputum samples.
Conclusions: Control of L. pneumophila sg 1 can be achieved by
careful management and surveillance of hot water systems in hos-
pital buildings. Negative cultures from water systems do not
guarantee the complete eradication of Legionella. Legionella
strains may still persist in the bioﬁlm of water tubings. In severely
immunosuppressed patients with pneumonia, Legionella infection
must always be suspected.
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P1455 Clindamycin resistance among Streptococcus
agalactiae isolates and genotypes
M. Agreda, F. El Knaichi, E. Martin, J. Picazo
Madrid, E
Background: Group B streptococci (GBS) are an important cause of
serious infections among adults with underlying or chronic dis-
eases. Penicillin is the antibiotic of election for this infections, and
for penicillin allergic patients, the alternative is erythromycin
(ERY) or clindamycin (CLN). The resistance rate for CLN in ERY-
resistant strains of GBS is 58% in our area. The primary mech-
anism of CLN resistance in S. agalactiae is a ribosomal methylase
[erm B, erm A (subclass erm TR)]. We studied the erm (B) and
erm (A) (subclass erm TR) codes for a rRNA methylase which
produces resistance to macrolide-lincosamide-streptogramin B
(MLSB) antibiotics. We investigated the relative frequency of
MLSB resistance determinants among CLN-resistant GBS isolates.
Methods: A total of 37 GBS isolates, with MICs to CLN higher
than MICs to ERY were collected during nine years (1994 to
2002). These strains were characterised by in vitro susceptibility
testing that was carried out by disc diffusion and E-test. The
strains found to be CLN resistant according to the NCCLS guide-
lines have been phenotypically and genotypically characterised.
We studied the isolates looking for the resistance phenotype by
disc diffusion using 2 mg CLN and 15 mg ERY discs. The pres-
ence of macrolide resistance genes [erm (B) and erm (A) subclass
erm (TR)] was detected by PCR. The following antibiotics were
tested by the NCCLS agar dilution method: ampicillin (AMP),
ERY, CLN, telithromycin (TEL), tetracycline (TET), vancomycin
(VAN) and ciproﬂoxacin (CIP).
Results: The PCR ampliﬁcation showed that 12 (32%) isolates har-
boured the erm B gene, 10 (27%) were positive with primers
speciﬁc for erm A (subclass erm TR) gene and 15 (40%) had both
genes erm B + erm A (subclass erm TR). The resistance rates of
GBS isolates were 0% for AMP, 89% for ERY, 100% for CLN, 0%
for TEL, 86% for TET, 0% for VAN and 3% for CIP.
Conclusions: The majority of our GBS strains had the presence of
erm B + erm A (subclass erm TR) genes. All GBS were suscept-
ible to AMP, VAN and TEL. The novel drug, TEL, retained good
activity against CLN-resistant strains.
P1456 Spread of the new sul3 gene in human and animal
Escherichia coli in Sweden
M. Grape, C. Greko, G. Kronvall
Stockholm, Uppsala, S
Objectives: To investigate the molecular basis for sulfonamide
resistance in clinical isolates of Enterobacteriaceae and to assess
the spread of sul3 in Sweden. This study was part of a follow-up
of an observed increasing resistance to trimethoprim and sulfona-
mides in clinical isolates of Escherichia coli despite a simultaneous
decline in co-trimoxazole consumption.
Methods: Antibiotic susceptibility tests were performed on 105
urinary tract infection isolates of Enterobacteriaceae. Sulfonamide
resistant strains were tested with PCR speciﬁc for the sulfonamide
resistance genes sul1, sul2 and the recently discovered sul3. Pre-
valence of sul3 in sulfonamide resistant E. coli isolates from
healthy Swedish chickens and pigs was also investigated with
PCR. Sequencing and plasmid analysis has been performed to
investigate the context of the gene.
Results: Of 64 sulfonamide resistant human isolates, 39 were pos-
itive for sul1 and 48 were positive for sul2, 25 isolates carried
both genes. Two of the isolates were negative for both sul1 and
sul2, but were in further tests shown to harbour sul3. Among 49
sulfonamide resistant isolates from chickens, none was positive
for sul3, while ﬁve of the 40 isolates from pigs carried the new
gene.
Conclusions: The only observations of sul3 so far are in E. coli from
pigs in Switzerland and E. coli from pigs, cattle and poultry in
Germany. The present study is the ﬁrst to identify sul3 in human
isolates. Additionally, it shows that the gene is spread both
among humans and animals also in Sweden. These results imply
a possible spread of resistance elements between pigs and
humans. The origin and prevalence of this new gene is important
to investigate and the genetic context of sul3 might provide clues
to the emergence of a new resistance gene to such old antibiotics
as sulfonamides.
P1457 Characterisation of a novel AAC (3) I enzyme found
in a class 1 integron from a Salmonella enterica isolate causing
traveller’s diarrhoea
R. Cabrera, J. Ruiz, P. Gon˜i, R. Go´mez-Lus, M. Jime´nez de Anta,
J. Gasco´n, J. Vila
Barcelona, Zaragoza, E
Objective: Detection of class 1 integrons present in Salmonella ent-
erica causing traveller’s diarrhoea and characterisation of a novel
AAC (3) I encoding gene.
Methods: Sixteen antibiotic-resistant Salmonella strains were
recovered from faeces of travellers to developing areas. The
presence of class 1 integrons was determined by PCR with speci-
ﬁc primers. The ampliﬁed products were recovered and se-
quenced in order to establish the genes carried. The sequences
were compared with those present in GeneBank. Analysis of
plasmids, as well as conjugation was performed in all integron-
borne isolates. Additionally, susceptibility to gentamicin C1a,
gentamicin C1, sisomicin, neomycin, dibekacin, kanamycin,
tobramycin, amikacin, netilmicin, apramycin, dactimicin, spec-
tinomycin, streptomycin, lividomycin and butyrosin was estab-
lished in the isolate carrying an AAC(3)I.
Results: Four out of 16 (25%) isolates presented at least one class
1 integron, all containing antibiotic-resistance genes. Three of the
strains presented a single integron that contained aadB plus catB3
genes, dfrA17 plus aadA5, and aac(3)I-like plus aadA7 genes,
while the remaining strain carried two integrons containing a
carb2 and aadA2 gene, respectively. Only one strain carried plas-
mids but no positive conjugation was obtained with either this or
the remaining isolates. The homology between the DNA and
amino acid sequences of the AAC(3)I-like enzyme and the
AAC(3)I enzyme were of 59% and 62%, respectively. The antibi-
otic-susceptibility to different aminoglycosides in this strain
showed resistance or decreased susceptibility to gentamicin C1a,
gentamicin C1, dactimicin, and sisomicin, in accordance with the
presence of an AAC(3)I. Resistance to streptomycin and spectino-
mycin was also shown, probably due to the presence of the aadA7
gene.
Conclusions: A high frequency of class 1 integrons has been detec-
ted in antibiotic-resistant Salmonella isolates causing traveller’s
diarrhoea. These integrons present a high variability of resistance
genes, mainly associated with aminoglycoside antibiotics. In this
line, a novel AAC (3) I encoding gene carried into an integron has
been identiﬁed.
P1458 ParE mutations in Pseudomonas aeruginosa clinical
isolates with a high level of ciproﬂoxacin resistance
S. Rejiba, A. Aubry, V. Jarlier, E. Cambau
Tunis, TN; Paris, F
Objectives: Our objective was to unravel the topoisomerase muta-
tions in clinical isolates of Pseudomonas aeruginosa resistant to ci-
proﬂoxacin. We previously studied 30 P. aeruginosa strains for
mutations in the quinolone resistance-determining regions of
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gyrA, gyrB and parC (Mouneime et al. 1999). Gyrase mutation was
observed for all of the isolates (90% in gyrA and 10% in gyrB),
and an additional QRDR parC mutation in two-third of the iso-
lates. In the present study, we searched for additional parE muta-
tion in all the isolates and for mutation outside the QRDR in the
isolates lacking QRDR mutation and harbouring a high level of
resistance to ciproﬂoxacin.
Methods: PCR ampliﬁcation and sequencing of QRDR parE was
applied to 30 strains isolated in Pitie-Salpetriere Paris and three
strains isolated in Tunis, not susceptible to ciproﬂoxacin (MICs 2
to 128 mg/L). For strains without mutation in parE QRDR, the
5’ end region of parE and of gyrB was also ampliﬁed and
sequenced.
Results: parE mutation was observed in 10 out of 33 isolates,
either in the QRDR (Asp420Asn) for eight strains or outside the
QRDR (Val200Met, Ala474Val) for two strains. These 10 isolates
shared a gyrA Thr83Ile mutation, no mutation in QRDR gyrB or
in QRDR parC, and ciproﬂoxacin MIC > 4 mg/L. For three
strains with a high level of resistance to ciproﬂoxacin but only
one gyrA mutation, no mutation was observed in parE, or in
the entire gyrB, leading to the hypothesis of another additional
mechanism of resistance such as multiple efﬂux pumps
enhancement.
Conclusions: parE mutations were observed in P. aeruginosa isolates
with a high level of ciproﬂoxacin resistance (MIC > 4 mg/L) in
addition to gyrase mutation (gyrA or gyrB), and in the absence of
parC mutation. All P. aeruginosa isolates with at least two topo-
isomerase mutations harboured ciproﬂoxacin MIC > 4 mg/L
whereas all isolates with ciproﬂoxacin MIC of 2 or 4 mg/L har-
boured only one gyrA mutation.
P1459 Contribution of outer membrane protein alterations
and beta-lactamases in carbapenem-resistant Acinetobacter spp.
M. Castanheira, J. Smayevski, R.N. Jones, T.R. Walsh
Bristol, UK; Buenos Aires, AR; North Liberty, USA
Objectives: As part of the SENTRY Program, Acinetobacter spp. iso-
lates have been screened for resistance to carbapenems (imipenem
[IMP] and meropenem [MER]) and ceftazidime (CTZ). Thirty-ﬁve
isolates exhibiting this proﬁle recovered in 2002 from Buenos
Aires, Argentina were evaluated.
Methods: All isolates were tested against CTZ, IMP, MER with
and without the serine-b-lactamase inhibitor BRL 42715 or the
pump inhibitor reserpine by agar dilution. Beta-lactamase activity
against imipenem and meropenem was evaluated using standard
spectroscopic techniques. The number of beta-lactamase was ﬁrst
evaluated using Isoelectric Focusing (IEF) experiments and PCR
reactions were undertaken to identify b-lactamase genes present
in the strains. The OMP proﬁle for each strain was determined
and the proteins with decreased expression were submitted to N-
terminal sequencing. Four susceptible isolates, recovered from the
same medical sites at the same period, were used as negative con-
trols.
Results: The isolates showed MICs of >64 mg/L against CTZ,
16–32 mg/L against IMP, 8–16 mg/L against MER. No signiﬁcant
differences in the MICs with the inhibitors were observed. IEF
experiments showed that the isolates possess from two to four dif-
ferent b-lactamases. These results clustered the isolates in three
different groups according to the beta-lactamases proﬁle:(I) iso-
lates with pIs of 9.0, 6.7, 5.8 and 5.4, (II) pIs of 9.0, 6.7, 5.8 and
(III) pIs of 9.0, 6.7. One strain of each group was submitted for
PCR with customer primers to blaTEM, blaCMY, blaCTX-M,
blaGES, blaKCP, blaIMIA, blaOXA, blaSHV b-lactamase genes.
Sequencing analyses of the amplicons conﬁrmed the presence of
blaTEM-1-like gene.
Conclusions: The decreased susceptibility against carbapenems in
Argentinean Acinetobacter spp. isolates can be due to decreased
expression of porins associated to hyper-expression of beta-lacta-
mases that normally have low afﬁnity to carbapenems. The low
levels of in vitro resistance against carbapenems may jeopardise
the treatment of infections caused by this pathogen.
P1460 Post-genomic identiﬁcation of a new subclasss B3
metallo-beta-lactamase (NOV-1) from Novosphingobium
aromaticivorans
J.D. Docquier, M. Stoczko, G. Amicosante, J.M. Fre`re,
G.M. Rossolini
Lie`ge, B; Siena, L’Aquila, I
Objectives: Due to the recent advance of genome sequencing pro-
jects, metallo-beta-lactamase (MBL) homologues have been found
to be widespread in microbial genomes, being also present in
those of higher organisms. These proteins share signiﬁcant
structural similarity with MBLs, deﬁning the MBL superfamily,
and can exhibit a variety of other functions, such as aryl- and
alkyl-sulfatase, cyclase, glyoxalase, etc. In the genome of Novosp-
hingobium aromaticivorans, a bacterium that presents notable
biotechnological interest because of its ability to produce glycosp-
hingolipids and to degrade aromatic hydrocarbons, an open read-
ing frame (ORF) was detected (Saro0160) which encodes a protein
sharing 17–28% identity with subclass B3 MBLs. In this work we
demonstrated that Saro0160 actually encodes an MBL, and investi-
gated the functional properties of this enzyme, named NOV-1.
Methods: N. aromaticivorans SMCC F199 was grown in mineral
medium at 20 C. Beta-lactamase activity was assayed spectropho-
tometrically. The blaNOV-1 ORF was cloned under the transcrip-
tional control of the T7 promoter in the expression vector pET-9a
to obtain plasmid pET-NOV-1. Recombinant plasmids were trans-
formed in Escherichia coli BL21(DE3) to evaluate beta-lactamase
production.
Results: A crude extract of N. aromaticivorans, prepared from
cells grown in liquid medium, exhibited hydrolytic activity
against imipenem (sp. act., 38 nmol/min.mg of protein), that
was inhibited >90% after incubation in the presence of 5 mM
EDTA. The Saro0160 ORF, which encodes a putative protein of
372 residues, was cloned in an expression vector. Expression of
this ORF in E. coli led to the production of an EDTA-inhibitable
imipenemase activity (sp. act., up to 1130 nmol/min.mg of pro-
tein). If compared with other subclass B3 enzymes, NOV-1
exhibits the highest identities with THIN-B and L1 (28% and
25%, respectively) and a notably longer N-terminal domain (85
additional residues in comparison with L1). A truncated gene,
starting from an alternative ATG codon located 249 bp down-
stream and cloned in the same vector/host system, did not
yield any beta-lactamase activity. The NOV-1 enzyme was sub-
jected to functional characterisation.
Conclusions: The metallo-beta-lactamase homologue found in the
N. aromaticivorans genome encodes a functional MBL. The NOV-1
enzyme is a new subclass B3 MBL that shows peculiar functional
and structural features.
P1461 New aminoglycoside and chloramphenicol
acetyltransferase-encoding gene cassettes in class 1 integrons
from multiresistant Pseudomonas aeruginosa clinical isolates
J.D. Docquier, C. Mugnaioli, F. Luzzaro, R.A. Musmanno,
G.M. Rossolini
Lie`ge, B; Siena, Varese, I
Objectives: The integron system represents a powerful site-speci-
ﬁc recombination mechanism for the dissemination and expres-
sion of small mobile monogenic units, the gene cassettes. A
large repertoire of gene cassettes carry resistance determinants,
such as genes encoding drug modifying enzymes, low-afﬁnity
targets, and efﬂux pumps. Characterisation of integron cassette
arrays from clinical isolates has led to the discovery of several
new resistance genes. In this work, we report on the molecular
characterisation of integrons from clinical isolates of Pseudomon-
as aeruginosa, and on the discovery of two original gene cas-
settes carrying new aminoglycoside- and chloramphenicol-
acetyltransferases determinants.
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Methods: P. aeruginosa 2306/01 and 208/02 were two epidemio-
logically unrelated clinical isolates from the University Hospi-
tal of Varese (northern Italy), that exhibited a multidrug
resistant phenotype and produced the acquired metallo-beta-
lactamases (MBLs) VIM-2 and IMP-2, respectively. Characteri-
sation of the variable region of class 1 integrons was carried
out by a PCR mapping and sequencing approach. The func-
tion of the new resistance determinants carried on gene cas-
settes was investigated by cloning and expression experiments
in Escherichia coli.
Results: Molecular characterisation of isolates 2306/01 and 208/
02 revealed the presence of two integrons in each of them. In
addition to the MBL-encoding integrons, that were different in
each isolates and contained known gene cassettes, both isolates
carried an identical shorter integron with an array of two new
gene cassettes. The ﬁrst cassette encodes an AacA aminoglyco-
side acetyltransferase similar to AacA4 (97% identity with the
AacA4 encoded by integron In110). The second cassette encodes
a new CatB variant, named CatB10, that shares maximum iden-
tity with CatB3 and CatB2 (84% and 83%, respectively). The
attC site of this cassette is also original, showing the strongest
similarity (93% identity) with the attC site of the CatB5-enco-
ding cassette found in Tn840. The function of the new resist-
ance determinants was investigated by expression studies in
E. coli.
Conclusions: Two new resistance gene cassettes have been identi-
ﬁed. Systematic characterisation of gene cassettes present in integ-
rons from clinical isolates is a powerful approach for discovery of
new resistance genes and gene cassettes.
P1462 Hyperproduction of AmpC beta-lactamase in a
clinical isolate of Escherichia coli associated with a 30-base pair
deletion in the attenuator region of ampC
F. Ferna´ndez-Cuenca, A. Pascual, L. Martı´nez-Martı´nez
Seville, E
Objectives: To describe a novel mutation in the attenuator of the
ampC of an AmpC-hyperproducing clinical isolate of Escherichia
coli (Ec 47/94).
Methods: Ec 47/94 was isolated from a urine sample submitted at
the Clinical Microbiology Department, University Hospital Virgen
Macarena, Seville, Spain (1994). A microdilution assay (NCCLS
guidelines) was used to determine the MICs of cefoxitin (FOX),
cefotaxime (CTX), ceftazidime (CAZ), cefepime (FEP) and cefpi-
rome (CPM), alone or in combination with ﬁxed concentrations
(4 mg/L) of two inhibitors of serine beta-lactamases: BRL42715
(BRL) or clavulanic acid (CLV). The isoelectric point (pI) and the
inhibition proﬁle of beta-lactamases with CLV or cloxacillin (CLX)
were determined by isoelectric focusing. Hydrolysis of cephalori-
dine (CFL) determined by spectrophotometry was used as an
indicator of AmpC production. Mutations in the promoter and at-
tenuator of ampC were determined by direct nucleotide sequen-
cing of the PCR products generated using primers speciﬁc for this
region of ampC.
Results: The MIC (mg/L) of CPM was not affected (0.5) in the
presence of BRL. The MICs of FOX, CTX and FEP decreased
from >256 to 16 (FOX), from 32 to 0.5 (CTX) and from 0.5 to
0.25 (FEP) by BRL. In contrast, the MICs of these cephalospo-
rins were not reduced by CLV. A band of beta-lactamase with
a pI9 (inhibited by cloxacillin but not by CLV) was observed.
Hydrolysis of CFL was 435 nmoles/mg of protein. The promo-
ter of ampC showed ﬁve point mutations at positions 88 (C
to T), 82 (A to G), 42 (C to T), 18 (G to A) and 1 (C to
T). A deletion of 30 nucleotides between positions +16 to +45
containing the dyad symmetry region of the ampC attenuator
was also observed.
Conclusions: The hyperproduction of AmpC beta-lactamase in Ec
47/94 is related with a 30-bp deletion of the ampC attenuator.
P1463 In vivo selection of Enterobacter aerogenes with
reduced susceptibility to cefepime associated with either
decreased expression of an outer membrane protein of 40 kDa
or hyperproduction of AmpC beta-lactamase
F. Ferna´ndez-Cuenca, A. Pascual, J.-M. Rodrı´guez-Martı´nez,
L. Martı´nez-Martı´nez
Seville, E
Objectives: To evaluate the mechanism(s) of decreased susceptibility
to cefepime (FEP) in clinical isolates of Enterobacter aerogenes (Ea).
Methods: Three consecutive isolates (Ea1, Ea2, and Ea3) cultured
from bronchial aspirates from the same patient were evaluated.
Identiﬁcation was performed with the VITEK 2 system. The clonal
relationship among isolates was determined by REP-PCR. MICs of
FEP, cefotaxime (CTX), cefoxitin (FOX) and ceftazidime (CAZ)
were determined by microdilution (NCCLS), alone and/or com-
bined with 4 mg/L of clavulanate (CV) or BRL 42715 (BRL), or
250 g/L of cloxacillin (CX). Production of ESBLs was detected by
disc diffusion (NCCLS) and Etest (CT/CT-CV and CZ/CZ-CV).
The isoelectric point (pI) and the inhibition proﬁle of beta-lactamas-
es (BLs) with CV or CX were determined by isoelectric focusing.
Hydrolysis of cephaloridine (CF) and FEP was determined by spec-
trophotometry. The presence of TEM- and SHV-type ESBL genes
was assessed by PCR. The ampR-ampC genes were sequenced. The
outer membrane proteins (OMPs) were studied by SDS-PAGE.
Results: The three isolates showed identical REP-PCR pattern. All
three isolates were resistant (MICs in mg/L) to FOX (>256), CTX
(>32) and CAZ (64). MICs of FEP were 0.5 (Ea1), 2 (Ea2) and 32
(Ea3). The MICs of CTX and FEP were reduced up to 1 and
0.25 by BRL, and to 0.5 and 0.03 (Ea1), 0.125 and 0.03 ( Ea2) and
1 and 0.5 (Ea3) by CX. CV did not affect the MICs of CTX and
FEP. ESBLs were not detected. Ampliﬁcation of TEM- or SHV-
type genes was not observed. The three isolates showed the same
pattern of BLs (pIs 7.9-8.3, inhibited by CX, but not by CV).
Hydrolysis (nmoles/mg) of CF and FP was 3741.0 and 1.3 (Ea1),
4000.6 and 2.1 (Ea2) and 3797.4 and 17.3 (Ea3). The sequences of
ampR-ampC genes of Ea1 and Ea2 were identical to that of the E.
aerogenes strain deposited in the GeneBank (accession AF211348).
For Ea3, however, a point mutation in position 311 of the ampC
caused a change of Val to Glu. Three OMPs of 51, 40 and 38 kDa
were observed in the three isolates, but the expression of the
40 kDa-OMP in Ea2 was reduced.
Conclusions: Decreased susceptibility to FEP in Ea2 is related with
reduced expression of an OMP of 40 kDa, whereas that resistance
to FEP in Ea3 is associated with the hyperproduction of AmpC.
P1464 Analysis of the mutations in the pbp genes of
penicillin-nonsusceptible pneumococci from Turkey
M. Bicmen, Z. Gulay
Izmir, TR
Objective: To investigate the alterations in pbp1a, 2b and 2x genes
that cause penicillin resistance in Streptococcus pneumoniae isolated
in Turkey.
Methods: pbp sequence analysis of a total of 21 S. pneumoniae (8
high level (PenR), 9 low level (PenI) penicillin resistant and 4
penicillin susceptible isolates) was performed by using ABI Prism
Big Dye Terminator Cycle Sequencing Ready Reaction kit. The
sequences were compared with PBP1a, 2b, 2x nucleotide and
amino acid sequences of PenS isolate R6 and PenI/ PenR strains
provided from GenBank by using Clustal X program. KA, KS and
KA/KS values, and transition /transversion ratios were deter-
mined by Mega version 2.1.
Results: When compared with the sequence of R6, the nucleotide
and peptide sequences of PenI/R isolates contained up to 14.9%
and 8.5% divergence, respectively. Phylogenetic trees were con-
structed according to the pbp sequences and it was seen that most
Turkish isolates clustered together with high bootstrap values at a
separate branch, apart from the GenBank sequences. The most com-
mon alteration in the PBP1a sequences of our isolates, was a T371A
mutation in the active site STMK motif. A 574NTGY577 block was
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also detected in all isolates. A T451A and a E481G mutation was
found in the PBP2b sequences in 65% and 86% of the PenI/R iso-
lates, respectively. All isolates also possessed a SVES/TK block
between the 570 and 574th aminoacids, instead of the QLQPT
sequence of R6. The analysis of the pbp2x genes revealed a T338A
alteration in the STMK motif in 71% of the isolates. Three isolates
also had a Q552E change located near the KSG box. Moreover, a seg-
ment of 406 nucleotides that is 32.7% divergent from the R6 homo-
logue, showed 97% similarity to the pbp2b sequence of S. mitis.
Conclusions: This is the ﬁrst study that analysed the alterations in
the pbp sequences of pneumococci isolated in Turkey. As repor-
ted previously, the emergence of penicillin resistant S. pneumonaie
is a consequence of alterations in the three major PBPs.
P1465 Mutations in erm(B) associated with rare, low-level
telithromycin resistance in Streptococcus pneumoniae: 3-year
data from PROTEKT
D. Farrell, I. Morrissey, S. Bakker, D. Felmingham
London, UK
Objectives: Since 1999, the susceptibility of S. pneumoniae to telith-
romycin (TEL) has been tracked in the PROTEKT global surveil-
lance programme, and strains showing phenotypic resistance to
TEL have undergone molecular analysis to determine underlying
resistance mechanisms.
Methods: S. pneumoniae isolates, 13 684 in number, were collected
over three consecutive respiratory seasons (1999–2002) from
patients with community-acquired respiratory tract infections in
32 countries. TEL MICs were determined centrally using the
NCCLS microbroth dilution method and interpreted using
NCCLS breakpoints (resistant 4 mg/L) as approved by the
NCCLS SAST, January 2003. Multilocus sequence typing, pulsed-
ﬁeld gel electrophoresis and serotyping were performed on TEL-
resistant (TEL-R) isolates. The full erm(B) gene (including promo-
ter and control peptide regions) and 4 copies of the 23S rRNA L4
and L22 genes were ampliﬁed and sequenced.
Results: TEL showed potent antipneumococcal activity, with no
evidence of an increase in TEL MIC over time (mode MIC and
MIC90 of 0.008 mg/L and 0.12 mg/L, respectively, in each year).
Among erm(B)-positive strains (n ¼ 2736), the TEL mode and
MIC90 were 0.03 mg/L and 0.5 mg/L, respectively. Only 10 TEL-
R isolates (0.07%) were identiﬁed, two in Year 1, two in Year 2
and six in Year 3 (7 had MICs of 4 mg/L, 3 had MICs of 8 mg/
L): all tested positive for the erm(B) gene and negative for the 23S
rRNA L4 and L22 mutations associated with MLSB resistance.
Five TEL-R isolates had a 2 base-pair change (TA to AG) in the
SD2 site at the start of erm(B). Three TEL-R isolates had a 136
base-pair deletion in the erm(B) promoter region, resulting in
removal of the SD2 site: fusion of the remnants of the control pep-
tide and the erm(B) gene resulting in the formation of a new pro-
tein, 24 amino acids longer, with SD1 now controlling expression.
No erm(B) mutations were identiﬁed in the remaining two TEL-R
isolates. There was no evidence of reproducible clonal spread of
TEL-R isolates between centres.
Conclusions: TEL demonstrates potent in vitro activity against S.
pneumoniae, with no shift in susceptibility to this antibacterial
noted over the 3-year study period. Resistance to TEL was rare
(<0.1%) and of low level when it did occur, with no evidence of
clonal spread. The mutations described here are thought to result
in increased or constitutive expression of the erm(B) gene, how-
ever, these and other possibilities are yet to be determined.
P1466 Fitness costs of apramycin resistance plasmids
conferring cross-resistance to gentamicin and tobramycin
C.M. Yates, D.J. Shaw, M.E.J. Woolhouse, S.G.B. Amyes
Edinburgh, UK
Objectives: The aminoglycoside apramycin (Apr) has been used
extensively in animal husbandry in the United Kingdom since
1978. Apr is not used in humans, but plasmid-mediated apramy-
cin resistance (AprR) has been detected in human isolates of Sal-
monella, Klebsiella and Escherichia coli. The aims of this study
were to assess the cost of carriage of AprR plasmids and to deter-
mine their transfer frequencies.
Methods: Weekly faecal samples were collected for 3 months from
birth, from 11 calves that had not been treated with aminoglyco-
sides. AprR E. coli were selected with TBX agar containing 8 mg/
L Apr. MICs were determined following BSAC guidelines. Plas-
mid transfer frequencies were measured between E. coli K12
strains by both the end-point method and as a ratio of transconju-
gants (T) to donors (D). Growth rates of plasmid-carrying and
plasmid-free strains were measured in both minimal media (MM)
and Luria Broth (LB) by serial dilution and OD600.
Results: AprR E. coli was found in six of 11 calves. All AprR E. coli
(45) were cross-resistant to tobramycin, gentamicin, and netilmi-
cin. The presence of AprR E. coli was unrelated to calf age
(F1139 ¼ 1.26, P ¼ 0.26) or sampling date (F1139 ¼ 1.22,
P ¼ 0.27). AprR was conferred by three conjugative plasmids
(pUK2001, pUK2002 and pUK2003). pUK2001 and pUK2002 trans-
ferred at high frequencies (approximately 10e-2 T/D h-1,
1.16  10e-11 ml per cell h-1). pUK2002 and pUK2003 also carried
tetracycline and streptomycin resistance. Analysis of variance of
growth rates of plasmid-carrying and plasmid-free E. coli J53 dem-
onstrated no signiﬁcant differences in growth rates in either MM
or LB, when measured by serial dilution or OD600 (P ¼ 0.707).
T-tests revealed that growth rates did not differ signiﬁcantly when
plasmid-carrying and plasmid-free E. coli K12 strains were grown
in direct competition (P ¼ 0.722). Plasmid segregation was dis-
counted, as mixed-effect models of the changes in cell numbers
over time revealed no signiﬁcant difference in the recovery of
plasmid-carrying and plasmid-free cells (P ¼ 0.166).
Conclusions: AprR plasmids with high transfer frequencies were
detected in commensal E. coli despite no aminoglycoside usage.
The presence of AprR plasmids conferring cross-resistance to
medically important drugs, and the apparent lack of a ﬁtness cost
associated with carriage, poses severe implications for the trans-
mission of these resistance determinants into clinical bacteria.
P1467 High-level aminoglycoside resistance of
Streptococcus bovis isolates in a teaching hospital in Hong
Kong – studies on prevalence and resistance mechanisms
V.C.Y. Chow, R.C.Y. Chan, M.-L. Chin, A.F.B. Cheng
Hong Kong, HK
Objectives: Optimal therapy for S. bovis endocarditis requires a
combination of penicillin and aminoglycoside for synergistic effect
(1,2)7 . High-level gentamicin resistance (HLGR) is well recognised
in enterococci due to the presence of the bifunctional enzyme
Aac(60)-Ie-Aph(200)-Ia.(3) On the other hand, high-level gentamicin
resistance in S. bovis has not been reported (4–6). The objectives of
this study were to determine the prevalence of HLGR in blood
culture isolates of S. bovis from year 1990 to 2002 and to investi-
gate the mechanisms of resistance in these isolates.
Methods: A total of 59 unduplicated isolates of S. bovis were col-
lected from the Prince of Wales Hospital, Hong Kong. The S. bovis
isolates were identiﬁed to species level by the API 32 Strept sys-
tem. Antimicrobial susceptibility testing was performed by the
standard agar dilution method according to the NCCLS guide-
lines (7). The standard disc diffusion test using gentamicin
120 mg disc was also performed (7). To detect HLGR genes, PCR
was performed according to the method of Vliegenthart et al. (8).
Results: Susceptibilities proﬁles of S. bovis were shown in Table 1.
All except one HLGR isolates were from Year 2001 and 2002. In
Year 2001, 4/9 (44%) of isolates were HLGR while in Year 2002,
2/7 (28%) were HLGR. The antibiotic susceptibility patterns of
the seven isolates with HLGR were shown in Table 2. When
standard disc diffusion test using gentamicin 120 mg disc was
performed, all seven isolates had a zone diameter of 0 mm.
Among the 59 isolates, aac(6’)-Ie-aph(2’’)-Ia gene was detected in
all seven isolates exhibiting HLGR. All other 52 isolates did not
harbour this gene.
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Conclusions: This is the ﬁrst report of high-level gentamicin
resistance in S. bovis. The rapid emergence of HLGR since year
2001 with up to 44% of isolates with HLGR is alarming. The
most likely mechanism is due to bifunctional enzyme Aac(6’)-
Ie-Aph(2’’)-Ia. Routine screening of HLGR is recommended for
all clinically signiﬁcant blood culture isolates in order to avoid
inadvertent use of short course combination therapy of penicillin
and gentamicin which may lead to treatment failure for endo-
carditis and unnecessary usage of gentamicin, a drug with
potential toxicity.
P1468 Molecular characterisation of a new variant of
IND-type metallo b-lactamase expressed in a clinical isolate of
CDC group Gram-negative asaccharolityc rod
B. Caporale, M. Perilli, M.L. Mezzatesta, S. Stefani, G. Celenza,
F. De Santis, M. Fiore, G.M. Rossolini, G. Amicosante
L’Aquila, Catania, Siena, I
Objectives: The aim of this work was that to characterise the met-
allo b-lactamase (MBL) determinant present in a Gram-negative
rod belonging to the CDC group II B, isolated from sputum of a
patient from the Haematology Unit of the Hospital Ferrarotto in
Catania (Italy). The strain, did not grow in MacConkey agar and
at 42 C was urease-, indole-, and oxidase-positive, and was able
to hydrolyse gelatine. It was resistant to imipenem, meropenem
and ceftazidime but susceptible to piperacillin/tazobactam by
both diffusion and dilution susceptibility testing.
Methods: MBL production was tested by spectrophotometric
method. Genomic DNA was analysed by Southern blot using sev-
eral metallo-b-lactamase probes including: blaIND-3, blaIND-2,
blaVIM-1, blaIMP-1, blaGOB-1. PCR experiments were performed
with 20 ng of genomic DNA and using the following primers:
IND-for/ 50ATGAAAAAAAGAATTCAGTTCTTTA and IND-rev/
50 TTATTTTTTGTTAAGAAGTTCAAGA. Amplicon generated by
PCR was directly sequenced on both strands using an ABI PRISM
377 DNA sequencer. The deduced amino acid sequence of protein
was compared with those of natural IND b-lactamases reported in
GenBank. The amplicon was cloned in pGEM-T easy vector and
the b-lactamase was expressed in Escherichia coli JM109.
Results: MBL activity was detected in a crude extract of the iso-
late. The Southern blot assay, performed with several metallo-b-
lactamase probes, revealed the strongest hybridisation signal with
the blaIND-3 probe. The PCR analysis using the IND primers
yielded an amplicon of 720 bp, encoding an IND variant that was
different from IND-3 by 18 amino acid residues.
Conclusions: A new IND MBL variant was identiﬁed in a CDC
group II B clinical isolate. The present report points to the pres-
ence of MBL genes in clinical isolates of this group of bacteria.
MBL production can be a mechanism of carbapenem resistance in
similar isolates.
P1469 Characterisation of beta-lactam resistance among
clinical Escherichia coli strains in Portugal
M. Ferreira, E. Ferreira, M. Canic¸a, GEMVSA
Lisbon, P
Objectives: As part of an antimicrobial resistance surveillance pro-
gram we evaluated the prevalence and mechanisms of beta-lactam
resistance in E. coli in Portugal which is mainly attributed to beta-
lactamase production.
Methods: Unduplicated strains, 2447 in number, (83% from urine)
were collected consecutively from 15 hospitals and three public
health laboratories, during 6 months in 1999. Disc diffusion selec-
ted amoxicillin resistant (AmxR) strains and MICs of AmxR E. coli
(1176 strains) were determined against 20 antibiotics by agar dilu-
tion. Isoelectric focusing was used to characterise beta-lactamases.
Extended spectrum beta-lactamases (ESBL) were selected by syn-
ergy with clavulanate and by a multiplex-PCR method and were
identiﬁed by sequencing.
Results: Among 2447 E. coli 48% were AmxR. All AmxR strains
were susceptible to imipenem, but 88%, 8%, 19%, 12%, 0.8% and
0.9% were resistant to Amx-clavulanate, piperacillin-tazobactam,
mecillinam, cefuroxime, cefotaxime and ceftriaxone, respectively;
2.6% were resistant to both ceftazidime and aztreoname; 1113/
2248 (49.5%) and 63/199 (31.7%) AmxR strains accounted for hos-
pital and community acquired infections, respectively. We detec-
ted higher prevalence to AmxR in urinary tract infections from
patients in ICU 15/24 (63%) and surgery 24/42 (57%) than in
outpatients 60/191 (31%). Forty-six AmxR plus cefoxitin suscept-
ible strains (3.8%) showed synergy between C3G and CL, and
AmxR plus cefoxitin resistant strains with that synergy accounted
to 23/1176 (2%). Molecular plus phenotype methods showed that
beta-lactam resistance in E. coli was mainly due to the production
of TEM-1, AmpC, OXA, SHV-1, ESBL (TEM-derived) and IRT
beta-lactamases.
Conclusions: This study shows the high prevalence of beta-lactam
resistance in E. coli strains from nosocomial origin, in Portugal. It
also highlights the importance of rational use of this family of
antibiotics, and the need to continue surveillance and infection
control programmes.
P1470 Molecular basis of fusidic acid resistance in
Staphylococcus aureus from patients with atopic dermatitis
undergoing therapy with fusidic acid
A.J. O’Neill, A.R. Larsen, A.S. Henriksen, I. Chopra
Leeds, UK; Copenhagen, DK
Objectives: We examined the basis of fusidic acid (fus) resistance
in a collection of S. aureus strains recovered from 18 patients being
treated for atopic dermatitis with topical fusidic acid.












Penicillin 0.06–0.12 0.12 0.12 0
Imipenem 0.015–0.06 0.03 0.12 0
Cefotaxime 0.03–0.25 0.12 0.12 0
Vancomycin 0.25–0.5 0.5 0.5 0
Erythromycin 0.03–>512 0.06 >512 52.5
Clindamycin 0.03–>512 0.06 512 52.5
Gentamycin 4–>4096 4 1024 11.8*
Kanamycin 32–>4096 64 > 4096 NAy
Amikacin 8–512 32 64 NAy
Netilmicin 1–512 4 16 NAy
Streptomycin 8–2048 32 64 1.6
Tetracycline 0.25–256 128 256 86.4
Chloramphenicol 2–16 4 8 1.6
Levoﬂoxacin 1–64 2 4 1.6
Linezoid 0.5–2 2 2 NAy
Quinupristindalfopristin 0.25–8 1 4 NAy
*Breakpoint for high-level aminoglycoside resistance for enterococci
(i.e. >512 mg/l for gentamicin and >200 mg/l for streptomycin) is
used
yNA, no interpretive NCCLS breakpoints are available





















SB10 0.06 >512 256 128 >4096 >4096 32 64 64
SB28 0.12 >512 16 128 >4096 >4096 64 512 512
SB30 0.12 >512 0.5 128 >4096 >4096 64 128 128
SB33 0.12 >512 512 256 2048 >4096 32 16 32
SB34 0.12 512 128 0.25 2048 >4096 32 32 32
SB40 0.12 >512 512 256 1024 >4096 32 16 32
SB41 0.12 >512 512 256 512 >4096 32 8 32
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Methods: PFGE-typing was conducted according to the HAR-
MONY protocol, and susceptibility testing performed using Etest.
Strains were examined for fus resistance polymorphisms in the
drug target by PCR ampliﬁcation and DNA sequencing of fusA.
For detection of the acquired staphylococcal fus-resistance deter-
minant, fusB, southern hybridisation was employed to probe both
total DNA and puriﬁed plasmid DNA preparations. Strains were
deﬁned as resistant or susceptible to fus according to breakpoints
recommended by the British Society for Antimicrobial Chemother-
apy (MIC 1 lg/ml: susceptible, MIC  2 lg/ml: resistant).
Results: Strains from 18 patients were examined, nine of whom
carried fus-sensitive strains at the start of treatment. In four of the
latter group of patients, cross-infection with a fus-resistant strain
occurred during the period of treatment as judged by the isolation
of strains exhibiting 70% PFGE homology with the original, sen-
sitive isolate. In the other ﬁve patients in this group, resistant
strains developed during treatment. The resistant isolates from all
nine patients carried mutations in fusA that involved analogous
substitutions to those found in laboratory-derived fusR mutants.
The remaining 9/18 patients carried strains that were fully- or
intermediately resistant (MIC range of 1.5 to >256 lg fus/ml)
from the outset, and no increase in resistance or cross-infection
with more highly resistant strains was observed during treatment.
Resistance in strains from this second group of patients resulted
from the presence of the fusB determinant (2/9), resistance poly-
morphisms in fusA (3/9) and additional, unidentiﬁed mechanisms
(4/9).
Conclusions: S. aureus strains recovered from 18 patients with
atopic dermatitis being treated with fus exhibited various mecha-
nisms of resistance to the antibiotic, including mutations in fusA
(12/18), carriage of fusB (2/18) and the presence of other, unchar-
acterised determinants (4/18).
P1471 High frequency of association between
CTX-M-beta-lactamase-coding genes and the ISEcp1
insertion element
M. Pimkin, I.S. Palagin, M. Stepanova, M. Edelstein
Smolensk, RUS
Objectives: CTX-M beta-lactamases are becoming an increasingly
alarming problem throughout the world due to their fast spread.
This is often addressed to the possible transfer of CTX-M-coding
genes with mobile genetic elements. Indeed, several studies have
shown an association of blaCTX-M genes with the ISEcp1 inser-
tion sequence or the putative recombinase gene orf513. However,
such studies have been conﬁned to relatively small numbers of
strains. We have studied the association of blaCTX-M genes with
ISEcp1 using a large collection of CTX-M-producing enterobacteri-
al strains obtained from 21 Russian hospitals.
Methods: The strains studied were 28 Escherichia coli (EC), 87 Kle-
bsiella pneumoniae (KP) and 36 Proteus mirabilis (PM). They com-
prised 17, 48 and 22 distinct genetic types, respectively, as
determined by ERIC-PCR and RAPD typing and produced CTX-
M-1-cluster enzymes (94.7%), i.e. CTX-M-3 and CTX-M-15, and a
CTX-M-2-cluster enzyme (5.3%) – CTX-M-5. Two PCRs with
ISEcp1-speciﬁc primers were used to identify the linkage of
blaCTX-M genes with ISEcp1. One forward primer (F1) matched
the 3’-end sequence of tnpA and another (F2) matched the right
terminal repeat (RTR) sequence of ISEcp1. A common reverse pri-
mer (R) was located internally to blaCTX-M. Previously character-
ised EC and Citrobacter freundii strains harbouring blaCTX-M
genes associated with either ISEcp1 or orf513 were included as
positive and negative controls, respectively.
Results: Positive PCR results with primers F2-R were observed for
28 (100%) EC, 86 (98.9%) KP and 35 (97.2%) PM isolates. Ampliﬁ-
cation with primers F1-R additionally conﬁrmed the association of
blaCTX-M genes with ISEcp1 in 25 (89.3%) EC, 85 (97.7%) KP
and 34 (94.4%) PM isolates. According to the length of PCR prod-
ucts, ISEcp1 was located approximately 50 bp upstream of the
CTX-M ORFs in all EC, KP and PM isolates expressing CTX-M-1-
cluster enzymes and approximately 20 bp upstream of blaCTX-M-
5 in eight EC isolates. An insertion of 700 bp sequence between
tnpA and RTR was detected in a single KP isolate of a unique
genetic type. Two isolates (PM and KP) which failed to produce
PCR products with either of the primer pairs also represented
unique genetic types.
Conclusions: We conclude that CTX-M-coding genes of different
genetic subtypes have a strong association with the ISEcp1 inser-
tion element in nosocomial Enterobacteriaceae from Russia. This
in part may explain their notoriously rapid spread.
P1472 Fluconazole resistance mechanisms in C. krusei
clinical isolates. The contribution of efﬂux pumps
J. Guinea, M. Sa´nchez-Somolinos, T. Pelaez, O. Cuevas,
J. Martı´nez-Alarco´n, L. Alcala´, P. Mun˜oz, E. Bouza
Madrid, E
Objective: Infections caused by C. krusei have purportedly
increased during recent years and the inherent resistance of this
agent to ﬂuconazole is well known. The main resistance mechan-
ism for ﬂuconazole is the diminished sensitivity of the target
enzyme cytochrome P450 sterol 14 l-demethylase (CYP51) to inhi-
bition by azole agents. According to studies using a limited num-
ber of strains, an alternative mechanism of resistance could be
based on the activity of efﬂux pumps. The aim of our study was
to know the possible contribution of efﬂux pumps in conferring
resistance to ﬂuconazole in a large study of C. krusei isolates.
Methods: We obtained 22 C. krusei strains from different sources:
urine (4), mucous membranes (4), genital (3), respiratory (2), cathe-
ters (3), sterile ﬂuids (4), wound (1) and 1 ATCC 6258 strain. The
activity of efﬂux pumps was checked using the inhibitor CCCP
(carbonyl cyanide 3-chloro-phenylhydrazone) which could
decrease the minimum inhibitory concentration (MIC) if resistance
was correlated to this mechanism. We established a concentration
of 0.5 mg/ml of CCCP, and veriﬁed that it did not kill the yeast.
The susceptibility patterns of our isolates for six antifungal drugs
(amphotericin B, ﬂuconazole, itraconazole, ketoconazole, ﬂucyto-
sine and voriconazole) were determined according to an NCCLS
M27-A protocol modiﬁcation (Sensititre Yeast One). We tested all
the strains before and after adding the CCCP to the RPMI medium.
Results: The MIC90s and ranges of the drugs were identical before
and after CCCP treatment: amphotericin B 0.5 mg/ml [1–0.25];
ﬂuconazole 32 mg/ml [64–8]; itraconazole 0.125 mg/ml [0.25–
0.03]; ketoconazol 0.25 mg/ml [0.25–0.03]; ﬂucytosine 4 mg/ml
[8–1] and voriconazole 0.125 mg/ml [0.25–0.06]. The MIC for ﬂuc-
onazole was higher than for the other antifungals. The new triaz-
oles appeared to be quite active and the MICs were lower. Only
one isolate showed a twofold decrease in MIC to ﬂuconazole
when CCCP was added. We did not ﬁnd any multi-resistant
strains.
Conclusions: According to our study with C. krusei, the role of
efﬂux pumps inhibited by CCCP in the resistance to ﬂuconazole
is scarce.
P1473 Characterisation of the Ambler class B chromosome-
encoded b-lactamases SLB-1 and SFB-1 from Shewanella
livingstonensis and Shewanella frigidimarina
L. Poirel, C. Heritier, P. Nordmann
Le Kremlin Bicetre, F
Shewanella livingstonensis and Shewanella frigidimarina are psychro-
philic Gram-negative rods belonging to the Alteromonadaceae
family. Two strains isolated from Antarctic coastal areas were
studied for their b-lactamase content since carbapenem-hydroly-
sing oxacillinases have been recently characterised from other
Shewanella species, with demonstration of their role in acquired
resistance in Enterobacteriaceae. Shotgun cloning experiments
gave recombinant clones expressing Ambler class B enzymes.
SLB-1 and SFB-1, identiﬁed from S. livingstonensis and S. frigidima-
rina, respectively, that hydrolyse penicillins and ceftazidime and
at a lower level imipenem. These metallo-enzymes are inhibited
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by EDTA but not by clavulanic acid, as for class B b-lactamases.
SLB-1 and SFB-1 shared 67% amino acid identity, and are weakly
related to the IMP-type (40%), VIM-type (30%) enzymes, and to
SPM-1 (30%). This study underlines the fact that the Shewanella
species are environmental bacteria that may constitute a reservoir
for carbapenem-hydrolysing enzymes, as observed with Flavobac-
teriaceae. Interestingly, this study showed that Shewanella spp.
may be the source of carbapenemases belonging to Ambler class
B and Ambler class D groups.
P1474 Evidence for an efﬂux pump affecting carbapenem
susceptibility in Bacteroides fragilis
K. Aldridge, K. Lolans, P. Schreckenberger, J.P. Quinn
New Orleans, Chicago, USA
Objectives: We sought evidence for an efﬂux pump mechanism
affecting carbapenems among clinical isolates of B. fragilis.
Methods: Recent isolates were obtained from a multicentre net-
work of microbiology laboratories serving tertiary care hospitals
in the USA. MICs were done by an NCCLS-approved broth
microdilution method in the presence or absence of these pump
inhibitors: reserpine (0.125–0.40 mcg/ml), verapamil (1.56–
100 mcg/ml) and B-naphthylamide (3.13–100 mcg/ml). We tested
ertapenem, meropenem and imipenem, as well as cefoxitin, cefo-
taxime, piperacillin-tazobactam, moxiﬂoxacin and chlorampheni-
col. Two strains with discordant susceptibility for ertapenem
(8–16 mcg/ml) and imipenem (2–4 mcg/ml) were studied in more
detail: outer membrane proteins (OMPs) were separated by SDS-
PAGE and stained with Coomassie blue. ATCC25285 was inclu-
ded in all MIC and OMP experiments.
Results: Imipenem susceptibility was affected by reserpine, but
not the other inhibitors, in all strains (see Table):
In two clinical isolates, imipenem MICs declined 32 and 64 fold
respectively; the ATCC strain showed a 4-fold decline. Other
beta-lactams were affected to a lesser degree, 2 to 8 fold. OMP
analysis revealed overexpression of a band at 48 kD in the two
clinical isolates, which had higher MICs for ertapenem than imi-
penem. Sequencing of this protein is in progress.
Conclusions: 1. We found phenotypic evidence for an efﬂux mech-
anism affecting carbapenem susceptibility in these strains. Imipe-
nem seemed to be the most affected. 2. The overexpressed 48 kD
OMP in organisms with higher ertapenem MICs may be an efﬂux
pump.
P1475 Macrolide resistance and its genetic mechanism in
Streptococcus pneumoniae in Finland 2002, with special
reference to telithromycin resistance
M. Rantala, P. Huovinen, J. Jalava and The Finnish Study Group
for Antimicrobial Resistance
Objectives: The aims of this study were to follow the development
of macrolide resistance, especially telithromycin resistance, in
Streptococcus pneumoniae in Finland and to investigate genetic
mechanisms of macrolide resistance.
Materials and methods: S. pneumoniae strains, 1007 in number, were
collected from 24 FiRe laboratories, which represent the whole
country. Strains were isolated both from non-invasive (n ¼ 878)
and invasive (n ¼ 129) infections. The mininum inhibitory concen-
tration (MIC) to macrolides (erythromycin, azithromycin, spiramy-
cin, telithromycin and clindamycin) was tested by using agar
plate dilution technique. The presence of resistance genes: mef(A/
E), erm(B), erm(TR), was tested with a multiplex-PCR -method
from the strains with erythromycin MIC equal or higher than
0.25 mcg/ml.
Results: Of 1007 pneumococcal strains, 21% (n ¼ 215) were resist-
ant to erythromycin (I + R, MIC equal or higher than 0,5 mcg/
ml). Five of these strains had intermediate susceptibility. Resist-
ance to azithromycin was 33%, and to clindamycin 11%. Seven
per cent of pneumococci (n ¼ 71) had reduced susceptibility to te-
lithromycin (MIC equal or higher than 1 mcg/ml). The genotype
was tested from 224 strains (22%). Mef(A/E) was the most com-
mon genotype; 48% of strains were positive (n ¼ 107), 40% of
strains harboured erm(B) gene (n ¼ 90), and erm(TR) was found
from one strain only. Double mechanism, mef(A/E) + erm(B),
was detected from 5 strains (1%). PCR results were negative in
9% of tested strains (n ¼ 21). All those strains, which had
reduced susceptibility to telithromycin, also had resistance mech-
anism in their genome (mef(A/E) n ¼ 35, erm(B) n ¼ 33, and dou-
ble-mechanism n ¼ 3).
Conclusions: Resistance to macrolide-lincosamides is widespread
and is increasing among pneumococci in Finland. In macrolide
resistant pneumococci, mef(A/E) seems to be still the most com-
mon mechanism in Finland, although erm(B) is also frequently
present. The interesting ﬁnding was that unexpectedly high pro-
portion of pneumococci (7%) had reduced susceptibility to telith-
romycin.8
P1476 Antibiotic and biocide resistance mechanisms in
Escherichia coli O157
M. Braoudaki, A. Hilton
Birmingham, UK
Background: Bacterial resistance to antibiotics and biocides is a
prevalent problem, which may be exacerbated by the common-
place and often unnecessary inclusion of biocides into domestic
products.
Objectives: This study investigated potential adaptive resistance in
Escherichia coli O157 to commonly employed antibacterial agents
in order to identify mechanisms underlying any resistance
obtained.
Methods: E. coli O157 strains were serially exposed to sub-inhibi-
tory concentrations of erythromycin (ERY), benzalkonium chloride
(BKC), chlorohexidine (CHX) and triclosan (TLN). Following each
passage the MIC of the antibacterial and any adaptive resistance
was recorded. Adaptive resistance was readily promoted follow-
ing only two sub-inhibitory exposures. Permeability changes in
the outer membrane, including LPS, cell surface charge and hy-
drophobicity and the presence of an active efﬂux were investi-
gated as possible resistance strategies. The outer membrane and
LPS proﬁles were analysed by SDS-PAGE and visualised by Coo-
massie blue and silver staining, respectively. The cell surface
charge and hydrophobicity were investigated employing micro-
electrophoresis and microbial adhesion to hydrocarbons (MATH
assay). Efﬂux activity was examined by comparing the level of
resistance in pre- and post-adapted strains in the presence of the
efﬂux inhibitor, reserpine. In addition, the FabI gene of pre, 1st
and post- adapted O157 was sequenced and compared, in order
to investigate the presence of any possible mutations conferring
increased resistance.
Results: Examination of the outer membrane LPS did not reveal
any signiﬁcant changes between pre- and post-adapted strains.
There was no correlation between cell surface charge and hydro-
phobicity. However, the hydrophobicity of the cells increased as




MIC various carbapenems in the presence of efﬂux
pump inhibitor
fold decrease
Efﬂux pump inhibtor (EPI) concentration
(ug/ml)-Reserpine
0 1.25 2.5 5 0 20 40
ATCC25285 Imipenem 2–0.002 0.25 0.25 0.25 0.25 0.25 0.25 0.0625 4
Meropenem 2–0.002 0.125 0.125 0.125 0.125 0.125 0.125 0.0625 2
Ertapenem 2–0.002 0.125 0.125 0.125 0.125 0.125 0.0625 0.0313 4
LSU5 Imipenem 2–0.002 >2 >2 >2 >2 >2 2 0.125 >¼32
Meropenem 32–0.0313 16 16 16 16 16 16 8 2
Ertapenem 16–0.015 8 8 8 8 3 16 4 2
LSU11 Imipenem 2–0.002 2 2 2 2 1 0.0625 64
Meropenem 32–0.0313 8 8 8 8 4 4 " 8
Ertapenem 16–0.015 2 4 4 4 4 4 " 4
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efﬂux system was the most likely mechanism of BKC and CHX
resistance, whereas a FabI mutation was associated with TLN-
adapted strains. The adaptive resistance to erythromycin, BKC,
CHX and TLN in cells of E. coli O157 was stable for over 30 pas-
sages in biocide-free media.
Conclusions: In summary, increased cell surface hydrophobicity,
the presence of the FabI mutation in addition to that of an active
efﬂux pump could facilitate the acquisition of antibacterial resist-
ance in E. coli O157 providing cross-resistance to nine of 17 anti-
microbials investigated.
P1477 A novel SHV-derived extended-spectrum beta-
lactamase (SHV-52) that hydrolyses ceftazidime through a
single-amino-acid substitution (L169R)
L. Ma, J. Alba, S. Kimura, Y. Ishii, M. Ishiguro, L.K. Siu
Taipei, TW; Tokyo, Osaka, JP
ESBL producing bacteria comprise one of the most serious resist-
ance problems in hospitals especially in nosocomial infections.
New ESBLs have emerged rapidly because of the overuse of anti-
biotics. A new SHV-derived extended-spectrum beta-lactamase
(temporarily designated as SHV-52) conferring high-level resist-
ance to ceftazidime but not cefotaxime was identiﬁed from an
island-wide surveillance in 1998. Escherichia coli TSARI 981223,
which is resistant to ampicillin, cephalothin, cephaloridine, cefpo-
doxime and ceftazidime while being sensitive to cefoxitin, ceftri-
axone, cefotaxime, imipenem and the ﬁrst-generation cephem
cefazolin was isolated from the urine of a patient treated with
beta-lactam antibiotics. Resistance to beta-lactams was transferred
by conjugation from E. coli TSARI 981223 to E. coli JP995, and the
transferred plasmid was about 50 kbp. The pI of this enzyme was
8.2. The ceftazidime resistant gene was cloned from the trans-
ferred plasmid. The sequence of the gene was determined, and
open reading frame of the gene was found to consist of 861 bases
(The GenBank accession number is AY223863). Comparison of
SHV-52 with other SHV beta-lactamases suggests that the substi-
tution of arginine for leucine-169 is important for the substrate
speciﬁcity. Characterisation of the enzyme by molecular biological
and enzymological methods will provide us information of the
extension of substrate speciﬁcity. The three-dimensional model of
the enzyme will provide critical information in modelling and
developing new antibiotics in the future.
Mycobacterial diagnosis
P1478 Evaluation of a RAPIDTM bioactive ampliﬁcation
with probing Mycobacterium tuberculosis (RAPIDTM BAP-MTB)
assay for identiﬁcation of M. tuberculosis in respiratory
specimens
S.K. Wang, C.Y. Huang, P.R. Hsueh
Taipei, Tainan, TW
Objectives: To evaluate a novel molecular diagnostic assay for
identiﬁcation of M. tuberculosis in respiratory specimens.
Methods: Six hundred respiratory specimens obtained from
patients treated at National Taiwan University Hospital from July
2003 to October 2003. RAPIDTM Bioactive Ampliﬁcation with Pro-
bing (BAP) M. tuberculosis (RAPIDTM BAP-MTB) assay was used
and the results were compared with those obtained from acid-fast
microscopy, conventional cultures using BACTEC MGIT 960 Sys-
tems, and clinical history.
Results: The RAPIDTM BAP-MTB assay could detect as low as 10
fentogram of MTB genomic DNA. The overall time for processing
the RAPIDTM BAP-MTB assay took about 5 h. Among the 600
samples, 56 (9.3%) were culture positive for MTB. One specimen
was culture positive for MTB but negative using RAPIDTM BAP-
MTB assay. Twelve samples were positive by the novel method
but had negative cultures for MTB. The sensitivity of the novel
method was 97.8% and the speciﬁcity was 97.3%.
Conclusions: RAPIDTM BAP-MTB assay is a promising method for
rapid identiﬁcation of MTB in respiratory specimens.
P1479 Early laboratory diagnosis of pulmonary
tuberculosis. How to evaluate the results?
J. Lago, E. Alvares, H. Pinto, A. Reme´dios, A. Silva Grac¸a
Lisbon, P
Objective: The culture examination in Lowenstein–Jensen media,
although inexpensive and speciﬁc, requires several weeks since
growth of Mycobacterium tuberculosis species relatively to the MB/
BacT system. The aim of this study was to evaluate the efﬁcacy of the
MB/BacT culture system in pulmonary tuberculosis patients.
Methods: The authors realised a retrospective study of 22 clinical
cases with pulmonary tuberculosis which diagnosis was
conﬁrmed by the mycobacteriologic test of sputum, bronchial
aspirate and/or bronchoalveolar lavage. To evaluate the efﬁcacy,
we used the chi-square test relatively to the recovery rate, and the
t student test to the detection time.
Results: The mean age was 52.5  20.6 years and 15 were male.
The major symptoms were productive cough (95.4%) and vesper-
tine fever (72.3%). By the radiological image, 36.4% had pulmon-
ary tuberculosis that was very extensive. Relative to the
examination of the culture, we veriﬁed that in 18 patients the Lo-
wenstein–Jensen media was positive with 81.8% of sensibility,
while in the MB/BacT system the sensibility was more elevated,
95.5% (P < 0.0001). The detection time in MB/BacT system was
14.0  9.2 days and in LJ media 23.0  5.0 days (P < 0.0001).
Conclusions: The MB/BacT system had a higher recovery rate and
a lower detection time than Lowenstein–Jensen media and could
be applied as a routine method to detection of M. tuberculosis.
P1480 Rapid cultivation and improved detection of
Mycobacterium tuberculosis and other mycobacterial species by
use of culture supplements
I. Szpinda, I. Olsen, T. Tonjum
Oslo, N
Objectives: Rapid detection of the growth of mycobacterial species
and susceptibility testing in liquid media has greatly reduced the
time by which the overall processing of culture-positive samples
is completed. This procedure has also reduced efforts invested in
culture negative samples. The detection of minimal growth at an
early stage combined with the use of nucleic acid-based tests for
mycobacterial species identiﬁcation and their drug susceptibility
markers provide a unique opportunity for more rapid diagnostics.
However, the time required for growth and less than optimal
media are still limiting factors for the performance of culture sys-
tems. Our aim is to improve the sensitivity and reduce the time
for the detection of mycobacteria in clinical specimens.
Methods: Clinical samples investigated for the presence of myco-
bacteria were cultivated in the culture system BACTEC MGIT
960 system which employs the Middlebrook 7H9 medium and a
ﬂuorescent indicator for growth detection. The samples were culti-
vated in the regular BBLTM Middlebrook 7H9 medium with and
without the addition of culture supplements. Among the culture
supplements added were bovine serum albumin and hemin.
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Results: Among the 800 clinical samples investigated for the presence
of mycobacteria, 54 were positive for Mycobacterium tuberculosis. The
culture supplements improved the recovery of M. tuberculosis from
patients and increased the sensitivity of M. tuberculosis cultivation by
20%. Furthermore, the mycobacterial culture supplements reduced
the time required for the detection of growth of M. tuberculosis
5.4 days from an average of 16.2 days (range 8–24 days) without sup-
plement addition to an average of 10.8 days (range 2–22 days) with
supplement. The sensitivity and rapidity of culture were also
enhanced for the detection of other mycobacterial agents, but to var-
ious extents in the different species investigated.
Conclusions: Signiﬁcantly shorter cultivation time and 20% higher
sensitivity in M. tuberculosis cultivation was achieved by adding
culture supplements to liquid Middlebrook 7H9 medium. Also, a
number of non-tuberculous mycobacterial species grew faster with
culture supplements addition than without. These results hold
promise for signiﬁcant improvements in culture-based mycobacte-
rial diagnostics.
P1481 Identiﬁcation of clinical nontuberculous
mycobacteria isolates by using polymerase chain reaction–
restriction enzyme analysis in a teaching hospital
O. Bedir, A. Albay, O. Kisa, O. Baylan, L. Doganci
Ankara, TR
Objectives: Because of the increasing incidence of non-tuberculous
mycobacteria (NTM) infections and their clinical importance, in
terms of strategies for treatment and the epidemiological implica-
tions, the rapid differentiation of causative mycobacteria is import-
ant. Identiﬁcation of clinical isolates of mycobacteria to the species
level is primarily based on cultural characteristics and biochemical
tests. These conventional tests take several weeks, and sometimes
fail to provide precise identiﬁcation. The use of liquid culture sys-
tems like BACTEC 460-TB system in the clinical laboratory
improves the ability to detect the growth of mycobacteria. Recently
developed molecular methods, such as DNA sequence analysis, Po-
lymerase Chain Reaction–Restriction Enzyme Analysis (PRA), Sin-
gle-Stranded Conformation Polymorphism Analysis (SSCP), and
DNA probe tests, offer identiﬁcation of this NTM from a positive
liquid culture medium prior to detection of growth on solid media.
Methods: Seventeen NTM isolates identiﬁed using BACTEC 460
TB during the study period (March 2001–April 2003) were ana-
lysed by the PRA method for identiﬁcation of NTM subspecies.
Due to the low NTM prevalence in our laboratory, the identiﬁca-
tion of all mycobacterium by PRA method would increase cost
and labour. So, we also added the evaluation of cord formation to
our study as a simple, cheap and reliable method for the prelim-
inary diagnosis of Mycobacterium tuberculosis complex (MTK). All
MTK and NTM isolates were identiﬁed deﬁnitely by cord forma-
tion in this study.
Results: We detected 11 of 17 isolates as M. gordonae, one as
M. abscessus type 1, one as M. intracellulare type 1, one as M. non-
chromogenicum type 2, two as M.genavense and one isolate as
M. thermoresistible.
Conclusions: PRA method is a rapid, easy and reliable method that
provides detection of multiple subspecies in a single step for iden-
tiﬁcation of NTM in developed microbiology laboratories. On the
other hand, the evaluation of cord formation is cost-effective in
the laboratories with low NTM prevalence and helpful for the
selection of molecular study method.
P1482 Tuberculosis of the parotid gland. Diagnosis by
polymerase chain reaction
T. Kontopoulou, P. Fanourgiakis, M. Samarkos, D. Loverdos,
C. Peppas, D. Rontogianni, E. Vaidakis
Athens, GR
Introduction: Tuberculous (TB) parotitis is a rare condition in
developed countries and most cases have been documented in
Africa and India. Even where disease is prevalent, TB infection of
the PG is rare as the sole disease focus. It presents as a swelling
or abscess involving the parenchyma of the gland either through
haematogenous spread or from infection of lymph nodes within
or around it.
Case report: A 35-year-old Greek woman presented with a gradu-
ally increasing swelling of the left PG of 9 months’ duration, but
was otherwise well. She was given several courses of different anti-
biotics and underwent an evacuating puncture with no improve-
ment. She had two discharging sinuses and the overlying skin was
reddish, with a normal temperature. Left cervical lymphadenopa-
thy was present. Laboratory investigations showed a mild lympho-
cytopenia. Tuberculin test had a weal of 9 mm. Staining for acid-
fast bacilli (AFB) and culture of the discharge were both negative.
Chest radiograph was normal. Contrast enhanced CT showed an
enlarged left PG with ﬁlling defects and a mass extending to the
parapharyngal region. Histopathological examination revealed a
ﬂorid granulomatous process with areas of necrosis. Staining for
AFB was negative but tissue was not cultured for Mycobacteria.
Parafﬁn sections’ PCR was positive for Mycobacterium tuberculo-
sis complex and TB parotitis was diagnosed. Afterwards a three-
drug antituberculous regimen was started and being now in the
third month of therapy, she shows progressive improvement.
Discussion: TB parotitis is usually not suspected as a possible
cause of parotid tumour, because there may be no clinical clues
for this. It is very important for the clinician to have the oppor-
tunity to review the case when the suspicion of tuberculosis
arises. Such an opportunity is provided by PCR, which is a rapid
– within 48 hours – and sensitive technique for the detection of
mycobacterial DNA in formalin-ﬁxed and parafﬁn-embedded tis-
sue stored even for more than 5 years.
P1483 Polymerase chain reaction based detection of
Mycobacterium tuberculosis complex in lupus vulgaris: a case
report
O. Baylan, E. Arca, A. Ozcan, O. Kisa, A. Albay, L. Doganci
Ankara, TR
In recent years, cutaneous tuberculosis (CTB) with an atypical
clinical appearance has become more common in developing
countries and is often confused with other granulomatous derma-
tosis. The diagnosis of CTB remains troublesome, because of the
difﬁculty of detecting mycobacteria in skin lesions by conven-
tional laboratory methods. Lupus vulgaris (LV), the commonest of
all forms of CTB can affect earlobes as well as the other parts of
the body. In this article, we present a 20-year-old male patient
with LV of left earlobe. In the initial period, pyodermia was the
misdiagnosis and the patient was treated superﬂuously with anti-
biotics for four years, elsewhere. The deﬁnitive diagnosis of the
disease was conﬁrmed by polymerase chain reaction (PCR). Myco-
bacteria could not be seen or isolated by stained smears and con-
ventional and radiometric culture methods from the skin biopsy
specimens. The lesion was treated successfully with antitubercu-
lous chemotherapy (ATBC). PCR is a reliable and a very rapid
method for establishing or conﬁrming the diagnosis of CTB as
seen in our patient.
P1484 Failure to detect the IS6110 repetitive DNA element
of Mycobacterium tuberculosis in exhaled breath condensate of
patients with active pulmonary tuberculosis
R. Jain, C. Schriever, L. Danziger, S. Franzblau, S. Cho,
R. Glowacki, S. Welbel, I. Rubinstein
Chicago, USA
Objective: To detect the presence of IS6110 repetitive DNA ele-
ment of Mycobacterium tuberculosis (MTB) in exhaled breath con-
densate (EBC), a simple, non-invasive method to sample
pulmonary lining ﬂuid of patients with active pulmonary tubercu-
losis.
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Methods: Ten hospitalised patients with positive sputum smears
for MTB were identiﬁed by routine microscopy. Sputum samples
were sent for routine culture and susceptibilities. EBC was collec-
ted from these patients within 6 days of initiating anti-tuberculous
therapy (median, 36 h). EBC samples were concentrated by high-
speed centrifugation and then analysed by RT-PCR using primers
designed to amplify a 245 base-pair IS6110 DNA fragment of
MTB. Ampliﬁed DNA was detected by ethidium bromide stain-
ing, agarose gel electrophoresis and conﬁrmed by SaI digestion.
Exogenous MTB DNA was added to EBC samples to detect PCR
inhibitors. EBC samples were also cultured on Lowenstein/Jensen
agar plates for 6 weeks.
Results: MTB was identiﬁed in nine out of 10 routine sputum cul-
tures. One isolate was identiﬁed as M. kansasii. The IS6110 repetit-
ive DNA element of MTB was not detected in any of the 10 EBC
samples. By contrast, exogenous MTB DNA added to EBC sam-
ples evoked the characteristic band pattern of MTB on agarose gel
electrophoresis. Cultures of EBC showed no growth of MTB.
Conclusions: The IS6110 repetitive DNA element of MTB was not
detected in EBC in patients with active pulmonary tuberculosis.
This could be related, in part, to anti-tuberculous therapy initiated
before collection of EBC. We suggest that EBC should be collected
from these patients before initiating anti-tuberculous therapy.
P1485 Is it necessary to incubate for eight weeks
specimens submitted to the mycobacteriology laboratory?
M.J. Ruiz-Serrano, O. Cuevas, L. Alcala´, N. Garcı´a-Escribano,
O. Pe´rez-Olaso, M. Marı´n, D. Garcı´a-Viedma, E. Bouza
Madrid, E
Objectives: Traditionally, the recommended incubation time for
specimens submitted to the mycobacteriology laboratory is eight
weeks. Today, with the introduction of liquid media in laboratory
routine, the time for detection of mycobacteria could be redu-
ced. The aim of this study is to analyse the reduction of the incu-
bation time from 8 to 6 weeks and to evaluate its impact on the
number of mycobacteria recovered.
Methods: We studied all mycobacteria strains isolated during the
period 2000–2002. The specimens were decontaminated by stand-
ard procedures and inoculated onto liquid media (MGIT), and
solid media (Lowenstein-Jensen Pyruvate (LJP)). The incubation
times for MGIT and LJP were 6 weeks and 8 weeks, respectively.
Growth rates were: one-fold each hour for MGIT and one-fold
each week for LJP.
Results: During the study period, we recovered 1769 mycobacteria,
(907 Mycobacterium tuberculosis complex (MTB), 699 Mycobacterium
avium complex (MAC), and 163 other non-tuberculous mycobacte-
ria (NTM)). Of these, only 93 (5.3%) were recovered in LJP after
more than 42 days although 72 out of 93 also grew in MGIT (incu-
bation time <42 days). Therefore, 21 strains grew only in LJP after
more than 42 days. These mycobacteria were grouped as follows:
15 MAC, 2 MTB and 4 NTM. We reviewed the total specimens of
patients with these 21 mycobacteria and in all cases the mycobac-
teria were isolated in other specimens, with the result that a diag-
nosis could be made in all patients.
Conclusions: The reduction of incubation time from eight to six
weeks does not involve a signiﬁcant reduction in the number of
mycobacteria recovered. It can lighten the workload of the myco-
bacteria laboratory and provide physicians with prompt results.
P1486 A new molecular method for the identiﬁcation of
mycobacteria in clinical samples
M. Sa´nchez-Somolinos, M. Ruiz-Serrano, E. Rodriguez,
M. Marı´n-Arriaza, D. de Garcı´a Viedma, E. Bouza
Madrid, Guadalajara, E
Objectives: Nowadays, molecular methods for the identiﬁcation of
signiﬁcant mycobacteria are tedious and cumbersome, and they
are not available in all laboratories. This study evaluates two new
assays for the identiﬁcation of mycobacteria: Genotype MTBC for
the species included in Mycobacterium tuberculosis complex and
Genotype Mycobacterium for the most frequent mycobacteria.
Methods: We selected strains isolated in our laboratory and used
ATCC strains as a quality control; MTBC isolates were previously
identiﬁed by two different methods: AccuProbe and biochemical
tests (Bch T), and non-tuberculous mycobacteria (NTM) were
identiﬁed by PRA, Bch T and GL-chromatography. Geno-
typeassay is based on the ampliﬁcation of the 16S-23S rDNA
spacer region followed by reverse hybridisation. The assay takes
approximately 6 hours to complete.
Results: We analysed 10 MTBC + 22 NTM strains. Geno-
typeMTBC correctly identiﬁed ﬁve M. tuberculosis, four M. bovis
(one of them BCG) and one M. africanum. Genotype Mycobacte-
rium accurately identiﬁed some strains of M. chelonae, M. celatum,
M. fortuitum, M. gordonae, M. kansasii, M. malmoense, M. peregri-
num, M. intracellulare, M. avium, and M. tuberculosis complex. Dis-
crepant results were observed only in two strains.
Conclusions: Genotype is a rapid, easy and reliable tool for the
identiﬁcation of signiﬁcant mycobacteria. Genotype MTBC is the
only commercially available assay that permits the identiﬁcation
of M. tuberculosis complex at species level. Using Genotype My-
cobacterium it is possible to identify 13 species including the most
relevant mycobacteria.
P1487 Fast and sensitive detection of the Mycobacterium
tuberculosis complex by real-time PCR
S.O. Cramer, F. Matinmehr, D. Hillemann
Hamburg, Borstel, D
Objectives: Tuberculosis is the most frequent fatal bacterial dis-
ease worldwide and causes approximately three million deaths
every year. Apart from Mycobacterium bovis BCG in humans
tuberculosis can be caused by all members of the Mycobacterium
tuberculosis complex. The number of mycobacteria in clinical
samples can be very low and their detection by culture usually
takes between one week and two months. For this reason we
developed a real-time PCR assay (RealArt M. tuberculosis TM
PCR Reagents) for the use with the ABI PRISM 7000 SDS
instrument (Applied Biosystems, USA) which allows the fast
and reliable diagnosis of tuberculosis even in patients releasing
low numbers of mycobacteria.
Methods: The real-time assay ampliﬁes a region of the mycobac-
terial 16S rDNA using primer binding sites that are conserved in
all members of the M. tuberculosis complex. The generation of
the speciﬁc amplicon is detected by a dual-labelled ﬂuorogenic
probe. In addition, the real-time assay contains a second heterol-
ogous PCR system for the detection of a so-called ‘internal con-
trol’. This can be used to control the DNA puriﬁcation
procedure as well as the existence of possible PCR inhibitors. To
assess the usability of the real-time assay for clinical diagnostics
48 M. tuberculosis culture positive and 48 culture negative spu-
tum samples were examined.
Results: The real-time PCR assay detects the members of the M.
tuberculosis complex with an analytical sensitivity of 10 bacterial
genomes per PCR. Its speciﬁcity is very high since neither atyp-
ical mycobacteria nor several other bacteria tested generated a
signal in the ABI PRISM 7000 SDS instrument. The examination
of the 96 sputum samples showed that the real-time PCR assay
exhibits a speciﬁcity of 100%. The sensitivity was 100% for
smear positive and 95.8% for smear negative samples compared
with the results from culture. One per cent of the samples
showed an inhibition.
Conclusions: The described real-time assay is a sensitive and
highly speciﬁc tool for the detection of the members of the M.
tuberculosis complex. Its integrated internal control allows the
exclusion of false negative results due to puriﬁcation loss or inhi-
bition of the PCR.
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P1488 Five-year experience with Roche Amplicor PCR
assay for Mycobacterium tuberculosis
I. Gros, J.-M. Naccache, P. Blondel, S. Desligneres, F. Lhote,
D. Mechali, C. Chaplain
Saint Denis, F
Objectives: The clinical indications and economic consequences of
Mycobacterium tuberculosis (MTB) PCR test could be controversial.
Before analysing the cost-effectiveness of this method, we evalu-
ated the performances on the Amplicor(R) MTB test (Roche) in
our hospital in Seine Saint Denis (northern suburbs of Paris)
where there is a high incidence of tuberculosis. In 2001, the inci-
dence was 34/100 000 compared with 11/100 000 nationally.
Methods: We investigated 732 decontaminated samples (NALC-
NaOH) collected from 588 patients during ﬁve years. The routine
prescription included 527 extra-pulmonary (EP) specimens and
205 respiratory specimens. The internal control was incorporated
into the ampliﬁcation reaction. The MTB PCR test was compared
with Mycobacterial culture (Lowenstein–Jansen and coletsos
media). Results were interpreted with an adjusted ‘gold standard’
incorporating clinical diagnosis.
Results: Of 732 specimens, 40 were inhibitory, 83 were culture +/
PCR+, 13 were culture +/PCR and 36 were culture/PCR+.
Among cultures + samples, 18 were smear positive. After inter-
pretation of results, three samples culture/PCR+ were inter-
preted as false positive results. The overall sensibility was 89%
and the speciﬁcity 99%. For EP specimens the sensibility and
speciﬁcity were 85% and 99%, respectively. One third of EP
tuberculosis was diagnosed only with PCR and clinical context.
Of 82 abscess aspirates and samples of spondylitis and spondylo-
discitis, 28 were culture+/PCR+, 13 were culture-/PCR+, none
was culture+/PCR-. After interpretation of discrepancies the sen-
sibility was 100% and the speciﬁcity 95%.
Conclusions: Our study conﬁrms that Amplicor(R) MTB test is a
sensitive and speciﬁc method for detecting MTB complex. The
results are particularly interesting in EP tuberculosis where we
need a rapid and accurate laboratory diagnosis.
P1489 Comparison of the MB/BacT culture system and the
Lowenstein–Jensen medium for detection of Mycobacteria from
respiratory samples
J. Lago, A. Reme´dios, A. Silva Grac¸a
Lisbon, P
Objective: For the isolation of Mycobacteria from clinical speci-
mens, the use of liquid media as well as solid media is recom-
mended. The aim of this study was to compare the MB/BacT
system to solid culture media, in terms of reliability and rapidity
of mycobacterial growth from respiratory samples.
Methods: Clinical respiratory samples, 679 in number, were inocu-
lated in the MB/BacT system and on two LJ slants; N-acetyl-L-
cysteine-NaOH method (ﬁnal concentration 2%) was used for
decontamination and smear from the sediment were prepared
from all specimens and examined for acid-fast bacteria by the
Tan–Thiam–Hok method. The mycobacteria isolated were identi-
ﬁed by the Accuprobe culture identiﬁcation test. All tests were
conducted according to the manufacturer’s instructions. Recovery
rate, detection time and contamination rate were calculated.
Results: In both methods, we isolated 124 strains (18.3%) identi-
ﬁed as Mycobacterium tuberculosis complex (Mt), 92 (74.2%) from
smear positive and 32 (25.8%) from smear negative samples. The
recovery rate with the MB/BacT was higher than that with LJ
[116 (93.5%) versus 100 (80.6%)], P < 0.0001. Contamination rate
were 5.5% in MB/BacT and 5.0% in LJ. The overall correlation
between the two culture media for detection of Mt was 74.8%,
although it was higher in smear-positive samples (82.1%). The
mean time to detection was 11.4 days for the MB/BacT and
18.7 days for the LJ (P < 0.0001).
Conclusions: These results indicate that the MB/BacT system is
more efﬁcient and faster than LJ, for the recovery of Mt in respir-
atory samples.
P1490 Comparison of the performance of different assays
for the immune-diagnosis of tuberculosis based on ESAT-6 and
CFP10 selected peptides
D. Vincenti, S. Carrara, R. Casetti, V. Di Virgilio, M. Amicosante,
F. Poccia, E. Girardi, D. Goletti
Rome, I
Mycobacterium tuberculosis ESAT-6 and CFP-10 puriﬁed protein
and its peptides are currently being evaluated as antigens for the
immune diagnosis of TB. We set up an ELISPOT assay for IFN-
gamma whose novelty consists of two multiepitopic peptides
from ESAT-6 protein, selected by computational analysis, that
allows the discrimination between latent and active TB and the
monitoring of the efﬁcacy of anti-TB therapy (Vincenti et al., Mol
Med 2003; Carrara et al., Clin Infec Dis, in press). It is important
to ﬁnd new strategies to increase the sensitivity of the diagnostic
assays. Thus, the objective of this study was to assess the per-
formance of this assay based on ELISPOT against other technical
assays used in immunology laboratories, such as ELISA on cell
culture supernatants, ELISA on plasma from whole blood cul-
tures, proliferation assay evaluated by thymidine incorporation,
intracellular cytokine staining evaluated by FACS. PBMC or
whole blood from patients with active TB microbiologically con-
ﬁrmed (positive culture from biological ﬂuids and/or PCR from
biopsies specimens) were seeded in the presence or absence of
ESAT-6 and CFP-10 proteins, their selected peptides, PPD, recall
antigens, mitogens and their own controls. The results were
obtained within one day by the ELISA on plasma or by FACS
analysis, within 2 days by ELISPOT, and 5 days by proliferation
assay or ELISA on cell supernatants. We found that the sensitivity
of the ELISPOT assay was signiﬁcantly higher compared with the
proliferation assay (P < 0.05, to ELISA on cell culture supernatants
and to FACS analysis although not statistically signiﬁcant. How-
ever, a similar sensitivity was found between the results obtained
by ELISPOT assay and ELISA on plasma from whole blood cul-
tures. On the other hand, FACS analysis allowed the identiﬁcation
of the single cells involved in Mycobacterium tuberculosis-speciﬁc
responses. In conclusion, immune-diagnostic assays based on the
response to ESAT-6 and CFP10 selected peptides obtained by ELI-
SPOT or ELISA performed on plasma from whole blood are com-
parable, whereas a sub-optimal sensitivity is found with
proliferation assay, FACS analysis and ELISA on cell culture sup-
ernatants.
P1491 Evaluation of the BDProbeTec ET system for direct
detection of Mycobacterium tuberculosis complex in respiratory
and extra-respiratory specimens
M. Lecuona, M.A. Miguel, M. Cuervo, M.J. Ramos, B. Castro,
O. Diez, A. Sierra
Sta Cruz de Tenerife, E
Objective: To evaluate the usefulness of BDProbeTec ET system
for direct detection of Mycobacterium tuberculosis complex (MTBC)
by comparing results to those of conventional mycobacterial cul-
ture performed with BACTEC MGIT 960 and Lowestein–Jensen
medium.
Method: Four hundred and ninety two samples (382 respiratory
and 110 extra-pulmonary) from patients with negative smear
microscopy and a high probability of tuberculosis were assessed
by BDProbeTec and by culture for mycobacteria. In all samples
the internal ampliﬁcation control (IAC) was successfully per-
formed.
Results: Of 492 specimens, 29 grew MTBC (and in ﬁve cultures
grew nontuberculous mycobacteria). BDProbeTec ET detected 25
of the 29 MTBC culture-positive specimens and gave a positive
result in 10 of the 463 negative cultures, resulting in initial overall
sensitivity, speciﬁcity and positive and negative predictive values
of 86.2%, 97.8%, 71.4% and 99.1%, respectively. BDProbeTec ET
was positive in none of the nontuberculous mycobacteria. After
analysing respiratory and extra-pulmonary samples separately,
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the sensitivity and speciﬁcity values of the BDProbeTec ET were
90%, 97.5% and 77.7%, 99% respectively.
Conclusions: These data suggest that the performance is good for
negative smear samples and that sensitivity increases when analy-
sing respiratory specimens. The BDProbetec ET system offers the
advantage of including an IAC in the specimen well.
P1492 Evaluation of timing, number and yield of blood
cultures in the detection of Mycobacterium tuberculosis
bacteraemia in HIV-infected patients in Portugal
T. Hanscheid, J. Melo-Cristino, C. Monteiro, L. Marques-Lito,
M. Salgado
Lisbon, P
Objective: To investigate the number, timing and yield of myco-
bacterial blood cultures (BC) for the detection of Mycobacterium
tuberculosis complex (MTC) in HIV-infected patients in Portugal.
Methods: BC (Myco/F-Lytic) collected from 1998 to 2001 from
HIV-infected individuals with culture proven MTC were retro-
spectively studied, including time and number of BC, as well as
time, number, specimen type and result of all concurrent myco-
bacterial cultures. Conventional, non-mycobacterial BC (Bact/
Alert FA) was inoculated with serial dilutions of MTB to deter-
mine the ability of MTB to grow in the medium. Subsequently, all
non-mycobacterial BC (Bact/Alert FA) collected from HIV-posit-
ive patients that remained negative after 7 days of incubation in
the Bact/Alert instrument were prospectively investigated for the
presence of MTB by auramine staining (and culture were indica-
ted).
Results: In the retrospective part of the study, a total of 1181 BC
from 858 patients were collected. One hundred and ﬁfty-seven
HIV-positive patients had culture proven TB (any kind of speci-
men). Of these, 44 patients (28%) had 48 positive BC for MTC. In
29 cases, BC were the quickest or only way to diagnosis with a
mean of 22 days to positivity (range 11–46). In six of ten patients
who had two or more BC collected, discordant results between
the multiple BC were observed. Positive BC were collected signiﬁ-
cantly earlier during admission than negative BC from patients
with extrapulmonary/disseminated TB (61% versus 19% within
48 hours, P < 0.01). The serial dilution experiments showed that
the new Bact/Alert FA medium (supplement: charcoal) supports
the growth of MTB down to an inoculum of less than 10 bacteria/
ml and that auramine staining detected all positive BC. In the
ongoing prospective part, 220 BC from 85 patients have been
checked so far for the presence of mycobacteria. Five conventional
BC from two patients yielded mycobacteria.
Conclusions: BC are useful to provide rapid cultural conﬁrmation
of TB in HIV-infected patients in a setting such as Portugal. They
should be collected as early as possible after admission. Interest-
ingly, the new Bact/Alert FA medium supplemented with char-
coal seems to support the growth of MTB. The ongoing
investigation of non-mycobacterial BC will try to establish if a sin-
gle BC is enough to detect the mycobacteraemic episode or if a
collection of multiple BC, perhaps at longer intervals (>12–14 h
apart), may increase yield further, as very rarely is 31 mycobacte-
rial BC collected.9
P1493 16S rRNA PCR for retrospective detection of
Mycobacterium spp in formalin-ﬁxed parafﬁn-embedded
archival specimens
B. Mulder, H. Wilke, F. Sutorius, R. Hendrix
Enschede, NL
After formalin-ﬁxation of clinical specimens culture of Mycobacteri-
um spp is impossible. PCR provides a rapid and sensitive alternat-
ive diagnostic method for the detection of Mycobacterium
tuberculosis or non-tuberculous mycobacteria in these clinical sam-
ples. We evaluated the usefulness of the 16S rRNA PCR combined
with reversed line blot for the retrospective detection of
(non)tuberculous mycobacteria in lymph node biopsies in which
granuloma were found microscopically according to the Nation-
wide Pathological Anatomic Automated Archive (PALGA). PCR
results were compared with previous clinical cultures if avail-
able. Mycobacterial DNA was shown in 12 of 51 materials
(24%). M. tuberculosis was found seven times (14%). The other
samples contained M. fortuitum (4 times) and M. avium, respect-
ively. Clinical culture of two more patients showed M. tuberculosis.
Three samples containing mycobacterial DNA, which showed
reactivity with genus probe pMyc5a but not with one of the speci-
ﬁc species probes, were determined by sequence analysis. We
conclude that, although sensitivity is lower than 100%, the 16S
rRNA PCR is also applicable retrospectively for the detection of
Mycobacterium spp. in formalin-ﬁxed parafﬁn-embedded archival
specimens of lymph node biopsies.
P1494 Identiﬁcation of mycobacteria with 16S ribosomal
RNA gene sequence analysis
B. Mulder, E. Oude Nijhuis, H. Wilke, R. Hendrix
Enschede, NL
Biochemical identiﬁcation of mycobacteria is a time-consuming
process due to their slow growth. Molecular techniques can speed
up this process. The currently used 16S rRNA PCR combined
with reversed line blot can only determine to species level if spe-
ciﬁc probes, which show a variable amount of disturbing cross
reactivity, are added. Sequential analysis of hypervariable
regions of the 16S ribosomal RNA gene can determine more my-
cobacteria to the species level without time-consuming subcultur-
ing. The aim of the study is to develop an identiﬁcation method
of mycobacteria by sequence analysis of hypervariable regions of
PCR-ampliﬁed 16S ribosomal RNA gene. The ampliﬁed region
has a length of about 590 base pairs. Sixty positive cultures of my-
cobacteria (e.g. Mycobacterium tuberculosis, M. avium, M. intracellul-
are, M. kansasii, M. chelonae, M. malmoense, M. scrofulaceum,
M. marinum and M. gordonnae) collected during the last 10 years
were analysed, including various strains which could not be
determined previously. The 16S rRNA genes sequence was com-
pared with the public RIDOM database of mycobacteria available
on the Internet. Results of the sequence analysis excellently
matched with reversed line blot and biochemical methods. Cross
reactivity in reversed line blot could be explained by probe and
strain sequence homology and one strain previously considered
as M. tuberculosis by mistake was now correctly identiﬁed as
Mycobacterium holsaticum. We conclude that sequence analysis of
mycobacteria is a reliable technique that is applicable for routine
use in our laboratory.
P1495 The role of tuberculosis skin test conversion in
detection of tuberculosis
O. Ergonul, R. Keskiner, B. Dokuzoguz
Ankara, TR
Objective: To determine the risk factors of tuberculin skin test
(TST) conversion among health care workers (HCW).
Methods: Two-step TST was performed, at the Ankara Numune
Education and Research Hospital and conversion test was per-
formed one year later. In 2001, 1006 physicians, 584 nurses, 408
laboratory technicians, 20 pharmacists, 197 management and ser-
vice ofﬁcers, 133 housekeeping personnel were actively working.
All HCWs working at the hospital were invited to participate in
the study. Logistic regression was performed for multivariate ana-
lysis.
Results: Of the 491 participants 408 (83%) had two-step TST posi-
tivity. Fifty HCWs out of 83 TST negatives had the third TST. TST
conversion rate was 20%. The mean age was 35. Conversion was
detected in 12 HCWs, 92% were female. In univariate analysis,
the number of BCG scars, working in internal medicine, follow-
up TB patient within last year, age <30 years were found to be
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signiﬁcantly associated with the outcome (P < 0.05). TST conver-
sion rate was higher among HCWs, with working duration of
<1 year (P ¼ 0.146), and an annual income <$2500 (P ¼ 0.278),
although statistically not signiﬁcant. However the conversion rate
was not associated with public transportation to the hospital
(P ¼ 0.180), entertained at crowded settings out of the hospital
(P ¼ 0.705). None of the subjects had a history of TB in their fam-
ilies. None of the TST converted subjects had a history of contact
with a TB patient outside of the hospital. None had had BCG vac-
cination within 10 years. In multivariate analysis, the HCWs who
followed up TB patients in the last year were found to have
higher risk of TST conversion (OR;8, CI;1.2–55.6, P ¼ 0.035),
although all the HCWs declared that they had complied with the
protective measures. For every extra BCG vaccination detected on
physical examination, a ﬁve time increase in TST conversion rate
was detected (OR;5, CI;1.4–18.4, P ¼ 0.014). TST converted HCWs
were screened by their chest X-rays. In the chest X-ray of one
HCW, cavitation was detected. The computerised tomography
supported the diagnosis. Acid-fast bacteria in her sputum were
investigated three times, and the bacteria were detected in all the
samples. She was treated for 6 months.
Conclusions: Younger female HCWs, who are following up the
tuberculosis patients, are under risk of TB infection. A systematic
surveillance of HCWs is helpful in Turkey, although the preval-
ence of TST positivity is rather high.
Mycobacterial infection: epidemiology
P1496 Mycobacterium kansasii infection in Spain: results
from an epidemiologic national survey (2000–2003)
F. Alcaide, L. Calatayud, M. Santı´n, J. Dorca, G. Rufı´, R. Martı´n
and the Mycobacterium kansasii Spanish Working Group
(GEMKA)
Objective: Mycobacterium kansasii (MK) has been identiﬁed as an
agent of disease worldwide. However, its incidence varies signiﬁ-
cantly from area to area. Nowadays, there are no available data
on MK infection in Spain. The objectives of this study were (1) to
establish the frequency and geographical distribution of MK infec-
tion in Spain; (2) to study the relationship with several demogra-
phic characteristics; (3) to know the distribution of the different
subtypes of MK isolates in Spain.
Methods: A retrospective (3 years) and prospective (1 year) sur-
veillance (2000–2003) of all patients infected with MK in the 17
Autonomous Communities of Spain was carried out. Cases of MK
infection were identiﬁed from 92 microbiology laboratories of ref-
erence hospitals (GEMKA). Demographic, clinical and microbio-
logic data were recorded in a standardised questionnaire. Clinical
signiﬁcance of the isolates was ascertained according to the
American Thoracic Society’ criteria. Genetic characterisation to
subspecies level of each MK isolated (one per patient) was per-
formed by PCR-RFLP analysis of hsp65 gene.
Results: A total of 598 cases were identiﬁed during the study per-
iod from 15 Autonomous Communities: Euskadi (n ¼ 215), Cata-
lunya (n ¼ 192), Madrid (n ¼ 51), Arago´n (n ¼ 38), Valencia
(n ¼ 20), Asturias (n ¼ 19), Andalucı´a (n ¼ 16), Navarra (n ¼ 13),
Castilla-Leo´n (n ¼ 12), Canarias (n ¼ 7), Cantabria (n ¼ 5), Galicia
(n ¼ 4), Extremadura (n ¼ 3), Murcia (n ¼ 2), and Castilla-La
Mancha (n ¼ 1). The mean age was 53 years and 80.4% were male.
The HIV-infected patients (12.1%) were younger than non-infected
ones (87.9%) (mean age, 37 vs. 55 years, P < 0.001). Clinical MK
disease was detected in 75% and 72.1% of HIV-infected and non-
infected patients, respectively. Pulmonary involvement was
observed in 94.5% of cases. Seventy-four of 80 (92.5%) MK isolates
analysed from different geographical areas were subtype I.
Conclusions: MK is a pathogenic and frequent mycobacteria isola-
ted from several geographical regions of Spain, especially in den-
sely populated areas. Subtype I seems to be the most frequent
subtype isolated.
P1497 A case of disseminated tuberculosis presenting as
Crohn’s disease
O. Tabak, I. Yurdakul, A. Dobrucali, H. Uzunismail, S. Demirci,
C. Akman, S. Erdamar
Istanbul, TR
A 29-year-old man presented with abdominal pain, diarrhoea,
dysphonia, disphagia and weight loss. With these symptoms and
colonoscopic ﬁnding of inﬂammatory bowel disease he was
referred to our clinic as infected with Crohn’s disease. Further-
more, he was given medical treatment according to this diagnosis
consisting of corticosteroids. We planned to investigate tuberculo-
sis in this patient whose complaints increased despite the steroid
therapy. For the diagnosis, colonoscopy was performed at ﬁrst
and multiple ulcers were seen in the cecum, transverse colon and
ascending colon; ileocecal valve was inﬁltrated. Regarding diffuse
involvement of Crohn’s disease, upper GIS endoscopy was per-
formed in order to see the oral cavity, oesophagus, stomach and
duodenum. As a result, the oesophagus was found to be normal;
edema in the epiglottic area and pangastritis were observed. Colo-
nic biopsies indicated granulomas and were positive for acid-fast
bacilli. Acid-fast bacilli were also positive in the sputum. In addi-
tion to that, chest x-ray and thorax CT showed bilateral inﬁltrates
in both pulmonary apices. PCR test for Mycobacterium tuberculosis
was positive all for biopsy, sputum and stool. According to the
diagnosis of disseminated tuberculosis, anti-tuberculous therapy
(INH + Rifampin + Pyrazinamide + Streptomycine) was started
and a good response was observed at the end of two weeks. Later
on, the diagnosis was absolutely conﬁrmed by the cultures. Tuber-
culosis should be added in differential diagnosis in the patients
suspected of Crohn’s disease particularly before starting immuno-
suppressive therapy.
P1498 Mycobacterial contamination of a transfusion unit:
lessons for the routine screening of blood products
H. Sprecher, S. Davidson, G. Rabino, I. Kassis, R. Finkelstein,
I. Oren
Haifa, IL
Objectives: Current guidelines recommend screening of blood
units for a large number of pathogens at the exclusion of non-
treponemal bacterial and mycobacterial organisms, based on the
assumption that bacterial infection in healthy donors are unlikely
to be asymptomatic. In the present study, we describe the identiﬁ-
cation of M. mucogenicum contamination of a blood unit in an im-
munocompromised patient.
Methods: Samples from blood units were incubated in a BAC-
TEC9000. Upon detection of bacterial growth, positive samples
were inoculated into blood agar. DNA was extracted from bacter-
ial colonies. A 439-bp fragment encompassing the hsp-65 gene
was PCR-ampliﬁed and subsequently digested with BstEII and
HaeIII endonucleases. Bacterial DNA was also PCR-ampliﬁed
using a primer pair speciﬁc for conserved regions of 16S rRNA.
The nucleotide sequence of the resulting amplicons was estab-
lished and analysed using the BLAST software.
Results: A 76-year-old female patient with acute myelogenous
leukaemia, developed severe rigors following transfusion of a
blood unit. Cultures obtained from the blood unit grew Gram-
positive weakly acid fast rods that were identiﬁed, based on mor-
phological criteria, as Nocardia sp. However, PCR-RFLP analysis
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revealed a restriction pattern compatible with that of atypical my-
cobacteria. The identity of the contaminant was ultimately estab-
lished as M. Mucogenicum, based on BLAST analysis of the
bacterial 16S rRNA sequence.
Conclusions: Mycobacteria have the capacity to grow on regular
blood agar instead of traditional egg-based agar. This fact, which
was recently demonstrated experimentally (JCM 41:1710), may
lead to misidentiﬁcation of the growing pathogen. Accordingly,
the mycobacterium species isolated in the present study was ini-
tially categorised as Nocardia sp., and only recognised as M. muco-
genicum following molecular typing. The present case suggests the
need to assess the value of large-scale routine screening of blood
products for bacterial and mycobacterial contaminants, especially
before transfusion to immunocompromised patients.
P1499 Tuberculous meningitis in Northern Greece
F. Kamaria, S. Zisopoulou, A. Papalexandri, D. Kolokotroni,
A. Kansouzidou
Thessalonica, GR
Objective: The aim of this study is the presentation of tuberculous
meningitis cases of the adult department of the Thessaloniki Infec-
tious Diseases Hospital, where patients of all Northern Greece are
attended to.
Patients and Methods: The hospital archives were surveyed retro-
spectively and cases of meningitis, classiﬁed as tuberculous dur-
ing the years 1990–2003, were studied. Data was collected
regarding history, clinical, laboratory and radiological ﬁndings,
therapy and outcome.
Results: Fifty-eight cases were identiﬁed, 30 males and 28 females,
from 15 to 80 years old, mean age (x+/-SD) 52+/)6 years. Twenty-
four (41%) patients were admitted in stage I, 27 (47%) in stage II
and 7 (12%) in stage III. Symptoms had appeared for a median of
19 (2–120) days before admission. The diagnosis of 23 (40%)
patients was deﬁnite, because Mycobacterium tuberculosis was cul-
tured from CSF. The rest of the patients fulﬁlled some of the fol-
lowing criteria for the diagnosis of tuberculous meningitis: long
periods of symptoms before the admission, high CSF protein level,
low CSF glucose level, favourable response to antituberculous ther-
apy. The duration of hospitalisation was 30 (3–90) days. CSF ﬁnd-
ings at the admission were (x+/-SD): cells 216+/)291 mm3, protein
263+/-295 mg/dl, CSF glucose/blood glucose 0.29+/)0.07 mg/dl,
lactate 47+/)18 mg/dl. The mortality rate was 10.5% (6/58), while
19% (11/58) of the patients had permanent sequelae. CTs or MRIs
from 51 patients showed that: 17 patients had hydrocephalus, ﬁve
had meningeal enhancement, three had infarction, two TB spondy-
litis, one intradural tuberculoma of spinal cord and two brain tu-
berculomas, while 21 patients had normal images. Morbidity and
mortality rates were higher in patients >60 years old and in
patients admitted in stage II or III. Patients >60 years old were
admitted more frequently in late stage than younger ones.
Conclusion: Tuberculous meningitis still remains a very serious
disease with a high incidence of mortality and morbidity, especi-
ally among elder people and in late stage.
P1500 Isolation frequency of Mycobacterium sp. in
extrapulmonary clinical sources
S. Nikolaou, S. Kanavaki, A. Skroubellou, P. Papageorgiou,
S. Karambela, E. Varonou, A. Papavasileiou, F. Kontos,
V. Tamvakis
Athens, GR
Objective: We investigated the isolation frequency of Mycobacteri-
um sp. strains in extrapulmonary clinical sources, in the period
1998–2002.
Methods: From the total of 87 530 clinical specimens received in
the National Mycobacterium Reference Center of Athens for
the purpose of tuberculosis laboratory diagnosis, 12 362 (14%)
concerned extrapulmonary body sites. In particular, 6197 (50.1%)
were pleural ﬂuid, 2486 (20.1%) urine and 1655 (13.4%) blood
and bone marrow, while there were smaller numbers of ascetic
ﬂuid, cerebrospinal ﬂuid, pericardial and peritoneal ﬂuids, pus
and biopsies from lymph nodes, skin and tissues. All specimens
were processed by the NALC- NaOH method as recommended
by CDC, stained and cultured in parallel on Lo¨wenstein–Jensen
medium, on the automated Bactec MGIT 960 system or on the
radiometric Bactec 460TB system. All isolates were identiﬁed by
Accuprobe tests (Gene probe, Inc.) and by classical biochemical
criteria.
Results: Laboratory testing for mycobacterial infection was posit-
ive in 437/12362 (3.5%) extrapulmonary specimens. Speciﬁcally,
394/437 (90.2%) grew M. tuberculosis and 43/437 (9.8%) M. avium.
Regarding M. tuberculosis isolates, 152 were derived from pleural
ﬂuids, 70 from urine, 55 from lymph nodes, 42 from pus, 22 from
tissue biopsies, 14 from cerebrospinal ﬂuids, 14 from ascetic ﬂu-
ids, 8 from blood and bone marrows, 6 from upper respiratory
tract, 4 from bone biopsies, 2 from pericardial ﬂuids, 4 from gen-
ital tract, and one from a skin biopsy. Concerning M. avium iso-
lates, 16 were recovered from blood, 2 from bone marrows, 18
from lymph nodes, 4 from pleural ﬂuids, 2 from pus specimens
and one from a stool specimen.
Conclusions: The incidence of extrapulmonary tuberculosis was
detected to be 3.5%. M. tuberculosis was recovered from a vast
variety of clinical sources, while M. avium was recovered mainly
from blood and bone marrow specimens of HIV-infected patients
or from lymph nodes of young children.
P1501 Simultaneous occurrence of tuberculosis and
non-Hodgkin’s lymphoma within cervical lymph nodes
P. Fanourgiakis, I.I. Androulakis, A. Georgala, M. Vekemans,
G. Andry, E. Vaidakis, M. Aoun
Athens, GR; Brussels, B
Introduction: Tuberculosis of cervical lymph nodes is not unusual,
even in developed countries. This area is also a common site of
presentation of non-Hodgkin’s lymphoma. Nevertheless, concur-
rence of both diseases in the same lymph nodes is extremely rare.
Case report: A seventy-year-old woman of Italian origin was
admitted to our Institute due to unfavourable evolution of cervical
lymphadenopathy thought to be of tuberculous origin. No other
serious medical problems were referred. A familial history of pul-
monary tuberculosis was present. Six months before the admis-
sion bilateral cervical masses were ﬁrst developed and three
months later a biopsy of the left side revealed tissue pathology
compatible with TB. Acid-fast bacilli were visible with the Ziehl–
Neelsen stain. PCR was positive for M. tuberculosis complex. A
standard three-drug antituberculous regimen was initiated. Drug
susceptibility testing followed identiﬁcation and no resistance was
proved. There was no evidence of pulmonary disease. Haemato-
logical and biochemical proﬁle was normal. Despite strict adher-
ence to the treatment, node enlargement and appearance of new
masses occurred. As smears and cultures of ﬁne needle aspira-
tions turned negative and obstructive phenomena due to the com-
pression of the trachea ensued, complete excision of the involved
nodes was performed. The diagnosis of a diffuse large B-cell NHL
was established on the basis of morphologic and immunopheno-
typic features. Chemotherapy with CHOP was followed by mas-
sive relapse of the cervical masses and a few weeks later the
patient died.
Discussion: Although exceptional, we believe that the co-exist-
ence of NHL and TB is not random. Several studies propose
that TB could be a predisposing factor for NHL. There is also
enough evidence that NHL may cause TB reactivation. Increase
in interleukin-10 levels, produced by the neoplastic B-cells and
the inability of the CD4 T-cells of the malignant lymph node to
express their helper function may be the responsible mecha-
nisms.
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P1502 TB and HIV rates in Odessa, Ukraine: a dramatic
rise in the last decade
F. Drobniewski, V. Nikolayevskyy, Y. Bazhora, A. Asmolov,
Y. Balabanova, S. Servetsky
London, UK; Odessa, UKR
Infection with HIV has continued to escalate across countries of
the former Soviet Union including Ukraine. Less than 50 HIV
cases were diagnosed annually before 1994 but by June 2002,
47 988 cases had been ofﬁcially recorded with 11 388 cases (or
24% of the total) occurring in the previous 18 months. Unfortu-
nately, the rates of tuberculosis have also increased in parallel.
National rates of HIV, TB and HIV and TB co-infection underesti-
mate the real situation. Odessa and S. Ukraine reported higher
rates of HIV diseases than in the rest of the country.
Objective: To examine current and long-term trends of HIV, TB
and HIV with TB dual infection in Odessa region.
Materials and methods: Analysis of TB and HIV incidence data in
Odessa oblast from 1962 to 2002.
Results and discussion: In 1962, the incidence of TB in the Odessa
region was 178 cases per 100 000 cases, but this declined to 73.0,
42.0 and 41.6 cases per 100 000 in 1972, 1982 and 1992 respectively
rising to 80.4 in 2002. TB mortality in Odessa has nearly doubled
in the same time from 10.2/100 000 to 21.6/100 000. Overall, TB
incidence, TB prevalence, HIV incidence and HIV prevalence were
80.4, 330.1, 46.4 and 241.0 cases per 100 000 population respect-
ively in 2002. Of those TB cases ofﬁcially registered within the
Odessa TB dispensary system, in 2001, 281 persons or 7.5% of the
total were HIV positive. There are estimated to be 650 000 IVDU
in the Ukraine. The proportion of HIV infection acquired through
IVDU in the Ukraine has fallen (72.7% in 1997 to 54.2% in 2000),
and this may represent an increasing role for heterosexual trans-
mission. As part of an effective strategy to prevent the coalescing
of the two outbreaks there is a need for (1) more detailed epi-
demiology on both HIV and TB regionally as well as nationally,
including anonymous linked and unlinked HIV seroprevalence
studies in the general population and risk-groups and drug resist-
ance surveys in TB patients; (2) behaviour modiﬁcation campaigns
with appropriate education delivered by professionals and peer-
groups; (3) harm intervention strategies including condom provi-
sion, interruption of mother-to-child transmission and needle
exchange; (4) improved TB diagnosis and case management and
institute-effective mechanisms to limit TB transmission within
institutions such as hospitals and prisons, particularly to HIV-pos-
itive patients.
P1503 IS6110 RFLP analysis ofMycobacterium tuberculosis
strains in the Free State province, South Africa
A. van der Spoel van Dijk, M.N. Janse van Rensburg
Bloemfontein, ZA
Objectives: Genotypes of Mycobacterium tuberculosis (TB) strains
vary in geographical areas, e.g. the W-Beijing strain has been
reported as the cause of disease and outbreaks in Asia, across
Africa and in the United States. The Haarlem strain is well repor-
ted while the recently reported DRF150 strain has so far been
found only in South Africa. In South Africa epidemiological stud-
ies have been limited to the Western Cape and Mpumalanga
provinces. The aim of this study was to determine the tuberculo-
sis disease dynamics in semi-rural populations in the central Free
State province of South Africa.
Methods: IS6110-RFLP typing was done according to internation-
ally approved methods using TB strains isolated from smear pos-
itive patients attending nine clinics in three regions of the Free
State province over a period of three years.
Results: Fingerprinting was performed on 218 strains. Almost 63%
of the patients were men, 48% in the age group 20–39 and 43% in
the age group 40–59 years. Seventy two percent of males were
represented in clusters. Small clusters of 2–6 strains were found.
One cluster of six consisted of strains with only four bands and
two of these strains were subdivided using spoligotyping. All
clusters had strains from newly diagnosed and previously treated
TB patients. Contact could be established between members of
two clusters while another cluster contained strains from patients
from the same clinic suggesting interpersonal transmission. The
Recent Transmission Rate was calculated as 20.18%. No strains
similar to the W-Beijing family were found, a strain that is com-
mon in the Western Cape. One strain was found to belong to the
newly described Cape Town DRF150 resistant cluster.
Conclusions: It is evident that the molecular epidemiology of
tuberculosis in the Free State differs from that of the rest of the
country. Bigger family groups were evident at a 65% similarity
index and further studies could conﬁrm the opinion that transmis-
sion rates might be higher and should be calculated differently.
The fact that no W-Beijing strains were found could be due to
high unemployment and therefore low migration of patients
between study areas. The ﬁndings of this study indicate the need
for continuous resistance monitoring, molecular epidemiological
surveillance and active contact tracing as part of the Free State
Tuberculosis Control Program.
P1504 Infections due to non-pigmented rapidly growing
mycobacteria (NPRGM) in a university hospital
J. Esteban, F. Santos-O’Connor, J.I. Garcia-Cia, A. Ortiz, F. Soriano
Madrid, E
Objectives: To determine the frequency, clinical signiﬁcance, treat-
ment and outcome of the isolates of NPRGM in a university hos-
pital during the period 1979–2002.
Methods: Patients with isolates of NPRGM were selected for a ret-
rospective study from the records of the mycobacteriology labor-
atory between June 1979 and December 2002. Clinical charts were
reviewed according to a predeﬁned protocol, and clinical signiﬁ-
cance was evaluated according to accepted criteria.
Results: NPRGM were identiﬁed in 71 patients (5.4% of all
patients with mycobacterial isolates). Seven patients were from
other hospitals, and 64 patients were selected for the study. After
reviewing, in 19 cases the isolates were considered clinically signi-
ﬁcant, and two more cases were considered as doubtful. No res-
piratory isolate was considered signiﬁcant. Eleven isolates were
identiﬁed as Mycobacterium chelonae, two as M. fortuitum, two as
M. abscessus and two as M. peregrinum. Seven patients had skin
and soft tissue infections, three had disseminated infection, two
cases each of osteomyeltis, peritonitis in CAPD, and diabetic foot
infection, and one case each of urinary tract infection, arthritis,
diarrhoea, conjunctivitis and surgical site infection. Antimicrobials
were selected for therapy performed according to individualised
susceptibility tests. Surgery for removal of foreign bodies or
sequestra was performed when these bodies were present. All but
one patient were cured. One case was treated with antitubercu-
lous drugs despite the identiﬁcation and susceptibility study of
the isolate, and persisted for several months.
Conclusions: NPRGM can be the cause of clinical syndromes in
one third of the cases, mainly when the isolate is from a non-res-
piratory source in our media. Therapy with selected antibiotics
and surgery, when needed, lead to cure of all patients.
P1505 Osteoarticular infections due to mycobacteria in a
university hospital
J.I. Garcia-Cia, J. Esteban, A. Ortiz, F. Soriano
Madrid, E
Objectives: To study clinical and microbiological features of osteo-
articular infections due to mycobacteria diagnosed in our laborat-
ory over the last 20 years.
Methods: We carried out a retrospective study of clinical charts of
patients with isolates of mycobacteria from osteoarticular samples
between 1982 and 2003.
Results: Thirty-four cases (11 men, 23 women, mean age: 60.06,
range 5–88) of skeletal tuberculosis (33 M. tuberculosis, 1 M. bovis)
423Clinical Microbiology and Infection, Volume 10, Supplement 3, 2004
were found. Locations were vertebral in 13, knee in seven, hip in
ﬁve, wrist in ﬁve, elbow in three and six from other locations. In
ﬁve cases, the disease affected two or more joints. Previous pul-
monary tuberculosis and contact transmission were the most
important predisposing factors. No patient was immigrant, and
only two patients were HIV+. Pain was the main clinical presenta-
tion (25) followed by fever (11). In one case, a hip prosthesis was
present, and the strain was isolated also from it. The tuberculin
test reaction was positive in 20 patients out of 23. In 14 cases, the
acid-fast strain was positive at least in one sample. All strains
were susceptible to all ﬁrst-line drugs, except for M. bovis and
pyrazinamide. Three patients died because of diseases other than
tuberculosis. Nine patients (26.5 %) had residual abnormalities.
All patients were treated with antituberculous drugs, 21 of them
also required surgery. Four cases (all men) had isolates of rapidly
growing mycobacteria (RGM). In three cases (two M. chelonae, one
M. abscessus), the isolate was considered as signiﬁcant (one joint,
two from bone), representing an 8.1% of all osteoarticular infec-
tions due to mycobacteria. All three patients were cured with
proper chemotherapy and surgery.
Conclusions: Osteoarticular tuberculosis is still an important form
of extrapulmonary tuberculosis, but has different risk factors than
other forms of the disease. The outcome of tuberculous disease is
good in all cases, but residual abnormalities appeared in almost
one quarter of the patients. Osteoarticular mycobacteriosis in our
hospital have been caused by RGM. In these cases, proper chemo-
therapy and removal of foreign bodies or necrotic tissue was
necessary for a good evolution of the patients.
P1506 Mycobacterium malmoense lymphadenitis in Spain:
ﬁrst two cases in immunocompetent patients
A.I. Lo´pez-Calleja, M.A. Lezcano, S. Samper, F. De Juan,
M.J. Revillo
Zaragoza, E
Objectives: Mycobacterium malmoense is a slow-growing, non-phot-
ochromogenic mycobacterium that has been recognised as nontu-
berculous pathogen in northern and northwestern Europe.
Recently, it has been isolated from clinical samples in other areas.
It can cause pulmonary and extrapulmonary disease and also dis-
seminated infection. The objective is to present two cases of M.
malmoense lymphadenitis in two immunocompetent children in
Spain. These are the ﬁrst documented cases of extrapulmonary
infection by M. malmoense in our country.
Case report and methods: Two patients, an eight-year-old boy and a
two-year-old girl were referred for evaluation of an enlarged pain-
less superﬁcial lymph node on the cervical area. One ﬁne needle
aspiration biopsy was performed in both cases to establish the
diagnosis. Specimens were decontaminated and seeded onto
Lo¨wenstein–Jensen slants and into a liquid system, the BacT/
Alert(R) MP (BioMe´rieux, inc. Durham).
Results: Microscopic examination of specimens yielded few acid-
fast bacilli in both cases. Cultures in liquid medium showed
growth of mycobacteria after 72 days in the ﬁrst case, and 36 days
in the second. Primary cultures on Lo¨wenstein–Jensen remained
negative after 75 days. Cultures were conﬁrmed as slow-growing
mycobacteria, non-photochromogenic; M. malmoense was identi-
ﬁed by polymerase chain reaction and restriction enzyme pattern
analysis (PRA) and on analysis of the 16S-rRNA gene
Conclusions: Unilateral cervical lymphadenitis is the most fre-
quent extrapulmonary infection due to M. malmoense, and pre-
dominantly affects children. To ensure a sensitive primary
isolation of M. malmoense, it is crucial to carefully choose cul-
ture media and conditions. New clinical isolates from different
countries and the isolation from the environment question the
fact that M. malmoense is exclusively limited to speciﬁc zones.
Probably, M. malmoense is present in many geographic areas
and may colonise or cause infections in humans and animals.
We want to draw the attention of microbiologists and clinicians
to this emergent pathogen that should be added to the list of
nontuberculous mycobacteria responsible for disease in immu-
nocompetent patients.
P1507 Central nervous system tuberculosis:
epidemiological, clinical features and outcome in 133 patients
B. Kilani, L. Ammari, H. Tiouiri, F. Kanoun, C. Marrakchi,
A. Goubontini, F. Zouiten, T. Ben Chaabane
Tunis, TN
Objectives: To describe epidemiological, clinical features and out-
come in adults with central nervous system tuberculosis.
Patients and methods: We performed a retrospective study of all
cases of central nervous tuberculosis hospitalised in our depart-
ment during a 20-year period.
Results: A total of 133 patients (81 females and 52 males) were
included. The mean age was 37 years (ages ranged 17–88 years).
20 patients (15%) had a history of tuberculosis. The clinical symp-
toms and signs on the admission were fever in 83.5%, headache
in 85.7% and neck stiffness in 87.2%, compatible with tuberculous
meningitis; alteration in consciousness and focal neurologic signs
are present in 63 patients (47.4%). Paraplegia or hemiplegia was
present in 33 patients (24.8%) and extraneurologic tuberculosis
was associated in 51.8%. The spinal ﬂuid at admission was clear
in 63% of patients, and in most cases, the cell count results were
under 300 cells/mm3, with predominantly lymphocytes in 85% of
cases. Low level of glucose was seen in 101 patients (80%),
whereas elevated proteins up to 1 g/L was observed in 70% of
patients. In ﬁve cases without meningitis, the spinal ﬂuid was
normal. Mycobacterium tuberculosis was isolated in the cerebrospi-
nal ﬂuid of 31 patients (25%). Abnormal chest X-ray was found in
49.6% of the patients. Cranial CT scan and MRI showed hydro-
cephalus (36 cases), tuberculomas (30 cases), leptomeningitis (28
cases), infarction (16 cases) and abcesses (2 cases). In ﬁve cases,
tuberculomas or abcesses were associated to hydrocephalus with-
out meningitis. All the patients were treated with antituberculous
drugs and steroids. The overall mortality was 19.5%. Permanent
neurological sequelae were seen in 10 patients (7.5%).
Conclusions: Tuberculosis of the central nervous system continues
to be an important problem in developing countries including
Tunisia. The disease is still severe, and mortality and morbidity
remains high. Early diagnosis should be considered to improve
prognosis.
P1508 Information system of bacillary tuberculosis –
5 years transition
V. Prı´kazsky´, M. Havelkova´, V. Polanecky´
Prague, CZ
Background: Tuberculosis has a long surveillance history in the
Czech Republic. However, only in the past few years have we
experienced important changes in epidemiology of tuberculosis as
well as in implementation of improved notiﬁcation approaches.
Objectives: The aim of this work was to present new features in
the notiﬁcation of tuberculosis in the Czech republic and summa-
rise changes in epidemiology of tuberculosis evident in routine
surveillance.
Methods: Notiﬁcation of tuberculosis is done in two independent
systems, the Register of tuberculosis and the Information System
of Bacillary Tuberculosis. The ﬁrst one, the Register of tuberculo-
sis is based on obligatory reporting by physicians. The second
one, the ISBT is based on laboratory reporting and it collects pos-
itive laboratory ﬁndings that are notiﬁed on compulsory basis
also. The ISBT is controlled by the National Reference Laboratory
for mycobacteria of the NIPH. This system serves as a source of
microbiological information and validating device for the register
of tuberculosis in laboratory-proven tuberculosis cases. We stud-
ied data from the last ﬁve years (1997–2002).
Results: The average yearly burden of requested investigations is
about 200 000 and they are positive in approximately 3.5%. The
majority of these requests is for therapy checking and contact
investigations. Since 1998 we have observed a steady decrease in
TB prevalence (from 10.3 to 8/100 000). The age structure of
patients remained almost unchanged with an increase in men in
late productive age (40–54). It is ﬁve times higher than that of
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women in the same group. The trend of open tuberculosis preval-
ence is decreasing slower than the total ﬁgure. There are substan-
tial geographical differences (from >12/100 000 in Prague and
west Bohemia to <6/100 000 in some eastern regions). Prevalence
of cases with MDR tuberculosis is ﬂuctuating around 3% and do
not show any trend yet. New cases of tuberculosis are diagnosed
among legal migrants and immigrants and there is an increasing
tendency. They are mainly young people and some of them are
infected with MDR strain.
Conclusions: Surveillance of tuberculosis is gaining importance in
the changing pattern of cases with increasing importance of for-
eign-born persons and threat of MDR TB being partly imported
from abroad. In the Czech Republic, the low incidence country
technical means have increasing importance in improving surveil-
lance methods.
P1509 Evaluation of PPD conversions in prisoners in
Bandarabbas, Iran
P. Davoodian, J. Zerang, M. Darvishkhah
Bandarabbas, IR
Objectives: Prisoners are in the high-risk groups for TB infection
and disease. Prevalence of TB in prison is higher than in the com-
munity (more than 100 times). PPD conversion in prisoners in
Bandarabbas is studied in this research.
Methods: We carried out this descriptive research in the Bandarab-
bas prison for six months. We selected prisoners with over one
year conviction from quarantine. In the ﬁrst step, we did PPD test
on 400 prisoners out of which were selected 120 prisoners that
had PPD test less than 5 mm. After 6 months we repeated the
PPD test in 87 prisoners who had negative PPD test. We could
not carry out PPD tests in 33 prisoners for various reasons.
Results: We observed 53 cases (60.9%) that had PPD conversion
with over 10-mm duration. So 34 cases (39.1%) that remained had
negative PPD. The minimum age of the prisoners was 18 and the
maximum was 74 years. The minimum of PPD conversion was
2 mm and the maximum was 36 mm. The maximum PPD conver-
sion was observed in Iv drug abusers among the 25–34 age group.
Conclusions: The high prevalence of PPD conversion in this
research indicates that there is a high contamination rate of TB in
prison. So for prevention of TB we propose to start INH prophyl-
axy in those prisoners that have over 6 months conviction and
have had PPD conversion.
P1510 Clinical manifestation of leprosy in a pregnant
woman
B. Boeddinghaus, C. Brandt, R. Enzensberger, V. Gies, R. Ludwig,
S. Kramme, V. Brade
Frankfurt, Hamburg, D
Objectives: More than ﬁve million people are infected with Myco-
bacterium leprae globally. Due to high socioeconomic standards,
however, leprosy has become rare in the Western world. The
objective is to describe the clinical manifestation of leprosy during
pregnancy in a 29-year-old, otherwise healthy, southeast-Asian
woman that presented with a rash, itching and arthralgia to the
University hospital in Frankfurt/Main, Germany. Initially, the
patient received prednisone for reactive arthritis, but was subse-
quently treated with dapsone, rifampin and clofazimine.
Methods: The clinical isolate was detected in a skin biopsy by
stains for acid-fast bacilli and was ampliﬁed by PCR for Mycobac-
teria spp. Genetic identiﬁcation was achieved by speciﬁc PCR for
M. tuberculosis complex and M. leprae. The specimen was inocula-
ted on liquid and solid mycobacterial culture media.
Results: Microscopy of skin smears revealed a multibacillary dis-
ease variant with microorganisms being arranged like cigars.
PCR for Mycobacteria spp. revealed a weak signal that could only
be further identiﬁed by a positive result in a PCR speciﬁc for
M. leprae. PCR reaction speciﬁc for M. tuberculosis complex
remained negative. The isolate was noncultivatable after 8 weeks
of incubation.
Conclusions: In the present case, the pregnancy-induced immuno-
suppression has led to the manifestation of a previously subclinical
M. leprae infection. Stains for acid-fast bacilli should be performed
in patients with skin lesions and a travel history to tropical coun-
tries. The laboratory diagnosis can be largely made through the
application of molecular techniques to infected tissues.
P1511 Tuberculous spondylitis in Cukurova, Turkey
Y. Tasova, T. Sarpel, S. Inal, N. Saltoglu, B. Kurtaran, A. Sanli
Adana, TR
Objective: To evaluate features of tuberculous(tb) spondylitis cases
in the Cukurova region of Turkey.
Methods: Twenty patients (pts) with tb spondylitis followed
between January 1998 and August 2003 were evaluated. Tuberculin
and brucella agglution tests were made. Diagnosis of spondylitis
was made on the following criteria: (a) isolation of Mycobacterium
tuberculosis showed asido-resistant basil with Ehrlich–Ziehl–Neel-
sen from specimens obtained from the site of spinal involvement
and sputum; (b) clinical evidence of the disease; (c) histopathologi-
cal examination; (d) radiological ﬁndings by plain radiography and
computerised tomography or magnetic resonance imaging (MRI).
All patients were followed up for at least 6 months.
Results: Of the 20 patients 9 were male. Mean age was 42. Mean
time between the onset of the symptoms and the time of diagnosis
was 30 months (min. 2 months–max. 9 years). Tuberculosis was
disseminated in eight patients. Frequent constitutional complaints
were; back pain (n: 19), weight loss (n: 8), paresis (n: 7), night sweat-
ing (n: 5). Physical ﬁndings were determined as follows: tenderness
at the vertebrae region (n: 11), fever (n: 6) and tenderness of the
sacriliac joint (n: 5).Tuberculin test were positive in ﬁve patients.
Elevated erythrocyte sedimentation rates (>20 mm/hr) in 14
patients and increased CRP levels (>10 mg/L) in 11 patients were
detected. Chest graphy in six patients was abnormal. In only ﬁve
patients was involvement limited to one vertebra. Thoracolumbar
vertebraes were the most affected (n: 9) followed by lumbar spine
(n: 5) and thoracal spine (n: 4). M. tuberculosis was isolated from the
site of infection in seven patients. Two of the strains were resistant
to y´soniasid. All of the histopathological examinations revealed
caseation of granulomatous necrosis. The most frequent MRI ﬁnd-
ings were compression (n: 7), psoas abscess (n: 7), paravertebral tis-
sue inﬂammation (n: 4), epidural abscess (n: 2). All the patients
were given four drugs for antituberculosis treatment for at least
nine months. One of the patients died because of sepsis under the
therapy. At the end of the therapy 10 patients remained with se-
quelaes. While seven of them were mild to moderate, three of them
were severe. During the follow-up period there wasn’t any relapse.
Conclusions: Half the patients remained with sequelaes and 40%
of the patients had disseminated disease. For early diagnosis and
to prevent complications tuberculous spondylitis should be con-
sidered in patients with back pain, in our region.
P1512 Evaluation of mono- and multiresistance to primer
antituberculous agents of Mycobacterium tuberculosis strains
recovered from Greek and immigrant patients with newly
diagnosed pulmonary tuberculosis
S. Nikolaou, S. Kanavaki, P. Papageorgiou, A. Skroubellou,
S. Karambela, F. Kontos, E. Varonou, V. Sgoutzos, V. Tamvakis
Athens, GR
Objective: We evaluated the Isoniazid (INH) and Rifampicin (RIF)
monoresistance (resistance to only one of these drugs), as well as
the multidrug resistance (resistance to INH and RIF) of Mycobac-
terium tuberculosis strains recovered from Greek and immigrant
patients with newly diagnosed pulmonary TB, at the National
Mycobacterium Reference Center of Athens, during the 10-year
period from 1993–2002.
425Clinical Microbiology and Infection, Volume 10, Supplement 3, 2004
Methods: Clinical M. tuberculosis strains were obtained from 3368
Greek patients and 730 immigrant patients with newly diagnosed
pulmonary TB. Among the immigrants, 189 were repatriated
Greeks from Eastern European countries and 551 were foreigners
from other countries. All M. tuberculosis strains were identiﬁed by
Accuprobe tests (Gene probe, Inc.) and by classical biochemical
criteria. The susceptibility testing of strains was performed by the
method of proportion on Lo¨wenstein–Jensen medium, or by using
the radiometric Bactec 460TB system or the automated Bactec
MGIT 960 system (Bactec SIRE; Becton Dickinson).
Results: For INH, the monoresistance rate was 4.5% for Greeks,
6.5% for foreigners and 17.9% for the repatriated Greek patients.
For RIF, the monoresistance rate was 0.4%, for Greeks, 0.5% for
foreigners and 0.5%, for the repatriated Greek patients. Multidrug
resistance rate was 2.5% for Greeks, 5.4% for foreigners and 10%
for the repatriated Greek patients. The comparison of the monore-
sistance rates, at the beginning (1993) to the end (2002) of the
study period, showed a twofold increase for INH in both Greek
and repatriated Greek patients, while in the foreigners it showed
a slight decrease. For the multidrug resistance rates, there was an
eightfold increase in Greek patients, a twelvefold increase in
repatriated Greeks and a twofold increase in foreigners.
Conclusions: During the last 10-year period, in all the three groups
of patients studied, a quite low incidence of RIF mono resistance
(<1%) was detected, in contrast to the high incidence of INH
monoresistance and multidrug resistance. This particular data
should be an alert in using reliable and time-consuming methods
of evaluating the susceptibility rates of antituberculous agents.
Nosocomial infections: II
P1513 A European consensus on infection control
professionals’ training
B. Cookson on behalf of the HELICS Education Group10
Objectives: To prepare and disseminate an inventory of European
training in nosocomial infection control and establish a European
core standard curriculum validated by a DG SANCO funded HE-
LICS (Hospital Infection Linked to Infection Control through Sur-
veillance) education working party comprising people in charge
of training programmes.
Methods: Eighteen experts were nominated by their country repre-
sentatives for the HELICS Advisory Board. Questionnaires were
designed and piloted in two or three volunteer countries and then
sent to the rest of the group with indicated deadlines. Email was
used to exchange questionnaires, data and views. Lichart qualitat-
ive scorings were used throughout the project. ExcelTM was used
for data entry in some instances or to analyse responses. Infection
control nursing (ICN) and doctor/epidemiologist (ICD) training
requirements and courses were explored. Four syllabus templates
were used to develop audit tools to assess the content of current
courses in a ‘proof of principle’.
Results: The group was happy to use an UK syllabus developed
by a multidisciplinary group as a basis for the core curriculum
questionnaire design. The various requirements for ICNs and
ICDs and the current courses run in each country were agreed
and an inventory established. Countries had very different train-
ing schemes, accreditation requirements and amounts of time
available or expected for lectures and distance, or ‘own-time’,
learning. Accreditation for infection control nurses and or doctors
was implemented in many countries or was being considered in
the rest. Most (nine) were in favour of problem-solving tests and
written examinations and 11 liked projects. However, other meth-
ods were less popular. The templates and audit tools were well
received. A core competency initiative was to be considered in the
future and could help rationalise courses. The major stumbling
block we had was identifying the sources of funding for possible
international activities where ‘fellows’ could travel to other cen-
tres for training and reﬂection.
Conclusions: Considerable progress has been made in agreeing the
syllabus and content of Infection Control courses. There is a real
will to progress in EU qualiﬁcation but central funding for this
has not been identiﬁed thus far.
P1514 The Academy for Infection Management: AIMing
to improve outcomes in nosocomial infections
J. Rello, M.H. Kollef, A. Shorr
Tarragona, E; St Louis, Washington, USA
Objectives: The early use of appropriate empiric antibiotics in
nosocomial infections reduces mortality, morbidity and length of
hospital stay, with obvious beneﬁts to patients, physicians and
payors. The intention of the Academy for Infection Management
(AIM) is to communicate this new treatment paradigm to health-
care professionals worldwide.
Methods: A faculty of multidisciplinary experts in infection man-
agement has deﬁned a set of core principles and devised educa-
tional materials, which were introduced to a multidisciplinary
audience of almost 3000 delegates at three international and 12
national AIM educational meetings during 2003 and 2004. The
educational materials are available via a dedicated, free-access
website, http://www.infectionacademy.org.
Results: The AIM website provides education for those involved
in the management of serious nosocomial infections. More than
3000 healthcare professionals are registered users of the website.
Materials can be downloaded and edited for use at national,
regional or institutional meetings, or for self-guided learning.
Patient case studies, in the form of slide presentations and inter-
active key question workmats, are a major feature of the website.
Almost 80% of attendees at the ﬁrst two meetings (n ¼ 101)
thought the educational standard of materials was very good/
excellent. Summaries of key publications supporting the AIM
principles are also available. Topics include clinical management,
antibiotic resistance, pharmacokinetic/pharmacodynamic princi-
ples and pharmacoeconomic considerations for infection manage-
ment. The website also provides a forum to ask members of the
faculty speciﬁc questions on the management of nosocomial infec-
tions.
Conclusions: The AIM website provides a continuous educational
resource for healthcare professionals with access to the latest
materials supporting the concept of using appropriate antibiotics
early in nosocomial infections.
P1515 Diversity of infection control policies and practices
in European hospitals: report from the ARPAC project
D. Wagner, M. Struelens, B. Cookson, A. Voss, F. MacKenzie,
J. Bruce, I.M. Gould and the ARPAC Steering Committee11
Objective: To assess the organisation and human resources alloca-
ted in 2001 to Infection Control Programmes (ICP) in European
hospitals.
Methods: Questionnaire surveys on policies and practices for sur-
veillance and control of nosocomial infection and antibiotic
resistance in 2001 in 167 acute care hospitals in 34 European
countries.
Results: In 96 hospitals (90%), an infection control (IC) commit-
tee was present, including mainly: microbiologists (87%), clini-
cians (80.2%), infection control nurses (ICN) (74%), infection
control doctors (ICD) (64%), pharmacists (62%), chief executives
(58%). One or more ICNs with speciﬁc training in infection
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control were present in 79% centres whereas only 38% had
one or more specially trained ICDs. A link nurse system was
present hospital-wide in 29% or in high-risk units in 16% cen-
tres. An ICP with annual objectives/progress reports was devel-
oped in 72% and was reviewed by senior management 70%.
Hand hygiene (HH) for health workers (HCWs) was promoted
by education in 84% centres and by written guidelines in 88%.
These had been updated 4—5 yrs in 40% centres. The guide-
lines recommended: wearing gloves for all contacts with body
ﬂuids (93%); washing/disinfecting hands after removing gloves
(90%) and use of alcohol-based solutions (70%) and/or medic-
ated/antiseptic soap (42%) for decontamination of non-soiled
hands. Education sessions for HCWs in IC practices was repor-
ted by 77% hospitals and mainly targeted qualiﬁed nurses
(71%), junior medical staff (51%) and cleaning staff (51%).
Observation/feedback on HH practices was performed by 46%
centres but only 1% audited any of their IC protocols. The IC
Team provided regular reports to the IC Committee in 66%
centres. Epidemiological reports on the prevalence of patients
infected with multi-resistant ‘alert’ organisms were published
by 38% of participants.
Conclusions: These results indicate a wide variation in ICP
amongst European hospitals. The promotion of HH techniques is
well developed but audit of other IC policies and feedback of sur-
veillance data is limited. There is a need to deﬁne the minimum
core element of effective ICPs and to strengthen resources to har-
monise their implementation.
P1516 Infection control policies for multiresistant ‘alert’
organisms in European hospitals: report from the ARPAC
project
D. Wagner, M. Struelens, J. Bruce, F. MacKenzie, I.M. Gould,
B. Cookson, P. Broek van den, A. Voss
Brussels, B; Aberdeen, London, UK; Leiden, Nijmegen, NL
Objective: To assess the speciﬁc measures implemented to control
transmissible antibiotic resistant bacteria or ‘Alert Organisms’ in
European hospitals in 2001.
Methods: Questionnaire surveys on policies and practices for sur-
veillance and control of Alert Organisms (AO) in 2001 in 167
acute care hospitals in 34 European countries.
Results: In 87% of hospitals, the laboratory provided AO detec-
tion reports to the infection control team, for the following
organisms: methicillin resistant S. aureus (MRSA: 89%), glyco-
peptide resistant Enterococci (GRE: 60%), third generation ce-
phalosporins resistant K. pneumoniae (C3RKP: 60%), carbapenem
resistant A. baumannii (CRAB: 48%), C. difﬁcile (CDIFF: 42%),
gentamicin resistant P. aeruginosa (37%). For MRSA, active
screening of carrier was performed in patients in 55% of hospi-
tals and in health care workers (HCW) in 46%. Screening for
other AO was performed by 6% to 17% of hospitals depending
on the organism. Contact precautions were used for the care of
MRSA patients in the majority of centres (gloves: 65%; gown:
56%). These precautions were used for other AO by fewer cen-
tres: GRE (gloves: 44%; gown: 40%), C3RKP (gloves: 45%;
gown: 36%), CRAB (gloves: 41%; gown: 32%) and CDIFF
(gloves: 48%; gown: 41%). In addition, placement of colonised
patient in single rooms varied by organism, from 59% (MRSA)
to 29% (CRAB). For MRSA patients some centres completed
these measures with use of mask (40%), mupirocin decolonisa-
tion of patients (77%) and cohorting care (40%).
Conclusions: A majority of European hospitals participating to the
ARPAC survey have implemented laboratory-based surveillance
of antimicrobial resistant AO. Local AO control policies include a
variety of special barrier precautions for the care of colonised
patients. MRSA is the most frequently targeted AO. The determi-
nants of this broad diversity of control programmes require fur-
ther study.
P1517 Inﬂuence of prophylactic antibiotic regimen on
resistance rates of Staphylococcus epidermidis in orthopaedic
surgery
B. Tiodorovic, M. Mitkovic
Nis, CS
Objective: Prospective analysis of the impact of prophylactic anti-
biotic regimen on resistance rates of Staphylococcus epidermidis in
total hip and knee replacement.
Methods: Oxacillin (two doses of 2 g) was used for prophylaxis
between 2000 and 2003. In 2002, the regimen was changed to a
ﬁrst generation cephalosporin and adapted to current resistance
status on a yearly basis. Starting in October 2002, an intraopera-
tive bacteriological sample was taken routinely in all total hip and
knee replacements. Between October 2000 and October 2003, sam-
ples were obtained from 178 endoprosthesis and a bacterium
could be grown in 18 (10.11%); 14(7.68%) with bacterial growth
had no evidence of infection on clinical grounds and were classi-
ﬁed as aseptic whereas the remaining seven (3.9%) procedures
(early and late infection as well as referred cases) showed also
clinical signs of infections and were classiﬁed as septic.
Results: In the area of prophylaxis with oxacillin septic cases
showed a methicillin resistance of S. epidermidis (MRSE) in
48.7% and aseptic cases in 27%. After the switch to a ﬁrst gen-
eration cephalosporin and yearly adaptation of the drug regi-
men according to the resistance status the MRSE rate gradually
declined from 15.3% in 2001 to 3.1% in 2002 for aseptic cases
and 54.7% in 2001 to 9.3% in 2002 for septic cases. This
decline in resistance towards methicillin of Staphylococcus epider-
midis was paralleled by a decline of infection rate from 1.8% in
2001 to 0.3 in 2002.
Conclusions: Prophylactic use of a ﬁrst generation cephalosporin
with yearly adaptation according to the resistance status proved
beneﬁcial both in reducing the methicillin resistance of S. epider-
midis (27%–3.1%) and the overall infection rate (1.8%–0.3%) in
endoprosthetic surgery.
P1518 New views on large bowel surgery
chemoprophylaxis. Compared administration of one dose of
ticarcilline/clavoulanic acid against two
P. Ntasiou, K. Kanellakopoulou, S. Pinis, N. Galanakis,
A. Dervisoglou, P. Giannakakis, H. Giamarellou
Pireus, Athens, GR
Objectives: According to recent studies, data concerning chemo-
prophylaxis in colorectal surgery have changed. In this prospect-
ive study, we present our experience from issuing one against
two doses of Ticarcilline/Clavoulanic acid as chemoprophylaxis
in colectomies. The necessity of administering postoperative
chemoprophylactic agents is analysed as far as it concerns avoid-
ance of surgical site infection.
Methods: From December 2002 to December 2003, 32 patients (19
men and 13 women with the mean age of 69.12 and 64.36 years
respectively) underwent colectomy due to malignant (26 patients)
or benign disease (six patients). Nineteen were deemed high-risk
patients due to coexisting diseases (cardiac disease, diabetes melli-
tus, respiratory disease, renal insufﬁciency, hepatic insufﬁciency,
obesity, cortisone therapy). All patients were divided into two
groups at random. In group A, one dose of Ticarcilline/Clavoul-
anic acid was administered intra-operatively, while in group B,
two doses of the same antibiotic were administered (the ﬁrst one
intra-operatively and the second postoperatively). Thereafter, all
patients were under clinical and laboratory monitoring for surgi-
cal site infection.
Results: Surgical site infection was developed in six out of 32
patients under study. Four patients (two from each group) suf-
fered from wound suppuration, while two had intra-abdominal
abscess formation (equally presented in each group). Culture iso-
lates were Escherichia coli in ﬁve patients and Enterococci in four.
Treatment consisted of wound drainage and systemic antibacterial
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agents in cases of wound suppuration while in cases of intra-
abdominal infection, administration of two antimicrobials or Imi-
penem was performed. All patients were cured. The mean hospi-
talisation was 15.7 days.
Conclusions: Reviewing our material, it appears that beneﬁts ari-
sing from administering additional postoperative antimicrobial
prophylaxis in colorectal surgery were statistically insigniﬁcant.
Nevertheless the number of patients under study is still small, so
it would be unsafe to extract a conclusion.
P1519 New aspects concerning chemoprophylaxis in
elective cholecystectomy
A. Dervisoglou, K. Kanellakopoulou, S. Pinis, N. Galanakis,
S. Pierakakis, P. Giannakakis, P. Dasiou, C. Iordanou,
S. Liveranou, H. Giamarellou
Pireus, Athens, GR
Objectives: Intra-abdominal abscess can result from elective chole-
cystectomy due to spilled stones or bile, infested with bacteria.
Cefuroxime has been considered as the most appropriate agent to
be given for chemoprophylaxis in elective cholecystectomies. Nev-
ertheless, Enterococci infest bile and are sensitive to Ampicillin/
Sulbactam rather than Cefuroxime. Even though Enterococci are
lethal if implicated in intra-abdominal sepsis, the need for anti-
enterococcal prophylaxis has not been studied yet.
Methods: During the period extending from July 2002 to December
2003, 188 patients (71 male and 117 female, mean aged 60.86 and
56.85 years respectively) underwent elective cholecystectomy.
Eighty-nine (47.34%) were deemed high-risk patients. Cultures
from gall-bladder bile and mucosa were taken from all patients.
Cefuroxime 1.5 g, or Ampicillin/Sulbactam 3 g were administered
intra-operatively at random. The patients were under clinical and
laboratory monitoring for postoperative infection of the surgical
site.
Results: Forty-two (22.34%) patients revealed positive cultures.
More speciﬁcally the cultures’ results were the following: Entero-
cocci isolated in 21 patients, Escherichia coli in 12, Klebsiella in four,
Staphylococcus epidermidis in three, Citrobacter in three Enterobacter
cloacae in three, Streptococci in two, Citrobacter freundi in two, Bac-
teroides fragilis in two, Pseudomonas in one, Enterobacter aerogenus in
one and Acinetobacter in one. Among the patients that revealed
negative cultures, two suffered from sterile collection of the
wound and one presented on the 7th postoperative day with
wound suppuration and CNS isolation in pus culture. From the
patients that had a microbe isolated in the gall bladder and bile
cultures, one developed wound infection with E. coli and Klebsiella
(that patient revealed the same bacteria in bile and mucosal cul-
tures), one suffered from postoperative suppuration of the wound
and CNS isolation in the pus, while two patients were hospital-
ised in ICU due to respiratory insufﬁciency. Mortality rate was
nil. The mean hospitalisation and the mean postoperative hospi-
talisation were 7.43 and 4.57 days respectively.
Conclusions: Chemoprophylaxis had the same results in both
groups. Nevertheless anti-enterococcal prophylaxis should be con-
sidered as far as Enterococcus is isolated in a great number of
patients with positive cultures.
P1520 Ceftriaxone vs. other antibiotics for surgical
prophylaxis
S. Esposito, S. Noviello, A. Vanasia, P. Venturino
Naples, I
Objectives: To investigate possible differences in prophylaxis with
ceftriaxone compared with other antimicrobial agents for surgi-
cal–site infections (SSI) and remote infections such as respiratory
(RTI) and urinary tract infections (UTI).
Methods: The efﬁcacy of ceftriaxone (CRO) was compared with
that of other antibiotics in the perioperative prophylaxis of local
(SSIs) and remote (RTIs and UTIs) infections in a meta-analysis of
randomised controlled trials published between 1984 and 2003.
The analysis was based on a 2  2 contingency table with classiﬁ-
cation by treatment and number of infections obtained from indi-
vidual studies. The global estimate of the effective treatment was
obtained with the weighted mean of the log OR (Odd Ratio)
according to Mantel–Haenszel and associated conﬁdence intervals
(CI) at 95%. All the calculations have been performed using SAS
vs.8. Chi-square test was performed.
Results: Evaluations were performed on 48 studies, for a total of
17 565 patients. Four hundred and six patients (4.8%) in the CRO
group and 525 (6.3%) in the comparator group developed a SSI,
log Odd Ratio 0.30 (CI 0.50 to 0.13) P < 0.0001. RTIs were
observed in 292 (6.01%) patients in the CRO group and in 369
patients in the comparator group (7.6%), log Odd Ratio 0.30 (CI
0.55 to 0.09), P ¼ 0.0013. UTIs were reported for 2.2% of CRO
prophylaxed patients compared with 3.74% of patients prophy-
laxed with other drugs [log Odd Ratio 0.54 (CI 1.18 to 0.16),
P < 0.0001]. Overall, in clean surgery 195 (5.1%) and 234 (6.2%)
patients developed an SSI in the CRO and comparator group,
respectively [log Odd Ratio 0.22 (CI 0.51 to 0.01), P ¼ 0.0476].
RTIs were prevented for all but 1.57% of patients (CRO group)
and 2.62% (comparators group), P ¼ 0.01 in clean surgery and for
9.54% (CRO group) vs. 11.6% (comparators group), P ¼ 0.01.
While results observed in clean surgery did not evidence a statisti-
cally signiﬁcant superiority of CRO in preventing UTI’s insurgence
[Log OR 0.21 (CI. /0.65), P ¼ 0.7702), this was shown in the
clean–contaminated surgery. In fact, 4.47% of patients in the CRO
group vs. 7.52% of patients in the comparator group developed an
UTI [log OR 0.56 (CI 1.25 to 0.16), P < 0.0001]. Adverse
events were observed in a similar proportion in the CRO prophy-
laxis and the comparator group (0.35% and 0.23%). Duration of
prophylaxis did not inﬂuence the outcome of infections.
Conclusions: The meta-analysis showed that CRO is statistically
superior to other antibiotics in preventing both local and remote
post-operative infections.
P1521 Monitoring of antibacterial prophylaxis in general
surgery: results from a multicentre Italian incidence study
M. Fiorio, F. Vigano, A. Marvaso, M. Larosa – The KIR-NOS
Study Group12
Objective: the CDC recommendations represent the standard for
antimicrobial prophylaxis of clean/clean contaminated surgery in
which ﬁrst or second generation cephalosporins are indicated.
The aim of this study was to monitor antimicrobial prophylaxis in
Italian general surgery wards where penicillin was routinely used.
Methods: This study was carried out from the 1st of April to the
31st of May ‘02 in 32 general surgeries performed in large hospi-
tals all round Italy. All operated patients were surveyed by the
surgeon during and after hospital stay up to 30 days from opera-
tion for nosocomial infection (NI) diagnosis; patterns of antimicro-
bial prophylaxis (timing, duration and type) were collected in an
electronic case report form.
Results: Surgical procedures, 3066 in number, were performed,
75.4% of them with NNIS risk index 0–1 and 86.8% clean (with
prosthesis: 42.7%) or clean/contaminated. More than 50% of the
operations were represented by colcestectomia (20.0%), herni-
orrhaphy (17.1%), colon surgery (12.0%) and appendectomy
(10.5%). Among operated patients with clean and elective clean/
contaminated or contaminated surgery 86.4% received antimicro-
bial prophylaxis; 59.0% for clean interventions. Amoxocillin/cla-
vulanate (28.3%), followed by ceftizoxima (11.4%) and
ampicillin/sulbactam (9.6%) were the most prescribed antibiotics.
Only one antibiotic was used in 88.8% of patient with prophy-
laxis. Treatment was given on the same day of surgery to 89.6%
of treated patients, in 47.1% and 43.5% of cases before and at
induction of intervention respectively. Patients treated with ce-
phalosporins were at higher risk for developing NI [RR: 1.6; 95%
CI: 1.05–2.44] with respect to patient treated with penicillin: the
two groups were comparable for age, sex and NNIS risk index;
however, a majority of herniorrhaphy and mastectomy were
represented in the penicillin groups with respect to cefalosporin.
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A separated analysis in herniorrhaphy patients conﬁrmed an in-
cremented RR of 3.18 in patients treated with cephalosporin.
Conclusion: A high use of antibiotics was observed in clean sur-
gery, particularly a high use of penicillin/protected was docu-
mented in all class of surgery. Rationale for antibiotic treatment in
clean non-prosthetic surgery is controversial.
P1522 Prognosis of unknown origin bacteraemias in
critically ill patients
S. Sancho, R. Zaragoza, A. Artero, J.J. Camarena, R. Gonza´lez,
J. Alberola, J.M. Nogueira
Valencia, E
Objective: To determine whether unknown origin bacteraemia
(UOB) is an independent risk factor of mortality in critically ill
patients with bloodstream infections.
Material and methods: All clinically signiﬁcant bacteraemias in a
12-bed intensive care unit of a teaching hospital, from 1996 to
2003, were evaluated for clinical and microbiological characteris-
tics. We assessed risk factors for hospital mortality by multivariate
logistic regression with the SPSS package (9.0).
Results: Eighty-ﬁve (36%) of 235 episodes of bacteraemia in critic-
ally ill patients were of unknown origin. Eighty-six percent of epi-
sodes of UOB were hospital acquired. The mean age of patients
with UOB was 64.4  14.4 years. Factors associated with UOB
were: nosocomial origin (P ¼ 0.034) and non-severe sepsis
(P < 0.001). The aetiology of UOB was CNS (32%), Acinetobacter
baumannii (12%), Staphylococcus aureus (12%), Enterococcus spp.
(11%), Pseudomonas aeruginosa (6%), Escherichia coli (5%) and oth-
ers (22%). The prevalence of CNS was higher in episodes of UOB
(P < 0.001), and the prevalence of A. baumannii and E. coli was
lower in UOB than in known origin bacteraemias (P ¼ 0.007 and
P ¼ 0.001). Global and related death rates were 51% and 21% in
UOB, and 54% and 21% in episodes of known origin, respectively
(P ¼ 0.616 and P ¼ 0.208). The factors associated with global mor-
tality in all episodes of bacteraemia were severe sepsis, septic
shock and nosocomial origin. Septic shock was associated with
related mortality, but not with UOB.
Conclusions: Contrary to previous reports, an unknown source of
bacteraemia was not independently associated with a fatal out-
come in critically ill patients.
P1523 Attributable mortality of nosocomial candidemia
caused by Candida albicans and Candida non-albicans species in
critically ill patients
S. Blot, J. De Waele, K. Vandewoude, D. De Bacquer, E. Hoste,
J. De Schuijmer, J. Decruyenaere, F. Colardyn
Ghent, B
Background: We previously reported a nonsigniﬁcant attributable
mortality rate in nosocomial candidemia in intensive care unit
(ICU) patients [1,2]. It remains uncertain whether candidemia
involving Candida non-albicans spp are associated with worse out-
come in comparison with Candida albicans candidemia in this par-
ticular patient population.
Methods: In a retrospective study (1992–2000) attributable mortal-
ity for C. albicans and C. non-albicans candidemia was investigated
and compared in ICU patients. Two independent matched cohort
studies were performed. Matching was (1:2-ratio) based on sever-
ity of underlying disease and acute illness (APACHE II score and
admission diagnosis) and length of ICU stay prior to the onset of
the candidemia. As expected, mortality can be derived from APA-
CHE II. This matching procedure results in an equal prognosis for
cases and control subjects. Attributable mortality is determined by
subtracting the hospital mortality rate of the controls from that of
the candidemic cases.
Results: During the study period 73 of the 29727 ICU admissions
were complicated with microbiologically documented candidemia
(2.5/1000 admissions). Fifty-one episodes were caused by C. albicans
and 22 by C. non-albicans spp (17 C. glabrata, 3 C. parapsilosis, 1 C. kru-
sei, 1 C. tropicalis). In the C. albicansmatched cohort study an attribut-
able mortality of 3.9% was found (95% CI: 13–21%) as mortality
rates for cases and controls were respectively 43.1% and 39.2%
(P ¼ 0.771). In the C. non-albicans matched cohort study an attribut-
able mortality of 9.1% was found (95% CI: 16–34%) as mortality
rates in cases and controls were 59.1% and 50.0% (P ¼ 0.663). Both
attributable mortality rates were not statistically signiﬁcant. Conse-
quently, the difference between them was also not signiﬁcant.
Conclusions: No difference in attributable mortality in candidemia
involving C. albicans vs. C. non-albicans spp was observed in this
cohort of ICU patients.
References
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P1524 Predictors of nosocomial Acinetobacter baumannii
bacteraemia in an intensive care unit
R. Zaragoza, A. Artero, J.J. Camarena, S. Sancho, J. Navarro,
R. Gonza´lez, J.M. Nogueira
Valencia, E
Objectives: Acinetobacter baumannii has been named as the methi-
cillin-resistant Staphylococcus aureus of Gram-negative pathogens,
specially after the steady rise in the number of isolates and the
reports of many Intensive Care Unit outbreaks. The aim of this
study was to identify independent risk factors for developing Aci-
netobacter baumannii hospital-acquired bacteraemia (ABB).
Material and methods: Study of nosocomial bacteraemias in a med-
ical-surgical intensive care unit in a teaching hospital, during a
seven-year period (from 1996 to 2003). To analyse the predispo-
sing factors for developing ABB appropriate clinical and epidemi-
ological variables were recorded from clinical charts. We used
stepwise logistic regression analysis to determine independent
predictors of ABB. SPSS (9.0) software was used for data analysis.
Results: Fifty-nine (29%) of 202 nosocomial bacteraemias were due to
Acinetobacter baumannii. The mean age of patients with ABB was
60.5  17.7 years and the relation between men/women was 2.4. The
principal origins of ABB were respiratory (57%), catheter (17%)
unknown (17%). Polymycrobial bacteraemia was identiﬁed in 55%
of episodes of ABB. Septic shock was present in 31.6%. The mean
length of stay in the hospital was 44.0 days and the mean of days of
hospitalisation before the onset of bacteraemia was 19.7  20. Among
the strains identiﬁed, 74% were multidrug-resistant and 28% were
imipenem-resistant. The global and related mortality rate for ABB
was 45.3% and 25.4% respectively. Risk factors for ABB were
mechanical ventilation (OR 4.35; IC 95% 1.06–17.86: P ¼ 0.04), respir-
atory source of infection (OR 9.41; IC 95% 3.51–25.16: P < 0.0001),
and previous use of cephalosporins (OR 3.61; IC 95% 1.40-9.40;
P ¼ 0.007) whereas less than ten days of hospitalisation before the
onset of bacteraemia (OR 0.35; IC 95% 0.14–0.87: P ¼ 0.02) and the
presence of any cardiac comorbidity (OR 0.29; IC 95% 0.09–0.90:
P ¼ 0.03) were preventive factors in the multivariate analysis.
Conclusions: More than 10 days of hospitalisation, the use of
mechanical ventilation, pneumonia as source of bacteraemia and
the previous use of cephalosporins must be considered as risk fac-
tors for developing ABB.
P1525 Antibiotics cycling in ICU: results of 1.5-year
experience
D. Protsenko, S. Yakovlev, B. Gelfand, Y. Romanovskiy,
A. Yaroshetsky
Moscow, RUS
Objectives: The aim of the investigation was to study changes of
antibiotic resistance of VAP pathogens after the use of the strategy
of ‘antibiotics cycling’.
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Methods: The material of the present study is the results of the
investigation carried out during the period from June 2002 up to
October 2003 in the medical ICU department of Moscow’s munici-
pal clinical hospital. From January 2000 to June 2002 (I period) the
combination of ceftazidime (6 g/day) with amikacin (1 g/day)
was used as empirical antibacterial therapy of VAP, and from
June 2002 to October 2003 (II period) – cefepime (4 g/day) as a
single-drug therapy. Nine hundred and thirty-seven strains of dif-
ferent pathogens of VAP were studied. Antibiotic resistance of
P. aeruginosa and Enterobacteriacae as most widely spread causative
agents of VAP (33.4% and 18.6% correspondingly) was studied.
The material was obtained by BAL. Sensitivity of pathogens to the
tested antibiotics was determined by the disc-diffusion method.
Results: The total consumption of amikacin, ceftazidime and
cefepime in the ICU department during the ﬁrst period was
2043, 1632 and 158 g and during the second period, consumption
of cefepime was 2836 g while amikacin and ceftazidime were
excluded.
Conclusions: Exclusion of ceftazidime and amikacin for
17 months resulted in 7% decrease of resistance of P. aeruginosa
to ceftazidime. It was not possible to overcome the high level
of resistance to amikacin during that period. It was not
revealed to increase in resistance to cefepime despite its wide
use during the 17 months.
P1526 Evaluation of the risk factors for mortality and
nosocomial infection in intensive care units
A. C¸olpan, E. Akinci, A. Erbay, N. Balaban, H. Bodur
Ankara, TR
Objective: Evaluation of risk factors for mortality and nosocomial
infection in ICU patients
Patients and Methods: We conducted a prospective study between
May 2002 and November 2002 in surgical and medical ICUs of
Ankara Numune Education and Research Hospital. The analysis
involved 334 patients who were followed in the ICUs for at least
48 hours.
Results: Among the 334 patients, 104 (31.1%) had ICU acquired
infections. The overall mortality rate in the ICU was 46.7%. The
mortality rate was signiﬁcantly higher in the patients with
nosocomial infections (66.3%) than in noninfected patients
(37.8%) (P < 0.001). In the multivariate analysis, the mean
length of stay in ICU (OR 1.11, 95% –1.06–1.17), the mean
length of intubation (1.15 95% CI 1.05–1.25), total parenteral
nutrition (TPN) (OR 8.52, 95% CI 2.93–24.83) and enteral nutri-
tion (OR 3.22, 95% CI 1.65–6.3) were independently associated
with infection. The mean age (OR 1.03, 95% CI 1.01–1.05), mean
APACHE II score (OR 1.11, 95% CI 1.04–1.17), mechanical venti-
lation (OR 6.28, 95% CI 2.50–15.79), stay in medical/surgical
ICU (OR 0.31, 95% CI 0.14–0.69), central venous catheter (OR
4.89, 95% CI 1.79–13.23), use of antibiotic (OR 0.43, 95% CI
0.21–0.86) and coma (OR 2.29, 95% CI 1.20–3.26) were independ-
ently associated with mortality.
Conclusions: Nosocomial infection risk increased 8.5 times in the
use of TPN and 3.2 times in enteral nutrition. The most important
risk factors for mortality were older age, high APACHE II score
and coma and among procedures, central venous catheters and
mechanical ventilation. The mortality rate was 6 times higher in
the mechanically ventilated patients.
P1527 Knowledge, attitude and behaviour of health care
workers in two Indonesian teaching hospitals on the island of
Java
D.O. Duerink, D. Roeshadi, H. Wahyono, P.J. Van den Broek on
behalf of the AMRIN study group (Indonesia and The Netherlands)
Objectives: Knowledge, attitude and behaviour of health care
workers concerning infection control are important determinants
of the level of hospital hygiene. They also reﬂect the success of
the infection control organisation in an institution. Not much is
known about infection control in Indonesia. Therefore our study
investigated knowledge, attitude and (self-reported) behaviour of
health care workers in two Indonesian teaching hospitals by
means of an inquiry.
Methods: A questionnaire was carried out amongst healthcare
workers of the departments of internal medicine, surgery, paediat-
rics, obstetrics & gynaecology and ICU. The goal of the question-
naire was explained and anonymous analysis of the results was
guaranteed to the participants. Participants completed the ques-
tionnaire during sessions in which one of the researchers or infec-
tion control nurses were present to check whether they worked
individually, and to answer questions.
Results: A representative sample of more than 50% of all doctors,
nurses and assistant-nurses of the involved departments of both
hospitals (n ¼ 1045) completed the questionnaire. Their answers
showed that, in both hospitals, only a minority of personnel is
vaccinated against hepatitis B (41.6 and 30%), although the major-
ity has experienced needle stick accidents (64.1 and 86%), but did
not report them. The knowledge of blood-borne diseases is small
and there are no clear guidelines about handling of needle stick
accidents and the place of the infection control organisation in
these matters. There are not enough hand washing points and
there is an inconsistency in knowledge, attitude and behaviour
concerning the role of hands in infection control. The supply of
personal protective equipment such as gloves, masks and gowns
is insufﬁcient and the distinction between sterile and non-sterile
gloves is not clear. There is limited knowledge about wound care
and care for patients with a urinary catheter.
Conclusions: The questionnaire showed a deﬁcit of knowledge
regarding infection control in general and speciﬁcally regarding
hand hygiene, safe blood handling and personal protective equip-
ment.
P1528 Assessment of the impact of the microbiological
reports on the antibiotic treatment of bacteraemia
A. Vasilakopoulou, I. Stefanou, A. Pantazatou, J. Papaparaskevas,
A. Avlamis
Athens, GR
Objectives: Blood cultures rank among the most important investi-
gations in febrile patients. This study aims to assess the microbio-
logical reports’ impact on the choice of antimicrobial agents for
the treatment of bacteraemia.
Methods: A prospective study of 165 episodes of bacteraemia in a
tertiary care hospital. Data collected included demographic char-
acteristics, underlying diseases, focus of infection, culture results,
antibiotic treatment and outcome.
Results: The 165 bacteraemia cases are divided into group A
(92/165) and group B (73/165). Group A consists of 92 cases
(92/165 ¼ 55.7%) that were treated with appropriate empirical
therapy (microorganism sensitive to the antibiotic). Group B
consists of 14 bacteraemias (14/165 ¼ 8.4%) that didn’t receive
empirical therapy and 59 cases (59/165 ¼ 35.7%) that were trea-
ted with inappropriate primary therapy (microorganism resist-
ant to the antibiotic). After consultation with the laboratory
microbiologist and reporting of the blood culture results, there
was immediate change in therapy for 61/73 of group B bacter-
aemias and thus the proportion of appropriate treatment for the
total cases reached (92 + 61)/165 ¼ 92.7%. For the remaining
cases of group B, 3/73 were attributed to a multiresistant
microorganism and for 9/73 the blood culture report occurred
Resistance of Enterobacteriaceae and P. aeruginosa, %
Antibiotics
Enterobacteriaceae P. aeruginosa
I period II period I period II period
Amikacin 66 43 86 71
Ceftazidime 63 78 26 19
Cefepime 7 21 11 5
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after death of the patient. Change of therapy after the blood
culture result was also observed for 29/92 group A episodes (it
was appropriate, i.e. in compliance to the susceptibility reports).
Among group A bacteraemias the outcome was cure from the
infection for 82/92 ¼ 89.1% while for group B the respective
rate of cure was 53/73 ¼ 72.6%. This statistically signiﬁcant dif-
ference (chi-square test, P ¼ 0.006) in cure rates cannot be
attributed solely to the difference in appropriateness of empir-
ical therapy though.
Conclusions: Our study conﬁrms that blood culture results are
essential in optimising antimicrobial therapy. Furthermore, the
consultation of the microbiologist with the physician for every
case of bacteraemia is invaluable and increases the compliance of
therapy to the antibiotic susceptibility reports (the rate of appro-
priate therapy increased from 55.7% to 92.7%)
P1529 Nosocomial infection prevention and control
programme during hospital reconstruction
M. Gurgui, J. Barrio, A. Cotura, M. Galvez, C. Roig, A. Coloma,
M. Alvarez, P. Coll, G. Vazquez
Barcelona, E
Introduction: Nosocomial infection (NI) outbreaks have been asso-
ciated with construction activities in hospitals. As our hospital, a
Tertiary University Hospital with 600 beds and an average of
34 000 admissions/year, is constructing a new building with land
excavation and building demolition, a NI prevention and control
programme has been established. The design and results of this
surveillance method are presented.
Methods: An NI weekly prospective incidence study, from Febru-
ary 2001 to November 2003, of 30175 patients (4689 with major
surgical procedures) admitted in risk areas near the works was
carried out. Data was collected and processed by the Infectious
Diseases (ID) team. Basic data was obtained from the income cen-
sus. Microbiological results, antimicrobial prescription and seriat-
ed visits of ID consultants were used as sources for case
detection. CDC criteria and deﬁnitions of NI were used. Microbio-
logical air quality was checked in HEPA protected areas every
3 months and monthly in non-protected areas (366 samples).
When a problem was detected adequate correction measures were
taken.
Results: The global incidence rate was 3.2%. Weekly incidence of
NI oscillated from 1.1% to 4.9% with urinary tract infection being
the most frequent (0.8–3.6%). No increase of respiratory (0–2.5%)
or surgical infections (4–8%) was observed and no epidemic out-
breaks of aspergillosis, ﬁlamentous fungi or legionellosis were
detected. In patients with bone marrow transplant or heart trans-
plant admitted in the haematology or cardiology services there
was not an increase of the rate of invasive aspergillosis compared
with previous years.
Conclusions: (1) Longitudinal and prospective incidence studies,
air sampling and prevention measures are useful methods for the
follow-up of a new hospital construction-related nosocomial infec-
tions. (2) No increase of nosocomial infection rates or epidemic
outbreaks have been observed in our institution during hospital
construction.
P1530 Environmental organisms from different wards in a
teaching hospital
S. Dancer, M. Coyne, A. Thomson, A. Guleri, S.R. Alcock
Glasgow, UK
Objectives: An Intensive Care Unit (ITU), Stroke Unit (SU) and
Medical Day Bed Unit (MU) were subjected to a standardised
screening programme over a four-month period. The aim was to
examine environmental organisms from these wards and compare
their bacterial resistances in association with antimicrobial usage
on each ward.
Methods: Hand-touch sites such as door handles and computer
keyboards, and other sites such as ﬂoors and sinks were screened
using commercial dipslides. Organisms were quantitatively and
qualitatively assessed and subjected to antimicrobial susceptibility
testing. Antibiotic consumption data was obtained for the previ-
ous year for each unit and expressed in Deﬁned Daily Doses
(DDD)/1000 patient-days.
Results: The amount and identity of organisms from each ward
were similar but there were differences between wards regard-
ing microbial density from certain sites. Nearly 300 staphylo-
cocci were recovered as opposed to 64 Gram-negative bacilli.
Antibiotic resistance was signiﬁcantly associated with individual
wards, particularly for staphylococci (P < 0.0001) but also for
coliforms (P ¼ 0.04) and other Gram-negative organisms
(P ¼ 0.07) despite fewer numbers. ITU consumed 3110 DDD/
1000 patient-days, six times more than SU and MU. There were
further associations made between beta-lactam consumption and
methicillin resistance, and aminoglycoside consumption and
gentamicin resistance.
Conclusions: Antibacterial resistance is the only signiﬁcant differ-
ence between environmental bacteria from different wards, and
appears to reﬂect prescribing pressures placed on those wards.
The dirtiest ward visually (SU) had the least heavy microbial
growth from hand-touch sites and the least number of resistant
bacteria. ITU appeared much cleaner but demonstrated a higher
proportion of heavily contaminated hand-touch sites with mul-
tiple resistant bacteria. Thus, visual inspection of a ward may not
provide a reliable guide to the potential risk of infection from its
environment. The ﬁndings have implications for local antibiotic
policies, infection control and cleaning schedules.
P1531 New way of microbe decontamination from air –
MFI method
Z. Muszyn˜ski, I. Mirska
Poznan, PL
Objectives: In many branches of medicine, the microbiologically
clean air is a signiﬁcant condition either of microbial pollution or
infection reduction, i.e. in operating place, or medical staff infec-
tions.
Methods: The MFI method (Multifunction Ion Air Cleaning) of
Genano Oy, Finland was examined, using Nanobio E310 device,
from the point of its air decontamination efﬁciency. Tested device
work parameters are: cleaning capacity 250 m3/h, at air ﬂow velo-
city 0.5 m/s. The microbiological purity of exhausted air was
measured. Two methods were applied for qualitative and quanti-
tative tests; De Ville Biotechnology (MicroBio device), and contact
plates method (Oxoid). There were 10 test bacterial and fungal
types from ATCC collection (Rockville, USA). In quantitative tests,
a microbial suspension (aerosol) was used, density 10 6–10 8 cfu/
ml, aseptic conditions.
Results: Microbiological purity of air, after passing through the
air cleaning MFI device, determinated the removing and des-
troying of both bacteria and fungi from air. It is to be highly
effective towards a wide spectrum of microbes. The extent of
microbiological air contamination does not inﬂuence effective-
ness of air cleaning with the MFI method. Long-term (7 days)
work of Nanobio E310 device does not result in any changes in
efﬁciency of air cleaning with the MFI method, even in condi-
tions of high microbiological pollution of internal air. Research
done in experimental conditions, points out to signiﬁcant
microbes reduction in cleaned air. It appears to be at least 10%
bacteria and fungi less than in the beginning of the test, what
equals effectiveness 99.999% at particles range equal or more
than 0.003 lm.
Conclusions: The application of MFI technology, regarding appro-
priate assembling of air cleaning devices and preserving the air
exchange frequency, adequate to room cubature, equipment and
number of employees, enable reaching at least B air class of
microbial purity (<10 cfu/m3 of air) and/or 100, M3.5 air class,
ISO 5 according to the United States Federal Standard 09 E and
ISO standards as well.
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P1532 Disinfection of surfaces in hospital isolation rooms
with ultraviolet C (UVC) light, compared with chloramine
B.M. Andersen, H. Ba˚nrud, E. Bøe, O. Bjordal, F. Drangsholt
Oslo, Rud, Trondheim, N
The germicidal effect of ceiling- and wall-mounted ultraviolet C
(UVC) light at 254 nm in isolation units with negative pressure
(45 Pascal) was examined and compared with disinfection with
chloramine during end-disinfection after patient stay. Microbial
samples were taken from surfaces before and after disinfection
with UVC (33–47 min) and chloramine (5%, 1 h exposure) using
standard contact plates (20 cm2). The UVC-distribution in the
isolation units was monitored at 165 positions. The output on the
ﬂoor varied between 0.08 and 3.2 W/m2, with an average (SD)
of 2.2  0.5 W/m2 in the patient room, 2.0  0.7 W/m2 in the
sluice and 1.4  0.5 W/m2 in the bath/ decontamination room.
On other places, the values varied from 0.08 to 6.82 W/m2. The
units were UVC-disinfected for 33–47 min, corresponding to doses
ranging from 160 J/m2 in shadowed area to 19 230 J/m2 at the
highest exposed site. According to published UVC-dosimetry, the
survival of bacteria and bacterial spores are reduced by 90% with
doses ranging from 4–120 J/m2 and 100–365 J/m2, respectively.
Thus, UVC doses used in this study should be high enough to
inactivate most bacterial organisms, including spores, even on sur-
faces not directly exposed to UVC. UVC-disinfection signiﬁcantly
reduced the bacteria on surfaces directly or indirectly exposed to
UVC to a very low number (from c. 30 to 1–2 cfu/plate), as did
5% chloramine disinfection (from c. 30 to 1–2 cfu/plate) alone;
P < 0.001, and P < 0.001, respectively. Since cleaning before disin-
fection may be a risk for the staff in isolation units, disinfection
with UVC- or chemicals should always be performed ﬁrst. The
presence of completely shadowed areas in the isolation unit (the
bed rail, lockers, mattresses etc.) still needs disinfection by chemi-
cals before cleaning. Therefore, UVC may not be used alone, but
is a good additive to chemical disinfection, to lower the biological
burden of infectious agents in isolation units for high-risk infec-
tious patients.
P1533 Controlling procedures for reprocessing ﬂexible
gastrointestinal endoscopes – the value of g-control charts
T. Slotsbjerg, I. Petersen, H. Westh Copenhagen Clean-endoscope
Group13
Objectives: In our quality control (QC) program and in the interna-
tional literature, infection has been related to high-risk ﬂexible
gastrointestinal endoscopes (FE). Especially after over night prolif-
eration of micro-organisms in FE channels, patients can be at
infection risk. We used a Number-Between g-Type statistical Con-
trol Chart and associated statistical methods to identify unstable
FE reprocessing procedures.
Methods: We used microbial counts, CFUs, from ﬂush water
from the water channel before an endoscopy in our QC pro-
gram. Clean, critical and high-risk FEs were deﬁned. The g-con-
trol card is a ﬁgure where the X-axis represents the consecutive
number for a critical or high-risk FE, and the Y-axis the number
of clean FE between every critical or high-risk FE. A Center Line
(CLwd) illustrates the expected quality in reprocessing FE
deﬁned for a concrete type of washer-disinfector (WD). A CLmc
line shows the expected quality in reprocessing FE using only
manual cleaning (mc) of FE with no proliferation of micro-organ-
isms during storage. Thirteen endoscopy units from eight hospi-
tals in Copenhagen Hospital Corporation (H:S) and Copenhagen
County (KAS) participated in the program. CLwd was deter-
mined for three different WDs and CLmc from previous experi-
ments. g-control charts were produced for each endoscopy unit
allowing out of control evaluation in relation to occurrence of
critical and high-risk FEs.
Results: 7351 QC samples from FE were evaluated. We present
data on a g-control chart over a 5-year period from a department
using three 10-year-old Olympus ETD WDs showing the develop-
ment of an out of control situation. The FE reprocessing went
from in control to out of control with consecutive control points
below the CLwd and CLmc and with the occasional observation
of high-risk FE during the last two years. Out of control situations
can be detected if eight consecutive control points or 12 of 14 con-
secutive control points fall below the CLwd or CLmc.
Conclusions: The g-control chart was found to be a valuable statis-
tical tool allowing identiﬁcation of out of control procedures for
reprocessing FE. These data can show out of control manual
cleaning and give early signs of WDs in need of repair or are in
such bad condition they should be replaced. g-control charts are a
great improvement over the previously used p-control charts.
P1534 Preventing the spread of Legionella in hospital
wards: measures adopted in a polyclinic, Bologna
G. Finzi, P. Cacciari, N. Manoni, N. Alvaro, L. Mavilla
Bologna, I
Aims: Legionella represents a serious problem for old hospitals
that over the years have expanded in size and, as a result, have
added to the plumbing systems of the original buildings. In the
Policlinico S.Orsola-Malpighi which has highly specialised wards
for the treatment of patients who are particularly vulnerable to
infection such as transplant and cancer patients some parts of the
plumbing network are over 50 years old. A comprehensive and
radical overhaul of the plumbing system in order to eradicate
Legionella completely was not a realistic goal and so the target
set by the hospital was to prevent high-risk patients from being
exposed to infection.
Methods: Filters were ﬁtted to the taps and shower heads in the
rooms of high-risk patients in the following sectors: haematology,
oncology, paediatric onco-haematology, nephrology, surgery
(transplant patients). A monitoring programme was set up to
assess the efﬁciency of these measures. Until February 2003, single
samples were taken at intervals during the year. However, with
this method, low-level or intermittent contamination at outlets
where ﬁlters had been installed could not be identiﬁed and so
any evaluation of the plumbing system risked being distorted by
false negative results. For this reason, a new monitoring pro-
gramme was set up in March 2003 which involved taking regular
samples at every outlet under inspection.
Results: Over the years, about 50% of outlets not protected by ﬁl-
ters have shown Legionella contamination (32/year). With one
exception, all the levels of contamination found were within the
range where vigilance is recommended by existing regulations. In
contrast inspections of shower heads and taps ﬁtted with ﬁlters
have given only negative results (490 samples). Recently outlets
have also been monitored by repeated sampling to avoid false
negative results because of low-level or intermittent contamin-
ation. Outlets ﬁtted with ﬁlters were found to be uncontaminated
even when subjected to this type of inspection. The only exception
was one outlet, present in a room kept shut for several days,
which was found to be contaminated in two instances.
Conclusions: The data from the monitoring carried out indicate
that ﬁtting water outlets with ﬁlters is an effective way of avoid-
ing Legionella contamination so long as certain basic requirements
are met: ﬁlters must be installed in the correct position in the
plumbing system and must undergo periodic maintenance and
replacement.
P1535 Nosocomial Legionella infections conﬁrmed by
molecular typing
L. Franzin, D. Cabodi, N. Bonfrate
Turin, I
Objectives: Nosocomial origin of Legionellosis must be conﬁrmed
by molecular typing of Legionella strains isolated from patients
and from hospital water supply. In this study we used pulsed-
ﬁeld gel electrophoresis (PFGE) and random ampliﬁed polymor-
phic DNA PCR (RAPD-PCR) to type Legionella strains isolated
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from four patients, that acquired legionellosis in four different
hospitals, and related hospital environmental strains.
Methods: L. pneumophila serogroup 1 was isolated from the ﬁrst
patient (male, 68 years, immunosuppressed) and L. pneumophila 1,
2, 3, 6 in the related hospital water. L. pneumophila serogroup 1
was isolated from the second patient (male, 81 years, cardiopatic)
and L. pneumophila 1, 3, 4, 6 in the respective hospital water.
L. bozemanii was isolated from the third patient (female, 44 years,
immunosuppressed with autoimmune disease), L. pneumophila 1
and L. bozemanii in the related hospital water. In the last case,
L. pneumophila sero group 3 was isolated from patient (female,
77 years, immunosuppressed) and L. pneumophila serogroup 3 and
Legionella spp. from hospital environment. Strains from patients
and related hospital water supply were typed. PFGE of DNAs
cleaved with SﬁI and NotI was performed on 1% agarose gel
(CHEF DR III). Ampliﬁcation for RAPD-PCR was performed with
two primers using Ready-to-Go RAPD analysis beads and visual-
ized by staining with ethidium bromide and by electrophoresis on
polyacrylamide gel with GenePhor System.
Results: In all four cases, strains from patients and related hospital
environmental isolates showed the same genomic proﬁles by
PFGE and RAPD-PCR, while different patterns were found for
unrelated strains.
Conclusions: Molecular typing demonstrated that strains from
patients and from hospital hot water were genetically indistin-
guishable, showing that hospital water was the source of infec-
tion. The nosocomial origin would be probably unrecognized
without molecular techniques, that are very useful epidemiologi-
cal markers.
P1536 Experience with a chlorine dioxyde water treatment
system to control Legionella in a hospital hot water supply
G. Mascart, M. Doyen, K. De Cuyper
Brussels, B
Objectives: We evaluated the efﬁcacity of a chlorine dioxyde
(ClO2) system to reduce the signiﬁcant amount of Legionella pre-
sent in our hot water supply.
Methods: After an evaluation of the amount of Legionella in our
hot water supply, a chlorine dioxyde system marketed by Gulld-
ager was installed in October 2000. This system includes three
components: one pump injecting in the reaction chamber an aqu-
ous stabilised solution of chlorine dioxyde [Activ OX20]; one
pump injecting in the reaction chamber an activator [Activ 8]
and the reaction chamber. The Activ product is injected at the
entrance of the hot water supply. We controlled the amount of
Legionella at different places of the supply between December
2000 and March 2002. We also investigated the risk of corrosion
of the water pipes by placing small pieces of steel or steel and
zinc at a point before the injection of ClO2 and at another point
after the injection.
Results: Pretreatment measures revealed in July 2000 the presence
of Legionella in 19 of 22 (86.3%) water samples. In nine of 22
(40.9%) water samples the number of Legionella was above
103 ufc/L. The mean number of Legionella in the samples was
1541 ufc/L. Seven controls were made between October 2000
(installation of the ClO2 system) and march 2002. A 14-month per-
iod was necessary to see the efﬁcacity. In December 2001, two of
nine samples (22.2%) were positive but with <500 cfu/L and in
March 2002, three of 10 samples (30%) were positive but only one
sample had 103 cfu/L (mean number 468 cfu/L). Concerning the
corrosion of the steel pieces, the loss of weight after 96 days was
149.8 mg (initial weight 14.648 g) without ClO2 and 150.4 mg (ini-
tial weight 14 704 g) with ClO2. For the steel plus zinc, the loss of
weight was 1550.8 mg (initial weight 12.456 g) without ClO2 and
1415,1 with ClO2 (initial weight 12 953 g)
Conclusions: As a result of the structure of our water pipes net-
work and the presence of bioﬁlms it appears that ClO2 was
only effective in decreasing the Legionella level after 1 year.
Moreover the adjunction of ClO2 does not increase the risk of
corrosion.
P1537 Sustained antimicrobial activity of a novel triclosan
hand preparation
T. Karpanen, T. Worthington, P. Lambert, T. Elliott
Birmingham, UK
Objectives: (1) To assess the antimicrobial efﬁcacy of a novel 2%
triclosan hand preparation (THP) in the clinical setting; (2) To
determine the sustained antimicrobial activity of THP when adop-
ted as a part of routine hand hygiene; (3) To determine the effect
of repeated hand washing with soap and water on the sustained
antimicrobial activity of THP.
Methods: A controlled, randomised, prospective open trial was
undertaken during 2003. One hundred and two health care work-
ers (HCW) were recruited from acute surgical wards, critical care
units and a radiology department based at the University Hospi-
tal Birmingham NHS Trust, UK. Baseline levels of micro-organ-
isms on the hands of HCW were determined by standard
microbiological techniques. Fifty-two HCW applied THP as
recommended by the manufacturer; ﬁfty HCW did not apply
THP and served as controls. To assess the immediate antimicro-
bial efﬁcacy of THP, hands were sampled for micro-organisms at
one minute following application. HCW continued with their nor-
mal clinical practice and hands were further sampled for micro-
organisms at 1 and 3 h to determine any sustained antimicrobial
activity of THP. Data regarding the frequency of hand washing
and duration gloves were worn during the investigation was also
obtained. Alcohol hand rubs and medicated soap washes were
excluded during the assessment of THP.
Results: There was a signiﬁcant reduction in mean bacterial counts
in the study group compared with controls after 1 min, 1 h and
3 h following application of THP (P < 0.0001, <0.0001 and 0.0359
respectively). There were no signiﬁcant differences between the
groups in the number of times hands were washed with soap and
water [P ¼ 0.092 (1 h); P ¼ 0.43 (3 h)] and glove wearing
[P ¼ 0.47 (1 h); P ¼ 0.13 (3 h)].
Conclusions: THP has immediate and sustained antimicrobial activ-
ity on the hands of HCW in the clinical setting for at least 3 h. The
efﬁcacy of THP is unaffected by repeated hand washing with soap
and water. THP may be a beneﬁcial adjunct to normal hand
hygiene practice and may facilitate in reducing cross-infection.
P1538 Evaluation of bacteriological agents isolated from
operating room staff after hand scrubbing in Yazd medical
university hospitals
J. Hossain-Zadeh, M. Golvardy, M. Mohseni, M. Khalili
Yazd, IR; Boston, USA
Objective: Nosocomial infection is one the most important prob-
lem that causes mortality in all hospitals around the world. This
problem is more emphasised in operation room’s staff dealing
with. The aim of this study was to determine the rate infection
among operation room staff in the Yazd University hospitals of
Yazd city, Iran.
Method: One hundred and thirty-four personals of operation team
staff (81 men + 53 women) including surgeons; nurses and stu-
dent were involved in this cross-sectional study. Following swap-
ping from their hands after betadine scrubbing from four parts of
their hands, all samples were cultured using standard method for
detection of any possible bacteria. All detected bacteria were diag-
nosed using related biochemical tests. Simultaneously the demo-
graphic status such age, sex and period scrubbing time for all
cases was recorded separately in a special form.
Results: Species detected were staphylococci coagulase positive
(5.03%) and coagulase negative (40.7%). 70.9% of person’s nail
were infected with c+staph and 12.7% with c-staph 38.1% of
staff’s palm were infected with c-staph and 5.2% with c+staph,
23.9% of over hand of staph were infected with c-and 2.2% with
c+staph. 29.9% of the staff’s wrist were infected staph c- was
detected on 29.9% of the staff’s wrist. Infection among men was
found to be signiﬁcantly more (16%) than women (1.9%) for those
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staff who scrubbed their hands between 5 and 10 min. Only 3%
of studied population carried more than 50 colonies of bacteria.
Conclusions: The present study shows that men are more careless
against infection in scrubbing and nosocomial infection has been
found to be dominating among operation room’s staff, and their
nails are signiﬁcantly carried more infections agents. It may be
suggested that at least, 5 min scrubbing are recognised to mini-
mise the infection.
P1539 Evaluation of preventative methods in blood-borne
pathogens among health care workers
A. Tatsiopoulos, K. Mandraveli, M. Imprisimi, A. Politou,
S. Alexiou-Daniel
Thessaloniki, GR
Objectives: To estimate the risk and to evaluate the conditions of
exposure to blood-borne pathogens among health care workers
(HCWs). To conduct a comparison between present and past data
of our hospital.
Methods: The data was collected using a questionnaire and inclu-
ded: characteristics of the workers, type of occupational exposure,
immunity status of the exposed worker, infectivity of the source
patient and follow up serologic testing of the worker. Eight hun-
dred and eight incidents were enrolled between January 1998 and
December 2002. The data was compared with data collected of the
similar cohort during previous period (1990–97).
Results: We noticed an increase in the absolute number of repor-
ted incidents (808 vs. 284). Nurses appeared to have the highest
injury rate per year among all HCWs (4.1% vs. 3%). Lack of
attention remained the main cause of incidents (68% 1998–2002
vs. 51% 1990–97). Workers with short work experience (0–5 years)
were primarily affected (P < 0.001). Our results indicated a ser-
ious increase in the rate of incidents during the resheating of used
needles (46.7% vs. 18.3%), which was taken into consideration for
appropriate adjustment of the relevant hospital policy. Interest-
ingly the study demonstrated a decrease in the rate of incidents
involving HbsAg (+) and anti-HCV (+) patients (8.7 and 6.9%
during 1998–2002 vs. 20 and 17% during 1990–97 respectively).
During this period none of the reported incidents progressed to
seroconversion of the HCWs, where immune status to blood
borne pathogens was estimated. This ﬁnding is in line with our
previous survey.
Conclusions: An awareness of the HCWs as regards early report-
ing of such incidents was observed. Efforts by the infection con-
trol committee need to be more intense, in order to identify
unsafe practices and provide more adequate preventive measures.
Ventilator-associated pneumonia
P1540 Evaluation of patients with ventilator-associated
pneumonia
A. Erbay, H. Bodur, E. Akinci, N. Balaban, A. C¸olpan
Ankara, TR
Objective: To determine the epidemiology of ventilator associated
pneumonia (VAP) and to examine the characteristics and out-
comes of the patients with VAP.
Methods: Patients with the diagnosis of VAP, in surgical and med-
ical intensive care units (ICUs), were enrolled to the study and
followed prospectively. The diagnosis of VAP was based on posit-
ive quantitative culture of deep endotracheal aspirate (105 CFU/
mL) with new or increased purulent sputum and chest radio-
graph showing new or progressive inﬁltrate. The demographic
details, APACHE II score, length of ICU stay, length of mechan-
ical ventilation, surgery, comorbidities, nutritional status, isolated
micro-organisms and susceptibility results were recorded on indi-
vidual forms.
Results: During study period VAP was diagnosed in 26 patients,
18 (69.2%) of them were male. Mean age was 50.9  21.4. The
reasons for ICU admission were respiratory failure (46.2%),
trauma (23.1%), postoperative care (11.5%), cardio-pulmonary
arrest (3.9%), and other reasons (15.4%) respectively. The mean
duration of ICU stay was 26.8  22.3 days and the mean duration
of mechanical ventilation was 17.7  19.1 days. Comorbidity was
obtained in seven (26.9%) patients. APACHE II scores were
between 10 and 19 in 16 (61.5%) patients and above 20 in six
(23.1%) patients. VAP occurred at the 10.9  9.9th day of the
mechanical ventilation. Acinetobacter spp. was the most frequently
identiﬁed pathogen, found in nine (34.6%) of the episodes, fol-
lowed by Pseudomonas aeruginosa (19.2%), Klebsiella pneumoniae
(19.2%), methicilline resistant Staphylococcus aureus (15.4%). Over-
all mortality rate was 76.9%, but in seven of 20 died patients,
pneumonia was the direct reason of death. Risk factors leading to
death in VAP patients were longer ICU stay (42.4  31.5 and
21.1  15.2 days, respectively, P ¼ 0.028) and longer ventilation
time (30.9  33.3 and 12.8  6.7 days, respectively, P ¼ 0.03). No
statistically signiﬁcant difference was found between APACHE II
scores of the patients died because of VAP and survived. Three of
seven patients who died because of VAP, were infected by Acine-
tobacter spp. which were resistant to all antibiotics.
Conclusions: Ventilator-associated pneumonia is the most import-
ant complication of mechanical ventilation among ICU patients.
Preventive measures for nosocomial infections and appropriate
antibiotic treatment may be the most important step to reduce the
mortality because of VAP.
P1541 Usefulness of serial quantitative cultures of
bronchoalveolar lavage to control the development of antibiotic
resistance in Pseudomonas aeruginosa causing ventilator-
associated pneumonia
E. Tacconelli, M.A. Cataldo, F. Magnano, M.A. Pennisi,
M. Antonelli, U. Frank, R. Cauda
Rome, I; Freiburg, D
Background: Ventilator-associated pneumonia (VAP) caused by
Pseudomonas aeruginosa (PA) is a severe complication with high
mortality. In vitro data have shown that the majority of PA iso-
lates develop stable resistance after exposure to serial passages
containing antibiotics.
Objectives: To investigate whether antibiotic therapy for VAP
determines selection of antibiotic resistant PA in vivo; and to
determine whether there is a change in PA strains during antibi-
otic therapy.
Methods: A prospective cohort study started in September 2002.
Diagnosis of VAP required a positive quantitative culture of BAL;
new or persistent inﬁltrate on chest X-ray; >2 of the following:
hyper/hypopirexia, leucocytosis; purulent bronchial secretions;
and onset >48 h after starting mechanical ventilation (MV). Chest
X rays, haemochrome, SAPS II, and mini-BAL were obtained
before starting therapy and every 72 h. Genotyping was per-
formed by automated laser ﬂuorescence analysis of digital ﬁnger-
printing data.
Results: Twenty-six patients fulﬁlled the diagnostic criteria for
VAP within the ﬁrst year of study. Eleven patients (42%) with PA
VAP were enrolled with 49 serial BAL. The majority of patients
were males (72%) with a mean (SD) age 53 (18) years. Ninety per
cent of patients received antibiotics within 30 days. VAP had been
diagnosed after 17 (12) days from the MV. At enrolment, resist-
434 Abstracts
ance to >2 antibiotics has been detected in 55% of the strains. All
patients presented leucocytosis [mean, 17099 (8636/mmc)]. Six
patients (54%) had a negative culture of a mini-BAL obtained
after 72 h of therapy, the remaining 5 had PA still isolated. Com-
pared with patients with negative BAL at 72 h those with positive
BAL had excess of mortality (80% vs. 20%, OR 0.8, P ¼ 0.03), and
higher leucocytosis (26.566 vs. 17.566/mmc, P ¼ 0.02). Radiologi-
cal pictures and mean SAPS II did not change signiﬁcantly after
72 h. Two patients developed resistance to piperacillin-tazobactam
and imipenem after 8 and 11 days of therapy, respectively. All
patient-unique isolates of PA were genetically different, while
serial isolates from the same patients were identical.
Conclusions: Stepwise selection of resistance has been observed
in vivo during antibiotic therapy for VAP. Mortality rate is signiﬁ-
cantly higher in patients with PA still isolated after 72 h. These
preliminary data suggest that a mini-BAL after 72 h from therapy
may be useful to control antimicrobial susceptibility of the isolate
and to reduce mortality.
P1542 Preliminary bronchoalveolar lavage culture results
in ventilator-associated pneumonia
E. Giantsou, N. Liratzopoulos, N. Boubopoulos, I. Kouyoumtzi,
M. Panopoulou, S. Kartali, G.I. Minopoulos, K.I. Manolas
Alexandropolis, GR
Objectives: To determine the value of preliminary bacterial colony
counts for predicting ﬁnal Bronchoalveolar Lavage (BAL) results
in Ventilator Associated Pneumonia (VAP).
Methods: A total of 434 isolates from 208 quantitative BAL cul-
tures were analysed, in an observational cohort from September
2001 to March 2003, in one Intensive Care Unit, in a University
teaching hospital. Preliminary and ﬁnal colony counts for each
isolate were categorised as either no growth, insigniﬁcant (1-
99,999 cfu/mL),or signiﬁcant (100 000 cfu/mL).VAP was diag-
nosed on the basis of positive quantitative cultures. Sensitivity,
speciﬁcity, positive predictive value, negative predictive value of
preliminary results were estimated .Concurrent antibiotic therapy
was recorded if no growth or insigniﬁcant growth was detected
on preliminary results.
Results: On preliminary colony counts reports there were 100 iso-
lates with no growth, 109 with insigniﬁcant growth and 225 with
signiﬁcant growth. Overall preliminary results had sensitivity
96%, speciﬁcity 95%, positive predictive value 96% and negative
predictive value 95%. Preliminary BAL culture results accurately
predicted the presence or absence of VAP in 413 (95%) of the
BALs performed. Isolates with no growth (preliminary 100 and
ﬁnal 89 or 89%) had greater reliability in predicting the absence
of VAP than isolates with insigniﬁcant growth (preliminary 109
and ﬁnal 130 or 83%), whereas no difference was noted in false
negatives, while on antibiotics between insigniﬁcant and no
growth groups.
Conclusions: Preliminary BAL culture results with signiﬁcant or no
growth are highly predictive for similar ﬁnal results, whereas
results with insigniﬁcant growth are less reliable, in our data. Iso-
lates with signiﬁcant or no growth are clinically important and
antibiotics should be adapted appropriately or discontinued
respectively, before obtaining ﬁnal results.
P1543 Ventilator-associated pneumonia and modiﬁcation
of initially inappropriate antibiotic therapy according to
bronchoalveolar lavage culture results: timing and outcome
E. Giantsou, G. Liberakidis, M. Papageorgiou, E. Alepopoulou,
A. Grapsa, N. Liratzopoulos, G.I. Minopoulos, S. Kartali,
K.I. Manolas
Alexandropolis, GR
Objectives: To compare the impact on outcome, of early (<7 days
of mechanical ventilation) vs. late (7 days of mechanical ventila-
tion) modiﬁcation, according to bronchoalveolar lavage (BAL) cul-
ture results, of initially inappropriate antibiotic therapy of patients
with Ventilator Associated Pneumonia (VAP).
Methods: In total 159 subjects (95 males (60%) and 64 females
(40%),median age 61.25 years, range 21–87) diagnosed as having
VAP with quantitative culture results of BAL and receiving ini-
tially inappropriate antibiotic treatment were enrolled. Initial anti-
biotic was inappropriate when at least one developed micro-
organism was resistant to administered antibiotics and was modi-
ﬁed according to BAL cultures results when became available.
Parameters recorded included the timing of modiﬁcation (early
vs. late) according to when the VAP episode was developed and
the outcome.
Results: Inappropriate initial antibiotic therapy was modiﬁed early
in 50.94% (81 of 159) and late in 49.05% (78 of 159).Crude mortal-
ity was 20.12% (32 of 159). Crude mortality in case of early modi-
ﬁcation of inappropriate treatment was 4.9% (four of 81) and in
case of late modiﬁcation 35.89% (28 of 78). Apache II score
(t ¼ 1.459, P ¼ 0.1450) and Pseudomonas spp. (P > 0.005) develop-
ment did not differ signiﬁcantly between the two groups (early
and late modiﬁcation of initially inappropriate treatment).
Conclusions: In our data a more favourable outcome of patients
with VAP was observed when initially inappropriate empiric anti-
biotic therapy was modiﬁed according to BAL culture results
early (<7 days of mechanical ventilation) than late (<7 days of
mechanical ventilation).
P1544 Ventilation-associated pneumonia and de-escalation
practice, oriented by the results of bronchoalveolar lavage vs
transtracheal aspiration cultures
E. Giantsou, K. Romanidis, N. Boubopoulos, G. Liberakidis,
E. Alepopoulou, S. Kartali, G.I. Minopoulos, K.I. Manolas
Alexandropolis, GR
Objectives: To compare the impact on outcome of Ventilator Asso-
ciated Pneumonia (VAP) when de-escalate according to broncho-
alveolar lavage (BAL) vs. transtracheal aspirations (TTAs) culture
results. De-escalation therapy is based on the use of initial large
spectrum, ﬁrst hand therapy, that is reassessed when microbiolo-
gical data become available in order to reduce to a narrower spec-
trum therapy.
Methods: A total of 408 subjects, with clinical evidence for VAP,
were randomly assigned into two groups A and B. In group A
(n ¼ 208, males/females ¼ 125/83, median age 61.25 years, range
24–87 years) quantitative cultures (QCs) of BAL were taken
whereas in group B (n ¼ 200, males/females ¼ 131/69, median
age 58.90 years, range 24–87 years) QCs of TTAs. Initial antibiotic
therapy, when modiﬁed in the light of cultures results, was either
stopped if inappropriate or at least one strain resistant to adminis-
tered antibiotics or changed to another with a narrower spectrum.
The outcome in terms of crude mortality rates was assessed in
both groups.
Results: Patients diagnosed as having developed VAP in groups A
and B respectively were 81% (169 of 208) and 88% (175 of 200).
No signiﬁcant difference in age (t ¼ 1.33, P ¼ 0.183), Apache II
score (t ¼ 1.459, P ¼ 0.145) duration of mechanical ventilation
until samples were taken (t ¼ 0.511, P ¼ 0.609) or contribution of
medical vs. surgical patients (x2 ¼ 3.97, P ¼ 0.137) was detected
between groups A and B. The BAL and TTAs QCs results permit-
ted de-escalation in groups A and B respectively, in 94% (159 of
169) and 71.41% (125 of 175), whereas therapy remained
unchanged in 23.55% (49 of 208) and 37.5% (75 of 200). Overall
mortality in groups A and B was 30% (63 of 208) and 53% (105 of
200) (x2 ¼ 20.768, P < 0.005). Crude mortality when de-escalation
was applied in groups A and B respectively was 20.12% (32 of
159) and 71.41% (125 of 175) (x2 ¼ 23.294, P < 0.005) and when
therapy remained unchanged 37% (31 of 49) and 40% (45 of 75)
(P > 0.005).
Conclusions: In our data VAP patients had more favourable out-
come when de-escalation was applied t in the light of QCs of
BAL rather than TTAs.
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P1545 Pseudomonas aeruginosa and ventilator-associated
pneumonia: impact on outcome and duration of mechanical
ventilation
E. Giantsou, E. Efraimidou, I. Kouyoumtzi, M. Panopoulou,
A. Grapsa, N. Liratzopoulos, G.I. Minopoulos, S. Kartali,
K.I. Manolas
Alexandropolis, GR
Objectives: To compare Ventilator Associated Pneumonia (VAP)
because of Pseudomonas aeruginosa (PA) with VAP because of ﬂora
other the PA, in terms of duration of mechanical ventilation and
outcome.
Methods: A total of 208 patients [125 males (60%) and 83 females
(40%), median age 61.25 years, age range 21–87 years] diagnosed
as having developed VAP by quantitative culture results of bron-
choalveolar lavage (BAL) were enrolled between September 2001
and September 2003. Responsible for VAP ﬂora as PA or other than
PA, duration of mechanical ventilation up to VAP development
and up to discharge and outcome were the parameters recorded.
Results: VAP episodes were attributed to one pathogen in 120 epi-
sodes (58%) and multiple pathogens in 88 episodes (42%). In total
217 micro-organisms were developed in quantitative cultures of
BAL, and 107 (42%) were PA. VAP were attributed to other than
PA (OTPA) ﬂora in 106 (51%) and to PA (exclusively or to ﬂora
including PA among other strains) in 102(49%) episodes. The med-
ian value for APCHE II score in VAP episodes due to PA and due
to OTPA ﬂora was 15.57  4.52 and 16.25  4.86 respectively
(t ¼ 1.459, P ¼ 0.145). Crude mortality in VAP due to PA or OTPA
was 13.72% (14 of 102) and 16.98 (18 of 106) respectively
(P > 0.005). Median duration of ventilation I up to development of
VAP because of PA or to OTPA was 7.114 ¼ 6.27 and
9.21 ¼ 7.20 days respectively (P > 0.005). Duration of mechanical
up to discharge from Intensive Care in VAP because of PA or OTPA
was 8.49  7.63 and 8.13  6.79 respectively (t ¼ 0.511, P ¼ 0.609).
Conclusions: In our data no difference was detected between VAP
because of PA and VAP because of OTPA ﬂora, in terms of dur-
ation of mechanical ventilation and outcome.
P1546 Ventilator-associated pneumonia because of
glycopeptide-intermediate S. aureus in intensive care unit
patients: does vancomycin remain clinically effective?
S. Trad, A. Ben Ali, M. Garrouste-Orgeas, J.C. Nguyen Van,
J.F. Timsit, M.D. Kitzis, B. Misset, J. Carlet, F. Goldstein
Paris, F
Introduction: An increasing number of recent reports have sugges-
ted that Van was sub-optimal in the treatment of GISA infections.
This study looks at mortality of ICU patients with S. aureus VAP
because of MSSA, MRSA or GISA.
Methods: From 06/97 to 02/03, we extracted the following infor-
mation prospectively recorded from our database Outcomerea:
demographics characteristics, admission category, severity of ill-
ness at admission using the Simpliﬁed Acute Physiologic Score
(SAPS II), hospital mortality. All VAP were diagnosed using pro-
tected specimen brush and broncho-alveolar lavage samplings.
Van was monitored in all patients (pts). A Cox model with time-
dependent covariates was used to measure the impact of S. aureus
VAP on hospital mortality.
Results: Van administered as a continuous infusion was used
alone (21.4%) or in combination with fosfomycin (57.1%), fucidic
acid or synercid (21.4%) in GISA VAP. When adjusted on SAPS II
and category admission (medical vs. surgical), MRSA pneumonia
(OR: 2.50, 95% CI/ 0.6–10.06, P ¼ 0.20) and GISA pneumonia
(OR: 0.85, 95% CI: 0.14–5.05, P ¼ 0.85) were not associated with
an increased risk of mortality as compared with MSSA pneu-
monia pts.
Conclusions: Continuous IV Van therapy with accurate serum level
monitoring, achieving a 20–30 mg/L, appears effective in our
case-mix for the treatment of VAP because of GISA. Studies com-
paring Van to new available antibiotics are warranted and should
include, both a continuous IV regimen and a monitoring of Van
serum levels.
P1547 Incidence, risk factors and mortality of nosocomial
pneumonia in intensive care units: a prospective study
E. Alp, M. Guven, O. Yildiz, B. Aygen, A. Voss, M. Doganay
Kayseri, TR; Nijmegen, NL
Objectives: To determine the frequency, risk factors and mortality
of nosocomial pneumonia (NP).
Methods: Between February 2001 and February 2002 a prospective
study was conducted among intensive care units (ICU) patients of
the Erciyes University Hospital. Patients from the surgical ICU
(SICU) (24 beds), medical ICU (MICU) (nine beds) and burn unit
(seven beds) were included. Patients older than 16 years of age
were included. Data collection included physical examination
ﬁndings, APACHE II scores on admission and onset of NP, con-
sciousness, risk factors (intubation, MV, nasotracheal aspiration,
presence of nasogastric tube, enteral nutrition, tracheotomy), prior
surgery, immunosuppression, prior antimicrobial and antacid or
histamine type 2 (H2) blocker therapy, clinical outcome, length of
stay in ICU and in the hospital. NP was deﬁned according to the
Centers for Disease Control (CDC) Criteria. One hundred and
sixty three patients who were admitted to the ICU during the
same period but had no bacteriologic or histologic evidence of
pneumonia were used as a control group.
Results: Overall, 163 (6.8%) of the 2402 patients developed NP
and 75.5% (n ¼ 123) of all patients with NP were ventilator-asso-
ciated pneumonia (VAP). One hundred and sixty-three patients
who were admitted to the ICU during the same period but had
no bacteriologic or histologic evidence of pneumonia were used
as a control group. Coma, COPD, hypoalbuminaemia, mechanical
ventilation (MV), tracheotomy, presence of nasogastric tube, naso-
gastric aspiration, and previous treatment with broad spectrum
antibiotic were found as independent risk factors. Crude and
attributable mortality were 65 and 52.6%, respectively. The mor-
tality rate was ﬁve times greater in the cases (OR: 5.2; CI 95%:
3.2–8.3). The mean length of stay in the ICU and hospital in the
cases were longer than control group (P < 0.0001).
Conclusions: Patients requiring MV have a high frequency of NP.
NP is associated with poor prognosis and increases the length of
ICU and hospital stay.
P1548 Three-year surveillance of ventilatory-associated
pneumonia in a paediatric intensive care unit
A. Pawin˜ska, W. Kaminska, M. Migdal, J. Patzer,
D. Dzierzanowska
Warsaw, PL
Background: The aim of the study was to estimate the ethiology,
frequency of ventilatory-associated pneumonia in the PICU and
the contribution of patient’s endogenous ﬂora to the pathogenesis
of VAP.
Methods: Overall 177 patients admitted to the PICU between 01-01-
2000 and 31-12-2002 and required mechanical ventilation for more
than 2 weeks were enrolled to the study. Surveillance cultures of
BAL-ﬂuid, throat and rectum swabs were obtained on admission
and thereafter once weekly during the whole period of hospitalisa-
tion. Isolated strains were identiﬁed and susceptibility to antibiotics
was determined. The bacterial strains were typed by PFGE.
Results: Forty-nine of 177 patients, included in the study had pos-
itive BAL-ﬂuid culture on admission. The pathogens isolated from
BAL-ﬂuid at admission to the ward were as follows: Klebsiella
pneumoniae (13), Pseudomonas aeruginosa (10), Candida sp. (7),
MRSA (3), Serratia marcescens (3), Staphylococcus epidermidis (3),
Acinetobacter baumanii (2), Enterococcus faecalis (2) and Streptococcus
viridans (1), Enterobacter cloacae (1), Escherichia coli (1). In four cases
BAL-cultures were polymicrobial. Of 128 patients with negative
primary BAL-ﬂuid culture, 57 developed VAP during hospitalisa-
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tion. The organisms isolated from BAL-ﬂuid from VAP(+) patients
were: P. aeruginosa (20), K. pneumoniae (18), Stenotrophomonas malto-
philia (16), E. cloacae (7), S. marcescens (3), Acinetobacter (1), E. coli
(1), Enterococcus (1), MRSA (1). Seven cultures were polymicrobial
and four patients developed two episodes of VAP caused by dif-
ferent pathogens during respiratory treatment. The same organ-
isms were isolated from BAL-ﬂuid and throat and/or from
rectum swabs in 89 of 95 VAP-patients. Majority of Klebsiella
and Pseudomonas isolates obtained from BALs of different patients
had identical PFGE patterns, but isolates of Enterobacter and Ste-
notrophomonas were different. PFGE typing conﬁrmed that ﬁve
cases of VAP were caused by micro-organisms (K. pneumoniae 2,
P. aeruginosa 3) present at the time of admission. The remaining
VAPs were due to nosocomial ﬂora.
Conclusions: The majority of infection developed in our PICU was
caused by secondary endogenous ﬂora. Our results conﬁrmed
close relationship between endogenous ﬂora of individual patients
treated in the PICU and development of VAP.
P1549 Antimicrobial resistance of Gram-negative bacilli
isolated from patients with ventilator-associated pneumonia in a
Turkish university hospital
A. Yuce, N. Yapar, M. Erdenizmenli, S. Senger
Izmir, TR
Objectives: Ventilator Associated Pneumonia (VAP) is an import-
ant cause of mortality throughout the world. The aim of this
study is to investigate the antibacterial resistance of gram negative
basilli isolated from respiratory samples of patients having VAP.
Methods: The study included 60 Pseudomonas aeruginosa, 35 Acine-
tobacter spp, 28 Klebsiella pneumoniae and ﬁve Escherichia coli isola-
ted from tracheal aspiration and bronchoalveolar lavage samples
of patients having VAP. The antibiotic susceptibilities and Exten-
ded-spectrum beta-lactamase producing (ESBL) were determined
by ETest (AB BIODISK) using Mueller-Hinton agar (OXOID)
according to NCCLS recommendations.
Results: The antibiotic resistance of the strains are presented in the
Table. ESBL production ratio was 32% for K. pneumoniae strains
while it is produced by none of E. coli strains.
Conclusions: In our study the most common gram negative bacilli
causing lower respiratory tract infections, P. aeruginosa and Acine-
tobacter spp were noticed as resistant to many antimicrobials
including carbapenems. However, regarding all the strains, carb-
apenems and cefepime were identiﬁed as the most effective anti-
microbial agents.
P1550 Nosocomial pneumonia in postsurgical patients in
the increased care unit
P. Bakakos, D. Mallios, K. Tzagkaraki, G. Hillas, C. Moschos,
S. Marinopoulos, A. Rasidakis
Athens, GR
Objectives: In the Increased Care Unit of our hospital, severely-ill
patients (pts) are often hospitalised because of a failure of post-
surgical resuscitation.
Methods: We evaluated 80 pts, (40 men, 40 women), mean age
62.5  19 years. The mean duration of hospitalisation was
5.6  7.7 days. The cause of the surgical intervention was as fol-
lows: acute abdomen (20 pts, 25%), ileus (14 pts 17.5%), open
lung biopsy (12 pts 15%), abdominal Ca (eight pts 10%), trau-
matic haemothorax or pneumothorax (six pts 7.5%), pneumonec-
tomy (six pts 7.5%), rupture of concave viscera (four pts 5%),
aortal or abdominal aneurysm (four pts 5%), and miscellaneous
(six pts 7.5%).
Results: The total mortality was 42.5%. Twelve of 80 pts (15%)
developed nosocomial pneumonia with positive cultures of endo-
bronchial secretions in the ﬁrst 36–72 h of hospitalisation in the
Increased Care Unit (eight Staphyl. aureus, four Pseud. aeruginosa).
In 14 of 80 pts (17.5%) pneumonia occurred later and the causat-
ive micro-organism was isolated from the culture of endobronchi-
al secretions after the third day of hospitalisation in the Increased
Care Unit (eight S. aureus, four Acinetobacter sp. and 2 P. aeruginosa).
In the subgroup of pts with early-onset pneumonia (ﬁrst 3 days),
the mortality was 75%, while in the subgroup with late-onset
pneumonia (after third day) the mortality was 57.1%. No statisti-
cal difference was detected in APACHE II score between the two
subgroups (17.8  6.9, 16.5  6.6 respectively). No correlation was
found between mortality and age, sex or the cause of surgical
intervention.
Conclusions: Our ﬁndings indicate that in postsurgical pts that
require increased care the development of pneumonia during the
ﬁrst 3 days of their hospitalisation in the Increased Care Unit
(indication of colonisation or pre-existing infection possibly
unidentiﬁed) is related to a more severe prognosis.
P1551 The colonisation with polyresistant strains and




Objective: The colonisation and microaspiration are supposed to
be important factors in the development of ventilator-associated
infections. The spectrum of bacteria, isolated from both the oro-
pharynx and the bronchoalveolar lavage ﬂuids of 30 ventilated
multiple severe trauma patients in intensive care unit (ICU)
were studied in the period of 1–20 days from the onset of the
diseases.
Methods: The identiﬁcation of isolated bacteria was performed by
classical methods, and the susceptibility to antibiotics was tested
by Kirby–Bauer method according to NCCLS’s criteria. The sus-
ceptibility to Ciproﬂoxacin (CIP), Imipenem (IMP), Amikacin
(AN), Ceftazidim (CAZ), Cefepim (FEP) was examined. The dou-
ble-disk synergy test was used to detect extended-spectrum beta-
lactamases (ESBL) production.
Results: In the ﬁrst 4 days of admission, the strains ESBL-produ-
cing K. pneumoniae resistant to AN, susceptible to CIP and IMP
were isolated from the oropharynx in 40% ICU patients, there
being no infectious involvement of respiratory tract. Eighty per
cent patients who stayed at the hospital for more than 7 days were
demonstrated to have mucous membranes colonised additionally
with pyoverdin-producing strains P. aeruginosa, being resistant to
CIP, AN, IMP and susceptible to CAZ and FEP. Starting with the
tenth day of the patient’s stay in ICU, the microbial spectrum of
oropharynx presented the P. aeruginosa associated with K. pneumo-
niae, Acinetobacter spp. and Enterococcus spp. The similar associa-
tions were found in the process of microbiological study of
bronchoalveolar lavage ﬂuids in patients with the developed venti-
lator-associated bronchopulmonary infectious complications.
Conclusions: Thus, the study of the rate of colonisation and the
bacterial spectrum characteristics of the oropharynx showed that
the bronchopulmonary infectious complications in ventilated mul-
tiple severe trauma patients may be due to the aspiration of hos-
pital strains, colonising oropharynx early following the patient’s
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P1552 Changing epidemiology of multiresistant
Acinetobacter baumannii in intensive care and burns unit
patients, Sydney, Australia
T. Gottlieb, R. Bradbury, E. Cheong
Concord, AUS
Objectives: Review of multidrug-resistant Acinetobacter baumannii
(MRAB) incidence in a University teaching Hospital with a major
Burns Centre over 4 years 2000–2004. Relationship of number and
severity of burns and ICU rebuilding on cross-infection and bac-
teraemia rates. Impact of external source of MRAB, following
Bali Bombing in October 2002 on changing MRAB epidemiology.
Methods: Monthly retrospective review of pharmacy and laborat-
ory data, including susceptibility data. RFLP typing of MRAB iso-
lates.
Results: Longitudinal survey of MRAB incidence will be presented
graphically. The original strain of MRAB (clone A – meropenem
R, amikacin S) appeared in July 2000 and became the dominant
MRAB phenotype. Close correlation existed with numbers of
patients with severe burns and MRAB colonisation; cannula infec-
tion and bacteraemia. The rate increased during ICU rebuilding
when housed in a temporary facility, indicating failures in infec-
tion control as a factor in increased infection rates. Transfer to a
new facility resulted in reduced MRAB, but burn severity and
duration of ICU stay continue to be a predictor for individual
patient MRAB infection. From July 2000 to September 2002 there
were 52 MRAB bacteraemias. In 56%, bacteraemia (and cannula
tip infection) was the ﬁrst indicator of MRAB colonisation. After
the Bali bombing in October 2002, eight victims were admitted to
ICU. On admission, 7/8 were colonised with MRAB, with 12 dif-
ferent susceptibility phenotypes demonstrable, including isolates
susceptible only to polymyxin. All differed to MRAB clone A.
Some of these strain types have now supplanted the original clone
A, as dominant MRAB epidemic strains. Genetic relatedness typ-
ing presentation and performance is being planned. There has
been a resultant increase in demand for polymyxin use for sus-
pected MRAB infection. Environmental swabs have yielded vari-
able results. Faulty mattresses provided a maintained reservoir for
MRAB, but alterations have not curtailed ongoing transmission.
Conclusions: MRAB epidemiology is complex, particularly when
multiple clones become prevalent. Burns patients are at high risk
for colonisation and bacteraemia. Ongoing transmission is affected
by multiple factors including ward design, antibiotic use and
Burns Unit activity.
P1553 Antibiotic susceptibility of Acinetobacter strains
isolated in blood cultures of children
E. C¸iftc¸i, E. Ayberkin, H. Gu¨riz, A.D. Aysev, E. Ince, U¨. Dogru
Ankara, TR
Objectives: To determine the frequency and antibiotic susceptibil-
ity of Acinetobacter strains in blood cultures in Turkish children.
Methods: Blood culture results of children who had been admitted
to Children’s Hospital at Ankara University Medical School in
1992–2002 were retrospectively reviewed. Antibiotic susceptibility
of Acinetobacter strains was determined by disc diffusion method.
Intermediate-resistant strains were considered as resistant.
Results: Seventy-six of 1269 (6%) blood cultures were positive for
Acinetobacter strains. Acinetobacter strains constituted 13.8% of blood
cultures positive for all Gram-negative organisms. Acinetobacter
baumannii (68 strains) was the most common serotype followed by
A. lwofﬁi (seven strains) and A. haemolyticus (one strain). Antibiotic
susceptibilities of all Acinetobacter strains were as follows: ampicillin
30%, ampicillin–sulbactam 78%, amoxicillin–clavulanate 70%, pip-
eracillin 66%, piperacillin–tazobactam 88%, cephalothin 14%, cefu-
roxime 39%, ceﬁxime 42%, ceftriaxone 31%, ceftazidime 46%,
cefotaxime 53%, cefoperazone 50%, cefoperazone–sulbactam 81%,
cefepime 71%, aztreonam 44%, imipenem 100%, meropenem
100%, ciproﬂoxacin 93%, oﬂoxacin 90%, amikacin 86%, gentamicin
85%, netilmicin 76%, tobramycin 72%, and trimethoprim–sulfa-
methoxazole 64%.
Conclusions: Carbapenems, ﬂuoroquinolones, piperacillin–tazobac-
tam and cefoperazone–sulbactam are the most effective agents
against Acinetobacter strains isolated in blood cultures of children
in our hospital. The results of our study demonstrate that antibi-
otic resistance is an important problem for Acinetobacter infections
in Turkey.
P1554 Epidemiological characterisation of Acinetobacter
baumanii isolated in a university hospital
M.I. Ramos, T. Delgado, M. De Frutos Serna, M. Lecuona,
M. Garcia Prados, A. Sierra
La Laguna, E
Objective: The aim of the study was to determinate the epidemio-
logical patterns of Acinetobacter baumannii isolates in a tertiary
Hospital.
Methods: During the period from 01 January 2000 to 15 November
2003 we performed a prospective study of all medical charts from
patients with A. baumanii isolates. Identiﬁcation and susceptibility
testing was performed by the VITEK II (Biomerieux) automatised
system. A case of nosocomial infection was deﬁned using the cri-
teria established by the CDC (1998, USA).
Results: During this period, 129 A. baumanii strains were collected
from 115 patients: 60 (46%) were collected from patients hospital-
ised at medical ward, 43 (33%) isolates from surgery wards and
23 (17%) from the intensive care units patients. The average hos-
pital stay before A. baumanii was detected was 37.2 days and the
mean age was 61 years old (range 5 days to 92 years). The sources
of isolates were as follows: wounds 51 (40%), respiratory speci-
mens 29 (23%), urine 28 (22%), catheters nine (6%), blood seven
(5%) and others samples ﬁve (3%). Forty of 129 (31%) were no-
socomial infections: 12 (30%) urinary tract infections, eight (20%)
surgical site infections, eight (20%) skin and soft tissues infec-
tions, seven (17.5%) bloodstream (six primary bacteraemia, one
catheter-related infection) and ﬁve (12.5%) respiratory tract infec-
tions. Ninety-nine per cent of the isolates were susceptible to imi-
penem. Seventy-three per cent were susceptible to amikacin,
56.5% to piperacillin–tazobactam, and 43% to ceftazidime. We
did not ﬁnd outbreaks.
Conclusions: At the moment A. baumanii is not yet a health prob-
lem in our hospital. However, in order to prevent nosocomial out-
breaks and multiresistant strains, surveillance, antibiotic policies
and infection control measures should be supported.
P1555 Acinetobacter baumanii isolated from surgical
patients
S. Baka, I. Logginidis, E. Chatzoudi, E. Gamaletsos, S. Demeridou,
E. Choustoulakis, E. Kouskouni
Athens, GR
Objectives: Acinetobacter baumanii (A.b.) has emerged as an import-
ant nosocomial pathogen showing usually an increasing resistance
to antibiotics. The purpose of our study was to investigate A.b.
strains isolated in our hospital for a 3-year period.
Methods: Beginning January 2001 to November 2003 all strains of
A.b. isolated from surgical patients were studied. Isolation of A.b.
was based on standard methods, while identiﬁcation and antibi-
otic susceptibility testing were carried out using the VITEK Sys-
tem, ATB Expression (BioMerieux, France).
Results: Ninety-ﬁve strains of A.b. from 33 surgical patients were
isolated. Of the 33 patients 23 were males (69.7%) and 10 were
438 Abstracts
females (30.3%). Most of the patients (75.8%) were or had been in
the ICU when A.b. was isolated. The median time of stay in the
ICU prior to the detection of A.b. was 20.2 days (range 2–65). The
most common isolation sites were surgical wound infection
(46.3%) and blood (21,0%). Most of the patients (60,6%) had
undergone surgery and 36.4% were on mechanical ventilation
device. Of the antimicrobial agents tested the most active against
A.b. strains isolated were carbapenems (meropenem with 14%
and imipenem with 19% resistance). Cefepim presented moder-
ated activity (46% resistance) and the same was true for the com-
bination piperacillin + tazobactam (51% resistance). Most of the
strains were resistant to piperacillin (69%), amikacin (78%) and
ceftazidime (85%).
Conclusions: Colonisation with A.b. occurred mostly in patients
who had been in the ICU and in those who underwent surgery.
The strains isolated from our hospital were highly resistant posing
a serious threat to hospitalised patients.
P1556 A. baumannii clonal dissemination in Brazilian
intensive care units during 2002
C. Mendes, J. Sampaio, S. Sinto, S. Leao, C. Oplustil, P. Turner,
C. Kiffer – MYSTIC Brazil Group
Objective: To investigate the clonal dissemination of multiresistant
A. baumannii causing nosocomial infections within and between
Brazilian intensive care units, which participated in the MYSTIC
Program Brazil 2002.
Methods: Twenty-two A. baumannii isolates with the same pheno-
typic characteristics were collected during 2002 at two centres in
Sa˜o Paulo city (centre nos 1 and 4). Isolates resistant to either me-
ropenem or imipenem were studied. They were analysed by
pulsed-ﬁeld gel electrophoresis (PFGE). SpeI genomic restriction
fragments were separated with CHEF-DR III System. Electropho-
retic patterns were analysed with GelCompar II v. 2.5 (Applied
Maths, Kortrijik, Belgium). Interpretative criteria used were those
described by Tenover et al.
Results: Eight major clones were identiﬁed (A, A1, A2, A3, B, F,
G, H). Clone A is constituted of ﬁve isolates with indistinguish-
able patterns, three from centre nos 1 and 2 from centre no. 4,
indicating clonal dissemination between centres. Clones A1, A2,
A3 are closely related to clone A, probably representing clonal
dissemination within centre no. 1. Clone B is possibly related to
clone A, also present in centre no. 1. Clones F and G are constitu-
ted of two isolates each and are closely related, both present in
centre no. 4 indicating clonal dissemination within centre. Clones
H and H1 are constituted of three isolates that are closely related,
also indicating clonal dissemination within centre no. 1.
Conclusions: Clonal dissemination was detected within (clones A,
A1, A2, A3, B, F, G, H) and between centres (clone A). These ﬁnd-
ings are important when analysing surveillance data, as suscepti-
bility rates may be signiﬁcantly affected with elevated resistance
mainly because of due to clonality.
P1557 One hundred ﬁfty Acinetobacter spp. isolates –
identiﬁcations by API and VITEK systems
A. Sledzinska, E. Czarniak, A. Samet, J. Kur
Gdansk, PL
Objective: Comparison of identiﬁcation of one hundred ﬁfty Acine-
tobacter spp. isolates obtained from 1996 to 1999.
Methods: From May 1996 to January 1999 Acinetobacter spp. isola-
ted from clinical and environmental specimens were identiﬁed by
API 20 NE and VITEK system (bioMerieux). Forty-ﬁve isolates
(30%) were obtained from wounds, 35 (23%) from blood, 33
(22%) from respiratory system, 17 (11%) from environmental
examinations and 19 (13%) from other clinical specimens.
Results: Using API 20 NE we differentiated eight phenotypes of
Acinetobacter spp. Only one isolate was identiﬁed as A. lwofﬁi, 149
were identiﬁed as A. baumanii. The predominant phenotypes
were: phenotype e-0041073 – 46.6% (n ¼ 70), phenotype c-0001073
– 36% (n ¼ 54) and phenotype g-0041473 – 8.6% (n ¼ 13). VITEK
system differentiated six phenotypes with predominant phenotype
II-30111000004 – 82,6% (n ¼ 124). Comparison of phenotypes
obtained by API and VITEK system shows that predominant phe-
notypes were eII-0041073/30111000004 (59 isolates – 39.3%) and
cII-0001073/30111000004 (48 isolates – 32%).
Conclusions: During the 4-year period two predominant pheno-
types of A. baumannii were identiﬁed. Endemic outbreak was sus-
pected which prompted us to conduct molecular epidemiology
study.
P1558 Bacteraemia due to Stenotrophomonas maltophilia
strains in children
E. Ayberkin, E. C¸iftc¸i, H. Gu¨riz, A.D. Aysev, E. Ince,
S. Arsan, G. Yavuz, U¨. Dogru
Ankara, TR
Objectives: To evaluate the clinical features, antibiotic treatment
and prognosis of Stenotrophomonas maltophilia bacteraemia in Turk-
ish children in a university hospital.
Methods: Patients whose blood cultures had been found to be pos-
itive for S. maltophilia at the Children’s Hospital of Ankara Uni-
versity Medical School in 1992–2002 were retrospectively
evaluated. Antibiotic susceptibility of S. maltophilia strains was
determined with disc diffusion method. Susceptibility to ciproﬂ-
oxacin was also determined with agar dilution method.
Results: Thirty-one of 1269 (2.4%) blood cultures were positive for
S. maltophilia that constituted 5.6% of blood cultures positive for
all Gram-negative organisms. All bacteraemia episodes were
hospital-acquired. Twenty-two patients (71%) had an underlying
illness. Twenty patients (65%) were receiving antibiotic therapy
within the previous week. Septicaemia and pneumonia due to S.
maltophilia bacteraemia were the most common clinical diagnoses.
Ciproﬂoxacin or trimethoprim–sulfamethoxazole in combination
with/without an aminoglycoside were the most common selected
antibiotics for the treatment of S. maltophilia infections. Only one
child died during acute S. maltophilia bacteraemia episode. Anti-
biotic susceptibilities of 31 S. maltophilia strains to various antibiot-
ics are as follows; penicillin G 0%, ampicillin 0%, ampicillin–
sulbactam 0%, amoxicillin–clavulanate 0%, piperacillin 0%, ticar-
cillin–clavulanate 68%, cephalothin 22%, cefuroxime 19%, ceﬁxi-
me 32%, ceftriaxone 27%, ceftazidime 21%, cefotaxime 25%,
cefoperazone 0%, cefoperazone–sulbactam 55%, cefepime 33%,
aztreonam 0%, meropenem 0%, ciproﬂoxacin 100%, oﬂoxacin
100%, amikacin 38%, gentamicin 22%, netilmicin 41%, tobramy-
cin 45%, chloramphenicol 25%, doxycycline 91%, and trimetho-
prim–sulfamethoxazole 85%. Ciproﬂoxacin susceptibility was
determined as 49% by agar dilution method.
Conclusions: Our study demonstrates that although S. maltophilia
bacteraemia is rare in children, the antibiotic resistance is an
important problem in these strains. Tetracyclines, trimethoprim–
sulfamethoxazole and ﬂuoroquinolones are the most effective
agents against S. maltophilia strains isolated from blood cultures of
children in our hospital. However, ciproﬂoxacin susceptibility
should be determined by dilution methods. Prompt administra-
tion of appropriate antibiotics improves the prognosis of S. malto-
philia bacteraemia.
P1559 Typing of hospital strains of Stenotrophomonas
maltophilia by pulsed-ﬁeld gel electrophoresis
W. Kaminska, J. Patzer, A. Pawin˜ska, J. Wieczynska,
D. Dzierzanowska
Warsaw, PL
Objectives: To characterise the epidemiological relationships
among Stenotrophomonas maltophilia isolates in the surgery and
intensive care unit (ICU) of our hospital over a 12-month period
in which an increased number of isolates was observed.
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Patients and Methods: Majority of the surgery patients were liver
transplant recipients, and other surgical and ICU patients with
severe underlying diseases, predisposing the drug-resistant infec-
tions. S. maltophilia strains were isolated from blood, surgical
wounds, drainages, BAL, throat and stool. A total of 72 clinical
strains were characterised by antibiotype and 54 were character-
ised by genotype [pulsed-ﬁeld gel electrophoresis (PFGE) diges-
tion with XbaI]. Identiﬁcation was conﬁrmed by the API 20 NE
system. Antimicrobial susceptibility testing was performed using
disc-diffusion methods according to the NCCLS recomendations.
Results: Almost all strains had different genomic patterns in PFGE.
Only four patients from ICU were infected or colonised by the same
strain. Strains from an individual patient with different antibiotype
patterns, or ESBL+ and ESBL, had the same PFGE pattern.
Conclusions: PFGE revealed the endogenous source of S. malto-
philia that had infected and colonised all surgical patients, and
only few clonal infections or colonisations existing among ICU
patients. This ﬁnding conﬁrms the selective role of carbapenems’
therapy in the risk of S. maltophilia infections.
P1560 The Stenotrophomonas maltophilia K279a genome
sequence project
M. Avison, A. Okazaki, V. Gould, J. Parkhill
Bristol, Cambridge, UK
Objectives: S. maltophilia is an important, emerging, nosocomial
pathogen. Isolates are generally highly resistant to beta-lactams,
macrolides and aminoglycosides, ﬂuoroquinolones, tetracyclines
and chloramphenicol. The threat of S. maltophilia comes from its
multi-drug resistance, its ability to form bioﬁlms, and so colonise
surfaces of medical devices, and its ability to produce virulence
factors. We report here preliminary analysis of the genome
sequence of a clinical S. maltophilia isolates, K279a from Bristol
(UK).
Methods: S. maltophilia isolate K279a is in the same 16S rRNA sub-
group as the type strain, and was isolated in 1995 from a bacter-
aemia oncology patient. Genomic DNA was produced by the
CTAB method, sheared, and ligated into the cloning vector
pUC18. Shotgun sequencing was performed and raw sequence
data assembled into contigs. Contigs were searched using tBlastn
for homologues to database sequences.
Results: Currently, 62 854 reads totalling 44.736 Mb of raw
sequence have been performed, giving a theoretical coverage of
99.99% of the genome. There are currently, 413 contigs > 1kb
(362 contigs > 2 kb) with a total size of 4.835 Mb. Blast analysis
reveals six operons being homologous to known tripartite multi-
drug efﬂux pumps; smeDEF, smeABC, homologues of the Pseu-
domonas aeruginosa mexCD and mexEF, and of the Acinetobacter
baumanii adeABC. A homologue of the Xanthomonas campestris
rpf cluster, which is involved in quorum sensing and virulence
factor production, has been located. This system is unique to
members of the Xanthomonas group (which includes S. malto-
philia), which do not produce the quorum-sensing signal, homo-
serine lactones. A number of putative virulence factor genes
have been located.
Conclusions: Determination of the S. maltophilia genome sequence
will allow knock-out mutagenesis to determine which genes are
important for multidrug resistance, bioﬁlm formation and viru-
lence factor production, which together give this bacterium its
potential for future threat in the clinical setting.
P1561 Subgrouping of Stenotrophomonas maltophilia
isolates by 16S rRNA sequence allows prediction of beta-lactam
resistance proﬁle
A. Okazaki, V. Gould, M. Avison
Bristol, UK
Objectives: Stenotrophomonas maltophilia is an important, emerging,
nosocomial pathogen. Isolates are generally highly resistant to
beta-lactams, macrolides and aminoglycosides, ﬂuoroquinolones,
tetracyclines and chloramphenicol. Isolates from Bristol (UK),
have been subgrouped according to 16S rRNA sequence into
three: A, B and C. Interestingly, group A isolates are resistant to
all beta-lactams because of inducible L1 and L2 beta-lactamases;
Group B isolates are resistant to all beta-lactams except later gen-
eration cephalosporins because only L1 is inducible; Group C iso-
lates are not resistant to beta-lactams, because they do not express
inducible beta-lactamases. The aim of this study was to see if sim-
ilar groupings of S. maltophilia isolates could be found in a collec-
tion of isolates from another European country.
Methods: Seven Turkish S. maltophilia isolates were used. 16S
rRNA sequencing was performed using PCR. Beta-lactamase
induction was attempted using imipenem (2 mg/L for 2 h) in
nutrient broth grown cultures. Nitroceﬁn-hydrolysis assays used a
spectrophotometer and crude cell extracts. MICs were determined
by E-test, using Muller–Hinton agar.
Results: From 16S rRNA sequencing, the seven Turkish isolates
were divided into four groups, three isolates were identical to
Bristol group A, two isolates to Bristol group B and one isolate to
Bristol group C. One isolate (group D) had a novel 16 S rRNA
sequence. Beta-lactamase induction, coupled to assays of com-
bined L1 + L2 activity (in the absence of EDTA), or L2 activity
alone (in the presence of EDTA) conﬁrmed that the Turkish group
A, B and C isolates behaved exactly like the equivalent Bristol iso-
lates. Group D isolates have an inducible L1 only. The proﬁle of
beta-lactamase inducibility reﬂected beta-lactam resistance levels;
with group B and D isolates having lower MICs of cephalosporins
than group A isolates, and group C isolates not being resistant to
beta-lactams at all.
Conclusions: We have shown that not all S. maltophilia isolates
have the same proﬁle of beta-lactamase expression, and so resist-
ance, but the pattern is not random. There is a clear link between
16S rRNA sequence subtype and expression of beta-lactamases.
Knowledge of such a link might be important in a clinical setting.
P1562 Expression of putative pathogenicity factors by
clinical isolates of Stenotrophomonas maltophilia
R. Podschun, H. Sahly, N. Vellmer, U. Ullmann
Kiel, D
Objectives: Stenotrophomonas maltophilia is increasingly reported to
cause nosocomial infections in the immunocompromised, ventila-
ted patient. However, little is known about its pathogenicity fac-
tors. The present study investigates the ability of clinical isolates
of S. maltophilia to express characters that are considered to be
virulence factors in other nonfermenters.
Methods: A total of 92 S. maltophilia clinical isolates were investi-
gated. For comparison, 50 clinical Pseudomonas aeruginosa strains
were included in the study. Haemolytic activity was examined on
sheep blood agar, and elastase production on elastin-trishydro-
chloride agar after incubation of the bacteria for 3 h at 37C. Sus-
ceptibility to the bactericidal activity of serum was examined by
determining the survival rates for 3 h in 75% normal human
serum. Induction of respiratory burst as a gauge of phagocytosis
of the bacteria by neutrophils was measured by the luminol-
enhanced chemiluminescence test.
Results: Production of elastase was detected more frequently
among S. maltophilia isolates (77%) than among P. aeruginosa
strains (64%), while haemolytic activity could be observed in both
species with similar frequencies (100% vs. 98%). Stenotrophomonas
maltophilia isolates were found to be signiﬁcantly less often serum
resistant (10%) than P. aeruginosa strains (30%). In contrast, the
level of respiratory burst induction in neutrophils by S. maltophilia
isolates was signiﬁcantly higher than that observed by P. aerugi-
nosa strains (P < 0.0001).
Conclusions: Our results show that, except serum resistance prop-
erties, the ability of clinical S. maltophilia isolates to express char-
acters regarded as pathogenicity factors is similar (haemolysin,
elastase expression) or even higher (no stimulation of neutrophils)
than that of P. aeruginosa, and indicate a pathogenic potential of
S. maltophilia.
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P1563 Outbreak of Pseudomonas putida bloodstream
infection
M.B. Souza Dias, V.L. Borrasca, V. Stempliuk, M.H. Miyake,
A. Colli, M.R. Arau´jo
Sa˜o Paulo, BR
Objectives: Describe the investigation and control of the outbreak.
Methods: Hospital Sirio-Libanes is a private 250 bed community
hospital in Sao Paulo (Brazil), with predominantly surgical and on-
cologic patients. Pseudomonas putida was isolated in blood cultures
(BC) from eight patients in 2 days – an outbreak was suspected.
Positive BC and bacteria were identiﬁed by automated methods
(Bactec and Vitek). Strains were genotyped by RAPD using ERIC 2
as primer. A case was any patient with a BC positive for P. putida.
All ﬁrst eight cases had tumours and carried a central venous cath-
eter (CVC); therefore the heparin lock solution was suspected. Pre-
ﬁlled heparin syringes were recently bought from a new caterer. All
patients charged for heparin lock (since the day the ﬁrst case
received it) who carried a CVC were called in for catheter drawn
BC, irrespective of signs/symptoms. After blood drawing, long-
term CVCs were locked with amicacin and heparin and oral ciproﬂ-
oxacin was started. Most patients with positive BC and long-term
CVC were treated with IV and local (lock) antimicrobial agents and
short-term (n ¼ 5) CVCs were removed promptly.
Results: P. putida was isolated from one of three valid lots of hep-
arin lock syringes in use and from BC of 32 patients. A total of
154 patients had been charged for the heparin syringe. Thirty non-
symptomatic patients with a CVC were called in and 26 attended;
seven of 26 had chills and fever after CVC manipulation. Fourteen
of 26 nonsymptomatic and 18 symptomatic patients had P. putida
isolated. Eleven patients had BC drawn from both the CVC and
venipuncture – seven had positive BC only from the CVC (ﬁve
symptomatic) and four had positive BC from both sites (three
symptomatic). BC from 10 patients also yielded Stenotrophomonas
maltophilia. Only ﬁve of 27 long-term CVC had to be removed.
Genotyping of P. putida from patients showed three different band
patterns; two of these were also found in heparin isolates to the
present moment.
Conclusions: (1) Manipulated preﬁlled heparin solution plastic
syringes were contaminated with P. putida; (2) BC collected
through the CVC may be preferable to venipuncture in the diag-
nosis of CVC-related infections; (3) Most long-term CVC (22 of 27)
were salvaged with IV associated with lock antimicrobial therapy;
(4) The clinical and epidemiological signiﬁcance of the S. malto-
philia isolates is unclear and under investigation.
P1564 Burkholderia cepacia complex in an Italian cystic
ﬁbrosis centre: epidemiology and clinical course of patients
infected with different, Burkholderia cenocepacia RecA strains
G. Manno, C. Dalmastri, S. Tabbacchioni, P. Vandamme,
L. Minicucci, L. Romano, L. Chiarini, A. Bevivino
Genoa, Rome, I; Ghent, B
Objective: Bacteria of the Burkholderia cepacia complex (Bcc) are
important pathogens in cystic ﬁbrosis (CF) patients (pts). Bcc com-
prises at least nine species or genomovar. Aim of this study was
to assess the epidemiology of Bcc recovered from pts attending
the CF Centre at the Gaslini Children’s Hospital (Genova, Italy)
from 1984 to 2001.
Methods: A total of 195 Bcc isolates were recovered from 75 of 326
(23%) of pts in regular follow up in the study period. The genom-
ovar of all isolates was determined by RFLP analysis of recA gene
and conﬁrmed by PCR of recA with genomovar-speciﬁc primers.
All strains were typed by RAPD analysis. The clinical course of
pts infected by different species was determined comparing: infec-
tion with P. aeruginosa prior Bcc acquisition, changes in lung func-
tion (FEV1) and body weight in the 2-year Bcc postacquisition
period, mortality in long-term period.
Results: Burkholderia cenocepacia (genomovar III) is the predomin-
ant species recovered from the CF pts infected with Bcc in the
Genoa Centre. Of the other eight species comprising the Bcc, only
few isolates belonging to Bc genomovar I, B. stabilis, and B. pyrroc-
inia were found. Of the four recA lineages of B. cenocepacia, most
pts harboured IIIB strains. Patient-to-patient spread of Bcc among
CF pts was mostly associated with B. cenocepacia strains, in partic-
ular with IIIA and IIID recA lineages. Mortality was signiﬁcantly
higher in pts infected with Bcc than in noninfected pts. All deaths
were associated with the presence of B. cenocepacia. Within B. ceno-
cepacia, infection with epidemic strains belonging to lineages IIIA
and IIID was associated with higher mortality than with lineage
IIIB strains. No signiﬁcant differences in lung function, body
weight and mortality rate were observed between pts infected
with epidemic strains belonging to either B. cenocepacia IIIA or B.
cenocepacia IIID.
Conclusions: Our study conﬁrms the prevalence of B. cenocepacia
among Bcc-infected CF pts and the high percentage of mortality
associated with this species. The major role of an epidemic strain
belonging to the recently identiﬁed recA lineage IIID in spreading
Bcc infection among CF pts has been recognised for the ﬁrst time.
Hepatitis C
P1565 Pegylated interferon-alpha2a and ribavirin in
HIV-HCV co-infected patients
G. Cariti, S. Bonora, F.G. De Rosa, O. Bargiacchi, S. Audagnotto,
D. Aguilar, F. Lipani, M. Bonasso, C. Tettoni, A. Poggio,
M. Gobber, P.G. Orsi, M. Anselmo, F. Indiveri, G. Ferrea,
A. Sinicco, T. De Blasi, R. Raiteri, G. Di Perri
Turin, Verbania, Vercelli, Alessandria, Savona, Genoa, Sanremo, I
Objectives: Standard interferon treatment of Hepatitis C Virus
(HCV) infection in HIV-positive patients had low response rates,
with or without ribavirin (RBV). Better outcomes have been
obtained with pegylated interferons, although liver toxicity of
antiretroviral drugs, immune restoration and metabolic syn-
dromes are major confounding variables in co-infected patients.
We started an open, multicentre, prospective study with pegylat-
ed interferon-alpha2a (PegIFN) and RBV in co-infected patients
not undergoing antiretroviral treatment.
Methods: Inclusion criteria were: absence of antiretroviral treatment
(ART) for more than 24 weeks, CD4+ cell count 350/mm3, HIV-
RNA < 30 000 copies/mL, and biopsy-proven chronic C hepatitis.
Patients were treated with PegIFN alpha2a 180 lg subcutaneously
weekly and RBV 800 mg po daily for 48 weeks. HIV-RNA, HCV-
RNA, CD4+ cell count and ALT level were monitored.
Results: As of October 2003, 28 patients (median age: 39 years)
started the treatment. HCV non-1 genotype was found in 88% of
patients. At 12 and 24 weeks, respectively, 58.3 and 62.5% of
patients had virological response (HCV-RNA < 100 copies/mL),
and 75% of patients had biochemical response. There was no sig-
niﬁcant decrease of median CD4+ cell count from the baseline
and HIV-RNA did not change signiﬁcantly. Five patients (17.8%)
discontinued treatment because of adverse effects.
Conclusions: A virological response was obtained in more than
50% of patients. These data indicate that administration of Peg-
IFN and ribavirin may be effective in co-infected patients. Treat-
ment of HCV infection without concomitant ART may offer some
advantages: avoidance of hepatotoxicity of antiretroviral drugs
and no immune restoration syndrome potentially complicating
the treatment. Moreover, a CD4+ cell count above 350/mm3 is
associated with a good immune system activity. Limits of our
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study were the high prevalence of non-1 HCV genotypes, which
is known to be associated with a better response rather than geno-
type 1.
P1566 Compliance and response to PEG-IFN alpha and
Ribavirin combined treatment of a special category of chronic
hepatitis C patients, the ex-users of intravenously administered
narcotic substances
C. Drakoulis, E. Stavropoulou, E. Nikitidis, S. Nikolaou, C. Malli,
E. Katsadorou, M. Minadaki
Piraeus, GR
Purpose: Evaluation of both compliance and response to PEG-IFN
alpha and Ribavirin combined treatment of a special category of
chronic hepatitis C patients, the ex users of intravenously admin-
istered narcotic substances.
Material and Methods: Sixty-two patients who had stopped using
addictive substances about 6 months before initiating combined
treatment with PEG-IFN alpha were studied. Among them 57
were men and ﬁve were women (average age 31 years old).
Results: As regards this category of patients, compliance with
treatment was poor. A 20.9% (13 patients) fully complied with
treatment, 29.1% (18 patients) partly complied with it (did not
return for the second biopsy and PCR tests), while 46.7% (29
patients) did not follow the treatment recommended. Two of 13
treatment-abiding patients had to interrupt it, because of very
serious side-effects, such as severe weight loss and peronial nerve
paresis. The S.V.R. of the 13 treatment-abiding patients is assessed
to 84.9%.
Conclusions: The intravenous narcotic substances users abide by
the recommended treatment to a very limited extent, while they
respond to combined PEG-IFN alpha and Ribavirin treatment to a
great extent. This greater extent of response is attributed to the
patients’ young age as well as the prevailing genotype 3.
P1567 Effects of combination treatment with interferon
and ribavirin on endothelial cell inﬂammatory integrins and
stress markers in advanced chronic hepatitis C
I. Korzh, I. Fedotova, V. Nemtsova
Kharkov, UKR
Objectives: Individuals with chronic hepatitis C (CHC) progress to
cirrhosis and hepatic cancer. Individuals with advanced CHC are
coagulopathic and can manifest ﬁbrinolysis. The coagulopathy is
a consequence of hepatocytic dysfunction. The ﬁbrinolysis repre-
sents a response to local endothelial cell injury. Interferon and rib-
avirin decrease necroinﬂammation in chronic hepatitis C with or
without virological clearance. The aim of this study was to evalu-
ate the effect of combination therapy with interferon and ribavirin
on endothelial cell inﬂammatory integrins and measures of endot-
helial stress.
Methods: Immediately prior to the treatment in 53 individuals
with advanced CHC, the plasma levels of tissue factor (TF),
thrombomodulin (TM), soluble ICAM-1 (s-ICAM-1), soluble
VCAM-1 (s-VCAM-1), soluble L-Selectin (s-L-Selectin), the pro-
thrombin time and the activated partial thromboplastin time were
determined. The same parameters were assayed at 1, 4, 12 and
24 weeks.
Results: TF and TM levels were very high at baseline consistent
with a vascular endothelial stress response. Similarly s-ICAM-1, s-
VCAM-1 as well as L-Selectin levels were increased. At 4 weeks
after the therapy, a marked reduction in TM, ICAM-1 and
VCAM-1 and to a lesser degree TF and L-Selectin levels was
observed. This reduction persisted for 24 weeks. No change in
measures of ﬁbrinolysis [plasminogen activator inhibitor-1 (PAI-
1), total tissue factor pathway inhibitor (t-TFPI), activated tissue
factor pathway inhibitor (TFPIa), d-dimers (DD), and ﬁbrinogen
levels] occurred.
Conclusions: Based upon these data it can be concluded that: (1)
combination therapy with interferon and ribavirin corrects the co-
agulopathy seen in advanced CHC; (2) reduces endothelial cell
injury and/or stress as evidenced by the TF, TM, s-ICAM-1 and s-
VCAM-1 levels in plasma; (3) these changes in coagulation
occurred without inducing a propagated vascular thrombosis.
P1568 Inﬂuence of interleukin-10 therapy on endothelial
cell proteins in patients with chronic hepatitis C
O. Korzh
Kharkov, UKR
Objectives: Hepatitis C virus (HCV) infects hepatocytes and util-
izes the hepatocyte to replicate. In so doing, many hepatocyte
activities are shifted from their native state to one reﬂecting liver
cell stress. Thrombomodulin and tissue factor are endothelial cell
proteins that are expressed as a result of tissue injury or stress.
The aim of this study was determine the effect of interleukin (IL)-
10 administrations on levels of thrombomodulin and tissue factor
in patients with HCV-related liver disease.
Methods: Forty-three patients with chronic hepatitis C who had
failed antiviral therapy were enrolled in a 6-month treatment regi-
men with SQ IL-10 given daily or thrice weekly. Liver biopsies
were performed before and after therapy. The levels of thrombo-
modulin and tissue factor in plasma and hepatocyte cytosol have
been evaluated.
Results: IL-10 led to signiﬁcant improvement in serum ALT (mean
ALT: day 0 ¼ 151  14 vs. month 6 ¼ 78  11; P < 0.05). Hepatic
inﬂammation score decreased by at least two in 17 of 43 patients
(mean decrease from 5.7  0.5 to 4.8  0.7, P < 0.05) and 14 of 43
showed a reduction in ﬁbrosis score (mean change from 6.1  0.7
to 5.1  0.2, P < 0.05). IL-10 caused a decrease in thrombomodulin
level both in plasma and cytosol (P < 0.01). These changes parallel
the improvement in ALT. The levels of tissue factor in plasma
and cytosol varied minimally between baseline and after IL-10
therapy.
Conclusions: IL-10 therapy appears to decrease disease activity in
patients with HCV-related liver disease. Thrombomodulin may be
unique marker of cellular and endothelial stress present in indi-
viduals with chronic hepatitis C. This marker might be useful
during the clinical course of chronic hepatitis C, as a means of
gauging the tissue response to therapy.
P1569 Correlation between endothelial haemostatic
markers in patients with chronic hepatitis C
O. Korzh
Kharkov, UKR
Objectives: Thrombosis of the small intrahepatic veins has been
suggested to trigger liver tissue remodelling. It has been sugges-
ted to be quantiﬁed by measuring plasma markers, such as von
Willebrand factor and thrombomodulin and soluble adhesion
molecules. We hypothesized there may exist a correlation between
the plasma levels of von Willebrand factor, thrombomodulin, and
tissue plasminogen activator antigen (tPAag) as markers of endot-
helial cell dysfunction and the serum concentrations of soluble
adhesion molecules and monocyte chemoattractant protein-1
(MCP-1) in patients with chronic hepatitis C.
Methods: Patients (n ¼ 117) with chronic hepatitis C without
malignancy, a history of venous thrombosis, or antiviral/immuno-
suppressive therapy within the last 6 months and matched con-
trols (n ¼ 115) were included. To evaluate possible inﬂuence of
acute phase reaction, reinvestigation was performed after
6 months.
Results: The concentrations of von Willebrand factor, thrombo-
modulin and tPAag in plasma were signiﬁcantly higher in
patients with chronic hepatitis C as compared with healthy sub-
jects (P ¼ 0.017, P < 0.05 and P < 0.001, respectively), still statisti-
cally signiﬁcant after 6 months and also after adjustment for
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established risk factors. The patients also had signiﬁcantly higher
concentrations of soluble vascular cell adhesion molecule-1
(sVCAM-1) and MCP-1 compared with healthy controls (P < 0.001
for both comparisons). There were strong correlations between the
concentration of soluble intercellular adhesion molecule-1
(sICAM-1) and von Willebrand factor in patients with chronic
hepatitis C (r ¼ 0.64, P < 0.001), between the concentration of
thrombomodulin and sVCAM-1 (r ¼ 0.62, P < 0.001), and between
tPAag sVCAM-1 (r ¼ 0.51, P < 0.05). Furthermore, a negative cor-
relation was observed between the concentration of thrombomo-
dulin and the cell surface expression of CD11b on monocytes and
granulocytes in the peripheral circulation (P < 0.05 in both cases).
Conclusions: The strong correlation between markers of endothel-
ial dysfunction and soluble adhesion molecules in patients with
chronic hepatitis C strengthen the view that an ongoing stress on
endothelial cells is present in these patients. This may play a
pathophysiological role in the progression of disease.
P1570 The role of antibodies against NS5 protein of
hepatitis C virus (HCV) and IgM antibodies against HCV as
predictive factors to the treatment with interferon alpha in
patients with chronic hepatitis C
V. Mitsura
Gomel, BLR
Objectives: Antibodies against NS5 protein of hepatitis C virus
(HCV) and IgM antibodies against HCV (anti-HCV IgM) were
studied as predictors of response to the therapy with interferon
alpha in patients with chronic hepatitis C living in Gomel region,
the most affected by Chernobyl catastrophe.
Methods: A study was carried out in 36 patients with chronic
hepatitis C who were treated with interferon alpha in Gomel
region. The antibodies against NS5 (anti-NS5) and anti-HCV IgM
were studied before the course of treatment by means of ELISA
test. There were 16 (44.4%) anti-NS5 positive and 19 (52.8%) anti-
HCV IgM positive sera samples. Virologic response (undetectable
HCV-RNA in serum) was evaluated in 3 months of treatment.
Virologic response was detected in 16 (44.4%) of patients, nonre-
sponse – in 20 (55.6%) of patients.
Results: Anti-NS5 before the course of treatment was revealed in
25.0% of responders vs. 60.0% in nonresponders (chi-square ¼
4.41; P ¼ 0.036); anti-HCV IgM – in 31.3% of responders vs.
70.0% of nonresponders (chi-square ¼ 5.36; P ¼ 0.021).
Conclusions: Antibodies anti-NS5 and anti-HCV IgM were revealed
signiﬁcantly more frequently in nonresponders to alpha-interferon
therapy. Both anti-NS5 and anti-HCV IgM showed predictive
value of response to interferon therapy of chronic hepatitis C.
P1571 Evaluation of the total hepatitis C virus core antigen
in patients with chronic hepatitis: comparison with quantiplex
branched DNA 3.0
G. Giuliani, P. Musardo, L. Drago, A. Lombardi, M.R. Gismondo
Milan, I
Objectives: The aim of our study was to evaluate the correlation
between quantitative total hepatitis C virus core antigen and
HCV-RNA levels in patients treated with pegylated IFN-a2b
(PEG-IFN) plus ribavirin combination therapy.
Methods: A total of 46 patients aged 20–65 years infected by geno-
type 1, 2, 3, 4 were enrolled to this prospective study. Patients were
anti-HCV positive, pretreatment viral load (bDNA 3.0; Bayer Diag-
nostics) >20 000 UI/mL with histologically conﬁrmed chronic
hepatitis and abnormal activity of aminotransferases lasting at least
6 months before the start of therapy. Patients were treated with
PEG-IFN plus ribavirin for 6 months (genotype 2, 3), and for
12 months (genotype 1, 4). HCV-RNA not detectable (cut-off:
<615 UI/mL to <3200 copies/mL) at 3 months was deﬁned as early
response (ER), at 6 and 12 months as end of treatment response
(ETR) for genotype 2–3 and genotype 1–4, respectively. Total HCV
Core Ag quantiﬁcation and HCV-RNA viral load was assessed at
baseline and after 3, 6, 9 and 12 months (M3, M6, M9, M12). Total
HCV Core Ag quantiﬁcation was assessed using Ortho track-C
assay (Ortho-Clinical Diagnostics, Raritan, NJ, USA) and HCV-
RNA was assessed using the Quantiplex brached DNA 3.0 (bDNA
3.0) assay (Bayer Diagnostics, Emmeryville, CA, USA). All assays
were performed according to the manufacturer’s instructions.
Results: After 6 months, 31 patients (67.4%) were negative for
both HCV-RNA and HCV-Ag, 12 (26.1%) positive for both, two
(4.3%) HCV-RNA positive but HCV-Ag negative, and one (2.2%)
HCV-RNA negative but HCV-Ag positive (1.6 pg/mL). After
12 months, 36 (78.2%) were negative for both HCV-RNA and
HCV-Ag, nine (19.6%) positive for both, and one (2.2%) HCV-
RNA positive but HCV-Ag negative.
Conclusions: The HCV-Ag test showed a strong correlation with
HCV-RNA levels (percentage of concordance ranging from 94 to
98%).
P1572 Rapid and accurate quantitation of different HCV
genotypes by optimisation of a new real-time PCR test
L. Tagliaferro, P. Menegazzi, M. De Donno, J.L. McDermott,
F. Bertolotti, I. Martini, O.E. Varnier
Lecce, Genoa, I
Objectives: Although there are a wealth of information about and
numerous assays for HCV RNA detection in serum and plasma,
real-time PCR has not yet been applied to viral load measurements.
Methods: We had developed a single step Real Time RT-PCR pro-
tocol for accurate quantitation of HCV RNA in plasma samples
using the LightCycler and dual hybridisation probes technologies.
HCV RNA quantiﬁcation in clinical samples was based on the
ampliﬁcation of only one 170 000 IU/mL RNA reference standard
(Accurun 305, BBI), which was compared with the previously
quantiﬁed standard curve.
Results: The inter-assay coefﬁcient of variation and the standard
deviation of the reference standard was about 3% and 1, respect-
ively, over a period of 8 months. A total of 960 plasma samples
were tested and HCV RNA was quantiﬁed in 528 samples with
levels varying from 5.7  101 to 2.52  109 IU/mL. The amplicons
were removed from the LightCycler glass capillaries, puriﬁed
from the 5’LC and 3’FL probes, and used for automated sequence
analysis (Visible Genetics – Bayer diagn). The genotype was
assessed for 112 HCV positive samples: the majority were type 1b
(33.0%) and 2 (32.1%), but genotypes 4 and 5 were also identi-
ﬁed. The melting temperatures of the probes obtained for each
genotype will be compared with those temperatures calculated
from the sequence analysis of the ampliﬁed targets to verify the
feasibility of HCV genotyping by Real Time PCR.
Conclusions: The new HCV quantiﬁcation method seems to be
rapid, accurate, reproducible and able to quantitate all HCV geno-
types. HCV typing by melting temperatures study has to be fur-
ther optimised.
P1573 Genotyping distribution of hepatitis C virus in
patients with HCV infection in Northern Greece
A. Tatsiopoulos, K. Mandraveli, D. Papadopoulou,
S. Alexiou-Daniel
Thessalonica, GR
Objectives: The genotypes’ distribution of hepatitis C virus in dif-
ferent groups of patients with hepatitis C and its correlation with
age, virus load and ways of contamination.
Methods: One hundred and sixty patients with HCV infection –
before the commencement of therapy – who were admitted to
AHEPA University Hospital between January 2000 and Decem-
ber 2002. HCV-RNA presence was assessed by reverse transcrip-
tion-PCR (HCV Monitor CA-Roche). Reverse hybridisation test
of the ampliﬁcations was used for the genotyping (Inno-Lipa/
Innogenetics).
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Results: Thirty-four of the patients (21.25%) have been multitrans-
fused, 11 (6.9%) presented with end stage renal disease (ESRD)
under hemodialysis, 2 (1.25%) were patients with HIV coinfection,
42 (26.2%) were intravenous drug users (IVDU) and 71 were
sporadic cases (SC) of hepatitis C with unknown source of infec-
tion. The SC samples were distributed into four groups according
to their age: <30, 31–40, 41–50, >50 years. The most common geno-
type in all groups of patients was 1b (77 of 160 ¼ 48%) followed
by genotype 3 (38 of 160 ¼ 23.7%). Genotypes 2 and 4 were less
common, with 15 cases of genotype 2 (9.3%) and 10 cases of gen-
otype 4 (6.2%). High level of viraemia >100 000 copies/mL was
observed in 127 of 160 samples (79.4%) with the following distri-
bution: genotype 1b: 96.1%, genotype 3: 73.7%, genotype 4: 70%.
The lowest viraemia was observed in the other subtypes of geno-
type 1. The genotype 1b was observed in 71.4% (20 of 28) of the
patients older than 50 years and genotype 3 was more frequent in
patients younger than 40 years (15 of 43 ¼ 34.8%).
Conclusions: Genotype 1b is the most common in all groups of
patients. In particular, for patients older than 50 years it was asso-
ciated with higher levels of virus load in comparison to other sub-
types of the genotype 1. The same observation does not include
other genotypes.
P1574 Use of transcription mediated ampliﬁcation method
(TMA), line probe assay (LiPA) and branched DNA (bDNA)
assay, to study chronic hepatitis C in a group of intravenous
drug users
M. Christoﬁdou, G. Economides, G. Dimitracopoulos
Patras, GR
Objectives: To study the prevalence of hepatitis C virus (HCV)
infection, the distribution of HCV genotype and the correlation of
HCV genotype and viral load among patients with Chronic Hepa-
titis C, in a group of Intravenous Drug Users (IVDU).
Methods: Serum samples from 32 men IVDU, range age 25–
40 years, were screened for anti HCV (MEIA HCV 3.0 Axsym;
Abbott). Anti HCV positivity was conﬁrmed by an immunoblot
assay (INNO-LIA HCV III Innogenetics). HCV RNA was deter-
mined by TMA (HCV RNA Qualitative Assay, Versant) in all anti
HCV positive sera. TMA is an isothermal autocatalytic target
ampliﬁcation method, very sensitive, which has the potential to
detect low viraemia approximately 5 IU/mL HCV RNA. Genotyp-
ing was carried out after a short, 2 h PCR procedure in TMA
product. PCR-TMA product was used for HCV genotyping, which
was carried out by a reverse hybridisation test LiPA (HCV Geno-
type Assay, LiPA, Versant). Viral load of HCV RNA positive sera
was quantiﬁed by a bDNA assay (HCV RNA 3.0 Assay, b-DNA,
Versant).
Results: Among 32 IVDU 22 had antibodies for HCV (anti HCV)
and active viraemia with HCV RNA positive in serum. The distri-
bution of HCV genotypes was 3a in 11 cases, one in eight cases
(4-1a, 4-1b) and 2a/2c in three cases.
Conclusions: In the above group of IVDU the prevalence of HCV
infection was high (68%) and the predominant genotype was 3a
(50%). Viral load among HCV RNA positive patients was 520–
1.237  106 IU/mL, whereas none of them had evidence of mixed
HCV infection.
P1575 Molecular epidemiology of hepatitis C among drug
users, correlation with clinical parameters, sexual behaviour and
drug-related risk behaviour
C. Matheı¨, G. Robaeys, M. Van Ranst, P. Van Damme, F. Buntinx
Leuven, Genk, Antwerp, B
Background: The Hepatitis C virus (HCV) is a single stranded
RNA virus exhibiting an important genetic diversity. Determining
the genotype is crucial for epidemiological as well as for clinical
analysis since HCV genotypes differ in geographic distribution, in
response to treatment and according to the route of transmission.
The objective of this study was to determine the genotypic vari-
ation among drug users in Flanders and to relate the genotype
distribution to the characteristics of the population.
Methods: HCV-RNA quantiﬁcation and genotyping was per-
formed on stored samples from 161 anti-HCV positive injecting
and noninjecting drug users. A standardised interview providing
information on their socio-demographic status, drug-related and
sexual risk behaviour was available for each drug user.
Results: HCV-RNA was present in 152 of 161 samples. The geno-
type could be determined for 148 cases. Genotype 1 was predom-
inant (48.6%), followed by genotype 3 (41.2%), genotype 4 (8.8%)
and genotype 2 (1.4%). In the univariate analysis HCV genotype
was related to geographic region, history of IDU, number of sex-
ual partners last year, having a tattoo and the presence of anti-
HBc. In the multivatiate analysis having no history of injecting
drug use (IDU) was conﬁrmed as a statistically signiﬁcant predic-
tor for an infection with genotype 1. Predictors for an infection
with genotype 3 were found to be the presence of anti-HBc anti-
bodies and a history of injecting drug use. Being tattooed
emerged as a statistically signiﬁcant predictor for an infection
with genotype 4.
Conclusions: The prevalence of HCV-RNA among anti-HCV posit-
ive drug users was 94%, being considerably higher than the
expected 60–80% chronicity rate. Furthermore, the distribution of
HCV genotypes in IDU differs signiﬁcantly from the distribution
among non-IDU, genotype 3 being predominant among the for-
mer and genotype 1 among the latter. Finally, the results of this
study are suggestive for a role of tattooing practices in the spread
of HCV among drug users.
P1576 Evaluation of total HCV core antigen detection in
haemodialysis patients
A.I. Aller, L. Calbo, J.L. De Francisco, J.C. Alados, C. De Miguel
Jerez de la Frontera, E
Objective: The aim of this study is to evaluate an immunoenzy-
matic antigenic detection for early diagnosis of hepatitis C virus
(HCV) infection in dialysis patients.
Patients and Methods: We used the enzyme-linked immunosorbent
assay (Ortho HCV 3.0 ELISA test System; Ortho-Clinical Diagnos-
tics) for the detection of antibody to HCV in 144 patients with
chronic renal failure treated in the haemodialysis department of
our hospital. Total HCV Core Antigen was determined by an im-
munoassay (Track-C, Ortho Total HCV Antigen Assay, Ortho-
Clinical Diagnostics) and compared with measures obtained by
Cobas Amplicor HCV test version 2.0 (Cobas Amplicor and Cobas
Amplicor Monitor HCV, Roche Molecular Systems). All assays
were performed according to the manufacturer’s instructions. The
cut-off value for HCV Antigen was 1.5 pg/mL. The cut-off value
for the Cobas Amplicor HCV test was 50 UI/mL and for the Am-
plicor HCV Monitor test was 600 UI/mL.
Results: The patients with anti HCV antibody-positive (25) showed
a global correlation between the HCV Core Antigen and the Am-
plicor HCV test of 92% (Table 1) and the patients with anti HCV







PCR HCV Positive 17 1





PCR HCV Positive 0 1
PCR HCV Negative 4 114
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Conclusions: There was a good correlation between the HCV-PCR
and the HCV Core Antigen. This assay is a new useful test for
early detection of HCV infection in this study group.
P1577 Clinical evaluation of the male sexual partners of
HCV-infected pregnant women
E. Minola, C. Passerini Tosi, G. Rizzo, M. Arosio, A. Goglio,
F. Suter
Bergamo, I
To determine the risk of heterosexual transmission of hepatitis C
virus (HCV) and to identify other risk factors for HCV seroposi-
tivity in heterosexual couples. We have investigated a cohort of
pregnant women HCV-Ab +ve.
Materials and Methods: During September 1994 and November
2003, at the Maternity Dpt. in Bergamo 26 308 consecutive sub-
jects, aged 16–47 years (mean 31  SD 5 years), were tested for
anti-HCV on screening and 728 women (2.8%) were anti-HCV+ve.
In those anti-HCV+ve, ALT, HCV-RNA and HCV viral load (and
HCV genotype in those viraemic) were determined. 383 women
(52.6%) were at their ﬁrst pregnancy. A previous history of intra-
venous drug addiction (IVDU) or haemotransfusion of both,
patient and partner, was investigated, a clinical evaluation and
serum levels of ALT was performed. These determinations were
performed, at 24–26w of gestation, at delivery and 6 months after.
HIV or HBV coinfection was present in 50 (6.7%) and 14 cases
(2%), with two cases of triple infection. HCV genotypes were
determined in 479 viremic pregnant women: 1b, 2, 1a, 3a, 4 and
indeterminate one accounted for 30, 24, 20, 19, 6 and 1%, respect-
ively. ALT levels were over the ULN in 51% initially, in 5% at
the third trimester and in 49% 6 months after delivery. Sexual
partners were investigated, to check anti-HCV+vity. Heroin abuse,
blood transfusion(s), health care employment, and unknown
source were responsible for HCV infection in 35, 17, 6, and 42%.
Results: In all 728 male partners (100%) were checked for
HCV+vity and in 160 of them (21.9%) was +ve. Among these 160
+ve partners, 143 (89.4%) were IVDUs, 13 (8.1%) reported haemo-
transfusion, and four (2.5%) did not report any risk factors.
Discussion: High rate of anti-HCV+vity (21.9%) was observed in
the group of regular sexual partners of the anti-HCV+ve pregnant
women. Hundred and forty-three of the 160 anti-HCV+ve men
(89.4%) were IVDUs, and 13 (8.1%) received transfusion(s) sug-
gesting that the greatest risk factor for HCV infection is related to
the presence of blood-borne risk factor(s) (97.5%) and it makes
difﬁcult to distinguish the contribution of sexual activity to the
risk of HCV transmission.
P1578 Outcome of pregnancy in hepatitis C
virus infection
A. Sariola, P. Koskela, P. Finne, A. Ja¨rvenpa¨a¨, K. Melen,
S. Riikonen, I. Julkunen
Helsinki, FIN
In the Western countries the incidence of hepatitis C virus
(HCV) infection has steadily been increasing especially among
young adults. It is thus likely that an increasing prevalence of
HCV infection is also found in pregnant women. To assess the
frequency of HCV infection in the metropolitan area of Helsinki
selected anti-HCV antibody testing was carried out for pregnant
women during the years 1991–1999. Altogether 145 mothers
were identiﬁed among 44 680 mothers. The frequency of anti-
HCV positivity rose from 0.13% in 1991 to 0.43–0.53 in 1997–
1999. In early 1990s only 20% of mothers knew about their se-
ropositivity, whereas by the end of the follow-up period almost
70% of mothers knew about their HCV infection already before
the pregnancy. Intravenous drug abuse was the major risk factor
(71% of cases) for contracting the disease. In 90% of the moth-
ers chronic HCV infection was well under control and in this
population the mean serum alanine aminotransferase (ALT) val-
ues decreased towards the end of the pregnancy. However, 10%
of anti-HCV Ab positive mothers developed intrahepatic choles-
tasis (odds ratio 16.4) as characterised by itching and elevated
serum bile acid levels. The corresponding value in the control
pregnancies was only 0.7%. Anti-HCV Ab positive mothers
were younger, delivered earlier and gave birth to babies with
smaller birth weight as compared with control deliveries. To
have a more comprehensive view of the problem of HCV infec-
tion during pregnancy randomly selected serum specimens from
the Finnish maternity cohort were tested. 2000–5000 serum spec-
imens were tested in selected cohorts (1985, 1990, 1995 and
2000). In 1985, the prevalence was 0.19% and it steadily role to
0.42% in 2000. In the metropolitan area of Helsinki the preval-
ence was higher being 0.68% and 0.70 in 1997 and 2002,
respectively. Our study indicates that there is an increasing
problem of HCV infection in pregnant women in Finland.
Although most women cope well with their disease during
pregnancy there is a subpopulation of mothers who develop
cholestasis and their liver status should thus be followed-up
carefully. Testing of all mothers for serum anti-HCV antibodies
is recommended.
P1579 Prevalence of hepatitis C virus infection and risk
factors in an incarcerated population in Iran
Z Mohtasham Amiri, M. Rezvani, M.A. Jafari Shakib, R. Jafari
Shakib, H. Asadi Nejad
Rasht, IR
Objective: Hepatitis C virus (HCV) is a leading cause of liver fail-
ure and liver transplantation in adults. Identiﬁed risk factors for
HCV infection include intravenous (IV) drug use, exposure to
infected blood products, and intranasal drug use, High-risk sexual
activity [multiple sexual partners, history of sexually transmitted
disease (STD)], tattooing and skin piercing. The purpose of this
study was to determine the prevalence of HCV and high-risk
behaviours in drug addiction inmates.
Methods: We conducted a cross-sectional prevalence study of
HCV infection in drug addiction inmates who were admitted to a
prison in Guilan province, north of Iran, between September 2003
and October 2003. Subjects were asked questions regarding behav-
iours that might put them at risk for acquiring HCV, and blood
was drawn for HCV antibody testing use of an enzyme-linked
immunosorbent assay (ELISA I´I´) and positive samples rechecked
with Western blot.
Results: Four hundred and ﬁfty inmates participate in the sero-
prevalence study. The mean age of respondents was 34.7  9 SD,
(range from 18 to 65) year. Duration of addiction was 9.6  8
SD years and 49% were treacle addiction, 17.3% heroin addiction,
11.5% cannabis addiction and others had addiction to more than
one substance. HCV risk behaviours were common in this popula-
tion: intravenous drug use (15.3%), intranasal drug use (56.2%)
and tattoos (55.5%). Two hundred and two study subjects (44.9%)
were HCV antibody positive. HCV-positive status was signiﬁ-
cantly associated with history of intravenous drug use, having




Anti-HCV in 728 Regular
Male Sexual Partners
Pregnant Women Positive (n ¼ 160) Negative (n ¼ 568)
Present (n ¼ 258) 128* 135
Absent (n ¼ 470) 37** p< 0.0001 433
*All IVDUs. **20 IVDUs, 13 had received at least one transfusion,
and four had no apparent risk factor.
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Conclusions: Infection with hepatitis C is endemic in Iranian pris-
ons. Better access to harm reduction strategies is needed in this
environment and future studies should address the need for tar-
geted HCV screening and education of prison inmates regarding
risks for HCV.
P1580 HCV genotypes in the Slovak Republic
K. Koncova, J. Kazar
Bratislava, SK
Objectives: Liver diseases caused by hepatitis C virus (HCV) pose
a serious public health problem. HCV presents a group of highly
variable strains due to variability in nucleotide sequence between
the virus isolates. To indicate effective therapy of HCV infection,
it is important to determine not only the presence of active virus
in the patient’s body, but also to specify the HCV genotype. The
object of this study was to determine incidence of HCV genotypes
in the patients included into the therapeutic process in the Slovak
Republic.
Methods: Altogether 302 patients were chosen for this study,
based on their HCV RNA positivity in the serum as detected by
PCR method (Cobas Amplicor version 2 test, Roche). Then, the
speciﬁc genotype and/or subtype of these amplicons was deter-
mined by hybridisation to speciﬁc probes with genotyping test
Inno-Lipa HCV II, Innogenetics.
Results: Of 302 sera tested, HCV genotype 1 was found in 234
(77.5%) cases, genotype 3 in 64 (21.2%) cases and in four (1.3%)
positive cases the genotype could not be determined. More
detailed analysis revealed 1a subtype in 15 (5,0%), 1b subtype in
203 (67.2%), 1a/1b in ﬁve (1.7%) cases, but 11 cases belonging to
the genotype 1 were indeterminable subtypes. In the genotype 3,
there were 63 (20.9%) 3a subtypes and 1 (0.3%) 3a/3b sub-
type. As to the age distribution, in the group of patients older
than 30 years, the genotype 1 highly predominated with 189
(97.4%) cases, whereas the genotype 3 occurred in four (2.1%)
cases only and in one (0.5%) case the genotype could not be
determined. In contrast, in the group of patients younger than
30 years, the genotype 3 prevailed with 60 (55.5%) cases followed
by 45 (41.7%) cases of the genotype 1 and 3 (2.8%) indetermin-
able genotypes.
Conclusion: From our study follows that the genotype 1, the most
difﬁcult to treat is the most common in the Slovak Republic.
However, in the younger population (<30 years, with higher inci-
dence of drug addicts), the genotype 3 prevails.
P1581 Genotypical proﬁle of infection by HCV
D. Blanco, A. Marin, I. Gonzalez, M. Nun˜ez, M. Viqueira,
A. Gomez, J. Piqueras
Cartagena, E
The infection by the HCV is the most important cause of the
viral hepatitis, as by the number as by the gravity of its com-
plications, in addition to the possibility of an effective treat-
ment. We have studied the epidemiological characteristics of
the infection by HCV in an area about 311 720 people, detecting
314 carriers (prevalence of 1007 by 100 000 inhabitants). The
average age is of 41 years old (range 13–79), corresponding the
majority to men (76.8%), with an average age of 39.8 years old,
lower than the women (44.6). The global genotypical distribu-
tion shows the group 1 as the most frequent (64%), following
of the 3 (21%) and the 4 (11%), although the genotype changes
based on other parameters like the co-infection with HIV.
Among HIV+ the most frequent is the 1a (30.8%), following 3a
(23.1%), 1b (21.2%), 4c/4d (16.1%), etc. In the other side
among population HIV – the most frequent is 1b (50.1%),
following of 3a (19.2%), 1a (16.5%), 4c/4d (5.1%), etc. Other
genotypes have been in a proportion far below. Globally, in the
distribution by sex, 1b emphasises the predominance of the
genotype 1b (47.9% in women and 32.8% in men), following of
1a with similar numbers (21.9 and 23.7%). It is only showed
signiﬁcant differences in the genotype 3a in relation to sex,
since it is detected in 9.6% of women and 24.1% of men; in
four position is 4c/4d with percentage next to 10% in both
groups. In relation to the route of infection, the parenteral one
was the most frequent (76.6%) mainly in HIV (79.7%), to which
is added 3.9% whose route could by sexual, in addition to the
previous one. The rest of transmission routes were inferior to
5%. When studying the years since the infection was acquired,
we have observed that between the no-HIV group the incidence
had not varied, whereas in HIV+ it decreased. With these
results we observed the existence of a high prevalence of HCV
in our sanitary area, fundamentally in men, related to infection
by HIV in half of the cases, mainly parenteral acquisition (with
tendency to the diminution in the HIV carriers) showing great
predominance the genotype 1, varying in the different popula-
tions.
P1582 Distribution of HCV genotypes among patients in
Sa˜o Paulo, Brazil
H.H. Caiaffa Filho, A.Z.A. Latif, P.R. Canesin, A.C. Lucena,
M.N. Burattini
Sa˜o Paulo, BR
Objectives: HCV is a major cause of chronic hepatitis and has
become the most chronic blood-borne infection all over the
world. It is estimated that 200 million people are currently infec-
ted with HCV, and around 3.5 million people contract the virus
each year. HCV genotyping is important not only as predictive
factor for therapeutic response, but also for epidemiological
data, development of vaccines, and other viral biological studies.
The main objective of the present study was to determine the
HCV genotype distribution in patients assisted at the Hospital
das Clinicas – School of Medicine University of Sa˜o Paulo (Sa˜o
Paulo, Brazil).
Methods: From May to December 2003, the Molecular Biology
Laboratory received in its routine basis, 1300 HCV qualitative
PCRs (Amplicor, Roche Diagnostic Systems, Brazil), mean 160
tests/month; approximately 60% of these tests are positive.
HCV genotyping were performed in 279 samples, mean 35
tests/month, using the commercial kit INNO-LiPA HCV (Inno-
genetics, N.V., Ghent, Belgium, distributed by Bayer Diagnostics,
Brazil).
Results: Of 279 HCV-genotyped patients, 137 (49.1%) were males
and 142 (50,8%) were females; the age varied from 21 to 80 years
old, 24% were in the age range of 21–40 years old, 57% in 41–
60 years old and 19% were over 60 years old. The distribution of
genotypes were as follows: Two samples were nontypeable by
the method used and were sent to sequencing.
Conclusions: HCV subtype 1b is the most prevalent follow by sub-
type 3a in the population studied. HCV infection was more pre-
valent among older patients (>50 years old) and gender was not
found as a signiﬁcant factor.
Genotype
1 1a 1b 1a/1b 2 2b 2a/2b 3 3a 4 5 6
No. 26 45 133 5 1 1 1 1 63 1 0 0
tests
% 9.40 16.25 48 1.8 0.36 0.36 0.36 0.36 22.75 0.36 0 0
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Sexually transmitted diseases
P1583 Prevalence of C. trachomatis infection in the general
population and in a sexually transmitted disease centre in the
Balearic Islands, Spain
J. Reina, O. Gutie´rrez, E. Ruiz de Gopegui, M. Gonzalez
Palma de Mallorca, E
Objectives: We report a prospective study about the prevalence of
genitourinary infections by C. trachomatis in the general popula-
tion and in a group of prostitutes treated in an STD clinic during
the year 2002.
Methods: The clinical samples (urethral and endocervical swabs)
were inoculated in shell vials of McCoy cell line (Vircell, Spain)
and incubated for 48–72 h at 36C and then stained with a mono-
clonal antibody against MOP of C. trachomatis (MicroTrak, Ireland)
using a direct immunoﬂuorescence assay.
Results: Over the study period 1504 clinical samples were stud-
ied. Of these 580 (38.5%) were urethral samples from males.
C. trachomatis was isolated in 19 (3.2%) of these samples. Of the
female samples (endocervical) 606 (65.5%) were obtained from
the general population, of these ﬁve (0.8%) were positive for
C. trachomatis, and 318 (34.5%) were from a the group of prosti-
tutes. In this group 9 (2.8%) cases of infection by C. trachomatis
were detected (P < 0.05). In all samples studied 33 (2.2%) were
positive for C. trachomatis. The prevalence of the infection by
C. trachomatis in the last few years in our geographical area
(Balearic Islands, Spain) is as follows: in 1999 men 2.5% and
women 0.9%; in 2000 men 2.8% and women 0.6%; and in 2001
men 1.8% and women 1%.
Conclusions: An stable prevalence of infection by C. trachomatis
is observed in the general population in recent years with a
positivity percentage for men statistically higher (P < 0.05) to
that detected in women. In the high-risk group of the prosti-
tutes a prevalence of 2.8% was detected. This value is very
much higher (P < 0.05) than that of the general population and
similar to detected in men with the clinical diagnosis of ure-
thritis.
P1584 Chlamydia trachomatis infection and risk of
preterm birth
V. Yonkova, V. Lyoutzkanova, V. Savouleva
Varna, BG
A group of 103 unselected consecutive patients presenting for
routine prenatal care were examined for Chlamydia trachomatis
(CT) in the clinic of Obstetrics and Gynecology of Varna city.
The aim was to determine whether serologic evidence of CT
during pregnancy is a risk factor for preterm delivery (before
37 weeks’ gestation). A total of 21 women (20%) were found to
be seropositive for IgG antibodies to CT. They were similar to
the seronegative women with respect to maternal age, history of
preterm birth, obstetric or medical problem, smoking status, his-
tory of drug abuse, educational status and psychosocial stressors.
The seropositive women were signiﬁcantly more likely than the
seronegative women to have a preterm birth [24% (5/21) vs. 7%
(6/82); P ¼ 0.029]. The positive predictive value of a seropositive
result for preterm birth was 31% (ﬁve of 16); the negative pre-
dictive value of a seronegative result for preterm birth was 8%
(six of 76). In conclusion, women with serologic evidence of CT
may be at risk for preterm birth. Further study is required to
determine whether serologic testing for CT should be a routine
part of prenatal care.
P1585 Prevalence of Chlamydia trachomatis in Istanbul
among men with urethritis
A. Agacﬁdan, H. Beka, M. Onel, A. Kadioglu, T. Lama
Istanbul, TR
Background: Chlamydia trachomatis one of the most wide sexually
transmitted bacterial diseases. It is also known to cause urethritis.
However only small number of studies in Turkey have investi-
gated the causes of urethritis.
Objectives: To determine the prevalence of C. trachomatis among
men with symptomatic urethritis in Istanbul, Turkey.
Methods: Men with diagnosis of urethritis at the Istanbul Faculty
of Medicine from January to November 2003 were screened for C.
trachomatis by Gene-Probe ampliﬁed C. trachomatis assay using
urethral swabs.
Results: The study enrolled 720 men. The prevalence of C. tracho-
matis was 116 of 720 or 16.1%.
Conclusions: C. trachomatis is commonly found in men in Istanbul,
Turkey. Further surveys are needed in order to determine the pre-
valence of other sexually transmitted pathogens in patients with
urethritis in Turkey.
P1586 The prevalence of pathogenic micro-organisms in
men with nongonococcal urethritis
J. Tiodorovic, B. Tiodorovic, G. Tasic
Nis, YU
Objectives: The goal of the study is to ﬁnd out the etiologic agents
in men with nongonococcal urethritis and search the prevalence
of Chlamydia trachomatis, Ureaplasma urealyticum, Mycoplasma ho-
minis and Trichomonas vaginalis.
Methods: This study incudes 200 men with nongonococcal urethri-
tis. U. urealyticum and M. hominis were diagnosted by using Myci-
fast ‘All-In’ test, C. trachomatis was diagnosed by direct
immunoﬂuorescent test. T. vaginalis was diagnosed by the exam-
ination of wet preparations.
Results: C. trachomatis was isolated in 43.0%, U. urealyticum in
27%, M. hominis in 1,5%, U. urealyticum + M. hominis in 6.5%,
C. trachomatis + U. urealyticum in 30.2%, C. trachomatis + U. urea-
lyticum + M. hominis in 2.0%, C. trachomatis + M. hominis in 8.1%,
T. vaginalis in 2.5% of patients.
Conclusions: We can conclude that C. trachomatis and U. urealyti-
cum are important pathogen agents in patients with urethral dis-
charge. Mixed infections are very common, and it is very
important to have it in mind for correct and complete therapy.
P1587 Microbiological aspects of male urethritis observed
from 1990 to 2002 in a central military hospital, Algiers
M. Naim, W. Amhis, A. Chabani, D. Tiouit
Algiers, DZ
Objectives: To determine the aetiology of the male urethritis
observed at the Sexually Transmitted Diseases out patient depart-
ment of the Central Military Hospital of Algiers. To evaluate the
Gonococcal Urethritis (GU) and the Nongonococcal Urethritis
(NGU) frequency. To determine also the place of Chlamydia
trachomatis and other agents of the NGU.
Methods: The patients were addressed to our out patient depart-
ment by the unit’s physician of different military regions or by
the university military hospital’s specialists. A questioning and a
clinical exam were made and a specimen executed. In the laborat-
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ory, a direct optic microscopy exam was performed immediately,
the specimen was afterwards isolated on the speciﬁc medium for
Neisseria gonorrhoeae (GC agar + Polyvitex), identiﬁed with NH
gallery (Biomerieux*). We searched for the betalactamase of the
NGPP strains by the Ceﬁnase test (Biomerieux*) and the suscepti-
bility to the antibiotics of the strains of N. gonorrhoeae was tested
by agar diffusion method according to NCCLS. The research of
C. trachomatis was performed by DIF (direct immunoﬂuorescence)
with monoclonal antibodies and ELISA (antigen).The Mycoplasma
were isolated on the speciﬁc medium: Mycoplasma DUO
(Biorad*) and Mycoplasma IST (Biomerieux*). The other aetiologi-
cal agents were isolated and identiﬁed according to the classical
methods.
Results: 1705 urethral specimens were analysed in our laboratory.
1143(67%) were positive and 562 (23%) were negative. The reparti-
tion of the aetiological agents was: 384 cases (22.52%) of C. tracho-
matis, 369 cases (21.64%) of N. gonorrhoeae, and 140 cases (08.21%)
of Ureaplasma urealyticum, etc. The mean NGPP incidence was 45%
between 1990 and 2002, but we have observed a crescent evolution
of this incidence during these 12 years (from 12.5% in 1990 to 64%
in 2002). We observed also resistances of Neisseria gonorrhoeae to co-
trimoxazol (81%) and to tetracycline (¼1%).
Conclusions: These results show that from 2000, C. trachomatis took
the place of N. gonorrhoeae which was until 1999 the ﬁrst aetiologi-
cal agent of the urethritis in our country. Besides, we have
observed the decrease of the undetermined aetiology urethritis
rate; this is probably due to a better diagnostic and therapeutic
taking charge of this disease and the result of the strategy that
was adopted since 1999 in the military medium.
P1588 Women prefer self-collection of vaginal swabs
which are as effective for the diagnosis of Chlamydia
trachomatis and Neisseria gonorrhoeae as urine, cervical swabs
and clinician-collected vaginal swabs
M. Chernesky, J. Lane, D. Martin, J. Jordan, D. Fuller, D. Willis,
P. Fine, W. Janda, J. Schachter, E.W. Hook
Hamilton, CAN; San Diego, New Orleans, Pittsburgh, Indianapolis,
Jacksonville, Houston, Chicago, San Francisco, Birmingham, USA
Background: Chlamydia trachomatis (CT) and Neisseria gonorrhoeae
(GC) are easily transmitted because of high asymptomatic infec-
tion rates in women and men. Diagnostic and treatment goals are
to screen sexually active men and women using noninvasive sam-
ples tested by sensitive and speciﬁc assays.
Methods: A total of 1464 women from eight geographically diverse
prevalence sites in Northern America were enrolled. They consen-
ted to the collection of two cervical swabs (CS) and one clinician-
collected vaginal swab (CVS). Patients also self-collected a ﬁrst
catch urine (FCU) and a vaginal swab (PVS) by following a simple
set of illustrated instructions. Samples were tested for CT and GC
by the APTIMA Combo 2 assay and APTIMA CT and APTIMA
GC assays (GenProbe Incorporated, pending FDA clearance). One
CS and FCU were tested by the BD ProbeTec Assay (Becton Dick-
enson). After vaginal swab self-collection women completed a
questionnaire to determine ease or difﬁculty of the collection pro-
cedures. Preferences were compared by biological and beha-
vioural factors.
Results: The prevalence of CT and GC were 12.5 and 5.4%;
equally determined from PVS or CVS which yielded an equal
number or more positive patients than CS or FCU by all the
assays. FCU. More than 90% reported vaginal swab self-collection
very easy. Preference of a PVS over a pelvic examination or urine
collection was 76 and 60%. If a PVS was available to investigate
sexually transmitted infections (STI), 94% indicated they would
get tested more often. Factors such as age, education, English as a
second language, and past experience with an STI did not inﬂu-
ence their indicated preference.
Conclusions: This data indicates that PVS tested for CT and GC by
the APTIMA assays would enable women to choose this noninva-
sive specimen and facilitate implementation of screening pro-
grammes.
P1589 Comparison of sequence typing and opa-typing for
discrimination of Neisseria gonorrhoeae
N. Bilek, I.M.C. Martin, G. Kinghorn, B.G. Spratt, C.A. Ison
London, Shefﬁeld, UK
Objective: To observe the variation in genes targeted by Neisseria
gonorrhoeae molecular typing methods by applying opa-typing
and a recently developed sequence-based method (NG-MAST) to
isolates from sexual contacts within known transmission chains.
To assess the levels of discrimination and concordance afforded
by these methods.
Methods: NG-MAST involves sequencing internal fragments (490
and 390 bp) of two highly polymorphic loci, por and tbpB, which
encode an outer membrane protein porin and a component of the
transferring-binding protein, respectively. Each unique sequence
at por and tbpB was assigned an ‘allele number’ providing each
gonococcal isolate with a two digit allelic proﬁle. Each unique all-
elic proﬁle was assigned as a sequence type (ST). The NG-MAST
results were compared with opa-typing results. Transmission
chains were constructed by identifying sexual contacts who had
been mutually named at interview.
Results: A total of 28 transmission chains were identiﬁed, compri-
sing 13 pairs, 10 chains of three, two chains of ﬁve and one chain
each of four, seven and eight individuals; 85 isolates from 84 indi-
viduals were available for study. 19 of the 28 chains were known
to be part of two larger clusters. NG-MAST identiﬁed 16 ST’s
among the isolates from patients in the transmission chains, com-
pared with 24 opa-types. In 13 chains, ST and opa-type were
totally concordant. In two chains they were predominantly con-
cordant except for two isolates, which differed in ST between sex-
ual contacts, but only by a single nonsynonymous substitution in
por. In 10 chains, the opa-type differed between direct contacts
whereas the ST remained consistent. There were three chains in
which both opa-type and ST differed between sexual contacts,
suggesting transmission of multiple strains.
Conclusions: These results indicate that sequencing the por and
tbpB gene fragments provides somewhat less discrimination than
analysing the family of opa-genes, but the former procedure is
simpler and produces unambiguous data. Both NG-MAST and
opa-typing are highly discriminatory typing methods but NG-
MAST identiﬁes larger clusters of indistinguishable isolates,
whereas opa-typing gives a ﬁner discrimination within the chains
and may more often result in isolates from sexual contacts that
appear to be distinct.
P1590 Local outbreak of ciproﬂoxacin-resistant Neisseria
gonorrhoeae in Finland
P. Ka¨rpa¨noja, L. Lindholm, A. Hakanen, K. Lounamo,
H. Sarkkinen
Lahti, Turku, FIN
Objectives: After many years of decrease, the number of uncom-
plicated gonorrhoea cases increased remarkably in Pa¨ija¨t-Ha¨me
Hospital District (approximately 200 000 inhabitants) in Finland.
The incidence rate in 2002 was 1.46/10 000 inhabitants com-
pared with 0.44 in the whole country. A special feature of this
epidemic was that it mostly consisted of ciproﬂoxacin-resistant
isolates. As part of the epidemiological survey, we analysed the
susceptibilities of Neisseria gonorrhoeae isolates in the years 2001–
2003 in this area.
Methods: Fifty-three N. gonorrhoeae strains were isolated between 1
January 2001 and 11 September 2003 in the laboratory of clinical
microbiology of Pa¨ija¨t-Ha¨me Central Hospital. The specimens
were originally cultured on selective agar plates (Oxoid, UK). The
identiﬁcation was based on Gram-staining and positive oxidase
reaction followed by conﬁrmation with the Accuprobe N. gonor-
rhoeae idenﬁcation test (Gen-Probe Inc., USA). The MIC-values
were determined using the agar dilution method by NCCLS for
penicillin, tetracycline, ceftriaxone and ciproﬂoxacin. Beta-lacta-
mase was tested using the nitroceﬁn disc method (Ab Biodisk,
Solna, Sweden).
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Results: Eleven, 34 and ﬁve strains were cultured in years 2001,
2002 and 2003, respectively. Resistance rates to penicillin, tetracyc-
line, ceftriaxone and ciproﬂoxacin varied annually. In the year
2002, the highest number of ciproﬂoxacin-resistant isolates (85%)
was detected. All ciproﬂoxacin-resistant strains during this 3-
year period (n ¼ 32) were resistant or intermediate to penicillin
(27 beta-lactamase positive, ﬁve negative) and tetracycline. Seven
of these (19%) showed slightly elevated MIC-values for ceftriax-
one (0.5 mcg/mL). According to NCCLS guidelines these are
interpreted as nonsusceptible. The ﬁrst ciproﬂoxacin-resistant
isolate was cultured in December 2001 and was probably impor-
ted from Thailand. Due to rapid increase of ciproﬂoxacin-resistant
strains ceftriaxone replaced ﬂuiroquinolones as the drug of choice.
After November 2002 no ciproﬂoxacin-resistant isolates have been
found. Contact tracing by interviewing the patients was unsuc-
cessful. Molecular typing will be conducted to analyse the similar-
ity of the N. gonorrhoeae-strains.
Conclusions: This observation emphasises the importance of con-
tinuous surveillance of antimicrobial susceptibility of N. gonorrhoeae
isolates to guide the treatment. Therefore, culture should remain
the basic laboratory method for the diagnosis of this disease.
P1591 Characterisation of ciproﬂoxacin-resistant Neisseria
gonorrhoea isolated in Italy
P. Stefanelli, C. Vasta, P. Mastrantonio
Rome, I
Objectives: Antimicrobial susceptibility of Neisseria gonorrhoea iso-
lates was monitored as part of a pilot surveillance programme
started in April 2003 in Italy. Among 76 gonococci collected in the
ﬁrst 7 months of this study, 21 (27.63%) resulted resistant to ci-
proﬂoxacin (CipR). The aim of this study was to characterise and
to deﬁne the patterns of mutations at gyrA and parC genes in
these gonococcal isolates.
Methods: Susceptibility testing was performed by E-test method
following the manufacturer’s procedures. The 21 CipR strains
were further differentiated according to serovars and pulsed-ﬁeld
gel electrophoresis (PFGE) proﬁle. Mutations in the two target
genes were identiﬁed by PCR and direct sequencing of the ampli-
ﬁed products.
Results: From April to November 2003, 27.63% of the isolated
strains were CipR (21 of 76 N. gonorrhoea). Their MICs ranged
from 6 to 32 mcg/mL. Six of them were isolated from patients
with previous ciproﬂoxacin therapy. Ten of these 21 were also
penicillin resistant (MIC  2 mcg/mL). All the 21 CipR strains,
except two, belonged to serovar IB, the remaining were cross-
reacting IA/IB. Three different unrelated PFGE proﬁles were
identiﬁed. DNA sequencing showed that the most common muta-
tions had amino acid substitutions of Ser91 to Phe, Asp95 to Gly
or Ala of the gyrA and Asp86 to Asn, Ser87 to Asn or Arg, Glu91
to Lys of parC. A further mutation, Ala123 to Pro was found in
one strain in the parC gene.
Conclusions: The resistance was present among different types of
strains, suggesting that the incidence of CipR strains in Italy was
not exclusively due to the appearance of a single clone. Cross-
resistance between ciproﬂoxacin and the structurally unrelated
penicillin was observed, as already described, in all those strains
harbouring the Ser91-Phe mutation in the gyrA gene. As ciproﬂ-
oxacin is recommended as the ﬁrst line of therapy for gonorrhoea,
the emergence of a signiﬁcant resistance should be taken into
account for the therapeutical choices.
P1592 Antimicrobial resistance of Neisseria gonorrhoeae,
and emerging ﬂuoroquinolone resistance in Russia
M. Zoubkov, A. Kubanova, T. Vahnina, T. Priputnevich
Moscow, RUS
Background: Neisseria gonorrhoea is adept at developing mecha-
nisms of resistance to antimicrobial agents, and there is a continu-
ing need for information on antimicrobial susceptibility patterns.
Here we describe the susceptibility of 52 N. gonorrhoea isolates to
ﬁve antibiotics of main groups which using in treatment of gonor-
rhoea in Russia such as: ciproﬂoxacin, penicillin, ceftriaxone,
erythromycin and tetracycline.
Methods: Isolates of N. gonorrhoea were obtained from mail
patients with acute urethritis who visited three sexual transmitted
disease clinics in Moscow from December 2002 through May
2003. The susceptibility to antibiotics was determined by the agar
dilution method using GC-II agar base with IsoVitaleX supple-
ment and twofold dilutions of antibiotics according to NCCLS.
For quality control used N. gonorrhoea ATCC 49226. Beta-lacta-
mase production was tested by using nitroceﬁn disks (Ceﬁnase;
BBL Microbiology Systems).
Results: Only one strain of N. gonorrhoea was b-lactamase positive,
though only 10% of isolates was sensitive to penicillin (MIC90,
8 lg/mL). Resistance to tetracycline was slightly lower, with 23%
of strains were sensitive, and 64% of strains were intermediate
resistant (MIC ¼ 0.5–1 lg/mL). The most active was ceftriaxone
(MIC90 < 0.125 lg/mL) all N. gonorrhoea isolates were susceptible.
Unexpected result was detection high level resistance to ﬂuoroqui-
nolone, with 56% of isolates being resistant (MIC90 ¼ 32 lg/mL).
A 75% of strains were susceptible to erythromycin, and 25%
being intermediate resistant (MIC90 ¼ 1 lg/mL).
Conclusions: This study indicates that high level resistance to
penicillin in all probability relate with chromosomal resistance,
and ﬂuoroquinolone resistance in Neisseria gonorrhoea is emerged
in Russia. Ceftriaxone and erythromycin were the most active
drugs.
P1593 Susceptibilities of Neisseria gonorrhoea and
Ureaplasma urealyticum isolates from male patients with
urethritis to several antibiotics including telithromycin
D. Aydin, O¨. Ku¨c¸u¨kbasmaci, N. Go¨nu¨llu¨, Z. Aktas
Istanbul, TR
Objectives: Despite the reports of antibiotic resistance in Neisseria
gonorrhoea and Ureaplasma urealyticum all over the world, there are
very few studies for antibiotic susceptibility of these pathogens in
Turkey. The goal of the study was to determine the antibiotic sus-
ceptibilities of N. gonorrhoea and U. urealyticum strains isolated in
Istanbul.
Methods: The MICs of telithromycin, azithromycin, clarithromycin,
erythromycin, gemiﬂoxacin, moxiﬂoxacin, levoﬂoxacin, ciproﬂoxa-
cin, oﬂoxacin, norﬂoxacin, doxycycline and tetracycline against 78
N. gonorrhoea and 31 U. urealyticum strains which were isolated as
causes of urethritis were determined and compared. Additionally,
the activities of penicillin and ceftriaxone against N. gonorrhoea
strains were explored.
Results: The susceptibility rates for penicillin and tetracycline in
N. gonorrhoea strains were 35.9 and 24.3%, respectively. All gono-
coccal strains were susceptible to ceftriaxone with very low MICs
(MIC90 ¼ 0.008 mg/mL). Quinolone resistance was detected in a
single strain of N. gonorrhoea (1.3%). Ciproﬂoxacin was the most
active quinolone against N. gonorrhoea (MIC90 ¼ 0.008 mg/mL)
while gemiﬂoxacin and moxiﬂoxacin were the most active against
U. urealyticum (MIC90 ¼ 0.25 mg/mL) and the quinolone-resistant
N. gonorrhoea strain (MICs ¼ 0.25 mg/mL). Telithromycin was
highly active against N. gonorrhoea and U. urealyticum strains
(MIC90 ¼ 0.25 mg/mL and 0.12 mg/mL, respectively).
Conclusions: Due to the very low susceptibility rates of tetracycline
and penicillin, they should not be the option in empirical treat-
ment of N. gonorrhoea infections. There is still no resistance or
intermediate susceptibility or even decreased susceptibility against
ceftriaxone among gonococci, and ceftriaxone continues to be the
ﬁrst choice antibiotic for treatment of gonococcal urethritis. For
co-infections due to N. gonorrhoea and U. urealyticum, the ketolide
telithromycin may be used as a treatment alternative according to
our in vitro results. This ﬁnding has to be supported by further
clinical studies. Within the quinolones, ciproﬂoxacin is still the
most effective against N. gonorrhoea.
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P1594 Occurrence of Ureaplasma urealyticum and
Mycoplasma hominis among immigrant prostitutes and
nonselected patients
S. Noviello, V. Cuniato, F. Bellitti, E. Nocera, S. Esposito
Naples, I
Objectives: Ureaplasma urealyticum and Mycoplasma hominis are fre-
quently isolated by uro-genital tract being associated with differ-
ent clinical syndromes. They assume a particular epidemiological
importance in prostitutes due to their possible sexual transmis-
sion. We evaluate the U. urealyticum and M. hominis prevalence
and its possible relationship to behavioural risk factors by a pros-
pective study carried on immigrant prostitutes from sub-Saharian
area and nonselected patients with clinical signs of uro-genital
infection.
Patients and Methods: Between 1999 and 2002, 195 immigrant pros-
titutes (average age 26 years) and 227 nonselected patients resi-
dent in Naples (average age 35.2 years) underwent a
microbiological investigation to detect possible presence of myco-
plasms in endocervical swabs possibly associated with other bac-
terial pathogens. Mycoplasmas’ identiﬁcation, colony count and
in vitro susceptibility tests to erythromycin (E), josamycin,
tetracycline, doxicicline and oﬂoxacin (OFX) was performed by
means of Mycoplasma IST kit (bio-Me´rieux); identiﬁcation of
other micro-organisms was based on morphological features and
biochemical tests (API system, bio-Me´rieux).
Results: Overall, positive samples (>104 UCC/mL) were detected
in 100 of 195 (51.3%) and in 75 of 227 (33%) of immigrant prosti-
tutes and nonselected patients, respectively. U. urealyticum was
isolated in 78 of 100 (78%) of immigrant prostitutes and in 71 of
75 (94.6%) of nonselected patients. The contemporary detection of
U. urealyticum and M. hominis was noted in seven (7%) immigrant
prostitutes and in three (4%) nonselected patients. Association of
mycoplasms with Gardnerella vaginalis was observed in 35% of
immigrant prostitutes and 3% of nonselected patients. In the
immigrant prostitutes group, detection of mycoplasms was related
to the number of daily sexual partners and to the condom use: a
number of partners < or >5 resulted in 4 and 30% of positivity,
respectively; condom use/not use ¼3.7%/16% positivity. Sus-
ceptibility pattern of mycoplasms ranged between <50% (E, OFX)
and >94% (other drugs).
Conclusions: The incidence of mycoplasms in immigrant prosti-
tutes is higher than nonselected patients and correlated to a num-
ber of well-deﬁned risk factors. The rate of resistance to
conventional drugs remains low.
P1595 Serological screening for sexually transmitted
diseases among immigrants in Italy
S. Noviello, V. Cuniato, F. Bellitti, E. Nocera, S. Esposito
Naples, I
Objectives: Immigration has reached big proportions in Western
Countries. The poor economic and social conditions of immigrants
together with difﬁculties to access to healthcare institutions and
proper sanitary information constitute enormous risk to acquire
and/or to transmit sexually transmitted diseases. Within a project
aimed to make easy the immigrants’ access to social sanitary facil-
ities and to educational and sanitary prevention interventions, we
carried on an epidemiological survey among immigrants to evalu-
ate the incidence of the main sexually transmitted diseases in
order to realise proper educational programs directed to sexually
transmitted diseases prevention.
Patients and Methods: In the period between October 1999 and
January 2003, 976 subjects (M/F: 357/605; average age 27 years,
range 18–54), referring to the Volunteers Association ‘J.E. Masslo’,
underwent a serological screening directed to detect the following
markers: anti-HIV, HBsAg, anti-HCV and MHA-TP. Informed
consent was obtained prior performing tests. Most of subjects
came from Nigeria (61.4%), the remaining from other sub-Sahari-
an countries and Eastern Europe.
Results: Overall, 161 (16.5%) subjects resulted positive for one se-
rological marker: Forty-one of the 83 positive females (49.4%)
were prostitutes.
Conclusions: The positivity rate of serological markers for sexually
transmitted diseases is signiﬁcantly high among immigrants; pros-
titution and related factors represent the major risk in this popula-
tion. Appropriate educational campaigns are mandatory in order
to reduce the sexually transmitted diseases transmission.
P1596 Updated proﬁle of infections in premature
deliveries in the obstetrics department of a medical university,
Gdansk
J. Komarnicka, K. Leszczynska, A. Samet, K. Preis, D. Lautembach
Gdansk, PL
Introduction: In the majority of premature deliveries, particularly
those ended before 28 Hbd, bacterial infection of a fetal egg is
involved. Premature delivery and premature fetal membrane
breaking are frequently connected with bacterial vaginosis, UTI,
gonococcal and streptococcal cervical infection. However the role
of infections caused by Chlamydia, Mycoplasma, Ureaplasma, Tricho-
monas and Candida is not fully understood. Recently Mycoplasma
or Ureaplasma or both were isolated from vaginitis as the only
potential pathogens responsible for premature delivery.
Objectives: The aim of this work was the epidemiological, microbi-
ologic and clinical characteristics of infections connected with pre-
mature deliveries and premature fetal membrane breaking.
Methods: Eighty-seven pregnant patients with premature delivery
symptoms and preterm rupture of oocystic membrane were exam-
ined and cervical swabs were taken. Cultures and identiﬁcation
were performed by standard methods. For isolation and identiﬁ-
cation of Mycoplasma – Mycoplasma Duo tests and A7 Agar (bio-
Merieux) were used.
Results: Forty-six patients (53%) had positive cultures. Escherichia
coli was recovered from 21 cases (46%). In 18 cases Ureaplasma
urealyticum (39%), three – Mycoplasma hominis (0.6%), 11 – Gardne-
rella vaginalis (24%), 11 – S. epidermidis (24%), seven – E. faecalis
(15%) and seven – Candida albicans were found. S. aureus, S. aga-
lactiae, P. mirabilis, Corynebacterium sp., Prevotella bivia, K. pneumo-
niae, Peptostreptococcus magnus were isolated in monomicrobial
cultures. M. hominis or U. urealyticum were detected in eight
patients as the only potential pathogens.
Conclusions: A 53% of women hospitalised because of imminent
premature delivery had endocervical infection. The most frequent
pathogen was E. coli. Signiﬁcant number of Ureaplasma and Myco-
plasma infections were detected.
P1597 Incidence of simultaneous chlamydial and
Mycoplasma infection in women of reproductive age
K. Avdeliodi, M. Simou, S. Tzortzatou, I. Glynou, H. Nikolaou,
H. Kada, P. Psychiko
Athens, GR
Objectives: To determine the incidence of simultaneous chlamydial
and Mycoplasma infection in women of reproductive age in order
to avoid problems inﬂuencing conception.
HIV+ve: 54 (33.5%); M/F:14/40
HbsSAg +ve: 58 (36%); M/F:36/22
HCV+ve: 25 (15.5%); M/F:17/8
MHA-TP+ve: 24 (15%); M/F:17/7
Fourteen (1.4%) subjects resulted contemporary positive for two markers:
HIV-HBsAg+ve: 8 (57.1%); M/F:3/5
HIV-HCV+ve: 1 (7.1%); M/F:1/0
HIV-MHA-TP+ve: 1 (7.1%); M/F:1/0
HBsAg-HCV+ve: 1 (7.1%); M/F:1/0
HBsAg-MHA-TP+ve: 3 (21.4%); M/F:2/1
450 Abstracts
Methods: A total of 1700 cervical and vaginal smears of women in
reproductive age who attended the Outpatient Dpt. of our Hospi-
tal were tested for the presence of Chlamydia trachomatis and
Mycoplasma. The detection of C. trachomatis was performed
using the ligase chain reaction method (Lcx, ABBOTT) and Myco-
plasma identiﬁcation and sensitivity test was performed using the
Mycofast Screening Evolution 2 kit (International Microbio,
France).
Results: Of 1700 specimens a percentage of 3.88% were positive
for C. trachomatis, 24.28% were positive for Mycoplasma (21.49%
U. urealyticum, 2.78% M. hominis). Of 66 Chlamydia-positive spec-
imens 18 were positive for Mycoplasma (27.27%). M. hominis iso-
lates showed resistance to Roxithromycin in a percentage of
85.9% and to Oﬂoxacine 24.5%. U. urealyticum isolates showed
resistance to Roxithromycine in a percentage of 7.8% and to Oﬂ-
oxacine 4.3%.
Conclusions: The incidence of simultaneous chlamydial and Myco-
plasma infection among Chlamydia positive patients is high
(27.27%). The prevalence of genital Mycoplasma is high (24.28%)
and the prevalence of resistance to antimicrobial agents is consid-
erable especially for M. hominis. Simultaneous chlamydial and
Mycoplasma infection could be a problem inﬂuencing fertility.
P1598 Prevalence of Mycoplasma in female genital tract
and susceptibility to antimicrobial agents
M. Simou, K. Avdeliodi, S. Tzortzatou, I. Glynou, T. Lazaraki,
H. Kada
Athens, GR
Objectives: To determine the prevalence of Mycoplasma hominis
and Ureaplasma urealyticum in vaginal smears of women of repro-
ductive age and their susceptibility to antimicrobial agents.
Methods: A total of 2047 vaginal smears of women in reproductive
age who attended the Outpatient Dpt. of our Hospital were tested
for the presence of M. hominis and U. urealyticum. The identiﬁca-
tion of Mycoplasma and sensitivity test were performed using the
Mycofast Screening Evolution 2 kit (International Microbio,
France).
Results: Of 2047 specimens 497 (24.28%) were positive for
Mycoplasma. A total of 440 specimens (21.49%) were positive
for U. urealyticum. From 440 U. urealyticum-positive specimens
111 gave positive results in 1/1000 dilution, 127 in 1/10 000 dilu-
tion and 202 in 1/100 000 dilution. A total of 57 specimens
(2.78%) were positive for M. hominis in 1/10 000 dilution. In 48
cases (9.66%) both U. urealyticum and M. hominis were identi-
ﬁed. Among 440 U. urealyticum isolates 34 were resistant to
Roxithromycin (7.73%), 19 to Oﬂoxacin (4.31%) and ﬁve to
Doxycycline (1.13%). Among 57 M. hominis isolates 49 were
resistant to Roxithromycin (85.96%), 14 to Oﬂoxacine (24.56%)
and two to Doxycycline (3.5%). In 48 cases of simultaneous
U. urealyticum and M. hominis infection resistance to Roxithromy-
cine was 64.5%, to Oﬂoxacine 18.45% and to Doxycycline 2%.
Conclusions: The incidence of Mycoplasma infection in genital tract
of women in reproductive age is relatively high (24.28%). Resist-
ance to antimicrobials is high especially for M. hominis and could
be a therapeutic problem inﬂuencing conception and leading to
infertility.
P1599 Incidence and in vitro sensitivity of genital
mycoplasmas to antibiotics
J. Spiliopoulou, H. Panagou, A. Meletiou, M. Alexandrou,
E. Zagotzidou, A. Vogiatzi
Athens, GR
Objective: The aim of this study was to evaluate the prevalence of
genital mycoplasmas, U. urealyticum (U.u) and M. hominis (M.h),
and their antimicrobial susceptibility to six antibiotics [tetracycline
(TE), peﬂoxacin (PEF), oﬂoxacin (OFX), doxycycline (DO), erythro-
mycin (E), clarithromycin (CLA).
Material and Methods: Vaginal specimens were collected from 967
women (742 natives, 225 foreigners), aged between 16 and
72 years, attending the outpatients’ department of gynaecology in
our hospital during a 7-month period. Each sample was cultured
onto a A7 agar plate and incubated at 37C for 48 h. The enumer-
ation and susceptibility testing of genital mycoplasmas were
determined by use of a commercially available system (Mycoplas-
ma system-Lioﬁlchem s.r.l, Italy).
Results: Of 967 women examined, 427 (44.15%) were positive for
M. hominis and/or U. urealyticum. In particular, 359 (84%) yielded
isolates of U.u (259 natives, 100 foreigners), seven (1.6%) of M.h
(six natives, one foreigner) while 61 (14.3%) presented both spe-
cies (49 natives, 12 foreigners). The prevalence of U.u among
native (37.32%) and foreign (46.95%) women was statistically sig-
niﬁcant (P < 0.001). Almost all strains of U.u were sensitive to DO
(98.32%) and PEF (98.05%). Resistance was found to OFX
(2.52%), TE (2.24%) and E (1.68%). All strains of M.h were sus-
ceptible to TE and fully resistant to E and CLA. Among the 61
patients who were colonised by both species, the most frequent
patterns of resistance were as follows: 25 isolates resistant to E
and CLA with intermediate resistance to OFX, 18 resistant to E
and CLA, four showed resistance to E with intermediate resis-
tance to OFX and CLA and three were resistant to E with inter-
mediate resistance to CLA. It is noticeable that one strain isolated
from a patient with mixed infection was fully resistant to OFX,
PEF, E, CLA and intermediate resistant to DO and TE.
Conclusions: (1) Not one isolate studied was resistant to all antibiot-
ics tested. Nevertheless, resistance to more than one antibiotic was
quite frequent, especially when both genital mycoplasmas were pre-
sent, (2) The frequency of acquired resistances does not justify modi-
ﬁcations in the usual treatment of genital mycoplasma infections.
P1600 Genome differences and detection of pathogenic
Treponema pallidum subspecies
P. Matejkova, D. Smajs, S.J. Norris, G.M. Weinstock
Brno, CZ; Houston, USA
Objectives: Genus Treponema includes several pathogenic spiro-
chetes (e.g. Treponema pallidum subsp. pallidum is the causative
agent of syphilis, T. pallidum subsp. pertenue causes yaws).
Today’s serological tests are negative in early stages of trepone-
mal infection and cannot distinguish between syphilis and yaws.
Identiﬁcation of chromosomal sequences speciﬁc for these patho-
gens can be used for selective PCR diagnostics of seropositive
samples of sera from patients suspect of early treponemal infec-
tion and for discrimination of pallidum and pertenue subspecies.
Methods: DNA-microarray hybridisation of ﬂuorescent-labelled
cDNA obtained by direct labelling of treponemal chromosomal
DNA was performed. 31 genes of three strains of T. pallidum
subsp. pertenue have been sequenced. Diagnostics of individual
strains is based on PCR reaction.
Results: Chromosomal DNA of T. pallidum subsp. pallidum strain
Nichols was compared with genomic DNA isolated from three
different strains of T. pallidum subsp. pertenue (strain Gauthier,
Samoan D, CDC-2). No signiﬁcant changes have been detected.
However, 31 genes with highest/lowest and equal pallidum/pert-
enue ratio have been selected and sequenced. Altogether,
31 166 bp (2.74% of the genome size) were analysed. No region
of extensive sequence heterogeneity was detected. However, 19
different single nucleotide polymorphisms (SNPs) were identiﬁed:
four SNPs in Gauthier strain, 18 in Samoan D and 19 SNPs in
CDC-2. Twelve (of 19) SNPs cause amino acid changes. Character-
istic pattern of SNPs for each strain allowed PCR speciﬁc detec-
tion of these sequence changes. We developed PCR diagnostics to
distinguish pallidum strains from pertenue strains and to unam-
biguously detect pertenue strains. This PCR test is based on a pri-
mer 30-terminal nucleotide perfect match requirement. Two
parallel reactions are performed for each exclusive SNP using two
primers varying at 30-end nucleotide position.
Conclusions: Comparative genomics and sequencing of selected
genes of closely related treponemes causing different diseases
allowed to design sequence speciﬁc diagnostic test. To further
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prove this diagnostic ampliﬁcation, this test will be performed on
sera samples from seropositive patients.
P1601 Comparative genomics of Treponema pallidum ssp.
pallidum and Treponema paraluiscuniculi
D. Smajs, P. Matejkova, S.J. Norris, G.M. Weinstock
Brno, CZ; Houston, USA
Objectives: Genomes of closely related treponemes, Treponema pal-
lidum ssp. pallidum (Nichols) and Treponema paraluiscuniculi were
compared using several techniques of genomics and molecular
biology. T. pallidum ssp. pallidum is the causative agent of a highly
invasive human disease syphilis whereas T. paraluiscuniculi is not
pathogenic to humans.
Methods: DNA microarray technology has been utilised to com-
pare genomic DNA of both treponemes. Microarrays containing
all 1039 annotated ORFs of T. pallidum subspecies pallidum (Nich-
ols) were used. This approach identiﬁed genes that are missing or
have heterologous sequence in T. paraluiscuniculi. To identify
genes that are present in addition to gene set of T. pallidum ssp.
pallidum, whole genome ﬁngerprinting has been performed. More-
over, gene expression of 84 T. pallidum and T. paraluiscuniculi
genes has been monitored using real-time RT-PCR approach. Over
60 short chromosomal regions of T. paraluiscuniculi have been
sequenced to estimate the frequency of nucleotide changes when
compared with genome sequence of T. pallidum ssp. pallidum.
Results: After labelling of chromosomal DNA using random hexa-
mers and hybridisation to the DNA microarray, at least 10 T. par-
aluiscuniculi genes showed signiﬁcantly lower signals when
compared with signals of T. pallidum ssp. pallidum. These genes
were clustered at least in ﬁve chromosomal regions in vicinity of
tpr regions and code for hypothetical proteins with unknown
function. PCR ampliﬁcation and subsequent restriction analysis of
61% of the T. paraluiscuniculi and T. pallidum ssp. pallidum ge-
nomes revealed difference in nine BamH I target sites and four
deletions/insertions in T. paraluiscuniculi chromosome. Among 84
genes tested with real-time RT-PCR, 12 showed signiﬁcant differ-
ences in gene expression. In general, genes encoding proteins
involved in electron transport were less expressed in T. paraluiscu-
niculi and higher expression was observed in genes encoding Tpr
proteins. Sequencing of more than 9.7 kb of T. paraluiscuniculi gen-
ome in short regions dispersed throughout the chromosome
revealed, on an average, one nucleotide change per 183 bp.
Conclusions: Observed differences in genome content and compo-
sition provide insights into the different pathogenic potential of
both treponemes and help to deﬁne genetic basis of syphilis.
P1602 An outbreak of primary and secondary syphilis
among HIV seropositive patients in Korea
H.C. Jang, W.B. Park, K.D. Lee, C.S. Lee, S.W. Park, Y.J. Choi,
H.B.Kim, M.D. Oh, K.W. Choe
Seoul, Cheonan, Goyang, KOR
Objectives: This study was performed to characterise the epidemi-
ology and clinical features of an outbreak of syphilis among HIV
sero-positive patients in Korea.
Methods: A retrospective case review of patients diagnosed with
primary and secondary syphilis in the period July 1998 to Septem-
ber 2003 was carried out at Seoul National University Hospital in
Korea. To estimate incidence, person-years (PYs) of all HIV sero-
positive patients who visited the hospital in the same period were
also calculated every 6 months.
Results: In a 51-month period, 465 HIV-positive patients were fol-
lowed up at Seoul National University Hospital. 38 cases of pri-
mary and secondary syphilis were diagnosed; two cases were
primary syphilis and the other 36 cases were secondary syphilis.
All cases were men. The incidence of primary and secondary
syphilis was 4.10 per 100 PYs during the period. There was no
case during July 1998 to December 2001, and then the incidence
has risen till September 2003 (5.55 per 100 PYs to 18.80 per 100
PYs). The rate of primary and secondary syphilis was 4.32 times
higher among homosexual and bisexual men than heterosexual
men (95% CI 1.87–11.17), and 10.92 times higher among patients
who did not receive HAART than patients who were receiving
HAART (95% CI 5.47–21.79). The incidence of primary and secon-
dary syphilis among patients who were receiving HAART has
risen continuously (0.86 per 100 PYs to 15.73 per 100 PYs).
Conclusions: The outbreak of primary and secondary syphilis
among HIV-positive patients started in 2002 and has been escalat-
ing, especially among homosexual/bisexual men and patients
who did not receive HAART.
P1603 Incidence of syphilis in AREA 2 of Madrid during
4 years: a retrospective study (2000–2003)
A. Perkins, J. Rodriguez, A. Alonso, A. Perez de Ayala,
M. Lo`pez-Brea, C. Casal
Madrid, E
Syphilis is a sexual transmitted infectious disease caused by Trepo-
nema pallidum. This venereal pathology is successfully treated with
penicillin but its incidence has increased during the last decade.
Objectives: The aim of this study was to determine the incidence
of syphilis diagnosed by serological tests in the Serology laborat-
ory at the Microbiology Department of the H. U. La Princesa in
Madrid.
Methods: The diagnosis of syphilis was made using treponemal
tests of microhaemagglutination assay for antibodies (MHA-TP)
and ﬂuorescent treponemal antibody absorption (FTA-ABS) and
nontreponemal test (regain) based on ﬂocculation (VDRL). Sex
and nationality of patients were studied. Provenience of serum
samples was also searched.
Results: A total of 462 cases of syphilis were found (102, 22.1%
during 2000; 91, 19.7% during 2001; 140, 30.3% during 2002 and
129, 27.9% during 2003). 169 (36.6%) were females and 293
(63.4%) males. 417 (90.2%) were Spanish and 45 (9.8%) were for-
eigners. MHA-TP results were: 342 (74.1%) positives, nine (1.9%)
doubtful results, 53 (11.5%) weak positives and 58 (12.5%) negat-
ives. FTA-ABS results were: 110 (23.8%) positive++ and 352
(76.2%) positive+++. VDRL results were: 186 (40.2%) positives
and 276 (59.8%) negatives. 228 (49.3%) of the serum samples pro-
ceeded from patients attended at hospital, mainly from Depart-
ments of Infectious Diseases (78; 34.2%), Dermatology (49; 21.5%),
Neurology (41; 17.9%), Psychiatry (14; 6.1%), Internal Medicine
(12; 5.2%), Gastroenterology (11; 4.8%), Rheumatology (7; 3.1%)
and Ophthalmology (6; 2.6%).
Conclusions: (1) The incidence of syphilis in Madrid has increased
during the last years. (2) Syphilis affected more frequently males
(63.4%). (3) Approximately 10% of the positive samples belonged
to foreigner patients. (4) 40.2% of the cases were secondary syphilis.
P1604 Epidemiology of syphilis in a hospital in Tunis
Z. Amel, B. Lilia, S. Sameh, M. Kemiti
Tunis, TN
Syphilis is an infectious disease sexually transmitted with obliga-
tory declaration and whose pathogenic agent is Treponema pallidum.
It appears clinically by a succession of phases during which the
Treponema can be highlighted by direct or indirect methods. The
existence of quiet clinical phases during which the diagnosis is not
currently possible that by test serologic one of the major difﬁculties
of the tracking of syphilis constitutes. Before accusing a psychiatric
cause, we carry out a research of the neurosyphilis systematically.
Indeed, this can associate a neurological syndrome being able to
lead the complete physical forfeiture or a driving psychiatric syn-
drome in a true irrational state. Our work concerned 8251 serums
and 134 LCR (spinal puncture) coming from patients addressed to
the psychiatric hospital of Razi from January 1996 to December
2003 for serology of syphilis and neurosyphilis. Half of the patients
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had an age ranging between 40 and 60 years, 70% were unmarried
and 80% were without job. Our syphilitic serology comprised each
time two reactions: agglutination (VDRL coal) and speciﬁc passive
haemagglutination (TPHA). The results showed a prevalence of the
disease syphilitic serum and neurological at the man (65–70%) what
is in conformity with the literature. The prevalence of serum syph-
ilis is higher in the age breaked ranging between 20 and 45 years; it
should be counted a few years before the neurosyphilis is not
declared. 60–80% of our patients are unmarried (reﬂexion of a great
freedom of manners) and without job; a better social integration
could make regress the disease. We noticed that the prevalence
decreased as for syphilitic serology (it passed from 7.6% in the
5 years of 1986–1990 and 4.7% of 1991–1995 than ﬁnally to 2.9%
currently). On the contrary, the prevalence of the neurosyphilis
appreciably increased passing from 1.6 to 3.47% in 10 years. The
efforts provided in regards national ﬁght against the MST thus
seem to give results concluding, although cases of neurosyphilis
continue to be reported.
P1605 Sexually transmitted HAV
C. Minari, G. Gubertini, G. Orlando, C. Pastecchia, A. Cargnel
Milan, I
Objectives: To determine epidemiological characteristic for HAV
infection admission in two Infectious Diseases Department in Italy.
Methods: Review of clinical records for epidemiology and risk fac-
tors for patients with HAV infection admitted from January 2000
to November 2003 in the I and II Department of Infectious Dis-
eases, L. Sacco Hospital (Milan, Italy).
Results: In the considered period 71/4325 (1.64%) patients have
been admitted for HAV infection (mean age 33.88  8.517). The rate
of admission rose from 1.48% in 2000 to 2.9% in 2003 (P ¼ 0.0013).
HAV infection among travellers to highly endemic countries
decreased from 31.25% in 2000 to 23.33% in 2003. In the same per-
iod the male/female ratio raised from 1.28 to 14.0 (P ¼ 0.0165).
HAV acquired as a food-borne disease was observed in 43 of 71
(60.56%) patients while in 25 of 71 (35.21%) HAV infection was
probably acquired through sexual exposure. A cluster of HAV
infection among MSM was indeed observed during 2003 with a
sharp increase both in admission for HAV infection and sexual
exposure. In the last year admission for HAV infection was obser-
ved in 19 MSM among 28 total male admissions for HAV (67.85%).
Conclusions: In Italy HAV infection declined in the last decades for
the improvement of social-economic and hygienic conditions leav-
ing a growing percentage of young adults unprotected against
HAV infection. Vaccine protection for travellers directed toward
highly endemic countries is becoming a relatively common practice
which can protect against the great majority of HAV infection
acquired through the oral route, reported in 65.2% of the national
cases (SEIEVA 2002) and in 60.56% in our report. In young unpro-
tected MSMHAVmust be considered, as a sexually transmitted dis-
ease and the need of HAV vaccine within this risk group must be
evaluated for the potential severe evolution of this disease in adults.
P1606 Prevalence of sexually transmitted viruses in Polish
commercial sex workers including HIV-seropositive individuals
B. Bucholc, J. Slusarczyk, M. Drop, Z. Dajek
Warsaw, PL
Objective: Patients infected with the human immunodeﬁciency
virus (HIV) are often co-infected with other viruses, especially
hepatitis viruses. Sera of patients with sexually transmitted dis-
eases (syphilis, gonorrhoea, chlamydiosis, HPV, and HIV infec-
tions) and sera from healthy blood donors were investigated for
presence of hepatitis B virus (HBV), hepatitis C virus (HCV), hepa-
titis G virus (GBV-C/HGV) transfusion transmitted virus
(TTV). High prevalence of TTV infection recently has been repor-
ted among blood donors and patients with liver disease. However,
as with GBV-C/HGV, the disease potential of TTV and its principal
modes of transmission are unclear. To assess possible sexual trans-
mission, of TTV we examined the prevalence of TTV viraemia
among female sexual workers in Warsaw. To demonstrate exposure
by this route all subjects were simultaneously examined for infec-
tions associated with risk behaviours HBV, HCV, HGV/GBV-C.
Methods: Presence of HBV, HCV, HGV and TTV was analysed in
plasma samples from 20 HIV1-infected commercial sex workers
(CSWs), from 20 HIV-1 uninfected CSWs and from 40 the blood
donors. The prevalence of HBV, HCV, HGV, TTV was estimated
on the basis of polymerase chain reaction (PCR).
Results: The prevalence of HBV was 0% in blood donors and HIV-1
negative CSWs and 15% in HIV-1-positive CSWs. The prevalence
of HCV was 2,5% in blood donors, in HIV-1 negative CSWs was 55
and 40% in HIV-1-positive CSWs. The prevalence of HGV was in
these groups is 0, 0 and 5%, respectively. The prevalence of TTV
exposure in the STD clinic was statistically signiﬁcant higher. In a
comparison of the subjects with STD vs. those without STD, the pre-
valence of TTV was, 90% in HIV-1-positive and 65% in HIV-negat-
ive CSWs vs. 55% on the basis of PCR results. There was a
statistically signiﬁcant higher prevalence of hepatitis B virus, hepa-
titis C virus and HGV/GBV-C, exposure in the STD clinic com-
pared with the group who never had received treatment for a STD.
Conclusions: The accumulated evidence indicate that hepatitis C
virus can be transmitted by sexual contact but much less efﬁ-
ciently than other sexually transmitted viruses, including trans-
mitted transfusion virus. We suggest that TTV infection have a
diverse route of transmission. The prevalence rate of TTV is very
high in certain risk groups.
P1607 Is systematic screening of hepatitis C virus (HCV)
in sexually transmitted diseases (STD) clinics necessary?
L. Metola, V. Ibarra, J.R. Blanco, L. Rosel, J.A. Oteo
Logron˜o, E
Developed studies about the sexual transmission of VHC show
contradictory results. Although in many of them the prevalence of
the infection for VHC is higher than in general population, most
of the agencies do not recommend routinely detection of Anti-
HCV antibodies in STD’s clinics. In La Rioja (Spain), the seroprev-
alence rate of AntiHCV is 2%.
Objective: To evaluate the rentability of HCV systematic screening
in patients who come to our hospital STD clinic.
Material and Methods: All the patients that come to STD clinic in
La Rioja Hospital from January 1999 to February 2003 were stud-
ied (n ¼ 803). The HCV antibodies were detected by means of a
conventional ELISA test. In all the positive samples, conﬁrmation
was performed by PCR.
Results: Ten of 803 studied samples presented AntiHCV antibod-
ies (1.24%), and in eight of them, RNA determination by PCR
was positive.
Conclusions: Our results suggest that people who come to STD
clinics do not represent a special risk group for the HCV infection.
The systematic serologic study of HCV in this kind of clinics is
not effective, as the prevalence is not higher than the prevalence
in the general population.
P1608 Clinical evolution of anal and cervical HPV
dysplasic lesions in HIV-1 infected patients
G. Orlando, C. Minari, M. Fasolo, R. Beretta, A. Cargnel
Milan, I
Objective: To evaluate clinical evolution of genital HPV dysplasic
lesions in HIV-1 positive subjects.
Methods: Comparative study on clinical evolution of anal and cer-
vical diplasic HPV-related lesions in HIV-1 infected males and
females. All HIV+ outpatients attending the STD service with gen-
ital dysplasia identiﬁed through cytology have been enrolled.
High grade resolution anoscopy and colposcopy, Digene Hybrid
Capture HPV DNA test and histology, CD4 T-cell counts, HIV
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RNA, antiretroviral treatments were evaluated at baseline and on
follow up. Progression (P), Regression (R) and Stable persistent
(SP) lesions were evaluated.
Results: Among the 143 HIV+ patients enrolled (116 F and 27 M) 112
cervical and 36 anal dysplasic lesions were observed. On enrolment
56 patients were receiving ART including PI (HAART). Baseline cer-
vical lesions were LSIL in 94.64%, HSIL in 4.4% and negative in
0.8%. Anal lesions were LSIL in 86.11%. In ﬁve cases dysplasia was
assessed trough high-resolution anoscopy. Digene test was negative
in 11.60%, low risk genotypes (LR) were observed in 7.14%, high
risk genotypes (HR) in 33.92% and LR/HR in 47.32%. Mean fol-
low up in 104 (70.27%) cases was 581 days (median 378 days).
Patients with cervical and anal lesions were comparable for age,
baseline mean CD4 T-cell counts, viral load, CDC stage and HPV
HR genotypes while higher percentage of non-HAART treatment in
the cervical lesions group was recorded (P < 0.0001). No differences
in clinical evolution were observed in relation to the baseline ART.
Progression rate was 11.53%: 10.12% for cervical and 16% for anal
lesions (P NS). Time to progression was shorter for anal lesions:
median survival time 379 vs. 1394 days in anal and cervical lesions
respectively (log rank test P < 0.0001). Similar results are obtained if
only patients with HAART are considered.
Conclusions: The risk of invasive cancers in HIV+ patients has been
related to onchogenic serotypes, persistence and co-infection with
several HPV genotypes, baseline CD4 T-cell counts, plasma HIV
viral load and ART. We observed a higher rate of spontaneous
regression of cervical lesions and a higher progression rate, within
2 years from the diagnosis, in anal than cervical localisations in the
presence of comparable baseline values of such parameters suggest-
ing a different natural history related to the anatomical site of the
lesions. More extensive studies are needed to verify such data.
P1609 Bacterial vaginosis in patients with genital HPV
infection
A. Kuch, A. Szkaradkiewicz, P. Pieˆta, M. Wal, Z. Muszyn˜ski
Poznan, PL
Objectives: Human papillomavirus (HPV), particularly HPV 16
and 18, is now recognised as the main cause of cervical cancer. It
has been suggested that bacterial vaginosis and altered vaginal
ﬂora may be a risk factor for sexually transmitted diseases (STD).
The aim of study was relationship between genital HPV infection
and bacterial vaginosis.
Methods: This study were performed on 120 women between 21
and 42 years of age and sexually active. Vaginal ﬂora was examined
by Gram’s stain, standardised scoring criteria (Nugent’s score). Bac-
terial vaginosis was diagnosed if a score was 7–10, a score of 4–6
indicated intermediate vaginal ﬂora and a score of 0–3 normal vagi-
nal ﬂora. In addition, presence of Lactobacillus spp. and Gardnerella
vaginalis was conﬁrmed by culture. HPV DNA type: 16 and 18 was
detected using PCR ampliﬁcation assay (ampliﬁcation of DNA frag-
ment which encoded E6 gene). Results: In the group of 120 women,
56 had bacterial vaginosis and intermediate vaginal ﬂora, including
10 with HPV16 infection. The remaining 64 patients manifested nor-
mal vaginal ﬂora and only 1 had signs of HPV16 infection. None of
the patients had DNA HPV18.
Conclusions: The results indicate that women with genital HPV
oncogenic type infections are at increased risk for BV.
P1610 Testing for oncogenic HPV in PaP liquid
preservative ﬂuid (Tripath Sure PathTM) correlates with
cytopathology and Digene sampler results
J. Kapala, M. Chernesky, J. Patel, S. Chong, D. Jang, K. Biers,
J. Mahony
Brampton, Hamilton, CAN
Objective: Recent approval by the FDA of adjunctive screening for
high risk (HR) HPV with PAP testing led us to examine (a) the
utility of the Digene HCII HR HPV test on specimens collected by
the Digene sampler (DS) vs. residuum from the SurePathTM liquid
preservative (LP) after PAP testing (b) correlation of HR HPV test
results with PAP cytopathology.
Methods: A total of 320 women consented to the collection of an
LP followed by a DS. Samples from group 1 (n ¼ 106) were tested
unfrozen. Discordant samples were freeze-thawed, retested twice
and tested by PCR. Samples from group II (n ¼ 214) were freeze-
thawed before testing. Patients were considered infected when
positive in LP and DS, or positive in one sample two of three
times. A volume of 2 mL was used for testing with 90 min dena-
turation.
Results: In the ﬁrst group 20 were positive in both samples. Re-
testing 20 discordants increased the positives to 27 and suggested
a beneﬁt of freezing to reduce discordancy. PCR testing did not
contribute to discordant analysis. In group II (n ¼ 214) 54 posi-
tives matched and 13 were discordant. After discordant analysis
63 patients were considered positive. Combining the positives and
negatives of both groups the LP detected 92% (83 of 90) and DS
84.4% (76 of 90) of the positives. Normal cytology was observed
in 79.2% (182 of 230) of the patients without HR HPV compared
with 37.8% (34 of 90) of the HPV infected group. The PAP results
for the 58 HPV positives were two carcinomas, 13 HSIL, 31 LSIL,
eight ASCUS, and ﬁve benign cellular changes (BCC). Abnormal
PAP results in the HPV negative group were BCC (29 of 48) with
the remainder LSIL or ASCUS.
Conclusions: HR HPV testing on LP identiﬁed most of the infected
women. Infection with HR HPV correlated with cervical abnor-
malities.
P1611 Epstein–Barr virus (EBV) and cervix uterine cancer
A. Szkaradkiewicz, M. Wal, A. Kuch, P. Pieˆta
Poznan, PL
Objectives: Present data indicate that EBV may infect human epi-
thelial as well as suggest a speciﬁc and active role of the virus in
carcinogenesis. Therefore, in this study we aimed to examine
whether, apart from human papillomavirus (HPV), also EBV may
be associated with cervical intraepithelial neoplasia (CIN).
Methods: The studies were performed on 19 CIN-positive women,
aged 21–42 years. Based on cytology screening, in 10 women mild
dysplasia (CIN grade I) (subgroup 1) was diagnosed while in the
remaining nine women – moderate (CIN grade II), severe dyspla-
sia (CIN grade III) or carcinoma in situ (CIS) (subgroup 2). All cer-
vical specimens were tested for the presence of EBV DNA and
HPV DNA (Sharp Signal System, Digene). In addition, attempts
were made to detect HPV 16 and HPV 18 using other PCR ampli-
ﬁcation techniques. In parallel, sera of all patients were tested for
IgG anti-EA antibodies (ETI-EA-G, DiaSorin), IgG anti-VCA anti-
bodies (ETI-VCA-G, DiaSorin) and IgG anti-EBNA antibodies
(ETI-EBNA-G, DiaSorin).
Results: In subgroup 1 all women proved HPV negative. At the
same time, in two of them presence of EBV DNA was detected. In
turn, in subgroup 2 seven women proved HPV 16-positive and
two cases were HPV-negative. In all women of the subgroup pres-
ence of EBV DNA was documented. Serum anti-EBV antibodies
were detected In all women In both subgroups. In all the cases,
the serological pattern typical for past EBV infection was docu-
mented.
Conclusions: The results indicate that EBV may be involved in cer-
vix uterine cancer aetiopathogenesis.
P1612 Prospective study on the risk factors associated with
cervical dysplasia and cervical carcinoma
M. Petrican, A. Craciun, S. Tomasian
Constanta, RO
Objective: The aim of the study was to evaluate the risk factors –
both infectious and noninfectious-associated with the occurrence
of cervical dysplasia and cervical carcinoma.
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Material and Methods: The study comprises 250 patients that
addressed to gynaecologists for specialised consult, control and/
or treatment. The patients have been asked to fulﬁl an anonymous
questionnaire regarding the age of initiation of sexual activity,
numbers of pregnancies and/or abortions, sexual behaviour, con-
traceptive use, number of sexual partners over the years, previous
genital infections or other genital pathology known, data regard-
ing smoking habits. The laboratory exams for all patients included
Papanicolau tests, cervical bacterial and parasitary cultures, anti-
body testing for Chlamydia trachomatis, Herpes simplex, syphillis,
hepatitis B and C and HIV.
The patients were divided in three relatively equal groups as num-
ber: group A: without signiﬁcant pathological changes; group B:
with cervical dysplasia in different stages; group C: with cervical
carcinoma conﬁrmed both cytologically and colposcopically.
Results: The most signiﬁcant risk for the occurrence of cervical
dysplasia and carcinoma was associated with: the initiation of sex-
ual activity before 16 years of age, one or more pregnancy/abor-
tion before 18 years of age, more than three sexual partners
during lifetime, previous sexual transmitted diseases, use of
empirical local contraceptives (e.g. vitamin C, quinine) for more
than 5 years, low socio-economic status, smoking more than 20
cigarettes per day at the moment of diagnosis. The prevalence of
infectious factors were higher in groups B and C than in group A:
– Trichomonas vaginalis: 62% in group B, 51% in group C, com-
pared with 12% in group A;
– Candida albicans: 47% in group B, 38% in group C, compared
with 14% in group A;
– Gram-negative and gram-positive cocci: 29% in group B, 8% in
group C, 13% in group A;
– Enterobacteriaceae: 5% in group B, 4% in group C, 5% in
group A.
– Coccobacilli: 14% in group B, 12% in group C, 9% in group A
Conclusions: The carcinogenesis of uterine cervix is a multifactorial
process involving different factors that intricate and conditions
each other. The factors that determine a so-called ‘sexual pol-
lution’ regard the ambient, sexual habits and the contamination
with bacterial, viral and parasitic germs. A primary prophylaxis
of cervical carcinoma cannot be conceived without taking into
consideration, all these factors.
Diagnostic methods: antibiotic susceptibility
P1613 Direct susceptibility testing of positive Bac T Alert
blood culture by disk diffusion and preliminary bacterial
identiﬁcation
I. Mansoor, E. Deberg, P. Ninfa, C. Leroy
Baudour, B
Objectives: The procedure described by the NCCLS for susceptibil-
ity testing requires subculture of the broth on agar media. Results
are available to clinicians 48 h after positive blood cultures. The
outcome of patients with septicaemia depends on early treatment
with appropriate antimicrobial agents. This study evaluated sus-
ceptibility results obtained by using bacterial pellets and prelimin-
ary classiﬁcation of bacteria based on tube coagulase (TCT) and
cytochrome oxidase test (COT). Results for COT and TCT tests are
obtained after 15 min and 4.5 h, respectively and are helpful for
the choice of antibiotics.
Methods: A bacterial pellet was obtained by centrifugation of an
aliquot of culture broth in a serum separator tube. Bacteria were
collected from the gel with a cotton swab and suspensions equiv-
alent to 0.5, 1.0 and 2.0 Mc Farland (McF) were made. A colony
count was performed in order to ascertain the proper colony den-
sity used. Susceptibility testing were done with the three inocula
and directly from one drop of broth (nonstandardised inoculum
:NSI) on Mueller Hinton agar, Oxacillin Screen and Vancomycin
Screen plates. TCT and COT tests were performed with the bac-
terial pellet obtained after centrifugation. A total of 40 signiﬁcant
positive blood cultures were investigated (1 isolate per patient).
28 Gram-negative (408 antimicrobial agent-organism combina-
tions-AAOC) and 12 Gram-positive (108 AAOC) isolates were
analysed. A scoring system was adopted for analysis of discrepan-
cies: 5 points for very major errors (false susceptibility – VME), 3
points for major errors (false resistance – MAE), 1 point for minor
errors (MIE) and 0 point for no error.
Results: For the gram-negative isolates categorical agreements of
93.1, 95.8, 93.6 and 94.4% were obtained with the NSI, 0.5, 1.0 and
2.0 McF suspensions, respectively. VME were observed in 1.0%
with (NSI, 0.5, 1.0 McF) and 1.2% (2.0 McF). MAE in 0.2% (NSI,
0.5 McF). MIE were observed in 5.6, 2.9, 5.4 and 4.4% with NSI,
0.5, 1.0, 2.0 McF inocula, respectively. For Gram-positive cocci cat-
egorical agreements were observed in 87.0% (NSI), 90.7% (0.5,
1.0, 2.0 McF). VME were observed with all suspensions in 0.9% of
cases. No MAE was found. MIE were found in 12% (NSI) and
8.3% (0.5, 1.0, 2.0 McF). No discrepancies were observed for TCT
and COT tests.
Conclusion: Preliminary susceptibility results could be given to cli-
nicians 24 h earlier, however, certain results need to be conﬁrmed
by the NCCLS method.
P1614 Evaluation of the VITEK 2 system for rapid direct
identiﬁcation and susceptibility testing from positive blood
cultures
C. Berhin, Y. Glupczynski, Y. De Gheldre
Yvoir, B
Objectives: We aimed to evaluate the accuracy of direct inocula-
tion of VITEK2 cards from positive blood culture bottles to
achieve rapid bacterial identiﬁcation (ID) and antibiotic suscepti-
bility testing (AST).
Methods: Positive BacT/Alert blood cultures sampled between 05/
2002 and 11/2003 were included. Direct inoculation of bacterial
suspensions to VITEK 2 ID and AST cards was made by differen-
tial centrifugation of blood cultures. The types of VITEK 2 ID and
AST cards inoculated (Gram-negative, staphylococci, streptococci/
enterococci) were selected according to the morphology of the
organisms on direct Gram-stain. Results of the rapid method were
compared with those of the routine methods based on API identi-
ﬁcation systems and AST by the Kirby-Bauer disc diffusion
method according to NCCLS guidelines.
Results: A total of 166 clinically relevant isolates were investi-
gated. Overall, 103 (62%) were correctly identiﬁed to the species
level. Sixty-three (38%) strains could not be identiﬁed due to var-
ious reasons (haemolysis, insufﬁcient bacterial pellet, residual
traces of charcoal) but no strain was misidentiﬁed. The rapid
method proved mostly accurate for ID of Enterobacteriaceae (EB)
[80/91 (87%) and enterococci (8/10) but not for Gram-negative
nonfermenters (GNNF) nor for streptococci and staphylococci
(only 20–40% correct ID). Direct susceptibility performed for 103
strains (80 EB, 10 GNNF, 13 staphylococci) and including 1210
antibiotic-isolate combinations gave an overall essential agreement
of 93%. Most discordances corresponded to minor errors (4.5%)
while major (S by VITEK2, R by routine testing) and very major
errors (R by VITEK2, S by routine testing) were found in 0.7 and
1.5% of all organism-antibiotic combinations, respectively. The
rates of agreement between the rapid and the conventional meth-
ods ranged from 86 to 100% depending on the antibiotics, but
there were no clustering of discordances for speciﬁc antibiotic-
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isolate combinations. The reporting time for the direct testing of
susceptibility against the 13 antibiotics for 103 blood culture iso-
lates by the VITEK2 system ranged from 4.5 to 18.1 h.
Conclusion: Direct inoculation is directly applicable as routine
method for ID and AST of EB and enterococci, but not for GNNF,
staphylococci or streptococci. Compared with conventional meth-
ods that require 1 or 2 days, this method can make same-day
reporting possible and it may thus permit better patient manage-
ment.
P1615 Antibiotic susceptibility test on pathogens isolated
in ICU using the Uro-Quick system
S. Roveta, F. Cavallini, A. Marchese, E.A. Debbia
Genoa, I
Objectives: The Uro-Quick, an automatic instrument widely used
for the screening of bacteriuria, was previously employed to
detect antibiotic resistance in well-characterised bacterial strains
(J Chemother 16, 2004 in press) and in uropathogens. In this study
pathogens isolated in ICU of a great Italian hospital during the
period September–November 2003 were examined employing the
Kirby–Bauer technique for antibiotic susceptibility tests and this
usual system was compared with the new rapid Uro-Quick
method.
Methods: Antibiotic (in appropriate concentration) was introduced
in a vial containing 2 mL of Mueller–Hinton (MH) broth, then
0.5 ml of broth containing 5  105–106 cells/mL of the strain to
test were added in each vial containing the antimicrobial mole-
cules and even in a drug-free vial as control. After 3 and 5 h of
incubation (Gram-negative or Gram-positive strains, respectively)
the instrument printed the results: no growth and a growth curve
like the control is representative of a susceptible and resistant
strain respectively. Gram negative strains were tested against ci-
proﬂoxacin (CIP), ampicillin (AM), aztreonam (ATM), co-clavula-
nate (AMC), piperacillin/tazobactam (TZP), ceftazidime (CAZ),
cefotaxime (CTX), cefuroxim (CXM), ceftriaxone (CRO), imipenem
(IPM), amikacin (AN), gentamycin (GM) and trimethoprim–sul-
phamethoxazole (SXT), while Gram-positive bacteria against CIP,
clindamycin (CM), erythromycin (E), IPM, linezolid (LZD), AM or
penicillin (P), rifampicine (RA) GM, streptomycin (S), tetracycline
(TE), vancomycin (VA), oxacillin (OXA) and SXT.
Results: The Gram-negative strains tested were 121 and the Gram-
positive 144, agreement between the two methods was 93%
against Gram-negative (SXT and CTX 98.3%, CIP 97.5%, GM
96.7%, CRO 96%, AN and CAZ 95%, IPM 94%, AM 92%, CXM
and AMC 90%, TZP 88%, ATM 84%) and 95% against Gram-
positive (AM 100%, LZD 99%, CM, IPM, VA and S 97%, CIP,
RA, TE and SXT 95%, E 92%, OXA and P 94%, GM 88.4%) path-
ogens.
Conclusion: Against major pathogens (staphylococci, enterococci
and Enterobacteriaceae) agreement between the Uro-Quick system
and the Kirby–Bauer method was always more than 90%. On the
basis of the present ﬁndings the rapid method appears useful in
severe nosocomial infections because the rapid detection (in 3 or
5 h) of antibiotic susceptibility allows a more direct treatment,
reduce the empiric therapy and the diffusion of resistant patho-
gens.
P1616 Comparison of Phoenix, Vitek and Vitek 2
automated identiﬁcation and susceptibility testing systems
D. Brown, T. Milne, D. Livermore
Cambridge, London, UK
Objectives: To compare identiﬁcation (ID) and susceptibility test-
ing results (AST) obtained with the Becton Dickinson PHOENIX
System (PH) and the BioMe´rieux VITEK (V1) and VITEK2 (V2)
systems in tests on a challenge set of organisms.
Methods: Strains tested were 125 S. aureus (SA), 84 coagulase-neg-
ative staphylococci (CNS), 240 Enterobacteriaceae (EN), and 107
nonfermenting Gram-negative rods (NF) comprising 78 Pseudo-
monas spp. (PS), 19 S. maltophilia (SM) and 10 Acinetobacter spp.
(AC). The strains were biased towards those with resistance to
various antimicrobial agents. Identiﬁcation and antimicrobial sus-
ceptibility tests were run in the three systems simultaneously.
Susceptibility interpretations made by the expert systems were
used in the comparisons. Reference identiﬁcation was by API
(BioMe´rieux) or PCR. Susceptibility discrepancies were assessed
against agar dilution MICs determined by NCCLS methods.
Results: Accuracy of identiﬁcation (%) to species level by PH, V1
and V2 compared with reference identiﬁcations was, 98.4, 100 and
98.4, respectively, for SA; 73, 57, and 79 for CNS; 96.3, 95.4 and
96.3 for EN; 96.3, 95.3 and 77.6 for NF. With SA there were up to
1.6% major and 2% minor discrepancies in susceptibility categori-
sation between systems with 1431 organism–agent combinations
tested. With CNS there were up to 9.0% major and 3.2% minor
discrepancies for 831 organism-agent combinations tested – dis-
crepancies were most common with oxacillin. For staphylococci
there were fewer discrepancies between PH and V2 than between
V1 and either V2 or PH. With EN there were up to 4.2% major
and 15.6% minor discrepancies in susceptibility categorisation
among 3080 organism–agent combinations tested. For NF there
were up to 4.2% major and 8.5% minor discrepancies in suscepti-
bility among 503 organism–agent combinations tested.
Conclusions: Identiﬁcation in all systems was generally reliable for
SA, EN and NF (although V2 reported some strains of Pseudomon-
as spp. and Acinetobacter spp. as nonfermenters). Identiﬁcation of
CNS to species level was less reliable, particularly with the V1
system. With this collection, which included a high proportion of
resistant organisms, there was very good agreement in susceptibil-
ity categorisation between systems with SA but less so with other
organisms.
P1617 The application of two disc methods and the E-test
for detecting extended-spectrum beta-lactamases (ESBL) in
clinical strains of K. pneumoniae and E. coli
E. Andrzejewska, A. Szkaradkiewicz
Poznan, PL
Objectives: The aim of this study was to compare the effectiveness
of two disc methods and the Etest applied for the detection of
ESBLs.
Methods: We tested 148 clinical strains of E. coli and 78 strains of
K. pneumoniae. All the strains were examined by using the follow-
ing tests: double-disc synergy test (DDST) according to Jarlier
(cefotaxime, ceftazidime, aztreonam and clavulanic acid), disc test
according to Appleton (cefpodoxime, cefpodoxime + clavulanic
acid) and also by Etest (cefotaxime, cefotaxime + clavulanic acid
and ceftazidime, ceftazidime + clavulanic acid).
Results: In the case of K. pneumoniae, the activity of the ESBLs was
detected among 30 strains – both in Jarlier test, Appleton test and
the Etest. Among E. coli, four strains were found ESBL-positive in
the Jarlier’s test. However only three of these strains were ESBL-
positive when Appleton test and Etest were used.
Conclusions: (1) ESBLs must be routinely detected in clinical
strains E. coli and K. pneumoniae. (2) All the methods used for
detecting ESBL in K. pneumoniae strains are equally effective. (3)
Two tests (Appleton test and Etest) were found to be more useful
for detecting ESBLs in E. coli strains.
P1618 Sensitivity and cost-effectiveness of different
phenotypic methods for the detection and conﬁrmation of
extended-spectrum beta-lactamases including an inexpensive
novel method
R. Colodner, N. Keller, B. Chazan, R. Raz
Afula, Tel Hashomer, IL
Objectives: To evaluate the sensitivity and cost-effectiveness of
extended-spectrum beta-lactamases (ESBLs) detection and conﬁr-
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mation methods in our country, including an inexpensive modiﬁ-
cation of the original Jarlier’s method.
Methods: The sensitivity and cost-effectiveness of Single Disk Dif-
fusion Test (SDDT), Inhibitor Potentiated Double Disk (IPDD),
and Etest, were evaluated in a collection of 326 ESBL-positive
organisms isolated in Israel, including E. coli, Klebsiella spp., Pro-
teus spp., and Enterobacter spp. In addition, Aproximation Test
(AT), a modiﬁcation of the original Jarlier’s method using ﬁrst
and second-generation cephalosporins, was evaluated.
Results: The sensitivity of the different methods varied from 66.9%
for SDDT with ceftazidime to 98.8% for Etest with cefotaxime alone.
Several combinations of tests reached a sensitivity of 100%.
Conclusions: IPDD using cefotaxime and ceftazidime, or ceftazi-
dime and cefpodoxime proved to be the best options in our coun-
try in terms of sensitivity and cost-effectiveness. However, AT
with cephalotin and cefuroxime, an inexpensive method, can be
used for the ﬁrst screening of ESBLs with acceptable results.
P1619 Evaluation of the Etest MBL for detecting
metallo-beta-lactamases in carbapenem-resistant Pseudomonas
aeruginosa isolates
M. Maniati, S. Pournaras, Z. Bersos, A.N. Maniatis
Larissa, GR
Objectives: Carbapenem resistance mediated by the acquired met-
allo-b-lactamases (MBLs) of IMP and VIM types is increasing in
several countries particularly among Pseudomonas aeruginosa clin-
ical isolates and limits the usefulness of beta-lactams. The purpose
of this study was to evaluate the performance of the Etest MBL, a
phenotypic test commonly in use for the detection of metallo-b-
lactamases in P. aeruginosa, in a region with a high-prevalence of
MBL-producing pseudomonads.
Methods: Eighty-eight clinical isolates of P. aeruginosa resistant to
both imipenem and meropenem isolated during 2 years (2002–
2003) from separate patients in the University Hospital of Thes-
saly were included in this study. The susceptibility of the isolates
to various antibiotics including carbapenems was examined by
the disk diffusion method. Detection of the genes blaIMP and bla-
VIM that code for MBLs and have been described in Mediterra-
nean regions was performed by polymerase chain reaction (PCR)
using consensus primers for each gene. Finally, all isolates were
tested with Etest MBL strips according to the manufacturer (AB
Biodisk, Solna, Sweden).
Results: Fifty-ﬁve of 88 isolates showed positive result for the
presence of blaVIM by PCR. blaIMP genes were not detected in
any isolate tested. The Etest MBL was indicative of MBL produc-
tion (EDTA potentiated imipenem activity by ?Y´ 8 times16 ) in all
but two of the blaVIM positive isolates, while it was positive in
additional 21 isolates with a negative PCR reaction. In two isolates
Etest MBL was negative while PCR gave a speciﬁc PCR product.
All isolates that exhibited MIC for both carbapenems of > 64 mg/
L had an imipenem/imipenem plus EDTA ratio of >40 and car-
ried blaVIM Cgene, while all discrepancies were observed in iso-
lates with carbapenem MICs of 8–16 mg/L.
Conclusions: The Etest MBL strips are a quick and easy method to
perform in routine clinical laboratories. The discrepancies in the
detection of low-level carbapenem-resistant isolates suggest that
in such cases the use of this method may require the use of an
additional assay, such as PCR.
P1620 Evaluation of BDXpertTM System for interpretation
of antibiotic susceptibility testing results for Streptococcus
species
M. Deal, J. Pollitt, M. Gosnell, B. Turng, T. Wiles, D. Callihan,
J. Reuben
Sparks, USA
Objectives: Antibiotic resistance in Streptococcus (STR) species has
increased worldwide in the past decade. The NCCLS (USA) and
CA-SFM (France) publish AST standards to interpret in vitro sus-
ceptibility results. Both standards also include relevant therapy
warnings and guidelines for interpreting intrinsic susceptibility/
resistance and cross-resistance when appropriate. Such informa-
tion can be communicated to assist clinicians in selection of opti-
mal therapy for patients with streptococcal infections. The
BDXpert System was developed for the BD PhoenixTM System
and BD EpiCenterTM to interpret AST test results and communi-
cate appropriate comments recommended by NCCLS or SFM.
This study evaluates the functionality of expert rules created spe-
ciﬁcally for interpreting AST results for STR.
Methods: Comments listed in the NCCLS M100-S13 and CA-SFM
Report 2003 were converted into expert rules used in the BDXpert
system. Special rules were created to detect the following resistance
markers: high-level penicillin resistance (HLPSP) and low-level
penicillin resistance (LLPSP) in S. pneumoniae (SP), inducible MLSb/
efﬂux (MEFF), constitutive MLSb (MLSb), and resistance to high-
level streptomycin (HLSR), gentamicin, and kanamycin (HLKR).
Actions and associated messages were implemented as speciﬁed in
the standard documents. A total of 95 challenge strains possessing
these resistance mechanisms were selected based on previously
determined genotypic and phenotypic characteristics to evaluate
the effectiveness of BDXpert rules. Reports were reviewed by at
least two human experts for the accuracy of actions or messages.
Results: MIC values were interpreted correctly according to the
breakpoints in the respective standard. Evaluation of 64 SP iso-
lates using both NCCLS and SFM criteria demonstrated correct
detection of HLPSP (20), LLPSP (26), MEFF (21), or MLSb (22).
When SFM criteria were applied, HLSR or HLKR was also detec-
ted in 19 strains. Of 11 S. pyogenes strains tested, MEFF and MLSb
phenotype were detected in three strains each. Expert messages
identifying intrinsic resistance or communicating appropriate
therapeutic warning were consistent with AST results and species.
Conclusions: The BDXpert System reliably detects and reports
resistance markers in STR. Special messages, including therapy
warnings, intrinsic resistance/susceptibility and cross-resistance
can be used to communicate timely and accurate information to
clinicians for proper antimicrobial therapy.
P1621 Evaluation of cefepime with and without clavulanic
acid for the detection of extended-spectrum beta-lactamases in
Enterobacteriaceae species
E. Smith Moland, T.J. Lockhart, J.A. Black, L.B. Olson, A. Hossain,
N.D. Hanson, K.S. Thomson
Omaha, USA
Background: NCCLS conﬁrmatory extended spectrum beta-lacta-
mase (ESBL) test methods using ceftazidime (CAZ) and cefotaxime
with and without () clavulanic acid (CA) are recommended only
for E. coli (EC) and Klebsiella spp. (KLs). ESBLs are increasingly
reported in other species of Enterobacteriaceae (EN). Detection of
ESBLs in all species is critical for therapy and infection control.
Methods: We evaluated the utility of cefepime (FEP)  10 mcg/mL
CA as an ESBL conﬁrmatory test using TREK frozen microdilution
(MB) panels with a FEP range of (0.06–128 mcg/mL) and FEP/CA
range of (0.03/10–32/10 mcg/mL). Strains tested were recent US
clinical isolates and included 216 ESBL producing (56 from species
other than EC and KLs), and 452 non-ESBL beta-lactamase produ-
cing strains, characterised for beta-lactamase production by pheno-
typic, biochemical and molecular methods. A subset of isolates
[Serratia marcescens (n ¼ 12), K. pneumoniae (n ¼ 4), and K. oxytoca
(n ¼ 1)] which produced an SHV-7 like enzyme was also tested
using E-test FEP  CA strips. These isolates were CAZ  CA posit-
ive for ESBL production and negative with FEP  CA in MB tests.
Results: The FEP  CA combination was 88% sensitive and 87%
speciﬁc in the MB tests. The FEP  CA test detected 21 ESBLs in
isolates that were highly resistant to CAZ and co-produced chro-
mosomal or plasmid-mediated AmpC beta-lactamases. There were
59 false-positive results; mainly in EC (n ¼ 16), K. pneumoniae
(n ¼ 17), K. oxytoca (n ¼ 17) and P. mirabilis ( n ¼ 4). The E-test
FEP  CA strips detected 10 of the subset of 17 isolates with
SHV-7 like ESBLs that were negative with FEP  CA with MB.
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Conclusions: The false-positive results in this study indicated that
FEP  CA should be used cautiously for ESBL detection in EC
and KLs. Furthermore FEP  CA was not reliable for the detec-
tion of SHV-7 like ESBLs, especially in MB tests. FEP  CA was
most useful for ESBL detection in EN that co-produce an AmpC
beta-lactamase.
P1622 Evaluation of the MicroScan ESBL Plus
conﬁrmation panel for Enterobacteriaceae-producing
extended-spectrum beta-lactamases
E. Cercenado, N. Garcı´a-Escribano, J. Garcia-Martinez, E. Bouza
Madrid, E
Objectives: The increasing emergence of Enterobacteriaceae-produ-
cing extended-spectrum-beta-lactamases (ESBL) is a cause of con-
cern and their detection is important in the laboratory. We
evaluated the MicroScan ESBL Plus conﬁrmation panel (Dade
Behring, Sacramento, CA, USA) for the detection of 12 Enterobac-
teriaceae-producing ESBL species.
Methods: Two-hundred strains were studied: 185 were isolated
from patients at our institution, 12 belonged to a well-deﬁned
previously published collection of Entrobacteriaceae with differ-
ent resistance mechanisms, and three were control strains:
E. coli ATCC 25922, K. pneumoniae ATCC 700603 and P. aerugi-
nosa ATCC 27853. A total of 168 isolates produced ESBL and
comprised 135 strains targeted by the NCCLS ESBL test (E. coli,
K. oxytoca and K. pneumoniae) and 33 nontarget strains (Salmon-
ella spp., P. mirabilis, S. marcescens, Enterobacter spp., and C. fre-
undii). In addition, we tested 14 AmpC-hyperproducing (AmpC-
h) E. coli, 13 K1-hyperproducing (K1-h) K. oxytoca, and two
AmpC-h E. cloacae. Susceptibility testing was performed by the
broth microdilution method following the manufacturer’s
instructions, and readings were performed visually after
18–24 h. of incubation at 35C.
Results: Sensitivity and speciﬁcity of the MicroScan panel for the
target bacteria were 97 and 71%, respectively; sensitivity and spe-
ciﬁcity for nontarget bacteria were 89 and 100%, respectively.
Eighteen strains were classiﬁed incorrectly: 10 isolates of K1-h K.
oxytoca and 1 AmpC-h E. coli were misidentiﬁed as ESBL produc-
ers; and seven ESBL-positive isolates were not detected [E. coli (1
strain), K. pneumoniae (2), Salmonella spp. (1), C. freundii (1), E. cloa-
cae (1), and S. marcescens (1)]. In these seven strains, the synergy
effect of clavulanic acid was observed in the double-disk synergy
test using only the cefepime disk. The chromosomal AmpC-pro-
ducing micro-organisms might produce high levels of AmpC in
addition to ESBL (MICs of cefoxitin >32 mg/L), and the remain-
ing ESBL-producers showed either very high or very low ceftazi-
dime and cefotaxime MICs.
Conclusions: The MicroScan ESBL Plus conﬁrmation panel showed
excellent performance in detecting target micro-organisms,
although misidentiﬁcation of a non-ESBL producer as an ESBL
producer was frequent with K1-h K. oxytoca. Addition of cefepime
and clavulanic acid to the panel may signiﬁcantly improve detec-
tion of ESBL-producing strains.
P1623 Evaluation of the ability of Italian laboratories to
detect beta-lactam resistance phenotypes in Enterobacteriaceae:
a proﬁciency study by the Associazione Microbiologi Clinici
Italiani (AMCLI)
G. Gesu, F. Luzzaro, G. Ortisi, S. Malandrin, A. Endimiani,
L. Pagani, G. Rossolini on behalf of AMCLI Antimicrobials Study
Committee
17
Objectives: To evaluate, at a countrywide level, the proﬁciency of
Italian laboratories to detect beta-lactam resistance phenotypes,
including those mediated by extended-spectrum beta-lactamases
(ESBLs), in well-characterised isolates of Enterobacteriaceae.
Methods: On June 2003, 60 clinical microbiology laboratories located
in different Italian regions entered this nationwide proﬁciency
study. All participating laboratories received ﬁve well-characterised
strains of Enterobacteriaceae producing ESBLs (Klebsiella pneumoni-
ae/SHV-12, Klebsiella oxytoca/SHV-12, Proteus mirabilis/TEM-52,
Escherichia coli/CTX-M-1, and K. pneumoniae/SHV-18), and two
hyper-producers of chromosomal enzymes (an AmpC-hyperpro-
ducing E. coli, and a K1-hyperproducing K. oxytoca). In addition
three reference strains (E. coli ATCC 25922, E. coli ATCC 35218, and
Pseudomonas aeruginosa ATCC 27853), were also provided as a blind
internal quality control. Each laboratory was requested to use the
routine methods for identiﬁcation and susceptibility testing (AST).
Expected results were established by two independent reference
laboratories according to the NCCLS guidelines.
Results: Identiﬁcation to species and genus level was correctly
reported in 96.0 and 99.5% of cases, respectively. The perform-
ances in AST were different depending on the species and type of
ESBL produced. Approximately 30% of laboratories failed to
apply NCCLS rules with Klebsiella spp. producing SHV-type ES-
BLs. In these cases, very major errors were mostly related to cefo-
taxime (18.4%), ceftriaxone (23.4%) and cefepime (26.2%). A
higher rate of failure occurred in detecting the ESBL phenotype of
CTX-M-1-producing E. coli (44.1%) and TEM-52-producing P. mir-
abilis (67.8%). These two strains were incorrectly reported as sus-
ceptible to ceftazidime in 44.1 and 55.9% of cases, respectively.
On the contrary, the isolates hyperproducing chromosomal
enzymes were correctly reported more frequently, although an
ESBL-mediated resistance mechanism was erroneously reported
in about 15% of cases. Notably only 27 of 60 centres used a con-
ﬁrmatory test for ESBL production.
Conclusions: Detection of ESBLs is still a problem for clinical
laboratories. Laboratory methods for AST appear to be performing
better when well known enzymes are involved, whereas they fail
to report resistance when facing emerging enzymes (e.g. CTX-M-
type) or organisms not well recognised as ESBL-producing by cur-
rent international guidelines (e.g. P. mirabilis).
P1624 Characteristics of methicillin-resistant
Staphylococcus aureus (MRSA) undetected by Vitek 2
V. Vernet-Garnier, D. Forte, L. Brasme, F. Bureau-Chalot,
J.D. Capelle, J. Madoux, C. De Champs
Reims, F
Objectives: The aim of this study was to compare different pheno-
typic methods for detection of methicillin-resistant Staphylococcus
aureus that appeared methicillin susceptible with Vitek 2 but that
carry the mecA gene.
Methods: Between November 2001 and June 2003, 771 strains of
MRSA were detected by multiplex PCR analysis of nucA, mecA
and 16S rRNA genes. Among these strains, 31 (4%) appeared
methicillin susceptible by Vitek 2 susceptibility card AST-P515
(bioMe´rieux). We compared: (i) disc-diffusion method using oxa-
cillin 5 mg (CA-SFM breakpoint) and cefoxitin 30 mg (inhibition
diameter: 27 mm), (ii) agar dilution MICs, (iii) ATB STAPH sys-
tem (bioMe´rieux), (iv) standard Etest procedure. Population analy-
sis proﬁles method was used to detect heteroresistance level.
Results: Methicillin resistance was demonstrated among 11/31
strains (35%) using agar dilution MICs, 14/31 strains (45%) by
disk diffusion method using oxacillin disk, 21/31 strains (68%)
using standard Etest, 22/31 strains (71%) using ATB STAPH sys-
tem, 30/31 strains (97%) by disc-diffusion method using cefoxitin
disk. Population analysis proﬁles method demonstrated extreme
heteroresistance among all the strains tested ; 28/31 (90%) were
compatible with Tomasz’s class 1 (1/108 of the native population),
and 3/31 (10%) with class 2.
Conclusions: These data suggest that the MRSA strains undetected
by Vitek 2 could be classiﬁed as heteroresistant MRSA. PCR
detection of mecA gene represent the gold standard for methicil-
lin-resistance diagnosis though cefoxitin disk diffusion can actu-
ally be considered as the most accurate phenotypic method to
detect methicillin resistance among S. aureus. However, clinical
relevance of these heteroresistant strains remains to be evaluated.
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P1625 Bench validation of methicillin resistance detection
by Vitek 2 in clinical staphylococci isolates
A. Wenger, I. Nahimana, G. Prod’hom, J. Bille, K. Jaton
Lausanne, CH
Objectives: Test nonselected clinical strains of staphylococci for
oxacillin (OX) susceptibility by Vitek2 (VT2) instrument and by
Kirby-Bauer (KB) and devise a strategy to solve discrepancies.
Methods: During a month (August 2003) all clinically signiﬁcant sta-
phylococci isolated in our laboratory, except blood culture isolates,
were tested simultaneously by VT2 AST P-523 card and by OX disc
diffusion using NCCLS guide lines and M100-S9 interpretive cri-
teria. All discrepancies between the three tests [OX calculated MIC
(OXMIC); growth in the presence of 3 mg/L OX + 2% NaCl
(OXST); disc diffusion (OXKB)] were resolved by the following com-
plementary tests: induced PBP2’, mecA gene by PCR and identiﬁca-
tion to the species level for coagulase-negative staphylococci (CNS).
Results: There were 196 S. aureus (SA) (27 MRSA) and 38 CNS (23
MRSE) tested. The bacterial suspension could be prepared from pri-
mary plates for 111 (57%) of SA and for 14 (37%) of CNS. Only two
strains needed repetition because of mixed inoculum. 14 of the SA
(7%) and eight of the CNS (21%) [S. capitis (1), S. epidermidis (1),
S. lugdunensis (1) and S. saprophyticus (5)] needed complementary
tests. 21 of them were mecA gene and PBP2’ negative while the
S. epidermidis strain was positive for both. Of the 14 SA, four were
false MRSA by VT2 and 10 were ﬂagged by the Advanced Expert
System because of discordances between OXMIC and OXST. Of the
eight CNS, the ﬁve S. saprophyticus were false MRSE by both
OXMIC and OXKB and the S. lugdunensis by OXMIC only; one
S. capitis was ﬂagged because of growth in OXST well, and the last
was the MR S. epidermidis missed by OXKB. Thus in this routine
setting the PPV/NPV of VT2 for detecting methicillin resistance in
SA vs. CNS were 87%/100% vs. 79%/100%. By comparison these
ﬁgures for KB were 100%/100% vs. 67%/91%.
Conclusions: We found the strategy of combining VT2 with OXKB
and with induced PBP2’ detection the best way to safely detect
mixed inocula, to quickly solve either ﬂagged results on VT2 or
discordances between the three tests. It allowed us specially to
improve the speciﬁcity of methicillin detection in CNS.
P1626 Detection of clinical MRSA strains in routine
diagnostic laboratory
M. Slomka, A. Szymanowska, A. Rokosz, A. Sawicka-Grzelak,
M. Luczak
Warsaw, PL
Objectives: The aim of this study was to compare results obtained
with two methods of methicillin resistance determination in Sta-
phylococcus aureus strains, e.g. the disc-diffusion method and the
ATB STAPH 5 (version 2000) method.
Methods: The methicillin resistance of 120 S. aureus strains was
examined. All strains were isolated from ambulatory or hospital-
ised patients of the Infant Jesus Clinical Hospital – Centre for
Trauma Treatment in Warsaw, from April to July, 2002. Two ref-
erence control strains (1. MSSA-PSSA S. aureus ATCC 25923,
2. methicillin-resistant S. aureus MR 3) were used in the study.
Strains were identiﬁed biochemically with the automatic ATB
Expression system – ID 32 STAPH strips (bioMerieux, Poland)
according to the recommendations of the producer. Identiﬁcation
was conﬁrmed with Slidex Staph-Kit (bioMerieux, Poland). Methi-
cillin resistance (MR) was determined with: the disc-diffusion
method (according to NCCLS recommendations) using Mueller-
Hinton 2 agar (bioMerieux, Poland) and 1 mcg oxacillin discs
(OXOID Ltd, England), and the ATB Expression system – ATB
STAPH 5 strips (version 2000) according to the recommendations
of the producer (bioMerieux, Poland).
Results: A total number of 120 S. aureus strains were examined to
determine their methicillin resistance with methods mentioned
above. In the case of 116 (97%) of cultured strains, consistent results
of both methods were obtained. Proper results for control strains
were achieved. Thirty clinical strains of S. aureus (25% of all exam-
ined strains) showed methicillin resistance in the both methods, 86
strains (72%) were indicated as MSSA in the case of four strains
(3%), results of the both methods were inconsistent.
Conclusions: High consistency of the results of two methods: the
disc-diffusion and the ATB STAPH 5 (version 2000) applied for
detection of methicillin-resistant S. aureus (MRSA) strains was
revealed. The ATB STAPH 5 (version 2000) test seems to be equally
efﬁcient for routine determination of MRSA and MSSA strains as
the disc-diffusion method, and may be used alternatively.
P1627 Comparison of two methods for screening
of MRSA carriers
M. Cordova, A. Jacquet, H. Siegrist
La Chaux-de-Fonds, CH
Objective: Since isolation frequencies of methicillin-resistant Staphy-
lococcus aureus (MRSA) in Switzerland are rising, we set out to ﬁnd
a screening method with optimal sensitivity for MRSA recovery.
Among all protocols implemented in this country, the two methods
using (1) Mueller–Hinton/oxacillin enrichment broth combined
with mannitol-salt agar for subculture (MHO/MSA) and (2) manni-
tol-salt broth combined with mannitol-salt-oxacillin agar (MSB/
MSO) are most frequently used in major laboratories. Although
both methods are able to identify MRSA carriers we investigated
their ability to identify possible lower levels of MRSA carriage such
as during decontamination of patients and other carriers.
Methods: We compared the two methods using 156 clinical sam-
ples for MRSA screening. In addition, we challenged their sensi-
tivity in vitro at lower levels of MRSA loads (10(5)-10(3) CFU)
using 50 well characterised MRSA strains and different incubation
periods 24-72 h.
Results: From the 156 clinical samples, MHO/MSA and MSB/MSO
isolated 20 (12.8%) and 21 (13.5%), respectively (P ¼ 1.000). How-
ever, the in vitro studies showed, for a load of 10 (5) MRSA CFU,
sensitivities of 46% for MHO/MSA and 100% for MSB/MSO
(P < 0.0001) after 72 h incubation. At 48 h incubation, isolation rates
were 12% for MHO/MSA and 100% for MSB/MSA. Shorter incu-
bation times and lower MRSA loads resulted in even poorer yields
for MHO/MSA while MSB/MSO remained highly sensitive.
Conclusions: Both methods appeared to be equally sensitive when
applied to clinical samples of untreated MRSA carriers. For low
MRSA numbers and shorter incubation times, however, MSB/
MSO was signiﬁcantly superior to MHO/MSA. We also found
that MRSA workup after incubation was less tedious in the labor-
atory with the MSB/MSO method.
P1628 Comparative study of various methods, NCCLS
M27-A2, EUCAST and ATB Fungus 2 (bioMe´rieux) for the
in vitro antifungal susceptibility testing of Candida sp.
C. Durussel, D. Parreno, L. Nougier, V. Monnin, G. Zambardi,
J. Bille
Lausanne, CH; La Balme-les-Grottes, F
Objectives and Methods: Reference methods (NCCLS M27-A2 and/or
EUCAST E. Dis. 7.1) and the newly commercialised ATB FUNGUS 2
strip (visual reading) were compared for determination of the in vitro
susceptibility to Amphotericin B (AMB), Flucytosine (5-FC), Flucon-
azole (FCA), and Itraconazole (ITR) of 93 Candida sp. clinical isolates
(40 C. albicans, 15 C. glabrata, 11 C. tropicalis, seven C. parapsilosis, six
C. dubliniensis, six C. krusei, eight other species). Were also added in
this study, a comparison between NCCLS and EUCAST methodolo-
gies for Voriconazole (VRC), and a comparison between NCCLS
micro-dilution and NCCLS macro-dilution methods for AMB.
Results: Overall essential agreement (2 dilution) between NCCLS
and EUCAST was 100, 90, and 86% for 5-FC, FCA, and VRC,
respectively; between NCCLS and ATB FUNGUS 2, 99, 94, and
100% for 5-FC, FCA, and AMB; between EUCAST and ATB FUN-
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GUS 2, 100, 92, and 88% for 5-FC, FCA, and ITR; between NCCLS
micro-dilution and macro-dilution methods for AMB, 98%.
MIC50, MIC90, range MIC and modal MIC values were within 1
dilution for the three methods and all antifungals, except
ITR. Among the seven isolates with known mechanism of resist-
ance to azoles, all were correctly detected with EUCAST and ATB
FUNGUS 2 methods and all but one with NCCLS. Among the 15
isolates found to be resistant or susceptible dose dependant to 5-
FC or FCA by either one of both reference methods, the number
of minor, major and very major discrepancies (accordingly to
NCCLS breakpoints) found for one method in comparison with
the two others were as follows, respectively: 4, 0, 1 by EUCAST;
1, 1, 0 by NCCLS and 2, 0, 0 by ATB FUNGUS 2.
Conclusion: The comparison between NCCLS M27-A2, EUCAST E.
Dis 7.1 and ATB FUNGUS 2 showed good essential agreements
(>90%) between all methods and for all antifungal agents, except
ITR (ATB FUNGUS 2 vs. EUCAST, 88%) and VRC (EUCAST vs.
NCCLS, 86%). In particular, for isolates found to be resistant by
one reference method, very few major and very major discrepan-
cies were observed. According to this study, both reference meth-
ods and ATB FUNGUS 2 show similar performance results.
P1629 Evaluation of a new generation of Sabouraud
gentamicine chloramphenicol medium for the isolation of yeasts
and moulds in clinical specimens
N. Velay, E. Basso, F. Made´, E. Tissier, F. Villeval
Craponne, F
Sabouraud gentamicine chloramphenicol 2 (SGC2) is a second-
generation selective media recommended for the isolation of ye-
asts and moulds from clinical samples. The Sabouraud gentamicin
chloramphenicol (SGC) was reformulated in order to improve the
pigmentation of moulds and the fertility of yeasts.
Objective: The purpose of this study was to compare the perform-
ance of SGC2, in terms of fertility, pigmentation and selectivity,
with SGC (bioMe´rieux).
Methods: Ninety-seven micro-organisms (47 yeasts, 21 moulds and
29 bacteria) were tested in parallel on the two SGC media and a
reference medium: Sabouraud dextrose for yeasts and moulds
and trypticase soya agar for bacteria. Fungi were inoculated using
a technique allowing an enumeration after incubation. Yeasts
were incubated during 3 days at 37C and moulds at 25C and/or
37C during 7 days according to the media package insert infor-
mation. Bacteria were inoculated by a semi-quantitative culture
method with a 10 lL loop and incubated for 7 days at 37C. Enu-
meration, growth intensity, morphology of colony were studied
simultaneously for all media after incubation.
Results: On 47 yeasts inoculated, 42 grew on the reference med-
ium. SGC2 enabled the growth of 40 strains whereas 36 strains
grew on SGC after 72 h of incubation. For the 21 moulds incuba-
ted at 37C during 7 days, 15 strains showed a growth on the ref-
erence medium. SGC2 enabled the growth of 11 strains with the
correct morphology. On SGC, nine strains showed a growth but
only three gave the expected colouration. At ambient temperature
during 7 days, 20 strains grew on reference medium. Sixteen
moulds grew on SGC2, among them 15 showed the expected pig-
mentation, whereas only three of 14 strains were observed with
the right aspect on SGC. For the 29 bacteria tested, 2 and 3 strains
grew on SGC2 and SGC after 24 h, respectively.
Conclusion: The SGC2 medium is signiﬁcantly superior to the SGC
for the growth of moulds and yeasts, the selectivity for bacteria
being equivalent. This new formula demonstrates a good capacity
to obtain colonies with a speciﬁc morphology, which is very
important for the orientation of the diagnosis of fungal infections.
P1630 Detection of hetero-resistant MRSA: Controlled
comparison of oxacillin/cefoxitin susceptibility testing by disk
diffusion, agar screen, Vitek-2 and BD Phoenix automated
systems
C. Nonhoff, G. Mascart, M.J. Struelens, C. Van Den Borre,
O. Denis
Brussels, B
Objectives: To compare the performance of disk diffusion, agar
screen and automated systems for detection of hetero-resistant
and recent epidemic strains of methicillin-resistant Staphylococcus
aureus (MRSA) using oxacillin and cefoxitin.
Methods: This study included two sets of strains. The ﬁrst set
comprised MRSA (n ¼ 67), representative major epidemic PFGE
types recovered in Belgian hospitals, and methicillin susceptible S.
aureus (MSSA) (n ¼ 61) isolates collected during National Micro-
biological Surveys conducted in 2001–2003. The second set com-
prised ‘challenge strains’ (n ¼ 31) (hetero-MRSA) with low
oxacillin resistance level (MIC < 16 lg/mL) collected since 1995.
Oxacillin susceptibility was tested by oxacillin agar screen method
(6 lg/mL) (OAS), oxacillin and cefoxitin disk diffusion methods
and by the automated Phoenix and Vitek-2 systems. Oxacillin disk
diffusion was determined by two methods according to NCCLS
recommendations (oxacillin 1 lg, 35C for 24 h incubation) (oxa-1)
and to French CA-SFM recommendations (oxacillin 5 lg, 30C for
24–48 h incubation) (oxa-5). Oxacillin and cefoxitin MICs were
determined by the agar dilution method. Oxacillin resistance was
conﬁrmed by multiplex PCR for mecA gene.
Results: The overall sensitivities for oxacillin resistance detection
were 97, 94, 93, 89 and 87% for OAS, oxa-1, oxa-5, Phoenix and
Vitek-2, respectively. All methods were fully speciﬁc (100%). All
methods showed sensitivity >99% with epidemic MRSA. In con-
trast, hetero-MRSA isolates were detected with sensitivity of 90,
81, 81, 65 and 71% for OAS, oxa-1, oxa-5, Phoenix and Vitek-2,
respectively. Oxa-5 disk diffusion method had to be interpreted
after 48 h incubation because 15% of strains were falsely reported
as susceptible after 24 h. Cefoxitin testing showed MIC > 4 lg/
mL by agar dilution and by the Phoenix system in 98% of MRSA
strains and zone diameter for cefoxitin was <20 mm in 99.5% by
disk diffusion.
Conclusions: Cefoxitin testing by disk diffusion and by Phoenix
system were the most sensitive and speciﬁc methods for oxacillin
resistance detection, particularly for hetero-MRSA strains. Auto-
mated systems need further optimisation for detection of low-
level MRSA strains.
Diagnostic methods: serology
P1631 Comparison of three commercial methods for the
diagnosis of pertussis in single serum samples
F. de Ory, M.-E. Guisasola, M. Ferna´ndez, T. Minguito,
N. Herranz, J.-C. Sanz
Majadahonda, Madrid, E
Objective: Laboratory diagnosis of pertussis by isolation or identi-
ﬁcation of the bacteria is hampered by the difﬁculties of testing
early samples taken in the acute phase of the disease; the same
happens with the study of seroconversion in paired sera, because
is difﬁcult to have an acute, negative sample. The quantiﬁcation
of antibodies against pertussis toxin (PT) in a single serum sample
has been suggested as a useful diagnostic approach of pertussis.
We have compared three serological methods in their application
for the quantiﬁcation of antibodies against different antigens as
diagnostic tools of Bordetella pertussis infection in single serum
samples.
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Methods: We have used serum samples from 18 patients from an
outbreak of pertussis in vaccinated children, as well as 79 controls
from general population. Both cases and controls had the same
age (mean age 6.3 and 6.7 years, respectively), and received the
same number of doses (3.7 and 3.5, respectively) and type of vac-
cine (whole cellular vaccine). All the samples were tested by three
commercial methods designed for detecting antibodies against a
mixture of PT and ﬁlamentous haemagglutinin (FHA) (Mardx,
United States), IgG against whole cell antigens (Serion, Germany),
and IgG and IgA against PT and FHA in separate determinations
(Pertusscan, Sweden). The diagnostic cut off of the assays was
established.
Results: According to the cut off provided by the manufacturers,
the sensitivity ranged from 27.8% (IgA-TP, Pertusscan) to 94.4%
(Serion and Mardx); the speciﬁcity varied from 59.5% (Serion) to
89.9% (Mardx), being >95% for all determinations in Pertusscan.
By modifying the cut off values, the ﬁgures were strongly
improved. The sensitivity and speciﬁcity values of Serion
(>300 units) were 72 and 91%. The corresponding values of
Mardx assay (ratio sample absorbance/cut off >2.0) were 94 and
98%. The best ﬁgures in Pertusscan were 83% (sensitivity) for
and about 90% (speciﬁcity) for IgG against HAF and PT (ratio
sample absorbance/cut off >1.0).
Conclusions: The use of commercially available serological meth-
ods to test single serum samples seems to be useful tools for the
diagnosis of pertussis, once the diagnostic conditions of the assays
were established. The application of commercial kits will improve
the knowledge of the real incidence of pertussis.
P1632 An enzyme immunoassay for measuring speciﬁc
IgG antibodies to tetanus toxoid
R. Budd, C. Budd, F. Alcock, R. George, K. Broughton,
A. Bradwell
Birmingham, London, UK
Objective: In this study, performance characteristics of a tetanus
toxoid IgG EIA were investigated.
Methods: Tetanus vaccines utilise a denatured form of tetanus
toxin (tetanus toxoid) and the antibody response to these vaccines
can be measured by enzyme immunoassay (EIA). In this study,
the performance of Binding Site Ltd UK tetanus toxoid IgG EIA is
assessed. In addition a correlation was performed against an in-
house EIA from Respiratory and Systemic Infections Laboratory,
Central Public Health Lab, London.
Results: The kit is calibrated against the NIBSC reference material
76/589. The assay measuring range is 0.01–7.0 IU/mL. The analyt-
ical sensitivity of the assay was measured at 0.0093 IU/mL. In-
tra-assay precision was found to be 5.1% or less by assaying a
low, medium and high level sample each 16 times. Inter-assay
precision was shown to be 8.8% or less on the same samples
measured on three separate occasions. To determine the effect of
potentially interfering substances, high and low samples were
assayed with and without the addition of a range of standard
interference substances, was <5% variation was observed. Linear-
ity was assessed using three positive samples, comparison of the
achieved values by linear regression gave values of greater than
R2 ¼ 0.998 in each case. A correlation was performed against an
in-house EIA from Respiratory and Systemic Infections Laborat-
ory, Central Public Health Lab, London using 71 serum samples.
Linear regression showed good correlation with R2 ¼ 0.7346.
Using a result of >0.1 IU/mL as indicative of a protective level of
speciﬁc antibodies, the overall correlation of the two assays was
93.3%
Conclusions: From the results achieved in this study, The Binding
Site EIA appears to be a suitable assay for measurement of speci-
ﬁc IgG antibodies to tetanus toxoid. The results also correlated
well with an existing in-house enzyme immunoassay.
P1633 A new enzyme immunoassay for the measurement
of speciﬁc IgG antibodies to diphtheria toxoid and correlation
with the Vero Cell Assay
R. Budd, D. Taylor, F. Alcock, R. George, K. Broughton,
A. Bradwell
Birmingham, London, UK
Objective: In this study the performance characteristics of Diph-
theria toxoid IgG enzyme immunoassay (EIA), were investigated
together with its correlation to the VCA.
Methods: Classically neutralising antibodies to Diphtheria have
been measured by an in-vitro toxin neutralisation assay, the VCA.
Diphtheria vaccines utilise a denatured form of diphtheria toxin
(diphtheria toxoid) and the antibody response to these vaccines
can also be measured by (EIA). In this study a new EIA from The
Binding Site Ltd UK, was assessed and its results correlated to
those of the VCA as performed by the Respiratory and Systemic
Infections Laboratory, Central Public Health Lab (London).
Results: The ELISA kit is calibrated, against the NIBSC reference
material 00/496. The assay measuring range is 0.004–3.0 IU/mL.
Intra-assay precision was found to be between 5.8 and 2.7% by
assaying a low (0.06 IU/mL), medium (0.71 IU/mL) and high
(2.6 IU/mL) level sample each 16 times. Assay linearity was
assessed using three positive samples, comparison of the achieved
and expected values by linear regression gave values of greater
than R2 ¼ 0.99 in each case. A correlation was performed against
the VCA, using 34 serum samples. Linear regression showed
excellent correlation with R2 ¼ 0.96. Using a result of >0.01 IU/
mL as indicative of a minimum protective level of speciﬁc anti-
bodies, the overall agreement of the two assays was 96%.
Conclusions: From the results achieved in this study, The Binding
Site assay appears to be an accurate and precise assay for the
measurement of speciﬁc IgG antibodies to Diphtheria toxoid. It
could be considered a possible alternative to the VCA, with the
signiﬁcant advantages of speed, ease of use and adaptability to
automation.
P1634 Application of gene recombination and
chromatography of bio-afﬁnity for production of the puriﬁed
Yersinia enterocolitica protein antigens – use of the recombinant
YopD protein in serodiagnosis of enteric illness and reactive
arthritis
W. Rastawicki, R. Gierczyn˜ski, M. Jagielski, B. Kwiatkowska
Warsaw, PL
Objectives: Yersinia enterocolitica causes a variety of infections in
human, including enterocolitis, acute mesenteric lymphadenitis,
erythema nodosum and reactive arthritis. Both whole Yersinia bac-
teria and puriﬁed lipopolysaccharide (LPS) have been used as
antigens for detecting antibodies in sera of patients. However
cross-reactions in the ELISA between Y. enterocolitica and other
pathogens have been described. Therefore high speciﬁc antigens,
free of lipopolysaccharide, based on Yersinia outer membrane pro-
teins (YOPs), or adhesins: Ail, YadA, Invasin or Myf are needed.
The aim of this study was to evaluate the usefulness of gene
recombination technique using the pET-30 Ek/LIC expression vec-
tor for production a 36-kDa YOP called YopD and evaluate of this
puriﬁed protein as antigen in serodiagnosis of yersiniosis.
Methods: Protein YopD of Y. enterocolitica was expressing in
Escherichia coli BL21 (DE3) using the pET-30 Ek/LIC expression
vector. Puriﬁcation of the expressed enzyme from suspensions of
E. coli cells treated with Bug BusterTM Protein/Extraction Reagent
was accomplished by immobilised metal (Ni2þ) afﬁnity column
chromatography (His-trap). The IgM, IgG and IgA class antibod-
ies to YopD were measured in 100 serum samples collected from
patients suspected for yersiniosis and 100 blood donors. The
obtained results were compared with the results of ELISA with
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LPS and YOPs isolated from the culture of Y. enterocolitica super-
natant under calcium deﬁcient conditions, as antigens.
Results: In the case of patients suspected in clinical investigation
for yersiniosis most frequently the positive results were obtained
in IgG class of antibodies (41.0%). IgM and IgA antibodies were
detected in 33.0 and 10.0% serum samples, respectively. In sera
obtained from blood donor’s antibodies, in all immunoglobulin
classes, to YopD antigen were detectable signiﬁcantly rarely
(P < 0.001). A very high (94.0–100.0%) speciﬁcity and good sen-
sitivity (67.0–80.0%) was displayed by the ELISA with YopD in
relation to ELISA with LPS and YOPs antigens. IgA and IgG
more frequently were found in sera of adult persons with arthri-
tis and immunoglobulin M in the sera of children with enteric
illness.
Conclusions: The recombinant YopD protein puriﬁed by chroma-
tography of bio-afﬁnity may be used in serodiagnosis of yersinio-
sis as a high speciﬁc antigen free of Yersinia lipopolysaccharides.
P1635
Abstract withdrawn.
P1636 Quantitative detection of anti-Chlamydia
pneumoniae IgG and IgA antibodies by ELISA: comparison to
the microimmunoﬂuorescence test
D. Taglialatela, G. Anniballo, M.-L. Genna, V. Formicola,
E. Simone de
Naples, I
Objectives: Serological analysis represents the current routine
method for the diagnosis of Chlamydia pneumoniae infections
because the direct research by PCR can be difﬁcult. Seroepidemio-
logical studies have shown that the detection of speciﬁc IgG anti-
bodies in single serum specimens have a limited diagnostic value.
Only a signiﬁcant increase of speciﬁc antibody titers in paired
sera is accepted as a serological indication of an acute C. pneumo-
niae infection. The microimmunoﬂuorescence assay (MIF), which
requires expertise to perform, was considered, for a long time, the
‘gold standard’ method. MIF leads to variable results, urging
the need for more objective test methods. Now, automated
enzyme-linked immunosorbent assay (ELISA), which is more
standardised, allows to deﬁne antibody titers comparable to MIF,
but without any subjective bias. The aim of our study was a
comparison between two quantitative assay methods: a second
generation ELISA-based assay and MIF.
Methods: We selected serum samples during normal laboratory
routine from patients with C. pneumoniae infection: 131-paired sera
were collected from a adult population with high or low respirat-
ory tract infections that showed high serum level C. pneumoniae-
speciﬁc IgA and/or IgG antibodies in MIF (SeroFia, Savyon, IL,
USA), and serum samples from 105 apparently healthy children
without antibodies (according to MIF) against C. pneumoniae,
C. trachomatis, C. psittaci which were used as a control group.
C. pneumoniae-speciﬁc IgA and IgG antibodies were also deter-
mined in these two groups of serum samples by a commercial
quantitative ELISA test (Cp-Quant Eurospital, I). The tests were
performed as recommended by the manufacturer.
Results: The concordance of the results of the MIF and CP
Quant for the adult patients was 96% for the IgG determination
and 93% for the IgA. All 105 healthy children were negative
for both IgG and IgA in ELISA test. There was a very high
overall agreement between the results of the two different
methods.
Conclusions: The results obtained by ELISA overlap those obtained
by a traditional MIF assay and show that the ELISA quantitative
test is highly reliable. In addition, the rapidity, the ease of use,
the possible automation as well as the easy analytical interpret-
ation independent of the subjective evaluation of the operator, are
important advantages. The ELISA quantitative test can be used as
an alternative clinical diagnostic test to MIF.
P1637 Evaluation of Mycoplasma pneumoniae commercial
tests for detection of serum antibodies using PCR as ‘the gold
standard’
M.F.C. Beersma, K. Dirven, H.-J. Gerritsen, A.P. van Dam,
E.C. Claas, H. Goossens
Leiden, NL; Antwerp, B
Aim of the Study: Serological methods are most widely used for
diagnosis of Mycoplasma pneumoniae (MP) infection, but very few
studies have evaluated available commercial tests. We studied
commercial MP IgG and IgM EIAs using PCR for detection of MP
as gold standard.
Methods: Twenty-nine MP PCR-positive patients (49 serum sam-
ples) were included from two prospective studies on acute lower
respiratory tract infections (LRTI). Control sera were tested from
(i) 20 patients with acute LRTI negative for M by PCR and from
(ii) 61 patients with microbiological documented LRTI other than
MP, but without PCR exclusion. The different EIAs tested were
Platelia (Bio-Rad); SeroMP (Savyon); Serion classic (Virion/Seri-
on); Biotest EIA (Biotest); Ridascreen EIA (r-Biopharm); AniLab-
systems EIA (Labsystems); Novum EIA (Novum Diagnostica);
Diagnosys EIA (MP products); Genzyme/Virotech EIA; Immuno-
Well EIA (Genbio); Immunocard EIA (Meridian). In addition, the
complement ﬁxation test (CFT) and Serodia-Myco II agglutination
test (Fujirebio) were included.
Results: The sensitivities of IgM EIAs ranged from 7 to 23% in the
ﬁrst 6 days after onset of disease to 29–86% after more than
16 days of illness. IgG EIAs detected seroconversion or a signiﬁ-
cant rise of IgG titers in 47–63% of the PCR-positive patients. IgM
tests with the best results for both sensitivity and speciﬁcity were
AniLabsystems EIA (86%/92%), Diagnosys EIA (71%/94%) and
Serodia-MycoII (80%/87%), whereas other IgM tests failed to
achieve satisfactory results for either the sensitivity (below 70%
after 16 days) or speciﬁcity (below 80%). False-positive EIA IgM
results occurred more frequently in the control patients with acute
EBV infection. The sensitivity and speciﬁcity of the CFT (99%/
95%) exceeded those of the commercial IgM tests at all clinical
time-points.
Conclusions: Evaluation of the currently available serological EIAs,
CFT, and agglutination test for M. pneumoniae using PCR as gold
standard, showed substantial differences between the perform-
ances of the assays.
P1638 Recombinant antigens of Ureaplasma spp. as a
possible tool for a serological test
F. Echahidi, G. Muyldermans, O. Soetens, S. Lauwers,
A. Naessens
Brussels, B
Objectives: Ureaplasma spp. (14 serotypes) are frequently isolated
from the lower genital tract of men and women, and are related
to adverse pregnancy outcome. The development of serological
assays for Ureaplasma spp. antibodies has been hampered by the
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low purity of antigen used in the assays and by the difﬁculty to
obtain large quantities of the antigen. The aim of the present
study is to produce recombinant antigens for all serotypes for the
development of a serological assay.
Methods: The multiple banded antigen (MBA) of Ureaplasma spp.
is a surface expressed antigen. It is one of the major antigens rec-
ognised during infection and is present in all serotypes. This
makes it a suitable candidate for use in serological assays. The
coding part of the MBA gene from the serotypes was ampliﬁed
by PCR. The PCR products were cloned by ligation into a pTrc-
His Topo plasmid followed by transformation into E. coli compet-
ent cells. Expression of the antigens was induced by IPTG addi-
tion. The expressed proteins, containing a poly-His tag, were
puriﬁed and analysed by western blot assay (WBA) using an anti-
poly His antibody and by ELISA and WBA using the 14 serotype-
speciﬁc monoclonal antibodies (MAbs).
Results: Except for serotypes 1, 6 and 13, the MBA was success-
fully expressed for all serotypes. MBAs of serotypes 2, 3, 4, 5, 8, 9,
10, 12 and 14 were recognised by serotype speciﬁc MAbs in
ELISA. Moreover, preliminary analysis of the MBA-3 in ELISA
using human sera from serotype 3 infected patients has shown
promising results.
Conclusions: These results indicate that the puriﬁed recombinant
multiple banded antigens are promising for de detection of anti-
bodies against Ureaplasma spp. serotypes.
P1639 Syphilis Fast, a rapid treponemal test for the
serodiagnosis of syphilis
P. Tajada Alegre, M. Gutie´rrez, R. De-Julia´n, A. Morente,
M.Garcı´a-Collı´a, M. Baquero, A. Pe´rez-Rivilla, J.L. Go´mez-Garce´s
Madrid, E
Background: Syphilis remains a signiﬁcant cause of morbidity with
an estimated annual incidence of 12 million new cases worldwide.
Serologic tests play a decisive role in the diagnosis of syphilis.
Two types of serologic test are used: nontreponemal and trepone-
mal tests. The main limitation of current treponemal tests is that
they cannot be used in situations where a very rapid diagnosis is
required. On account of this disadvantage, rapid recombinant
antigens based tests have been recently introduced in routine
syphilis serology.
Objective: To evaluate a new treponemal test, Syphilis Fast (DI-
ESSE Diagnostica Senese, Italy) for the rapid serodiagnosis of
syphilis in comparison with other serological tests. The Syphilis
Fast test is a latex agglutination test based on polystyrene parti-
cles coated with three immunodominant proteins of Treponema
pallidum with molecular weight of 15, 17 and 42 kDa, obtained in
Escherichia coli by recombinant technology.
Patients and methods: A total of 303 sera were analysed by a non-
treponemal test, the Rapid Plasma Reagin test (RPR) and the
combination of two treponemal tests (Syphilis Fast and Mercia
Syphilis Total EIA). Reactive specimens were further conﬁrmed
using a ﬂuorescent treponemal antibody absorption test (FTA-
Abs), considered as the gold standard in serodiagnosis of syph-
ilis. The study population included immigrants and returning
travellers from sub-Saharan Africa, patients with risk behaviour
for sexually transmitted diseases and HIV (homosexuals or
bisexuals, intravenous drug users, patients with multiple sexual
partners), immigrant sex workers, adopted children, pregnant
women and patients with neurological symptoms or genital cuta-
neous lesions.
Results: Agreements between the FTA-Abs and the Syphilis Fast
were 98% (297/303, three false-reactive and three false nonreac-
tive results), and between the FTA-Abs and the Mercia Syphilis
Total EIA were 97.4% (295/303, eight false nonreactive results).
Comparatively, Syphilis Fast was found more sensitive than Mer-
cia Syphilis Total EIA for the detection of syphilis (97.8 vs. 94.2%)
and slightly less speciﬁc (98.2% vs. 100%).
Conclusions: Syphilis Fast is a rapid, cost-effective, easy-to-use and
reliable assay. The results of this study indicate that the Syphilis
Fast may be an alternative to other treponemal tests for routine
serodiagnosis of syphilis in clinical laboratories.
P1640 A multiplexed syphilis IgM serological test for the
diagnosis of Treponema pallidum infection
H. Yu, S. Binder, F. Torres, C. Hixson, S. Garcia, J. Wang, P. Chen
Hercules, USA
Objectives: Serological tests for syphilis IgM include FTA-ABS 19S
IgM, FTA-ABS immunoglobulin (IgM), and IgM capture ELISA.
In recent years, the Western blot (WB) IgM syphilis test has
become a popular method to verify syphilis infection. Due to per-
formance limitations of EIA syphilis tests [Schmidt et al., J Clin
Microbiol (2000) 38: 1279–1282], and the laborious nature of FTA-
ABS and WB analyses, IgM serology tests for syphilis are not
often performed on adult samples. We developed a multi-analyte
immunoassay for antibodies to Treponema pallidum in human
serum and plasma on the automated, high-throughput, random
access Bio-Rad BioPlex 2200 immunoassay analyzer. Using ﬂuor-
escent magnetic microspheres with discrete spectral addresses,
recombinant proteins were immobilised and simultaneously eval-
uated for the presence of IgG and IgM antibodies. This technology
was used to simultaneously detect anti-T. pallidum r17 and r47
proteins as markers in each analysis to identify the presence of
early infection.
Methods: The BioPlex 2200 syphilis IgM test was compared with
various methods including the Meddens m-capture EIA, a modi-
ﬁed TPPA, and two WB tests (Mikrogen recomBlot Treponema
IgM and Trinity T. pallidum IgM MarBlotTM strip test).
Results: Using adult specimens, the BioPlex 2200 syphilis IgM test
had 75.5% sensitivity and 92.3% speciﬁcity (n ¼ 201) compared
with the Meddens EIA. In comparison with a composite of EIA,
TPPA-IgM, and Trinity WB (either two or three positives in this
three assay panel was interpreted as a positive result), the BioPlex
2200 yielded 89.4 and 97.8% sensitivity and speciﬁcity (n ¼ 186),
respectively (equivocal results removed). In a like comparison
using the Mikrogen WB test, the BioPlex 2200 syphilis IgM test
yielded 100% sensitivity and 97.1% speciﬁcity (n ¼ 189). With use
of a syphilis performance panel, all samples with an RPR > 1:8
showed a positive result in the BioPlex 2200 test. The Bio-Rad
IgM test detected early seroconversion with a longitudinal panel
of a patient’s sera. Also, a comparison of the Meddens EIA to
Trinity WB tests showed only 90.9% sensitivity and 74.0% specif-
icity (n ¼ 150).
Conclusions: Current syphilis IgM tests are lacking in clinical sen-
sitivity and/or speciﬁcity. The Bio-Rad BioPlex 2200 IgM test for
syphilis compares very favorably to a composite analysis by mul-
tiple methods. The BioPlex 2200 immunoassay analyzer provides
a multiplexed test with testing time and full automation.
P1641 Evaluation of GLP antigen for serodiagnosis of
human leptospirosis
E. Calo´ Romero, R. Morozetti Blanco, C. Motta Bernardo,
M.C. Outeiro
Gorla Sa˜o Paulo, BR
Leptospira is a genus of spirochetal bacteria and the causative
agent of leptospirosis, a zoonotic disease with a global distribu-
tion. The extensive serovar diversity has been attributed to differ-
ences in the structure and composition of lipopolysaccharide
(LPS). Much work has focused on the role of leptospiral LPS in
immunity. Preparations of leptospiral LPS can elicit protective in
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immunity, but this immunity is generally serovar-speciﬁc. Among
the many antigens isolated from pathogenic Leptospira, glycolipo-
protein (GLP) is likely to be involved in the pathogenesis of the
disease inducing lymphocyte and monocyte activation. The focus
of research on protective antigens and better serodiagnostic strat-
egies has shifted toward conserved antigens, which may be able
to stimulate heterologous immunity. The identiﬁcation of leptospi-
ral antigens expressed during infection has potentially important
implications for the development of new serodiagnostic and im-
munoprotective strategies. In this work, we study candidate anti-
gens for serodiagnosis using the ELISA-dotblot reactivity of sera
from patients with leptospirosis conﬁrmed by microscopic agglu-
tination test (MAT). ELISA-dotblot analysis was performed using
sera from patients with leptospirosis and sera from patients with
other diseases as negative control. GLP is identiﬁed as a candidate
antigen for serodiagnosis of leptospirosis. Seven-day-old culture
of Leptospira interrogans serogroup Icterohaemorrhagiae was used
for preparing the antigen. Serum samples were assayed by
ELISA-dotblot using our antigenic preparation and by a micro-
scopic agglutination test (MAT) using 19 serovars. The antigen
prepared had aproximately 220 lg/mL of GLP. IgG antibodies
didn’t show reactivity in all positive sera by MAT. However, on
the basis of IgM response, all positive sera by MAT were found to
react with GLP. None of the controls were positive. These prelim-
inary observations demonstrate that GLP is a newly identiﬁed
antigen which is recognised by sera from patients with leptospiro-
sis. These data provide tools to understand the pathogenesis of le-
ptospirosis and the identiﬁcation of candidate antigens for
serodiagnosis and immunoprotection.
P1642 Comparison of three different Toxocara ELISA and
Western blotting methods in respect of sensitivity and
speciﬁcity
J. Danka, I. Kucsera, E. Orosz, Z. Sze´na´si
Budapest, HUN
Objectives: Human toxocarosis is caused by the larval stage of dif-
ferent Toxocara species. Due to the lack of speciﬁc clinical signs,
the diagnosis is usually based on the detection of anti-toxocaral
IgG or IgG + IgM antibodies by indirect ELISA or by Western blot
(WB) methods. All these tests utilise the excretory–secretory (ES)
antigens obtained from in vitro maintained T. canis larvae. The
home-made tests of different laboratories and commercial ELISAs
of different manufacturers vary in their procedural parameters
and in their performance characteristics, which can cause difﬁcul-
ties in the comparison and interpretation of the results. The objec-
tive of our investigations was to study the outcome of some tests.
Methods: A total of 147 serum samples of patients with clinically
suspected Toxocara infection were selected on the basis of the
results obtained by the home-made ELISA test. The whole range
of OD values was covered by these sera (52 negative, 14 border-
line and 81 weak to strongly positive samples). The results of our
home-made ELISA were compared with two commercial ELISA
tests (EIA T. canis IgG, Test-Line, Czech Republic and T. canis
IgG ELISA, Novatec, Germany) and with a WB method (Toxo-
cara Western Blot IgG, LDBIO, France). The sensitivity and specif-
icity of each ELISA test were computed in relation to the WB
results.
Results: The sensitivity of the home-made, Test-Line and Novatec
ELISA was 63, 51, 56%, while the speciﬁcity was 95, 100, 100%,
respectively. The distribution of the negative and positive results
was signiﬁcantly inﬂuenced by the cut-off level of the given test.
The best ﬁtting of semiquantitative results was found between the
home-made and Test-Line ELISA. The borderline and negative
(but close to borderline) ELISA results of the home-made, the
Test-Line and the Novatec ELISA were found to be positive by
the WB in 84, 96 and 97% of cases, respectively.
Conclusion: The high proportion of WB positive patients with
negative-ELISA results suggests that low level antibodies can
frequently occur in clinical samples. These data underline the
necessity of the conﬁrmation of the negative and borderline
ELISA results with WB.
P1643 Evaluation of multiplexed IgG and IgM
immunoassays for infectious mononucleosis and Epstein-Barr
virus using the Bio-Rad BioPlex 2200 immunoassay analyser
R. Bruehl, H. Scholz, L. Cuadra, F. Torres, J. Wang, R. Kaul,
K. Yu, P. Chen, S. Binder
Hercules, USA
Objective: Diagnosis of infectious mononucleosis (IM) and clinical
assessment of Epstein-Barr virus (EBV) infection involves detec-
tion of IgG antibodies to three EBV antigens and IgM antibodies
to the EBV viral capsid antigen (VCA) and non-EBV heterophile
antigens. Typical identiﬁcation of these antibodies involves mul-
tiple independent EIA and agglutination immunoassays and is
not amenable to high throughput analysis. The objective of this
study is thus to develop automated high throughput IgG and IgM
immunoassays for EBV that generate composite data to differenti-
ate between acute IM and secondary infection.
Method: Using the Bio-Rad BioPlex 2200 immunoassay analyser,
which is an automated high throughput multiplex platform, we
report the detection of IgG and IgM antibodies against EBV and
heterophile antigens and compare our results to those generated
by commercially available tests. The assays employ an array of
control and antigen-coated ﬂuoromagnetic beads with discrete
spectral addresses assigned to each substrate. Results are reported
as an index value relative to a four-point calibration curve and
are sorted based on the ﬂuorescent emission assigned to each ana-
lyte or control bead.
Results: Concordance testing for IgG against the Trinity (TM) EIA-
revealed relative sensitivity and speciﬁcity values of 100% (217/
218) and 95% (38/40), 60% (31/52) and 98% (205/210) and 100%
(215/216) and 93% (43/46) for VCA, early diffuse antigen, and
nuclear antigen-1, respectively. Concordance testing for VCA and
heterophile IgM against the Diasorin ETI EIA and Wampole
Laboratories MONO-LATEX (R) test revealed relative sensitivity
and speciﬁcity values of 99% (107/108) and 97% (86/89), and
100% (11/11) and 96% (94/98), respectively.
Conclusions: In contrast to conventional serological tests, the Bio-
Plex 2200 assays offer a rapid method for acquiring composite
IgG and IgM data for diagnosing acute IM and identifying EBV
infection. The inclusion of control beads in every sample ensures
reliable results and the ability to process up to 100 primary sam-
ple tubes per hour and access samples continuously offers signiﬁ-
cant advantages over standard protocols.
P1644 Evaluation of sensitivity and speciﬁcity of six
combined P24 antigen and HIV antibody screening assays
T.D. Ly, S. Laperche, C. Brennan, A. Vallari, A. Ebel, J. Hunt,
L. Martin, D. Daghfal, S. Devare
Ivry sur Seine, Paris, F; Illinois, USA
Early detection of human immunodeﬁciency virus (HIV) infec-
tion is critical for clinical diagnosis and safety of blood prod-
ucts.
Objectives: To evaluate performance of six HIV-combined antigen–
antibody (Ag/Ab) assays: AxSYM HIV Combo, Enzygnost HIV
Integral, Genscreen Ag/Ab Plus, Murex HIV Ag/Ab Combo, VI-
DAS HIV DUO and Vironostika HIV Uniform II Ag/Ab. Two-
third generation antibody-only assays (Genscreen HIV 1/2 v.2
and Ortho HIV 1/2 antibody Capture) were also evaluated.
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Methods: The specimens for sensitivity evaluation included: 25
seroconversion panels, HIV-1 antigen panel of 31 cell-culture
derived, diverse group M subtypes and group O (each isolate tes-
ted at 2, 5, 10, 25 pg/mL of P24 Ag) and 669 of HIV-1 or HIV-2
samples collected from various areas of the word. For speciﬁcity,
1005 unselected HIV negative samples collected from four French
laboratories were used.
Results: For the detection of P24 Ag, Murex and AxSYM
showed the best limit detection of P24 Ag (6–8 pg/mL) irres-
pective of train, VIDAS DUO could detect 12 pg/mL except for
some subtypes C strains and the limit detection of Genscreen
Plus was 20 pg/mL except subtype F and group O. The Viro-
nostika and Enzygnost that did not detect any of the HIV
strains at 25 pg P24/mL. Of 25 seroconversion panels, AxSYM
and Murex detected the ﬁrst positive bleed in 23 and 21 panels
respectively, whereas VIDAS DUO, Genscreen Plus, Enzygnost,
Vironostika, Genscreen v.2 and Ortho detected the ﬁrst positive
bleed in 12, 10, 6, 6, 5 and 4 panels, respectively. The 553 HIV-
1 group M, 6 HIV-1 group O and 110 HIV-2 positive samples
were detected by all assays except Genscreen HIV 1/2 v.2
which missed 1 group O, VIDAS DUO missed 1 subtype F, En-
zygnost missed 1 subtype C and Genscreen Plus missed 1 sub-
type B. The speciﬁcity for assays were: Ortho 100%; Genscreen
Ag/Ab Plus 99.9%; AxSYM Combo 99.8%; Enzygnost 99.7%;
Vironostika and Murex Combo 99.6%; VIDAS DUO 99.5% and
Genscreen HIV v.2 99.4%.
Conclusions: These results show that the Ag/Ab HIV com-
bined assays present better performance when compared with
third generation antibody assays, however, there are signiﬁ-
cant sensitivity and speciﬁcity differences among combination
assays.
P1645 Evaluation of sensitivity and speciﬁcity of
a new generation of Immunocomb II HCV for the detection
of anti-hepatitis C virus antibodies
P. Veillon, A. Calvo, F. Lunel-Fabiani
Angers, Coubevoie, F
Objectives: To evaluate a new generation of the ImmunoComb II
HCV assay (PBS Orgenics) in comparison with Axsym HCV 3.0
(Abbott Laboratories) for the detection of anti-hepatitis C virus
(HCV) antibodies (Ab).
Methods: We have studied three populations of patients; 162 preg-
nant women, 397 patients with chronic HCV infection and well
known genotype (InnoLipa II, Innogenetics); with the following
distribution: 224 patients with HCV genotype 1, 33 patients with
HCV genotype 2, 88 patients with HCV genotype 3, 40 patients
with HCV genotype 4 and 11 patients with HCV genotype 5a;
and 224 patients with undetectable anti-HCV Ab. Discordant sam-
ples were tested and conﬁrmed with Ortho ELISA HCV 3.0 and
RIBA HCV 3.0 (Ortho-Clinical Diagnostics). The rapid test Immu-
noComb II HCV assay have six rows; A for specimen diluent, B
for washing, C for conjugate, D and E for washing and F for
chromogenic substrate.
Results: Results obtained in pregnant women were respectively
for Axsym HCV 3.0 and ImmunoComb HCV II: Detectable 2/2,
Doubtful 3/2, Undetectable 157/158; in patients with chronic
HCV infection: Detectable 395, Doubtful one, undetectable one
for ImmunoComb HCV II and in patients with undetectable
anti-HCV Ab: detectable 0/1, doubtful 5/2, undetectable 219/
221.
Conclusions: The new generation of ImmunoComb II HCV assay
has a good sensitivity (99.7%) and a good speciﬁcity (100%). This
test is easy and quick to perform and results could be obtained in
routine laboratories without the need of special equipment or
training.
P1646 Western immunoblotting for serologic diagnosis of
human candidosis
F. Persat, D. Martin, M.A. Piens, S. Picot
Lyon, F
Objective: To improve the reliability of the serodiagnosis of
human deep Candida infection, a western immunoblot analysis
was evaluated in a retrospective study.
Methods: Conditions of immunoblot were standardised then sera
of different ﬁve groups of patients were tested: group 1, healthy
blood donors (n ¼ 40), group 2, patients with systemic candidosis
with Candida isolated from at least one blood culture (n ¼ 58),
group 3, patients with probable or proven candidosis with
Candida isolated from a sterile site except blood culture (n ¼ 52),
group 4, patients hospitalised with Candida isolation in a periph-
eral site (n ¼ 25) and group 5, patients without isolation of Can-
dida but with positive serology with routine techniques (n ¼ 33).
Results: After standardisation of the technique, the lecture method
was deﬁned with exclusion of nonspeciﬁc bands. 52% of patients
from the group 2 and 48% from the group 3 were positively
detected by immunoblot technique. Only 16% were detected in
group 4 and none in group 1 under these conditions. Only 6% of
the patients from the group 5, with positive Candida serology in
routine diagnosis, were detected by immunoblot analysis. Most of
patients from this group 5 had a liver transplantation (57%),
explaining a probable nonspeciﬁc serologic reactivity with routine
techniques. Patients with probable or proved candidosis gave then
results signiﬁcantly different from patients without candidosis,
the test showing a good positive predictive value (93.2%).
Conclusions: These ﬁndings suggest that western immunoblot test
could be used as a good, conﬁrmatory method for the detection of
Candida antibodies in patient serum.
P1647 Advanced serological tests for the diagnosis of
African tick bite fever
M. Jensenius, P.-E. Fournier, S. Vene, S. Ringertz, B. Myrvang,
D. Raoult
Oslo, N; Marseille, F; Solna, S
Objectives: The serological diagnosis of African tick bite fever
(ATBF), a spotted fever group (SFG) rickettsiosis caused by Rick-
ettsia africae and an emerging health problem in international trav-
ellers to sub-Saharan Africa, is troublesome with many available
tests having either poor sensitivity or poor speciﬁcity, or both.
Methods: We evaluated the sensitivity and species speciﬁcity of a
multiple-antigen immunoﬂuorescence assay (IFA) and a multiple-
antigen Western blot (WB) assay in detecting antibodies against
SFG rickettsiae and R. africae in paired serum samples collected
from 40 consecutive patients with ATBF. Samples from patients
with only nonspecies-speciﬁc antibodies detectable were also tes-
ted by cross-adsorption assay (CA).
Results: Antibodies against SFG rickettsia were detected by IFA in
18/40 (45%) patients and by WB in 40/40 (100%) patients
(P < 0.001). During the ﬁrst 2 weeks of illness, the corresponding
estimates were four of 40 (10%) and nine of 40 (23%), respectively
(P ¼ 0.03). By comparing titres and staining characteristics, the
multiple-antigen IFA demonstrated speciﬁc antibodies against R.
africae in six of 18 (33%) IFA-positive patients. WB detected reac-
tions to speciﬁc protein antigens of R. africae in 22/40 (55%) cases.
For seven of 13 (53%) patients with only nonspecies-speciﬁc anti-
bodies detectable by WB, CA demonstrated speciﬁc antibodies
against R. africae.
Conclusions: Our study demonstrates that WB is signiﬁcantly more
sensitive than IFA when diagnosing consecutive cases of ATBF,
also during the acute phase when most patients are likely to pre-
sent. The species speciﬁcity of WB may be further increased by
the use of CA in selected cases. The status of IFA as the consid-
ered serological reference method in the diagnosis of ATBF
should be re-evaluated.
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P1648 Evaluation of two procedures for direct inoculation
of Gram-negative aerobic and facultative anaerobic bacteria
from positive BACTEC blood cultures into the Phoenix
automated microbiology system
H. De Beenhouwer, M. Struelens, E.J. Perea, I. Autenrieth
Aalst, Brussels, B; Seville, E; Tubingen, D
Objectives: To validate and evaluate the inter-laboratory concor-
dance of two methods of specimen preparation for direct inocula-
tion of PHOENIX with culture suspensions from positive
BACTEC blood culture vials, compared with the routine PHOE-
NIX method for ID and AST.
Methods: Multi-centre prospective clinical trial with parallel pro-
cessing of clinical samples by investigational and reference meth-
ods. BACTEC vials were processed within 24 h after positivity.
Only aerobic and facultative anaerobic Gram-negative rods were
included. Differential centrifugation method (DIFF): bacteria were
recuperated through two consecutive centrifugation steps (10 s at
6400 g; supernatant 60 s at 20 800 g).Gel separation method (SST):
bacteria were recuperated through one centrifugation step (2000 g
for 1 min) using a Vacutainer SST II gel tube. Reference method
(REF): standard procedure starting from a pure overnight culture
on solid media. ID accuracy was calculated at genus and species
level. AST accuracy (category concordance and error rates) was
determined for 19 antibiotics.
Results: A total of 226 isolates were obtained, of which 210 could
be included in the study. DIFF and SST identiﬁed 92.1 and 91.6%
of the isolates to the genus level and 90.7 and 90.2% to the species
level, respectively; no identiﬁcation was obtained for 10 (4.8%) vs.
13 (6.1%) isolates. AST concordance of DIFF and SST with REF
was 95.4% vs. 94.1%, with only 0.26% vs 0.33% Very Major
Errors. Reporting time for ID + AST with DIFF and SST was 10 h,
54 min and 11 h, 21 min vs. REF 11 h, 09 min.
Conclusions: Excellent results were obtained with both inoculum
preparation methods for ID and AST testing. No major differences
were observed between methods or sites. The short reporting time
obtained with direct inoculation may be relevant to improve the
management of bacteremic patients.
P1649 Clinical and organisational factors associated with
negative blood cultures from general internal medicine wards
B.P. Ehrenstein, V. Ehrenstein, C. Henke, H.J. Linde,
J. Scho¨lmerich, T. Glu¨ck
Regensburg, D; Boston, USA
Objective: Blood cultures (BC) help deﬁning pathogen and resist-
ance spectra. At the same time, the beneﬁts of BC results in the
management of individual patients – and therefore their cost
effectiveness are disputed. We aimed to identify clinical and
organisational factors associated with negative BC results for obli-
gate pathogens (OP) for BC from patients in general internal
medicine wards.
Methods: We abstracted charts of patients who had at least one
BC (blood volume per BC approximately 20 mL) drawn on a gen-
eral internal medicine ward of our tertiary care hospital in the
year 2000. We retrieved and evaluated in a multiple logistic
regression the following factors for their association with BC neg-
ative for OP: site and time of BC draw; presence of central venous
catheter; prior BC taken in the emergency room or intensive care
unit; any antibiotic treatment in prior 7 days; intravenous antibiot-
ics in prior 2 days; temperature (value of <40C; no rise or rise
<2C); leucocyte count (value of <12/nL; no rise or rise <2/nL),
C-reactive protein (CRP) level (value of >100 mg/L; rise by
>50 mg/L), general and special nursing categories (1 vs. 2 or 3),
and prior order written in the chart to draw BC in case of fever.
We also evaluated the number of BC within diagnostic episodes
(DE): consecutive BC from a single patient taken <3 days apart
were attributed to the same DE.
Results: A total of 96 (13%) of 711 BC from 310 patients were pos-
itive, 59 (8%) yielded OP. Temperature <40C [odds ratio (OR)
2.0; 95% conﬁdence interval (CI) 1.0–3.8], any antibiotic treatment
in the prior 7 days [OR 2.3; CI 1.2–3.8], no rise of leucocyte count
or <2/nL [OR 2.3; CI 1.2–4.2], rise of CRP >50 mg/L [OR 3.1; CI
1.1–9.0], and a low general nursing category [OR 4.0; CI 1.7–9.1]
were independently (P < 0.05) associated with negative BC for
OP. Of the 470 DE, 40 (9%) yielded OP. Of the 156 DE with more
than 1 BC, 17 DE yielded OP. Two of the 17 DE yielded two dif-
ferent OP, and three failed to identify the OP in the ﬁrst BC taken.
Obtaining more than three BC within 3 days identiﬁed no addi-
tional OP.
Conclusions: A good overall clinical state of the patient represen-
ted by the lowest general nursing category and an already docu-
mented CRP rise >50 mg/L showed the strongest associations
with negative BC results for OP. Therefore, rise in CRP should
not encourage the draw of BC. Obtaining more than three BC
within 3 days identiﬁed no additional OP.
P1650 Reducing the rate of blood culture contamination
A. Itzhaki, T. Lazarovitch, K. Ovadia, I. Gazit, J. Karpuch
Zriﬁn, IL
Objectives: At our Medical Center, blood cultures are drawn by
resident physicians, interns and medical students. More than 20
000 blood cultures are examined at our institution every year,
10% of the samples being positive. About 2.5 of total blood cul-
tures grow bacteria considered a contaminant. At the beginning of
2002, we implemented an intervention programme for 3 months
in an attempt to reduce contamination rates in the internal medi-
cine wards, where the largest proportion of blood cultures is
taken.
Methods: The infectious diseases team conducted an education
campaign on the subject of the technique of blood culture
sampling in each of six internal medicine wards. Residents,
interns and students who drew blood cultures were asked to
sign their full names on the requests accompanying the blood
samples, and each one of them was instructed to be responsible
for his culture results. A few residents were found to be
‘Super-Contaminators’ and these were asked particularly to
adhere to the proper technique of blood sampling and skin
decontamination.
Results: During March, April and May 2002, 1786, 1780 and 1688
blood samples were drawn respectively for cultures in the internal
medicine wards. In March, when the intervention program began,
the contamination rate was 4.6%, in April the rate decreased to
2.6% and diminished further to 1.8% in May. Disappointingly,
but not unpredictably, the rate of contamination increased as soon
as the intervention programme ended. Comparing the results of a
whole year (a year prior to the intervention period and a year
afterwards), we found no difference in contamination rates – 5.65
and 5.36%, respectively.
Conclusions: Our programme intervened on two levels: the ﬁrst
was education regarding the technique of drawing blood cultures;
the second was to try and make every physician responsible for
his own samples. The efforts to reduce blood culture contamin-
ation rates were effective only in the period immediately follow-
ing the intervention programme. In a hospital, where resident
physicians and students collect blood cultures instead of skilled
phlebotomists, a continuous effort is needed for the education of
the staff.
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P1651 Comparison percentage of blood culture (BC)
contamination in four hospital units and corrective sampling
and processing after training
M. Yaghobi
Tehran, IR
Objectives: The aim of study was monitor and improve BC samp-
ling and necessary role of training.
Methods: This study performed in two phases based on TQM
training with Focus-PDCA procedure. In the ﬁrst phase we had
the retrospective study for collecting data BC contamination in
the forth ﬁrst month of the year and we calculated the rate of
blood contamination between four hospital units (ICU, NICU
level I, NICU level II, and pediatric). Then we have initiated addi-
tional training of staff. In the second phase is collected blood con-
tamination’s data in the forth second month of the year (after
training).
Results: Comparative’s study between the results of BC contamin-
ation before and after training is showed that contamination of
NICU I was 2.9% before training and 1.3% after training NICU II
was 7.7% before training and 4.2% after training ICU was 5%
before training and 1.6% (at), pediatric was 5.2% before training
and 3.6% after training. Also it was comprised the results of BC
contamination between each month (8 months) for four units.
Conclusions: Cost related to false-positive blood culture results (i.e.
contaminant) are associated with 40% higher charges for IV anti-
biotics and microbiology testing. So training will be more cost efﬁ-
cient. The rate of contamination after training decreased 2–3% in
four hospital units.
P1652 Prospective study to evaluate differential time-to-
positivity in the diagnosis of port-related bloodstream infection
J.L. del Pozo Leo´n, A. Aguinaga Pe´rez, S. Herna´ez Crespo,
M. Lamata Subero, A. Rodrı´guez Macı´as, M.F. Rubio Vallejo,
M. Fdez-Alonso, J. Leiva Leo´n
Pamplona, E
Objectives: Intravascular catheters are indispensable in modern-
day medical practice. Diagnosis of port related bloodstream infec-
tion (PRBI) remains difﬁcult without catheter removal. Clinicians
usually avoid removal of the port because reinsertion of a new
catheter carries substantial risks. Blot et al. described in 1998 a
method that evaluated the differential time to positivity (DTP), as
determined by a continuous blood culture monitoring system, for
qualitative blood cultures drawn simultaneously from the catheter
and a peripheral vein, to diagnose catheter related bloodstream
infection. However, this method has not been validated in long-
term tunnelled catheters. The aim of the present study is to asses
the value of DTP for the diagnosis of PRBI using paired quantita-
tive blood cultures as the standard criterion to deﬁne PRBI.
Methods: During a 3-year period (June 2000–June 2003) patients
with port suspected as being the primary source of fever were
studied prospectively. Two qualitative and two quantitative cul-
tures of blood samples were simultaneously obtained from a per-
ipheral vein and through the port. A difference between the
peripheral and port blood qualitative culture in time to detection
>120 min was used as the cut-off point to diagnose PRBI.
Results: A total of 129 episodes occurred in 119 patients during
the study period. Ten patients were excluded of the study because
they were diagnosed of pocket-site infection. Forty patients were
being treated with antibiotics when blood samples were obtained.
Of the 109 episodes, 83 (76.2%) were PRBI and 26 (23.8%) were
non-PRBI, as determined by the standard criterion. The median
time to positivity of the blood samples for PRBI (462.12 min;
range, 50 to 2010 min) was signiﬁcantly greater than that for
non-PRBI (33.07 min; range, 510 to 450 min); P < 0.001. The
sensitivity, speciﬁcity and predictive values of positive and nega-
tive results of DTP compared with quantitative cultures were 85.5,
80.8, 93.4 and 63.6% respectively.
Conclusions: Differential time to positivity is an easy and reliable
method to diagnose port related bloodstream infection without
removing of the catheter, when compared with quantitative blood
cultures.
P1653 Procalcitonin rapid test in the diagnosis of sepsis
K. Grozdanovski, Z. Milenkovic, P. Kalamaras, K. Karovski,
V. Urosevic, D. Jovanovska, M. Cvetanovska, V. Semenakova
Skopje, MK
Background: Procalcitonin (PCT) has been suggested to aid in diag-
nosis, monitoring and outcome prediction in septic patients.
Objective: The aim of the study is to determinate clinical useful-
ness of rapid semi-quantitative test for detection of PCT
(B.R.A.H.M.S. PCT-Q, B.R.A.H.M.S.-Diagnostica GmbH, Ger-
many) in septic patients within 24 h of admission. We analysed
12 medical patients treated in the intensive care unit (six with
sepsis, ﬁve with severe sepsis and one patient with septic
shock). In patients with sepsis PCT levels were: <0.5 ng/mL
(n ¼ 1); 0.5 ng/mL (n ¼ 1); 2 ng/mL (n ¼ 3); 10 ng/mL
(n ¼ 1). In patients with severe sepsis PCT levels were: 2 ng/
mL (n ¼ 1); 10 ng/mL (n ¼ 4). The patient with septic shock
had PCT level 10 ng/mL.
Conclusions: Measurement of plasma PCT with semi-quantitative
PCT-Q test allow rapid support in the diagnosis of septic patients.
However follow-up of PCT during clinical course of illness and
its correlation with outcome is still to be determined.
P1654 Usefulness of plasma procalcitonin (PCT) in
diagnosis of microbial infection among adults patients
D. Dimou, M. Belechri, N. Marougas, N. Ioakimides, A. Karali,
C. Kotsovassilis, P. Tsiodra, S. Chini, C. Keramidas
Athens, GR
Objectives: To study the possible discriminative role of procalcito-
nin (PCT) in differentiating acute fever because of bacterial infec-
tion from fever of other inﬂammatory processes, in patients
treated in an internal medicine department.
Methods: We prospectively examined 121 patients with acute fever
admitted in our department. Variables recorded included patient
demographics and principal diagnosis. PCT, C-reactive protein
(CRP), Erythrocyte Sedimentation Rate (ESR) and white blood cell
count (WBC) were measured. Blood samples were collected
24–48 h after the presence of fever. The outcome was determined
as survivors and non-survivors. Patients were distinguished
according to aetiological diagnosis, based on clinical assessment
and laboratory results, to those with fever because of bacterial
infection (Group A) and those with fever of other inﬂammatory
processes (Group B). Among statistical tests applied were Stu-
dent’s t-test and Chi-Square. The ability of PCT to predict patients
with bacterial infection was evaluated by performing receiver
operative characteristic curves analyses.
Results: Of 121 study patients, 81 (66.9%) had fever because of
bacterial infectious and 40 (33.1%) because of other inﬂammatory
processes. The mean plasma concentrations of PCT in patients
with bacterial infectious were 3.27 ng/mL (SD 6.29) while in
patients of Group B 0.41 ng/mL (SD 0.5). Subgroup analysis in
Group A, shows that patients with sepsis had higher values of
PCT 12.74 ng/mL (SD 10.48) compared with other patients with
bacterial infection (P ¼ 0.02). Patients in Group A, had as expec-
ted, higher values of ESR (P < 0.0001) and CRP (P ¼ 0.001). The
mean values of WBC did not differ between the two groups,
while percentage of neutrophil differ at a signiﬁcant level
(P < 0.0001). 81.8% of patients who died had PCT levels higher
than 0.5 ng/ml compared with 43.8% of survivors (p ¼ 0.03). Pre-
dictive accuracy for bacterial infectious expressed as area under
the receiver operating characteristics curve was 0.74 for PCT (95%
CI 0.65–0.83), 0.75 for ESR (95% CI 0.65–0.84) and CRP 0.69 (95%
CI 0.50–100).
Conclusions: PCT can probably be used as a useful tool in the ini-
tial work up of patients with fever. Supplemented by other biolo-
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gical indicators, PCT can help in make decisions about antibiotic
therapy in patients treated in an internal medicine department.
P1655 Should procalcitonin be introduced in the
diagnostic criteria for the systemic inﬂammatory response
syndrome and sepsis?
E.J. Giamarellos-Bourboulis, P. Grecka, P. Giannopoulou,
D. Voros, K. Mandragos, H. Giamarellou
Athens, GR
Objectives: To deﬁne whether procalcitonin should be introduced
in the diagnostic criteria of sepsis.
Methods: Procalcitonin was estimated in the sera of 105 critically
ill patients by an immunochemiluminometric assay. Diagnosis
was settled by three types of criteria; (A) the ACCP/SCCM 1992
criteria; (B) the ACCP/SCCM criteria and concentrations of pro-
calcitonin above 1.0 ng/mL as indicative of both systemic inﬂam-
matory response syndrome (SIRS) and sepsis and (C) the ACCP/
SCCM criteria and concentrations of procalcitonin between 0.5
and 1.1 ng/mL as indicative of SIRS and above 1.1 ng/mL as
indicative of sepsis.
Results: Median procalcitonin of patients with SIRS, sepsis and
septic shock diagnosed by criteria A was 1.15, 5.49 and 13.75 ng/
mL upon presentation of their syndrome respectively. That of
patients diagnosed with SIRS, sepsis, severe sepsis and septic
shock by criteria B was 2.52, 2.70, 8.30 and 12.95 ng/mL respect-
ively; and that of patients diagnosed with SIRS, sepsis, severe sep-
sis and septic shock by criteria C was 0.69, 2.64, 8.30 and
12.94 ng/mL. Criteria A identiﬁed 53 (50.5%) patients with SIRS,
19 (18.1) with sepsis, one (0.9%) with severe sepsis and 24
(22.9%) with septic shock; respective diagnosis by criteria B were
28 (26.7%), 10 (9.5%), 11 (10.5%) and 27 (25.7%); and respective
diagnosis by criteria C were 20 (19.0%), 27 (25.7%), 10 (9.5%) and
27 (25.7%). Sensitivity of concentrations between 0.5 and 1.1 ng/
mL was 25.6% for SIRS; and above 1.1 ng/mL 92.8% for sepsis.
Conclusions: Despite the limited diagnostic value of procalcitonin
for SIRS, concentrations of procalcitonin above 1.1 ng/mL are
highly indicative for sepsis.
P1656 Procalcitonin as a diagnostic aid in osteomyelitis
and septic arthritis
Y. Butbul-Aviel, R. Halevy, A. Koren, W. Sakran
Afula, IL
Objective: To evaluate the diagnostic value of Procalcitonin (PCT)
in the detection of osteomyelitis (Om) and septic arthritis (Sa) in
children.
Methods: PCT, C reactive protein (CRP), erythrocyte sedimentation
rate (ESR) and white blood cell (WBC) were measured in children
admitted with suspicion of osteomyelitis or septic arthritis. PCT
was measured by the PCT-Q Kit, PCT immunochromatography
assay, based on monoclonal and polyclonal antibodies against cat-
acalcin. B.R.A.H.M.S. The results were divided into four categor-
ies, normal (under 0.5 nn/mL), mildly elevated (0.5–2 nn/mL)
high (2–10 nn/mL) and very high value (>10 nn/mL). The diag-
nosis of Om was made by two of the following diagnostic criteria:
(1) presence of purulence of bone, (2) positive bone or blood cul-
ture, (3) localized erythema oedema or both or (4) a positive ima-
ging study either on radiography, Tc scintigraphy or magnetic
resonance imaging.
Results: A total of 43 children were evaluated. Eleven (25.5%)
with the diagnosis of Om, 11 with septic arthritis (25.5%) diag-
nosed by aspiration of sinovial ﬂuid, six children (13.9%) were
diagnosed as soft tissue infection. Transient synovitis or reactive
arthritis were diagnosed in another six children (13.9%), three of
them (6.9%) were diagnosed later on as juvenile rheumatoid arth-
ritis. Six children have another different diagnosis (13.9%). WBC
was higher in Sa compare with Om and other diagnosis:
16.2  7.3  109/L, 11.8  4.9  109/L and 13.2  5.5  109/L
respectively (P ¼ 0.221). ESR on admission was higher among the
children diagnosed with Om compared with those with Sa and
other diagnosis (67  37.7 vs. 53  27 vs. 49  37). CRP on admis-
sion was higher among the children subsequently diagnosed as Sa
compared with those with Om and other diagnosis but the differ-
ences were not signiﬁcant (98.5  76.3 vs. 85.1  93.4 vs.
73.7  95.4). PCT value was mildly elevated in six of 11 patients
with Om (66.7%) and only three children with the diagnosis of Sa
(33.3%) had a mildly elevated value. Among the children with
other diagnosis there were no positive PCT values.
Conclusions: PCT was found to be a good tool in the diagnosis of
osteomyelitis but not in septic arthritis. Larger studies are needed
to conﬁrm our ﬁndings.
P1657 Comparison of the time-to-positivity of hub-blood
vs. peripheral-blood cultures as useful tool for diagnosing
catheter-related infection
V. Mirovic, B. Tomanovic
Belgrade, CS
Objectives: To evaluate the differential time to positivity (DTP) of
paired blood cultures drawn simultaneously via the catheter hub
and from a peripheral venous site as a diagnostic tool for cath-
eter-related infection (CRI).
Methods: During 2002–03 period, 96 simultaneous hub-blood and
peripheral-blood cultures were obtained from patients with sus-
pected CRI. We recorded the DTP between hub-blood and periph-
eral-blood cultures with an automatic device (BacT/Alert system,
Organon Teknika) for detection of blood culture positivity.
Results: The same micro-organism was found in both hub-blood
and peripheral blood cultures in 46 (48%) of the 96 episodes of
suspected CRI. Of these 46, 37 (80%) were associated with bacter-
aemic CRI (the DTP was over 2 h), whereas CRI was excluded in
the remaining nine. The major micro-organisms involved in bac-
teraemic CRI were: Candida spp. (n¼10), coagulase-negative sta-
phylococci (n ¼ 7), Klebsiella pneumoniae (n ¼ 6), Acinetobacter spp.
(n ¼ 3), Morganella morganii (n ¼ 3), Staphylococcus aureus (n ¼ 2),
Escherichia coli (n ¼ 2), Serratia spp. (n ¼ 2), Stenotrophomonas
maltophilia (n ¼ 2), Enterococcus spp. (n ¼ 1), and Pseudomonas ae-
ruginosa (n ¼ 1).
Conclusions: Our results show that the measurement of the delay
between the positivity of hub-blood and peripheral blood cultures
can be a simple and useful tool for diagnosing CRI, and can be
proposed for routine practice in hospitals using automatic devices
for detection of positive blood cultures.
P1658 Comparison of the VersaTREK to the ESP Culture
System II for blood cultures
V. LaBombardi, D. Fett, A. Kamel, N. Sullivan
New York, Sun Prairie, USA
Objective: A series of studies were conducted comparing the next
generation blood culture instrument, the VersaTREK (VT) to the
ESP Culture System II (ESP). These studies were conducted in the
laboratories of Trek Diagnostic Systems (TS), Sun Prairie WI, USA
and St. Vincent’s Hospital (SVH) New York, New York, USA.
Methods: VT 80 ml blood culture bottles and ESP 80 mL blood
culture bottles were seeded with suspensions of a variety of
micro-organisms. These bottles were incubated in their respective
instruments and compared as to the time required to detect a pos-
itive culture and the quality of the curves generated. A clinical
trial was conducted using specimens routinely collected for blood
culture from inpatients at SVH.
Results: The initial seeded studies at TS included 45 different
Gram Negative and Gram Positive bacteria, and yeast. Comparing
the ESP 80A bottle to the Redox 1 (VT) bottle, isolates in the VT
had a shorter time to detection (TTD) than in the ESP with 44 of
45 of the isolates by an average time of 1.08 h. The resulting
graph proﬁles in the VT were equal to, or better than, those
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generated in the ESP. Comparisons of the ESP anaerobic bottle to
the VT Redox 2 yielded similar results. Seeded studies were con-
ducted at SVH with 69 isolates representing 13 different species
of bacteria and yeast. Comparing the two systems, 11 of 13 spe-
cies were seen to have a faster TTD in the VT than in the ESP.
Preliminary data on over 300 samples from an ongoing clinical
trial comparing the recovery and TTD from patient specimens has
shown the VT to be at least comparable with the ESP for these
two criteria.
Conclusions: Seeded and clinical data has demonstrated that the
VT is at least comparable with the ESP for blood cultures and
has validated the VT for use in the clinical microbiology labor-
atory.
P1659 Comparison of the effect of delayed entry into two
different blood culture systems (Bactec 9240 and BacT/Alert 3D)
on culture positivity
O.A. Akan, E. Yildiz
Ankara, TR
Automated continuously monitoring blood culture systems
brought many advantages into laboratory practice such as
rapid detection of agents and labor reduction. Delay in the
specimen transport is one of the problems that may effect the
culture positivity in clinical laboratories. To evaluate the differ-
ence between effect of delayed entry into blood culture systems
[Bactec 9240 (BD) and BacT/Alert 3D (BA)] on detection of
bacterial growth in blood culture media (Bactec 92 F, 93 F and
BacT/Alert FA, BacT/Alert FAN), standard inoculums (25 cfu)
of micro-organisms frequently isolated from blood cultures; Sta-
phylococcus aureus, Escherichia coli, Enterococcus faecalis, Acinetob-
acter baumannii, Haemophilus inﬂuenzae, Bacteroides fragilis and
Streptococcus pneumoniae were inoculated into blood culture bot-
tles which contained 2 mL of sterile human blood. The bottles
were cultured using two instruments after they were stored at
room temperature and at 35C incubators for 0, 4, 6, 12, 24
and 48 h. Five sets (60 pairs) of each bacteria were studied for
each temperature. All the positive and negative cultures (after
5 days ) were recorded and subcultures were performed. None
of the cultures were false negative in the ﬁrst 12 h of delay
except two strains (S. pneumoniae and H. inﬂuenzae) in BA, after
preincubation at 35C. At 24 h of delay, false negativity was
14/60 for BD (E. coli 4, A. baumannii 3, E. faecalis 4 S. pneumo-
niae 3), 8/60 for BA (S. pneumoniae 8). False negative results
were from bottles preincubated at 35C in BD. At 48 h of
delay, false negativity rate was 34/70 for BD (E. coli 10, B. fra-
gilis 10, E. faecalis 6, S. pneumoniae 5, A. baumannii 2, H. inﬂuen-
zae 1), 15/70 for BA (S. pneumoniae 9, A. baumannii 3, B. fragilis
3). For delayed preincubation (24–48 h) false negativity was
more common in BD especially for storage at 35C. BA had
difﬁculty to detect S. pneumoniae starting from 24 h preincuba-
tion. Failures to detect microbial growth is noticed after 24 h
for both systems. This may not be a disadvantage in clinical
laboratory practice at institutions where specimen transportation
work regularly.
P1660 The diagnosis of brucellosis by use of BACTEC
9050 blood culture system
H. Uncu, T. Turunc, Y. Demiroglu, H. Arslan
Adana, Ankara, TR
Objectives: The diagnosis of brucellosis is generally made when a
standard tube agglutination titre of 1/160 or more for anti-Brucel-
la antibodies in the presence of compatible clinical signs and
symptoms. In this study we aimed to describe the rate and dur-
ation of isolation of Brucella spp. from blood culture by using an
automated blood culture system (BACTEC 9050).
Methods: Between March and December 2003, 31 adults were
diagnosed as brucellosis by means of positive standard tube
agglutination (>160) cultures and clinical manifestations. Blood
cultures were obtained from the patients whom standard tube
agglutination titres were 1/160 or more. Ten millilitres of blood
were inoculated in a Bactec Plus aerobic/F bottle and incubated
in BACTEC 9050 automated system. The bottles were kept in
incubation for 21 days and they were subcultured when the
machine signalised the growth. A blind subculture was per-
formed after 21 days for the negative cultures.
Results: 31 patients, all of the patients with positive standart tube
agglutination had bacteremia A positive result appeared in
3.5 days (84 h) as mean. Earlier detection were seen in second day
and latest one at sixth days.
Conclusion: We concluded that automated BACTEC culture system
can isolate Brucella spp. in a fast and efﬁcient way. And we sug-
gest at least 7 days in the case of Brusellosis suspicious.
P1661 Modiﬁcation of ‘gold standard’ method for the
diagnosis of Chlamydia trachomatis infection using peripheral
blood leucocyte culture
T. Saralidze, T. Shvelidze, P. Gabunia, L. Mohchevishvili,
E. Saralidze
Tbilisi, GEO
Chlamydia trachomatis is the most common disease among sexu-
ally transmitted diseases world-wide. Evidence of the family
character of this infection additionally underlines the importance
of the diagnosis of C. trachomatis infection especially its con-
cealed, latent forms with asymptomatic course among adults
and children as well. Considering the persistence of C. trachoma-
tis infection in the organism and knowing that the most accurate
method for the diagnosis of this infection in clinical specimens
from all sites is the tissue culture technique employing ciclohexi-
mide treated McCoy cells, so called ‘golden standard’ we deci-
ded to investigate the cytomorphological peculiarities of
C. trachomatis in the cultures of peripheral blood leucocytes of
patients with urogenital chlamydiosis. For this aim the periph-
eral blood leucocytes of 14 patients infected only by C. trachoma-
tis infection were studied using the original method of
culturing. The diagnosis of C. trachomatis was conﬁrmed by
direct ﬂuorescent-antibody technique. In vitro morphological
inclusions speciﬁc for C. trachomatis were revealed in the cyto-
plasm of monocytes-macrophages, segmented neutrophils and
even in lymphocytes, especially among children. In all cells
these inclusions appeared to be PAS-positive cytochemically
stained on glycogen. The use of peripheral blood leucocyte cul-
ture enabled us to diagnose the infection of C. trachomatis for
the ﬁrst time in 24 patients. Among them were two children at
the age of 3 and 6 years and four patients with myelodysplastic
syndrome, who applied to us for the estimation of immune
reactivity of organism according to the amount of macrophage-
lymphocyte rosette formation in vitro (Georgia Patent N 1296).
In these cases the diagnosis of C. trachomatis infection was con-
ﬁrmed by direct or indirect immunoﬂuorescent assays. Accord-
ing to our studies the macrophage-lymphocyte rosette formation
was signiﬁcantly decreased in 85% of patients with urogenital
chlamydiosis composing 12–25% instead of 37.2  2.5%
(observed in healthy donors). pointing to the decreasing of the
functional activity of immunocompetent cells. Results of our
research show that blood leucocyte culture methods can be used
for the diagnosis of latent forms of chlamydial infection and for
the estimation of the efﬁcacy of treatment and immune reactiv-
ity of organism as well.
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P1662 Infections due to Abiotrophia defectiva and
Granulicatella adiacens: identiﬁcation by sequencing of 16S
rDNA and clinical manifestations
L. Senn, K. Jaton, A. Wenger, J. Bille, T. Calandra, G. Prod’hom
Lausanne, CH
Background: The taxonomy of nutritionally variant streptococci
(NVS) has recently been modiﬁed, including the genus Abiotrophia
created in 1995 and the new genus Granulicatella proposed in
2000. Reported clinical manifestations of NVS infections are endo-
carditis, septicemia and bacteremia. Isolated cases of keratitis,
endophthalmitis, brain abscess, iatrogenic meningitis and osteo-
myelitis have also been described.
Objectives: Identify by molecular tool the NVS strains isolated
from clinical specimens in our clinical laboratory, and correlate
the molecular identiﬁcation with the clinical diagnosis.
Methods: The strains of NVS isolated during the ﬁve last years from
blood culture or vascular endograft specimen were retrieved from
storage (one strain per patient) and identiﬁed by partial 16S rRNA
sequence analysis. Patient’s charts were reviewed and clinical char-
acteristics were reported for each documented infection due to NVS.
Results: NVS were isolated from seven patients during the 5-year
period. Identiﬁcation based on partial 16S rRNA sequence analy-
sis showed two genogroups: Abiotrophia defectiva (3) and Granulica-
tella adiacens (4). Clinical diagnoses for the three patients with
A. defectiva were endocarditis in two, plus septic metastatic arthritis
in one of them, and aortic endograft infection in one. For the four
patients with G. adiacens, clinical diagnosis was febrile neutropenia
with bacteremia in all four, plus possible endocarditis in one. Risk
factors were malignant hemopathy (3) and solid tumour (1).
Conclusions: In our small serie, G. adiacens appears to be associated
with bacteremia in febrile neutropenic patients, in contrast to A.
defectiva, observed in non-neutropenic patients.
P1663 Mediterranean spotted fever: study of 29 cases
E. Louro, A. Campos, J. Leita˜o, A. Carvalho, R. Santos, C. Reis,
E. Almiro, A. Porto
Coimbra, P
Introduction: Mediterranean spotted fever also known as bou-
tonneuse fever is an estival endemic zoonosis in the Mediterra-
nean region. The dog tick, Rhipicephalus sanguineus, does the
accidental transmission of Rickettsia conorii to men.
Aims: The authors claim to demonstrate the distribution of the
disease in a Medicine Department during the period 1993-2003
relatively to sex, age, clinical symptoms, residence, job, animal
contacts, seasonal distribution, ‘tache noire’ location, analytical
alterations, complications and treatment.
Methods: Retrospective study of Mediterranean spotted fever
between 1993 and 2003 in the Medicine III Department of Coim-
bra University Hospital.
Results: The peak incidence occurred during summer season, both
sexes were equally reached with a predominance on the sixth and
seventh decades of life. The ‘tache noire’ was not observe in all
patients and the main clinical manifestations were fever and ma-
culopapular rash involving the palms and soles. The more fre-
quent laboratory alterations observed were: increased AST and
ALT, thrombocytopenia and hiponatremia. The common compli-
cations were: shock, pneumonia and disseminated intravascular
coagulation. Ten of the 29 patients had a positive serological
result for R. conorii. Treatment with doxycycline was the most fre-
quent adopted.
Conclusions: Generally, boutonneuse fever is a benign disease but,
as it can progress to severe ill (shock, pneumonia) and lead to
signiﬁcative increase in mortality, is advisable to maintain a close
follow-up of this cases.
P1664 A rare cause of wound infection: Shewanella
putrefaciens
C. Bulut, C. Go¨kcek, G. Ertem, Y. Erdem, M.A. Bayar, E. Karakoc¸,
N. Tu¨lek
Ankara, TR
Objectives: Shewanella putrefaciens is a saprophyte micro-organism
distributed commonly in water and soil. Isolates of S. putrefaciens
from human clinical specimens are uncommon and usually repre-
sent colonisation. It causes a wide range of infection from mild
cellulitis to life threatening septicemia or endocarditis. We des-
cribe a scalp infection caused by S. putrefaciens in a healthy man.
Case: A 27-year-old man was admitted to the Department of Neu-
rosurgery of Ankara Training and Research Hospital with wound
infection on the scalp after accidentally hitting his head to a rock
under the sea 5 days before. After the trauma his wound had
been sutured at the emergency room. A purulent discharge had
developed 3 days later. On physical examination, there was only
a 10 cm length, superﬁcial incision surrounding erythema area
with purulent discharge on left parietal localisation. Other phys-
ical examination ﬁndings were normal. The full blood count
showed a minor leucocytosis (14 000/mm3). The lesion was deb-
rided and resutured. Culture was taken from the lesion. The
patient was given empirical antimicrobial therapy with intraven-
ous cefazolin 3 g/day and a protective dressing on the affected
region. On the third day from admission and the start of the ther-
apy, wound culture became positive for S. putrefaciens. The identi-
ﬁcation of the isolate was performed using mini API instrument
with ID32 E (bioMerieux sa, Marcy-I’Etoile, France). The micro-
organism was sensitive to ceftazidime, cefepime, cefoperazone, ci-
proﬂoxacin, gentamicin, imipenem and aztreonam. The treatment
was changed to ciproﬂoxacin (500 mg bid, p.o.). He responded
well to the treatment. He was discharged on the ﬁfth day, still on
treatment with ciproﬂoxacin, which was deﬁnitely withdrawn
10 days later.
Conclusion: Although S. putrefaciens infection are very rare it
should be considered if a history of a marine contact is obtained.
P1665 Pathogens isolated from ambulatory patients with
acute upper-respiratory tract disease
A. Samet, E. Dziemaszkiewicz, E. Arlukowicz, J. Komarnicka
Gdansk, PL
Objectives: The aim of study was to estimate the frequency of bac-
terial infections in ambulatory patients with acute-respiratory tract
disease.
Methods: We examined ambulatory patients from January to
March 2003. A pharyngeal swab was taken from each patient.
Microorganisms were identiﬁed by standard methods. Disc-diffu-
sion susceptibility testing was done according to NCCLS.
Results: We examined 124 patients with acute upper respiratory
tract infection aged 6 months to 72 years. (mean age 29.8 years).
None of them was treated with antibiotic before microbiological
examination. Each patient suffered had a 2–10 days history of
upper-respiratory tract disease. A total of 44 (35.5%) pts had
bronchitis, six (4.8%) laryngitis, 63 (50.8%) pharyngitis, eight
(6.45%) sinusitis. Bacterial aetiology of infection was conﬁrmed in
76 patients (61.3%). In other cases we found normal ﬂora. The
most often isolated pathogens were B-haemolytic streptococci
(39.2%) susceptible to almost all antibiotics, S. aureus (29.4%)
majority resistant to penicillin, H. inﬂuenzae (23.5%) mostly multi-
susceptible. S. pneumoniae we isolated in 6.8% (with one strain
resistant to penicillin) and M. catarrhalis (1.1%).
Conclusions: (i) B-haemolytic streptococci were the most frequent
aetiological agents in ambulatory patients suffering from upper
respiratory tract infections. (ii). Most of isolated patogens were
multisusceptible. (iii). Patients with negative cultures were suspec-
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ted to have viral infections. (iv). High percentage of S. aureus may
represent colonisation.
P1666 Characteristics of microbiologic proﬁle in cervical
samples of pregnant women and nonpregnant healthy young
women
V. Kaliterna, N. Kucisec-Tepes, L. Pejkovic, E. Borzic, Z. Barisic,
V. Zoranic, I. Jelicic
Split, Zagreb, HR
Objectives: This study compares frequency of the most common
isolates of genital tract between two groups: pregnant women (in
ﬁrst and third trimester of pregnancy) and nonpregnant healthy
young women. Our goal was to deﬁne how many of them have
colpitis in compare with them who have only colonisation.
Methods: Collected samples, endocervical swabs, were treated
according to the standard laboratory procedures. Methods inclu-
ded: direct smear for inﬂammatory cells, dominant growth of etio-
logic bacterial agent after standard cultivation, biotyping,
determination of antibiotic susceptibility and mycologic identiﬁca-
tion.
Results: During the 1-year period of investigation 95 pregnant
women (each one in ﬁrst and third trimester of pregnancy) and
102 nonpregnant healthy young women were controlled. All
women were in generative age (20–43 years old). The patients
with inﬂammatory cells (>10 per ﬁeld), clinical symptoms and iso-
late were considered to have colpitis. The cases with microbiologi-
cal isolate, epithelial cells in direct smear were considered as
colonisation. The most common isolates in pregnant women in
ﬁrst trimester were: S. agalactiae (14%), E. Coli (11.5%), Candida
(15.4%), while in third trimester the most common isolates were:
Candida (32%), E. coli (7.6%) and S. agalactiae (6.4%). The isolates
of nonpregnant healthy women included: S. agalactiae (8.8%), E.
coli (8.8%) and Candida (16.6%). We noticed that women with
isolated S. agalactiae or E. coli had deﬁcit of Lactobacillus (only 11–
13%) in comparison with women without pathogens (50–54%) in
both groups. Inﬂammatory cells were found in 12.7% direct
smears of nonpregnant women and in 5% of pregnant women.
Conclusion: In this study the most common isolates were S. aga-
lactiae in ﬁrst trimester of pregnancy. Candida was the most fre-
quent in third trimester, which is in connection with elevate of
pH in late pregnancy (but only 21.6% of them had conidial
forms in direct smears which can be considered as infection).
Lactobacillus concentracion is severely depressed in women with
some other isolates wich can be explained as run for free areas.
Amount of inﬂammatory cells is signiﬁcantly elevated in non-
pregnant women. Such a ﬁnding could be both the result of bet-
ter control in pregnancy and the fact that pregnant women
usually have only one partner. A complete evaluation of the cer-
vical swabs in pregnancy should be preventive strategy for use-
ful informations to obstetricians in order to avoid neonatal
diseases.
P1667 Respiratory symptoms during leptospirosis: a
retrospective study of nine patients
P. Tattevin, S. Jaure´guiberry, M. Dupont, G. Le´veiller,
R. Flicoteaux, C. Arvieux, C. Michelet
Rennes, F
Objectives: To describe leptospirosis of the lung in a rural area of
France (Brittany).
Methods: We retrospectively reviewed medical records and chest
radiographs of 34 consecutive patients with serologically con-
ﬁrmed leptospirosis admitted in our institution during years
1992–2002. To be qualiﬁed as conﬁrmed leptospirosis, cases had
to meet all three following criteria: (i) clinically compatible illness;
(ii) presence of thermo resistant antigen or class IgM antibody
(ELISA) titre of at least 1:400; (iii) positive microscopic agglutin-
ation test with a titre of at least 1:100.
Results: Nine patients (26.5%) had respiratory symptoms on
admission. They were eight males and one female with a mean
age of 47 years. Symptoms on admission included cough (n ¼ 4),
shortness of breath (n ¼ 4), cyanosis (n ¼ 2) and haemoptysis
(n ¼ 1). Six patients had pulmonary radiographic abnormalities
including : (i) diffuse, ill-deﬁned, ground glass density (n ¼ 3); (ii)
diffuse alveolar opacities (n ¼ 2); (iii) small nodular density
(n ¼ 1). Seven patients reported exposure source including hunt-
ing (n ¼ 2), ﬁshing (n ¼ 2), fresh water swimming (n ¼ 2) and
canoeying (n ¼ 1). All patients had high grade fever on admission
with a mean of 40.1C. Other common features included headache
(n ¼ 4), vomiting (n ¼ 3) and myalgia (n ¼ 3). The most common
biological abnormalities included elevated liver enzymes (n ¼ 8),
proteinuria (n ¼ 7), lymphopenia (n ¼ 6), haematuria (n ¼ 5),
renal failure (n ¼ 4), anaemia (n ¼ 4) and elevated neutrophils
count (n ¼ 4). PaO2 was measured for three patients while they
were breathing room air and was at 32, 55 and 66 mmHg. No
patients required ventilation support. Suspected diagnosis on
admission included: leptospirosis (n ¼ 2), bacterial pneumonia
(n ¼ 2), intoxication (n ¼ 1), inﬂuenza (n ¼ 1), viral hepatitis
(n ¼ 1), biliary tract lithiasis (n ¼ 1) and rapidly progressive
glomerulonephritis (n ¼ 1). The ﬁrst serological testing for lepto-
spirosis was positive for ﬁve patients (55%). Serovar could be
determined for seven patients, including L. australis (n ¼ 3),
L. grippotyphosa (n ¼ 2) and L. ictero-hemorragiae (n ¼ 2). Seven
patients were treated with penicillin G or A; two patients received
no antibiotics. All patients were cured.
Conclusion: Patients with leptospirosis may present predominantly
with aspeciﬁc pulmonary symptoms. In these patients, leptospiro-
sis must be suspected when there is a potential exposure to rats,
especially in case of high grade fever, myalgia, hepatitis and renal
abnormalities.
P1668 Abscesses of skin and skin structures: insights from
a randomised study of ertapenem vs. piperacillin-tazobactam
R. Gesser, K. McCarroll, C. Chan, M. DiNubile
West Point, USA
Objectives: Ertapenem (ETP), a group I carbapenem, was as effect-
ive as piperacillin/tazobactam (P/T) in the treatment of complica-
ted skin and skin-structure infections. In this subgroup analysis,
we compare the demographics, microbiology, need for surgical
intervention, and response to therapy in patients with and with-
out abscesses.
Methods: In a double-blind study with sponsor blinding, adults
with complicated skin or skin-structure infections of moderate-
severe intensity requiring 7–14 days of parenteral antibiotic ther-
apy were randomised within two strata to receive ETP 1 g once a
day or P/T 3.375 g every 6 h. Patients with pressure ulcers or
with diabetic or neuropathic lower extremity infections (stratum I)
were excluded from this analysis. Results for stratum II patients
with and without abscesses were analysed using clinically evalua-
ble patients (EP analysis) and all treated patients satisfying the
case deﬁnition [modiﬁed intent-to-treat (MITT) analysis]. Clinical
response was assessed 10–21 days post-therapy test of cure
(TOC). Patients with missing assessments were counted as failures
in the MITT analysis. Surgical procedures during the ﬁrst 48 h of
study therapy were regarded as part of standard care. Patients
requiring extensive debridement or incision and drainage (I + D)
after the initial 48 h were considered failures.
Results: A total of 141/281 (50%) EP had abscesses. EP with
abscesses did not appreciably differ from those without abscesses
in age, gender, race, or severity of infection. The N (%) of EP with
vs. without abscess infected by the most common pathogens were:
53 (38%) vs. 50 (36%) for S. aureus; 26 (18%) vs. 29 (21%) for hae-
molytic streptococci; 33 (23%) vs. 40 (29%) for Enterobacteriaceae;
4 (3%) vs. 5 (4%) for P. aeruginosa; and 122 (87%) vs. 43 (31%) for
anaerobic/microaerophilic bacteria. Extensive debridement or
I + D was performed in 75% of EP with abscesses and 49% with-
out abscesses during the 48 h before or after initiation of study
therapy. Median duration (range) of therapy in EP was 7 (3–15)
and 8 days (5–16) for ETP and P/T when abscesses were present
471Clinical Microbiology and Infection, Volume 10, Supplement 3, 2004
vs. 9 (5–16) and 9 days (4–17) when absent. Favourable response
rates are shown in the Table.
Conclusions: Response rates to ETP once a day or P/T four times
a day were similar for patients with or without abscesses. Anaer-
obic bacteria were recovered more often when an abscess was
present. Early operative intervention was performed in a higher
proportion of patients with abscesses.
P1669 Classiﬁcation of clinically-relevant micro-organisms
in nonmedical environments
D. Bowers, T. Domanski
Annapolis, USA
Objectives: History and modern research have shown us that the
looming crisis of antimicrobial resistance cannot be avoided, but
it can be controlled. Our ability to control the rate at which
resistance develops and spreads requires an understanding of
bacterial adaptation, colonisation and infection. Environmental
studies are the ﬁrst important step in clarifying the evolutionary
trends and molecular relationships between strains of commu-
nity associated bacteria. Data from such studies can provide
information used to develop viable long-term strategies for the
treatment of infectious disease. The objectives of this study were
to collect, isolate and characterise samples of S. aureus from
areas utilised by midshipman athletes at the United States Naval
Academy.
Methods: Environmental samples were collected from 16 indoor
and outdoor varsity and intramural athletic areas. These samples
were classiﬁed in several steps including their gross morphology,
determinative biochemical activities and DNA sequences. In addi-
tion, the results obtained from environmental samples were corre-
lated with local clinical isolates, and sequence comparison of
speciﬁc genomic loci was performed.
Results: Observed differences in antibiotic sensitivity, protein A
and coagulase production in samples indicated the presence of at
least three to ﬁve distinct strains of S. aureus. Three strains exhib-
ited resistance to oxacillin.
Conclusions: The increasing prevalence of observed antibiotic
resistance in athletic facilities is representative of many factors
that have complicated recent attempts to model bacterial interac-
tion and evolution in nonmedical environments, but new genetic
information and effective evolutionary trend analysis will reﬁne
the relationships between such strains. Systematic surveillance
and documentation of environmental factors such as weather, fre-
quency of use, and methods of cleaning can then be added to
model and eventually control the development and spread of anti-
microbial resistance.
P1670 Comparison of azithromycin and amoxicillin for
treatment of adult patients with solitary erythema migrans
S. Lotric-Furlan, M. Logar, V. Maraspin, J. Cimperman, T. Jurca,
F. Strle
Ljubljana, SI
Objective: To evaluate the effectiveness and side-effects of azithro-
mycin and amoxicillin for treatment of adult patients with solitary
erythema migrans.
Methods: Consecutive adult patients with typical erythema
migrans were enrolled in a prospective study on early Lyme bor-
reliosis at the Department of Infectious Diseases in Ljubljana dur-
ing 1997. Patients receiving antibiotics at their ﬁrst visit, having
clinical evidence of disseminated Borrelia burgdorferi s.l. infection,
and/or being pregnant were excluded. They were randomised to
receive either azithromycin 500 mg b.i.d. for the ﬁrst day, followed
by 500 mg once a day for the following 4 days (AZT) or amoxicil-
lin 1000 mg t.i.d. for the ﬁrst 5 days, followed by 500 mg t.i.d. for
the following 10 days (AMO). Basic epidemiological data were
obtained by means of questionnaires. Serum IgM and IgG anti-
body titre against B. burgdorferi s.l. were determined by IFA with-
out absorbtion. Titres of 31:256 were interpreted as positive. In all
patients skin biopsy had been accomplished prior to the institution
of antibiotic treatment and specimen cultured in MKP medium.
Results: A total of 133 patients, 77 (57.9%) females and 56 (42.1%)
males, aged 16–83 years (median 49) were included in this study.
65 patients were evaluated in AZT group and 68 patients in AMO
group. No differences in epidemiological and pretreatment char-
acteristics were present comparing the two groups. Median dur-
ation of skin lesions after the institution of treatment was 7 days
(1–60) in the AZT group and 7 days (2–180) in the AMO group
(P ¼ 0.325). During the follow-up of 12 months none of the
patients developed major late manifestations of Lyme borreliosis
but in six patients severe minor manifestations appeared: in two
(3.1%) from AZT group and in four (5.9%) included in AMO
group. Isolation rates of B. burgdorferi s.l. from skin before treat-
ment (25/65 vs. 33/68; P ¼ 0.319) and 2–3 months after therapy
(0/25 vs. 0/33) were comparable for the two groups. Three (4.6%)
AZT group patients and one (1.5%) patient from AMO group
reported mild gastrointestinal discomfort (P ¼ 0.358).
Conclusions: Treatment of adult patients with solitary erythema
migrans with two different antibiotics exhibited equal effective-
ness and comparable side-effects. The outcome of borrelial infec-
tion after 1 year was favourable in both treatment groups.
P1671 Refractory gingivitis in a patient with
osseointegrated implant by the transmission of Actinobacillus
actinomycetemcomitans
Z. Barna, A´. To´th, Z. Budai
Budapest, HUN
Objectives: The presence of periodontopathogenic bacteria is a
risk factor for peri-implantitis. Microbiological testing of the sub-
gingival ﬂora can be helpful to estimate the risk of implantation
failure. Periodontal pathogenes, especially Actinobacillus actin-
omycetemcomitans (A.a.) show a high potential of transmission of
family members. The purpose was introducing A. a. transmis-
sion in a couple with implantation. We examined the presence
of periodontopathogenic bacteria prior the implantation of a 42-
years-old patient. The result was negative, a double Restore gol-
den implant was made for her, succesfully. After 10 months,
suppuration appear next to the implant.The result of the micro-
biological cultivation was positive for the A.a. In order to detect
the potential source of infection we collected four different sam-
ples from the husband. We made cultivation from the dorsum of
the tongue, the buccal mucosa, the tonsils and pooled samples
of three teeth. A.a. was isolated from all of the places except the
dorsum of the tongue.
Methodes: The purpose of the investigation was to study of restric-
tion endonuclease analysis (REA)-types present in the oral cavity
of A. a. positive subjects and to study the possibility of transmis-
sion of A.a. within families. DNA of A.a. isolates was digested
with a combination of the restriction endonuclease PstI and Bam-
HI, after which DNA fragments were separated by agarose gel-
electrophoresis.
Results: The result showed only one REA-type is present.
Conclusions: Elimination of the periodontal pathogens from the
patient’s and partner’s oral cavity before administering dental
implant treatment may inhibit colonisation by these pathogenes
and reduce the risk of peri-implantitis.
at TOC assessment
Abscess ETP P/T
EP yes 63/70 90% 66/71 93%
no 61/73 84% 54/67 81%
MITT yes 76/97 78% 80/98 82%
no 78/110 71% 77/108 71%
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P1672 The micro-organisms isolated from sinovial ﬂuid
N. Balaban, S. Suzuk, B. Urunal, H. Bodur, V. Yetener
Ankara, TR
Objectives: Infectious arthritis is an infection of sinovial ﬂuid
caused by several microorganisms and may cause serious compli-
cations including degenaration of the joint if remains untreated.
So, early diagnosis and appropriate theurepatic approachment is
very important in prevention of complications and sequels. The
identiﬁcation of microorganisms that cause arthritis constitude the
basement of appropriate antimicrobial threapy. In that study we
aimed to isolate and identify the microorganisms that cause arth-
ritis, from the specimens of sinovial ﬂuids that are accepted to
our laboratory.
Method: We analysed 189 sinovial ﬂuid specimen sent from sev-
eral wards for identiﬁcation of infectious agent that cause arthri-
tis, from May 2002 to September 2003. Each material is stained in
either Gram or Ehrlich–Ziehl Neelsen methods. All of the speci-
men were inoculated to human blood agar, EMB Agar, Leuwen-
stein-Jensen and Sabourad media and also incubated automated-
calorimetric BacT/Alert microbial detection system (bioMeriux,
France). Growing Gram-positive and Gram-negative bacteria
were identiﬁed by using VITEC and API identiﬁcation system.
The yeast form microorganisms were identiﬁed by using germ
tube test and API ID 32 C system lactophenol cotton blue stain is
used to identify the ﬁlamentous fungal elements.
Results: We isolated the infectious agent in 103 of 189 sinovial
ﬂuid specimen that sent to our laboratory. The frequecy of isola-
ted microorganisms are in that order; Staphylococcus aureus 53
(51.47%), coagulase-negative Staphylococcus 20 (19.43%), Strepto-
coccus spp. seven (6.79), Acinetobacter calcoaceticus four (3.88%),
Brucella mellitensis three (2.91%), Pseudomonas aeruginosa three
(2.91%), Klebsiella pneumonia three (2.91%), Proteus mirabilis two
(1.94%), Enterococcus faecium one (0.97%), Aerococcus viridance one
(0.97 %), Salmonella schutmuelleri one (0.97%), Enterobacter aero-
genes one (0.97%), Alcaligenes xylosus one (0.97%), Mycobacterium
tuberculosis one (0.97%), Candida tropicalis one (0.97%), Aspergillus
fumigatus one (0.97%). According these results; Staphylococcus spp.
are the most common (71%) infection agents in infectious arthri-
tis. We determined the methicillin resistance in 29 (39.7%) of the
isolated staphylococcus strains (18 of them are MRSA and 11 are
MRCNS)
Conclusions: It will be suitable to initiate the empirical theurapy
towards to Staphylococcus strains especiallly having methicillin
resistance regarding to underlying disease and patients’ clinical
situations.
P1673 Charasteristics of cutaneous anthrax in Turkey
N. Baykam, O. Ergonul, S. Eren, A. Kocagul, H. Hasman,
B. Dokuzoguz
Ankara, TR
Objective: To evaluate the epidemiologic and clinical characteris-
tics of 53 adult cutaneous anthrax cases.
Methods: The charts of the patients, who had been hospitalised
between 1992 and 2003 in the Infectious Diseases and Clinical
Microbiology Department of Ankara Numune Education and
Research Hospital, were reviewed.
Results: The mean age was 47 and 36% were female. The most
common professions were farmers (59%), butchers(20%), and
housewives (17%). The mean incubation period was 8 days. Most
of the cases (60%) exposed to bacteria when butchering sick ani-
mals. Sixteen patients used antibiotic before addmission to hospi-
tal (30%). The most common effected site of lesions were hand
(38%) and ﬁnger (32%). Other sites were arm (8%), eyelid (8%)
and neck (4%). Dissemination of lesion was seen in 28% of
patients. Gram stain was positive in nine cases and culture was
positive in ﬁve cases for Bacillus anthracis. All except one patient
discharged and treated with penicillin and ciproﬂoxasin. One
patient with disseminated lesion on neck died, although steroid
was used with antibiotic.
Conclusion: Cutaneous anthrax is still a public health problem in
Turkey. Cutaneous anthrax should be considered in any patient
with a painless ulcer with vesicles, oedema and a history of expo-
sure to animals or animal products. Penicillin and ciproﬂoxacin
were effective in treatment of anthrax.
P1674 Prevalence b-haemolytic streptococci from throat
swabs in health care area from Pontevedra, Spain
V. Pulian, M. Hernandez, P. Alvarez, M.A. Pascual, M. Garcia
Pontevedra, E
Objectives: b-haemolytic group A, and G Streptococcus are a major
cause of upper-respiratory infection such of pharyngitis and ton-
sillitis. We studied the prevalence of b-haemolytic group A, C and
G Streptococcus in pharyngotonsillitis in our area.
Material: All throat swabs collected from our health care area,
including paediatric population, during 11 months of 2003 were
plated to blood agar in aerobic athmosphere and CNA medium in
anaerobically conditions and incubated at 35C during 48 h. Test-
ing for Lanceﬁeld’s Group was realised by Streptex (Remel Eur-
ope Ltd, UK). In addition to culture, rapid detection of group A
Streptococcus was performed in 326 throat specimens (Abbot Test-
pack Plus StrepA).
Results: From January 2003 to December 2003 a total of 1411
throat swabs from patients with pharyngotonsillitis were studied.
b-haemolytic streptococci were isolated in 270 (19%) of them: 114
(8%) from group A, 115 (8%) from group C and 32 (2.3%) from
group G. Streptococcus group B were isolated in 9 (0.6%) Table 1.
Only 49 (15%) from 326 rapid test of group A antigen were posit-
ive, and the rest ones wich were negative showed in the culture
other b-haemolytic streptococci (group C and G) and normal ﬂora
of the upper respiratory tract.
Conclusions: These results show a similar prevalence of Streptococ-
cus group A (8%) and Streptococcus group C (8%) and lower pre-
valence of Streptococcus group G (2.3%) in studied patients with
pharyngotonsillitis. The results of the rapid test, only has been
useful in the 15% of the cases studied (326). Then, the prevalence
of another b-haemolytic nongroup A support the convenience of
use culture besides rapid test to study the aetiology of pharyngo-
tonsillitis.We also want to detach the importance of anaerobically
conditions to recover other b-haemolytics nongroup A.
P1675 Acute bacterial sinusitis: 43 cases of complications
D. Stoll and the ORLI group18
Objectives: To describe the observed complications (C) of acute
bacterial sinusitis in France, the underlying diseases (or condi-
tions), the pathogens involved, the surgical and medical manage-
ment, and the prognosis.
Methods: Prospective study conducted by six French hospitals
between November 2001 and March 2003 in patients older than
15 years and hospitalised with a diagnosis of a complicated com-
munity-acquired, presumed bacterial sinusitis. The clinical, radio-
logical and bacteriological data were collected with
documentation of the surgical and medical management. A des-
criptive statistical analysis was performed.
Results: This is the ﬁrst prospective study performed in France in
this area, with a collection of 43 cases of C. They were: ocular
(n ¼ 15), meningo-encephalic (n ¼ 16, of which 12 cases of menin-
gitis), sub-cutaneous (n ¼ 8) or combined (n ¼ 4). No risk factor
(tobacco consumption, diabetes mellitus, use of corticosteroids,
viral infection) was present. When an antibiotic treatment was
prescribed before the onset of the C, it was in adequation with
the French guidelines. The C were noted after a pan sinusitis
(involvement of all sinuses) in the majority of the cases, or after a
frontal or sphenoid sinusitis. The responsible pathogens were
identiﬁed in 53% of the cases, mainly Streptococcus spp., with or
without combination to anaerobic bacteria. In the meningitis cases,
S. pneumoniae was the main causative pathogen. The medical
treatments prescribed were in accordance with the recommended
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standards. Conversely, the surgical management was more hetero-
geneous. Cure was obtained in 60% of the cases with a mortality
rate of 2%. Sequels, essentially ocular, were not rare. Successive C
could occur, indicating the need for a prolonged clinical and
radiological follow-up.
Conclusions: In adults, severe C following bacterial sinusitis are still
observed, in spite of an adequate antibiotic treatment and a suscep-
tibility of the pathogens to the usual antibiotics, with a high morbid-
ity and a residual mortality. Obtaining the complete disappearance
of the C is unrealistic, however the present low rate can be expected
to be maintained by an adequate antibiotic treatment, in terms of
choice of the drug and respect of the treatment duration. A better
standardisation of the surgical management is warranted.
P1676 Distribution of sites of infection and T-types of
b-haemolytic streptococci group A during a period of
hyperendemicity in a Danish region
T. Ejlertsen, K. Ekelund, H.C. Schønheyder
Aalborg, Copenhagen, DK
Objectives: The peak incidence of infections due to b-haemolytic
streptococci group A (GAS) is during the winter. In the beginning
of 2003, we became aware of more GAS infections than expected,
which coincided with many reports of impetigo from general
practitioners (GPs). In order to ascertain the problem we under-
took a prospective survey of GAS infections during February and
March 2003 in the Danish County of North Jutland.
Materials and methods: The Department of Clinical Microbiology,
Aalborg Hospital provides diagnostic bacteriology to the County of
North Jutland (approximately 500 000 inhabitants) and serves
around 300 GPs and seven hospitals. Information related to positive
cultures was obtained from GPs and hospital physicians. T-typing
was done by the Streptococcus Unit, Statens Serum Institut, Copen-
hagen. Retrospective data was retrieved from the department’s
laboratory information system (ADBakt, Autonik, Sweden).
Results: During February–March 2003, we observed a total of 421
GAS infections (approximately 90/100 000), an increase of 75%
compared with the same two months in 2002 and 60% above the
average for these 2 months during the previous 6 years. Preschool
children accounted for 48%, the age group 7–14 years 20%, young
aged 15–24 years 2%. A second peak incidence occurred in the
age group of 30–39 years (11%). The skin was the most common
site of infections (36%), followed by the middle ear (24%) and
throat (23%). Perianal streptococcal infections (PASI) came fourth
in line (6%). We diagnosed 26 cases of PASI (12 boys, eight girls
and six adults); most children were below 5 years of age. The
predominant T-types were T1 (47%) and T28 (20%). T1 was more
prevalent in middle ear (64%) than throat (51%) and skin infec-
tions (37%), whereas T28 was more prevalent in PASI (50%) than
skin infections (25%), middle ear (12%) and throat (11%).
Conclusions: During a period of hyperendemicity of GAS infec-
tions we found two T-types to be predominant and the clinical
spectrum seemed to be linked to the particular T-type: otitis
media to T1, and skin infections (incl PASI) to T28. We have pre-
viously experienced a community outbreak of PASI (Pediatr Infect
Dis J (2003) 22, 105–109), and the current observations underline
that PASI continues to be a clinical problem possibly linked to the
high prevalence of T28.
P1677 Assessment of documentation of markers of sepsis
and appropriateness of antimicrobial prescribing in an acute
medical admission unit prior to and following the introduction
of a sepsis stamp
D. Robson, A.M. Cadwgan, K.D. Wares, R.B.S. Laing,
J.G. Douglas, A.R. Mackenzie
Aberdeen, UK
Objectives: To assess the quality of recording of markers of sepsis
prior to commencement of antimicrobial therapy and adherence
to local antibiotic guidelines in an acute medical receiving unit
prior to and following the introduction of a sepsis stamp in the
clinical notes.
Methods: Data was gathered from case notes of all patients admit-
ted to a medical receiving unit and receiving antibiotics within
24 h of admission over a ﬁxed period of time in winter 2002. The
study was repeated in winter 2003 following the introduction of a
clinical stamp for recording markers of sepsis, which was included
on the clerking sheet for all patients, the same data was collected
from this second group of patients and the results compared. The
presence or absence of sepsis and its severity was assessed using a
scoring system based on a relevant clinical history plus two or
more of the following (one point for each positive), temperature
>38C or <36C, pulse >90/min, respiratory rate >20/min, white
cell count <4 or >12, blood pressure systolic <90 mmHg or diasto-
lic <60 mmHg. Total score <2, no sepsis; 2, sepsis, >2, with evi-
dence organ dysfunction e.g. confusion, hypoxia, severe sepsis; >2,
with systolic BP <90 mmHg refractory to ﬂuid replacement, septic
shock. The appropriateness of the antibiotic prescribed and route
was assessed based on local antibiotic policy.
Results: A total of 629 patients were included in the initial study
in 2002 and 200 so far in 2003, which is still ongoing. The mean
ages in the two groups were 66.3 years and 60.1 years, respect-
ively, with a male:female ratio of 43:57 and 47:53. The recording
of sepsis markers in the two groups is shown in graph 1. The
stamp itself was fully completed for 8% of the patients, partially
complete in 9.5% and ripped out, ignored or covered in 82.5%.
Patients (50%) did not meet sepsis criteria in the ﬁrst study and
64% in the second with 64.5 and 60.4% of patients being pre-
scribed antibiotics via the intravenous route. The choice of antibi-
otic was in accordance with local guidelines in 55% of patients in
the initial study and in 49% in the follow-up.
Conclusions: Recording of sepsis markers is poor particularly with
regard to respiratory rate and white cell count. Introduction of a
sepsis stamp did not improve this or appear to inﬂuence antibi-
otic prescribing practice. Intravenous antibiotics are often pre-
scribed inappropriately and although antibiotic guidelines are
available they are often not used.
P1678 Levoﬂoxacin experience in a general hospital
J. De La Torre, J.L. Prada, A. Del Arco, J. Aguilar, F. Moreno,
N. Montiel, I. Lopez
Marbella, E
Objective: To analyse the clinical proﬁle and the outcome of
patients treated with levoﬂoxacin (LF) in our hospital.
Method: Retrospective and descriptive study of all the in-patients
treated with LV oral or intravenous in our centre from September
2001 to April 2002. We used a general database (without the
patient from emergency, critical care, paediatry and gynaecology).
Results: We used LF in 225 patients. Mean age 67  15 years
(range 24–99). Gender, 68% male, comorbility, 35% suffered from
chronic obstruction to airﬂow (COAF), 26% diabetes and 6% HIV
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infection. We detected 19% of penicillin allergic patients. There
were previous treatment with other antibiotic in 30%, that antibi-
otic was 50% a b-lactamic. In previous months 19.3% suffered
from upper respiratory-tract infection. Up than 80% of LF was
indicated by respiratory infection, which were pneumonia in 45%,
no pneumonia in 37% (60% COAF exacerbated), 6% sinusitis, 2%
urinary tract infection, 2% abdominal infections and 1% skin
infection. Bacteria isolated were obtained in 41 cases (19%): E. coli
(seven cases), Pseudomonas (six cases) and S. pneumoniae (ﬁve
cases). Respiratory insufﬁciency was present over 50%. In 44
patients intravenous therapy was initiated and followed during a
mean time of 2.7 3 days and was completed orally during a
mean time of 7.2  4.1 days. A second antibiotic was associated
in 18% of cases, mainly a b-lactamic. LF was suspended in 17%:
5% by worsening, 7% by side-effects, 4% by resistance. A total of
17 patients died (7.6%) and two needed critical care. Side-effects:
six patients (2%) suffered from diarrhoea, ﬁve from nausea and
two rash. Serum kalium was touched on 25 cases (11%) without
clinical relevance.
Conclusions: In our area LF is an antibiotic used commonly in res-
piratory infections and as unique drug. It is specially used in
penicillin allergic patients. Normally the treatment is started by
intravenous way switching quickly to treatment by mouth with
good tolerance.
P1680 Characterisation of Staphylococcus xylosus strains
isolated from humans clinical material
D. Kuboskova, I. Sedlacek, P. Svec, P. Petras
Brno, Prague, CZ
Objectives: Staphylococci are common inhabitants of skin, skin
glands and mucous membranes of mammals and birds. Certain
Staphylococcus species are found as aetiological agents of a variety
of human and animal infections as well. S. xylosus and S. equorum
represents two phylogenetically and biochemically close species.
Although S. xylosus is usually only transient on humans and is
primarily acquired from domestic animals and their products it
has been isolated from clinical material, mainly from urinary-tract
infections. It is difﬁcult to distinguish S. xylosus and S. equorum on
the base of the biotyping. S. equorum was isolated from animal
sources, but it has not been isolated from human clinical speci-
mens yet.
Methods: A group of 18 presumptive S. xylosus strains isolated
from human clinical specimens and reference strains (S. xylosus,
S. equorum and S. gallinarum) were analysed by biochemical tests
and ribotyping. Biochemical properties were tested by API Staph
and ID 32 Staph kits and by conventional tests. Ribotyping was
done with EcoRI and HindIII restriction enzymes and a probe
complementary to 16S and 23S rRNA from E. coli.
Results: Phenotypic data of key tests corresponded with species
description of S. xylosus except for one intermediate strain S. xylo-
sus/S. equorum. Some results obtained for acid production were
different from S. xylosus description, but identiﬁcation to the spe-
cies level was acceptable. Ribotyping with EcoRI divided tested
strains into two groups, the S. xylosus group and smaller group
which, as we supposed, belongs to the S. equorum species. This
group contained of two reference strains and four clinical isolates.
Group S. equorum was clearly distinguished also with HindIII, but
S. xylosus group was divided into three smaller groups by using
HindIII. Results of ribotype proﬁles did not correspond with bio-
chemical characterisation of the isolates.
Conclusions: There were identiﬁed 17 S. xylosus strains and one
intermediate strain S. xylosus/S. equorum by biochemical tests.
Contrary to biotyping, the colony size on the P agar and the ribo-
typing with both used restriction enzymes, showed, that four
strains from tested series represent S. equorum species. This is the
ﬁrst case of occurrence S. equorum in human clinical specimens.
Ribotyping with EcoRI and with HindIII showed heterogeneous
ribotype proﬁles. These results imply that this method could be
suitable for intraspecies characterisation of S. xylosus and S. equo-
rum.
P1681 Staphylococcus lugdunensis: an overlooked but easy
identiﬁable, frequent cause of abscesses in general practice
S. Bo¨cher, J. Prag
Viborg, DK
Objectives: Staphylococcus lugdunensis (Sl) is a coagulase-negative
Staphylococcus known as a rare cause of severe infections. As a con-
sequence of two serious infections we decided to optimise identiﬁ-
cation of Sl and make a comprehensive epidemiological analysis of
the Sl infections in Viborg County (population: 235 000), Denmark.
Methods: All specimens send to department of Clinical Microbio-
logy, Viborg County from July to December 2002 were included.
Specimens were inoculated on Columbia agar plates containing
5% sheep blood. Suspected staphylococci were identiﬁed by cat-
alase, slide coagulase test, colony phleomorphism, b-haemolysis,
and examined for a characteristic ‘Eikenella-like‘ smell after
2 days of incubation. Strains suspected to be Sl were examined
with API-ID-32-Staph. All cases positive with Sl were followed up
by a telephone interview with the general practitioners or by
reading the hospital records.
Results: When cultured on sheep blood agar, Sl develops a charac-
teristic smell on the second day of culturing. This smell together
with b-haemolysis and colony phleomorphism is very helpful as a
ﬁrst step screening for the presence of Sl in the routine cultures.
The total incidence of Sl infection in Viborg County was 4/10 000
per year. Sl infections were three times more common in general
practice than in hospitals. Sl was found in 13% of all microbiolog-
ically examined abscesses with bacterial growth from general
practice. Most patients were otherwise healthy. All patients nee-
ded antibiotics and/or surgical treatment. Most of the infections
were abscesses, and 70% of them were monocultures. The locali-
sation of the infections seems to be age dependent.
Conclusions: Calculated from our incidences 3–5% of the other-
wise healthy population will be Sl infected at least once during
their life span, and our ﬁndings are most probably a low estimate.
Sl is an important and common cause of abscesses. It should be
looked for and identiﬁed in all bacteriological examinations. Fur-
thermore the microbiologists should make all general practitioners
and hospital physicians acquainted with its name, the pathology
and the risk of serious complications.
P1682 Frequency and clinical spectrum of Staphylococcus
lugdunensis infections – a French national survey: preliminary
results
V. Blanc, R. Sanchez – Colle`ge de Bacte´riologie Virologie Hygie`ne
des Hoˆpitaux (ColBVH Study Group), France
Objectives: To evaluate frequency and clinical spectrum of Staphy-
lococcus lugdunensis infections in French general hospitals, over a
2-year period.
Methods: The ColBVH study group is a French network of 196
nonteaching sentinel hospitals. From January 2002 to December
2003, all correspondent laboratories of the group were asked to
declare via our website all cases of S. lugdunensis infection. Identi-
ﬁcation methods and susceptibility testing were performed as rou-
tinely by trained microbiologists. Clinical data were recorded in
view to describe the pattern of infections and to establish precise
clinical relevance of the isolates.
Results: A total of 94 cases of S. lugdunensis infection, correspond-
ing to 91 patients (56% males, median age 56 years), have been
recorded from 32 unlinked hospitals. The origin of the isolates are
skin and soft tissue (41), haemocultures (14), urine (nine), bone or
joint ﬂuid (nine), surgical wound (seven), i.v. catheter or pros-
thetic material (seven), various other sites (seven). S. lugdunensis
was isolated as a sole agent in 81% of cases. All but three cases
have been conﬁrmed as infections. Soft tissue abscesses (26) and
skin infections (19) are predominant (48% of the overall). The
other types of infection are: septicaemia (11), urinary-tract infec-
tions (eight), bone and joint infections (seven), surgical wound
infections (ﬁve), prosthetic material infections (ﬁve), endocarditis
(one), i.v. catheter-related infections (one), miscellaneous (ﬁve).
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The infection is nosocomially acquired in 31% of cases and associ-
ated with foreign device in 21%, mainly orthopaedic prosthetic
material (nine cases). 28% of the isolates are b-lactamase positive
and 2% are methicillin-resistant.
Conclusions: S. lugdunensis is now well recognized as a pathogen in
superﬁcial, but also deep serious infections. However, it may be dif-
ﬁcult for the laboratory to establish relationship between isolation of
S. lugdunensis and infection, as the bacteria is part of normal human
ﬂora, and may be isolated as colonising organism. Our survey was
conducted to evaluate the frequency of true S. lugdunensis infections,
and clinical data were collected and analysed in this aim. The pre-
liminary results conﬁrm the wide range of clinical patterns and
emphasise the predominance of skin and soft tissue infections. Fur-
ther investigations are actually conducted (i) to review the patients
medical records by and independant physician, (ii) to search for
virulence factors in the strains collected.
P1683 Changes in management and outcome of
Staphylococcus aureus bacteraemia 1996–2003
S. Bold, P. Vernazza, S. Henz, G. Eich
St. Gallen, CH
Objectives: Staphylococcus aureus is a common and important micro-
organism in modern medicine associated with increasing antibiotic
resistance. Mortality of S. aureus bacteraemia (SAB) has been repor-
ted to be as high as 30%. The aim of this study was to evaluate the
management, outcome and predictive factors of SAB between 1996
and 2003. The study also investigated the impact of the introduction
of an infectious diseases (ID) consult service in 2001.
Methods: All in-patients in the Cantonal Hospital St Gallen with
an episode of SAB between April 1996 and June 2003 were inclu-
ded. Exclusion criteria were: polymicrobial bacteraemia; only one
positive blood culture bottle without other signs of infection; if
SAB was not treated because of a terminal underlying disease, or
if the patients record was not available. We reviewed retrospec-
tively the patients records for demographic data, clinical course of
infection, underlying conditions, focus of SAB, treatment, compli-
cations and outcome. Treatment was considered to be adequate if
it was in accordance with the written guidelines of the ID service.
Results: Among 204 patients with SAB (136 community-acquired;
68 nosocomially acquired) 106 were cured, 41 (20%) died, nine
experienced a relapse, and 19 had persistent signs of infection. In
38 cases no outcome information was available. Risk factors for
mortality were sepsis or septic shock at presentation (P < 0.00001)
and age >65 years (P ¼ 0.04), but not inadequate treatment. In un-
ivariate analysis, inadequate choice of antibiotics (P ¼ 0.02) and
inadequate length of treatment (P < 0.001) were signiﬁcant predic-
tors of mortality. After the introduction of an ID consult service
the proportion of patients with inadequate treatment was signiﬁ-
cantly lower (P ¼ 0.03). Despite the improved management, mor-
tality was higher after the introduction of ID consultations.
However, we observed an increase in severity of disease and
underlying conditions during the same period. There was also an
increase in catheter related SAB (P < 0.001).
Conclusions: An increasing trend in severe cases of SAB was
observed over time. Improved management of SAB (adequate
selection of antibiotic drugs and appropriate length of therapy)
were associated with a better treatment outcome and with the
introduction of an ID consult service.
P1684 Clinical aspects and risk factors for mortality of
Staphylococcus aureus sepsis in a Swiss tertiary Centre
C. Kaech, L. Elzi, P. Sendi, R. Frei, U. Fluckiger
Basle, CH
Objectives: To analyse the clinical, therapeutic and microbiological
aspects of S. aureus (SA) sepsis occurring at the University Hospi-
tal Basel, with an emphasis on risk factors for mortality.
Methods: We retrospectively analysed the charts of 308 patients,
hospitalised between 1998 and 2002, who had a systemic inﬂam-
matory response syndrome and at least one positive blood culture
for SA. Bacteraemia due to MRSA was not analysed separately
since there were only six episodes (2%).
Results: We found 150 patients with community-acquired and 158
with nosocomial SA sepsis. 78 patients (52%) with community-
acquired infection had primary bacteraemia. The most common
focus for nosocomial SA sepsis was i.v. catheter-related infection
(96 episodes or 61%). There were 52 patients (17%) with endocar-
ditis. An infectious diseases (ID) specialist was consulted in 82%
of all cases. Empiric and deﬁnite antibiotic therapy were correct
in 77 and 88% of all episodes, respectively, according to the San-
ford Guide to Antimicrobial Therapy or to our written hospital
guidelines. The mean time between drawing blood cultures and
starting correct antibiotic therapy was 10.7 h. The most common
empiric therapy was amoxicillin/clavulanate; the most common
deﬁnite therapy was ﬂucloxacillin. 31 patients (10%) developed
septic shock, 70 (23%) had acute renal failure, and 73 (24%)
developed secondary infectious foci. ICU-care because of sepsis
was necessary in 66 patients (24%); 20 (6%) required mechanical
ventilation. Crude in-hospital mortality was 20%, the mean time
from the ﬁrst positive blood culture to death being 8 days. In
multivariate analysis, signiﬁcant risk factors for mortality were
age, alcoholism, chronic obstructive pulmonary disease, primary
SA bacteraemia, septic shock, and acute renal failure. Factors sig-
niﬁcantly associated with a better prognosis were i.v. catheter-
related infection as the source of bacteraemia and consultation of
an ID specialist.
Conclusions: Despite adequate antibiotic therapy and the progres-
ses of intensive care medicine, SA sepsis remains a serious infec-
tion with a high mortality. Notably, consulting an ID specialist
decreases the in-hospital mortality.
P1685 Microbiological results from a randomised,
open-label study of ertapenem vs. piperacillin/tazobactam
for the treatment of community-acquired intra-abdominal
infections requiring surgery
A. Dela Pena, W. Asperger, B. Warren, R. Kafka, R. Raz,
M. Shivaprakash, F. Vrijens, H. Giezek, C. Chan, M. Stek
Manila, PH; Halle, D; Parow, ZA; Innsbruck, A; Afula, IL Whitehouse
Station, USA Brussels, B
Objective: We compared the microbiological response rates of
ertapenem (ERT, a once-a-day parenteral group one carbapenem)
to that of piperacillin/tazobactam (P-T) in the treatment of IAI
requiring surgical intervention.
Methods: In an open-label, multicentre trial, 370 adults with clin-
ical and/or radiographic evidence of IAI who required surgery
were randomised to ERT 1 g or P-T 13.5 g daily for 4–14 days.
Appropriate specimens for aerobic and anaerobic cultures were
obtained at baseline and at the time of clinical failure if feasible.
Blood cultures were also collected throughout the study when
clinically indicated. The primary endpoint was the clinical efﬁcacy
in microbiologically and clinically evaluable patients 2 weeks
post-therapy [test of cure (TOC)]. Following the initial analyses, a
post hoc re-analysis was conducted after correcting for errors and
missing-data. Overall microbiological response required documen-
ted or presumptive eradication of all baseline intra-abdominal
and/or blood pathogen(s) in order to be favourable. Reported
here are the secondary endpoints of the post-hoc analysis examin-
ing the overall microbiological response rates and the clinical
response rates by baseline intra-abdominal or blood pathogen in
microbiologically and clinically evaluable patients.
Results: Baseline characteristics, median treatment duration
(6 days), and clinical response rates at TOC (>89%) were compar-
able in both treatment groups. 75.6 and 69.5% of all treated
patients in the ERT and P-T groups, respectively, had at least one
pathogen identiﬁed at baseline from IAI or blood cultures. The
large majority of baseline isolates, other than the infrequently
encountered isolates of P. aeruginosa and enterococci, were
susceptible to both study regimens. In the post hoc analysis, the
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overall microbiological response rates in the evaluable patients at
TOC were 95.2% for ERT and 93.2% for P-T [difference 1.9; 95%
CI (4.3, 8.6)]. Clinical response rates in evaluable patients at
TOC for the most common baseline pathogens are shown below.
Conclusion: The favourable microbiological response rates in
microbiologically evaluable patients treated with ertapenem were
similar to that of patients treated with piperacillin/tazobactam.
P1686 Ertapenem vs. piperacillin/tazobactam for the
treatment of intra-abdominal infections requiring surgical
intervention (OASIS-1): results of a prospective, randomised,
open-label study
A. Dela Pena, W. Asperger, F. Ko¨ckerling, R. Raz, R. Kafka,
B. Warren, M. Shivaprakash, F. Vrijens, H. Giezek, C. Chan
Manila, PH; Halle, Hannover, D; Afula, IL; Innsbruck, A; Parow, ZA;
Whitehouse Station, USA; Brussels, B19
Objective: We compared the efﬁcacy and safety of ertapenem (a
once-a-day parenteral group 1 carbapenem) to piperacillin/tazo-
bactam for the treatment of IAI requiring surgical intervention.
Methods: In a prospective, open-label, multicentre trial, 370
patients aged 18 years who had clinical and/or radiographic evi-
dence of IAI were randomised to either group A (n ¼ 180): er-
tapenem 1 g daily (i.v. or i.m.) or group B (n ¼ 190): P-T 3.375 g
Q6 h or 4.5 g Q8 h. Surgical intervention included open or laparo-
scopic surgery, and/or percutaneous intervention. The recommen-
ded treatment duration was 4–14 days. The primary endpoint was
the clinical efﬁcacy in microbiologically and clinically evaluable
patients 2 weeks post-therapy [test of cure (TOC)]. Following the
initial analyses, a post hoc re-analysis of the data was conducted
after correcting for errors and missing-data in the prior evaluabili-
ty determinations regarding nonstudy antimicrobials following
study therapy and follow-up data. Reported below are the results
of the post hoc analysis.
Results: Randomised patients [65.4% (242/370)] were protocol
evaluable at TOC. Baseline demographic and disease characteris-
tics of patients in both groups were generally similar. The most
common baseline pathogen isolated in both groups was E. coli
(A ¼ 54.4%; B ¼ 51.6%) while each of the others were isolated in
<10% of patients with the most prevalent one being B. fragilis
(A ¼ 8.9%; B ¼ 9.5%). Median days of therapy in all treated
patients were 6 days for both groups. Results on clinical cure
rates in protocol evaluable patients are included in table
below. The most common adverse events (AEs) in both groups
were pyrexia, diarrhea, vomiting and elevations of aminotransf-
erase levels. Discontinuation of therapy due to drug-related clin-
ical AEs was similar in both groups [1.7% (A), 1.6% (B)]. Six
patients (3.3%) in group A and three patients (1.6%) in group B
were reported to have a serious AE which was possibly, probably,
or deﬁnitely related to study drug.
Conclusions: These data demonstrated that ertapenem 1 g once a
day was as effective as piperaciilin/tazobactam for the treatment
of IAI requiring surgical intervention. Ertapenem was generally
well tolerated with comparable AE and discontinuation rates.
P1687 A prospective randomised trial comparing cefepime
plus metronidazole and imipenem-cilastatin for the treatment of
intra-abdominal infections
J. Garbino, P. Villiger, A. Caviezel, I. Uckay, P. Morel,
R. Matulionyte, A. Ondrusova, M. Puppo, D. Lew
Geneva, CH
Objectives: The objectives of the study were to do a comparison of
the efﬁcacy of parenteral cefepime plus metronidazole and imipe-
nem-cilastatin for the treatment of serious intra-abdominal infec-
tions in adult patients. They were also to obtain in-vitro
susceptibility data of pathogenic bacteria that cause intra-abdom-
inal infections.
Materials and methods: This was a prospective, randomised, com-
parative open study, conducted in a tertiary care hospital.
Patients: The patients included in the study were adults with a
clinically conﬁrmed diagnosis of intra-abdominal infections who
received either cefepime 2 g intravenously every 12 h in addition
to metronidazole 500 mg every 8 h or imipenem–cilastatin 500 mg
intravenously every 6 h.
Outcome: Complete clinical response was deﬁned as the absence
of pretreatment signs and symptoms of infection. Failure was
deﬁned as lack of changing or worsening of pretreatment signs
and symptoms of infection. Surgical infection management was
determined by the patients’ surgeon.
Results: A total of 122 patients were included in the study and 121
were evaluable (ITT). Sixty patients (33 men) received cefepime
plus metronidazole and 52 (87%) of them were cured; while 44
(72%) of 61 (27 men) patients in the imipenem–cilastatin arm
were cured (P ¼ 0.015). There were ﬁve failures in the cefepime
plus metronidazole arm and 16 failures in the imipenem–cilastatin
arm. Microbiological eradication was established in similar pro-
portions in both study groups (43 cefepime plus metronidazole
and 38 in the imipenem–cilastatin).
Conclusions: The results of the present study showed that cefepi-
me plus metronidazole was more effective than imipenem–cilasta-
tin in the treatment of intra-abdominal infections.
P1688 Microbiology and empirical treatment of pyogenic
liver abscesses: analysis of 105 cases
I. Terrancle, F. Mateos, L. Fuentes, R. Arjona, J.L. Pe´rez-Arellano,
B. Roca, F. Marcos, I. Ta´rraga, J.J. Blanch, A. Hdez-Belmonte,
E. Martı´nez-Alfaro from the Infectious Diseases Group of the
Spanish Society for Internal Medicine (SEMI20 )
Objectives: The aim of the present study was to analyse the micro-
biology of pyogenic liver abscesses (PLA) and to propose a more
effective empirical antibiotic treatment.
Methods: Multicentre and retrospective review of the PLA diagno-
ses and treated in six Spain’s hospitals during the year 1997–2003





Gram-negative aerobic bacilli 97/105(92.4%) 94/101(93.1%)
• E. coli 80/88(90.9%) 80/87(92.0%)
• K. Pnemoniae 10/12(83.3%) 4/4(100.0%)
• K. oxytoca 7/7(100.0%) 2/2(100.0%)
• Proteus mirabilis 5/5(100.0%) 4/4(100.0%)
• P. aeruginosa 11/11(100.0%) 5/6(83.3%)
Anaerobes 22/25(88.0%) 31/34(91.2%)
• Bacteroides spp 19/21(90.5%) 24/27(88.9%)
• Gram-positive Anaerobes 7/8(87.5%) 16/17(94.1%)
Gram-positive aerobic cocci 38/42(90.5% 29/32(90.6%)
Treatment Group
Ertapenem Piperacillin/Tazobactam
Time point Primary Post-hoc Primary Post-hoc
DCOT 129/132(97.7%) 131/131(100.0%) 117/121(96.7%) 117/122(95.9%)
TOC 107/119(89.9%) 116/124(93.5%)** 107/114(93.9%)* 110/118(93.2%)**
LFU 90/102(88.2%) 112/120(93.3%) 91/99(91.9%) 105/114)(92.1%)
*95%CI[-3.9(-11.5,3.4)]
**95%CI[0.3(-6.4,7.2)]
477Clinical Microbiology and Infection, Volume 10, Supplement 3, 2004
Results: A total of 105 patients with PLA were managed. Cultures
from blood and/or abscess cavity were performed in 72% (79/
105). In patients in whom culture/s were obtained, bacteria were
isolated in 94% (74/79). Gram-positive bacteria only were isolated
from 16% (17/79), Gram-negative bacteria only from 26% (27/
79), anaerobic bacteria only from 6% (six of 79) and polymicrobial
infection was present in 23% (24/79). Sensibilities of isolate bac-
teria to usual empirical antibiotic treatment were studied. Recov-
ered bacteria in patients with PLA were sensible to third-
generation cephalosporin with metronidazole in 77% and presen-
ted intermediate sensibility in 8%; to imipenem in 88% (interme-
diate: 10%); to ampicillin with gentamicin and metronidazole
were 75% (intermediate: 21%); to amoxicillin–clavulanete were
67% (intermediate: 21%) and to piperacillin–tazobactam were
70% (intermediate: 26%). Recovered bacteria presented more sen-
sibility to imipenem than to: amoxicillin-clavulanete (P ¼ 0.03;
RR ¼ 3.4), piperacillin–tazobactam (P ¼ 0.009; RR ¼ 3) and ampi-
cillin with gentamicin and metronidazole (P ¼ 0.05; RR ¼ 2.3).
Analysing bacterial sensibility to levoﬂoxacin with amoxicillin–
clavulanete was 97% (intermediate: 2.7%). Isolated bacteria have
more sensibility to levoﬂoxacin with amoxicillin–clavulanete than
to all the other studied empiric treatment: cephalosporin with
metronidazole (P < 0.01; RR ¼ 10.8), imipenem (P ¼ 0.02;
RR ¼ 5), ampicillin with gentamicin and metronidazole (P < 0.01;
RR ¼ 11.6), amoxicillin–clavulanete (P < 0.01; RR ¼ 17.4) and
piperacillin–tazobactam (P < 0.01; RR ¼ 15.3).
Conclusions: Recovered bacteria in PLA show better sensibility to
empiric treatment with Imipenem than amoxicillin–clavulanete
and piperacillin–tazobactam. The best theoretic empiric treatment
to PLA in this series is levoﬂoxacin with amoxicillin–clavulanete.
Additional investigations should be carried to conﬁrm the useful-
ness of levoﬂoxacin with amoxicillin-clavulanete.
P1689 Pyogenic liver abscess. A multicentre experience in
management
F. Mateos, I. Terrancle, R. Arjona, L. Fuentes, M. Hernandez,
B. Roca, F. Marcos, I. Ta´rraga, J.J. Blanch, E. Martı´nez-Alfaro
from the Infectious Diseases Group of the Internal Medicine
Spanish Society (SEMI21 )
Objectives: The aim of the present study was to examine our
experience over pyogenic liver abscess (PLA).
Methods: Multicentre and retrospective review of the PLA diag-
nosed and treated in six Spain hospitals during the year 1997–
2003 were studied. Statistical analysis was performed with the
SPSS software package.
Results: A total of 105 patients with PLA were managed. PLA was
more common in males (65%). The median age was 66 years
(range 28–91). Concomitant medical problems included diabetes
mellitus in 20 patients, neoplasm in four and transplantation in
two (one kidney and one liver). Most patients presented with non-
speciﬁc clinical and biochemical features. Preadmission, patients
were symptomatic for a median 17 days, with the most common
symptoms and signs being fever (84%) and abdominal pain/ten-
derness (67%). A raised ESR was the most common laboratory
found in about 86%. Ultrasonography was not as sensitive as
computed tomographic scans in detecting abscesses. Single lesions
were found in 70 patients, multiple lesions in 35. PLA occurring
more frequently in the right hepatic lobe (68%). The microorgan-
ism responsible was identiﬁed in 74 (71%) of the cases, with en-
terobacteria being the greatest number isolated. 52% of the
positive abscess cultures were polymicrobial. Escherichia coli was
the most common aetiological agent detected in cultures of blood
and abscess aspirates. Abscesses was classiﬁed by the presumed
route of hepatic invasion: (i) biliary tree (39, 37%), (ii) portal vein
(11, 9.5%), (iii) hepatic artery (11, 9.5%), (iv) direct extension from
contigous focus of infection (9, 8.6%) and (v) cryptogenic (35,
33%). All patients were treated with intravenous antibiotics. The
most commonly used antibiotic combination was a cephalosporin
3a G with metronidazole. Sixty-seven (63%) had both antibiotics
and radiologically guided percutaneous catheter drainage. All
these patients had abscesses with diameters measuring 2 or more
cm. Only 15 (14%) need surgery; 10 because another illness who
required surgery, four because of deterioration despite antibiotics
and drainage and two because of failure of percutaneous drain-
age. The case fatally rate was 9.5% (10).
Conclusions: PLA require a high index of suspiction for early diag-
nosis. Imaging techniques provide the main support in both the
diagnosis and treatment. When appropiate theraphy in the form
of antibiotics in combination with percutaneous drainage is
administered, morbility and mortality is low.
P1690 Two vs. four weeks ceftriaxone + metranidazol
treatment in percutaneously drained pyogenic liver absecess:
preliminary report
C. Agalar, S. Soylu, H. Donmez, F. Agalar, E. Tutuncu, S. Gul,
C. Diri, R. Turkyilmaz
Ankara, TR
Objectives: To evaluate the efﬁcacy of 2 week vs. 4 week antibiotic
treatment in percutaneously drained liver abscess.
Methods: This prospective randomised controlled study was con-
veyed on patients with limited number of pyogenic liver abscess
(<3), which can be drained by percutaneous techniques, and
infected cyst hydatid. The diagnosis was conﬁrmed by USG, CT,
Gram-stain examination and cultivation of drainage sample. Co-
exixtance with biliary obstruction and primary amoebic liver
abscess were exclusion criteria. All patients received ceftriaxone
(1 g b.i.d) + metranidazol (500 mg q.i.d). In the ﬁrst arm of the
study (n: 5), therapy was continued for 4 weeks, in the second
arm (n: 7), therapy was discontinued at the end of the second
week. Failure was deﬁned as inadequate drainage, responsiveness
to therapy, microbial resistance and need for open surgical inter-
vention. Repeat ultrasonographies were performed at 48, 96 h
after drainage procedure, 1, 3, 9 and 12 months, thereafter. All of
the patients were followed-up for at least 12 months.
Results: The groups were comparable regarding to the number,
diameter, and localisation of abscesses. All of the patients except
one were male. The duration of illness and convalescence period
did not differ between groups. The fever subsided after percuta-
neous drainage and antibiotic therapy, and subsidence did not
differ between groups. The cure rate was %100 in all of the
patients.
Conclusions: Despite the limited number of patients in the study,
it can be concluded that, 2 week period of antibiotic treatment is
effective as much as 4 week period, in adjunctive antibiotic of
pyogenic liver abscesses which are drained percutaneously.
P1691 Micro-organisms isolated from exit site of peritoneal
catheters in patients submitted to chronic ambulatory peritoneal
dialysis
E. Garcı´a-Pen˜uela, A. Perez de Ayala, D. Domingo, D. Monclus,
A. Cirugeda, M. Lopez-Brea
Madrid, E
Chronic ambulatory peritoneal dialysis (CAPD) is an alternative
to haemodialysis for patients with chronic renal failure and has
been a remarkable breakthrough in the management of these
patients. Many patients develop infection and its origin in most
cases appears to be contamination of the catheter by common skin
organisms.
Aim: The aim of this study was to know the microorganism that
infected the skin exit site of the catheter in patients submitted to
CAPD during a 4-year period.
Material and methods: A total of 817 samples obtained from 130
patients with suspicion of infection were processed. Skin swabs
from the exit site of peritoneal catheter were inoculated into agar
and chocolate plates and thioglicolate medium and incubated at
350C in O2 and CO2 atmospheres, respectively, for 48 h. Microor-
ganisms were identiﬁed and susceptibility performed using con-
ventional methodology.
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Results: A total of 704 samples (86.1%) were positive and 113
were negative (18.4%). The microorganisms isolated were as fol-
lows: 373 Corynebacterium sp. (52.9%), 149 Staphylococcus epider-
midis (21.1%), 39 other coagulase-negative Staphylococcus (5.5), 26
S. aureus (3.6%), 20 Escherichia coli (2.8%), 28 other Enterobacteria-
ceae (3.9%), 26 Pseudomonas aeruginosa (3.6%), 16 yeasts (2.2%),
six Streptococcus sp. (0.8%), and 10 other microorganisms (3.6%).
In 55 patients more than one microorganism was identiﬁed as
cause of infection.
Conclusions: A great percentage of samples obtained from patients
with suspicion of infection in the catheter insertion site yielded a
positive growth of a microorganism. More than 75% of the micro-
organisms isolated were related to those bacteria commonly found
in the skin (Corynebacterium sp. and Staphylococcus sp.).
P1692 Vertebral osteomyelitis in patients with
HIV-infection
M.E. Jime´nez-Mejı´as, J.D. Colmenero, C. Lo´pez Casanova,
J.D. Ruiz-Mesa, J. Palomino-Nica´s, J.M. Reguera Iglesias, A. Plata,
J. Pacho´n-Dı´az
Seville, Ma´laga, E
Objetives: To study the epidemiologic, clinical and diagnostic fea-
tures, and treatment and prognosis of vertebral osteomyelitis (VO)
in patients with HIV infection.
Patients and methods: Multicentre, prospective, transverse and des-
criptive study of 447 cases diagnosed of VO between January 1983
and October 2003. Inclusion criteria: (i) spinal inﬂammatory pain,
or fever and spinal pain on physical examination and (ii) imaging
ﬁndings compatible with VO and (iii) aetiologic diagnosis.
Results: Twenty patients of the total cases of VO (4.5%) were diag-
nosed of HIV infection. Seventeen were male (85%) and the mean
age was 31.6±6 years22 . All patients were drug addicts. Primary
infection foci: skin ﬁve (25%), lung three (15%), gastrointestinal
tract two, cardiovascular system two, osteoarticular two. In six
patients no previous infection was found. Previous bacteraemia:
four cases (20%). vertebral level affected: two cervical (10%),
seven dorsal (35%) and 11 lumbar (55%). The mean duration of
symptoms prior to diagnosis was 82.75O´175.2 days23 . Clinical fea-
tures: fever 17 cases (85%), inﬂammatory pain 16 (80%), constitu-
tional symptoms 11 (55%), neurological deﬁcit eight (40%). Blood
cultures were positives in ﬁve of 10 cases (50%), bone biopsy in
eight of 12 (67%), and adjacent infectious foci cultures in 100%
(14/14). Causal agents isolated: Staphylococcus aureus 10 (50%), My-
cobacterium tuberculosis six (30%), Salmonella spp. two (10%), Strept-
coccus pneumoniae one and polymicrobial aetiology one. Fifteen
patients (75%) had involvement of two or more vertebral bodies,
13 (65%) paravertebral masses, nine (45%) epidural abscesses and
four (20%) psoas abscesses. Eight cases (40%) required surgical
treatment. Four patients (20%) showed therapeutic failure (two
medical and two surgical failures). Five cases (25%) had severe
functional sequelae.
Conclusions: Previous bacteraemia or infection are frequent. VO in
HIV patients is caused by a variety of organisms. These results
strongly suggest the necessity of aetiological diagnosis. Diagnostic
yield of microbiological techniques is very high. Paravertebral and
epidural abscesses are frequent.
P1693 Imipenem-cilastatin treatment of osteoarticular
infections caused by multiresistant Gram-negative rods
M. Rottman, J.-N. Martin, P. Leclerc, E. Ronco, A. Lortat-Jacob,
J.-L. Gaillard, P. Piriou
Garches, Boulogne Billancourt, F
The emergence of multidrug resistant Gram-negative bacilli sus-
ceptible to hardly any b-lactam compound has led to infections
close to a therapeutic dead end. In such circumstances, imipe-
nem–cilastatin (I-C) is often the only remaining therapeutic
option. We report our experience with the prolonged administra-
tion of high-doses of I-C in the treatment of osteo-articular infec-
tions with bacteria resistant to other b-lactam agents (or fourth
generation cephalosporins in 14 cases). Our retrospective study
over 7 years included 29 patients with septic arthritis (n ¼ 3) con-
tinuous osteitis (n ¼ 6), septic nonunion (n ¼ 12) and prosthetic
joint infections (n ¼ 8). Treatment included an extensive surgical
debridement and postoperative combination antibiotherapy with
intravenous I-C and aminoside (54%) and/or ﬂuoroquinolones
(46%) and/or phosphomycin (29%). Associated microorganisms
requiring yet additionnal antimicrobial agents were associated in
17 (59%) cases. I-C was maintained for an average of 46 days
(extremes 21–90), at an average dose of 3.8 g/day (extremes 2–6).
The bacteria warranting I-C were cephalosporinase hyperproduc-
ing Enterobacter cloacae (38%), extended spectrum b-lactamases
producing enterobacteria (31%), Pseudomonas aeruginosa (21%)
and/or Acinetobacter baumanii (21%). Early outcome was favour-
able in 24 patients (82%). Two patients relapsed with the bacteria
requiring I-C, failure and two failed to negate succion ﬂuid cul-
tures: one was discharged with no change in his condition, one
agreed to a leg amputation and the third died of candidemic sep-
tic shock while still bacteriologically positive. Repeated secondary
colonisation and infection with yeasts led to a monitoring of yeast
load. per os amphotericin B and immediate treatment of urinary
colonisation prevented further systemic candidal infections. No
other tolerance incidents were noted. Acquired resistance
occurred only once in a P. aeruginosa isolate while imipenem–ci-
lastatin was chosen to cover an ESBL producing Escherichia coli.
Secondary treatment with ceftazidime was then successful in
eradicating P. aeruginosa. I-C has been widely used for the treat-
ment of mixed ﬂora infections as a wide spectrum antibiotic. We
report good tolerance of high posology long-term administration
in documented osteoarticular indications if yeast colonisation is
properly monitored, and eradication rates are comparable with
those reported in infections with susceptible bacteria.
P1694 Staphyloccocus aureus vs. Gram-negative bacilli
pyogenic vertebral osteomyelitis. A clinical, biological and
radiological comparative study
M.A. Baro´n Ramos, E. Jimenez Mejı´as, J.D. Ruiz Mesa,
J. Palomino-Nica´s, J.M. Reguera Iglesias, J. Chaco´n, J. Pacho´n,
J.D. Colmenero
Ma´laga, Seville, E
Objectives: Our aim was to deﬁne the possible clinical, biological
and radiological differences between the pyogenic vertebral osteo-
myelitis (PVO) produced by S. aureus (SAVO) and Gram-negative
bacilli (GNBVO), in order to identify an ‘aetiological predictor
proﬁle’ that allows us to initiate empirical treatment when the
aetiological agent causing the PVO has not been able to identify.
Methods: We reviewed a large series of 208 cases of PVO diag-
nosed, treated and followed up homogenously in two tertiary care
centers. Of the total of the sample 83 cases (39.9%) and 41
(19.7%) were SAVO and GNBVO, respectively. The clinical, biolo-
gical and radiological features were compared for these two
groups. Coagulase-negative Staphylococcus and polimicrobial PVO
were excluded.
Results: E. Coli was the most common isolated bacterium trough
the GNBVO group followed by Pseudomona aeruginosa (16 and 11
cases, respectively). Meticilin-resistant S. aureus (MRSA) was
found in 21 cases (25.3%) and it was related with previous spinal
surgery (P ¼ 0.05). The mean age was higher in the GNBVO
patients than in those with SAVO (57.93  14.64 years vs.
50.00  16.45 years) (P ¼ 0.01). A previous either urinary or gas-
trointestinal infection was more frequent in the GNBVO group
whereas a cutaneous or a soft tissue infection was found to be sig-
niﬁcatively more frequent in the SAVO group (P ¼ 0.001). We
could not ﬁnd other relevant differences among the other features
analysed. The age and a previous infection remained statistically
different after the multivariant analysis.
Conclusion: GNBVO represents an important percentage of PVO.
In postsurgical PVO, MRSA incidence is considerable. A higher
age and a urinary or gastrointestinal infection preceding the PVO
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was signiﬁcaly related with a GNB aetiology. Therefore, in this
case empirical antimicrobial treatment should cover GNB when
PVO is diagnosed and the aetiologic agent has not been able to be
identiﬁed.
P1695 Characterisation of Salmonella paratyphi A strains
with reduced susceptibility to quinolone isolated from an
outbreak in Korea
S. Lee, D. Kim, C. Chang, H. Kim
Busan, KOR
Objective: Infections with Salmonella paratyphi possessing reduced
susceptibility to quinolone may compromise the effectiveness of
ciproﬂoxacin therapy that has been regarded as the drug of choice
for paratyphoid fever in Korea before. The purpose of this study
was to examine the antibiotic susceptibility and to characterise the
resistance mechanism of the S. paratyphi A isolates with decreased
susceptibility to quinolone isolated from an outbreak in Korea,
and to determine if the isolates were genetically similar or clonal.
Methods: A total of 10 clinical isolates of S. paratyphi A, nine from
an outbreak and one as control were used. Antibiotic susceptibil-
ity of S. paratyphi A to ampicillin, cephalothin, ceftriaxone, gen-
tamicin, tetracycline, chloramphenicol, nalidixic acid, oﬂoxacin,
ciproﬂoxacin and moxiﬂoxacin were determined by microdilution
broth test. The mutations that are responsible for quinolone resist-
ance in gyrA, gyrB, parC, and parE genes of S. paratyphi A were
investigated using PCR ampliﬁcation and DNA sequencing of the
quinolone resistance determining regions. Reserpine, a known
efﬂux pump inhibitor, was used to determine whether an efﬂux-
mediated mechanism contributed to reduced susceptibility to
quinolone. Pulsed-ﬁeld gel electrophoresis were performed to
examine the clonal relatedness of the isolates.
Results: Among seven patients, three with ciproﬂoxacin therapy
showed no clinical responses and required retreatment with ceftri-
axone. Four patients treated with ceftriaxone as initial empirical
therapy had successful clinical reponses. All isolates were sensitive
to ampicillin, cephalothin, ceftriaxone, gentamicin, tetracycline,
chloramphenicol. The MICs of the quinolones of the clinical iso-
lates with reduced susceptibility to quinolone exhibited as follows:
nalidixic acid >1024 mg/L, oﬂoxacin 2 mg/L, ciproﬂoxacin 2 mg/
L, moxiﬂoxacin 2 mg/L. The sequence of QRDR of the gyrA gene
had a single mutation at position 83 (from TCC to TTC:from Ser to
Phe), but no mutations were found in the gyrB, parC, and parE
genes. Reserpine did not effect the MICs for ciproﬂoxacin, nalidixic
acid, oﬂoxacin and moxiﬂoxacin. PFGE analysis revealed identical
patterns in all isolates.
Conclusions: The sequence of the QRDR of gyrA in S. paratyphi A
strains with reduced susceptibility to quinolone which were isola-
ted from an outbreak had a single mutation at the Ser-83, and no
mutations were found in the gyrB, parC and parE genes.
P1696 Rise in isolation rates and nalidixic acid resistance
in Salmonella hadar due to common strains among poultry and
humans
L. Politi, P.T. Tassios, L.S. Tzouvelekis, M. Lambiri, A. Kansouzi-
dou, M. Pasiotou, K. Mellou, N. Vakalis, J. Kourea-Kremastinou,
T. Panagiotopoulos, N.J. Legakis
Athens, Thessalonica, Halkida, GR
Objectives: Recently, the isolation rates of Salmonella hadar have
placed it among the major foodborne serotypes in Greece. Whilst
there was no resistance to clinically important drugs, such as cefo-
taxime and ciproﬂoxacin, resistance rates to other drugs, including
tetracycline and nalidixic acid, were high. Our aim was to study
the resistance patterns and the genotypic diversity among human
and animal isolates of this serotype during 1998–2001, and investi-
gate the possible relationship of the resulting chromosomal types
with speciﬁc resistance phenotypes.
Methods: The study sample consisted of all human isolates from
1998 to 2001 (43 in total: 2, 4, 14 and 23 from 1998, 1999, 2000 and
2001, respectively) and all animal or animal feed isolates from
2000to 2001 (19 in total: two and 17 from 2000 and 2001, respect-
ively). Their susceptibility to 17 antimicrobial drugs [ampicillin
(Am), amoxicillin/clavulanic acid (Amc), ceftazidime (Caz),
cefotaxime (Ctx), amikacin (An), gentamicin (Gm), kanamycin (K),
netilmicin (Net), streptomycin (S), tobramycin (Tm), chloramphen-
icol (C), tetracycline (Te), sulphonamides (Sss), sulphomethoxaz-
ole/trimethoprim (Sxt), trimethoprim (Tmp), ciproﬂoxacin (Cip),
nalidixic acid (Na)] was tested on Mueller-Hinton agar by a disc-
diffusion assay according to NCCLS guidelines. PFGE of XbaI-
digested total DNA was performed in 1% agarose/0.5x TBE, in a
CHEF DRIII apparatus.
Results: All isolates were susceptible to Caz, Ctx, An, Gm, Net,
Tm, Cip. Resistance rates to other drugs ranged from 2% (C, Sss,
Sxt, Tmp) to 95% (Te). Resistance to nalidixic acid was at 90%.
The dominant resistance phenotypes among human isolates, Na-
STe and AmNaSTeAmc, ranged from 0 and 50% in 1998, to 78
and 13% in 2001. PFGE-distinguished three types (A–C), with
eight subtypes in type A. The majority of human isolates
belonged to subtypes A4 (40%), A2 (23%) and A3 (21%), predom-
inantly associated with isolates expressing resistance phenotypes
NaSTe (100%), NaSTe (70%) and AmNaSTeAmc (56%), respect-
ively. The majority of animal isolates belonged to subtypes A4
(79%) and A2 (11%), to which belonged all isolates with resist-
ance phenotypes NaSTe and KNaSTe, respectively.
Conclusions: The recent rise in S. hadar from human infections was
reﬂected by its rise amongst poultry isolates. Nalidixic acid resist-
ant S. hadar strains causing human gastroenteritis were indistin-
guishable, by PFGE, from poultry strains.
P1697 Investigation of clinical and laboratory ﬁndings of
antibiotic-associated diarrhoea
N. Yapar, A. Sener, B. Karaca, M. Yu¨cesoy, H. Tarakci, N. Cakir,
A. Yu¨ce
Izmir, TR
Objectives: The purpose of this study is to investigate the clinical
and laboratory ﬁndings including the spesiﬁc culture for C. difﬁcile
and toxin detection in stool specimens of patients with antibiotic
associated diarrhoea (AAD).
Methods: Between June 1998 and December 2003, 288 patients
were hospitalised with the diagnosis of AAD in our hospital. We
noted the patients’ age, gender, history of antibiotic usage, symp-
toms, physical ﬁndings (fever and degree of dehidratation), labor-
atory ﬁndings, and therapy costs. Direct microscopic examination
and routine culture of stool specimens were performed in all
patients. Toxin detection and spesiﬁc cultures could have been
performed only in 88 of the patients. Detection of toxin A was
performed by ELISA and we used cycloserin-cefoxitin-fructose-
agar for isolation of C. difﬁcile.
Results: Of the patients, 162 (56.2%) were male and 126 (43.8%)
were female. Their mean age was 40  3.0 years and mean dur-
ation of hospitalisation was 3  1.0 days (minimum 1–maximum
7). Most common symptoms were bloody diarrhoea (99.3%), tenes-
mus and/or abdominal discomfort (61.1%), and vomiting (37.5%).
Mild to moderate dehidratation (108 patients 36.8%), severe dehy-
drataion (two patients), and fever (one patient) were main clinical
ﬁndings. The patients with severe dehydratation have suffered
from colon cancer and the antibiotic therapy was initiated in the
hospital. Rest of the patients had no comorbid factors and all of
them had a history of previous oral outpatient antibiotic usage.
The time interval between antibiotic use and the onset of symp-
toms was 7 days in most of the patients (86%); mean time was
9  1.0 days. Sulbactam ampicillin was the most common agent
noted (76%). Neither toxin A positivity nor C. difﬁcile isolation
from the stool specimens were obtained. We also compared the
costs of these diagnostic procedures and therapeutic approaches
and saw that toxin A detection and spesiﬁc culture for C. difﬁcile
resulted an increase of 72 Euro cost per patient.
Conclusions: In our study, we observed that in most of the patients
with AAD, the disease had begun 7 days after the antibiotic use
and symptoms had been resolved within 3 days. Patients recov-
ered before the results of toxin tests and stool cultures were avail-
able and these procedures increased the cost of therapy.
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P1698 Serotyping and susceptibility testing of Shigella
isolates during summer outbreak of 2003 in an Iranian hospital,
Tehran
M. Rahbar, K. Bahar, B. Kia Darbandisari, M. Deldari
Tehran, IR
Objectives: The aim of this study was to determine serotyps and
susceptibility testing of Shigella isolates in Milad Hospital during
summer of 2003.
Methods: From June to October 2003 in total 669 stools and rectal
swabs from patients admitted to clinics of milad hospital were
sent to microbiology laboratory. All specimens were examined
microscopically and inoculated into bacteriological culture media
for isolation of enteropathogens. All isolated bacteria conﬁrmed
by biochemical methods and isolated Shigella species seotyped by
antisera (Bahar Afshan Company). Susceptibility testing per-
formed my disc-diffusion method as recommended by National
Committee for Clinical laboratories Standards (NCCLS M2-A7,
M100-S12).
Results: Of 669 specimen 55 specimens yielded Shigella species In
our study S. sonnei was the most prevalent serotype and accoun-
ted for (76.3%) of all isolates. The second prevalent serotype was
S. ﬂexneri with seven (12.2%) isolates followed by S. boydii and S.
dysenteriae each three (5.45%) isolates. The majority of patients
were children under 14 years old (85.5%). The mean age of
patients was 9.8 years (SD 16.3). Microscopical examination
showed leucocyte and erythrocyte in 80% of cases. More than
80% of isolates were resistant to ampicillin, trimethoprime–sul-
phametoxazole and tetracycline. The rate of resistance to nadixic
acid ciproﬂoacin cefotaxim, ceftrixone and amikacin were 11.7, 2,
2 and 9%, respectively.
Conclusion: It is concluded that S. sonnei was the prevalent sero-
types isolates in our hospital and there was a higher rate of
resistance to ampicillin, trimethoprime–sulphamethoxazol and tet-
racycline among isolates of Shigella serotypes in our hospital.
P1699 Characterisation, genomic location and distribution
of the cytolethal distending toxin genes in Shiga toxin-
producing Escherichia coli strains of non-O157 serogroups
M. Bielaszewska, M. Fell, L. Greune, R. Prager, A. Fruth,
H. Tscha¨pe, M.A. Schmidt, H. Karch
Munster, Wernigerode, D
Cytolethal distending toxins (CDTs) are a novel family of protein
toxins which interfere with the cell cycle of a broad spectrum of
mammalian cells and are produced by multiple pathogens. In this
study we used polymerase chain reaction (PCR) to target various
cdt alleles among 340 Shiga toxin-producing E. coli (STEC) human
isolates (130 eae-positive and 210 eae-negative) belonging to 100
different non-O157 serotypes. cdt was identiﬁed in 17 strains
which belonged to serotypes O73:H18, O91:H21, O113:H21, and
O153:H18, and were all eae-negative. Southern blot hybridisation
and sequence analysis demonstrated that in STEC of serotypes
O73:H18, O91:H21, and O113:H21 cdt is located on the chromo-
some and is closely related to cdt-V from STEC O157:H-. In con-
trast, in STEC O153:H18, cdt is on a large plasmid and is identical
to cdt-III from necrotoxigenic E. coli. cdt-I, cdt-II and cdt-IV alleles
were not identiﬁed. Supernatants of each of 17 cdt-positive STEC
progressively distended and subsequently disintegrated Chinese
hamster ovary (CHO) cells. No CDT activity was detected by the
CHO assay in any of the remaining 323 STEC strains that were
PCR-negative for cdt-I, cdt-II, cdt-III, cdt-IV and cdt-V suggesting
that no additional cdt allele undetectable by the PCR approaches
used occurred among the STEC strains investigated. Our data
demonstrate that two different cdt alleles with different genomic
locations encode biologically active CDT in STEC of particular
non-O157 serotypes. Among eae-negative STEC, cdt was associ-
ated with disease (haemolytic uraemic syndrome or diarrhea) vs.
asymptomatic infection (P ¼ 0.003) suggesting that CDT might
contribute to the pathogenicity of these organisms.
P1700 Vibrio cholerae in the south-east of Iran
H.A. Khazaei, N. Rezaei, G.R. Bagheri
Zabol, Tehran, IR
Objectives: Cholera continues to be an important public health
problem among many poorer communities, despite the bacterio-
logy and epidemiology of the disease having been described over
a century ago. In order to determine the prevalence of Vibrio chol-
erae in the southeast of Iran, this study was performed.
Methods: A total of 2466 patients with watery diarrhoea were
referred to the all hospitals related to Zabol Faculty of Medicine,
Sistan-Blouchestan province, situated in the south-east of Iran,
during 3 years (July 1998–October 2000).
Results: V. cholerae strains were isolated from 193 samples (7.83%).
All ages and social and economic strata were affected. Twenty-
seven per cent of all isolates were from children under the age of
5 years. Among these patients (116 males and 77 females), only 19
cases live in an urban area (9.8%). A total of 143 cases with chol-
era had been referred from rural area (74.1%), and the remaining
31 subjects came from neighbour country, Afghanistan (16.1%).
Eighty-one of these patients were among Afghan population
(41.9%). Of these 193 isolates, 179 were found to be V. cholerae O1
Ogawa strain (92.7%) and 14 were conﬁrmed to be V. cholerae
O139 (7.2%). Inaba and Hikojima sero-subtypes did not found in
our investigated patients. A total of 130 were inpatients and the
remaining 63 were outpatients. Six of these patients (3.11%) had
died because of the severity of their disease, severe dehydration
and electrolytes imbalance.
Conclusions: Priorities for cholera control remain public health
interventions through improved water and sanitation, improved
surveillance and access to healthcare facilities, and further devel-
opments in appropriate vaccines.
P1701 Neonatal septicaemia in dogs by Klebsiella
pneumoniae
A. Madio, G. Greco, M. Corrente, M. Totaro, C. Desario,
M. Campolo, G. Marsullo, D. Buonavoglia
Valenzano, Naples, I
Objectives: An outbreak of septicaemia in young dogs in a kennel
caused by a multiresistant strain of Klebsiella pneumoniae is des-
cribed.
Methods: Forty-ﬁve pups from 10 litters of ‘Pointer’ breed were
affected by severe respiratory signs and septicaemia about 3 days
after birth. The mortality rate of 100% was observed. The bitches
were healthy and they were usually fed with foodstuffs from a
hospital’s dining room. At necropsy the organs of the animals dis-
played haemorrhagic lesions. Samples of spleen, liver, kidney,
lungs and intestines of 10 pups and faecal and pharyngeal swabs
collected from the bitches were cultured on sheep blood agar,
McConkey (McC) agar, and brain–heart infusion agar. The organ-
isms were identiﬁed by a commercial micromethod (api-20E sys-
tem) and biochemical tests. The strains were tested for
susceptibility to 16 antimicrobics by disc agar diffusion method
and to genotyping by random ampliﬁed polymorphic DNA
(RAPD) analysis.
Results: Gram negative rods, nonhaemolytic, lactose-positive on
McC were identiﬁed as K. pneumoniae and were isolated from all
the organs of the puppies and from the swabs collected from the
bitches. The isolates exhibited the same antibiotype: resistant to
ampicillin, amoxicillin/clavulanic acid, azlocillin, bacitracin, ci-
proﬂoxacin, gentamicin, metronidazole, norﬂoxacin, cotrimoxaz-
ole, sulphonamide, streptomycin, oxacillin, tetracycline and
susceptible to imipenem and cefuroxime. The strains isolated from
the lungs and liver of the pups and from faecal and pharyngeal
swabs of the bitches displayed the same RAPD proﬁle.
Conclusions: K. pneumoniae is a common pathogen of humans, usu-
ally responsible for hospital-acquired infections. In dogs K. pneu-
moniae is rarely detected and generally it is not associated with
severe clinical signs. As the dogs were fed with foodstuffs from
a hospital’s dining room, the canine isolates might have a
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food-borne origin. The authors hypothesise that K. pneumoniae col-
onised the oropharynx of the bitches, and it was transmitted to
the puppies at the birth. Subsequently, the infected puppies devel-
oped a severe and fatal septicaemia.
Quinolones in vitro studies
P1702 Lower levels of in vitro nonsusceptibility to
Moxiﬂoxacin compared with other ﬂuoroquinolones in
Canadian clinical isolates of Streptococcus pneumoniae
J. Powis, J. Fuller, O. Vanderkooi, K. Green, D. Low – Canadian
Bacterial Surveillance Network24
Objectives: Increasing ﬂuorquinolone resistance in Streptococcus
pneumoniae (SPN) and concurrent treatment failures have led to
concerns about the activity of this class of antimicrobials. We ana-
lysed the in vitro activity of commonly used ﬂuoroquinolones
against clinical pneumococcal isolates from Canada to determine
the evolution of resistance to these agents.
Methods: SPN isolates were collected by the Canadian Bacterial
Surveillance Network, which is comprised of private and hospi-
tal-afﬁliated laboratories from across Canada. Laboratories were
asked to collect a deﬁned number of consecutive clinical isolates
followed by all sterile site isolates of SPN. In vitro susceptibility
testing was performed by broth microdilution using NCCLS
guidelines. Resistance to ciproﬂocacin was based on a MIC of
4 lg/mL. Genetic mutations in the parC and gyrA loci were
examined by molecular methods.
Results: A total of 13 408 clinical isolates, including all patient age
groups, were obtained from across Canada between 1996 and 2002.
In vitro susceptibility data are listed in the table below. There was
a signiﬁcant increase in nonsusceptibility to all ﬂuoroquinolones,
except moxiﬂoxacin, from the year 2000 to 2002 (P < 0.005). Fewer
isolates were nonsusceptible to moxiﬂoxacin than ciproﬂoxacin or
levoﬂoxacin (P < 0.05) in the year 2002. A total of 37 isolates not
susceptible to levoﬂoxacin were susceptible to moxiﬂoxacin.
Sequence analysis of parC and gyrA from 16 of these isolates
revealed that 14 (87.5%) and seven (43.8%) contained point muta-
tions in either parC or parC and gyrA, respectively.
Conclusions: Oxiﬂoxacin, which preferentially targets gyrA, appears
to be associated with lower levels of in vitro nonsusceptibility at
present, compared with parC targeted agents. With increasing non-
susceptibility to all other ﬂuoroquinolones tested from 2000 to 2002,
moxiﬂoxacin has not had a signiﬁcant increase in nonsusceptibility.
These ﬁndings may be explained by the improved activity of mox-
iﬂoxacin against isolates with parC mutations, and possibly parC/
gyrA double mutations. As the number of SPN isolates in Canada
with parC mutations increases, the utility of gyrA targeted agents
may become increasingly important.
P1703 Comparative bactericidal activity of moxiﬂoxacin,
gatiﬂoxacin, garenoxacin, and levoﬂoxacin at concentrations
simulating Cmax and 1/2Cmax
H. Musgrave, S. Campbell, C. Howley, R.J. Davidson
Halifax, CAN
Objectives: The ﬂuoroquinolones are bactericidal agents frequently
used in the treatment of respiratory tract infections. Here, we
compared the killing kinetics of moxiﬂoxacin (MXF), gatiﬂoxacin
(GAT), garenoxacin, (GAR) and levoﬂoxacin (LEV), against ﬂuoro-
quinolone susceptible and resistant Streptococcus pneumoniae (Sp)
at achievable serum concentrations.
Methods: Fifteen strains of Sp., ﬁve ﬂuoroquinolone (FQ) suscept-
ible, six parC mutants (low level FQ resistance) and four parC/
gyrA mutants (high level FQ resistance) were evaluated for their
bactericidal activity in Mueller–Hinton broth supplemented with
5% lysed horse blood. Cultures were inoculated at a density of
1  106 CFU/mL, incubated at 35C, and examined for viable
growth at 0, 1, 2, 4, 6, 12, and 24 h after exposure to the test
antibiotic at concentrations simulating Cmax or 1/2Cmax. Serum
concentrations of MXF, GAT, GAR, LEV (500 mg), and LEV
(750 mg), adjusted for protein binding, were 1.75, 3.2, 1.75, 3.7,
and 5.8 lg/mL. Protein binding of MXF, GAT, GAR, and LEV
were taken to be 50, 20, 75, and 30%. PCR was used to amplify
parC and gyrA and mutations were detected by DNA sequen-
cing.
Results: All ﬂuoroquinolones were highly bactericidal against sus-
ceptible strains of S. pneumoniae at both Cmax and 1/2Cmax con-
centrations. Typically, a 3-log drop in CFU was observed at 4–6 h
and complete eradication was achieved at 12 h. For parC mutants,
MXF and GAR consistently achieved complete bactericidal eradi-
cation in 12 h at Cmax and 12–24 h at 1/2Cmax. Regrowth was
observed in two of six strains exposed to LEV(500) and one strain
exposed to GAT at Cmax. DNA sequencing revealed the selection
of a gyrA mutation in each strain. At 1/2Cmax, regrowth was
observed in two strains with LEV(500) and one strain with
LEV(750). In high level FQ resistant parC/gyrA strains MXF and
GAR achieved a 3 log kill in two strains and were bacteriostatic
in two strains at Cmax. At 1/2Cmax, MXF and GAR were bac-
teriostatic. LEV and GAT had growth characteristics comparable
with the growth control at both Cmax and 1/2Cmax concentra-
tions.
Conclusions: All the ﬂuoroquinolones are extremely active against
susceptible S. pneumoniae. Superior killing kinetics were observed
with the MXF, GAT, and GAR compared with LEV against low
level (parC) ﬂuoroquinolone resistant S. pneumoniae. Only MXF
and GAR achieved bactericidal activity against high level (parC/
gyrA) ﬂuoroquinolone resistant S. pneumoniae.
P1704 Comparative in vitro activity of ﬂuoroquinolones
against clinical isolates of Streptococcus pneumoniae
R. Alonso, R. Cisterna
Vitoria-Gasteiz, Bilbao, E
Objectives: Fluoroquinolones are recommended for the treatment
of community-acquired pneumonia because increasing multidrug
resistance in Streptococcus pneumoniae. The incidence of ﬂuoroqui-
nolone resistance in clinical isolates of S. pneumoniae is relatively
low. The purpose of this study was to determine the local ﬂuoro-
quinolone susceptibility of S. pneumoniae.
Methods: Ninety-ﬁve nonduplicate, clinical isolates of S. pneu-
moniae were collected from January to November 2003 at Basurto
Hospital in Bilbao. Agar dilution MICs were determined for levo-
ﬂoxacin (Lev), sparﬂoxacin (Spx), gatiﬂoxacin (Gat), moxiﬂoxacin
(Mox), and gemiﬂoxacin (Gem) using Mueller–Hinton agar with
5% horse blood. Isolates were examined for evidence of efﬂux
mechanism by determining MICs to ciproﬂoxacin (Cip) in the
presence and absence of reserpine (10 mg/L).
Results: The MIC distribution, in mg/L, of the 95 strains is sum-
marised in the Table. The MIC90 of ciproﬂoxacin, levoﬂoxacin,
Year (% isolates NS)
Antimicrobial 1996 1997 1998 1999 2000 2001 2002
Ciproﬂoxacin 0.76 1.81 1.78 1.63 1.41 2.39 2.68
Levoﬂoxacin 0.24 0.71 0.34 0.47 0.97 1.42 2.17
Moxiﬂoxacin 0 0.51 0.21 0.38 0.92 1.01 1.38
Gatiﬂoxilin 0.28 0.51 0.27 0.38 0.92 1.24 1.96
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sparﬂoxacin, gatiﬂoxacin, moxiﬂoxacin, and gemiﬂoxacin was (in
mg/L): 2, 1, 0.5, 0.5, 0.25 and 0.06, respectively. Of the four
S. pneumoniae isolates with ciproﬂoxacin MIC25 !Y´ 4 mg/L, three iso-
lates showed a a fourfold or greater decrease in the ciproﬂoxacin
MIC in the presence of reserpine. The fourth ciproﬂoxacin-resist-
ant isolate was uniformly resistant to levoﬂoxacin, sparﬂoxacin,
gatiﬂoxacin, moxiﬂoxacin, and gemiﬂoxacin.
Conclusions: Overall, the data indicated that all the ﬂuoroquinolo-
nes are a valuable compounds for the treatment of S. pneumoniae
infections. Of the ﬂuoroquinolone tested, gemiﬂoxacin was the
most active agent.
P1705 The relationship between the mutant prevention
concentration and killing by ciproﬂoxacin and levoﬂoxacin for
clinical isolates of Pseudomonas aeruginosa
J. Blondeau, G. Hansen
Saskatoon, CAN
Objectives: Resistant subpopulations are recovered from large sus-
ceptible cultures when exposed to the MIC. For ﬂuoroquinolones
(FQ) the mutant prevention concentration (MPC) represents a
threshold required to inhibit resistant ﬁrst-step resistant mutant
present when 10 (10) cells are tested. We tested two strains of
Pseudomonas aeruginosa (PA) using MPC-based experiments at
MIC and MPC concentrations to determine the killing of PA by
ciproﬂoxacin (C) and levoﬂoxacin (L).
Method: For each experiment, cultures were grown to late log
phase, centrifuged and resuspended in 4 mL of Mueller–Hinton
broth and 1-mL aliquots were transferred into four ﬂasks contain-
ing 500 mL of broth and MIC or MPC drug concentrations.
Growth was sampled over 24 h on drug-free media and plates
containing 2 and 4 lg/mL of C and L.
Results: For strain 1 at MIC, 0.1 to 0.74 log reduction (LR)
was seen for C and L at 4 h. All cultures demonstrated re-
growth by 10 h. A +0.52 to +1.11 log regrowth was seen for all
cultures sampled at 24 h. Mutant growth was observed for four
cultures at all times tested. At MPC, 1.96 to 2.74 and 3 LR
occurred by 2 h and 8 h. At 24 h 5 to 6 log reduction was
observed. No mutant growth was seen with any C treated cul-
ture beyond 2 h. No mutant growth was seen with L at 24 h.
For strain 2 at MIC 1.69 to 2.3 LR was seen by 6 h. At 24 h
no growth reduction was observed. Mutant growth was
observed beyond 10h for all cultures tested. At the MPC 2 LR
was observed for all cultures by 2 h. At 24 h 4.5 to 6.3 LR
was observed. No mutant growth was observed with any cul-
ture after 2 h. At the MIC concentration +5 logs of mutant
growth was seen at 24 h.
Conclusions: MIC concentrations do not inhibit ﬁrst-step resistant
FQ resistant mutants present in large wild-type susceptible bacter-
ial cultures. Mutant subpopulations proliferate at the MIC. MPC
treated cultures resulted in rapid bactericidal killing of both wild
type and resistant cells. No mutant growth was seen at 24 h in
any MPC treated culture.
P1706 Activity of moxiﬂoxacin against 12 selected clinical
B. fragilis strains compared with seven other agents investigated
by time-kill kinetics
R. Schaumann, E. Rabenhorst, M. Funke, A. Rodloff
Leipzig, D
Objectives: The aim of the present study was to assess in vitro the
killing activity of moxiﬂoxacin, garenoxacin, gatiﬂoxacin, levoﬂ-
oxacin, clindamycin, imipenem, piperacillin/tazobactam, and met-
ronidazole against 12 selected clinical B. fragilis strains.
Methods: MIC values were determined by E-test for all strains and
antibiotics. The killing activity of the various antimicrobials was
assessed in vitro employing concentrations of 1/2, 1, 2, and 4
MIC established in 2.5 mL of appropriately supplemented Brucel-
la broth and a ﬁnal inoculum of approximately 1.5  107 CFU/
mL. At 0, 2, 4, 6, 12, and 24 h after incubation aliquots were
obtained and plated. After appropriate incubation CFU were
counted. All experiments were carried out in an anaerobic
chamber.
Results: MIC ranges (mg/L) were: moxiﬂoxacin, 0.25 to >32;
garenoxacin, 0.125–8; gatiﬂoxacin, 0.5 to >32; levoﬂoxacin, 0.75 to
>32; clindamycin, 0.03 to >256; imipenem, 0.125 to >32; piperacil-
lin/tazobactam, 0.125 to >256; metronidazole, 0.25 to >256. Moxiﬂ-
oxacin was bactericidal against most of the strains investigated
after 24 h of incubation at 2–4 MIC. All other antimicrobial
agents except clindamycin also showed bactericidal activity
against most of the strains investigated.
Conclusions: The bactericidal activity of moxiﬂoxacin against selec-
ted B. fragilis strains shown in this study warrants further investi-
gation into the use of moxiﬂoxacin as an agent to treat anaerobic
and aerobic/anaerobic mixed infections, respectively.
P1707 Selection of resistance in Pseudomonas
aeruginosa and Acinetobacter spp. by levoﬂoxacin and
ciproﬂoxacin alone and in combination with b-lactams and
an aminoglycoside
E. De Vecchi, L. Drago, L. Nicola, A. Colombo, M.R. Gismondo
Milan, I
Objectives: To evaluate the ability of levoﬂoxacin (LVX) and
ciproﬂoxacin (CIP) alone and in combination with ceftazidime
(CAZ), cefepime (CPM), imipenem (IMI), piperacillin/tazobactam
(PTZ) and amikacin (AMK) to select resistant mutants of Pseudo-
monas aeruginosa and Acinetobacter spp.
Methods: Clinical strains of P. aeruginosa (n ¼ 5) and Acinetobacter
spp. (n ¼ 5) susceptible to the drugs used in the study were
assayed. MICs were determined by the broth microdilution tech-
nique before and after ﬁve serial passages on agar plates contain-
ing a gradient from 0 to a chosen maximum of each antibiotic
alone or of LVX or CIP plus a b-lactam or AMK. Data were
expressed as ratio between the ﬁnal MIC value and the starting
one. For antimicrobial combinations, values obtained by a check-
erboard assay were considered as the initial MIC. Moreover, the
frequency rate of mutations induced by antibiotic concentrations
equal to the resistance breakpoints were calculated for each antibi-
otic alone and in combination.
Results: The medians of ratio between MICs of single antibiotics
were: 256 for AMK, 128 for CAZ, 64 for LVX, 32 for CIP, IMI, and
PTZ and 16 for CPM, thus generally giving MIC values above the
established breakpoints for resistance. When antimicrobial combi-
nations were used, the median of ratios ranged from 8 to 64 for
LVX and from 4 to 32 for CIP. For Acinetobacter spp., medians of
MIC ratios were 512 for LVX, 64 for CIP and PTZ, 32 for CPM,
eight for IMI and four for AMK and CAZ. Medians of MIC ratios
for combinations ranged from 8 to 128 for LVX and from 2 to 8
for CIP. When compared with the NCCLS breakpoints for resist-
ance a notable decrease in selecting resistant strains was observed
for combinations in respect to single antibiotic, with no strain
found resistant to LVX and CIP after serial passages. Similar
CMI(mg/L)
Agent 0.015 0.03 0.06 0.12 0.25 0.5 1 2 4 8 16
Cip 16 53 22 3 1
Lev 1 30 61 2 1
Spx 12 63 19 1
Gat 21 56 17 1
Mox 16 58 20 1
Gem 7 49 37 1 1
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results were observed for Acinetobacter spp., where one LVX-
resistant strain was selected by LVX + IMI and one CIP-resistant
strain was selected by combination of CIP with AMK, IMI, CAZ,
and CPM. Frequencies of mutations were higher for antibiotics
alone than for combinations. Combinations giving the highest
rates were CIP + AMK and CIP + PTZ, for which the frequency
of mutations for P. aeruginosa was 2  108 .
Conclusion: Use of combinations of ﬂuoroquinolones with b-lac-
tams and amikacin reduces the risk for in vitro selection of resist-
ant P. aeruginosa and Acinetobacter spp.
P1708 Mutant prevention concentrations of ciproﬂoxacin
and enroﬂoxacin against Salmonella enterica in vitro
L. Randall, S. Cooles, M. Woodward
New Haw, UK
Objectives: Fluoroquinolones are the antibiotics of choice for
treating human cases of salmonellosis, but strains can rapidly
become resistant, mainly via mutations in gyrA. The mutant
prevention concentration (MPC) has been deﬁned as the lowest
concentration of antibiotic to inhibit the emergence of mutants
from 1010 CFU. Previous workers have hypothesised that the
MPC as determined in vitro should minimise the emergence of
resistance in vivo. The aim of this study was to investigate the
mutant prevention concentrations of ciproﬂoxacin and enroﬂoxa-
cin in vitro against a panel of Salmonella enterica. The panel
included the following types: (i) fully antibiotic sensitive strains,
(ii) laboratory generated MAR phenotype mutants (cyclohexane
resistant and c. fourfold increase in resistance to unrelated anti-
biotics such as, b-lactams, chloramphenicol quinolones and tetra-
cycline), (iii) wild type MAR phenotype strains, (iv) gyrA
mutants and (v) gyrA mutants with the MAR phenotype of Sal-
monella enteritidis (n ¼ 5) and Typhimurium (n ¼ 5). Methods.
MICs were determined by the BSAC agar dilution method.
MPCs were determined by applying 1010 CFU of respective
strains to serially diluted antibiotic containing plates that were
incubated at 37C for 24 and 48 h. The MPC was recorded as
the lowest concentration of antibiotic to prevent the emergence
of any mutants at 24 h. Results. The MICs, MPCs and MPC/
MIC ratios for ciproﬂoxacin and enroﬂoxacin for the different
groups of Salmonella are shown in Table 1. All MPC/MIC ratios
for strains excluding MAR phenotype mutants without muta-
tions in gyrA were in the range 2–16. The MPC/MIC ratios for
the MAR phenotype mutants without mutation in gyrA were in
the range 2–64.
Conclusions: It was of interest to note that the MAR phenotype
mutants which lacked mutations in gyrA tended to have higher
MPC/MIC ratios than the other strains. Based on an MPC of 16
times the MIC, in vivo levels of 0.5 lg/mL of ciproﬂoxacin or en-
roﬂoxacin should be sufﬁcient to prevent the development of
ﬂuoroquinolone resistance in fully sensitive Salmonella strains.
P1709 Comparative in vitro resistance of the new
ﬂuoroquinolones among aerobic Gram-negative bacilli-resistant
to amikacin in a hospital setting: a 3-year study
E. Arroyo, D. Vera, C. Rivera-Vazquez, G. Gonzalez, S. Saavedra,
J. Gutierrez, C. Ramirez-Ronda
San Juan, PR
Objective: To assess the rate of resistance to ﬂuoroquinolones in
aerobic Gram-negative bacilli (GNB) that is resistant to amikacin
and to determine if the ﬂuoroquinolone resistance has increased
overtime with the use of this new medications.
Methods: From January 2000 to December 2002 aerobic GNB isolates
resistant to amikacin at the San Juan VAMC were prospectively col-
lected and tested for suceptibility to three ﬂuoroquinolones (levoﬂ-
oxacin, gatiﬂoxacin and moxiﬂoxacin). Percentage of resistance was
calculated per year of study and changes in resistance overtime
were evaluated with Chi-Square test.
Results: Fluoroquinolones resistance was analysed for the following
bacterias: P. aeruginosa, E. coli, Klebsiella, Enterobacter, Citrobacter, Ser-
ratia, P. mirabillis, Morganella and Proteus. E. coli overall resistance
was signiﬁcantly higher to moxiﬂoxacin (55.9%), gatiﬂoxacin
(55.9%) and levoﬂoxacin (52.3%). P. mirabilis was more susceptible
to levoﬂoxacin (16.8%resistance) than to the other quinolones (ga-
tiﬂoxacin 21.4%, moxiﬂoxacin 26.9%). P. aeruginosa showed a very
high resistance to levoﬂoxacin (69.5%), moxiﬂoxacin (77.5%) and
gatiﬂoxacin (72.9%). Isolates of Klebsiella sp. had lower resistance to
levoﬂoxacin (19.4%) and gatiﬂoxacin (18.8%) than to moxiﬂoxacin
with resistance of 29.6%. Serratia isolates were signiﬁcantly more
susceptible to levoﬂoxacin with only 7.0% resistance. The other
quinolones showed higher resistance to Serratia with gatiﬂoxacin
(15.0%)and moxiﬂoxacin (20.7%). E. coli and P. mirabilis showed a
statistically signiﬁcant increase in resistance overtime to all three
ﬂuoroquinolones. Resistance to Citrobacter, Enterobacter, Morganella
and Providencia remained unchanged through years on study.
Conclusions: The resistance to amikacin among GNB in our hospital
setting has required the use of alternative drugs. The new quinolones
have been used as an alternative in patients with resistance to amino-
glycosides but also emergence and evolution of quinolones resistance
has affected their use over the years. In our study this was noticed
especially on E. coli and P. mirabilis with a signiﬁcant increase in
resistance overtime. Some species including E. coli, P. aeruginosa, and
Providencia showed high resistance (>50%) to the three quinolones
tested. Species like Serratia, Klebsiella and Proteus had lower resistance
so in this species the use of quinolones could be a useful alternative.
P1710 Baselining levoﬂoxacin activity against
Gram-negative organisms collected in ﬁve European countries:
ﬁrst results from the 2003 GLOBAL Surveillance
M. Jones, R. Blosser, J. Karlowsky, D. Sahm
Herndon, USA
Background: Gram-negative organisms are common aetiological
agents in infections among inpatients and outpatients including com-
plicated (cUTI) and uncomplicated (uUTI) urinary tract, bloodstream,
and respiratory infections. Fluoroquinolones such as levoﬂoxacin
(LEV) provide an important therapeutic option to treat patients with
Gram-negative infections. The GLOBAL Surveillance 2003 surveyed
antimicrobial susceptibility among Gram-negative pathogens in ﬁve
European countries to obtain a current perspective of susceptibility
and enable future tracking of changes in susceptibility that may occur.
Methods: A total of 2430 Gram-negative isolates were isolated
from patient specimens (cUTI, uUTI, blood and respiratory) at
hospital laboratories in ﬁve European countries (Belgium, France,
Germany, Italy and Spain). Isolates were centrally tested by
NCCLS broth microdilution (M7-A6, 2003) against LEV and rele-
vant clinical comparator agents for each infection site. MICs were
interpreted as susceptible (S), intermediate, or resistant using the
NCCLS published interpretive criteria (M100-S13, 2003).
Results: Overall among Enterobacteriaceae (EB) collected from UTI,
LEV showed consistent activity with 75.0–92.8% S among isolates






MIClg/mL for- MPClg/mL(x MIC)for-
Ciproﬂoxacin Enroﬂoxacin Ciproﬂoxacin Enroﬂoaxin
Sensitive 2 0.03 0.03 0.5(16)
MAR laba 2 0.13 0.06–0.13
MAR WTb 2 0.13–0.25 0.13–0.25
gyrA 2 0.5 0.5
gyrA+MAR WT 2 0.5–2 1.2
aMAR phenotype strains generated in the laboratory by
passage with chloramphenicol or tetracycline.
bWild type strains with a MAR phenotype.
cgyrA +, strains with a mutation in gyrA.
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collected from cUTI and 69.6–97.6% S among isolates collected from
uUTI. Escherichia coli, the most common EB isolate causing cUTI,
showed regional variation with >80% S in Belgium, France and Italy,
76.3% S in Germany and 61.3% S in Spain. Among Klebsiella spp. from
cUTI, LEV S was 88.9% in Belgium, 87.5% in France, and 91.3–97.7%
in Germany, Italy, and Spain. LEV activity against Pseudomonas aerugi-
nosa ranged from 47.3% S among isolates from cUTI to 69.6% S among
isolates from uUTI. LEV S among EB isolates collected from blood-
stream infections ranged from 79.7% among Enterobacter spp. to 95.8%
among Proteus mirabilis. LEV showed potent activity against EB collec-
ted from respiratory sources with a range of 82.6% S among E. coli to
100% S among Enterobacter spp., with limited geographic variation.
Conclusions: Overall LEV was active against all EB tested, irres-
pective of the specimen source. The longitudinal tracking of anti-
microbial susceptibility through initiatives such as the GLOBAL
Surveillance is important to identify changing trends and help
guide antimicrobial use.
P1711 In vitro activity of three different ﬂuorquinolones
alone, or in combination against Pseudomonas aeruginosa
J. Parra, A. Pen˜a, T. Escobar, M. Martinez, N. Chueca,
M.-A. Martinez, G. Pie´drola, J. Herna´ndez-Quero
Granada, E
Introduction: Ciproﬂoxacin is usually perceived to have the great-
est activity against Pseudomonas. aeruginosa, however, other ﬂuoro-
quinolones also possess in vitro activity against this pathogen and
levoﬂoxacin has recently been reported as having, at least, the
same activity as ciproﬂoxacin. Owing to its high-level resistance
to many antimicrobials and, because of its ability to develop
resistance during therapy, the existence of other therapeutic
options, alone or in combination, is worthy.
Objectives and methods: The purpose of this study was to evaluate
the in vitro activities of different ﬂuoroquinolones (ciproﬂoxacin,
levoﬂoxacin, and moxiﬂoxacin) against P. aeruginosa isolates and
to compare the synergic effects of these ﬂuorquinolones in combi-
nation with other potent antipseudomonal agents (aminoglyco-
sides, ceftazidime and piperacillin-tazobactam). MICs were
performed on 150 isolates of P. aeruginosa obtained from the Clin-
ical Microbiology Laboratory of our Hospital. MICs of the ﬂuor-
quinolones were determined by Etest, and the synergistic effect
by a dilution method according to the NCCLS recommendations.
Resusts: We did not ﬁnd any statistically difference in the activity
against the clinical isolates of P. aeruginosa among ciproﬂoxacin
and levoﬂoxacin (69% of strains showed susceptibility to ciproﬂ-
oxacin vs. 68% to levoﬂoxacin). Moxiﬂoxacin was the less active
ﬂuorquinolone (58% of strains were susceptible to moxiﬂoxacin).
Isolates obtained at ICU showed the highest rate of resistance. Ci-
proﬂoxacin, levoﬂoxacin and moxiﬂoxacin all demonstrated
equivalent synergic effects against P. aeruginosa in vitro.
Conclusions: No signiﬁcant differences were found in rates of sus-
ceptibility of P. aeruginosa to ciproﬂoxacin and levoﬂoxacin. Both
ﬂuorquinolones and moxiﬂoxacin showed to have synergic activ-
ity against P. aeruginosa when tested in combicnation with other
antipseudomonal agents.
P1712 Effect of quinolones on Plesiomonas shigelloides
A. Hostacka, I. Ciznar, R. Melkova, K. Krovacek
Bratislava, SK; Uppsala, S
Objectives: Plesiomonas shigelloides is recognised as one of the mem-
bers among the expanding group of water and foodborne pathogens.
In the presented study the effect of subinhibitory concentrations (sub-
MICs) (1/4, 1/8, 1/16 of the MICs) of ﬁve quinolone antibiotics
(enoxacin, ciproﬂoxacin, norﬂoxacin, oﬂoxacin, peﬂoxacin) on two
P. shigelloides strains (H-human, W-surface water) was studied. It has
been known that sub-MICs of antibiotics do not kill bacteria however
they may have impact on their pathogenic potential.
Methods: The properties associated with putative pathogenic fac-
tors of this species were evaluated in vitro using tests for hydro-
phobicity, motility, lipase activity, sensitivity to hydrogen
peroxide and quorum sensing.
Results: Quinolones reduced hydrophobicity demonstrated by
adherence of bacteria to xylene at all sub-MICs tested in strain H
(with the exception of enoxacin at 1/8 and 1/16 of the MIC) and at
two sub-MICs (1/4 and 1/8 of the MICs) in strainW (with the excep-
tion of norﬂoxacin at 1/8 of the MIC). The strains after effect of some
quinolones changed surface hydrophobicity towards the hydrophi-
lic state. Motility of the strains treated with quinolones was in the
majority of cases enhanced. Only ciproﬂoxacin and norﬂoxacin at 1/
8 and 1/16 of the MICs in strain H and norﬂoxacin at 1/4 of the MIC
in strain W reduced motility. Lipolytic activity of antibiotic treated
strains was only slightly modiﬁed. Quinolones increased sensitivity
of P. shigelloides to hydrogen peroxide with the exception of enoxacin
and oﬂoxacin at all sub-MICs in strain H and norﬂoxacin (all sub-
MICs) and ciproﬂoxacin (one sub-MIC) in strain W. The tested
strains did not possess short chained acylated homoserine lactones
(AHLs) and quinolones did not evoke their production.
Conclusions: The experiments indicate that sub-MICs of quinolo-
nes modiﬁed putative virulence factors of P. shigelloides. The ques-
tion of pathogenetic relevance of the modiﬁcations of bacteria
after treatment with quinolones deserves further studies.
P1713 Comparitive in vitro activities of ciproﬂoxacin,
oﬂoxacin and levoﬂoxacin against nonfermentative bacteria
isolated from nosocomial infections
F. Ergin, H. Arslan, O. Kurt Azap, S. Karaman, G. Yapar
Ankara, TR
Objective: To compare the in vitro activities of new broad spec-
trum (levoﬂoxacin, LEV) and previously developed (ciproﬂoxacin
CIP, oﬂoxacin OFX) quinolones against clinical isolates of nonfer-
mentative bacteria.
Materials and methods: A total of 228 nonfermentative bacteria (107
P. aeruginosa, 86 A. baumanii, 26 S. maltophila, nine B. cepecia) recov-
ered from clinical isolates between January 2001 to January 2002
were studied. All isolates were identiﬁed by standart methods and
kept frozen at 20C until use. Antibiotic powders were provided
by their respective manufacturers (CIP Bayer, OFX and LEV Aven-
tis). MICs were determined by agar-dilution method on Muller–
Hinton agar and results were interpreted according to the recom-
mendations of NCCLS. Control strains were P. aeruginosa ATCC
27853 and E. coli ATCC 25922. MIC50 and MIC90 values are sum-
marised in Table 1.
Results: CIP was the most active compound tested againts P. aeru-
ginosa, while levoﬂoxacin and oﬂoxacin showed the best in vitro
activity against S. maltophilia and B. cepecia. We also found high
MIC values for all quinolones tested against A. baumanii.
Conclusions: The nonfermenters are usually resistant to acceptable
doses of many antibiotics. So the nosocomial infections caused by
these bacteria are frequently difﬁcult to treat. According to our
results CIP is still the most effective quinolone against P. aerugi-
nosa . Levoﬂoxacin and oﬂoxacin could become therapeutic
options for treating infections due to S. maltophilia and B. cepecia.
Table 1. MIC 50 and MIC 90 values of non-fermentataives bacteria
MIC(mg/L)
Bacteria(n) Antibiotic MIC 50 MIC 90 Range Susceptibility %
P. aeruginosa(107) CIP 0.25 16 <0.25–>16 74
OFX 1 32 <0.5–>32 47
LEV 1 32 <0.5–>32 73
A. baumanii(86) CIP 16 16 0.25–>32 8
OFX 8 16 <0.5–>32 8
LEV 16 32 <0.5–>32 9
S. maltophilia(26) CIP 2 4 1–>16 12
OFX 1 1 1–>32 96
LEV 1 4 1–>32 81
B. cepecia(9) CIP 2 16 1–>16 22
OFX 2 8 <0.5–8 89
LEV 4 32 1–32 11
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